,project_id,fiscal_year,report_title,principal_investigator,supervisor,research_org,lab_staff_within_org,extramural_collab,collab_other_NCI,collab_other_NIH,publications,url
0,BC000155-16,"October 01, 2005 -  September 30, 2006",The Effect of Phytochemicals on Biochemical Mechanisms Relevant to Carcinogenesi,Grace  Yeh; PhD,NULL,"Laboratory of Metabolism, NCI","Christopher J Macdonald



Sara  Bass



Pawel  Sienkiewicz



Yuk Sing Robert Cheng",NULL,"Terry  Moody; PhD (Experimental Biochemistry Sect)



Laurie  Zipper (National Cancer Institute)



David Anderson Wink (National Cancer Institute)



Miriam Christine Poirier; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Ciolino HP, MacDonald CJ, Memon OS, Bass SE, Yeh GC (2006). Sulindac regulates the aryl hydrocarbon receptor-mediated expression of Phase 1 metabolic enzymes in vivo and in vitro. Carcinogenesis  27, 1586-92.   https://doi.org/10.1093/carcin/bgi359




PubMed


 


PubMed ID 16531450",https://intramural.nih.gov/search/searchview.taf?ipid=43558
1,BC000189-13,"October 01, 2005 -  September 30, 2006",Dietary Regulation of BiochemicalMolecular Changes in Carcinogen Resistant Cells,Grace  Yeh; PhD,NULL,"Laboratory of Metabolism, NCI","Christopher J Macdonald



Sara  Bass



Pawel  Sienkiewicz



Yuk Sing Robert Cheng","Henry  Ciolino; PhD
(NCI)




Paul  Hergenrother
(Chemistry, University of Illinois)




S.  King
(Chemistry, Wake Forest University)




Edward  Sausville
(University of Maryland)




Keith  Singletary
(Department of Food Science and Human Nutrition, University of Illinois)",NULL,NULL,"Ordered by publication type and then author name.



1.
Dennis PA, Van Waes C, Gutkind JS, Kellar KJ, Vinson C, Mukhin AG, Spitz MR, Bailey-Wilson JE, Yeh GC, Anderson LM, Wiest JS (2005). The biology of tobacco and nicotine: bench to bedside. Cancer Epidemiol Biomarkers Prev  14, 764-7.   https://doi.org/10.1158/1055-9965.EPI-04-0652




PubMed



        
     
Free Article


 


PubMed ID 15824140
         Pubmed Central ID 3459058",https://intramural.nih.gov/search/searchview.taf?ipid=43560
2,BC003229-36,"October 01, 2005 -  September 30, 2006",T-Cell Antigen Recognition and Tumor Antigens,"Ettore  Appella; MD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Marco L Schito



Hiroshi  Yamaguchi","Esteban  Celis





Edward  Collins
(Dept. of Biochemistry and Biophysics, Univ. of North Carolina, Chapel Hill)




Albert  DeLeo
(Cancer Institute, Univ. of Pittsburgh)




Benjamin  Wizel-Cohen
(Health Center at Tyler, Univ. of Texas)",Jonathan D Ashwell; MD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Houtman JC, Yamaguchi H, Barda-Saad M, Braiman A, Bowden B, Appella E, Schuck P, Samelson LE (2006). Oligomerization of signaling complexes by the multipoint binding of GRB2 to both LAT and SOS1. Nat Struct Mol Biol  13, 798-805.   https://doi.org/10.1038/nsmb1133




PubMed


 


PubMed ID 16906159
    
     


 



2.
Schito ML, Demidov ON, Saito S, Ashwell JD, Appella E (2006). Wip1 phosphatase-deficient mice exhibit defective T cell maturation due to sustained p53 activation. J Immunol  176, 4818-25.   https://doi.org/10.4049/jimmunol.176.8.4818




PubMed


 


PubMed ID 16585576",https://intramural.nih.gov/search/searchview.taf?ipid=43561
3,BC004496-29,"October 01, 2005 -  September 30, 2006",Chromosomal Proteins and Chromosomal Functions,"Michael  Bustin; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI","Takashi  Furusawa



Yuri  Postnikov; MD, PhD



Eyal  Rand



Srujana  Cherukuri



Galina Ivanovna Belova



Gabi  Gerlitz



Show all 8","Marco  Bianchi
(NA, DIBIT)




Melinda K Duncan; PhD
(Biological Sciences, The University of Delaware)




Robert  Hock
(Wuerzburg U)




karolin  Luger
(Biochemsitry, Univ. of Colorado)




Leon  Mullenders
(Radiation Genetics, University of Leiden)




Yosef  Shiloh
(Tel Aviv University)


Show all 7","Andre A Nussenzweig; PhD (National Cancer Institute)



Yves  Pommier; PhD (National Cancer Institute)



Kenneth H Kraemer; MD (National Cancer Institute)",Yong-Chul  Kim (NIDDK),"Ordered by publication type and then author name.



1.
Birger Y, Davis J, Furusawa T, Rand E, Piatigorsky J, Bustin M (2006). A role for chromosomal protein HMGN1 in corneal maturation. Differentiation  74, 19-29.   https://doi.org/10.1111/j.1432-0436.2006.00054.x




PubMed



        
     
Free Article


 


PubMed ID 16466397
         Pubmed Central ID 3730489 


 



2.
Catez F, Ueda T, Bustin M (2006). Determinants of histone H1 mobility and chromatin binding in living cells. Nat Struct Mol Biol  13, 305-10.   https://doi.org/10.1038/nsmb1077




PubMed



        
     
Free Article


 


PubMed ID 16715048
         Pubmed Central ID 3730444 


 



3.
Furusawa T, Lim JH, Catez F, Birger Y, Mackem S, Bustin M (2006). Down-regulation of nucleosomal binding protein HMGN1 expression during embryogenesis modulates Sox9 expression in chondrocytes. Mol Cell Biol  26, 592-604.   https://doi.org/10.1128/MCB.26.2.592-604.2006




PubMed



        
     
Free Article


 


PubMed ID 16382150
         Pubmed Central ID 1346905 


 



4.
Rubinstein YR, Furusawa T, Lim JH, Postnikov YV, West KL, Birger Y, Lee S, Nguyen P, Trepel JB, Bustin M (2005). Chromosomal protein HMGN1 modulates the expression of N-cadherin. FEBS J  272, 5853-63.   https://doi.org/10.1111/j.1742-4658.2005.04980.x




PubMed



        
     
Free Article


 


PubMed ID 16279949
         Pubmed Central ID 3730465 


 



5.
Ueda T, Postnikov YV, Bustin M (2006). Distinct domains in high mobility group N variants modulate specific chromatin modifications. J Biol Chem  281, 10182-7.   https://doi.org/10.1074/jbc.M600821200




PubMed


 


PubMed ID 16484217
    
     


 



6.
Yang D, Chen Q, Yang H, Tracey KJ, Bustin M, Oppenheim JJ (2007). High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J Leukoc Biol  81, 59-66.   https://doi.org/10.1189/jlb.0306180




PubMed


 


PubMed ID 16966386",https://intramural.nih.gov/search/searchview.taf?ipid=43562
4,BC004504-34,"October 01, 2005 -  September 30, 2006",Alterations in Interacting Signaling Pathways that Initiate Squamous Carcinogene,"Stuart H Yuspa; MD



IRP Faculty Profile",NULL,"Laboratory of Cellular Carcinogenesis and Tumor Promotion, NCI","Andrew O Ryscavage



Joanna  Anders



Christophe  Cataisson



Christina K Cheng



Kwang Sun Suh



Ronald  Wolf



Show all 12","Jeffrey  Arbeit
(Surgery, Washington University)




Lena  Claesson-Welsh
(Genetics and Pathology, Uppsala University)




Robert  Eisenman
(Fred Hutchinson Cancer Research Center)




Saveria  Pastore
(Dermatology, Instituto Dermapatico del' Immaculata)




Jeffrey  Stock
(Biochemistry, Princeton University)




David  Threadgill; PhD
(Department of Genetics, University of North Carolina School of Medicine)","Paul  Goldsmith; PhD (National Cancer Institute)



Peter C Fitzgerald (National Cancer Institute)



Victor  Marquez; PhD (ORGANIC CHEMSTRY SECT)



Ola Mae Zack Howard (National Cancer Institute)



L Michelle Bennett; PhD (National Cancer Institute)","Jiliang  Gao (NIAID) 



Bijan  Ahvazi; PhD (NIAMS)","Ordered by publication type and then author name.



1.
Boeshans KM, Wolf R, Voscopoulos C, Gillette W, Esposito D, Mueser TC, Yuspa SH, Ahvazi B (2006). Purification, crystallization and preliminary X-ray diffraction of human S100A15. Acta Crystallogr Sect F Struct Biol Cryst Commun  62, 467-70.   https://doi.org/10.1107/S1744309106012838




PubMed



        
     
Free Article


 


PubMed ID 16682778
         Pubmed Central ID 2219979 


 



2.
Cataisson C, Pearson AJ, Tsien MZ, Mascia F, Gao JL, Pastore S, Yuspa SH (2006). CXCR2 ligands and G-CSF mediate PKCalpha-induced intraepidermal inflammation. J Clin Invest  116, 2757-66.   https://doi.org/10.1172/JCI27514




PubMed



        
     
Free Article


 


PubMed ID 16964312
         Pubmed Central ID 1560349 


 



3.
Li L, Sampat K, Hu N, Zakari J, Yuspa SH (2006). Protein kinase C negatively regulates Akt activity and modifies UVC-induced apoptosis in mouse keratinocytes. J Biol Chem  281, 3237-43.   https://doi.org/10.1074/jbc.M512167200




PubMed


 


PubMed ID 16338928
    
     


 



4.
Shiio Y, Suh KS, Lee H, Yuspa SH, Eisenman RN, Aebersold R (2006). Quantitative proteomic analysis of myc-induced apoptosis: a direct role for Myc induction of the mitochondrial chloride ion channel, mtCLIC/CLIC4. J Biol Chem  281, 2750-6.   https://doi.org/10.1074/jbc.M509349200




PubMed


 


PubMed ID 16316993
    
     


 



5.
Wolf R, Voscopoulos CJ, FitzGerald PC, Goldsmith P, Cataisson C, Gunsior M, Walz M, Ruzicka T, Yuspa SH (2006). The mouse S100A15 ortholog parallels genomic organization, structure, gene expression, and protein-processing pattern of the human S100A7/A15 subfamily during epidermal maturation. J Invest Dermatol  126, 1600-8.   https://doi.org/10.1038/sj.jid.5700210




PubMed


 


PubMed ID 16528363",https://intramural.nih.gov/search/searchview.taf?ipid=43563
5,BC004517-30,"October 01, 2005 -  September 30, 2006",DNA Repair in Human Cancer-Prone Genetic Diseases,"Kenneth H Kraemer; MD



IRP Faculty Profile",NULL,"Basic Research Laboratory, NCI","John  Digiovanna



Kyu-Seon  Oh



Jennifer  Boyle



Carine  Nadem



Jared Ravi Jagdeo



Tara  Rao","Douglas  Brash
(Neurology, Yale Univ)




Steffen  Emmert





Engin  Gozukara
(Biochemistry Department, Inönü University Medical School)




Yuko  Hirai
(Genetics, Radiation Effects Research Foundation)




N G  Jaspers
(Genetics, Erasmus Univ)




Allen  Lehmann
(Genome Damage and Stability Centre, Univ of Sussex)


Show all 11","Yun  Wang (Nucleic Acid NMR Section)



Carl C Baker; MD, PhD (Laboratory of Cellular Oncology)



Margaret Anne Tucker (National Cancer Institute)



Alisa  Goldstein; PhD (National Cancer Institute)



Thomas J Hornyak (National Cancer Institute)



Vincent J. Hearing; PhD (National Cancer Institute)","Raphael  Schiffmann; MD (NINDS) 



Ira W Levin; PhD (NIDDK) 



Nicholas  Patronas; MD (CC) 



Vilhelm A Bohr; MD, PhD (NIA) 



Brian Patrick Brooks; MD, PhD (NEI) 



Philip John Brooks; PhD (NIAAA)","Ordered by publication type and then author name.



1.
Emmert S, Wetzig T, Imoto K, Khan SG, Oh KS, Laspe P, Zachmann K, Simon JC, Kraemer KH (2006). A novel complex insertion/deletion mutation in the XPC DNA repair gene leads to skin cancer in an Iraqi family. J Invest Dermatol  126, 2542-4.   https://doi.org/10.1038/sj.jid.5700452




PubMed


 


PubMed ID 16794584
    
     


 



2.
Hirai Y, Kodama Y, Moriwaki S, Noda A, Cullings HM, Macphee DG, Kodama K, Mabuchi K, Kraemer KH, Land CE, Nakamura N (2006). Heterozygous individuals bearing a founder mutation in the XPA DNA repair gene comprise nearly 1% of the Japanese population. Mutat Res  601, 171-8.   https://doi.org/10.1016/j.mrfmmm.2006.06.010




PubMed


 


PubMed ID 16905156
    
     


 



3.
Liang C, Morris A, Schlücker S, Imoto K, Price VH, Menefee E, Wincovitch SM, Levin IW, Tamura D, Strehle KR, Kraemer KH, DiGiovanna JJ (2006). Structural and molecular hair abnormalities in trichothiodystrophy. J Invest Dermatol  126, 2210-6.   https://doi.org/10.1038/sj.jid.5700384




PubMed


 


PubMed ID 16728971
    
     


 



4.
Oh KS, Khan SG, Jaspers NG, Raams A, Ueda T, Lehmann A, Friedmann PS, Emmert S, Gratchev A, Lachlan K, Lucassan A, Baker CC, Kraemer KH (2006). Phenotypic heterogeneity in the XPB DNA helicase gene (ERCC3): xeroderma pigmentosum without and with Cockayne syndrome. Hum Mutat  27, 1092-103.   https://doi.org/10.1002/humu.20392




PubMed


 


PubMed ID 16947863
    
     


 



5.
Schlücker S, Liang C, Strehle KR, DiGiovanna JJ, Kraemer KH, Levin IW (2006). Conformational differences in protein disulfide linkages between normal hair and hair from subjects with trichothiodystrophy: a quantitative analysis by Raman microspectroscopy. Biopolymers  82, 615-22.   https://doi.org/10.1002/bip.20515




PubMed


 


PubMed ID 16557500",https://intramural.nih.gov/search/searchview.taf?ipid=43564
6,BC004582-31,"October 01, 2005 -  September 30, 2006",Mechanisms of Transition Metal-Induced Carcinogenesis,"Kazimierz S Kasprzak; PhD, DSc",NULL,"Laboratory of Comparative Carcinogenesis, NCI","Robert M Bare



Susan L North



Konstantin V Salnikow



Monika  Kaczmarek



Michael O Kayatta",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Kasprzak K   (2006) Nickel Toxicity and Carcinogenesis, in Metal Ions in Life Sciences: Nickel and Its Surprising Impact in Nature. Sigel A, Sigel H, Sigel R, eds., J. Wiley and Sons (Chichester, UK), in press.




 



2.
Kasprzak K   (2006) Nickel-Dependent Gene Expression, in Metal Ions in Life Sciences: Nickel and Its Surprising Impact in Nature. Sigel A, Sigel H, Sigel R, eds., J. Wiley and Sons (Chichester, UK), in press.




 



3.
Golebiowski F, Kasprzak KS (2005). Inhibition of core histones acetylation by carcinogenic nickel(II). Mol Cell Biochem  279, 133-9.   https://doi.org/10.1007/s11010-005-8285-1




PubMed


 


PubMed ID 16283522
    
     


 



4.
Kaczmarek P, Jezowska-Bojczuk M, Bal W, Kasprzak KS (2005). Determination of the stability constants and oxidation susceptibility of nickel(II) complexes with 2'-deoxyguanosine 5'-triphosphate and L-histidine. J Inorg Biochem  99, 737-46.   https://doi.org/10.1016/j.jinorgbio.2004.12.006




PubMed


 


PubMed ID 15708794
    
     


 



5.
Karaczyn A, Ivanov S, Reynolds M, Zhitkovich A, Kasprzak KS, Salnikow K (2006). Ascorbate depletion mediates up-regulation of hypoxia-associated proteins by cell density and nickel. J Cell Biochem  97, 1025-35.   https://doi.org/10.1002/jcb.20705




PubMed


 


PubMed ID 16288478
    
     


 



6.
Karaczyn AA, Golebiowski F, Kasprzak KS (2005). Truncation, deamidation, and oxidation of histone H2B in cells cultured with nickel(II). Chem Res Toxicol  18, 1934-42.   https://doi.org/10.1021/tx050122a




PubMed


 


PubMed ID 16359184
    
     


 



7.
Kasprzak K, Golebiowski F   (2006) Ni(II) affects ubiquitination of core histones H2B and H2A.  Exp Cell Res  3252-3259 pp.




 



8.
Kasprzak K, Kikawa K, Fields J, Maciag A, North S, Shiao Y, Anderson L   (2006) Effects of selenium supplementation on expression of glutathione peroxidase isoforms in cultured lung human adenocarcinoma cell lines.  Lung Cancer, in press.




 



9.
Kowara R, Karaczyn A, Cheng RY, Salnikow K, Kasprzak KS (2005). Microarray analysis of altered gene expression in murine fibroblasts transformed by nickel(II) to nickel(II)-resistant malignant phenotype. Toxicol Appl Pharmacol  205, 1-10.   https://doi.org/10.1016/j.taap.2004.10.006




PubMed


 


PubMed ID 15885260
    
     


 



10.
Pi J, He Y, Bortner C, Huang J, Liu J, Zhou T, Qu W, North SL, Kasprzak KS, Diwan BA, Chignell CF, Waalkes MP (2005). Low level, long-term inorganic arsenite exposure causes generalized resistance to apoptosis in cultured human keratinocytes: potential role in skin co-carcinogenesis. Int J Cancer  116, 20-6.   https://doi.org/10.1002/ijc.20990




PubMed


 


PubMed ID 15756686
    
     


 



11.
Salnikow K, Kasprzak KS (2005). Ascorbate depletion: a critical step in nickel carcinogenesis? Environ Health Perspect  113, 577-84.   https://doi.org/10.1289/ehp.7605




PubMed



        
     
Free Article


 


PubMed ID 15866766
         Pubmed Central ID 1257550 


 



12.
Topol IA, Nemukhin AV, Salnikow K, Cachau RE, Abashkin YG, Kasprzak KS, Burt SK (2006). Quantum chemical modeling of reaction mechanism for 2-oxoglutarate dependent enzymes: effect of substitution of iron by nickel and cobalt. J Phys Chem A  110, 4223-8.   https://doi.org/10.1021/jp055633k




PubMed


 


PubMed ID 16553373
    
     


 



13.
Waalkes MP, Liu J, Kasprzak KS, Diwan BA (2005). Metallothionein-I/II double knockout mice are no more sensitive to the carcinogenic effects of nickel subsulfide than wild-type mice. Int J Toxicol  24, 215-20.   https://doi.org/10.1080/10915810591000668




PubMed


 


PubMed ID 16126615
    
     


 



14.
Waalkes MP, Liu J, Kasprzak KS, Diwan BA (2006). Hypersusceptibility to cisplatin carcinogenicity in metallothionein-I/II double knockout mice: production of hepatocellular carcinoma at clinically relevant doses. Int J Cancer  119, 28-32.   https://doi.org/10.1002/ijc.21245




PubMed


 


PubMed ID 16432836",https://intramural.nih.gov/search/searchview.taf?ipid=43565
7,BC005051-03,"October 01, 2005 -  September 30, 2006",Signal Transduction Pathways of Transforming Growth Factor-beta,Anita B Roberts; PhD,NULL,"Laboratory of Cell Regulation and Carcinogenesis, NCI","Fang  Tian



Kathleen C Flanders; PhD



Arany  Praveen



Anil  Kumar



Christina  Stuelten",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43550
8,BC005093-28,"October 01, 2005 -  September 30, 2006",GrowthDifferentiation Factors in Organogenesis,Alan O Perantoni; PhD,NULL,"Laboratory of Comparative Carcinogenesis, NCI","Sergey  Plisov



Olga A Timofeeva



Honghe  Wang



Nirmala D Sharma



Yutaka  Ueda","Mark  de Caestecker
(Department of Medicine, Vanderbilt University)




Robert  Koesters","Terence P Yamaguchi; PhD (National Cancer Institute)



Gisela Esta Sterneck; PhD (National Cancer Institute)



Christopher J Michejda; PhD (National Cancer Institute)



Mark B Lewandoski (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Timofeeva OA, Plisov S, Evseev AA, Peng S, Jose-Kampfner M, Lovvorn HN, Dome JS, Perantoni AO (2006). Serine-phosphorylated STAT1 is a prosurvival factor in Wilms' tumor pathogenesis. Oncogene  25, 7555-64.   https://doi.org/10.1038/sj.onc.1209742




PubMed


 


PubMed ID 16799645",https://intramural.nih.gov/search/searchview.taf?ipid=43566
9,BC005148-27,"October 01, 2005 -  September 30, 2006",Mammary Tumorigenesis in Inbred and Feral Mice,Robert  Callahan; PhD,NULL,"Mammary Biology and Tumorigenesis Laboratory, NCI","Sharon A Bargo



David M Mccurdy



Ahmed M Raafat



Sahlah  Lawson



Marla I Hertz","Spyros  Artavanis-Tsakonas
(Developmental Biology and Cancer, Harvard Medical School)




Antonio  Marchetti
(Clinical Research Center, University of Chieti)




Robert  Rhoads
(LSU Shreveport)",NULL,NULL,"Ordered by publication type and then author name.



1.
Buttitta F, Martella C, Barassi F, Felicioni L, Salvatore S, Rosini S, D'Antuono T, Chella A, Mucilli F, Sacco R, Mezzetti A, Cuccurullo F, Callahan R, Marchetti A (2005). Int6 expression can predict survival in early-stage non-small cell lung cancer patients. Clin Cancer Res  11, 3198-204.   https://doi.org/10.1158/1078-0432.CCR-04-2308




PubMed


 


PubMed ID 15867213
    
     


 



2.
Lowther W, Wiley K, Smith GH, Callahan R (2005). A new common integration site, Int7, for the mouse mammary tumor virus in mouse mammary tumors identifies a gene whose product has furin-like and thrombospondin-like sequences. J Virol  79, 10093-6.   https://doi.org/10.1128/JVI.79.15.10093-10096.2005




PubMed



        
     
Free Article


 


PubMed ID 16014973
         Pubmed Central ID 1181551 


 



3.
Raafat A, Zoltan-Jones A, Strizzi L, Bargo S, Kimura K, Salomon D, Robert C   (2006) Kit and PDGFR-a activities are necessary for Notch4/Int3 induced tumorigenesis.  Oncogene, in press.




 



4.
Strizzi L, Bianco C, Raafat A, Abdallah W, Chang C, Raafat D, Hirota M, Hamada S, Sun Y, Normanno N, Callahan R, Hinck L, Salomon D (2005). Netrin-1 regulates invasion and migration of mouse mammary epithelial cells overexpressing Cripto-1 in vitro and in vivo. J Cell Sci  118, 4633-43.   https://doi.org/10.1242/jcs.02574




PubMed


 


PubMed ID 16176936
    
     


 



5.
Sun Y, Strizzi L, Raafat A, Hirota M, Bianco C, Feigenbaum L, Kenney N, Wechselberger C, Callahan R, Salomon DS (2005). Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis. Am J Pathol  167, 585-97.   https://doi.org/10.1016/S0002-9440(10)63000-3




PubMed



        
     
Free Article


 


PubMed ID 16049342
         Pubmed Central ID 1603555",https://intramural.nih.gov/search/searchview.taf?ipid=43567
10,BC005177-26,"October 01, 2005 -  September 30, 2006",Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA,Miriam Christine Poirier; PhD,NULL,"Laboratory of Cellular Carcinogenesis and Tumor Promotion, NCI","Ofelia  Olivero; PhD



M. Margaret  Pratt



Marie E Shockley","William  Baird
(Environmental and Molecular Toxicology, Oregon University)




Soterios  Kyrtopoulos
(National Hellenic Research Foundation, Institute of Biological Research and Biotechnology)




Allen  MacLean
(Obstetrics and Gynaecology, Royal Free and University of London Medical School)




David  Manchester
(Clinical Genetics and Metabolism, Children's Hospital, Denver)




Francis  Martin
(Biological Sciences, Lancaster University)




David  Phillips



Show all 11","Gene  Shearer; PhD (National Cancer Institute)



Sanford Martin Dawsey; MD (National Cancer Institute)



Mark  Schiffman; MD (National Cancer Institute)



Rashmi P Sinha; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Divi RL, Haverkos KJ, Humsi JA, Shockley ME, Thamire C, Nagashima K, Olivero OA, Poirier MC (2007). Morphological and molecular course of mitochondrial pathology in cultured human cells exposed long-term to Zidovudine. Environ Mol Mutagen  48, 179-89.   https://doi.org/10.1002/em.20245




PubMed


 


PubMed ID 16894629
    
     


 



2.
Divi RL, Leonard SL, Kuo MM, Nagashima K, Thamire C, St Claire MC, Wade NA, Walker VE, Poirier MC (2007). Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity. Environ Mol Mutagen  48, 201-9.   https://doi.org/10.1002/em.20201




PubMed


 


PubMed ID 16538687
    
     


 



3.
Divi RL, Leonard SL, Kuo MM, Walker BL, Orozco CC, St Claire MC, Nagashima K, Harbaugh SW, Harbaugh JW, Thamire C, Sable CA, Poirier MC (2005). Cardiac mitochondrial compromise in 1-yr-old Erythrocebus patas monkeys perinatally-exposed to nucleoside reverse transcriptase inhibitors. Cardiovasc Toxicol  5, 333-46.   https://doi.org/10.1385/ct:5:3:333




PubMed


 


PubMed ID 16244378
    
     


 



4.
Gwinn MR, Keshava C, Olivero OA, Humsi JA, Poirier MC, Weston A (2005). Transcriptional signatures of normal human mammary epithelial cells in response to benzo[a]pyrene exposure: a comparison of three microarray platforms. OMICS  9, 334-50.   https://doi.org/10.1089/omi.2005.9.334




PubMed


 


PubMed ID 16402892
    
     


 



5.
Keshava C, Divi RL, Whipkey DL, Frye BL, McCanlies E, Kuo M, Poirier MC, Weston A (2005). Induction of CYP1A1 and CYP1B1 and formation of carcinogen-DNA adducts in normal human mammary epithelial cells treated with benzo[a]pyrene. Cancer Lett  221, 213-24.   https://doi.org/10.1016/j.canlet.2004.08.038




PubMed


 


PubMed ID 15808407
    
     


 



6.
Mahadevan B, Arora V, Schild LJ, Keshava C, Cate ML, Iversen PL, Poirier MC, Weston A, Pereira C, Baird WM (2006). Reduction in tamoxifen-induced CYP3A2 expression and DNA adducts using antisense technology. Mol Carcinog  45, 118-25.   https://doi.org/10.1002/mc.20143




PubMed


 


PubMed ID 16329150
    
     


 



7.
Poirier M, Haverkos K, Humsi J, Nagashima K, Olivero O   (2006) Morphological and molecular course of mitochondrial pathology in cultured human cells exposed long-term to Zidovudine.  Environ Mol Mutagen, in press.




 



8.
Poirier M, Walker V, Carter M, Cook D, McCash C, Olivero O, Walker D   (2006) Cytotoxicity and mutagenicity of zidovudine, lamivudine and abacavir following exposure of human lymphoblastoid cells to single agents or drug combinations.  Environ Mol Mutagen  ePub ahead of print pp.",https://intramural.nih.gov/search/searchview.taf?ipid=43568
11,BC005216-35,"October 01, 2005 -  September 30, 2006",cAMP-Dependent Protein Kinase in Human Cancer: Basic Research,"Yoon S Cho-Chung; MD, PhD",NULL,"Basic Research Laboratory, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Cho-Chung YS (2006). Autoantibody biomarkers in the detection of cancer. Biochim Biophys Acta  1762, 587-91.   https://doi.org/10.1016/j.bbadis.2006.04.001




PubMed


 


PubMed ID 16730166
    
     


 



2.
Nesterova M, Johnson N, Cheadle C, Cho-Chung YS (2006). Autoantibody biomarker opens a new gateway for cancer diagnosis. Biochim Biophys Acta  1762, 398-403.   https://doi.org/10.1016/j.bbadis.2005.12.010




PubMed


 


PubMed ID 16483750",https://intramural.nih.gov/search/searchview.taf?ipid=43569
12,BC005254-25,"October 01, 2005 -  September 30, 2006",Regulation of HTLV-I Transcription,John N Brady; PhD,NULL,"Laboratory of Cellular Oncology, NCI","Michael  Radonovich



Meisheng  Zhou



Won-Kyung  Cho",NULL,Dinah  Singer; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Brady J, Kashanchi F (2005). Tat gets the ""green"" light on transcription initiation. Retrovirology  2, 69.   https://doi.org/10.1186/1742-4690-2-69




PubMed



        
     
Free Article


 


PubMed ID 16280076
         Pubmed Central ID 1308864 


 



2.
Brady J, Lu H, Cho W, Park H   (2006) CARM1 enhances transcription activity of the HTLV-1 LTR through direct interaction with Tax.  J. Virology, in press.




 



3.
Chevalier SA, Meertens L, Pise-Masison C, Calattini S, Park H, Alhaj AA, Zhou M, Gessain A, Kashanchi F, Brady JN, Mahieux R (2006). The tax protein from the primate T-cell lymphotropic virus type 3 is expressed in vivo and is functionally related to HTLV-1 Tax rather than HTLV-2 Tax. Oncogene  25, 4470-82.   https://doi.org/10.1038/sj.onc.1209472




PubMed


 


PubMed ID 16532031
    
     


 



4.
Gegonne A, Weissman JD, Zhou M, Brady JN, Singer DS (2006). TAF7: a possible transcription initiation check-point regulator. Proc Natl Acad Sci U S A  103, 602-7.   https://doi.org/10.1073/pnas.0510031103




PubMed



        
     
Free Article


 


PubMed ID 16407123
         Pubmed Central ID 1325967 


 



5.
Jang MK, Mochizuki K, Zhou M, Jeong HS, Brady JN, Ozato K (2005). The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol Cell  19, 523-34.   https://doi.org/10.1016/j.molcel.2005.06.027




PubMed


 


PubMed ID 16109376
    
     


 



6.
Jeong SJ, Pise-Masison CA, Radonovich MF, Park HU, Brady JN (2005). A novel NF-kappaB pathway involving IKKbeta and p65/RelA Ser-536 phosphorylation results in p53 Inhibition in the absence of NF-kappaB transcriptional activity. J Biol Chem  280, 10326-32.   https://doi.org/10.1074/jbc.M412643200




PubMed


 


PubMed ID 15611068
    
     


 



7.
Minn AH, Pise-Masison CA, Radonovich M, Brady JN, Wang P, Kendziorski C, Shalev A (2005). Gene expression profiling in INS-1 cells overexpressing thioredoxin-interacting protein. Biochem Biophys Res Commun  336, 770-8.   https://doi.org/10.1016/j.bbrc.2005.08.161




PubMed


 


PubMed ID 16143294
    
     


 



8.
Ohyama M, Terunuma A, Tock CL, Radonovich MF, Pise-Masison CA, Hopping SB, Brady JN, Udey MC, Vogel JC (2006). Characterization and isolation of stem cell-enriched human hair follicle bulge cells. J Clin Invest  116, 249-60.   https://doi.org/10.1172/JCI26043




PubMed



        
     
Free Article


 


PubMed ID 16395407
         Pubmed Central ID 1323261 


 



9.
Zhou M, Lu H, Park H, Wilson-Chiru J, Linton R, Brady JN (2006). Tax interacts with P-TEFb in a novel manner to stimulate human T-lymphotropic virus type 1 transcription. J Virol  80, 4781-91.   https://doi.org/10.1128/JVI.80.10.4781-4791.2006




PubMed



        
     
Free Article


 


PubMed ID 16641271
         Pubmed Central ID 1472077",https://intramural.nih.gov/search/searchview.taf?ipid=43570
13,BC005258-27,"October 01, 2005 -  September 30, 2006",Molecular Studies of Eukaryotic Gene Regulation,"Bruce  Paterson; PhD



IRP Faculty Profile",NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI","Concetta  Lipardi



Qin  Wei



Muktadir S Hossain



Steven L Htet",NULL,Yikang  Rong (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43571
14,BC005263-25,"October 01, 2005 -  September 30, 2006",Eukaryotic Chromatin Structure and Gene Regulation,"Carl  Wu; PhD



IRP Faculty Profile",NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI","Joseph W Landry



Manabu  Mizuguchi



Subhojit  Sen



Debbie  Wei



Wei-Hua  Wu



Hua  Xiao; PhD



Show all 11",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43572
15,BC005268-19,"October 01, 2005 -  September 30, 2006",Mechanism of Meiotic Recombination,"Michael Joseph Lichten; PhD



IRP Faculty Profile",NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI","Robert A Shroff



David E Eyre



Cyril  Buhler



Anuradha  Sourirajan



Yaron  Dayani



Tamara  Goldfarb",NULL,Munira A Basrai; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Lichten M, Rockmill B, Roeder G   (2006) Meiotic Chromosome Synapsis-Promoting Proteins Antagonize the Anti-Crossover Activity of Sgs1.  PLoS Genetics  e155 pp.




 



2.
Nakamura A, Sedelnikova OA, Redon C, Pilch DR, Sinogeeva NI, Shroff R, Lichten M, Bonner WM (2006). Techniques for gamma-H2AX detection. Methods Enzymol  409, 236-50.   https://doi.org/10.1016/S0076-6879(05)09014-2




PubMed


 


PubMed ID 16793405",https://intramural.nih.gov/search/searchview.taf?ipid=43573
16,BC005270-25,"October 01, 2005 -  September 30, 2006",Molecular Mechanism of Action of Phorbol Ester,"Peter  Blumberg; PhD



IRP Faculty Profile",NULL,"Molecular Mechanisms of Tumor Promotion Section, NCI","Nancy E Lewin



Larry V Pearce



Dazhi  Yang



Vladimir  Pavlyukovets



Jozsef  Lazar



Tetsurou  Ikeda



Show all 11","Tamas  Biro
(Dept. of Physiology, University of Debrecen)




Chaya  Brodie
(Department of Neurosurgery, Henry Ford Hospital)




Marcelo G Kazanietz; PhD
(Pharmacology, University of Pennsylvania)




Gary  Keck
(Dept. of Chemistry, University of Utah)




Alan P. Kozikowski
(Dept. of Medicinal Chemistry, University of Illinois at Chicago)




Jeewoo  Lee
(Medicinal Chemistry, Seoul National University)


Show all 8","Susan H Garfield  (Laboratory of Experimental Carcinogenesis)



Victor  Marquez; PhD  (ORGANIC CHEMSTRY SECT)



Yun  Wang  (Nucleic Acid NMR Section)



Stuart H Yuspa; MD  (Laboratory of Cellular Carcinogenesis and Tumor Promotion)",NULL,"Ordered by publication type and then author name.



1.
Blumberg PM   (2006) Complex regulation of TRPV1 by vanilloids, in TRP ion channel function in sensory transduction and cellular signaling cascades. Liedtke W, Heller S, eds., CRC Press, Inc (Boca Raton, FL), in press.




 



2.
Blumberg PM, Braun DC, Kedei N, Lazar J, Pavlyukovets V, PEARCE L   (2005) Insights into TRPV1 pharmacology provided by non-capsaicin ligands, in Turning up the Heat on Pain: TRPV1 Receptors in Pain and Inflammation. Malmberg A, Bley K, eds., Birkhauser Verlag (New York, NY), pp. 55-69.




 



3.
Braun DC, Cao Y, Wang S, Garfield SH, Hur GM, Blumberg PM (2005). Role of phorbol ester localization in determining protein kinase C or RasGRP3 translocation: real-time analysis using fluorescent ligands and proteins. Mol Cancer Ther  4, 141-50.




PubMed


 


PubMed ID 15657361
    
     


 



4.
Braun DC, Garfield SH, Blumberg PM (2005). Analysis by fluorescence resonance energy transfer of the interaction between ligands and protein kinase Cdelta in the intact cell. J Biol Chem  280, 8164-71.   https://doi.org/10.1074/jbc.M413896200




PubMed


 


PubMed ID 15611119
    
     


 



5.
Lee J, Jin MK, Kang SU, Kim SY, Lee J, Shin M, Hwang J, Cho S, Choi YS, Choi HK, Kim SE, Suh YG, Lee YS, Kim YH, Ha HJ, Toth A, Pearce LV, Tran R, Szabo T, Welter JD, Lundberg DJ, Wang Y, Lazar J, Pavlyukovets VA, Morgan MA, et al. [1 more author] (2005). Analysis of structure-activity relationships for the 'B-region' of N-(4-t-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]-thiourea analogues as TRPV1 antagonists. Bioorg Med Chem Lett  15, 4143-50.   https://doi.org/10.1016/j.bmcl.2005.06.006




PubMed


 


PubMed ID 15993063
    
     


 



6.
Lee J, Kang SU, Kil MJ, Shin M, Lim JO, Choi HK, Jin MK, Kim SY, Kim SE, Lee YS, Min KH, Kim YH, Ha HJ, Tran R, Welter JD, Wang Y, Szabo T, Pearce LV, Lundberg DJ, Toth A, Pavlyukovets VA, Morgan MA, Blumberg PM (2005). Analysis of structure-activity relationships for the 'A-region' of N-(4-t-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues as TRPV1 antagonists. Bioorg Med Chem Lett  15, 4136-42.   https://doi.org/10.1016/j.bmcl.2005.06.009




PubMed


 


PubMed ID 16005215
    
     


 



7.
Okhrimenko H, Lu W, Xiang C, Ju D, Blumberg PM, Gomel R, Kazimirsky G, Brodie C (2005). Roles of tyrosine phosphorylation and cleavage of protein kinase Cdelta in its protective effect against tumor necrosis factor-related apoptosis inducing ligand-induced apoptosis. J Biol Chem  280, 23643-52.   https://doi.org/10.1074/jbc.M501374200




PubMed


 


PubMed ID 15774464
    
     


 



8.
Pu Y, Perry NA, Yang D, Lewin NE, Kedei N, Braun DC, Choi SH, Blumberg PM, Garfield SH, Stone JC, Duan D, Marquez VE (2005). A novel diacylglycerol-lactone shows marked selectivity in vitro among C1 domains of protein kinase C (PKC) isoforms alpha and delta as well as selectivity for RasGRP compared with PKCalpha. J Biol Chem  280, 27329-38.   https://doi.org/10.1074/jbc.M414132200




PubMed


 


PubMed ID 15923197
    
     


 



9.
Qiang YW, Walsh K, Yao L, Kedei N, Blumberg PM, Rubin JS, Shaughnessy J, Rudikoff S (2005). Wnts induce migration and invasion of myeloma plasma cells. Blood  106, 1786-93.   https://doi.org/10.1182/blood-2005-01-0049




PubMed



        
     
Free Article


 


PubMed ID 15886323
         Pubmed Central ID 1895227 


 



10.
Tóth A, Boczán J, Kedei N, Lizanecz E, Bagi Z, Papp Z, Edes I, Csiba L, Blumberg PM (2005). Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain. Brain Res Mol Brain Res  135, 162-8.   https://doi.org/10.1016/j.molbrainres.2004.12.003




PubMed


 


PubMed ID 15857679
    
     


 



11.
Tóth A, Wang Y, Kedei N, Tran R, Pearce LV, Kang SU, Jin MK, Choi HK, Lee J, Blumberg PM (2005). Different vanilloid agonists cause different patterns of calcium response in CHO cells heterologously expressing rat TRPV1. Life Sci  76, 2921-32.   https://doi.org/10.1016/j.lfs.2004.10.056




PubMed


 


PubMed ID 15820503",https://intramural.nih.gov/search/searchview.taf?ipid=43574
17,BC005271-15,"October 01, 2005 -  September 30, 2006",Gene Regulation and Function: The B-ZIP Proteins,"Charles  Vinson; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI","Won-Jun  Oh



Andras  Orosz



Vikas  Rishi



Julian  Rozenburg",NULL,"Frank Jess Gonzalez; PhD (National Cancer Institute)



Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)",NULL,"Ordered by publication type and then author name.



1.
Acharya A, Rishi V, Moll J, Vinson C (2006). Experimental identification of homodimerizing B-ZIP families in Homo sapiens. J Struct Biol  155, 130-9.   https://doi.org/10.1016/j.jsb.2006.02.018




PubMed


 


PubMed ID 16725346
    
     


 



2.
FitzGerald PC, Sturgill D, Shyakhtenko A, Oliver B, Vinson C (2006). Comparative genomics of Drosophila and human core promoters. Genome Biol  7, R53.   https://doi.org/10.1186/gb-2006-7-7-r53




PubMed



        
     
Free Article


 


PubMed ID 16827941
         Pubmed Central ID 1779564 


 



3.
Nunez NP, Oh WJ, Rozenberg J, Perella C, Anver M, Barrett JC, Perkins SN, Berrigan D, Moitra J, Varticovski L, Hursting SD, Vinson C (2006). Accelerated tumor formation in a fatless mouse with type 2 diabetes and inflammation. Cancer Res  66, 5469-76.   https://doi.org/10.1158/0008-5472.CAN-05-4102




PubMed


 


PubMed ID 16707476",https://intramural.nih.gov/search/searchview.taf?ipid=43575
18,BC005317-23,"October 01, 2005 -  September 30, 2006",Role of Selenium in Cancer and Health,"Dolph Lee Hatfield; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Prevention, NCI","Bradley A Carlson



Rajeev K Shrimali



Aniruddha  Sengupta



Min-Hyuk  Yoo



Xueming  Xu","Marla  Berry
(Molecular Biology, U of Hawaii)




Vadim  Gladyshev
(Biochem, U of NE)




Ulrich  Schweizer
(Neuroscience Research Center and, Charit-Universittsmedizin Berlin)","Cindy D Davis (National Cancer Institute)



Jeffrey E Green; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Hatfield D, Gladyshev V   (2006) Preface, in Selenium: Its molecular biology and role in human health. Berry M, ed., Springer (New York), in press.




 



2.
Hatfield D, Gladyshev V   (2006) The 15-kDa selenoprotein (Sep15): functional analysis and role in cancer, in Selenium: Its molecular biology and role in human health. Berry M, ed., Springer (New York), in press.




 



3.
Hatfield D, Romero H, Xu X, Carlson B, Gladyshev V   (2006) Evolution of Sec decoding and the key role of selenophosphate synthetase in the pathway of selenium utilization, in Selenium: Its molecular biology and role in human health. Berry M, ed., Springer (New York), in press.




 



4.
Hatfield D, Xu X, Shrimali R, Sengupta A, Yoo M, Irons R, Zhong N, Lee B, Lovanov A, Gladyshev V   (2006) Mammalian and other eukaryotic selenocystein tRNAs, in Selenium: Its molecular biology and role in human health. Berry M, ed., Springer (New York), in press.




 



5.
Hatfield D, Xu X, Shrimali R, Sengupta A, Yoo M, Zhong N, Irons R, Davis C, Lee B, Novoselov S, Gladyshev V   (2006) Mouse models for assessing the role of selenoproteins in health and development, in Selenium: Its molecular biology and role in human health. Berry M, ed., Springer (New York), in press.




 



6.
Chen CL, Shim MS, Chung J, Yoo HS, Ha JM, Kim JY, Choi J, Zang SL, Hou X, Carlson BA, Hatfield DL, Lee BJ (2006). G-rich, a Drosophila selenoprotein, is a Golgi-resident type III membrane protein. Biochem Biophys Res Commun  348, 1296-301.   https://doi.org/10.1016/j.bbrc.2006.07.203




PubMed


 


PubMed ID 16920070
    
     


 



7.
Hatfield D   (2006) How selenium makes its way into protein as selenocysteine, the 21st amino acid in the genetic.  CCR Frontiers in Science  1-3 pp.




 



8.
Hatfield DL, Carlson BA, Xu XM, Mix H, Gladyshev VN (2006). Selenocysteine incorporation machinery and the role of selenoproteins in development and health. Prog Nucleic Acid Res Mol Biol  81, 97-142.   https://doi.org/10.1016/S0079-6603(06)81003-2




PubMed


 


PubMed ID 16891170
    
     


 



9.
Irons R, Carlson BA, Hatfield DL, Davis CD (2006). Both selenoproteins and low molecular weight selenocompounds reduce colon cancer risk in mice with genetically impaired selenoprotein expression. J Nutr  136, 1311-7.   https://doi.org/10.1093/jn/136.5.1311




PubMed


 


PubMed ID 16614422
    
     


 



10.
Labunskyy VM, Ferguson AD, Fomenko DE, Chelliah Y, Hatfield DL, Gladyshev VN (2005). A novel cysteine-rich domain of Sep15 mediates the interaction with UDP-glucose:glycoprotein glucosyltransferase. J Biol Chem  280, 37839-45.   https://doi.org/10.1074/jbc.M508685200




PubMed


 


PubMed ID 16129668
    
     


 



11.
Lobanov AV, Delgado C, Rahlfs S, Novoselov SV, Kryukov GV, Gromer S, Hatfield DL, Becker K, Gladyshev VN (2006). The Plasmodium selenoproteome. Nucleic Acids Res  34, 496-505.   https://doi.org/10.1093/nar/gkj450




PubMed



        
     
Free Article


 


PubMed ID 16428245
         Pubmed Central ID 1342035 


 



12.
Lobanov AV, Kryukov GV, Hatfield DL, Gladyshev VN (2006). Is there a twenty third amino acid in the genetic code? Trends Genet  22, 357-60.   https://doi.org/10.1016/j.tig.2006.05.002




PubMed


 


PubMed ID 16713651
    
     


 



13.
Novoselov SV, Calvisi DF, Labunskyy VM, Factor VM, Carlson BA, Fomenko DE, Moustafa ME, Hatfield DL, Gladyshev VN (2005). Selenoprotein deficiency and high levels of selenium compounds can effectively inhibit hepatocarcinogenesis in transgenic mice. Oncogene  24, 8003-11.   https://doi.org/10.1038/sj.onc.1208940




PubMed


 


PubMed ID 16170372
    
     


 



14.
Small-Howard A, Morozova N, Stoytcheva Z, Forry EP, Mansell JB, Harney JW, Carlson BA, Xu XM, Hatfield DL, Berry MJ (2006). Supramolecular complexes mediate selenocysteine incorporation in vivo. Mol Cell Biol  26, 2337-46.   https://doi.org/10.1128/MCB.26.6.2337-2346.2006




PubMed



        
     
Free Article


 


PubMed ID 16508009
         Pubmed Central ID 1430297 


 



15.
Sun QA, Su D, Novoselov SV, Carlson BA, Hatfield DL, Gladyshev VN (2005). Reaction mechanism and regulation of mammalian thioredoxin/glutathione reductase. Biochemistry  44, 14528-37.   https://doi.org/10.1021/bi051321w




PubMed


 


PubMed ID 16262253
    
     


 



16.
Xu XM, Mix H, Carlson BA, Grabowski PJ, Gladyshev VN, Berry MJ, Hatfield DL (2005). Evidence for direct roles of two additional factors, SECp43 and soluble liver antigen, in the selenoprotein synthesis machinery. J Biol Chem  280, 41568-75.   https://doi.org/10.1074/jbc.M506696200




PubMed


 


PubMed ID 16230358
    
     


 



17.
Yoo MH, Xu XM, Carlson BA, Gladyshev VN, Hatfield DL (2006). Thioredoxin reductase 1 deficiency reverses tumor phenotype and tumorigenicity of lung carcinoma cells. J Biol Chem  281, 13005-8.   https://doi.org/10.1074/jbc.C600012200




PubMed


 


PubMed ID 16565519",https://intramural.nih.gov/search/searchview.taf?ipid=43576
19,BC005318-24,"October 01, 2005 -  September 30, 2006",Structure-Function of Cytochrome P450,Fred  Friedman; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",NULL,"Matthew  Pincus
(Pathology, VA)




Stanley  Smith
(NIAMS)",NULL,NULL,"Ordered by publication type and then author name.



1.
Michl J, Scharf B, Schmidt A, Huynh C, Hannan R, von Gizycki H, Friedman FK, Brandt-Rauf P, Fine RL, Pincus MR (2006). PNC-28, a p53-derived peptide that is cytotoxic to cancer cells, blocks pancreatic cancer cell growth in vivo. Int J Cancer  119, 1577-85.   https://doi.org/10.1002/ijc.22029




PubMed


 


PubMed ID 16688716",https://intramural.nih.gov/search/searchview.taf?ipid=43577
20,BC005352-24,"October 01, 2005 -  September 30, 2006",Mechanisms in Perinatal Carcinogenesis,Lucy M Anderson; PhD,NULL,"Laboratory of Comparative Carcinogenesis, NCI","Yuk Sing Robert Cheng



Yih-horng  Shiao



Janet R Fields



Ki Narm  Ko



Cuiju  Wang



Sean D Mccann



Show all 7",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Anderson LM (2006). Environmental genotoxicants/carcinogens and childhood cancer: bridgeable gaps in scientific knowledge. Mutat Res  608, 136-56.   https://doi.org/10.1016/j.mrgentox.2006.02.016




PubMed


 


PubMed ID 16829162
    
     


 



2.
Anderson LM, Riffle L, Wilson R, Travlos GS, Lubomirski MS, Alvord WG (2006). Preconceptional fasting of fathers alters serum glucose in offspring of mice. Nutrition  22, 327-31.   https://doi.org/10.1016/j.nut.2005.09.006




PubMed


 


PubMed ID 16500559
    
     


 



3.
Schmidt AL, Anderson LM (2006). Repetitive DNA elements as mediators of genomic change in response to environmental cues. Biol Rev Camb Philos Soc  81, 531-43.   https://doi.org/10.1017/S146479310600710X




PubMed


 


PubMed ID 16893475",https://intramural.nih.gov/search/searchview.taf?ipid=43578
21,BC005367-23,"October 01, 2005 -  September 30, 2006",The Genetic Structure of Natural Populations Past and Present,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI","Shawn R Palmer



Shujin  Luo



Warren  Johnson



Carlos Antonio Driscoll; PhD



Mary A Thompson



Michael E Weedon



Show all 16","Eduardo  Eizirik
(Biosciences Department, Pontifcia Universidade Catlica do Rio Grande do Sul)




William J. Murphy
(NCI-FCRDC, NCI)","Beena  Neelam (National Cancer Institute)



Robert H Stephens (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Johnson WE, Eizirik E, Pecon-Slattery J, Murphy WJ, Antunes A, Teeling E, O'Brien SJ (2006). The late Miocene radiation of modern Felidae: a genetic assessment. Science  311, 73-7.   https://doi.org/10.1126/science.1122277




PubMed


 


PubMed ID 16400146
    
     


 



2.
Kim JH, Antunes A, Luo SJ, Menninger J, Nash WG, O'Brien SJ, Johnson WE (2006). Evolutionary analysis of a large mtDNA translocation (numt) into the nuclear genome of the Panthera genus species. Gene  366, 292-302.   https://doi.org/10.1016/j.gene.2005.08.023




PubMed



        
     
Free Article


 


PubMed ID 16380222
         Pubmed Central ID 1592465 


 



3.
Roca AL, Georgiadis N, O'Brien SJ (2005). Cytonuclear genomic dissociation in African elephant species. Nat Genet  37, 96-100.   https://doi.org/10.1038/ng1485




PubMed


 


PubMed ID 15592471
    
     


 



4.
Teeling EC, Springer MS, Madsen O, Bates P, O'brien SJ, Murphy WJ (2005). A molecular phylogeny for bats illuminates biogeography and the fossil record. Science  307, 580-4.   https://doi.org/10.1126/science.1105113




PubMed


 


PubMed ID 15681385
    
     


 



5.
Troyer JL, Pecon-Slattery J, Roelke ME, Johnson W, VandeWoude S, Vazquez-Salat N, Brown M, Frank L, Woodroffe R, Winterbach C, Winterbach H, Hemson G, Bush M, Alexander KA, Revilla E, O'Brien SJ (2005). Seroprevalence and genomic divergence of circulating strains of feline immunodeficiency virus among Felidae and Hyaenidae species. J Virol  79, 8282-94.   https://doi.org/10.1128/JVI.79.13.8282-8294.2005




PubMed



        
     
Free Article


 


PubMed ID 15956574
         Pubmed Central ID 1143723",https://intramural.nih.gov/search/searchview.taf?ipid=43579
22,BC005385-23,"October 01, 2005 -  September 30, 2006","The Development of the Domestic Cat, Felis catus, as an Animal Model for Genetic",Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI","Victor A David



Joan C Menninger



Carlos Antonio Driscoll; PhD



Bailey D Kessing



Marilyn  Raymond; PhD



Joan  Pontius



Show all 9","Greg  Barsh
(Howard Hughes Medical Institute, Stanford University School of Medicine)




Eduardo  Eizirik
(Biosciences Department, Pontifcia Universidade Catlica do Rio Grande do Sul)




John  Fyfe
(Michigan State U.)




Steven  Hannah
(Nestle Purina PetCare Co.)




Sree  Kanthaswamy
(Dept. of Anthropology & the CA National Primate Research Ctr., University of CA at Davis)




Rajendra  Kumar-Singh
(Dept. of Ophthalmology, Tufts University School of Medicine)


Show all 9","Beena  Neelam (National Cancer Institute)



Robert H Stephens (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Fyfe JC, Menotti-Raymond M, David VA, Brichta L, Schäffer AA, Agarwala R, Murphy WJ, Wedemeyer WJ, Gregory BL, Buzzell BG, Drummond MC, Wirth B, O'Brien SJ (2006). An approximately 140-kb deletion associated with feline spinal muscular atrophy implies an essential LIX1 function for motor neuron survival. Genome Res  16, 1084-90.   https://doi.org/10.1101/gr.5268806




PubMed



        
     
Free Article


 


PubMed ID 16899656
         Pubmed Central ID 1557767 


 



2.
Ishida Y, David VA, Eizirik E, Schäffer AA, Neelam BA, Roelke ME, Hannah SS, O'Brien SJ, Menotti-Raymond M (2006). A homozygous single-base deletion in MLPH causes the dilute coat color phenotype in the domestic cat. Genomics  88, 698-705.   https://doi.org/10.1016/j.ygeno.2006.06.006




PubMed


 


PubMed ID 16860533",https://intramural.nih.gov/search/searchview.taf?ipid=43580
23,BC005389-23,"October 01, 2005 -  September 30, 2006",Reproductive Strategies in Animal Species Emphasizing Developmental Biology,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI",James  Kehler,"William J. Murphy
(NCI-FCRDC, NCI)




Kristina  Narfstrom; DVM
(Veterinary Medicine, University of Missouri)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43581
24,BC005399-23,"October 01, 2005 -  September 30, 2006",Mechanistic Targeting of Lung Cancer,Lucy M Anderson; PhD,NULL,"Laboratory of Comparative Carcinogenesis, NCI","Richard J Calvert



Yuk Sing Robert Cheng



Laura  Fornwald



Janet R Fields



Gunamani  Sithanandam



Keith D Kikawa



Show all 8",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Anderson L, Kikawa K, Fields J, Maciag A, North S, Shiao Y, Kasprzak K   (2006) Effects of selenium supplementation on expression of glutathione peroxidase isoforms in cultured human lung adenocarcinoma cell lines.  Lung Cancer, in press.




 



2.
Anderson L, Tepper S, Kammouni W, Kritchevsky D   (2006) Elevated K-ras activity with cholestyramine and lovastatin, but not konjac mannan or niacin in lung - importance of mouse strain.  Biochemical Pharmacology, in press.




 



3.
Anderson LM (2005). Cancer biology and hormesis: comments on Calabrese (2005). Crit Rev Toxicol  35, 583-6.   https://doi.org/10.1080/10408440500246777




PubMed


 


PubMed ID 16422393",https://intramural.nih.gov/search/searchview.taf?ipid=43582
25,BC005445-22,"October 01, 2005 -  September 30, 2006",Analysis of Pathways that Suppress or Accelerate Premalignant Progression and Ma,"Stuart H Yuspa; MD



IRP Faculty Profile",NULL,"Laboratory of Cellular Carcinogenesis and Tumor Promotion, NCI","Andrew O Ryscavage



Joanna  Anders



Christina K Cheng



Luowei  Li



Kwang Sun Suh



Mayur  Parepally



Show all 7","Nadine  Darwich
(Biochemistry, American University in Beruit)




Adam  Glick; PhD
(NCI)




Shunsuki  Ishii
(Molecular Genetics, Riken Tsukuba Institute)",Peter  Blumberg; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Gerdes MJ, Myakishev M, Frost NA, Rishi V, Moitra J, Acharya A, Levy MR, Park SW, Glick A, Yuspa SH, Vinson C (2006). Activator protein-1 activity regulates epithelial tumor cell identity. Cancer Res  66, 7578-88.   https://doi.org/10.1158/0008-5472.CAN-06-1247




PubMed


 


PubMed ID 16885357
    
     


 



2.
Suh KS, Mutoh M, Gerdes M, Yuspa SH (2005). CLIC4, an intracellular chloride channel protein, is a novel molecular target for cancer therapy. J Investig Dermatol Symp Proc  10, 105-9.   https://doi.org/10.1111/j.1087-0024.2005.200402.x




PubMed


 


PubMed ID 16358817",https://intramural.nih.gov/search/searchview.taf?ipid=43583
26,BC005450-23,"October 01, 2005 -  September 30, 2006",Chromatin Structure and Gene Expression,"Gordon Lee Hager; PhD



IRP Faculty Profile",NULL,"Laboratory of Receptor Biology and Gene Expression, NCI","Carol T Comlish



Sam  John



Tom  Johnson



Akhilesh Kumar Nagaich



Yi  Qui



Anindya P Hendarwanto



Show all 10","Philippe  Georgel
(NCI)




Anthony  Imbalzano
(Department of Cell Biology, University of Massachusetts Medical School)




Bhavin  Parekh
(Lilly Corporate Center, Eli Lilly)




Ken  Pearce
(Gene Expression and Protein Biochemistry, GlaxoSmithKline Discovery Research)




Yingming  Zhao; PhD
(Biochemistry, UT Southwestern Medical Center)","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)



Sean Richard Davis; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Becker M, Becker A, Miyara F, Han Z, Kihara M, Brown DT, Hager GL, Latham K, Adashi EY, Misteli T (2005). Differential in vivo binding dynamics of somatic and oocyte-specific linker histones in oocytes and during ES cell nuclear transfer. Mol Biol Cell  16, 3887-95.   https://doi.org/10.1091/mbc.e05-04-0350




PubMed



        
     
Free Article


 


PubMed ID 15944219
         Pubmed Central ID 1182324 


 



2.
Hager GL, Elbi C, Johnson TA, Voss T, Nagaich AK, Schiltz RL, Qiu Y, John S (2006). Chromatin dynamics and the evolution of alternate promoter states. Chromosome Res  14, 107-16.   https://doi.org/10.1007/s10577-006-1030-0




PubMed


 


PubMed ID 16506100
    
     


 



3.
Qiu Y, Zhao Y, Becker M, John S, Parekh BS, Huang S, Hendarwanto A, Martinez ED, Chen Y, Lu H, Adkins NL, Stavreva DA, Wiench M, Georgel PT, Schiltz RL, Hager GL (2006). HDAC1 acetylation is linked to progressive modulation of steroid receptor-induced gene transcription. Mol Cell  22, 669-79.   https://doi.org/10.1016/j.molcel.2006.04.019




PubMed


 


PubMed ID 16762839",https://intramural.nih.gov/search/searchview.taf?ipid=43584
27,BC005453-22,"October 01, 2005 -  September 30, 2006",Cellular and Molecular Biology of the Hepatic Stem Cell Compartment,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI","Timothy V Benjamin



Elizabeth A Conner



Tanya N Hoang



Jeonghoon  Heo



Pal  Kaposi-Novak



Joe W Grisham



Show all 8","Hanne  Bisgaard
(Medical Biochemistry and Genetics, University of Copenhagen)




Nelson  Fausto
(Pathology, University of Washington School of Medicine)




Gen-Sheng  Feng
(Program in Signal Transduction and Stem Cells& Regeneration, Burnham Institute for Medical Research)




Stefan  Karlsson; MD, PhD
(University of Lund)




Ju-Seog  Lee; PhD
(NCI)




Peter  Nagy
(Pathology, Sammelweiss University)


Show all 8",Valentina  Factor (Cellular and Molecular Biology Section),NULL,"Ordered by publication type and then author name.



1.
Thorgeirsson S, Factor V, Uren T, Takahama Y, Lee J, Major M, Feinstone S   (2006) Hepatic precursors derived from murine embryonic stem cells contribute to regeneration of injured liver.  Hepatology, in press.




 



2.
Thorgeirsson SS, Grisham JW (2006). Hematopoietic cells as hepatocyte stem cells: a critical review of the evidence. Hepatology  43, 2-8.   https://doi.org/10.1002/hep.21015




PubMed


 


PubMed ID 16374844",https://intramural.nih.gov/search/searchview.taf?ipid=43585
28,BC005480-21,"October 01, 2005 -  September 30, 2006",Molecular Epidemiology and Molecular Carcinogenesis of Human Cancer,"Curtis  Harris; MD



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","Nobutoshi  Hagiwara



Elise Dawn Bowman



Mohammed A. Khan; PhD



Mary G Mcmenamin



Leah E Mechanic



Elisa A Spillare



Show all 16",NULL,Michael  Alavanja; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Harris C   (2006) Chemical Carcinogenesis, in Cancer Medicine, 7th Edition. Holland J, Frei E, Bast R, Kufe D, Pollock R, Weichselbaum R, eds., B.C. Decker, Inc. (Ontario, Canada), pp. 1-13.




 



2.
Bonner MR, Bennett WP, Xiong W, Lan Q, Brownson RC, Harris CC, Field RW, Lubin JH, Alavanja MC (2006). Radon, secondhand smoke, glutathione-S-transferase M1 and lung cancer among women. Int J Cancer  119, 1462-7.   https://doi.org/10.1002/ijc.22002




PubMed


 


PubMed ID 16642467
    
     


 



3.
Hagiwara N, Mechanic LE, Trivers GE, Cawley HL, Taga M, Bowman ED, Kumamoto K, He P, Bernard M, Doja S, Miyashita M, Tajiri T, Sasajima K, Nomura T, Makino H, Takahashi K, Hussain SP, Harris CC (2006). Quantitative detection of p53 mutations in plasma DNA from tobacco smokers. Cancer Res  66, 8309-17.   https://doi.org/10.1158/0008-5472.CAN-06-0991




PubMed


 


PubMed ID 16912213
    
     


 



4.
Harris CC (2006). Protein-protein interactions for cancer therapy. Proc Natl Acad Sci U S A  103, 1659-60.   https://doi.org/10.1073/pnas.0510948103




PubMed



        
     
Free Article


 


PubMed ID 16452164
         Pubmed Central ID 1413676 


 



5.
Pine SR, Mechanic LE, Bowman ED, Welsh JA, Chanock SC, Shields PG, Harris CC (2006). MDM2 SNP309 and SNP354 are not associated with lung cancer risk. Cancer Epidemiol Biomarkers Prev  15, 1559-61.   https://doi.org/10.1158/1055-9965.EPI-06-0217




PubMed


 


PubMed ID 16896050
    
     


 



6.
Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A  103, 2257-61.   https://doi.org/10.1073/pnas.0510565103




PubMed



        
     
Free Article


 


PubMed ID 16461460
         Pubmed Central ID 1413718 


 



7.
Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC (2006). Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell  9, 189-98.   https://doi.org/10.1016/j.ccr.2006.01.025




PubMed


 


PubMed ID 16530703
    
     


 



8.
Zheng YL, Loffredo CA, Alberg AJ, Yu Z, Jones RT, Perlmutter D, Enewold L, Krasna MJ, Yung R, Shields PG, Harris CC (2005). Less efficient g2-m checkpoint is associated with an increased risk of lung cancer in African Americans. Cancer Res  65, 9566-73.   https://doi.org/10.1158/0008-5472.CAN-05-1003




PubMed



        
     
Free Article


 


PubMed ID 16230422
         Pubmed Central ID 1403288 


 



9.
Croce CM, Harris CM, Schetter AM (submitted in 2006) Mir-21 For Diagnosing Poor Survival Prognosis Colon Adenocarcinoma. Patents issued: 8,084,199 (US in 2012); 2436782 (EP in 2013); 2436783 (EP in 2013); 2436784 (EP in 2013); 2436785 (EP in 2013); 2436785 (ES in 2013); 5230619 (JP in 2013); 8,338,102 (US in 2013); 8,338,105 (US in 2013); 8,338,106 (US in 2013); 8,349,568 (US in 2013); 8,338,104 (US in 2013); 8,343,725 (US in 2013); 8,338,103 (US in 2013); 2369017 (EP in 2014); 2455492 (EP in 2014); 2455493 (EP in 2014); 2455494 (EP in 2014); 2436786 (EP in 2014); 5778708 (JP in 2015); 2436787 (CH in 2016); 2436787 (EP in 2016); 2436787 (ES in 2016); 2436787 (FR in 2016). Patents pending: 2657030 (CA application); 200780033066.9 (CN application); 201310396056.9 (CN application); 07810382.7 (EP application); 2007272947 (AU application); 2013222027 (AU application); PCT/US2007/015892 (PC application); 13/295,440 (US application); 13/296,545 (US application); 15/057,308 (US application).




 



10.
Croce CM, Harris CM, Yanaihara NM (submitted in 2006) Microrna-based Methods For The Diagnosis, Prognosis And Treatment Of Lung Cancer. Patents issued: 7,943,318 (US in 2011); 2007205234 (AU in 2013); 1978986 (EP in 2013); 8,377,637 (US in 2013); 8,361,710 (US in 2013); 2012238336 (AU in 2014); 5451077 (JP in 2014); 2502630 (EP in 2015); 2502630 (ES in 2015); 2514433 (EP in 2016); 2514434 (EP in 2016); 2514433 (ES in 2016); 2514434 (ES in 2016); 2514433 (FR in 2016); 2514434 (FR in 2016); 2514433 (IT in 2016); 2514434 (IT in 2016). Patents pending: 2014203454 (AU application); 2633674 (CA application); 200780006750.8 (CN application); 201210312507.1 (CN application); 201410210166.6 (CN application); PCT/US2007/000103 (PC application).




 



11.
Harris C, Seike M, Wang X (submitted in 2006) Methods Of Determining The Prognosis Of An Adenocarcinoma. Patents issued: 2041313 (FR in 2011); 2041313 (GB in 2011); 2041313 (IT in 2011); 602007013405 (DE in 2011); 2041313 (EP in 2011); 9,464,324 (US in 2017).",https://intramural.nih.gov/search/searchview.taf?ipid=43586
29,BC005488-21,"October 01, 2005 -  September 30, 2006",Mechanisms of Inorganic Carcinogenesis,Michael  Waalkes; PhD,NULL,"Laboratory of Comparative Carcinogenesis, NCI","Wei  Qu; PhD



Yaxiong  Xie



Lamia Ilham Benbrahim-Tallaa; PhD



Elaine  Leslie



Robert A Goyer



Courtney K Henderson



Show all 12",NULL,NULL,"Raymond W. Tennant; PhD (NIEHS) 



David W Miller; PhD (OD) 



Colin F Chignell; PhD (NIEHS) 



Jau Shyong  Hong; PhD (NIEHS)","Ordered by publication type and then author name.



1.
Benbrahim-Tallaa L, Waterland RA, Styblo M, Achanzar WE, Webber MM, Waalkes MP (2005). Molecular events associated with arsenic-induced malignant transformation of human prostatic epithelial cells: aberrant genomic DNA methylation and K-ras oncogene activation. Toxicol Appl Pharmacol  206, 288-98.   https://doi.org/10.1016/j.taap.2004.11.017




PubMed


 


PubMed ID 16039940
    
     


 



2.
Benbrahim-Tallaa L, Webber MM, Waalkes MP (2005). Acquisition of androgen independence by human prostate epithelial cells during arsenic-induced malignant transformation. Environ Health Perspect  113, 1134-9.   https://doi.org/10.1289/ehp.7832




PubMed



        
     
Free Article


 


PubMed ID 16140617
         Pubmed Central ID 1280391 


 



3.
Devesa V, Adair BM, Liu J, Waalkes MP, Diwan BA, Styblo M, Thomas DJ (2006). Arsenicals in maternal and fetal mouse tissues after gestational exposure to arsenite. Toxicology  224, 147-55.   https://doi.org/10.1016/j.tox.2006.04.041




PubMed



        
     
Free Article


 


PubMed ID 16753250
         Pubmed Central ID 2365744 


 



4.
Kojima C, Qu W, Waalkes MP, Himeno S, Sakurai T (2006). Chronic exposure to methylated arsenicals stimulates arsenic excretion pathways and induces arsenic tolerance in rat liver cells. Toxicol Sci  91, 70-81.   https://doi.org/10.1093/toxsci/kfj117




PubMed


 


PubMed ID 16436460
    
     


 



5.
Leslie EM, Liu J, Klaassen CD, Waalkes MP (2006). Acquired cadmium resistance in metallothionein-I/II(-/-) knockout cells: role of the T-type calcium channel Cacnalpha1G in cadmium uptake. Mol Pharmacol  69, 629-39.   https://doi.org/10.1124/mol.105.014241




PubMed


 


PubMed ID 16282520
    
     


 



6.
Liu J, Xie Y, Ducharme DM, Shen J, Diwan BA, Merrick BA, Grissom SF, Tucker CJ, Paules RS, Tennant R, Waalkes MP (2006). Global gene expression associated with hepatocarcinogenesis in adult male mice induced by in utero arsenic exposure. Environ Health Perspect  114, 404-11.   https://doi.org/10.1289/ehp.8534




PubMed



        
     
Free Article


 


PubMed ID 16507464
         Pubmed Central ID 1392235 


 



7.
Liu J, Xie Y, Merrick BA, Shen J, Ducharme DM, Collins J, Diwan BA, Logsdon D, Waalkes MP (2006). Transplacental arsenic plus postnatal 12-O-teradecanoyl phorbol-13-acetate exposures associated with hepatocarcinogenesis induce similar aberrant gene expression patterns in male and female mouse liver. Toxicol Appl Pharmacol  213, 216-23.   https://doi.org/10.1016/j.taap.2005.10.010




PubMed


 


PubMed ID 16368122
    
     


 



8.
Qu W, Fuquay R, Sakurai T, Waalkes MP (2006). Acquisition of apoptotic resistance in cadmium-induced malignant transformation: specific perturbation of JNK signal transduction pathway and associated metallothionein overexpression. Mol Carcinog  45, 561-71.   https://doi.org/10.1002/mc.20185




PubMed


 


PubMed ID 16568437
    
     


 



9.
Qu W, Liu J, Fuquay R, Saavedra JE, Keefer LK, Waalkes MP (2007). The nitric oxide prodrug, V-PYRRO/NO, mitigates arsenic-induced liver cell toxicity and apoptosis. Cancer Lett  256, 238-45.   https://doi.org/10.1016/j.canlet.2007.06.009




PubMed



        
     
Free Article


 


PubMed ID 17658681
         Pubmed Central ID 2093999 


 



10.
Waalkes M, An D, Liu J   (2006) Current status and prevention strategy for coal-arsenic poisoning in Guizhou, China.  J Health Popul Nutr, in press.




 



11.
Waalkes M, Bai Y, Reece J, Williams J, Petrovich R, Liu D, Freeman M, Fahl W, Shugar D, Liu J, Collins S   (2006) Molecular mechanisms of Nrf2 activation and degradation; role of sequential phosphorylation by protein kinase CK2.  Cancer Res, in press.




 



12.
Waalkes M, Chen M, Shi J, Yang Q, Wu J, Li C   (2006) Mitigation of aberrant hepatic gene expression related to ethanol intoxication when mice are given ethanol as Maoti: possible role of metallothionein and heme oxygenase-1 induction by Maotai.  Exp Biomed, in press.




 



13.
Waalkes MP, Liu J, Kasprzak KS, Diwan BA (2006). Hypersusceptibility to cisplatin carcinogenicity in metallothionein-I/II double knockout mice: production of hepatocellular carcinoma at clinically relevant doses. Int J Cancer  119, 28-32.   https://doi.org/10.1002/ijc.21245




PubMed


 


PubMed ID 16432836
    
     


 



14.
Waalkes MP, Liu J, Ward JM, Diwan BA (2006). Enhanced urinary bladder and liver carcinogenesis in male CD1 mice exposed to transplacental inorganic arsenic and postnatal diethylstilbestrol or tamoxifen. Toxicol Appl Pharmacol  215, 295-305.   https://doi.org/10.1016/j.taap.2006.03.010




PubMed


 


PubMed ID 16712894
    
     


 



15.
Waalkes MP, Liu J, Ward JM, Powell DA, Diwan BA (2006). Urogenital carcinogenesis in female CD1 mice induced by in utero arsenic exposure is exacerbated by postnatal diethylstilbestrol treatment. Cancer Res  66, 1337-45.   https://doi.org/10.1158/0008-5472.CAN-05-3530




PubMed


 


PubMed ID 16452187",https://intramural.nih.gov/search/searchview.taf?ipid=43588
30,BC005522-19,"October 01, 2005 -  September 30, 2006",Role of Thyroid-Specific Enhancer-Binding Protein in Development and Homeostasis,"Shioko  Kimura; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI","Yoshihito  Sasaki



Takashi  Ozaki",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Amendola E, De Luca P, Macchia PE, Terracciano D, Rosica A, Chiappetta G, Kimura S, Mansouri A, Affuso A, Arra C, Macchia V, Di Lauro R, De Felice M (2005). A mouse model demonstrates a multigenic origin of congenital hypothyroidism. Endocrinology  146, 5038-47.   https://doi.org/10.1210/en.2005-0882




PubMed


 


PubMed ID 16150900
    
     


 



2.
Kusakabe T, Hoshi N, Kimura S (2006). Origin of the ultimobranchial body cyst: T/ebp/Nkx2.1 expression is required for development and fusion of the ultimobranchial body to the thyroid. Dev Dyn  235, 1300-9.   https://doi.org/10.1002/dvdy.20655




PubMed



        
     
Free Article


 


PubMed ID 16342117
         Pubmed Central ID 2435076 


 



3.
Kusakabe T, Kawaguchi A, Hoshi N, Kawaguchi R, Hoshi S, Kimura S (2006). Thyroid-specific enhancer-binding protein/NKX2.1 is required for the maintenance of ordered architecture and function of the differentiated thyroid. Mol Endocrinol  20, 1796-809.   https://doi.org/10.1210/me.2005-0327




PubMed



        
     
Free Article


 


PubMed ID 16601074
         Pubmed Central ID 2588428 


 



4.
Niimi T, Kurotani R, Kimura S, Kitagawa Y (2006). Identification and expression of alternative splice variants of the mouse Ppp1r3b gene in lung epithelial cells. Biochem Biophys Res Commun  349, 588-96.   https://doi.org/10.1016/j.bbrc.2006.08.091




PubMed


 


PubMed ID 16949035
    
     


 



5.
Yin Z, Gonzales L, Kolla V, Rath N, Zhang Y, Lu MM, Kimura S, Ballard PL, Beers MF, Epstein JA, Morrisey EE (2006). Hop functions downstream of Nkx2.1 and GATA6 to mediate HDAC-dependent negative regulation of pulmonary gene expression. Am J Physiol Lung Cell Mol Physiol  291, L191-9.   https://doi.org/10.1152/ajplung.00385.2005




PubMed


 


PubMed ID 16510470",https://intramural.nih.gov/search/searchview.taf?ipid=43589
31,BC005536-20,"October 01, 2005 -  September 30, 2006",Basic and Applied Studies in Development of an AIDS Vaccine,"Marjorie  Robert-Guroff; PhD



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Jacqueline H Mcphail



Mary K Aldrich



Ersell S Richardson



Lois Jean Patterson



Ruth  Florese



Thorsten  Demberg



Show all 10","Susan  Barnett
(Chiron Corporation)




Barbara  Ensoli
(Istituto Superiore di Sanita)




Donald  Forthal
(School of Medicine, Univ of CA)




Nancy  Haigwood
(Department of Microbiology, SBRI and the University of Washington)




Marta  Marthas
(University of California, Davis, California Regional Primate Center)




Krishna  Murthy; DVM
(Virology/Immunology, Southwest Foundation for Biomedical Research)


Show all 9","George N Pavlakis; MD, PhD (National Cancer Institute)



Genoveffa  Franchini; MD (National Cancer Institute)



David J Venzon; PhD (National Cancer Institute)



Barbara K Felber (National Cancer Institute)","George J Grimes (CC) 












David C Montefiori; PhD (NIAID)","Ordered by publication type and then author name.



1.
Florese RH, Van Rompay KK, Aldrich K, Forthal DN, Landucci G, Mahalanabis M, Haigwood N, Venzon D, Kalyanaraman VS, Marthas ML, Robert-Guroff M (2006). Evaluation of passively transferred, nonneutralizing antibody-dependent cellular cytotoxicity-mediating IgG in protection of neonatal rhesus macaques against oral SIVmac251 challenge. J Immunol  177, 4028-36.   https://doi.org/10.4049/jimmunol.177.6.4028




PubMed


 


PubMed ID 16951366
    
     


 



2.
Gómez-Román VR, Florese RH, Patterson LJ, Peng B, Venzon D, Aldrich K, Robert-Guroff M (2006). A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity. J Immunol Methods  308, 53-67.   https://doi.org/10.1016/j.jim.2005.09.018




PubMed


 


PubMed ID 16343526
    
     


 



3.
Gómez-Román VR, Florese RH, Peng B, Montefiori DC, Kalyanaraman VS, Venzon D, Srivastava I, Barnett SW, Robert-Guroff M (2006). An adenovirus-based HIV subtype B prime/boost vaccine regimen elicits antibodies mediating broad antibody-dependent cellular cytotoxicity against non-subtype B HIV strains. J Acquir Immune Defic Syndr  43, 270-7.   https://doi.org/10.1097/01.qai.0000230318.40170.60




PubMed


 


PubMed ID 16940858
    
     


 



4.
Gómez-Román VR, Grimes GJ, Potti GK, Peng B, Demberg T, Gravlin L, Treece J, Pal R, Lee EM, Alvord WG, Markham PD, Robert-Guroff M (2006). Oral delivery of replication-competent adenovirus vectors is well tolerated by SIV- and SHIV-infected rhesus macaques. Vaccine  24, 5064-72.   https://doi.org/10.1016/j.vaccine.2006.03.048




PubMed


 


PubMed ID 16621178
    
     


 



5.
Malkevitch NV, Patterson LJ, Aldrich MK, Wu Y, Venzon D, Florese RH, Kalyanaraman VS, Pal R, Lee EM, Zhao J, Cristillo A, Robert-Guroff M (2006). Durable protection of rhesus macaques immunized with a replicating adenovirus-SIV multigene prime/protein boost vaccine regimen against a second SIVmac251 rectal challenge: role of SIV-specific CD8+ T cell responses. Virology  353, 83-98.   https://doi.org/10.1016/j.virol.2006.05.012




PubMed


 


PubMed ID 16814356
    
     


 



6.
Robert-Guroff M (2007). Replicating and non-replicating viral vectors for vaccine development. Curr Opin Biotechnol  18, 546-56.   https://doi.org/10.1016/j.copbio.2007.10.010




PubMed



        
     
Free Article


 


PubMed ID 18063357
         Pubmed Central ID 2245896 


 



7.
Robert-Guroff M, Cafaro A, Ferrantelli F, Tripiciano A, Moretti S, Caputo A, Gavioli R, Ensoli F, Barnett S, Ensoli B   (2006) Problems and emerging approaches in HIV/AIDS vaccine development.  Expert Opinion on Emerging Drugs, in press.




 



8.
Robert-Guroff M, Voltan R, Cristillo A, Alvord W, Davis-Warren A, Zhou Q, Murthy K   (2006) Replicating Ad-recombinants encoding non-myristoylated rather than wild-type HIV Nef elicit enhanced cellular immunity.  AIDS, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=43590
32,BC005548-19,"October 01, 2005 -  September 30, 2006",Biological Functions of the Oncogenes Encoding Rho-Specific Exchange Factors,Toru  Miki; PhD,NULL,"Laboratory of Cell Biology, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Hara T, Abe M, Inoue H, Yu LR, Veenstra TD, Kang YH, Lee KS, Miki T (2006). Cytokinesis regulator ECT2 changes its conformation through phosphorylation at Thr-341 in G2/M phase. Oncogene  25, 566-78.   https://doi.org/10.1038/sj.onc.1209078




PubMed


 


PubMed ID 16170345
    
     


 



2.
Kamijo K, Ohara N, Abe M, Uchimura T, Hosoya H, Lee JS, Miki T (2006). Dissecting the role of Rho-mediated signaling in contractile ring formation. Mol Biol Cell  17, 43-55.   https://doi.org/10.1091/mbc.e05-06-0569




PubMed



        
     
Free Article


 


PubMed ID 16236794
         Pubmed Central ID 1345645 


 



3.
Miki T, Kang Y, Kim K, Kamijo K, Yoon H, Seong Y, Kuo Y, Kim S, Kuriyama R, Giam C, Ahn C, Lee K   (2006) Requirement of hCenexin for proper mitotic functions of polo-like kinase 1 at the centrosomes.  Mol. Cell. Biol, in press.




 



4.
Miki T, Ohno S   (2006) Nucleotide exchange factor ECT2 regulates epithelial cell polarity.  Cell. Signal  1604-1615 pp.




 



5.
Miki T, Xie X   (2006) Inhibition of protein kinase C zeta blocks attachment of stable kinetochore-microtubule to chromosomes.  Cell. Signal, in press.




 



6.
Niiya F, Tatsumoto T, Lee KS, Miki T (2006). Phosphorylation of the cytokinesis regulator ECT2 at G2/M phase stimulates association of the mitotic kinase Plk1 and accumulation of GTP-bound RhoA. Oncogene  25, 827-37.   https://doi.org/10.1038/sj.onc.1209124




PubMed


 


PubMed ID 16247472",https://intramural.nih.gov/search/searchview.taf?ipid=43591
33,BC005561-19,"October 01, 2005 -  September 30, 2006",Liver-Enriched Transcription Factors,"Frank Jess Gonzalez; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI","Yusuke  Inoue



Junko  Inoue



Akihide  Kamiya



Insook  Kim",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Bosse T, van Wering HM, Gielen M, Dowling LN, Fialkovich JJ, Piaseckyj CM, Gonzalez FJ, Akiyama TE, Montgomery RK, Grand RJ, Krasinski SD (2006). Hepatocyte nuclear factor-1alpha is required for expression but dispensable for histone acetylation of the lactase-phlorizin hydrolase gene in vivo. Am J Physiol Gastrointest Liver Physiol  290, G1016-24.   https://doi.org/10.1152/ajpgi.00359.2005




PubMed


 


PubMed ID 16223943
    
     


 



2.
Ding X, Lichti K, Kim I, Gonzalez FJ, Staudinger JL (2006). Regulation of constitutive androstane receptor and its target genes by fasting, cAMP, hepatocyte nuclear factor alpha, and the coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha. J Biol Chem  281, 26540-51.   https://doi.org/10.1074/jbc.M600931200




PubMed



        
     
Free Article


 


PubMed ID 16825189
         Pubmed Central ID 2991045 


 



3.
Gonzalez FJ (2006). Role of beta-catenin in the adult liver. Hepatology  43, 650-3.   https://doi.org/10.1002/hep.21154




PubMed



        
     
Free Article


 


PubMed ID 16557535
         Pubmed Central ID 1440290 


 



4.
Gonzalez FJ (2006). Role of HNF4alpha in the superinduction of the IL-1beta-activated iNOS gene by oxidative stress. Biochem J  394, e3-5.   https://doi.org/10.1042/bj20060005




PubMed



        
     
Free Article


 


PubMed ID 16479620
         Pubmed Central ID 1408685 


 



5.
Inoue Y, Peters LL, Yim SH, Inoue J, Gonzalez FJ (2006). Role of hepatocyte nuclear factor 4alpha in control of blood coagulation factor gene expression. J Mol Med (Berl)  84, 334-44.   https://doi.org/10.1007/s00109-005-0013-5




PubMed


 


PubMed ID 16389552
    
     


 



6.
Inoue Y, Yu AM, Yim SH, Ma X, Krausz KW, Inoue J, Xiang CC, Brownstein MJ, Eggertsen G, Björkhem I, Gonzalez FJ (2006). Regulation of bile acid biosynthesis by hepatocyte nuclear factor 4alpha. J Lipid Res  47, 215-27.   https://doi.org/10.1194/jlr.M500430-JLR200




PubMed



        
     
Free Article


 


PubMed ID 16264197
         Pubmed Central ID 1413576 


 



7.
Kikuchi R, Kusuhara H, Hattori N, Shiota K, Kim I, Gonzalez FJ, Sugiyama Y (2006). Regulation of the expression of human organic anion transporter 3 by hepatocyte nuclear factor 1alpha/beta and DNA methylation. Mol Pharmacol  70, 887-96.   https://doi.org/10.1124/mol.106.025494




PubMed


 


PubMed ID 16793932
    
     


 



8.
Kyrmizi I, Hatzis P, Katrakili N, Tronche F, Gonzalez FJ, Talianidis I (2006). Plasticity and expanding complexity of the hepatic transcription factor network during liver development. Genes Dev  20, 2293-305.   https://doi.org/10.1101/gad.390906




PubMed



        
     
Free Article


 


PubMed ID 16912278
         Pubmed Central ID 1553211 


 



9.
Maher JM, Slitt AL, Callaghan TN, Cheng X, Cheung C, Gonzalez FJ, Klaassen CD (2006). Alterations in transporter expression in liver, kidney, and duodenum after targeted disruption of the transcription factor HNF1alpha. Biochem Pharmacol  72, 512-22.   https://doi.org/10.1016/j.bcp.2006.03.016




PubMed


 


PubMed ID 16806085
    
     


 



10.
Miura A, Yamagata K, Kakei M, Hatakeyama H, Takahashi N, Fukui K, Nammo T, Yoneda K, Inoue Y, Sladek FM, Magnuson MA, Kasai H, Miyagawa J, Gonzalez FJ, Shimomura I (2006). Hepatocyte nuclear factor-4alpha is essential for glucose-stimulated insulin secretion by pancreatic beta-cells. J Biol Chem  281, 5246-57.   https://doi.org/10.1074/jbc.M507496200




PubMed


 


PubMed ID 16377800
    
     


 



11.
Shin M, Kim I, Inoue Y, Kimura S, Gonzalez FJ (2006). Regulation of mouse hepatic alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase, a key enzyme in the tryptophan-nicotinamide adenine dinucleotide pathway, by hepatocyte nuclear factor 4alpha and peroxisome proliferator-activated receptor alpha. Mol Pharmacol  70, 1281-90.   https://doi.org/10.1124/mol.106.026294




PubMed


 


PubMed ID 16807375
    
     


 



12.
Yang Q, Nagano T, Shah Y, Cheung C, Ito S, Gonzalez FJ (2008). The PPAR alpha-humanized mouse: a model to investigate species differences in liver toxicity mediated by PPAR alpha. Toxicol Sci  101, 132-9.   https://doi.org/10.1093/toxsci/kfm206




PubMed



        
     
Free Article


 


PubMed ID 17690133
         Pubmed Central ID 2197159",https://intramural.nih.gov/search/searchview.taf?ipid=43593
34,BC005562-19,"October 01, 2005 -  September 30, 2006",Xenobiotic-Metabolizing Enzymes,"Frank Jess Gonzalez; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI","Kristopher W Krausz



Xiaochao  Ma



Sarbani  Giri",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Chen C, Gonzalez FJ, Idle JR (2007). LC-MS-based metabolomics in drug metabolism. Drug Metab Rev  39, 581-97.   https://doi.org/10.1080/03602530701497804




PubMed



        
     
Free Article


 


PubMed ID 17786640
         Pubmed Central ID 2140249 


 



2.
Chen C, Meng L, Ma X, Krausz KW, Pommier Y, Idle JR, Gonzalez FJ (2006). Urinary metabolite profiling reveals CYP1A2-mediated metabolism of NSC686288 (aminoflavone). J Pharmacol Exp Ther  318, 1330-42.   https://doi.org/10.1124/jpet.106.105213




PubMed



        
     
Free Article


 


PubMed ID 16775196
         Pubmed Central ID 1551906 


 



3.
Cheung C, Ma X, Krausz KW, Kimura S, Feigenbaum L, Dalton TP, Nebert DW, Idle JR, Gonzalez FJ (2005). Differential metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in mice humanized for CYP1A1 and CYP1A2. Chem Res Toxicol  18, 1471-8.   https://doi.org/10.1021/tx050136g




PubMed


 


PubMed ID 16167840
    
     


 



4.
Cheung C, Yu AM, Chen CS, Krausz KW, Byrd LG, Feigenbaum L, Edwards RJ, Waxman DJ, Gonzalez FJ (2006). Growth hormone determines sexual dimorphism of hepatic cytochrome P450 3A4 expression in transgenic mice. J Pharmacol Exp Ther  316, 1328-34.   https://doi.org/10.1124/jpet.105.094367




PubMed


 


PubMed ID 16291874
    
     


 



5.
Giri S, Idle JR, Chen C, Zabriskie TM, Krausz KW, Gonzalez FJ (2006). A metabolomic approach to the metabolism of the areca nut alkaloids arecoline and arecaidine in the mouse. Chem Res Toxicol  19, 818-27.   https://doi.org/10.1021/tx0600402




PubMed



        
     
Free Article


 


PubMed ID 16780361
         Pubmed Central ID 1482804 


 



6.
Gonzalez FJ, Yu AM (2006). Cytochrome P450 and xenobiotic receptor humanized mice. Annu Rev Pharmacol Toxicol  46, 41-64.   https://doi.org/10.1146/annurev.pharmtox.45.120403.100007




PubMed



        
     
Free Article


 


PubMed ID 16402898
         Pubmed Central ID 1440291 


 



7.
Herraiz T, Guillén H, Arán VJ, Idle JR, Gonzalez FJ (2006). Comparative aromatic hydroxylation and N-demethylation of MPTP neurotoxin and its analogs, N-methylated beta-carboline and isoquinoline alkaloids, by human cytochrome P450 2D6. Toxicol Appl Pharmacol  216, 387-98.   https://doi.org/10.1016/j.taap.2006.06.003




PubMed


 


PubMed ID 16870220
    
     


 



8.
Idle JR, Gonzalez FJ (2007). Metabolomics. Cell Metab  6, 348-51.   https://doi.org/10.1016/j.cmet.2007.10.005




PubMed



        
     
Free Article


 


PubMed ID 17983580
         Pubmed Central ID 2140247 


 



9.
Ma X, Idle JR, Krausz KW, Tan DX, Ceraulo L, Gonzalez FJ (2006). Urinary metabolites and antioxidant products of exogenous melatonin in the mouse. J Pineal Res  40, 343-9.   https://doi.org/10.1111/j.1600-079X.2006.00321.x




PubMed



        
     
Free Article


 


PubMed ID 16635022
         Pubmed Central ID 1448215 


 



10.
Narimatsu S, Takatsu N, Yamano S, Inoue Y, Hanioka N, Kiryu K, Naito S, Gonzalez FJ, Yamamoto S (2006). The effect of dimethyl sulfoxide on the function of cytochrome P450 2D6 in HepG2 cells upon the co-expression with NADPH-cytochrome P450 reductase. Chem Biol Interact  159, 47-57.   https://doi.org/10.1016/j.cbi.2005.09.001




PubMed


 


PubMed ID 16214121",https://intramural.nih.gov/search/searchview.taf?ipid=43594
35,BC005596-37,"October 01, 2005 -  September 30, 2006",Pathogenesis of plasma cell tumors in mice,Michael  Potter; MD,NULL,"Laboratory of Genetics, NCI",Brad  Burkholder,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Kim BG, Li C, Qiao W, Mamura M, Kasprzak B, Kasperczak B, Anver M, Wolfraim L, Hong S, Mushinski E, Potter M, Kim SJ, Fu XY, Deng C, Letterio JJ (2006). Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. Nature  441, 1015-9.   https://doi.org/10.1038/nature04846




PubMed


 


PubMed ID 16791201",https://intramural.nih.gov/search/searchview.taf?ipid=43595
36,BC005597-17,"October 01, 2005 -  September 30, 2006",Biochemistry of Energy-Dependent (Intracellular) Protein Degradation,"Michael  Maurizi; PhD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Mark A Lies



Agnieszka  Szyk



Yang  Zhang



Sarada  Viswanathan



Ebenezer  Joseph",NULL,"Susan  Gottesman; PhD (National Cancer Institute)



Alexander  Wlodawer; PhD (National Cancer Institute)","Alasdair C Steven; PhD (NIAMS) 



Ann  Ginsburg; PhD (NHLBI)","Ordered by publication type and then author name.



1.
Rotanova TV, Botos I, Melnikov EE, Rasulova F, Gustchina A, Maurizi MR, Wlodawer A (2006). Slicing a protease: structural features of the ATP-dependent Lon proteases gleaned from investigations of isolated domains. Protein Sci  15, 1815-28.   https://doi.org/10.1110/ps.052069306




PubMed



        
     
Free Article


 


PubMed ID 16877706
         Pubmed Central ID 2242575 


 



2.
Szyk A, Maurizi MR (2006). Crystal structure at 1.9A of E. coli ClpP with a peptide covalently bound at the active site. J Struct Biol  156, 165-74.   https://doi.org/10.1016/j.jsb.2006.03.013




PubMed


 


PubMed ID 16682229",https://intramural.nih.gov/search/searchview.taf?ipid=43596
37,BC005598-17,"October 01, 2005 -  September 30, 2006",Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells,"Michael Marc Gottesman; MD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Adorjan  Aszalos



Carol O Cardarelli



Ding wu  Shen; PhD



Wilfred D Vieira



Joseph A Ludwig



Jill K Paterson



Show all 15","Jacob  Hochman
(Cell and Animal Biology, Hebrew University)




Gary  Kruh; MD, PhD
(Medical Science Division, Fox Chase Cancer Center)




Ariella  Oppenheim; PhD
(Hebrew University-Hadassah Medical School)




Balzs  Sarkadi
(Hematology & Immunology, Semmelweis Institute)




Michael  Seiden
(Hematology Oncology, Dana-Farber/Partners Cancer Care Program)




Brian P. Sorrentino; MD
(Div of Experimental Hematology, St Jude Children's Research Hosp)


Show all 7",Vincent J. Hearing; PhD (National Cancer Institute),Kevin G Chen; MD (NINDS),"Ordered by publication type and then author name.



1.
Gottesman M   (2006) How melanoma cells evade chemotherapy: role of transporter-dependent and independent resistance mechanisms, in From Melanocytes to Malignant Melanoma. Hearing V, Leong S, eds., Humana Press (Totowa, New Jersey), pp. 591-603.




 



2.
Ambudkar SV, Sauna ZE, Gottesman MM, Szakacs G (2005). A novel way to spread drug resistance in tumor cells: functional intercellular transfer of P-glycoprotein (ABCB1). Trends Pharmacol Sci  26, 385-7.   https://doi.org/10.1016/j.tips.2005.06.001




PubMed



        
     
Free Article


 


PubMed ID 15978680
         Pubmed Central ID 1350964 


 



3.
Bar-Sinai A, Bassa N, Fischette M, Gottesman MM, Love DC, Hanover JA, Hochman J (2005). Mouse mammary tumor virus Env-derived peptide associates with nucleolar targets in lymphoma, mammary carcinoma, and human breast cancer. Cancer Res  65, 7223-30.   https://doi.org/10.1158/0008-5472.CAN-04-3879




PubMed


 


PubMed ID 16103073
    
     


 



4.
Calcagno AM, Ludwig JA, Fostel JM, Gottesman MM, Ambudkar SV (2006). Comparison of drug transporter levels in normal colon, colon cancer, and Caco-2 cells: impact on drug disposition and discovery. Mol Pharm  3, 87-93.   https://doi.org/10.1021/mp050090k




PubMed


 


PubMed ID 16686373
    
     


 



5.
Chen KG, Gottesman MM (2005). Useful tool to generate unidirectional deletion vectors by utilizing the star activity of BamHI in an NcoI-BamHI-XhoI cassette. Biotechniques  38, 198, 200, 202, 204.   https://doi.org/10.2144/05382BM05




PubMed


 


PubMed ID 15727125
    
     


 



6.
Chen KG, Szakács G, Annereau JP, Rouzaud F, Liang XJ, Valencia JC, Nagineni CN, Hooks JJ, Hearing VJ, Gottesman MM (2005). Principal expression of two mRNA isoforms (ABCB 5alpha and ABCB 5beta ) of the ATP-binding cassette transporter gene ABCB 5 in melanoma cells and melanocytes. Pigment Cell Res  18, 102-12.   https://doi.org/10.1111/j.1600-0749.2005.00214.x




PubMed



        
     
Free Article


 


PubMed ID 15760339
         Pubmed Central ID 3915408 


 



7.
Chen KG, Valencia JC, Lai B, Zhang G, Paterson JK, Rouzaud F, Berens W, Wincovitch SM, Garfield SH, Leapman RD, Hearing VJ, Gottesman MM (2006). Melanosomal sequestration of cytotoxic drugs contributes to the intractability of malignant melanomas. Proc Natl Acad Sci U S A  103, 9903-7.   https://doi.org/10.1073/pnas.0600213103




PubMed



        
     
Free Article


 


PubMed ID 16777967
         Pubmed Central ID 1502551 


 



8.
Gottesman M, Xia D, Szakacs G   (2006) Defeating drug resistance in cancer.  Discovery Medicine  18-23 pp.




 



9.
Gottesman MM, Ling V (2006). The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research. FEBS Lett  580, 998-1009.   https://doi.org/10.1016/j.febslet.2005.12.060




PubMed


 


PubMed ID 16405967
    
     


 



10.
Kimchi-Sarfaty C, Brittain S, Garfield S, Caplen NJ, Tang Q, Gottesman MM (2005). Efficient delivery of RNA interference effectors via in vitro-packaged SV40 pseudovirions. Hum Gene Ther  16, 1110-5.   https://doi.org/10.1089/hum.2005.16.1110




PubMed



        
     
Free Article


 


PubMed ID 16149909
         Pubmed Central ID 1618762 


 



11.
Kimchi-Sarfaty C, Vieira WD, Dodds D, Sherman A, Kreitman RJ, Shinar S, Gottesman MM (2006). SV40 Pseudovirion gene delivery of a toxin to treat human adenocarcinomas in mice. Cancer Gene Ther  13, 648-57.   https://doi.org/10.1038/sj.cgt.7700943




PubMed



        
     
Free Article


 


PubMed ID 16498428
         Pubmed Central ID 1482740 


 



12.
Liang XJ, Mukherjee S, Shen DW, Maxfield FR, Gottesman MM (2006). Endocytic recycling compartments altered in cisplatin-resistant cancer cells. Cancer Res  66, 2346-53.   https://doi.org/10.1158/0008-5472.CAN-05-3436




PubMed



        
     
Free Article


 


PubMed ID 16489040
         Pubmed Central ID 1382193 


 



13.
Ludwig JA, Szakács G, Martin SE, Chu BF, Cardarelli C, Sauna ZE, Caplen NJ, Fales HM, Ambudkar SV, Weinstein JN, Gottesman MM (2006). Selective toxicity of NSC73306 in MDR1-positive cells as a new strategy to circumvent multidrug resistance in cancer. Cancer Res  66, 4808-15.   https://doi.org/10.1158/0008-5472.CAN-05-3322




PubMed



        
     
Free Article


 


PubMed ID 16651436
         Pubmed Central ID 1474781 


 



14.
Nussenblatt RB, Chan CC, Wilson WH, Hochman J, Gottesman M, CNS and Ocular Lymphoma Workshop Group (2006). International Central Nervous System and Ocular Lymphoma Workshop: recommendations for the future. Ocul Immunol Inflamm  14, 139-44.   https://doi.org/10.1080/09273940600630170




PubMed



        
     
Free Article


 


PubMed ID 16827214
         Pubmed Central ID 2518223 


 



15.
Shen DW, Liang XJ, Suzuki T, Gottesman MM (2006). Identification by functional cloning from a retroviral cDNA library of cDNAs for ribosomal protein L36 and the 10-kDa heat shock protein that confer cisplatin resistance. Mol Pharmacol  69, 1383-8.   https://doi.org/10.1124/mol.105.017525




PubMed



        
     
Free Article


 


PubMed ID 16394183
         Pubmed Central ID 1409811 


 



16.
Szakács G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM (2006). Targeting multidrug resistance in cancer. Nat Rev Drug Discov  5, 219-34.   https://doi.org/10.1038/nrd1984




PubMed


 


PubMed ID 16518375",https://intramural.nih.gov/search/searchview.taf?ipid=43597
38,BC005599-16,"October 01, 2005 -  September 30, 2006","Tumor Suppressor Protein, p53","Ettore  Appella; MD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Toshiaki  Hara



Sharlyn  Mazur; PhD



Hiroshi  Yamaguchi



Jeong Kyu Bang



Matteo  Rossi



Lisa Marie Jenkins



Show all 8","Edward  Collins
(Dept. of Biochemistry and Biophysics, Univ. of North Carolina, Chapel Hill)




Albert  DeLeo
(Cancer Institute, Univ. of Pittsburgh)




Albert  Fornace, Jr.
(Dept. of Genetics and Complex Diseases, Harvard School of Public Health)




James G. Omichinski; PhD
(Department of Biochemistry, University of Montreal)




Yang  Xu
(California Breast Cancer Research Program, University of California)",Jonathan D Ashwell; MD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Chao C, Wu Z, Mazur SJ, Borges H, Rossi M, Lin T, Wang JY, Anderson CW, Appella E, Xu Y (2006). Acetylation of mouse p53 at lysine 317 negatively regulates p53 apoptotic activities after DNA damage. Mol Cell Biol  26, 6859-69.   https://doi.org/10.1128/MCB.00062-06




PubMed



        
     
Free Article


 


PubMed ID 16943427
         Pubmed Central ID 1592865 


 



2.
Chua KF, Mostoslavsky R, Lombard DB, Pang WW, Saito S, Franco S, Kaushal D, Cheng HL, Fischer MR, Stokes N, Murphy MM, Appella E, Alt FW (2005). Mammalian SIRT1 limits replicative life span in response to chronic genotoxic stress. Cell Metab  2, 67-76.   https://doi.org/10.1016/j.cmet.2005.06.007




PubMed


 


PubMed ID 16054100
    
     


 



3.
Di Lello P, Jenkins LM, Jones TN, Nguyen BD, Hara T, Yamaguchi H, Dikeakos JD, Appella E, Legault P, Omichinski JG (2006). Structure of the Tfb1/p53 complex: Insights into the interaction between the p62/Tfb1 subunit of TFIIH and the activation domain of p53. Mol Cell  22, 731-40.   https://doi.org/10.1016/j.molcel.2006.05.007




PubMed


 


PubMed ID 16793543
    
     


 



4.
Dudgeon C, Kek C, Demidov ON, Saito S, Fernandes K, Diot A, Bourdon JC, Lane DP, Appella E, Fornace AJ, Bulavin DV (2006). Tumor susceptibility and apoptosis defect in a mouse strain expressing a human p53 transgene. Cancer Res  66, 2928-36.   https://doi.org/10.1158/0008-5472.CAN-05-2063




PubMed


 


PubMed ID 16540640
    
     


 



5.
Higashimoto Y, Asanomi Y, Takakusagi S, Lewis MS, Uosaki K, Durell SR, Anderson CW, Appella E, Sakaguchi K (2006). Unfolding, aggregation, and amyloid formation by the tetramerization domain from mutant p53 associated with lung cancer. Biochemistry  45, 1608-19.   https://doi.org/10.1021/bi051192j




PubMed



        
     
Free Article


 


PubMed ID 16460008
         Pubmed Central ID 2536691 


 



6.
Kawaguchi Y, Ito A, Appella E, Yao TP (2006). Charge modification at multiple C-terminal lysine residues regulates p53 oligomerization and its nucleus-cytoplasm trafficking. J Biol Chem  281, 1394-400.   https://doi.org/10.1074/jbc.M505772200




PubMed


 


PubMed ID 16291740
    
     


 



7.
Pedeux R, Sengupta S, Shen JC, Demidov ON, Saito S, Onogi H, Kumamoto K, Wincovitch S, Garfield SH, McMenamin M, Nagashima M, Grossman SR, Appella E, Harris CC (2005). ING2 regulates the onset of replicative senescence by induction of p300-dependent p53 acetylation. Mol Cell Biol  25, 6639-48.   https://doi.org/10.1128/MCB.25.15.6639-6648.2005




PubMed



        
     
Free Article


 


PubMed ID 16024799
         Pubmed Central ID 1190357 


 



8.
Schito ML, Demidov ON, Saito S, Ashwell JD, Appella E (2006). Wip1 phosphatase-deficient mice exhibit defective T cell maturation due to sustained p53 activation. J Immunol  176, 4818-25.   https://doi.org/10.4049/jimmunol.176.8.4818




PubMed


 


PubMed ID 16585576
    
     


 



9.
Shreeram S, Demidov ON, Hee WK, Yamaguchi H, Onishi N, Kek C, Timofeev ON, Dudgeon C, Fornace AJ, Anderson CW, Minami Y, Appella E, Bulavin DV (2006). Wip1 phosphatase modulates ATM-dependent signaling pathways. Mol Cell  23, 757-64.   https://doi.org/10.1016/j.molcel.2006.07.010




PubMed


 


PubMed ID 16949371",https://intramural.nih.gov/search/searchview.taf?ipid=43598
39,BC005617-18,"October 01, 2005 -  September 30, 2006",Molecular mechanisms of resistance to TGF-beta signaling,Seong-Jin  Kim; PhD,NULL,"Laboratory of Cell Regulation and Carcinogenesis, NCI","Suntaek  Hong



Tae-Aug  Kim



Seunghwan  Lim



Wook  Jin



Amy  Hobbie



Chohee  Yun



Show all 7","Isaac  Kim
(Division of Urologic Oncology, The Cancer Institute of New Jersey)




John  Letterio
(Division of Pediatric Hematology/Oncology, Case Western Reserve University)




Seok Hee  Park
(Department of Pathology, Inha University School of Medicine)




Poul  Sorensen
(Department of Pathology and Pediatrics, University British Columbia)




Xiao-Jing  Wang
(Departments of Dermatology & Otolaryngology, Oregon Health & Science University)","Lino  Tessarollo (National Cancer Institute)



James B Mitchell; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Choi KC, Lee YS, Lim S, Choi HK, Lee CH, Lee EK, Hong S, Kim IH, Kim SJ, Park SH (2006). Smad6 negatively regulates interleukin 1-receptor-Toll-like receptor signaling through direct interaction with the adaptor Pellino-1. Nat Immunol  7, 1057-65.   https://doi.org/10.1038/ni1383




PubMed


 


PubMed ID 16951688
    
     


 



2.
Jin W, Kim BC, Tognon C, Lee HJ, Patel S, Lannon CL, Maris JM, Triche TJ, Sorensen PH, Kim SJ (2005). The ETV6-NTRK3 chimeric tyrosine kinase suppresses TGF-beta signaling by inactivating the TGF-beta type II receptor. Proc Natl Acad Sci U S A  102, 16239-44.   https://doi.org/10.1073/pnas.0503137102




PubMed



        
     
Free Article


 


PubMed ID 16258068
         Pubmed Central ID 1283417 


 



3.
Kim BG, Li C, Qiao W, Mamura M, Kasprzak B, Kasperczak B, Anver M, Wolfraim L, Hong S, Mushinski E, Potter M, Kim SJ, Fu XY, Deng C, Letterio JJ (2006). Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. Nature  441, 1015-9.   https://doi.org/10.1038/nature04846




PubMed


 


PubMed ID 16791201
    
     


 



4.
Lee HJ, Yun CH, Lim SH, Kim BC, Baik KG, Kim JM, Kim WH, Kim SJ (2007). SRF is a nuclear repressor of Smad3-mediated TGF-beta signaling. Oncogene  26, 173-85.   https://doi.org/10.1038/sj.onc.1209774




PubMed


 


PubMed ID 16819512
    
     


 



5.
Lucas PJ, Kim SJ, Mackall CL, Telford WG, Chu YW, Hakim FT, Gress RE (2006). Dysregulation of IL-15-mediated T-cell homeostasis in TGF-beta dominant-negative receptor transgenic mice. Blood  108, 2789-95.   https://doi.org/10.1182/blood-2006-05-025676




PubMed



        
     
Free Article


 


PubMed ID 16788095
         Pubmed Central ID 1895588 


 



6.
Ryu JK, Song SU, Han JY, Chu YC, Lee M, Kim JS, Kim SJ, Suh JK (2005). Establishment of penile fibrosis model in a rat using mouse NIH 3T3 fibroblasts expressing transforming growth factor beta1. Biol Reprod  72, 916-21.   https://doi.org/10.1095/biolreprod.104.035089




PubMed


 


PubMed ID 15601922
    
     


 



7.
Yoo BM, Yeo M, Oh TY, Choi JH, Kim WW, Kim JH, Cho SW, Kim SJ, Hahm KB (2005). Amelioration of pancreatic fibrosis in mice with defective TGF-beta signaling. Pancreas  30, e71-9.   https://doi.org/10.1097/01.mpa.0000157388.54016.0a




PubMed


 


PubMed ID 15782092
    
     


 



8.
Zhang Q, Jang TL, Yang X, Park I, Meyer RE, Kundu S, Pins M, Javonovic B, Kuzel T, Kim SJ, Van Parijs L, Smith N, Wong L, Greenberg NM, Guo Y, Lee C (2006). Infiltration of tumor-reactive transforming growth factor-beta insensitive CD8+ T cells into the tumor parenchyma is associated with apoptosis and rejection of tumor cells. Prostate  66, 235-47.   https://doi.org/10.1002/pros.20340




PubMed


 


PubMed ID 16173028
    
     


 



9.
Zhang Q, Yang XJ, Kundu SD, Pins M, Javonovic B, Meyer R, Kim SJ, Greenberg NM, Kuzel T, Meagher R, Guo Y, Lee C (2006). Blockade of transforming growth factor-{beta} signaling in tumor-reactive CD8(+) T cells activates the antitumor immune response cycle. Mol Cancer Ther  5, 1733-43.   https://doi.org/10.1158/1535-7163.MCT-06-0109




PubMed


 


PubMed ID 16891459",https://intramural.nih.gov/search/searchview.taf?ipid=43599
40,BC005643-16,"October 01, 2005 -  September 30, 2006",Mechanism and Regulation of mRNA Export,Ravi  Dhar; PhD,NULL,"Basic Research Laboratory, NCI","Saravana P Selvanathan



Saikat  Saha",NULL,Andrew  Patterson (Gene Response Section),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43600
41,BC005645-17,"October 01, 2005 -  September 30, 2006",T-cell Transformation by Oncoviruses,"Genoveffa  Franchini; MD



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Jake R Fullen



Steven J Snodgrass



Risaku  Fukumoto



Vibeke  Andresen



Valerio William Valeri



Izabela  Bialuk",NULL,"Barbara K Felber (National Cancer Institute)



David J Venzon; PhD (National Cancer Institute)



Lawrence Elliot Samelson; MD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43601
42,BC005652-16,"October 01, 2005 -  September 30, 2006",Identification of Single Nucleotide Polymorphisms in Cancer-Related Genes,"Michael  Dean; PhD



IRP Faculty Profile",NULL,"Laboratory of Genomic Diversity, NCI","Shawn R Palmer



Zhang-Qun  Chen



Michael J Malasky



Mary  Mcnally



Julie  Sawitzke



Stefan Alexandrov Stefanov



Show all 12","Rando  Allikmets
(NCI)




Greg  Hageman
(Ophthalmology, University of Iowa)




Ken  Offitt
(Medicine, Sloan Kettering Cancer Center)




Joe  Sodroski
(Immunology & Infectious Diseases, Harvard School of Public Health)




Robert D Wells","Stephen J O'Brien; PhD (National Cancer Institute)



Thomas R O'Brien; BA, MPH, MD (National Cancer Institute)



Susan  Bates; MD (National Cancer Institute)



Antonio  Fojo; MD, PhD (National Cancer Institute)



Ola Mae Zack Howard (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Ali IU, Luke BT, Dean M, Greenwald P (2005). Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma. Br J Cancer  93, 953-9.   https://doi.org/10.1038/sj.bjc.6602806




PubMed



        
     
Free Article


 


PubMed ID 16205694
         Pubmed Central ID 1369968 


 



2.
Bacolla A, Collins JR, Gold B, Chuzhanova N, Yi M, Stephens RM, Stefanov S, Olsh A, Jakupciak JP, Dean M, Lempicki RA, Cooper DN, Wells RD (2006). Long homopurine*homopyrimidine sequences are characteristic of genes expressed in brain and the pseudoautosomal region. Nucleic Acids Res  34, 2663-75.   https://doi.org/10.1093/nar/gkl354




PubMed



        
     
Free Article


 


PubMed ID 16714445
         Pubmed Central ID 1464109 


 



3.
Dean M, An P, Gold B, Petersen D, O'huigin C, Nelson G, O'Brien S, Kirk G, Detels R, Buchbinder S, Donfield S, Shulenin S, Song B, Perron M, Stremlau M, Sodroski J, Winkler C   (2006) Effects of human TRIM5alpha polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection.  J. Virology  In Press pp.




 



4.
Dean M, O'Brien T, Bergeron J, Zhang M   (2006) Population distribution of the functional caspase- 12 allele.  Human Mutation  975 pp.




 



5.
Dong HF, Wigmore K, Carrington MN, Dean M, Turpin JA, Howard OM (2005). Variants of CCR5, which are permissive for HIV-1 infection, show distinct functional responses to CCL3, CCL4 and CCL5. Genes Immun  6, 609-19.   https://doi.org/10.1038/sj.gene.6364247




PubMed



        
     
Free Article


 


PubMed ID 16015368
         Pubmed Central ID 1369982 


 



6.
Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, Gehrs K, Cramer K, Neel J, Bergeron J, Barile GR, Smith RT, AMD Genetics Clinical Study Group, Hageman GS, Dean M, Allikmets R (2006) Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 38:458-62.




PubMed



        
     
Free Article


 


PubMed ID 16518403
         Pubmed Central ID 2921703 


 



7.
Guo XC, Scott K, Liu Y, Dean M, David V, Nelson GW, Johnson RC, Dilks HH, Lautenberger J, Kessing B, Martenson J, Guan L, Sun S, Deng H, Zheng Y, de The G, Liao J, Zeng Y, O'Brien SJ, Winkler CA (2006). Genetic factors leading to chronic Epstein-Barr virus infection and nasopharyngeal carcinoma in South East China: study design, methods and feasibility. Hum Genomics  2, 365-75.   https://doi.org/10.1186/1479-7364-2-6-365




PubMed



        
     
Free Article


 


PubMed ID 16848974
         Pubmed Central ID 3525159 


 



8.
Petersen DC, Glashoff RH, Shrestha S, Bergeron J, Laten A, Gold B, van Rensburg EJ, Dean M, Hayes VM (2005). Risk for HIV-1 infection associated with a common CXCL12 (SDF1) polymorphism and CXCR4 variation in an African population. J Acquir Immune Defic Syndr  40, 521-6.   https://doi.org/10.1097/01.qai.0000186360.42834.28




PubMed



        
     
Free Article


 


PubMed ID 16284526
         Pubmed Central ID 1369993 


 



9.
Si Z, Vandegraaff N, O'huigin C, Song B, Yuan W, Xu C, Perron M, Li X, Marasco WA, Engelman A, Dean M, Sodroski J (2006). Evolution of a cytoplasmic tripartite motif (TRIM) protein in cows that restricts retroviral infection. Proc Natl Acad Sci U S A  103, 7454-9.   https://doi.org/10.1073/pnas.0600771103




PubMed



        
     
Free Article


 


PubMed ID 16648259
         Pubmed Central ID 1464360 


 



10.
Allikmets RL, Dean ML, Gold AL, Hageman GL (submitted in 2006) Complement Proteins For Protection Against Age-related Macular Degeneration. Patents issued: 8,012,683 (US in 2011); 9,063,139 (US in 2015); 1996214 (EP in 2016). Patents pending: 11/894,784 (US application); PCT/US2007/003904 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=43551
43,BC005657-17,"October 01, 2005 -  September 30, 2006",Molecular Basis for the Pathogenesis of Murine Retroviruses,Sandra  Ruscetti; PhD,NULL,"Laboratory of Cancer Prevention, NCI","Charlotte A Hanson



Delores M Thompson



Joan L Cmarik



Tanya M Obreiter



Gordon R Macpherson



Takako  Suzuki



Show all 7","Paul  Hoffman
(Depts. of Neuroscience and Neurology, University of Florida School of Medicine)




Marcel  Leist
(Dept. of Neuroscience and Neurology, H. Lundbeck A/S)




Michiaki  Masuda
(Dokkyo University, Japan)","Michael I Lerman; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Nishigaki K, Hanson C, Ohashi T, Spadaccini A, Ruscetti S (2006). Erythroblast transformation by the friend spleen focus-forming virus is associated with a block in erythropoietin-induced STAT1 phosphorylation and DNA binding and correlates with high expression of the hematopoietic phosphatase SHP-1. J Virol  80, 5678-85.   https://doi.org/10.1128/JVI.02651-05




PubMed



        
     
Free Article


 


PubMed ID 16731906
         Pubmed Central ID 1472600",https://intramural.nih.gov/search/searchview.taf?ipid=43602
44,BC005673-16,"October 01, 2005 -  September 30, 2006",Diazeniumdiolate Chemistry as a Platform for Designing Nitric Oxide-Based Therap,Larry K Keefer; PhD,NULL,"Laboratory of Comparative Carcinogenesis, NCI","Michael Louis Citro



Keith M Davies



Paul J Donovan



Joseph  Saavedra



Raymond W Nims



Brett M Showalter



Show all 13","Kenneth  Anderson
(Dana-Farber Cancer Institute, Harvard)




Christian  Bogdan
(Universitat Freiburg, Institut fur Medizinische Mikrobiologie und Hygiene)




Melina  Kibbe
(Division of Vascular Surgery, Northwestern University)




Tanyel  Kiziltepe
(Dana-Farber Cancer Institute, Harvard)




Edward  Knaus
(Department of Chemistry, University of Alberta)




Mark  Meyerhoff
(Department of Chemistry, University of Michigan)


Show all 11","Mariam Q Malik (National Cancer Institute)



Xinhua  Ji; PhD (National Cancer Institute)



Michael  Waalkes; PhD (National Cancer Institute)



Jie  Liu (National Cancer Institute)



David Anderson Wink (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Hrabie JA, Citro ML, Chmurny GN, Keefer LK (2005). Carbon-bound diazeniumdiolates from the reaction of nitric oxide with amidines. J Org Chem  70, 7647-53.   https://doi.org/10.1021/jo050921y




PubMed


 


PubMed ID 16149795
    
     


 



2.
Inami K, Nims RW, Srinivasan A, Citro ML, Saavedra JE, Cederbaum AI, Keefer LK (2006). Metabolism of a liver-selective nitric oxide-releasing agent, V-PYRRO/NO, by human microsomal cytochromes P450. Nitric Oxide  14, 309-15.   https://doi.org/10.1016/j.niox.2006.01.003




PubMed


 


PubMed ID 16545970
    
     


 



3.
Keefer LK (2005). Nitric oxide (NO)- and nitroxyl (HNO)-generating diazeniumdiolates (NONOates): emerging commercial opportunities. Curr Top Med Chem  5, 625-36.   https://doi.org/10.2174/1568026054679380




PubMed


 


PubMed ID 16101424
    
     


 



4.
Miranda KM, Katori T, Torres de Holding CL, Thomas L, Ridnour LA, McLendon WJ, Cologna SM, Dutton AS, Champion HC, Mancardi D, Tocchetti CG, Saavedra JE, Keefer LK, Houk KN, Fukuto JM, Kass DA, Paolocci N, Wink DA (2005). Comparison of the NO and HNO donating properties of diazeniumdiolates: primary amine adducts release HNO in Vivo. J Med Chem  48, 8220-8.   https://doi.org/10.1021/jm050151i




PubMed


 


PubMed ID 16366603
    
     


 



5.
Reynolds MM, Hrabie JA, Oh BK, Politis JK, Citro ML, Keefer LK, Meyerhoff ME (2006). Nitric oxide releasing polyurethanes with covalently linked diazeniumdiolated secondary amines. Biomacromolecules  7, 987-94.   https://doi.org/10.1021/bm060028o




PubMed


 


PubMed ID 16529441
    
     


 



6.
Saavedra JE, Srinivasan A, Buzard GS, Davies KM, Waterhouse DJ, Inami K, Wilde TC, Citro ML, Cuellar M, Deschamps JR, Parrish D, Shami PJ, Findlay VJ, Townsend DM, Tew KD, Singh S, Jia L, Ji X, Keefer LK (2006). PABA/NO as an anticancer lead: analogue synthesis, structure revision, solution chemistry, reactivity toward glutathione, and in vitro activity. J Med Chem  49, 1157-64.   https://doi.org/10.1021/jm050700k




PubMed



        
     
Free Article


 


PubMed ID 16451080
         Pubmed Central ID 6522251 


 



7.
Shami PJ, Saavedra JE, Bonifant CL, Chu J, Udupi V, Malaviya S, Carr BI, Kar S, Wang M, Jia L, Ji X, Keefer LK (2006). Antitumor activity of JS-K [O2-(2,4-dinitrophenyl) 1-[(4-ethoxycarbonyl)piperazin-1-yl]diazen-1-ium-1,2-diolate] and related O2-aryl diazeniumdiolates in vitro and in vivo. J Med Chem  49, 4356-66.   https://doi.org/10.1021/jm060022h




PubMed


 


PubMed ID 16821795
    
     


 



8.
Showalter BM, Reynolds MM, Valdez CA, Saavedra JE, Davies KM, Klose JR, Chmurny GN, Citro ML, Barchi JJ, Merz SI, Meyerhoff ME, Keefer LK (2005). Diazeniumdiolate ions as leaving groups in anomeric displacement reactions: a protection-deprotection strategy for ionic diazeniumdiolates. J Am Chem Soc  127, 14188-9.   https://doi.org/10.1021/ja054510a




PubMed


 


PubMed ID 16218605
    
     


 



9.
Townsend DM, Findlay VJ, Fazilev F, Ogle M, Fraser J, Saavedra JE, Ji X, Keefer LK, Tew KD (2006). A glutathione S-transferase pi-activated prodrug causes kinase activation concurrent with S-glutathionylation of proteins. Mol Pharmacol  69, 501-8.   https://doi.org/10.1124/mol.105.018523




PubMed



        
     
Free Article


 


PubMed ID 16288082
         Pubmed Central ID 6522256 


 



10.
Waterhouse DJ, Saavedra JE, Davies KM, Citro ML, Xu X, Powell DA, Grimes GJ, Potti GK, Keefer LK (2006). Injectable formulation of disodium 1-[2-(carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolate (PROLI/NO), an ultrafast nitric oxide donor prodrug. J Pharm Sci  95, 108-15.   https://doi.org/10.1002/jps.20486




PubMed


 


PubMed ID 16315224
    
     


 



11.
Xu X, Veenstra TD, Fox SD, Roman JM, Issaq HJ, Falk R, Saavedra JE, Keefer LK, Ziegler RG (2005). Measuring fifteen endogenous estrogens simultaneously in human urine by high-performance liquid chromatography-mass spectrometry. Anal Chem  77, 6646-54.   https://doi.org/10.1021/ac050697c




PubMed


 


PubMed ID 16223252
    
     


 



12.
Velazquez Martinez CA, Keefer LA, Knaus EA, Saavedra JA, Showalter BA (submitted in 2006) Diazeniumdiolated Non-steroidal, Anti-inflammatory Drugs, Compositions Thereof, And Related Methods. Patent issued: 2007244903 (AU in 2012). Patents pending: 07782478.7 (EP application); PCT/US2007/067295 (PC application); 12/298,322 (US application); 2,650,383 (CA application).",https://intramural.nih.gov/search/searchview.taf?ipid=43603
45,BC005688-16,"October 01, 2005 -  September 30, 2006",Preventive and therapeutic T cell vaccines to mitigate HIV-1 replication; Preven,"Genoveffa  Franchini; MD



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Robyn  Parks



Steven J Snodgrass



Wen-Po  Tsai



Monica  Vaccari



Jean-Michel  Heraud



Janos  Nacsa



Show all 8","Aftab  Ansari
(NIAMS)




Michael R Betts





Claire  Chougnet
(CHRF, Children's Hospital)




Donald  Forthal
(School of Medicine, Univ of CA)




Hana  Golding
(CBER, FDA)




Jay  Hooper
(USAMRIID)


Show all 10","Barbara K Felber (National Cancer Institute)



George N Pavlakis; MD, PhD (National Cancer Institute)



Gene  Shearer; PhD (National Cancer Institute)



Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)



Lauren V Wood; MD (National Cancer Institute)



David J Venzon; PhD (National Cancer Institute)","Michael P Bray (NIAID) 



Richard A Koup; MD (NIAID) 



David A Price (NIAID) 



Daniel C Douek; MD (NIAID) 












David C Montefiori; PhD (NIAID)","Ordered by publication type and then author name.



1.
Hel Z, Tsai WP, Tryniszewska E, Nacsa J, Markham PD, Lewis MG, Pavlakis GN, Felber BK, Tartaglia J, Franchini G (2006). Improved vaccine protection from simian AIDS by the addition of nonstructural simian immunodeficiency virus genes. J Immunol  176, 85-96.   https://doi.org/10.4049/jimmunol.176.1.85




PubMed


 


PubMed ID 16365399
    
     


 



2.
Heraud JM, Edghill-Smith Y, Ayala V, Kalisz I, Parrino J, Kalyanaraman VS, Manischewitz J, King LR, Hryniewicz A, Trindade CJ, Hassett M, Tsai WP, Venzon D, Nalca A, Vaccari M, Silvera P, Bray M, Graham BS, Golding H, Hooper JW, Franchini G (2006). Subunit recombinant vaccine protects against monkeypox. J Immunol  177, 2552-64.   https://doi.org/10.4049/jimmunol.177.4.2552




PubMed


 


PubMed ID 16888017
    
     


 



3.
Hryniewicz A, Boasso A, Edghill-Smith Y, Vaccari M, Fuchs D, Venzon D, Nacsa J, Betts MR, Tsai WP, Heraud JM, Beer B, Blanset D, Chougnet C, Lowy I, Shearer GM, Franchini G (2006). CTLA-4 blockade decreases TGF-beta, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques. Blood  108, 3834-42.   https://doi.org/10.1182/blood-2006-04-010637




PubMed



        
     
Free Article


 


PubMed ID 16896154
         Pubmed Central ID 1895471 


 



4.
Nilsson J, Boasso A, Velilla PA, Zhang R, Vaccari M, Franchini G, Shearer GM, Andersson J, Chougnet C (2006). HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. Blood  108, 3808-17.   https://doi.org/10.1182/blood-2006-05-021576




PubMed



        
     
Free Article


 


PubMed ID 16902147
         Pubmed Central ID 1895475 


 



5.
Pal R, Venzon D, Santra S, Kalyanaraman VS, Montefiori DC, Hocker L, Hudacik L, Rose N, Nacsa J, Edghill-Smith Y, Moniuszko M, Hel Z, Belyakov IM, Berzofsky JA, Parks RW, Markham PD, Letvin NL, Tartaglia J, Franchini G (2006). Systemic immunization with an ALVAC-HIV-1/protein boost vaccine strategy protects rhesus macaques from CD4+ T-cell loss and reduces both systemic and mucosal simian-human immunodeficiency virus SHIVKU2 RNA levels. J Virol  80, 3732-42.   https://doi.org/10.1128/JVI.80.8.3732-3742.2006




PubMed



        
     
Free Article


 


PubMed ID 16571790
         Pubmed Central ID 1440474 


 



6.
Vaccari M, Trindade CJ, Venzon D, Zanetti M, Franchini G (2005). Vaccine-induced CD8+ central memory T cells in protection from simian AIDS. J Immunol  175, 3502-7.   https://doi.org/10.4049/jimmunol.175.6.3502




PubMed


 


PubMed ID 16148092",https://intramural.nih.gov/search/searchview.taf?ipid=43605
46,BC005691-15,"October 01, 2005 -  September 30, 2006",Inhibition of p53 Tumor Suppressor Function by HTLV-I,John N Brady; PhD,NULL,"Laboratory of Cellular Oncology, NCI",Michael  Radonovich,NULL,"Thomas Alexander Waldmann; MD, PhD (National Cancer Institute)



John  Janik; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Chevalier SA, Meertens L, Pise-Masison C, Calattini S, Park H, Alhaj AA, Zhou M, Gessain A, Kashanchi F, Brady JN, Mahieux R (2006). The tax protein from the primate T-cell lymphotropic virus type 3 is expressed in vivo and is functionally related to HTLV-1 Tax rather than HTLV-2 Tax. Oncogene  25, 4470-82.   https://doi.org/10.1038/sj.onc.1209472




PubMed


 


PubMed ID 16532031
    
     


 



2.
Jeong SJ, Pise-Masison CA, Radonovich MF, Park HU, Brady JN (2005). A novel NF-kappaB pathway involving IKKbeta and p65/RelA Ser-536 phosphorylation results in p53 Inhibition in the absence of NF-kappaB transcriptional activity. J Biol Chem  280, 10326-32.   https://doi.org/10.1074/jbc.M412643200




PubMed


 


PubMed ID 15611068
    
     


 



3.
Jeong SJ, Pise-Masison CA, Radonovich MF, Park HU, Brady JN (2005). Activated AKT regulates NF-kappaB activation, p53 inhibition and cell survival in HTLV-1-transformed cells. Oncogene  24, 6719-28.   https://doi.org/10.1038/sj.onc.1208825




PubMed


 


PubMed ID 16007163
    
     


 



4.
Kehn K, Fuente Cde L, Strouss K, Berro R, Jiang H, Brady J, Mahieux R, Pumfery A, Bottazzi ME, Kashanchi F (2005). The HTLV-I Tax oncoprotein targets the retinoblastoma protein for proteasomal degradation. Oncogene  24, 525-40.   https://doi.org/10.1038/sj.onc.1208105




PubMed


 


PubMed ID 15580311
    
     


 



5.
Kovanen PE, Young L, Al-Shami A, Rovella V, Pise-Masison CA, Radonovich MF, Powell J, Fu J, Brady JN, Munson PJ, Leonard WJ (2005). Global analysis of IL-2 target genes: identification of chromosomal clusters of expressed genes. Int Immunol  17, 1009-21.   https://doi.org/10.1093/intimm/dxh283




PubMed


 


PubMed ID 15980098
    
     


 



6.
Park HU, Jeong SJ, Jeong JH, Chung JH, Brady JN (2006). Human T-cell leukemia virus type 1 Tax attenuates gamma-irradiation-induced apoptosis through physical interaction with Chk2. Oncogene  25, 438-47.   https://doi.org/10.1038/sj.onc.1209059




PubMed


 


PubMed ID 16158050
    
     


 



7.
Pise-Masison CA, Brady JN (2005). Setting the stage for transformation: HTLV-1 Tax inhibition of p53 function. Front Biosci  10, 919-30.   https://doi.org/10.2741/1586




PubMed


 


PubMed ID 15569630
    
     


 



8.
Pise-Masison CA, Jeong SJ, Brady JN (2005). Human T cell leukemia virus type 1: the role of Tax in leukemogenesis. Arch Immunol Ther Exp (Warsz)  53, 283-96.




PubMed


 


PubMed ID 16088313
    
     


 



9.
Wamunyokoli FW, Bonome T, Lee JY, Feltmate CM, Welch WR, Radonovich M, Pise-Masison C, Brady J, Hao K, Berkowitz RS, Mok S, Birrer MJ (2006). Expression profiling of mucinous tumors of the ovary identifies genes of clinicopathologic importance. Clin Cancer Res  12, 690-700.   https://doi.org/10.1158/1078-0432.CCR-05-1110




PubMed


 


PubMed ID 16467078
    
     


 



10.
Zeng R, Spolski R, Finkelstein SE, Oh S, Kovanen PE, Hinrichs CS, Pise-Masison CA, Radonovich MF, Brady JN, Restifo NP, Berzofsky JA, Leonard WJ (2005). Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. J Exp Med  201, 139-48.   https://doi.org/10.1084/jem.20041057




PubMed



        
     
Free Article


 


PubMed ID 15630141
         Pubmed Central ID 2212766",https://intramural.nih.gov/search/searchview.taf?ipid=43606
47,BC005708-15,"October 01, 2005 -  September 30, 2006",Xenobiotic Receptors,"Frank Jess Gonzalez; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI","Connie  Cheung



Qian  Yang



Masahiro  Adachi



Tomokazu  Nagano",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Adachi M, Kurotani R, Morimura K, Shah Y, Sanford M, Madison BB, Gumucio DL, Marin HE, Peters JM, Young HA, Gonzalez FJ (2006). Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease. Gut  55, 1104-13.   https://doi.org/10.1136/gut.2005.081745




PubMed



        
     
Free Article


 


PubMed ID 16547072
         Pubmed Central ID 1513267 


 



2.
Burdick AD, Kim DJ, Peraza MA, Gonzalez FJ, Peters JM (2006). The role of peroxisome proliferator-activated receptor-beta/delta in epithelial cell growth and differentiation. Cell Signal  18, 9-20.   https://doi.org/10.1016/j.cellsig.2005.07.009




PubMed


 


PubMed ID 16109478
    
     


 



3.
Crosby MB, Svenson JL, Zhang J, Nicol CJ, Gonzalez FJ, Gilkeson GS (2005). Peroxisome proliferation-activated receptor (PPAR)gamma is not necessary for synthetic PPARgamma agonist inhibition of inducible nitric-oxide synthase and nitric oxide. J Pharmacol Exp Ther  312, 69-76.   https://doi.org/10.1124/jpet.104.074005




PubMed


 


PubMed ID 15356214
    
     


 



4.
Duran-Sandoval D, Cariou B, Percevault F, Hennuyer N, Grefhorst A, van Dijk TH, Gonzalez FJ, Fruchart JC, Kuipers F, Staels B (2005). The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition. J Biol Chem  280, 29971-9.   https://doi.org/10.1074/jbc.M501931200




PubMed


 


PubMed ID 15899888
    
     


 



5.
Gonzalez FJ (2005). Getting fat: two new players in molecular adipogenesis. Cell Metab  1, 85-6.   https://doi.org/10.1016/j.cmet.2005.01.004




PubMed


 


PubMed ID 16054047
    
     


 



6.
Gonzalez FJ, Yu AM (2006). Cytochrome P450 and xenobiotic receptor humanized mice. Annu Rev Pharmacol Toxicol  46, 41-64.   https://doi.org/10.1146/annurev.pharmtox.45.120403.100007




PubMed



        
     
Free Article


 


PubMed ID 16402898
         Pubmed Central ID 1440291 


 



7.
Gunton JE, Kulkarni RN, Yim S, Okada T, Hawthorne WJ, Tseng YH, Roberson RS, Ricordi C, O'Connell PJ, Gonzalez FJ, Kahn CR   (2005) Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes.  Cell 122:337-49.




PubMed


 


PubMed ID 16096055
    
     


 



8.
Hays T, Rusyn I, Burns AM, Kennett MJ, Ward JM, Gonzalez FJ, Peters JM (2005). Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis. Carcinogenesis  26, 219-27.   https://doi.org/10.1093/carcin/bgh285




PubMed


 


PubMed ID 15447978
    
     


 



9.
Jia Y, Guo GL, Surapureddi S, Sarkar J, Qi C, Guo D, Xia J, Kashireddi P, Yu S, Cho YW, Rao MS, Kemper B, Ge K, Gonzalez FJ, Reddy JK (2005). Transcription coactivator peroxisome proliferator-activated receptor-binding protein/mediator 1 deficiency abrogates acetaminophen hepatotoxicity. Proc Natl Acad Sci U S A  102, 12531-6.   https://doi.org/10.1073/pnas.0506000102




PubMed



        
     
Free Article


 


PubMed ID 16109766
         Pubmed Central ID 1187948 


 



10.
Kim DJ, Prabhu KS, Gonzalez FJ, Peters JM (2006). Inhibition of chemically induced skin carcinogenesis by sulindac is independent of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta). Carcinogenesis  27, 1105-12.   https://doi.org/10.1093/carcin/bgi346




PubMed


 


PubMed ID 16418176
    
     


 



11.
Lee CH, Olson P, Hevener A, Mehl I, Chong LW, Olefsky JM, Gonzalez FJ, Ham J, Kang H, Peters JM, Evans RM (2006). PPARdelta regulates glucose metabolism and insulin sensitivity. Proc Natl Acad Sci U S A  103, 3444-9.   https://doi.org/10.1073/pnas.0511253103




PubMed



        
     
Free Article


 


PubMed ID 16492734
         Pubmed Central ID 1413918 


 



12.
Lee H, Zhang Y, Lee FY, Nelson SF, Gonzalez FJ, Edwards PA (2006). FXR regulates organic solute transporters alpha and beta in the adrenal gland, kidney, and intestine. J Lipid Res  47, 201-14.   https://doi.org/10.1194/jlr.M500417-JLR200




PubMed


 


PubMed ID 16251721
    
     


 



13.
Marin HE, Peraza MA, Billin AN, Willson TM, Ward JM, Kennett MJ, Gonzalez FJ, Peters JM (2006). Ligand activation of peroxisome proliferator-activated receptor beta inhibits colon carcinogenesis. Cancer Res  66, 4394-401.   https://doi.org/10.1158/0008-5472.CAN-05-4277




PubMed


 


PubMed ID 16618765
    
     


 



14.
Matsusue K, Miyoshi A, Yamano S, Gonzalez FJ (2006). Ligand-activated PPARbeta efficiently represses the induction of LXR-dependent promoter activity through competition with RXR. Mol Cell Endocrinol  256, 23-33.   https://doi.org/10.1016/j.mce.2006.05.005




PubMed



        
     
Free Article


 


PubMed ID 16806672
         Pubmed Central ID 1544360 


 



15.
Miyata M, Matsuda Y, Tsuchiya H, Kitada H, Akase T, Shimada M, Nagata K, Gonzalez FJ, Yamazoe Y (2006). Chenodeoxycholic acid-mediated activation of the farnesoid X receptor negatively regulates hydroxysteroid sulfotransferase. Drug Metab Pharmacokinet  21, 315-23.   https://doi.org/10.2133/dmpk.21.315




PubMed


 


PubMed ID 16946559
    
     


 



16.
Morimura K, Cheung C, Ward JM, Reddy JK, Gonzalez FJ (2006). Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor alpha to Wy-14,643-induced liver tumorigenesis. Carcinogenesis  27, 1074-80.   https://doi.org/10.1093/carcin/bgi329




PubMed



        
     
Free Article


 


PubMed ID 16377806
         Pubmed Central ID 1447533 


 



17.
Naito H, Yamanoshita O, Kamijima M, Katoh T, Matsunaga T, Lee CH, Kim H, Aoyama T, Gonzalez FJ, Nakajima T (2006). Association of V227A PPARalpha polymorphism with altered serum biochemistry and alcohol drinking in Japanese men. Pharmacogenet Genomics  16, 569-77.   https://doi.org/10.1097/01.fpc.0000220565.90466.79




PubMed


 


PubMed ID 16847426
    
     


 



18.
Pedraza N, Rosell M, Villarroya J, Iglesias R, Gonzalez FJ, Solanes G, Villarroya F (2006). Developmental and tissue-specific involvement of peroxisome proliferator-activated receptor-alpha in the control of mouse uncoupling protein-3 gene expression. Endocrinology  147, 4695-704.   https://doi.org/10.1210/en.2006-0226




PubMed


 


PubMed ID 16857752
    
     


 



19.
Peraza MA, Burdick AD, Marin HE, Gonzalez FJ, Peters JM (2006). The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR). Toxicol Sci  90, 269-95.   https://doi.org/10.1093/toxsci/kfj062




PubMed


 


PubMed ID 16322072
    
     


 



20.
Rodríguez-Sosa M, Elizondo G, López-Durán RM, Rivera I, Gonzalez FJ, Vega L (2005). Over-production of IFN-gamma and IL-12 in AhR-null mice. FEBS Lett  579, 6403-10.   https://doi.org/10.1016/j.febslet.2005.10.023




PubMed


 


PubMed ID 16289099
    
     


 



21.
Shin M, Kim I, Inoue Y, Kimura S, Gonzalez FJ (2006). Regulation of mouse hepatic alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase, a key enzyme in the tryptophan-nicotinamide adenine dinucleotide pathway, by hepatocyte nuclear factor 4alpha and peroxisome proliferator-activated receptor alpha. Mol Pharmacol  70, 1281-90.   https://doi.org/10.1124/mol.106.026294




PubMed


 


PubMed ID 16807375
    
     


 



22.
Tong Y, Hara A, Komatsu M, Tanaka N, Kamijo Y, Gonzalez FJ, Aoyama T (2005). Suppression of expression of muscle-associated proteins by PPARalpha in brown adipose tissue. Biochem Biophys Res Commun  336, 76-83.   https://doi.org/10.1016/j.bbrc.2005.08.041




PubMed


 


PubMed ID 16125138
    
     


 



23.
Yang Q, Kurotani R, Yamada A, Kimura S, Gonzalez FJ (2006). Peroxisome proliferator-activated receptor alpha activation during pregnancy severely impairs mammary lobuloalveolar development in mice. Endocrinology  147, 4772-80.   https://doi.org/10.1210/en.2006-0437




PubMed



        
     
Free Article


 


PubMed ID 16857745
         Pubmed Central ID 1570154 


 



24.
Yang Q, Yamada A, Kimura S, Peters JM, Gonzalez FJ (2006). Alterations in skin and stratified epithelia by constitutively activated PPARalpha. J Invest Dermatol  126, 374-85.   https://doi.org/10.1038/sj.jid.5700056




PubMed


 


PubMed ID 16374467
    
     


 



25.
Zhang H, Zhang A, Kohan DE, Nelson RD, Gonzalez FJ, Yang T (2005). Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention. Proc Natl Acad Sci U S A  102, 9406-11.   https://doi.org/10.1073/pnas.0501744102




PubMed



        
     
Free Article


 


PubMed ID 15956187
         Pubmed Central ID 1166599 


 



26.
Zhang X, Tanaka N, Nakajima T, Kamijo Y, Gonzalez FJ, Aoyama T (2006). Peroxisome proliferator-activated receptor alpha-independent peroxisome proliferation. Biochem Biophys Res Commun  346, 1307-11.   https://doi.org/10.1016/j.bbrc.2006.06.042




PubMed


 


PubMed ID 16806075
    
     


 



27.
Zhang Y, Lee FY, Barrera G, Lee H, Vales C, Gonzalez FJ, Willson TM, Edwards PA (2006). Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice. Proc Natl Acad Sci U S A  103, 1006-11.   https://doi.org/10.1073/pnas.0506982103




PubMed



        
     
Free Article


 


PubMed ID 16410358
         Pubmed Central ID 1347977",https://intramural.nih.gov/search/searchview.taf?ipid=43607
48,BC005725-14,"October 01, 2005 -  September 30, 2006",ABC Transporters in Human Disease and Multidrug Resistance,"Michael  Dean; PhD



IRP Faculty Profile",NULL,"Laboratory of Genomic Diversity, NCI","Zhang-Qun  Chen



Stefan Alexandrov Stefanov



Hong  Lou



Adam K Olsh



Mark  Scally



Bhairavi  Tolani","Rando  Allikmets
(NCI)




Larry  Nogee
(Pediatrics, Johns Hopkins University)




Ina  Urbatsch
(Cell Biology and Biochemistry, Texas Tech University Health Sciences)","Susan  Bates; MD (National Cancer Institute)



Antonio  Fojo; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Annilo T, Chen ZQ, Shulenin S, Costantino J, Thomas L, Lou H, Stefanov S, Dean M (2006). Evolution of the vertebrate ABC gene family: analysis of gene birth and death. Genomics  88, 1-11.   https://doi.org/10.1016/j.ygeno.2006.03.001




PubMed


 


PubMed ID 16631343
    
     


 



2.
Chen ZQ, Dong J, Ishimura A, Daar I, Hinnebusch AG, Dean M (2006). The essential vertebrate ABCE1 protein interacts with eukaryotic initiation factors. J Biol Chem  281, 7452-7.   https://doi.org/10.1074/jbc.M510603200




PubMed


 


PubMed ID 16421098
    
     


 



3.
Dean M (2005). The genetics of ATP-binding cassette transporters. Methods Enzymol  400, 409-29.   https://doi.org/10.1016/S0076-6879(05)00024-8




PubMed


 


PubMed ID 16399363
    
     


 



4.
Dean M (2006). Cancer stem cells: redefining the paradigm of cancer treatment strategies. Mol Interv  6, 140-8.   https://doi.org/10.1124/mi.6.3.5




PubMed


 


PubMed ID 16809475
    
     


 



5.
Dean M, Annilo T (2005). Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates. Annu Rev Genomics Hum Genet  6, 123-42.   https://doi.org/10.1146/annurev.genom.6.080604.162122




PubMed


 


PubMed ID 16124856
    
     


 



6.
Dean M, Fojo T, Bates S (2005). Tumour stem cells and drug resistance. Nat Rev Cancer  5, 275-84.   https://doi.org/10.1038/nrc1590




PubMed


 


PubMed ID 15803154
    
     


 



7.
Dean M, Stalcup L, Harvey B, Weber J, Chloupkova M, Dumont M, Urbatsch I   (2006) Purification and ATP Hydrolysis of the Putative Cholesterol Transporters ABCG5 and ABCG8.  Biochemistry  9929-9939 pp.




 



8.
Garmany TH, Moxley MA, White FV, Dean M, Hull WM, Whitsett JA, Nogee LM, Hamvas A (2006). Surfactant composition and function in patients with ABCA3 mutations. Pediatr Res  59, 801-5.   https://doi.org/10.1203/01.pdr.0000219311.14291.df




PubMed


 


PubMed ID 16641205
    
     


 



9.
Henrich CJ, Bokesch HR, Dean M, Bates SE, Robey RW, Goncharova EI, Wilson JA, McMahon JB (2006). A high-throughput cell-based assay for inhibitors of ABCG2 activity. J Biomol Screen  11, 176-83.   https://doi.org/10.1177/1087057105284576




PubMed


 


PubMed ID 16490770
    
     


 



10.
Polgar O, Ozvegy-Laczka C, Robey RW, Morisaki K, Okada M, Tamaki A, Koblos G, Elkind NB, Ward Y, Dean M, Sarkadi B, Bates SE (2006). Mutational studies of G553 in TM5 of ABCG2: a residue potentially involved in dimerization. Biochemistry  45, 5251-60.   https://doi.org/10.1021/bi0521590




PubMed



        
     
Free Article


 


PubMed ID 16618113
         Pubmed Central ID 2548280",https://intramural.nih.gov/search/searchview.taf?ipid=43552
49,BC005740-14,"October 01, 2005 -  September 30, 2006",Transgenic Models for Prostate and Breast Cancer,Jeffrey E Green; MD,NULL,"Laboratory of Cell Regulation and Carcinogenesis, NCI","Dalit  Barkan



Zi-yao  Liu



Jung-Im  Huh



Tamaro  Hudson



Ting-Hu  Qiu



Mark  Hoenerhoff; DVM, PhD","Chu-Xia  Deng
(NIDDK)
















Khalil  Ahmed
(University of Minnessota, University of Minnessota)




Alfons  Calvo
(University of Navarra, University of Navarra)




Bruce  Crise
(SAIC, SAIC)




Eli  Ellson
(Weizmann Institute, Weizmann Institute)




Dianne  Hartle
(University of Georgia, University of Georgia)


Show all 13","Nealapheur L Khan (National Cancer Institute)



Dolph Lee Hatfield; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Green J, Michalowska A, Qiu T   (2006) A Bioinformatics Approach to the Analysis of Animal Models of Cancer, in Bioinformatics in Cancer and Cancer Therapy, in press.




 



2.
Hsieh CL, Xie Z, Liu ZY, Green JE, Martin WD, Datta MW, Yeung F, Pan D, Chung LW (2005). A luciferase transgenic mouse model: visualization of prostate development and its androgen responsiveness in live animals. J Mol Endocrinol  35, 293-304.   https://doi.org/10.1677/jme.1.01722




PubMed


 


PubMed ID 16216910
    
     


 



3.
Huang S, Li Y, Chen Y, Podsypanina K, Chamorro M, Olshen AB, Desai KV, Tann A, Petersen D, Green JE, Varmus HE   (2005) Changes in gene expression during the development of mammary tumors in MMTV-Wnt-1 transgenic mice.  Genome Biol 6:R84.




PubMed



        
     
Free Article


 


PubMed ID 16207355
         Pubmed Central ID 1257467 


 



4.
Huh JI, Calvo A, Charles R, Green JE (2006). Distinct tumor stage-specific inhibitory effects of 2-methoxyestradiol in a breast cancer mouse model associated with Id-1 expression. Cancer Res  66, 3495-503.   https://doi.org/10.1158/0008-5472.CAN-04-2372




PubMed


 


PubMed ID 16585173
    
     


 



5.
Oakes SR, Robertson FG, Kench JG, Gardiner-Garden M, Wand MP, Green JE, Ormandy CJ (2007). Loss of mammary epithelial prolactin receptor delays tumor formation by reducing cell proliferation in low-grade preinvasive lesions. Oncogene  26, 543-53.   https://doi.org/10.1038/sj.onc.1209838




PubMed


 


PubMed ID 16862169
    
     


 



6.
Zhang X, Mehta RG, Lantvit DD, Coschigano KT, Kopchick JJ, Green JE, Hedayat S, Christov KT, Ray VH, Unterman TG, Swanson SM (2007). Inhibition of estrogen-independent mammary carcinogenesis by disruption of growth hormone signaling. Carcinogenesis  28, 143-50.   https://doi.org/10.1093/carcin/bgl138




PubMed


 


PubMed ID 16916863",https://intramural.nih.gov/search/searchview.taf?ipid=43608
50,BC005753-14,"October 01, 2005 -  September 30, 2006",HIV Tat Transcriptional Activation,John N Brady; PhD,NULL,"Laboratory of Cellular Oncology, NCI","Meisheng  Zhou



Won-Kyung  Cho","Fatah  Kashanchi
(Department of Biochemistry, George Washington University Medical School)




Sergei  Nekhai
(Biochemistry Department, Howard University)",Dinah  Singer; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Ammosova T, Washington K, Debebe Z, Brady J, Nekhai S (2005). Dephosphorylation of CDK9 by protein phosphatase 2A and protein phosphatase-1 in Tat-activated HIV-1 transcription. Retrovirology  2, 47.   https://doi.org/10.1186/1742-4690-2-47




PubMed



        
     
Free Article


 


PubMed ID 16048649
         Pubmed Central ID 1187922 


 



2.
Gegonne A, Weissman JD, Zhou M, Brady JN, Singer DS (2006). TAF7: a possible transcription initiation check-point regulator. Proc Natl Acad Sci U S A  103, 602-7.   https://doi.org/10.1073/pnas.0510031103




PubMed



        
     
Free Article


 


PubMed ID 16407123
         Pubmed Central ID 1325967 


 



3.
Jang MK, Mochizuki K, Zhou M, Jeong HS, Brady JN, Ozato K (2005). The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol Cell  19, 523-34.   https://doi.org/10.1016/j.molcel.2005.06.027




PubMed


 


PubMed ID 16109376
    
     


 



4.
Zhou M, Lu H, Park H, Wilson-Chiru J, Linton R, Brady JN (2006). Tax interacts with P-TEFb in a novel manner to stimulate human T-lymphotropic virus type 1 transcription. J Virol  80, 4781-91.   https://doi.org/10.1128/JVI.80.10.4781-4791.2006




PubMed



        
     
Free Article


 


PubMed ID 16641271
         Pubmed Central ID 1472077",https://intramural.nih.gov/search/searchview.taf?ipid=43610
51,BC005785-12,"October 01, 2005 -  September 30, 2006",TGF-betas in breast cancer progression,"Lalage  Wakefield; PhD



IRP Faculty Profile",NULL,"Laboratory of Cell Regulation and Carcinogenesis, NCI","Binwu  Tang



Jeong-Seok  Nam



Ethan  Kohn



Mi-Jin  Kang



Catherine  Hooke","Jay  Harper
(Cytokine Biology, Genzyme Corp)




Scott  Lonning
(Gene Therapy, Genzyme Corp.)




Ian  Paterson





Michael  Sporn
(Pharmacology, Dartmouth Medical School)","Masaki  Terabe (National Cancer Institute)



Maxwell P Lee; PhD (National Cancer Institute)



Miriam R Anver (National Cancer Institute)



Kent W Hunter; PhD (National Cancer Institute)



Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Nam JS, Kang MJ, Suchar AM, Shimamura T, Kohn EA, Michalowska AM, Jordan VC, Hirohashi S, Wakefield LM (2006). Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells. Cancer Res  66, 7176-84.   https://doi.org/10.1158/0008-5472.CAN-06-0825




PubMed



        
     
Free Article


 


PubMed ID 16849564
         Pubmed Central ID 1557381 


 



2.
Nam JS, Suchar AM, Kang MJ, Stuelten CH, Tang B, Michalowska AM, Fisher LW, Fedarko NS, Jain A, Pinkas J, Lonning S, Wakefield LM (2006). Bone sialoprotein mediates the tumor cell-targeted prometastatic activity of transforming growth factor beta in a mouse model of breast cancer. Cancer Res  66, 6327-35.   https://doi.org/10.1158/0008-5472.CAN-06-0068




PubMed



        
     
Free Article


 


PubMed ID 16778210
         Pubmed Central ID 1528715 


 



3.
Tang B, Yoo N, Vu M, Mamura M, Nam JS, Ooshima A, Du Z, Desprez PY, Anver MR, Michalowska AM, Shih J, Parks WT, Wakefield LM (2007). Transforming growth factor-beta can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft model. Cancer Res  67, 8643-52.   https://doi.org/10.1158/0008-5472.CAN-07-0982




PubMed



        
     
Free Article


 


PubMed ID 17875704
         Pubmed Central ID 2427144",https://intramural.nih.gov/search/searchview.taf?ipid=43611
52,BC005793-12,"October 01, 2005 -  September 30, 2006",Mechanism of viral hepatitis-mediated hepatocarcinogenesis,"Xin Wei Wang; PhD



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","Anuradha Samantha Budhu



Marshonna J Forgues



Mi Jung  Lim",NULL,NULL,Wei  Wang; PhD (OD),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43612
53,BC005795-12,"October 01, 2005 -  September 30, 2006",p53 Tumor Suppressor Pathway,"Curtis  Harris; MD



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","John  Bradsher



Mary G Mcmenamin



Remy Marie Pedeux



Elisa A Spillare



Jiang-Cheng  Shen



Kensuke  Kumamoto



Show all 9","I.  Hickson
(Imperial Cancer Research Fund Laboratories, Oxford, UK)




V  Rotter
(Dept. of Cell Biology, The Weizman Institute of Science)",NULL,Ran  Zhang (NINDS),"Ordered by publication type and then author name.



1.
Hussain SP, Harris CC (2006). p53 biological network: at the crossroads of the cellular-stress response pathway and molecular carcinogenesis. J Nippon Med Sch  73, 54-64.   https://doi.org/10.1272/jnms.73.54




PubMed


 


PubMed ID 16641528
    
     


 



2.
Okano T, Gemma A, Hosoya Y, Hosomi Y, Nara M, Kokubo Y, Yoshimura A, Shibuya M, Nagashima M, Harris CC, Kudoh S   (2006) Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.  Oncol Rep 15:545-9.




PubMed


 


PubMed ID 16465410",https://intramural.nih.gov/search/searchview.taf?ipid=43613
54,BC005800-12,"October 01, 2005 -  September 30, 2006",Discovering Disease Susceptibility Genes in African Americans,Michael W Smith,NULL,"Laboratory of Genomic Diversity, NCI","Taras K Oleksyk



Ann  Truelove



Mary A Thompson



Michael E Weedon



Yvette  Berthier-schaad



Cheryl Ann Winkler","Francisco  De La Vega
(Applied Biosystems)




Myron  Essex
(Dept. of Immunology & Infectious Diseases, Harvard School of Public Health)




Dennis  Gilbert
(Chief Scientific Officer and Vice President for Research, Applied Biosystems)




Linda  Kao
(Dept. of Epidemiology, Johns Hopkins University)




Michael  Klag
(Johns Hopkins University)




Jason H. Moore; PhD
(Division of Biomedical Informatics, The Perelman School of Medicine)


Show all 13",Stephen J O'Brien; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Chretien JP, Coresh J, Berthier-Schaad Y, Kao WH, Fink NE, Klag MJ, Marcovina SM, Giaculli F, Smith MW (2006). Three single-nucleotide polymorphisms in LPA account for most of the increase in lipoprotein(a) level elevation in African Americans compared with European Americans. J Med Genet  43, 917-23.   https://doi.org/10.1136/jmg.2006.042119




PubMed



        
     
Free Article


 


PubMed ID 16840570
         Pubmed Central ID 2563202 


 



2.
Smith M, Hutcheson-Dilks H, Williams S, Moore J, Essex M, Ruiz-Pesini E, Wallace D, Tishkoff S, O'Brien S   (2006) Elevated male European and female African contributions to the genomes of African American individuals.  Human Genetics, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=43614
55,BC006140-30,"October 01, 2005 -  September 30, 2006",Studies of Histone Functions in Chromatin; H2AX and DNA DSBs,"William M Bonner; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI",NULL,NULL,Michael Joseph Lichten; PhD (National Cancer Institute),"Ronald D Neumann; MD (CC) 



Igor  Panyutin; PhD (CC) 



Irina  Panyutin; MD (CC)","Ordered by publication type and then author name.



1.
Nakamura A, Sedelnikova OA, Redon C, Pilch DR, Sinogeeva NI, Shroff R, Lichten M, Bonner WM (2006). Techniques for gamma-H2AX detection. Methods Enzymol  409, 236-50.   https://doi.org/10.1016/S0076-6879(05)09014-2




PubMed


 


PubMed ID 16793405
    
     


 



2.
Redon C, Pilch DR, Bonner WM (2006). Genetic analysis of Saccharomyces cerevisiae H2A serine 129 mutant suggests a functional relationship between H2A and the sister-chromatid cohesion partners Csm3-Tof1 for the repair of topoisomerase I-induced DNA damage. Genetics  172, 67-76.   https://doi.org/10.1534/genetics.105.046128




PubMed



        
     
Free Article


 


PubMed ID 16219777
         Pubmed Central ID 1456192",https://intramural.nih.gov/search/searchview.taf?ipid=43615
56,BC006150-25,"October 01, 2005 -  September 30, 2006","DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs","Yves  Pommier; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Gregory J Aune



Zhi-Yong  Liao



Christophe  Marchand



Keli  Agama



Ling-Hua  Meng



Jennifer A Seiler



Show all 12","William  Gmeiner
(PHARMACOLOGY, WAKE FOREST UNIVERSITY)




Lawrence F. Povirk; PhD
(Department of Pharmacology and Toxicology, Virginia Commonwealth University)","Frank M Balis; MD, PhD (National Cancer Institute)



Robert  Shoemaker (National Cancer Institute)



Robert J Fisher (National Cancer Institute)



Alexander  Wlodawer; PhD (National Cancer Institute)



Mirit I Aladjem; PhD (National Cancer Institute)



Frank Jess Gonzalez; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Brantley E, Antony S, Kohlhagen G, Meng L, Agama K, Stinson SF, Sausville EA, Pommier Y (2006). Anti-tumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces single-strand breaks and DNA-protein cross-links in sensitive MCF-7 breast cancer cells. Cancer Chemother Pharmacol  58, 62-72.   https://doi.org/10.1007/s00280-005-0127-z




PubMed


 


PubMed ID 16331501
    
     


 



2.
Chen C, Meng L, Ma X, Krausz KW, Pommier Y, Idle JR, Gonzalez FJ (2006). Urinary metabolite profiling reveals CYP1A2-mediated metabolism of NSC686288 (aminoflavone). J Pharmacol Exp Ther  318, 1330-42.   https://doi.org/10.1124/jpet.106.105213




PubMed



        
     
Free Article


 


PubMed ID 16775196
         Pubmed Central ID 1551906 


 



3.
Furuta T, Hayward RL, Meng LH, Takemura H, Aune GJ, Bonner WM, Aladjem MI, Kohn KW, Pommier Y (2006). p21CDKN1A allows the repair of replication-mediated DNA double-strand breaks induced by topoisomerase I and is inactivated by the checkpoint kinase inhibitor 7-hydroxystaurosporine. Oncogene  25, 2839-49.   https://doi.org/10.1038/sj.onc.1209313




PubMed


 


PubMed ID 16407843
    
     


 



4.
Kim Y, Sun Y, Chow C, Pommier YG, Simons SS (2006). Effects of acetylation, polymerase phosphorylation, and DNA unwinding in glucocorticoid receptor transactivation. J Steroid Biochem Mol Biol  100, 3-17.   https://doi.org/10.1016/j.jsbmb.2006.03.003




PubMed


 


PubMed ID 16723222
    
     


 



5.
Kohn KW, Aladjem MI, Weinstein JN, Pommier Y (2006). Molecular interaction maps of bioregulatory networks: a general rubric for systems biology. Mol Biol Cell  17, 1-13.   https://doi.org/10.1091/mbc.e05-09-0824




PubMed



        
     
Free Article


 


PubMed ID 16267266
         Pubmed Central ID 1345641 


 



6.
Liao Z, Thibaut L, Jobson A, Pommier Y (2006). Inhibition of human tyrosyl-DNA phosphodiesterase by aminoglycoside antibiotics and ribosome inhibitors. Mol Pharmacol  70, 366-72.   https://doi.org/10.1124/mol.105.021865




PubMed


 


PubMed ID 16618796
    
     


 



7.
Marchand C, Krajewski K, Lee HF, Antony S, Johnson AA, Amin R, Roller P, Kvaratskhelia M, Pommier Y (2006). Covalent binding of the natural antimicrobial peptide indolicidin to DNA abasic sites. Nucleic Acids Res  34, 5157-65.   https://doi.org/10.1093/nar/gkl667




PubMed



        
     
Free Article


 


PubMed ID 16998183
         Pubmed Central ID 1636436 


 



8.
Miao ZH, Agama K, Sordet O, Povirk L, Kohn KW, Pommier Y (2006). Hereditary ataxia SCAN1 cells are defective for the repair of transcription-dependent topoisomerase I cleavage complexes. DNA Repair (Amst)  5, 1489-94.   https://doi.org/10.1016/j.dnarep.2006.07.004




PubMed


 


PubMed ID 16935573
    
     


 



9.
Pommier Y (2006). Topoisomerase I inhibitors: camptothecins and beyond. Nat Rev Cancer  6, 789-802.   https://doi.org/10.1038/nrc1977




PubMed


 


PubMed ID 16990856
    
     


 



10.
Pommier Y, Weinstein JN, Aladjem MI, Kohn KW (2006). Chk2 molecular interaction map and rationale for Chk2 inhibitors. Clin Cancer Res  12, 2657-61.   https://doi.org/10.1158/1078-0432.CCR-06-0743




PubMed


 


PubMed ID 16675556
    
     


 



11.
Rao VA, Fan AM, Meng L, Doe CF, North PS, Hickson ID, Pommier Y (2005). Phosphorylation of BLM, dissociation from topoisomerase IIIalpha, and colocalization with gamma-H2AX after topoisomerase I-induced replication damage. Mol Cell Biol  25, 8925-37.   https://doi.org/10.1128/MCB.25.20.8925-8937.2005




PubMed



        
     
Free Article


 


PubMed ID 16199871
         Pubmed Central ID 1265790 


 



12.
Takemura H, Rao VA, Sordet O, Furuta T, Miao ZH, Meng L, Zhang H, Pommier Y (2006). Defective Mre11-dependent activation of Chk2 by ataxia telangiectasia mutated in colorectal carcinoma cells in response to replication-dependent DNA double strand breaks. J Biol Chem  281, 30814-23.   https://doi.org/10.1074/jbc.M603747200




PubMed


 


PubMed ID 16905549
    
     


 



13.
Yoshida A, Pommier Y, Ueda T (2006). Endonuclease activation and chromosomal DNA fragmentation during apoptosis in leukemia cells. Int J Hematol  84, 31-7.   https://doi.org/10.1007/bf03342699




PubMed


 


PubMed ID 16867899",https://intramural.nih.gov/search/searchview.taf?ipid=43616
57,BC006161-23,"October 01, 2005 -  September 30, 2006",DNA Topoisomerases as Target of Action of Anticancer Drugs,"Yves  Pommier; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Gregory J Aune



Zhi-Yong  Liao



Keli  Agama



Ling-Hua  Meng



Jennifer A Seiler



Olivier  Sordet



Show all 10","Mark  Cushman
(Medicinal Chemistry, Purdue University)




Lawrence F. Povirk; PhD
(Department of Pharmacology and Toxicology, Virginia Commonwealth University)",Melinda  Hollingshead (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Antony S, Agama KK, Miao ZH, Hollingshead M, Holbeck SL, Wright MH, Varticovski L, Nagarajan M, Morrell A, Cushman M, Pommier Y (2006). Bisindenoisoquinoline bis-1,3-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]isoquinoline)-6-propylamino}propane bis(trifluoroacetate) (NSC 727357), a DNA intercalator and topoisomerase inhibitor with antitumor activity. Mol Pharmacol  70, 1109-20.   https://doi.org/10.1124/mol.106.024372




PubMed


 


PubMed ID 16798938
    
     


 



2.
Kim Y, Sun Y, Chow C, Pommier YG, Simons SS (2006). Effects of acetylation, polymerase phosphorylation, and DNA unwinding in glucocorticoid receptor transactivation. J Steroid Biochem Mol Biol  100, 3-17.   https://doi.org/10.1016/j.jsbmb.2006.03.003




PubMed


 


PubMed ID 16723222
    
     


 



3.
Kohn KW, Pommier Y (2005). Molecular interaction map of the p53 and Mdm2 logic elements, which control the Off-On switch of p53 in response to DNA damage. Biochem Biophys Res Commun  331, 816-27.   https://doi.org/10.1016/j.bbrc.2005.03.186




PubMed


 


PubMed ID 15865937
    
     


 



4.
Liao Z, Thibaut L, Jobson A, Pommier Y (2006). Inhibition of human tyrosyl-DNA phosphodiesterase by aminoglycoside antibiotics and ribosome inhibitors. Mol Pharmacol  70, 366-72.   https://doi.org/10.1124/mol.105.021865




PubMed


 


PubMed ID 16618796
    
     


 



5.
Marchand C, Antony S, Kohn KW, Cushman M, Ioanoviciu A, Staker BL, Burgin AB, Stewart L, Pommier Y (2006). A novel norindenoisoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complex. Mol Cancer Ther  5, 287-95.   https://doi.org/10.1158/1535-7163.MCT-05-0456




PubMed



        
     
Free Article


 


PubMed ID 16505102
         Pubmed Central ID 2860177 


 



6.
Morrell A, Jayaraman M, Nagarajan M, Fox BM, Meckley MR, Ioanoviciu A, Pommier Y, Antony S, Hollingshead M, Cushman M (2006). Evaluation of indenoisoquinoline topoisomerase I inhibitors using a hollow fiber assay. Bioorg Med Chem Lett  16, 4395-9.   https://doi.org/10.1016/j.bmcl.2006.05.048




PubMed


 


PubMed ID 16750365
    
     


 



7.
Rao VA, Fan AM, Meng L, Doe CF, North PS, Hickson ID, Pommier Y (2005). Phosphorylation of BLM, dissociation from topoisomerase IIIalpha, and colocalization with gamma-H2AX after topoisomerase I-induced replication damage. Mol Cell Biol  25, 8925-37.   https://doi.org/10.1128/MCB.25.20.8925-8937.2005




PubMed



        
     
Free Article


 


PubMed ID 16199871
         Pubmed Central ID 1265790 


 



8.
Tangirala RS, Antony S, Agama K, Pommier Y, Anderson BD, Bevins R, Curran DP (2006). Synthesis and biological assays of E-ring analogs of camptothecin and homocamptothecin. Bioorg Med Chem  14, 6202-12.   https://doi.org/10.1016/j.bmc.2006.05.073




PubMed


 


PubMed ID 16793274
    
     


 



9.
Pommier Y, Agama K, Antony S, Cushman M (submitted in 2006) Novel Indenoisoquinoline Derivatives As Anti-proliferative Agents In Cancer Treatment. Patents issued: 8,053,443 (US in 2012); 5412113 (JP in 2014); 5567157 (JP in 2014); 8,829,022 (US in 2014); 9,217,010 (US in 2016); 2013214640 (AU in 2016). Patents pending: 2016203107 (AU application); 2,629,530 (CA application); 06837414.9 (EP application); 2013-155750 (JP application); PCT/US2006/043933 (PC application); 14/687,530 (US application); 14/698,335 (US application); 2006315599 (AU application).




 



10.
Pommier Y, Marchand C, Thibaut L (submitted in 2006) Tetracycline Compounds And Methods Of Treatment. Patent issued: 8,865,686 (US in 2015).",https://intramural.nih.gov/search/searchview.taf?ipid=43617
58,BC006173-21,"October 01, 2005 -  September 30, 2006",Dideoxynucleosides as Potential Anti-AIDS Drugs,Victor  Marquez; PhD,NULL,"Laboratory of Medicinal Chemistry, NCI",Pamela L Russ,NULL,Stephen H Hughes; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43618
59,BC006174-21,"October 01, 2005 -  September 30, 2006",Carbocyclic Nucleoside Isosteres as Potential Antitumor and Antiviral Agents,Victor  Marquez; PhD,NULL,"Laboratory of Medicinal Chemistry, NCI",Olaf R Ludek,"Riad  Agbaria
(Department of Virology, Ben-Gurion Univ of the Negev)




Jeffrey  Deschamps
(Crystallography, Naval Research Laboratory)




Shizuko  Sei
(Laboratory of Antiviral Drug Mechanisms, SAIC-Frederick)","Stephen H Hughes; PhD (National Cancer Institute)



William  Farrar (National Cancer Institute)



Joseph John Barchi (National Cancer Institute)","Kenneth A Jacobson; BA, MS, PhD (NIDDK) 



Adriaan  Bax; PhD (NIDDK)","Ordered by publication type and then author name.



1.
Comin MJ, Parrish DA, Deschamps JR, Marquez VE (2006). Synthesis of bicyclo[3.1.0]hexanes functionalized at the tip of the cyclopropane ring. Application to the synthesis of carbocyclic nucleosides. Org Lett  8, 705-8.   https://doi.org/10.1021/ol052886n




PubMed


 


PubMed ID 16468747
    
     


 



2.
Costanzi S, Joshi BV, Maddileti S, Mamedova L, Gonzalez-Moa MJ, Marquez VE, Harden TK, Jacobson KA (2005). Human P2Y(6) receptor: molecular modeling leads to the rational design of a novel agonist based on a unique conformational preference. J Med Chem  48, 8108-11.   https://doi.org/10.1021/jm050911p




PubMed



        
     
Free Article


 


PubMed ID 16366591
         Pubmed Central ID 2583457 


 



3.
Maderia M, Wu J, Bax A, Shenoy S, O'Keefe B, Marquez VE, Barchi JJ (2005). Engineering DNA topology with locked nucleosides: a structural study. Nucleosides Nucleotides Nucleic Acids  24, 687-90.   https://doi.org/10.1081/ncn-200060256




PubMed


 


PubMed ID 16248015
    
     


 



4.
Marquez VE, Choi Y, Comin MJ, Russ P, George C, Huleihel M, Ben-Kasus T, Agbaria R (2005). Understanding how the herpes thymidine kinase orchestrates optimal sugar and nucleobase conformations to accommodate its substrate at the active site: a chemical approach. J Am Chem Soc  127, 15145-50.   https://doi.org/10.1021/ja053789s




PubMed


 


PubMed ID 16248655
    
     


 



5.
Sun G, Voigt JH, Marquez VE, Nicklaus MC (2005). Prosit, an online service to calculate pseudorotational parameters of nucleosides and nucleotides. Nucleosides Nucleotides Nucleic Acids  24, 1029-32.   https://doi.org/10.1081/ncn-200059757




PubMed


 


PubMed ID 16248085",https://intramural.nih.gov/search/searchview.taf?ipid=43619
60,BC006176-21,"October 01, 2005 -  September 30, 2006",Enzyme Inhibitors as Potential Anticancer and Antiviral Drugs,Victor  Marquez; PhD,NULL,"Laboratory of Medicinal Chemistry, NCI","Dina M Sigano



Ji-Hye  Kang



Said  El Kazzouli","Riad  Agbaria
(Department of Virology, Ben-Gurion Univ of the Negev)




Manel  Esteller
(Cancer Epigenetics Laboratory, Spanish National Cancer Center)




Peter  Jones
(USC)




Rene  Jorgensen
(Department of Molecular Biology, University of Aarhus)




A. Rod  Merrill
(Department of Molecular Biology, University of Guelph)","Peter  Blumberg; PhD (National Cancer Institute)



Howard A Young; PhD (National Cancer Institute)



William  Farrar (National Cancer Institute)



James A Kelley; PhD (National Cancer Institute)



Marc C Nicklaus (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Costanzi S, Joshi BV, Maddileti S, Mamedova L, Gonzalez-Moa MJ, Marquez VE, Harden TK, Jacobson KA (2005). Human P2Y(6) receptor: molecular modeling leads to the rational design of a novel agonist based on a unique conformational preference. J Med Chem  48, 8108-11.   https://doi.org/10.1021/jm050911p




PubMed



        
     
Free Article


 


PubMed ID 16366591
         Pubmed Central ID 2583457 


 



2.
Hodge DR, Peng B, Pompeia C, Thomas S, Cho E, Clausen PA, Marquez VE, Farrar WL (2005). Epigenetic silencing of manganese superoxide dismutase (SOD-2) in KAS 6/1 human multiple myeloma cells increases cell proliferation. Cancer Biol Ther  4, 585-92.   https://doi.org/10.4161/cbt.4.5.1704




PubMed


 


PubMed ID 15908783
    
     


 



3.
Kang JH, Benzaria S, Sigano DM, Lewin NE, Pu Y, Peach ML, Blumberg PM, Marquez VE (2006). Conformationally constrained analogues of diacylglycerol. 26. Exploring the chemical space surrounding the C1 domain of protein kinase C with DAG-lactones containing aryl groups at the sn-1 and sn-2 positions. J Med Chem  49, 3185-203.   https://doi.org/10.1021/jm060011o




PubMed


 


PubMed ID 16722637
    
     


 



4.
Kang JH, Peach ML, Pu Y, Lewin NE, Nicklaus MC, Blumberg PM, Marquez VE (2005). Conformationally constrained analogues of diacylglycerol (DAG). 25. Exploration of the sn-1 and sn-2 carbonyl functionality reveals the essential role of the sn-1 carbonyl at the lipid interface in the binding of DAG-lactones to protein kinase C. J Med Chem  48, 5738-48.   https://doi.org/10.1021/jm050352m




PubMed



        
     
Free Article


 


PubMed ID 16134942
         Pubmed Central ID 2563800 


 



5.
Lee J, Kang JH, Han KC, Kim Y, Kim SY, Youn HS, Mook-Jung I, Kim H, Lo Han JH, Ha HJ, Kim YH, Marquez VE, Lewin NE, Pearce LV, Lundberg DJ, Blumberg PM (2006). Branched diacylglycerol-lactones as potent protein kinase C ligands and alpha-secretase activators. J Med Chem  49, 2028-36.   https://doi.org/10.1021/jm0509391




PubMed


 


PubMed ID 16539391
    
     


 



6.
Marquez V, Martin-Caballero J, Fraga M, Ruiz-Cabello J, Flores J, Desco M, Esteller M   (2006) The novel DNAmethylation inhibitor zebularine is effective against the development of murine T-cell lymphoma.  Blood  1174-1177 pp.




 



7.
Marquez VE, Barchi JJ, Kelley JA, Rao KV, Agbaria R, Ben-Kasus T, Cheng JC, Yoo CB, Jones PA (2005). Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapy. The magic of its chemistry and biology. Nucleosides Nucleotides Nucleic Acids  24, 305-18.   https://doi.org/10.1081/ncn-200059765




PubMed


 


PubMed ID 16247946",https://intramural.nih.gov/search/searchview.taf?ipid=43620
61,BC006177-21,"October 01, 2005 -  September 30, 2006",The Analytical Chemistry of Anti-AIDS Agents,James A Kelley; PhD,NULL,"Laboratory of Medicinal Chemistry, NCI",Christopher Cong Lai,"Riad  Agbaria
(Clinical Pharmacology, Ben-Gurion University of the Negev)




Nouri  Neamati
(NCI)","Victor  Marquez; PhD (National Cancer Institute)



John H Cardellina (National Cancer Institute)



Terrence R Burke; PhD (National Cancer Institute)



Yves  Pommier; PhD (National Cancer Institute)



Lawrence R Phillips (National Cancer Institute)



Joseph John Barchi (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Deng J, Kelley JA, Barchi JJ, Sanchez T, Dayam R, Pommier Y, Neamati N (2006). Mining the NCI antiviral compounds for HIV-1 integrase inhibitors. Bioorg Med Chem  14, 3785-92.   https://doi.org/10.1016/j.bmc.2006.01.040




PubMed


 


PubMed ID 16460953",https://intramural.nih.gov/search/searchview.taf?ipid=43621
62,BC006178-21,"October 01, 2005 -  September 30, 2006",Applications of New Mass Spectral Techniques,James A Kelley; PhD,NULL,"Laboratory of Medicinal Chemistry, NCI","Christopher Cong Lai



Holly L Haley",NULL,"Victor  Marquez; PhD (National Cancer Institute)



Peter P Roller; PhD (National Cancer Institute)



Kirk R Gustafson; PhD (National Cancer Institute)



William  Farrar (National Cancer Institute)



Lawrence R Phillips (National Cancer Institute)",Serge  Beaucage (OD),"Ordered by publication type and then author name.



1.
Ben-Kasus T, Ben-Zvi Z, Marquez VE, Kelley JA, Agbaria R (2005). Metabolic activation of zebularine, a novel DNA methylation inhibitor, in human bladder carcinoma cells. Biochem Pharmacol  70, 121-33.   https://doi.org/10.1016/j.bcp.2005.04.010




PubMed


 


PubMed ID 15885659
    
     


 



2.
Hodge DR, Peng B, Cherry JC, Hurt EM, Fox SD, Kelley JA, Munroe DJ, Farrar WL (2005). Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation. Cancer Res  65, 4673-82.   https://doi.org/10.1158/0008-5472.CAN-04-3589




PubMed


 


PubMed ID 15930285
    
     


 



3.
Jiang S, Li P, Lai CC, Kelley JA, Roller PP (2006). Design and concise synthesis of fully protected analogues of l-gamma-carboxyglutamic acid. J Org Chem  71, 7307-14.   https://doi.org/10.1021/jo061037q




PubMed


 


PubMed ID 16958524
    
     


 



4.
Kelley J, Lai C, Roller P   (2006) A practical synthesis of fully protected Lg-carboxyglutamic acid.  Tetrahedron Letters  23-25 pp.




 



5.
Marquez VE, Kelley JA, Agbaria R, Ben-Kasus T, Cheng JC, Yoo CB, Jones PA (2005). Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapy. Ann N Y Acad Sci  1058, 246-54.   https://doi.org/10.1196/annals.1359.037




PubMed


 


PubMed ID 16394141",https://intramural.nih.gov/search/searchview.taf?ipid=43622
63,BC006192-18,"October 01, 2005 -  September 30, 2006",Investigations on the integrated behavior of molecular regulatory networks that,"Kurt  Kohn; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI",Sohyoung  Kim,NULL,"James Carl Barrett; PhD (National Cancer Institute)



Joseph  Riss; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Kohn K, Kim S, Weinstein J, Pommier Y   (2006) Depicting combinatorial complexity with the molecular interaction map (MIM) notation.  Molec. Systems Biol, in press.




 



2.
Kohn KW, Aladjem MI (2006). Circuit diagrams for biological networks. Mol Syst Biol  2, 2006.0002.   https://doi.org/10.1038/msb4100044




PubMed



        
     
Free Article


 


PubMed ID 16738549
         Pubmed Central ID 1681476 


 



3.
Kohn KW, Aladjem MI, Weinstein JN, Pommier Y (2006). Molecular interaction maps of bioregulatory networks: a general rubric for systems biology. Mol Biol Cell  17, 1-13.   https://doi.org/10.1091/mbc.e05-09-0824




PubMed



        
     
Free Article


 


PubMed ID 16267266
         Pubmed Central ID 1345641 


 



4.
Pommier Y, Sordet O, Rao VA, Zhang H, Kohn KW (2005). Targeting chk2 kinase: molecular interaction maps and therapeutic rationale. Curr Pharm Des  11, 2855-72.   https://doi.org/10.2174/1381612054546716




PubMed


 


PubMed ID 16101442
    
     


 



5.
Pommier Y, Weinstein JN, Aladjem MI, Kohn KW (2006). Chk2 molecular interaction map and rationale for Chk2 inhibitors. Clin Cancer Res  12, 2657-61.   https://doi.org/10.1158/1078-0432.CCR-06-0743




PubMed


 


PubMed ID 16675556",https://intramural.nih.gov/search/searchview.taf?ipid=43623
64,BC006198-17,"October 01, 2005 -  September 30, 2006",Inhibitors of Tyrosine Kinase-Dependent Signalling as Anticancer Agents,"Terrence R Burke; PhD



IRP Faculty Profile",NULL,"Laboratory of Medicinal Chemistry, NCI","Kyeong  Lee; PhD



Fa  Liu



Won-Jun  Choi



Sung-Eun  Kim



Joshua D Thomas","Morag  Park
(Dept. Biochemistry and Oncology, McGill University)




Zhong-Yin  Zhang
(Dept. Pharmacology, Albert Einstein Medical School)","David S Waugh; PhD (Protein Engineering Section)



Donald P Bottaro; PhD (National Cancer Institute)



William  Farrar (National Cancer Institute)",Zhendan  Shi; PhD (NHLBI),"Ordered by publication type and then author name.



1.
Dharmawardana PG, Peruzzi B, Giubellino A, Burke TR, Bottaro DP (2006). Molecular targeting of growth factor receptor-bound 2 (Grb2) as an anti-cancer strategy. Anticancer Drugs  17, 13-20.   https://doi.org/10.1097/01.cad.0000185180.72604.ac




PubMed


 


PubMed ID 16317285
    
     


 



2.
Lee K, Boovanahalli SK, Nam KY, Kang SU, Lee M, Phan J, Wu L, Waugh DS, Zhang ZY, No KT, Lee JJ, Burke TR (2005). Synthesis of tripeptides as potent Yersinia protein tyrosine phosphatase inhibitors. Bioorg Med Chem Lett  15, 4037-42.   https://doi.org/10.1016/j.bmcl.2005.06.027




PubMed


 


PubMed ID 16039123
    
     


 



3.
Phan J, Shi ZD, Burke TR, Waugh DS (2005). Crystal structures of a high-affinity macrocyclic peptide mimetic in complex with the Grb2 SH2 domain. J Mol Biol  353, 104-15.   https://doi.org/10.1016/j.jmb.2005.08.037




PubMed


 


PubMed ID 16165154
    
     


 



4.
Plasencia C, Dayam R, Wang Q, Pinski J, Burke TR, Quinn DI, Neamati N (2005). Discovery and preclinical evaluation of a novel class of small-molecule compounds in hormone-dependent and -independent cancer cell lines. Mol Cancer Ther  4, 1105-13.   https://doi.org/10.1158/1535-7163.MCT-04-0288




PubMed


 


PubMed ID 16020668
    
     


 



5.
Yao ZJ, Lee K, Burke TR (2005). Incorporation of phosphotyrosyl mimetic 4-(phosphonodifluoromethyl)phenylalanine (F2Pmp) into signal transduction-directed peptides. Methods Mol Biol  298, 91-103.   https://doi.org/10.1385/1-59259-877-3:091




PubMed


 


PubMed ID 16044542",https://intramural.nih.gov/search/searchview.taf?ipid=43624
65,BC007333-15,"October 01, 2005 -  September 30, 2006",Pharmacology of HIV Viral DNA & Retroviral Integrases,"Yves  Pommier; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Christophe  Marchand



Keli  Agama","Elvira  Shults
(Laboratory of Medicinal Chemistry, Novosibirsk Institute of Organic Chemistry)




Kenneth  Stagliano
(Department of Biological, Chemical & Physical Sciences, ILLINOIS INSTITUTE OF TECHNOLOGY)","Robert  Yarchoan; MD (National Cancer Institute)



Terrence R Burke; PhD (National Cancer Institute)



Victor  Marquez; PhD (National Cancer Institute)



Stuart F J Le Grice; PhD (National Cancer Institute)



Peter P Roller; PhD (National Cancer Institute)",Donald M Jerina; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Deng J, Kelley JA, Barchi JJ, Sanchez T, Dayam R, Pommier Y, Neamati N (2006). Mining the NCI antiviral compounds for HIV-1 integrase inhibitors. Bioorg Med Chem  14, 3785-92.   https://doi.org/10.1016/j.bmc.2006.01.040




PubMed


 


PubMed ID 16460953
    
     


 



2.
Di Santo R, Costi R, Roux A, Artico M, Lavecchia A, Marinelli L, Novellino E, Palmisano L, Andreotti M, Amici R, Galluzzo CM, Nencioni L, Palamara AT, Pommier Y, Marchand C (2006). Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, biological activities, and mechanism of action. J Med Chem  49, 1939-45.   https://doi.org/10.1021/jm0511583




PubMed



        
     
Free Article


 


PubMed ID 16539381
         Pubmed Central ID 2602756 


 



3.
Johnson AA, Santos W, Pais GC, Marchand C, Amin R, Burke TR, Verdine G, Pommier Y (2006). Integration requires a specific interaction of the donor DNA terminal 5'-cytosine with glutamine 148 of the HIV-1 integrase flexible loop. J Biol Chem  281, 461-7.   https://doi.org/10.1074/jbc.M511348200




PubMed


 


PubMed ID 16257967
    
     


 



4.
Johnson AA, Sayer JM, Yagi H, Patil SS, Debart F, Maier MA, Corey DR, Vasseur JJ, Burke TR, Marquez VE, Jerina DM, Pommier Y (2006). Effect of DNA modifications on DNA processing by HIV-1 integrase and inhibitor binding: role of DNA backbone flexibility and an open catalytic site. J Biol Chem  281, 32428-38.   https://doi.org/10.1074/jbc.M605101200




PubMed


 


PubMed ID 16943199
    
     


 



5.
Marchand C, Krajewski K, Lee HF, Antony S, Johnson AA, Amin R, Roller P, Kvaratskhelia M, Pommier Y (2006). Covalent binding of the natural antimicrobial peptide indolicidin to DNA abasic sites. Nucleic Acids Res  34, 5157-65.   https://doi.org/10.1093/nar/gkl667




PubMed



        
     
Free Article


 


PubMed ID 16998183
         Pubmed Central ID 1636436 


 



6.
Semenova EA, Johnson AA, Marchand C, Davis DA, Yarchoan R, Pommier Y (2006). Preferential inhibition of the magnesium-dependent strand transfer reaction of HIV-1 integrase by alpha-hydroxytropolones. Mol Pharmacol  69, 1454-60.   https://doi.org/10.1124/mol.105.020321




PubMed


 


PubMed ID 16418335
    
     


 



7.
Stagliano KW, Emadi A, Lu Z, Malinakova HC, Twenter B, Yu M, Holland LE, Rom AM, Harwood JS, Amin R, Johnson AA, Pommier Y (2006). Regiocontrolled synthesis and HIV inhibitory activity of unsymmetrical binaphthoquinone and trimeric naphthoquinone derivatives of conocurvone. Bioorg Med Chem  14, 5651-65.   https://doi.org/10.1016/j.bmc.2006.04.034




PubMed


 


PubMed ID 16737818
    
     


 



8.
Zhao XZ, Semenova EA, Liao C, Nicklaus M, Pommier Y, Burke TR (2006). Biotinylated biphenyl ketone-containing 2,4-dioxobutanoic acids designed as HIV-1 integrase photoaffinity ligands. Bioorg Med Chem  14, 7816-25.   https://doi.org/10.1016/j.bmc.2006.07.064




PubMed


 


PubMed ID 16908168",https://intramural.nih.gov/search/searchview.taf?ipid=43625
66,BC007349-14,"October 01, 2005 -  September 30, 2006",New Strategies for Cancer Drug Discovery:  Integrative Pharmacogenomics and Phar,"John N Weinstein; MD, PhD",NULL,"Developmental Therapeutics Branch, NCI","William Curtis Reinhold



Margot  Sunshine



Hong  Cao



David  Kane



Uma  Shankavaram; PhD



Barry R Zeeberg; PhD



Show all 10","Michael  Barrett
(., TGen)




Paul  Blower
(., Ohio State Univ.)




Geoffrey  Cossman
(GeneLogic, Inc., .)




Carlo M Croce





Douglas  Dolginow
(., GeneLogic, Inc.)




Peggy  Eis
(., NimbleGen, Inc.)


Show all 20","Paul  Goldsmith; PhD (National Cancer Institute)



Robert H Stephens (National Cancer Institute)



Mirit I Aladjem; PhD (National Cancer Institute)



Louis  Staudt; MD (Lymphoid Malignancies Branch)



Richard D. Klausner; MD (National Cancer Institute)



Frank Jess Gonzalez; PhD (National Cancer Institute)","Peter Jonathan Munson; BA, MA, PhD (CIT) 



Henry M. Fales; PhD (NHLBI)","Ordered by publication type and then author name.



1.
Blower PE, Cross KP, Eichler GS, Myatt GJ, Weinstein JN, Yang C (2006). Comparison of methods for sequential screening of large compound sets. Comb Chem High Throughput Screen  9, 115-22.   https://doi.org/10.2174/138620706775541882




PubMed


 


PubMed ID 16475969
    
     


 



2.
Bussey KJ, Chin K, Lababidi S, Reimers M, Reinhold WC, Kuo WL, Gwadry F, Ajay, Kouros-Mehr H, Fridlyand J, Jain A, Collins C, Nishizuka S, Tonon G, Roschke A, Gehlhaus K, Kirsch I, Scudiero DA, Gray JW, Weinstein JN (2006). Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel. Mol Cancer Ther  5, 853-67.   https://doi.org/10.1158/1535-7163.MCT-05-0155




PubMed



        
     
Free Article


 


PubMed ID 16648555
         Pubmed Central ID 2733874 


 



3.
Fojo T, Farrell N, Ortuzar W, Tanimura H, Weinstein J, Myers TG (2005). Identification of non-cross-resistant platinum compounds with novel cytotoxicity profiles using the NCI anticancer drug screen and clustered image map visualizations. Crit Rev Oncol Hematol  53, 25-34.   https://doi.org/10.1016/j.critrevonc.2004.09.008




PubMed


 


PubMed ID 15607933
    
     


 



4.
Kane DW, Hohman MM, Cerami EG, McCormick MW, Kuhlmman KF, Byrd JA   (2006) Agile methods in biomedical software development: a multi-site experience report.  BMC Bioinformatics 7:273.




PubMed



        
     
Free Article


 


PubMed ID 16734914
         Pubmed Central ID 1539031 


 



5.
Kohn KW, Aladjem MI, Kim S, Weinstein JN, Pommier Y (2006). Depicting combinatorial complexity with the molecular interaction map notation. Mol Syst Biol  2, 51.   https://doi.org/10.1038/msb4100088




PubMed



        
     
Free Article


 


PubMed ID 17016517
         Pubmed Central ID 1681518 


 



6.
Kohn KW, Aladjem MI, Weinstein JN, Pommier Y (2006). Molecular interaction maps of bioregulatory networks: a general rubric for systems biology. Mol Biol Cell  17, 1-13.   https://doi.org/10.1091/mbc.e05-09-0824




PubMed



        
     
Free Article


 


PubMed ID 16267266
         Pubmed Central ID 1345641 


 



7.
Ludwig JA, Szakács G, Martin SE, Chu BF, Cardarelli C, Sauna ZE, Caplen NJ, Fales HM, Ambudkar SV, Weinstein JN, Gottesman MM (2006). Selective toxicity of NSC73306 in MDR1-positive cells as a new strategy to circumvent multidrug resistance in cancer. Cancer Res  66, 4808-15.   https://doi.org/10.1158/0008-5472.CAN-05-3322




PubMed



        
     
Free Article


 


PubMed ID 16651436
         Pubmed Central ID 1474781 


 



8.
Major SM, Nishizuka S, Morita D, Rowland R, Sunshine M, Shankavaram U, Washburn F, Asin D, Kouros-Mehr H, Kane D, Weinstein JN (2006). AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. BMC Bioinformatics  7, 192.   https://doi.org/10.1186/1471-2105-7-192




PubMed



        
     
Free Article


 


PubMed ID 16600027
         Pubmed Central ID 1524995 


 



9.
Morin RD, Chang E, Petrescu A, Liao N, Griffith M, Chow W, Kirkpatrick R, Butterfield YS, Young AC, Stott J, Barber S, Babakaiff R, Dickson MC, Matsuo C, Wong D, Yang GS, Smailus DE, Wetherby KD, Kwong PN, Grimwood J, Brinkley CP, Brown-John M, Reddix-Dugue ND, Mayo M, Schmutz J, et al. [24 more authors] (2006). Sequencing and analysis of 10,967 full-length cDNA clones from Xenopus laevis and Xenopus tropicalis reveals post-tetraploidization transcriptome remodeling. Genome Res  16, 796-803.   https://doi.org/10.1101/gr.4871006




PubMed



        
     
Free Article


 


PubMed ID 16672307
         Pubmed Central ID 1479861 


 



10.
Petersen D, Chandramouli GV, Geoghegan J, Hilburn J, Paarlberg J, Kim CH, Munroe D, Gangi L, Han J, Puri R, Staudt L, Weinstein J, Barrett JC, Green J, Kawasaki ES (2005). Three microarray platforms: an analysis of their concordance in profiling gene expression. BMC Genomics  6, 63.   https://doi.org/10.1186/1471-2164-6-63




PubMed



        
     
Free Article


 


PubMed ID 15876355
         Pubmed Central ID 1140753 


 



11.
Pommier Y, Weinstein JN, Aladjem MI, Kohn KW (2006). Chk2 molecular interaction map and rationale for Chk2 inhibitors. Clin Cancer Res  12, 2657-61.   https://doi.org/10.1158/1078-0432.CCR-06-0743




PubMed


 


PubMed ID 16675556
    
     


 



12.
Riss J, Khanna C, Koo S, Chandramouli GV, Yang HH, Hu Y, Kleiner DE, Rosenwald A, Schaefer CF, Ben-Sasson SA, Yang L, Powell J, Kane DW, Star RA, Aprelikova O, Bauer K, Vasselli JR, Maranchie JK, Kohn KW, Buetow KH, Linehan WM, Weinstein JN, Lee MP, Klausner RD, Barrett JC (2006). Cancers as wounds that do not heal: differences and similarities between renal regeneration/repair and renal cell carcinoma. Cancer Res  66, 7216-24.   https://doi.org/10.1158/0008-5472.CAN-06-0040




PubMed


 


PubMed ID 16849569
    
     


 



13.
Roschke AV, Lababidi S, Tonon G, Gehlhaus KS, Bussey K, Weinstein JN, Kirsch IR (2005). Karyotypic ""state"" as a potential determinant for anticancer drug discovery. Proc Natl Acad Sci U S A  102, 2964-9.   https://doi.org/10.1073/pnas.0405578102




PubMed



        
     
Free Article


 


PubMed ID 15703300
         Pubmed Central ID 549443 


 



14.
Staib F, Robles AI, Varticovski L, Wang XW, Zeeberg BR, Sirotin M, Zhurkin VB, Hofseth LJ, Hussain SP, Weinstein JN, Galle PR, Harris CC (2005). The p53 tumor suppressor network is a key responder to microenvironmental components of chronic inflammatory stress. Cancer Res  65, 10255-64.   https://doi.org/10.1158/0008-5472.CAN-05-1714




PubMed



        
     
Free Article


 


PubMed ID 16288013
         Pubmed Central ID 1421332 


 



15.
Lorenzi PL, Caplen NL, Weinstein JL (submitted in 2006) Materials And Methods Directed To Asparagine Synthetase And Asparaginase Therapies. Patents issued: 7,985,548 (US in 2011); 9,181,552 (US in 2016). Patent pending: PCT/US2007/005555 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=43626
67,BC007354-13,"October 01, 2005 -  September 30, 2006",Peptide-based Inhibitors of HDM2 Protein,Peter P Roller; PhD,NULL,"Laboratory of Medicinal Chemistry, NCI","Krzysztof A Krajewski



Sheng  Jiang",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43627
68,BC007363-12,"October 01, 2005 -  September 30, 2006",Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs,"Terrence R Burke; PhD



IRP Faculty Profile",NULL,"Laboratory of Medicinal Chemistry, NCI","Sachindra S Patil



Fa  Liu","Mamuka  Kvaratskhelia; PhD
(College of Pharmacy, Ohio State University)




Nouri  Neamati
(NCI)","Eric O Freed; PhD (National Cancer Institute)



Vinay K Pathak; PhD (National Cancer Institute)



Yves  Pommier; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Al-Mawsawi LQ, Fikkert V, Dayam R, Witvrouw M, Burke TR, Borchers CH, Neamati N (2006). Discovery of a small-molecule HIV-1 integrase inhibitor-binding site. Proc Natl Acad Sci U S A  103, 10080-5.   https://doi.org/10.1073/pnas.0511254103




PubMed



        
     
Free Article


 


PubMed ID 16785440
         Pubmed Central ID 1502509 


 



2.
Johnson AA, Santos W, Pais GC, Marchand C, Amin R, Burke TR, Verdine G, Pommier Y (2006). Integration requires a specific interaction of the donor DNA terminal 5'-cytosine with glutamine 148 of the HIV-1 integrase flexible loop. J Biol Chem  281, 461-7.   https://doi.org/10.1074/jbc.M511348200




PubMed


 


PubMed ID 16257967
    
     


 



3.
Li M, Mizuuchi M, Burke TR, Craigie R (2006). Retroviral DNA integration: reaction pathway and critical intermediates. EMBO J  25, 1295-304.   https://doi.org/10.1038/sj.emboj.7601005




PubMed



        
     
Free Article


 


PubMed ID 16482214
         Pubmed Central ID 1422164",https://intramural.nih.gov/search/searchview.taf?ipid=43628
69,BC007365-12,"October 01, 2005 -  September 30, 2006",Regulation of ADP-ribosylation factor,"Paul A Randazzo; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Cellular Oncology, NCI","Zhongzhen  Nie



Xiaoying  Jian; PhD



Hye-Young  Yoon



Fanny  Campa



Vi Luan  Ha



Hiroki  Inoue



Show all 8",NULL,Lino  Tessarollo (National Cancer Institute),"J Silvio  Gutkind; PhD (NIDCR) 



Kenneth Manao Yamada; MD, PhD (NIDCR) 



Bijan  Ahvazi; PhD (NIAMS) 



Susette C Mueller; PhD (NIDCR) 



James  Gruschus; PhD (NHLBI)","Ordered by publication type and then author name.



1.
Esteban PF, Yoon HY, Becker J, Dorsey SG, Caprari P, Palko ME, Coppola V, Saragovi HU, Randazzo PA, Tessarollo L (2006). A kinase-deficient TrkC receptor isoform activates Arf6-Rac1 signaling through the scaffold protein tamalin. J Cell Biol  173, 291-9.   https://doi.org/10.1083/jcb.200512013




PubMed



        
     
Free Article


 


PubMed ID 16636148
         Pubmed Central ID 2063819 


 



2.
Ha VL, Thomas GM, Stauffer S, Randazzo PA (2005). Preparation of myristoylated Arf1 and Arf6. Methods Enzymol  404, 164-74.   https://doi.org/10.1016/S0076-6879(05)04016-4




PubMed


 


PubMed ID 16413267
    
     


 



3.
Luo R, Jacques K, Ahvazi B, Stauffer S, Premont RT, Randazzo PA (2005). Mutational analysis of the Arf1*GTP/Arf GAP interface reveals an Arf1 mutant that selectively affects the Arf GAP ASAP1. Curr Biol  15, 2164-9.   https://doi.org/10.1016/j.cub.2005.10.065




PubMed


 


PubMed ID 16332543
    
     


 



4.
Nie Z, Hirsch DS, Luo R, Jian X, Stauffer S, Cremesti A, Andrade J, Lebowitz J, Marino M, Ahvazi B, Hinshaw JE, Randazzo PA (2006). A BAR domain in the N terminus of the Arf GAP ASAP1 affects membrane structure and trafficking of epidermal growth factor receptor. Curr Biol  16, 130-9.   https://doi.org/10.1016/j.cub.2005.11.069




PubMed


 


PubMed ID 16431365
    
     


 



5.
Nie Z, Randazzo PA (2006). Arf GAPs and membrane traffic. J Cell Sci  119, 1203-11.   https://doi.org/10.1242/jcs.02924




PubMed


 


PubMed ID 16554436
    
     


 



6.
Randazzo P, Domenica Castellone M, Gutkind J   (2006) Rac Inhibits Thrombin-Induced Rho Activation: Evidence of a Pak-Dependent GTPase Crosstalk.  J Mol Signaling, in press.




 



7.
Randazzo P, Miura K, Cuthbert E, Davis K, Ahvazi B, Casanova J   (2006) ARAP2 effects on the actin cytoskeleton are dependent on Arf6-specific GTPase-activating Protein Activity and binding to RhoAGTP.  J Cell Sci, in press.




 



8.
Yoon HY, Bonifacino JS, Randazzo PA (2005). In vitro assays of Arf1 interaction with GGA proteins. Methods Enzymol  404, 316-32.   https://doi.org/10.1016/S0076-6879(05)04028-0




PubMed


 


PubMed ID 16413279",https://intramural.nih.gov/search/searchview.taf?ipid=43629
70,BC008000-36,"October 01, 2005 -  September 30, 2006",Regulation of EGFR Gene Activity,Alfred Charles Johnson; PhD,NULL,"Laboratory of Molecular Biology, NCI","Jennifer D Rieker



Hideo  Ohtsuka",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43630
71,BC008226-30,"October 01, 2005 -  September 30, 2006",Prolactin Interactions in Mammary Gland Development and Tumorigenesis,Barbara V Vonderhaar; PhD,NULL,"Mammary Biology and Tumorigenesis Laboratory, NCI","Renqin  Duan



Erika P Ginsburg



Anita  Goldhar



Jessica M Faupel-Badger



Matthew J Meyer



Kamun  Chan



Show all 8","Patricia  Berg
(George Washington University)




Kennichi  Satoh
(Gastroenterology, Tohoku University School of Medicine)




Ameae  Walker; PhD
(Biomedical Sciences, UC-Riverside)","Gilbert  Smith; PhD (National Cancer Institute)



Nancy A Potischman (National Cancer Institute)



Paul  Goldsmith; PhD (National Cancer Institute)



David  Salomon; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Faupel-Badger JM, Prindiville SA, Venzon D, Vonderhaar BK, Zujewski JA, Eng-Wong J (2006). Effects of raloxifene on circulating prolactin and estradiol levels in premenopausal women at high risk for developing breast cancer. Cancer Epidemiol Biomarkers Prev  15, 1153-8.   https://doi.org/10.1158/1055-9965.EPI-05-0898




PubMed


 


PubMed ID 16775175
    
     


 



2.
Koduri S, Goldhar AS, Vonderhaar BK (2006). Activation of vascular endothelial growth factor (VEGF) by the ER-alpha variant, ERDelta3. Breast Cancer Res Treat  95, 37-43.   https://doi.org/10.1007/s10549-005-9028-4




PubMed


 


PubMed ID 16267616",https://intramural.nih.gov/search/searchview.taf?ipid=43631
72,BC008281-24,"October 01, 2005 -  September 30, 2006",Protein kinase A and Human Cancer: Translational Research,"Yoon S Cho-Chung; MD, PhD",NULL,"Basic Research Laboratory, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Cho-Chung YS (2006). Autoantibody biomarkers in the detection of cancer. Biochim Biophys Acta  1762, 587-91.   https://doi.org/10.1016/j.bbadis.2006.04.001




PubMed


 


PubMed ID 16730166
    
     


 



2.
Nesterova M, Johnson N, Cheadle C, Cho-Chung YS (2006). Autoantibody biomarker opens a new gateway for cancer diagnosis. Biochim Biophys Acta  1762, 398-403.   https://doi.org/10.1016/j.bbadis.2005.12.010




PubMed


 


PubMed ID 16483750",https://intramural.nih.gov/search/searchview.taf?ipid=43632
73,BC008303-34,"October 01, 2005 -  September 30, 2006",Regulation of Membrane Fusion by Viral and Cellular Proteins and Lipids,"Robert  Blumenthal; PhD



IRP Faculty Profile",NULL,"Center for Cancer Research Nanobiology Program, NCI","Anu  Puri; PhD



Yossef  Raviv



Mathias  Viard



Benitra T Johnson



Himanshu  Garg



Amy L Jacobs



Show all 7","Javad  Aman
(Medicine, USAMRID)




Robert W Doms; MD, PhD
(Microbiology, University of Pennsylvania)




Alfredo  Garzino-Demo
(Institute of Human Virology, University of Maryland Biotechnology Institute)




Robert  Hogan
(Image Analysis Lab,Research Technology Program, University of Georgia)




James  Hoxie
(CFAR, UPenn)




Robert I. Lehrer; MD
(David Geffen School of Medicine, UCLA)


Show all 7","Ji Ming  Wang; MD, PhD (National Cancer Institute)



Vineet Narain KewalRamani; PhD (National Cancer Institute)



Jeffrey D Lifson; MD (National Cancer Institute)



Eric O Freed; PhD (National Cancer Institute)



Stephen J Lockett; PhD (National Cancer Institute)



Francis W Ruscetti; PhD (National Cancer Institute)","Adriaan  Bax; PhD (NIDDK) 



G. Marius  Clore; PhD, MD (NIDDK)","Ordered by publication type and then author name.



1.
Dimitrov AS, Louis JM, Bewley CA, Clore GM, Blumenthal R (2005). Conformational changes in HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion and inactivation. Biochemistry  44, 12471-9.   https://doi.org/10.1021/bi051092d




PubMed



        
     
Free Article


 


PubMed ID 16156659
         Pubmed Central ID 1314968 


 



2.
Finnegan CM, Blumenthal R (2006). Fenretinide inhibits HIV infection by promoting viral endocytosis. Antiviral Res  69, 116-23.   https://doi.org/10.1016/j.antiviral.2005.11.002




PubMed


 


PubMed ID 16375981
    
     


 



3.
Fox TE, Finnegan CM, Blumenthal R, Kester M (2006). The clinical potential of sphingolipid-based therapeutics. Cell Mol Life Sci  63, 1017-23.   https://doi.org/10.1007/s00018-005-5543-z




PubMed


 


PubMed ID 16568241
    
     


 



4.
Gallo SA, Wang W, Rawat SS, Jung G, Waring AJ, Cole AM, Lu H, Yan X, Daly NL, Craik DJ, Jiang S, Lehrer RI, Blumenthal R (2006). Theta-defensins prevent HIV-1 Env-mediated fusion by binding gp41 and blocking 6-helix bundle formation. J Biol Chem  281, 18787-92.   https://doi.org/10.1074/jbc.M602422200




PubMed


 


PubMed ID 16648135
    
     


 



5.
Garg H, Blumenthal R (2006). HIV gp41-induced apoptosis is mediated by caspase-3-dependent mitochondrial depolarization, which is inhibited by HIV protease inhibitor nelfinavir. J Leukoc Biol  79, 351-62.   https://doi.org/10.1189/jlb.0805430




PubMed


 


PubMed ID 16330530
    
     


 



6.
Jaroniec CP, Kaufman JD, Stahl SJ, Viard M, Blumenthal R, Wingfield PT, Bax A (2005). Structure and dynamics of micelle-associated human immunodeficiency virus gp41 fusion domain. Biochemistry  44, 16167-80.   https://doi.org/10.1021/bi051672a




PubMed


 


PubMed ID 16331977
    
     


 



7.
Lund N, Branch DR, Mylvaganam M, Chark D, Ma XZ, Sakac D, Binnington B, Fantini J, Puri A, Blumenthal R, Lingwood CA (2006). A novel soluble mimic of the glycolipid, globotriaosyl ceramide inhibits HIV infection. AIDS  20, 333-43.   https://doi.org/10.1097/01.aids.0000206499.78664.58




PubMed


 


PubMed ID 16439866
    
     


 



8.
Raviv Y, Viard M, Bess JW, Chertova E, Blumenthal R (2005). Inactivation of retroviruses with preservation of structural integrity by targeting the hydrophobic domain of the viral envelope. J Virol  79, 12394-400.   https://doi.org/10.1128/JVI.79.19.12394-12400.2005




PubMed



        
     
Free Article


 


PubMed ID 16160166
         Pubmed Central ID 1211527 


 



9.
Rawat SS, Viard M, Gallo SA, Blumenthal R, Puri A (2006). Sphingolipids, cholesterol, and HIV-1: a paradigm in viral fusion. Glycoconj J  23, 189-97.   https://doi.org/10.1007/s10719-006-7924-4




PubMed


 


PubMed ID 16691502
    
     


 



10.
Wexler-Cohen Y, Johnson BT, Puri A, Blumenthal R, Shai Y (2006). Structurally altered peptides reveal an important role for N-terminal heptad repeat binding and stability in the inhibitory action of HIV-1 peptide DP178. J Biol Chem  281, 9005-10.   https://doi.org/10.1074/jbc.M512475200




PubMed


 


PubMed ID 16455666
    
     


 



11.
Wyss S, Dimitrov AS, Baribaud F, Edwards TG, Blumenthal R, Hoxie JA (2005). Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail. J Virol  79, 12231-41.   https://doi.org/10.1128/JVI.79.19.12231-12241.2005




PubMed



        
     
Free Article


 


PubMed ID 16160149
         Pubmed Central ID 1211532",https://intramural.nih.gov/search/searchview.taf?ipid=43633
74,BC008371-23,"October 01, 2005 -  September 30, 2006",DNA Deformations and Interactions with Transcription Factors,"Victor  Zhurkin; PhD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Feng  Cui



Difei  Wang",NULL,"Curtis  Harris; MD (National Cancer Institute)



Ettore  Appella; MD (National Cancer Institute)",Ronald D Neumann; MD (CC),"Ordered by publication type and then author name.



1.
Shen WH, Wang J, Wu J, Zhurkin VB, Yin Y (2006). Mitogen-activated protein kinase phosphatase 2: a novel transcription target of p53 in apoptosis. Cancer Res  66, 6033-9.   https://doi.org/10.1158/0008-5472.CAN-05-3878




PubMed


 


PubMed ID 16778175
    
     


 



2.
Staib F, Robles AI, Varticovski L, Wang XW, Zeeberg BR, Sirotin M, Zhurkin VB, Hofseth LJ, Hussain SP, Weinstein JN, Galle PR, Harris CC (2005). The p53 tumor suppressor network is a key responder to microenvironmental components of chronic inflammatory stress. Cancer Res  65, 10255-64.   https://doi.org/10.1158/0008-5472.CAN-05-1714




PubMed



        
     
Free Article


 


PubMed ID 16288013
         Pubmed Central ID 1421332",https://intramural.nih.gov/search/searchview.taf?ipid=43635
75,BC008382-23,"October 01, 2005 -  September 30, 2006",Computer Analysis of Nucleic Acid Structure,"Bruce Allen Shapiro; PhD



IRP Faculty Profile",NULL,"Center for Cancer Research Nanobiology Program, NCI","Kazimierz Wojcieck Kasprzak



Javed M Aman



Whitney A Hastings



Yaroslava G Yingling; PhD



Alan H Gee



Eckart  Bindewald



Show all 10","John  Casey
(Microbiology and Immunology, Georgetown University)




Gregory  Chirikjian
(Mechanical Engineering, Johns Hopkins University)




John  Grefenstette
(Bioinformatics and Compuational BIology, George Mason University)




Hugo  Martinez
(Consultant, SAIC)




R  Padmanabhan
(Department of Microbiology and Immunology, Geogetown University School of Medicine)




Anne  Simon
(Cell Biology and Molecular Genetics, University of Maryland)


Show all 7","Nancy H Colburn; PhD (National Cancer Institute)



Thomas Dana Schneider; PhD (National Cancer Institute)","John T Patton; BS, PhD (NIAID) 



Jack A Ragheb (NEI) 



Svetlana A Shabalina (NLM)","Ordered by publication type and then author name.



1.
Bindewald E, Schneider TD, Shapiro BA (2006). CorreLogo: an online server for 3D sequence logos of RNA and DNA alignments. Nucleic Acids Res  34, W405-11.   https://doi.org/10.1093/nar/gkl269




PubMed



        
     
Free Article


 


PubMed ID 16845037
         Pubmed Central ID 1538790 


 



2.
Bindewald E, Shapiro BA (2006). RNA secondary structure prediction from sequence alignments using a network of k-nearest neighbor classifiers. RNA  12, 342-52.   https://doi.org/10.1261/rna.2164906




PubMed



        
     
Free Article


 


PubMed ID 16495232
         Pubmed Central ID 1383574 


 



3.
Gee AH, Kasprzak W, Shapiro BA (2006). Structural differentiation of the HIV-1 polyA signals. J Biomol Struct Dyn  23, 417-28.   https://doi.org/10.1080/07391102.2006.10531236




PubMed


 


PubMed ID 16363877
    
     


 



4.
Linnstaedt SD, Kasprzak WK, Shapiro BA, Casey JL (2006). The role of a metastable RNA secondary structure in hepatitis delta virus genotype III RNA editing. RNA  12, 1521-33.   https://doi.org/10.1261/rna.89306




PubMed



        
     
Free Article


 


PubMed ID 16790843
         Pubmed Central ID 1524886 


 



5.
Seko Y, Cole S, Kasprzak W, Shapiro BA, Ragheb JA (2006). The role of cytokine mRNA stability in the pathogenesis of autoimmune disease. Autoimmun Rev  5, 299-305.   https://doi.org/10.1016/j.autrev.2005.10.013




PubMed


 


PubMed ID 16782553
    
     


 



6.
Shapiro B, Yingling Y, Chirikijian G   (2006) Structural and dynamical classification of RNA single-base bulges for nanostructure design.  J. Comp. Theor. Nanoscience  63-77 pp.




 



7.
Shapiro BA, Kasprzak W, Grunewald C, Aman J (2006). Graphical exploratory data analysis of RNA secondary structure dynamics predicted by the massively parallel genetic algorithm. J Mol Graph Model  25, 514-31.   https://doi.org/10.1016/j.jmgm.2006.04.004




PubMed


 


PubMed ID 16725358
    
     


 



8.
Tortorici MA, Shapiro BA, Patton JT (2006). A base-specific recognition signal in the 5' consensus sequence of rotavirus plus-strand RNAs promotes replication of the double-stranded RNA genome segments. RNA  12, 133-46.   https://doi.org/10.1261/rna.2122606




PubMed



        
     
Free Article


 


PubMed ID 16301600
         Pubmed Central ID 1370893 


 



9.
Yingling YG, Shapiro BA (2005). Dynamic behavior of the telomerase RNA hairpin structure and its relationship to dyskeratosis congenita. J Mol Biol  348, 27-42.   https://doi.org/10.1016/j.jmb.2005.02.015




PubMed


 


PubMed ID 15808851
    
     


 



10.
Yingling YG, Shapiro BA (2006). The prediction of the wild-type telomerase RNA pseudoknot structure and the pivotal role of the bulge in its formation. J Mol Graph Model  25, 261-74.   https://doi.org/10.1016/j.jmgm.2006.01.003




PubMed


 


PubMed ID 16481205
    
     


 



11.
Zhang J, Zhang G, Guo R, Shapiro BA, Simon AE (2006). A pseudoknot in a preactive form of a viral RNA is part of a structural switch activating minus-strand synthesis. J Virol  80, 9181-91.   https://doi.org/10.1128/JVI.00295-06




PubMed



        
     
Free Article


 


PubMed ID 16940529
         Pubmed Central ID 1563917",https://intramural.nih.gov/search/searchview.taf?ipid=43636
76,BC008396-18,"October 01, 2005 -  September 30, 2006",Molecular Information Theory,Thomas Dana Schneider; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI","Zehua  Chen



Ilya  Lyakhov



Danielle  Needle



Michael Y Levashov



Brent M Jewett



Adam C Diehl","James  Adair
(www.keystonenano.com, Keystone Nano)




Paul  Anagnostopoulos
(-, Windfall Software)




Raul Eduardo Cachau





Henry  Hess
(Department of Materials Science and Engineering, University of Florida)




Joseph  Lakowicz
(Department of Biochemistry, Center for Fluorescence Spectroscopy, University of Maryland School of Medicine)




Karen A Lewis



Show all 11","Robert J Fisher (National Cancer Institute)



Bruce Allen Shapiro; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bindewald E, Schneider TD, Shapiro BA (2006). CorreLogo: an online server for 3D sequence logos of RNA and DNA alignments. Nucleic Acids Res  34, W405-11.   https://doi.org/10.1093/nar/gkl269




PubMed



        
     
Free Article


 


PubMed ID 16845037
         Pubmed Central ID 1538790 


 



2.
Chen Z, Schneider TD (2006). Comparative analysis of tandem T7-like promoter containing regions in enterobacterial genomes reveals a novel group of genetic islands. Nucleic Acids Res  34, 1133-47.   https://doi.org/10.1093/nar/gkj511




PubMed



        
     
Free Article


 


PubMed ID 16493139
         Pubmed Central ID 1380254 


 



3.
Schneider TD (2006). Claude Shannon: biologist. The founder of information theory used biology to formulate the channel capacity. IEEE Eng Med Biol Mag  25, 30-3.   https://doi.org/10.1109/memb.2006.1578661




PubMed



        
     
Free Article


 


PubMed ID 16485389
         Pubmed Central ID 1538977",https://intramural.nih.gov/search/searchview.taf?ipid=43637
77,BC008579-13,"October 01, 2005 -  September 30, 2006",Functional Analysis of Cancer Genes from Human Chromosome 3p,"Michael I Lerman; MD, PhD",NULL,"Basic Research Laboratory, NCI","Laura  Geil



Igor  Kuzmin



Sergey  Ivanov



Alla  Ivanova



Fuh-Mei  Duh","Deborah  Angelony
(Biochemistry, Scuola Superiore Sant'Anna and IFC-CNR)




Charles  Buys
(Genetics, University of Groningen)




George  Klein
(MTC, Karolinska Institute)




Shu  Liao
(Pathology, UCI)




Dusty  Miller
(Basic Science, Fred Hutchinson Cancer Institute,)




Eric  Stanbridge
(Microbiology, UCI)


Show all 8",NULL,Richard  Childs; MD (NHLBI),"Ordered by publication type and then author name.



1.
Angeloni D, ter Elst A, Wei MH, van der Veen AY, Braga EA, Klimov EA, Timmer T, Korobeinikova L, Lerman MI, Buys CH (2006). Analysis of a new homozygous deletion in the tumor suppressor region at 3p12.3 reveals two novel intronic noncoding RNA genes. Genes Chromosomes Cancer  45, 676-91.   https://doi.org/10.1002/gcc.20332




PubMed


 


PubMed ID 16607615
    
     


 



2.
Ivanov SV, Salnikow K, Ivanova AV, Bai L, Lerman MI (2007). Hypoxic repression of STAT1 and its downstream genes by a pVHL/HIF-1 target DEC1/STRA13. Oncogene  26, 802-12.   https://doi.org/10.1038/sj.onc.1209842




PubMed


 


PubMed ID 16878149
    
     


 



3.
Miller AD, Vigdorovich V, Strong RK, Fernandes RJ, Lerman MI (2006). Hyal2, where are you? Osteoarthritis Cartilage  14, 1315-7.   https://doi.org/10.1016/j.joca.2006.08.004




PubMed


 


PubMed ID 16990026
    
     


 



4.
Yau WL, Lung HL, Zabarovsky ER, Lerman MI, Sham JS, Chua DT, Tsao SW, Stanbridge EJ, Lung ML (2006). Functional studies of the chromosome 3p21.3 candidate tumor suppressor gene BLU/ZMYND10 in nasopharyngeal carcinoma. Int J Cancer  119, 2821-6.   https://doi.org/10.1002/ijc.22232




PubMed


 


PubMed ID 16929489
    
     


 



5.
Yi Lo PH, Chung Leung AC, Xiong W, Law S, Duh FM, Lerman MI, Stanbridge EJ, Lung ML (2006). Expression of candidate chromosome 3p21.3 tumor suppressor genes and down-regulation of BLU in some esophageal squamous cell carcinomas. Cancer Lett  234, 184-92.   https://doi.org/10.1016/j.canlet.2005.03.036




PubMed


 


PubMed ID 15885884",https://intramural.nih.gov/search/searchview.taf?ipid=43638
78,BC008710-28,"October 01, 2005 -  September 30, 2006",Molecular Chaperones and DNA Replication,"Sue H Wickner; PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Joel R Hoskins



Matthew R Chenoweth; BA



Shannon M Doyle



Jodi  Camberg



Jonathan  Miller","Susan  Lindquist
(Biology, Whiteheat Institute for Biomedical Research)




Nancy  Trun; PhD
(NCI)




Michal  Zolkiewski; PhD
(Kansas State University)",Susan  Gottesman; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Bougdour A, Wickner S, Gottesman S (2006). Modulating RssB activity: IraP, a novel regulator of sigma(S) stability in Escherichia coli. Genes Dev  20, 884-97.   https://doi.org/10.1101/gad.1400306




PubMed



        
     
Free Article


 


PubMed ID 16600914
         Pubmed Central ID 1472289 


 



2.
Hoskins JR, Wickner S   (2006) Two peptide sequences can function cooperatively to facilitate binding and unfolding by ClpA and degradation by ClpAP.  Proc Natl Acad Sci U S A 103:909-14.




PubMed



        
     
Free Article


 


PubMed ID 16410355
         Pubmed Central ID 1347992",https://intramural.nih.gov/search/searchview.taf?ipid=43553
79,BC008714-29,"October 01, 2005 -  September 30, 2006",Bacterial Functions Involved in Cell Growth Control,"Susan  Gottesman; PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Nadim  Majdalani



Karl  Thompson



Yan Ning H Zhou



Colleen A Mccullen



Maude  Guillier



Jihane N Benhammou



Show all 7",NULL,"David J Fitzgerald; PhD (National Cancer Institute)



Sue H Wickner; PhD (DNA Molecular Biology Section)",Stephen H Leppla; PhD (NIAID),"Ordered by publication type and then author name.



1.
Bougdour A, Wickner S, Gottesman S (2006). Modulating RssB activity: IraP, a novel regulator of sigma(S) stability in Escherichia coli. Genes Dev  20, 884-97.   https://doi.org/10.1101/gad.1400306




PubMed



        
     
Free Article


 


PubMed ID 16600914
         Pubmed Central ID 1472289 


 



2.
Guillier M, Gottesman S (2006). Remodelling of the Escherichia coli outer membrane by two small regulatory RNAs. Mol Microbiol  59, 231-47.   https://doi.org/10.1111/j.1365-2958.2005.04929.x




PubMed


 


PubMed ID 16359331
    
     


 



3.
Guillier M, Gottesman S, Storz G (2006). Modulating the outer membrane with small RNAs. Genes Dev  20, 2338-48.   https://doi.org/10.1101/gad.1457506




PubMed


 


PubMed ID 16951250
    
     


 



4.
Hu Z, Zhang A, Storz G, Gottesman S, Leppla SH (2006). An antibody-based microarray assay for small RNA detection. Nucleic Acids Res  34, e52.   https://doi.org/10.1093/nar/gkl142




PubMed



        
     
Free Article


 


PubMed ID 16614443
         Pubmed Central ID 1435976 


 



5.
Majdalani N, Gottesman S (2005). The Rcs phosphorelay: a complex signal transduction system. Annu Rev Microbiol  59, 379-405.   https://doi.org/10.1146/annurev.micro.59.050405.101230




PubMed


 


PubMed ID 16153174
    
     


 



6.
Majdalani N, Heck M, Stout V, Gottesman S (2005). Role of RcsF in signaling to the Rcs phosphorelay pathway in Escherichia coli. J Bacteriol  187, 6770-8.   https://doi.org/10.1128/JB.187.19.6770-6778.2005




PubMed



        
     
Free Article


 


PubMed ID 16166540
         Pubmed Central ID 1251585 


 



7.
Tjaden B, Goodwin SS, Opdyke JA, Guillier M, Fu DX, Gottesman S, Storz G (2006). Target prediction for small, noncoding RNAs in bacteria. Nucleic Acids Res  34, 2791-802.   https://doi.org/10.1093/nar/gkl356




PubMed



        
     
Free Article


 


PubMed ID 16717284
         Pubmed Central ID 1464411 


 



8.
Tu X, Latifi T, Bougdour A, Gottesman S, Groisman EA (2006). The PhoP/PhoQ two-component system stabilizes the alternative sigma factor RpoS in Salmonella enterica. Proc Natl Acad Sci U S A  103, 13503-8.   https://doi.org/10.1073/pnas.0606026103




PubMed



        
     
Free Article


 


PubMed ID 16938894
         Pubmed Central ID 1557385 


 



9.
Zhou Y, Gottesman S (2006). Modes of regulation of RpoS by H-NS. J Bacteriol  188, 7022-5.   https://doi.org/10.1128/JB.00687-06




PubMed



        
     
Free Article


 


PubMed ID 16980505
         Pubmed Central ID 1595528",https://intramural.nih.gov/search/searchview.taf?ipid=43639
80,BC008727-28,"October 01, 2005 -  September 30, 2006",Gene Expression and Signal Transduction in Transformation and Differentiation,J. Frederic Mushinski; MD,NULL,"Laboratory of Genetics, NCI","James D Owens



Shalu  Gupta



Leigh-Ann  Cruz



Jason  Legrand","Sabine  Mai
(Genomic Centre for Cancer Research and Diagnosis, University of Manitoba)




Larisa  Romanova
(Massachusetts General Cancer Center, Harvard Medical School)




John  Shaughnessy
(Laboratory of Myeloma Geneitcs, University of Arkansas for Medical Sciences)




Qiming  Wang
(NCI)","Konrad  Huppi; MD, PhD (National Cancer Institute)



Jane Beth Trepel (National Cancer Institute)



Siegfried  Janz; MD, DSc (National Cancer Institute)



Joanna H Shih (National Cancer Institute)",Robert F Bonner; PhD (NICHD),"Ordered by publication type and then author name.



1.
Wang H, Owens JD, Shih JH, Li MC, Bonner RF, Mushinski JF (2006). Histological staining methods preparatory to laser capture microdissection significantly affect the integrity of the cellular RNA. BMC Genomics  7, 97.   https://doi.org/10.1186/1471-2164-7-97




PubMed



        
     
Free Article


 


PubMed ID 16643667
         Pubmed Central ID 1513394",https://intramural.nih.gov/search/searchview.taf?ipid=43640
81,BC008751-26,"October 01, 2005 -  September 30, 2006",Regulation of Gene Transcription,"Sankar  Adhya; PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Sudeshna  Kar



Konstantin  Virnik



Dale  Lewis; PhD



Fusheng  Guo; PhD



Thomas  Soares



Andrei  Trostel



Show all 11","Laura  Finzi
(University of Milan)




Kim  Sneppen
(Center for Models of Life, Niels Bohr Institute)",Victor  Zhurkin; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Adhya S, Black L, Friedman D, Hatfull G, Kreuzer K, Merril C, Oppenheim A, Rohwer F, Young R (2005). 2004 ASM Conference on the New Phage Biology: the 'Phage Summit'. Mol Microbiol  55, 1300-14.   https://doi.org/10.1111/j.1365-2958.2005.04509.x




PubMed


 


PubMed ID 15720541
    
     


 



2.
Adhya S, Franzini A, Galli G, Dunlap D, Lewis D, Finzi L   (2006) A novel TPM analysis: initial test on bacteriophage lambda system.  J. Physics.:Condems. Matter  S225-S234 pp.




 



3.
Adhya S, Garges S   (2006) Ribosomal protein S1 promotes transcriptional cycling.  RNA, in press.




 



4.
Oppenheim AB, Kobiler O, Stavans J, Court DL, Adhya S (2005). Switches in bacteriophage lambda development. Annu Rev Genet  39, 409-29.   https://doi.org/10.1146/annurev.genet.39.073003.113656




PubMed


 


PubMed ID 16285866
    
     


 



5.
Semsey S, Virnik K, Adhya S (2006). Three-stage regulation of the amphibolic gal operon: from repressosome to GalR-free DNA. J Mol Biol  358, 355-63.   https://doi.org/10.1016/j.jmb.2006.02.022




PubMed


 


PubMed ID 16524589
    
     


 



6.
Sukhodolets MV, Garges S, Adhya S (2006). Ribosomal protein S1 promotes transcriptional cycling. RNA  12, 1505-13.   https://doi.org/10.1261/rna.2321606




PubMed



        
     
Free Article


 


PubMed ID 16775305
         Pubmed Central ID 1524893",https://intramural.nih.gov/search/searchview.taf?ipid=43641
82,BC008752-26,"October 01, 2005 -  September 30, 2006",Thyroid Hormone Receptors in Health and Disease,"Sheueyann  Cheng; PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Li  Zhou; PhD



Hao  Ying



Osamu  Araki



Fumihiko  Furuya



Patrick  O'Shea



Celine Julie Guigon



Show all 7","A.C.  Bianco
(Brigham & Women's Hospital, Harvard University)




P.R.  Larsen
(Brigham & Women's Hospital, Harvard University)




J.K.  Liao
(Harvard University, Harvard University)




B.W.  O'MALLEY
(Baylor College of Medicine, Baylor College of Medicine)




M.D.  Ringel
(Comprehensive Cancer, Ohio State University College of Medicine)




J.  Samarut
(Normale Superieur, Normale Superieur)


Show all 10","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)



Chandramouli  Gadisetti (National Cancer Institute)



Drazen  Zimonjic; PhD (National Cancer Institute)



Nicolae C Popescu; PhD (National Cancer Institute)",John Allan Hanover; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Araki O, Ying H, Furuya F, Zhu X, Cheng SY (2005). Thyroid hormone receptor beta mutants: Dominant negative regulators of peroxisome proliferator-activated receptor gamma action. Proc Natl Acad Sci U S A  102, 16251-6.   https://doi.org/10.1073/pnas.0508556102




PubMed



        
     
Free Article


 


PubMed ID 16260719
         Pubmed Central ID 1283481 


 



2.
Barnard JC, Williams AJ, Rabier B, Chassande O, Samarut J, Cheng SY, Bassett JH, Williams GR (2005). Thyroid hormones regulate fibroblast growth factor receptor signaling during chondrogenesis. Endocrinology  146, 5568-80.   https://doi.org/10.1210/en.2005-0762




PubMed


 


PubMed ID 16150908
    
     


 



3.
Cheng S   (2006) An unliganded thyroid hormone nuclear Beta receptor induces pituitary tumors.  Frontiers in Science  4-5 pp.




 



4.
Cheng S   (2006) Mutations of thyroid hormone nuclear receptors and disease.  Frontiers in Science, in press.




 



5.
Cheng S, Furuya F, Zhao L, Araki O, West B, Hanover J, Willingham M   (2006) Aberrant accumulation of PTTG induced by a mutated thyroid hormone Beta receptor inhibits mitotic progression.  J Clinic Invest, in press.




 



6.
Furuya F, Hanover JA, Cheng SY (2006). Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone beta receptor. Proc Natl Acad Sci U S A  103, 1780-5.   https://doi.org/10.1073/pnas.0510849103




PubMed



        
     
Free Article


 


PubMed ID 16446424
         Pubmed Central ID 1413672 


 



7.
Kato Y, Ying H, Zhao L, Furuya F, Araki O, Willingham MC, Cheng SY (2006). PPARgamma insufficiency promotes follicular thyroid carcinogenesis via activation of the nuclear factor-kappaB signaling pathway. Oncogene  25, 2736-47.   https://doi.org/10.1038/sj.onc.1209299




PubMed


 


PubMed ID 16314832
    
     


 



8.
O'Shea PJ, Bassett JH, Cheng SY, Williams GR (2006). Characterization of skeletal phenotypes of TRalpha1 and TRbeta mutant mice: implications for tissue thyroid status and T3 target gene expression. Nucl Recept Signal  4, e011.   https://doi.org/10.1621/nrs.04011




PubMed



        
     
Free Article


 


PubMed ID 16862217
         Pubmed Central ID 1513065 


 



9.
Siesser WB, Zhao J, Miller LR, Cheng SY, McDonald MP (2006). Transgenic mice expressing a human mutant beta1 thyroid receptor are hyperactive, impulsive, and inattentive. Genes Brain Behav  5, 282-97.   https://doi.org/10.1111/j.1601-183X.2005.00161.x




PubMed


 


PubMed ID 16594981
    
     


 



10.
Ying H, Furuya F, Willingham MC, Xu J, O'Malley BW, Cheng SY (2005). Dual functions of the steroid hormone receptor coactivator 3 in modulating resistance to thyroid hormone. Mol Cell Biol  25, 7687-95.   https://doi.org/10.1128/MCB.25.17.7687-7695.2005




PubMed



        
     
Free Article


 


PubMed ID 16107715
         Pubmed Central ID 1190271",https://intramural.nih.gov/search/searchview.taf?ipid=43642
83,BC008753-24,"October 01, 2005 -  September 30, 2006",Immunotoxin Therapy of Solid and Hematopoietic Tumors:  Preclinical Studies,"Ira H Pastan; MD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Masanori  Onda



Richard A Beers



Mitchell  Ho



Tomoko  Ise



Satoshi  Nagata; PhD



Laiman  Xiang



Show all 10","Darell  Bigner
(Dept. of Pathology, Duke University Medical Center, Dept. of Pathology)




Giuliana  Salvatore
(Universita degli Studi di Napoli)","Raffit  Hassan (National Cancer Institute)



Robert J Kreitman; MD, PhD (National Cancer Institute)



David J Fitzgerald; PhD (National Cancer Institute)",Jorge A Carrasquillo; MD (CC),"Ordered by publication type and then author name.



1.
Attia P, Powell DJ, Maker AV, Kreitman RJ, Pastan I, Rosenberg SA (2006). Selective elimination of human regulatory T lymphocytes in vitro with the recombinant immunotoxin LMB-2. J Immunother  29, 208-14.   https://doi.org/10.1097/01.cji.0000187959.45803.0c




PubMed



        
     
Free Article


 


PubMed ID 16531821
         Pubmed Central ID 1473974 


 



2.
Ho M, Nagata S, Pastan I (2006). Isolation of anti-CD22 Fv with high affinity by Fv display on human cells. Proc Natl Acad Sci U S A  103, 9637-42.   https://doi.org/10.1073/pnas.0603653103




PubMed



        
     
Free Article


 


PubMed ID 16763048
         Pubmed Central ID 1480459 


 



3.
Ho M, Onda M, Wang QC, Hassan R, Pastan I, Lively MO (2006). Mesothelin is shed from tumor cells. Cancer Epidemiol Biomarkers Prev  15, 1751.   https://doi.org/10.1158/1055-9965.EPI-06-0479




PubMed


 


PubMed ID 16985043
    
     


 



4.
Kennedy PE, Bera TK, Wang QC, Gallo M, Wagner W, Lewis MG, Berger EA, Pastan I (2006). Anti-HIV-1 immunotoxin 3B3(Fv)-PE38: enhanced potency against clinical isolates in human PBMCs and macrophages, and negligible hepatotoxicity in macaques. J Leukoc Biol  80, 1175-82.   https://doi.org/10.1189/jlb.0306139




PubMed


 


PubMed ID 16923920
    
     


 



5.
Onda M, Willingham M, Nagata S, Bera TK, Beers R, Ho M, Hassan R, Kreitman RJ, Pastan I (2005). New monoclonal antibodies to mesothelin useful for immunohistochemistry, fluorescence-activated cell sorting, Western blotting, and ELISA. Clin Cancer Res  11, 5840-6.   https://doi.org/10.1158/1078-0432.CCR-05-0578




PubMed


 


PubMed ID 16115924
    
     


 



6.
Pastan I, Hassan R, Fitzgerald DJ, Kreitman RJ (2006). Immunotoxin therapy of cancer. Nat Rev Cancer  6, 559-65.   https://doi.org/10.1038/nrc1891




PubMed


 


PubMed ID 16794638
    
     


 



7.
Pastan I, Mahesh S, Shen D, Liu B, Siu W, Hwang F, Wang Q, Chan C, Nussenblatt R   (2006) Eradication of tumor colonization and invasion by a B cell specific immunotoxin in a murine model of human primary intraocular lymphoma (PIOL).  Cancer Res, in press.




 



8.
Yokokawa J, Palena C, Arlen P, Hassan R, Ho M, Pastan I, Schlom J, Tsang KY (2005). Identification of novel human CTL epitopes and their agonist epitopes of mesothelin. Clin Cancer Res  11, 6342-51.   https://doi.org/10.1158/1078-0432.CCR-05-0596




PubMed



        
     
Free Article


 


PubMed ID 16144939
         Pubmed Central ID 1351144 


 



9.
Zhang Y, Xiang L, Hassan R, Paik CH, Carrasquillo JA, Jang BS, Le N, Ho M, Pastan I (2006). Synergistic antitumor activity of taxol and immunotoxin SS1P in tumor-bearing mice. Clin Cancer Res  12, 4695-701.   https://doi.org/10.1158/1078-0432.CCR-06-0346




PubMed


 


PubMed ID 16899620
    
     


 



10.
Kuan C, Bigner D, Pastan I (submitted in 2006) Antibodies And Immunotoxins That Target Human Glycoprotein Nmb. Patents issued: 8,039,593 (US in 2012); 8,445,216 (US in 2013); 9,115,196 (US in 2015). Patent pending: PCT/US2006/042735 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=43643
84,BC008756-19,"October 01, 2005 -  September 30, 2006",Genetically Engineered Mice as Models to Study Receptor Tyrosine Kinase Function,"Glenn  Merlino; PhD



IRP Faculty Profile",NULL,"Laboratory of Cell Regulation and Carcinogenesis, NCI","Chamelli  Jhappan; PhD



Yanlin  Yu



Richard D Sharp



Linan  Ha



Muhammad R Zaidi



Chi-Ping  Day","Edward  De Fabo
(GWU)




Ron  DePinho
(Dana Farber, Harvard)




Frances  Noonan
(GWU)




Hitoshi  Takagi
(First Dept of Internal Medicien, Gunma University School of Medicine)




Timothy  Triche
(Keck School of Medicine, USC)




Thomas  Tuting
(Dermatology, University of Bonn)","Javed  Khan; MD (National Cancer Institute)



Melinda  Hollingshead (National Cancer Institute)



Snorri S. Thorgeirsson; MD, PhD (National Cancer Institute)



Miriam R Anver (National Cancer Institute)



Chand  Khanna; MD (National Cancer Institute)



Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"Ordered by publication type and then author name.



1.
Gareau DS, Lagowski J, Rossi VM, Viator JA, Merlino G, Kulesz-Martin M, Jacques SL (2005). Imaging melanoma in a murine model using reflectance-mode confocal scanning laser microscopy and polarized light imaging. J Investig Dermatol Symp Proc  10, 164-9.   https://doi.org/10.1111/j.1087-0024.2005.200408.x




PubMed


 


PubMed ID 16363066
    
     


 



2.
Ha L, Noonan FP, De Fabo EC, Merlino G (2005). Animal models of melanoma. J Investig Dermatol Symp Proc  10, 86-8.   https://doi.org/10.1111/j.1087-0024.2005.200409.x




PubMed


 


PubMed ID 16358815
    
     


 



3.
Otsuka T, Horiguchi N, Kanda D, Kosone T, Yamazaki Y, Yuasa K, Sohara N, Kakizaki S, Sato K, Takagi H, Merlino G, Mori M (2005). Overexpression of NK2 inhibits liver regeneration after partial hepatectomy in mice. World J Gastroenterol  11, 7444-9.   https://doi.org/10.3748/wjg.v11.i47.7444




PubMed



        
     
Free Article


 


PubMed ID 16437714
         Pubmed Central ID 4725174 


 



4.
Schoeffner DJ, Matheny SL, Akahane T, Factor V, Berry A, Merlino G, Thorgeirsson UP (2005). VEGF contributes to mammary tumor growth in transgenic mice through paracrine and autocrine mechanisms. Lab Invest  85, 608-23.   https://doi.org/10.1038/labinvest.3700258




PubMed


 


PubMed ID 15765121
    
     


 



5.
Tormo D, Ferrer A, Gaffal E, Wenzel J, Basner-Tschakarjan E, Steitz J, Heukamp LC, Gütgemann I, Buettner R, Malumbres M, Barbacid M, Merlino G, Tüting T (2006). Rapid growth of invasive metastatic melanoma in carcinogen-treated hepatocyte growth factor/scatter factor-transgenic mice carrying an oncogenic CDK4 mutation. Am J Pathol  169, 665-72.   https://doi.org/10.2353/ajpath.2006.060017




PubMed



        
     
Free Article


 


PubMed ID 16877364
         Pubmed Central ID 1698803 


 



6.
Yu Y, Davicioni E, Triche TJ, Merlino G (2006). The homeoprotein six1 transcriptionally activates multiple protumorigenic genes but requires ezrin to promote metastasis. Cancer Res  66, 1982-9.   https://doi.org/10.1158/0008-5472.CAN-05-2360




PubMed


 


PubMed ID 16488997",https://intramural.nih.gov/search/searchview.taf?ipid=43644
85,BC008757-19,"October 01, 2005 -  September 30, 2006",Bio-Therapies for the Treatment of Cancer and Infectious Disease,"David J Fitzgerald; PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Robert J Sarnovsky



Diana  Pastrana



Roy  Irving



Victoria  Chen



Lolita S Nidadavolu","Guojun  Bu
(Pediatrics, Washington University School of Medicine)




Everett  Greenberg
(Microbiology, U of Washington)




Randall  Mrsny
(Trinity Biosystems)","Ira H Pastan; MD (National Cancer Institute)



Sankar  Adhya; PhD (National Cancer Institute)



Susan  Gottesman; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Hsieh JC, Tham DM, Feng W, Huang F, Embaie S, Liu K, Dean D, Hertle R, Fitzgerald DJ, Mrsny RJ (2005). Intranasal immunization strategy to impede pilin-mediated binding of Pseudomonas aeruginosa to airway epithelial cells. Infect Immun  73, 7705-17.   https://doi.org/10.1128/IAI.73.11.7705-7717.2005




PubMed



        
     
Free Article


 


PubMed ID 16239575
         Pubmed Central ID 1273878 


 



2.
Pastan I, Hassan R, Fitzgerald DJ, Kreitman RJ (2006). Immunotoxin therapy of cancer. Nat Rev Cancer  6, 559-65.   https://doi.org/10.1038/nrc1891




PubMed


 


PubMed ID 16794638
    
     


 



3.
Pastrana DV, FitzGerald DJ (2006). A nonradioactive, cell-free method for measuring protein synthesis inhibition by Pseudomonas exotoxin. Anal Biochem  353, 266-71.   https://doi.org/10.1016/j.ab.2006.03.043




PubMed


 


PubMed ID 16647035",https://intramural.nih.gov/search/searchview.taf?ipid=43645
86,BC008759-15,"October 01, 2005 -  September 30, 2006",Molecular Modeling and Bioinformatics,"Byungkook  Lee; PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Yoonsoo  Hahn



Bangalore K Sathyanarayana



James J Vincent



Chin-Hsien  Tai



Changhoon  Kim","Roland  Dunbrack
(Institute for Cancer Research, Fox Chase Cancer Center)




Jean  Garnier; PhD





Giuseppe  Graziano





Alfonso  Valencia
(Protein Design Group, CNB-CSIC)",Ira H Pastan; MD (National Cancer Institute),"Peter Jonathan Munson; BA, MA, PhD (CIT)","Ordered by publication type and then author name.



1.
Bera TK, Saint Fleur A, Lee Y, Kydd A, Hahn Y, Popescu NC, Zimonjic DB, Lee B, Pastan I (2006). POTE paralogs are induced and differentially expressed in many cancers. Cancer Res  66, 52-6.   https://doi.org/10.1158/0008-5472.CAN-05-3014




PubMed


 


PubMed ID 16397215
    
     


 



2.
Egland KA, Liu XF, Squires S, Nagata S, Man YG, Bera TK, Onda M, Vincent JJ, Strausberg RL, Lee B, Pastan I (2006). High expression of a cytokeratin-associated protein in many cancers. Proc Natl Acad Sci U S A  103, 5929-34.   https://doi.org/10.1073/pnas.0601296103




PubMed



        
     
Free Article


 


PubMed ID 16585525
         Pubmed Central ID 1458675 


 



3.
Hahn Y, Bera TK, Pastan IH, Lee B (2006). Duplication and extensive remodeling shaped POTE family genes encoding proteins containing ankyrin repeat and coiled coil domains. Gene  366, 238-45.   https://doi.org/10.1016/j.gene.2005.07.045




PubMed


 


PubMed ID 16364570
    
     


 



4.
Hahn Y, Lee B (2005). Identification of nine human-specific frameshift mutations by comparative analysis of the human and the chimpanzee genome sequences. Bioinformatics  21 Suppl 1, i186-94.   https://doi.org/10.1093/bioinformatics/bti1000




PubMed


 


PubMed ID 15961456
    
     


 



5.
Hahn Y, Lee B (2006). Human-specific nonsense mutations identified by genome sequence comparisons. Hum Genet  119, 169-78.   https://doi.org/10.1007/s00439-005-0125-6




PubMed


 


PubMed ID 16395595
    
     


 



6.
Sam V, Tai CH, Garnier J, Gibrat JF, Lee B, Munson PJ (2006). ROC and confusion analysis of structure comparison methods identify the main causes of divergence from manual protein classification. BMC Bioinformatics  7, 206.   https://doi.org/10.1186/1471-2105-7-206




PubMed



        
     
Free Article


 


PubMed ID 16613604
         Pubmed Central ID 1513609 


 



7.
Tress M, Tai CH, Wang G, Ezkurdia I, López G, Valencia A, Lee B, Dunbrack RL (2005). Domain definition and target classification for CASP6. Proteins  61 Suppl 7, 8-18.   https://doi.org/10.1002/prot.20717




PubMed


 


PubMed ID 16187342
    
     


 



8.
Vincent JJ, Tai CH, Sathyanarayana BK, Lee B (2005). Assessment of CASP6 predictions for new and nearly new fold targets. Proteins  61 Suppl 7, 67-83.   https://doi.org/10.1002/prot.20722




PubMed


 


PubMed ID 16187347",https://intramural.nih.gov/search/searchview.taf?ipid=43646
87,BC008905-25,"October 01, 2005 -  September 30, 2006",Tumor gene expression in vitro and in vivo,"Douglas  Lowy; MD



IRP Faculty Profile",NULL,"Laboratory of Cellular Oncology, NCI","Richard B Braverman



Alex  Papageorge



Xiaolan  Qian; MD, PhD



William C Vass



Laura  Asnaghi



Guorong  Li",NULL,"Kent W Hunter; PhD (National Cancer Institute)



Nicolae C Popescu; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43647
88,BC008952-20,"October 01, 2005 -  September 30, 2006",Oncogenes and tumor suppressors in murine acute myeloid leukemia,"Linda  Wolff; PhD



IRP Faculty Profile",NULL,"Laboratory of Cellular Oncology, NCI","Juraj  Bies



Richard P Koller



Jan  Markus



Michael  Rosu-Myles



Thomas  Paul","Michelle  Le Beau
(Medicine, Universtiy of Chicago)




Janet  Rowley
(Medicine, University of Chicago)




Michael  Thirman
(Medicine, University of Chicago)",Peter D Aplan; MD (National Cancer Institute),"Paul P. Liu; MD, PhD (NHGRI)","Ordered by publication type and then author name.



1.
Wolff L   (2006) Retroviral insertional mutagenesis and its application to genetically engineered mice, in Progress in Virus Research. Nova Science Publishers, Inc. (New York), pp. 267-300.




 



2.
Markus J, Garin M, Bies J, Galili N, Raza A, Thirman M, Le Beau M, Rowley J, Liu P, Wolff L   (2007) Methylation-independent silencing of the tumor suppressor INK4B (p15) by CBFb-SMMHC in acute myeloid leukemia with inv(16).  Cancer Res 67:992-1000.




 



3.
Wolff L, Ackerman SJ, Nucifora G (2005). Meeting report: Sixth International Workshop on Molecular Aspects of Myeloid Stem Cell Development and Leukemia, Annapolis, May 1-4, 2005. Exp Hematol  33, 1436-42.   https://doi.org/10.1016/j.exphem.2005.09.011




PubMed


 


PubMed ID 16338485",https://intramural.nih.gov/search/searchview.taf?ipid=43648
89,BC009003-24,"October 01, 2005 -  September 30, 2006",The Role of Cripto in the Pathogenesis of Breast and Colon Cancer,David  Salomon; PhD,NULL,"Mammary Biology and Tumorigenesis Laboratory, NCI","Caterina  Bianco; MD



Luigi  Strizzi



Shin  Hamada



Mario  Mancino



Kazuhide  Watanabe



Bernadine  Akukwe","Gabriella  Minchiotti
(CNR, Institute of Genetics)




Masaharu  Seno
(Biotechnology, Okayama University)",NULL,NULL,"Ordered by publication type and then author name.



1.
Ahmed R, Zoltan-Jones A, Strizzi L, Bargo A, Kimura K, David S, Callahan R   (2006) Kit and PDGFR-a activities are necessary for Notch4/Int3 induced tumorigenesis.  Oncogene, in press.




 



2.
Bianco C, Strizzi L, Mancino M, Rehman A, Hamada S, Watanabe K, De Luca A, Jones B, Balogh G, Russo J, Mailo D, Palaia R, D'Aiuto G, Botti G, Perrone F, Salomon DS, Normanno N (2006). Identification of cripto-1 as a novel serologic marker for breast and colon cancer. Clin Cancer Res  12, 5158-64.   https://doi.org/10.1158/1078-0432.CCR-06-0274




PubMed


 


PubMed ID 16951234
    
     


 



3.
Mechsner S, Bartley J, Loddenkemper C, Salomon DS, Starzinski-Powitz A, Ebert AD (2005). Oxytocin receptor expression in smooth muscle cells of peritoneal endometriotic lesions and ovarian endometriotic cysts. Fertil Steril  83 Suppl 1, 1220-31.   https://doi.org/10.1016/j.fertnstert.2004.11.038




PubMed


 


PubMed ID 15831296
    
     


 



4.
Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello MR, Carotenuto A, De Feo G, Caponigro F, Salomon DS (2006). Epidermal growth factor receptor (EGFR) signaling in cancer. Gene  366, 2-16.   https://doi.org/10.1016/j.gene.2005.10.018




PubMed


 


PubMed ID 16377102
    
     


 



5.
Salomon D, Strizzi L, Mancino M, Rehman A, Hamada S, Watanabe K, De Luca A, Jones B, Balogh G, Russo J, Mailo D, Palaia R, DAiuto G, Botti G, Perrone F, Normanno N   (2006) Identification of Cripto-1 as a novel serological marker for breast and colon cancer.  Clinical Cancer Research, in press.




 



6.
Strizzi L, Bianco C, Normanno N, Salomon D (2005). Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis. Oncogene  24, 5731-41.   https://doi.org/10.1038/sj.onc.1208918




PubMed


 


PubMed ID 16123806
    
     


 



7.
Strizzi L, Bianco C, Raafat A, Abdallah W, Chang C, Raafat D, Hirota M, Hamada S, Sun Y, Normanno N, Callahan R, Hinck L, Salomon D (2005). Netrin-1 regulates invasion and migration of mouse mammary epithelial cells overexpressing Cripto-1 in vitro and in vivo. J Cell Sci  118, 4633-43.   https://doi.org/10.1242/jcs.02574




PubMed


 


PubMed ID 16176936
    
     


 



8.
Sun Y, Lowther W, Kato K, Bianco C, Kenney N, Strizzi L, Raafat D, Hirota M, Khan NI, Bargo S, Jones B, Salomon D, Callahan R (2005). Notch4 intracellular domain binding to Smad3 and inhibition of the TGF-beta signaling. Oncogene  24, 5365-74.   https://doi.org/10.1038/sj.onc.1208528




PubMed


 


PubMed ID 16007227",https://intramural.nih.gov/search/searchview.taf?ipid=43649
90,BC009029-14,"October 01, 2005 -  September 30, 2006",Mechanisms of CTL-Mediated Antitumor Activity In Vivo in Mouse Models of Active,Scott  Abrams; PhD,NULL,"Laboratory of Tumor Immunology and Biology, NCI","Trina J Stewart



Kristy M Greeneltch



Monika  Schneider","Kebin  Liu
(Biochemistry & Molecular Biology, Medical College of Georgia)




Michail  Sitkovsky
(Biology & Pharmaceutical Sciences, Northeastern Univ)","James W Hodge; PhD (National Cancer Institute)



Philip M Arlen; MD (National Cancer Institute)



Kevin A Camphausen; MD (National Cancer Institute)",Richard  Childs; MD (NHLBI),"Ordered by publication type and then author name.



1.
Abrams S, Gorelik E, Prasad S, Ronchese F, Lukashev D, Wong M, Huang X, Caldwell S, Liu K, Smith P, Chen J, Jackson E, Apasov S, Sitkovsky M   (2006) A2A adenosine receptor protects tumors from antitumor T cells.  Proc. Natl. Acad. Sci. USA  13132-13137 pp.




 



2.
Gelbard A, Garnett CT, Abrams SI, Patel V, Gutkind JS, Palena C, Tsang KY, Schlom J, Hodge JW (2006). Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysis. Clin Cancer Res  12, 1897-905.   https://doi.org/10.1158/1078-0432.CCR-05-1761




PubMed



        
     
Free Article


 


PubMed ID 16551875
         Pubmed Central ID 1865094 


 



3.
Liu K, Caldwell SA, Abrams SI (2005). Cooperative disengagement of Fas and intercellular adhesion molecule-1 function in neoplastic cells confers enhanced colonization efficiency. Cancer Res  65, 1045-54.




PubMed


 


PubMed ID 15705906
    
     


 



4.
Liu K, Caldwell SA, Greeneltch KM, Yang D, Abrams SI (2006). CTL adoptive immunotherapy concurrently mediates tumor regression and tumor escape. J Immunol  176, 3374-82.   https://doi.org/10.4049/jimmunol.176.6.3374




PubMed


 


PubMed ID 16517705
    
     


 



5.
Lundqvist A, Abrams SI, Schrump DS, Alvarez G, Suffredini D, Berg M, Childs R (2006). Bortezomib and depsipeptide sensitize tumors to tumor necrosis factor-related apoptosis-inducing ligand: a novel method to potentiate natural killer cell tumor cytotoxicity. Cancer Res  66, 7317-25.   https://doi.org/10.1158/0008-5472.CAN-06-0680




PubMed


 


PubMed ID 16849582",https://intramural.nih.gov/search/searchview.taf?ipid=43650
91,BC009052-17,"October 01, 2005 -  September 30, 2006",Papillomavirus Virion Proteins and Vaccines,"John  Schiller; PhD



IRP Faculty Profile",NULL,"Laboratory of Cellular Oncology, NCI","Christopher  Buck



Cynthia D Thompson



Patricia  Day; PhD



Rebecca  Richards



Jeffrey  Roberts","Martin  Muller
(Tumor Virology, German Cancer Research Institute)




Denise  Nardelli-Haefliger
(Centre Hospitalier Universitaire Vaudois)




Richard  Roden
(Pathology, Johns Hopkins University)




Martin  Sapp
(University of Mainz)","Allan  Hildesheim; PhD (National Cancer Institute)



Samir N. Khleif; MD (National Cancer Institute)



Ligia  Pinto (Interdisciplinary Studies Sect)



Jacek Tadeusz Lubkowski (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Buck CB, Day PM, Thompson CD, Lubkowski J, Lu W, Lowy DR, Schiller JT (2006). Human alpha-defensins block papillomavirus infection. Proc Natl Acad Sci U S A  103, 1516-21.   https://doi.org/10.1073/pnas.0508033103




PubMed



        
     
Free Article


 


PubMed ID 16432216
         Pubmed Central ID 1360544 


 



2.
Buck CB, Thompson CD, Roberts JN, Müller M, Lowy DR, Schiller JT (2006). Carrageenan is a potent inhibitor of papillomavirus infection. PLoS Pathog  2, e69.   https://doi.org/10.1371/journal.ppat.0020069




PubMed



        
     
Free Article


 


PubMed ID 16839203
         Pubmed Central ID 1500806 


 



3.
Franco EL, Bosch FX, Cuzick J, Schiller JT, Garnett GP, Meheus A, Wright TC (2006). Chapter 29: Knowledge gaps and priorities for research on prevention of HPV infection and cervical cancer. Vaccine  24 Suppl 3, S3/242-9.   https://doi.org/10.1016/j.vaccine.2006.06.038




PubMed


 


PubMed ID 16950013
    
     


 



4.
Kämper N, Day PM, Nowak T, Selinka HC, Florin L, Bolscher J, Hilbig L, Schiller JT, Sapp M (2006). A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes. J Virol  80, 759-68.   https://doi.org/10.1128/JVI.80.2.759-768.2006




PubMed



        
     
Free Article


 


PubMed ID 16378978
         Pubmed Central ID 1346844 


 



5.
Kamangar F, Qiao YL, Schiller JT, Dawsey SM, Fears T, Sun XD, Abnet CC, Zhao P, Taylor PR, Mark SD (2006). Human papillomavirus serology and the risk of esophageal and gastric cancers: results from a cohort in a high-risk region in China. Int J Cancer  119, 579-84.   https://doi.org/10.1002/ijc.21871




PubMed


 


PubMed ID 16496409
    
     


 



6.
Lowy DR, Schiller JT (2006). Prophylactic human papillomavirus vaccines. J Clin Invest  116, 1167-73.   https://doi.org/10.1172/JCI28607




PubMed



        
     
Free Article


 


PubMed ID 16670757
         Pubmed Central ID 1451224 


 



7.
Pinto LA, Viscidi R, Harro CD, Kemp TJ, García-Piñeres AJ, Trivett M, Demuth F, Lowy DR, Schiller JT, Berzofsky JA, Hildesheim A (2006). Cellular immune responses to HPV-18, -31, and -53 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles. Virology  353, 451-62.   https://doi.org/10.1016/j.virol.2006.06.021




PubMed


 


PubMed ID 16863657
    
     


 



8.
Qian J, Dong Y, Pang YY, Ibrahim R, Berzofsky JA, Schiller JT, Khleif SN (2006). Combined prophylactic and therapeutic cancer vaccine: enhancing CTL responses to HPV16 E2 using a chimeric VLP in HLA-A2 mice. Int J Cancer  118, 3022-9.   https://doi.org/10.1002/ijc.21781




PubMed


 


PubMed ID 16425257
    
     


 



9.
Richards RM, Lowy DR, Schiller JT, Day PM (2006). Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection. Proc Natl Acad Sci U S A  103, 1522-7.   https://doi.org/10.1073/pnas.0508815103




PubMed



        
     
Free Article


 


PubMed ID 16432208
         Pubmed Central ID 1360554 


 



10.
Schiller JT, Nardelli-Haefliger D (2006). Chapter 17: Second generation HPV vaccines to prevent cervical cancer. Vaccine  24 Suppl 3, S3/147-53.   https://doi.org/10.1016/j.vaccine.2006.05.123




PubMed


 


PubMed ID 16950002
    
     


 



11.
Wright TC, Bosch FX, Franco EL, Cuzick J, Schiller JT, Garnett GP, Meheus A (2006). Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts. Vaccine  24 Suppl 3, S3/251-61.   https://doi.org/10.1016/j.vaccine.2006.06.064




PubMed


 


PubMed ID 16950014",https://intramural.nih.gov/search/searchview.taf?ipid=43651
92,BC009100-21,"October 01, 2005 -  September 30, 2006",Melanoma and Melanogenesis,Vincent J. Hearing; PhD,NULL,"Laboratory of Cell Biology, NCI","Julio C Valencia; MD



Elodie  Le Pape



Barbara  Bellei



Yoshinori  Miyamura



Thierry  Passeron



Karolien  Van Den Bossche



Show all 8","Zalfa  Abdel-Malek





Gregory  Barsh
(Department of Pediatrics, Stanford University)




Janusz  Beer
(Center for Devices & Radiological Health, Food & Drug Administration)




Dorothy  Bennett
(Centre for Molecular Signaling, St. George's University of London)




Douglas  Brash
(Neurology, Yale Univ)




Donald  Hunt
(Department of Chemistry, University of Minnesota)


Show all 14",NULL,NULL,"Ordered by publication type and then author name.



1.
Ando H, Wen ZM, Kim HY, Valencia JC, Costin GE, Watabe H, Yasumoto K, Niki Y, Kondoh H, Ichihashi M, Hearing VJ (2006). Intracellular composition of fatty acid affects the processing and function of tyrosinase through the ubiquitin-proteasome pathway. Biochem J  394, 43-50.   https://doi.org/10.1042/BJ20051419




PubMed



        
     
Free Article


 


PubMed ID 16232122
         Pubmed Central ID 1386001 


 



2.
Berens W, Van Den Bossche K, Yoon TJ, Westbroek W, Valencia JC, Out CJ, Marie Naeyaert J, Hearing VJ, Lambert J (2005). Different approaches for assaying melanosome transfer. Pigment Cell Res  18, 370-81.   https://doi.org/10.1111/j.1600-0749.2005.00263.x




PubMed



        
     
Free Article


 


PubMed ID 16162177
         Pubmed Central ID 1360235 


 



3.
Chen KG, Valencia JC, Lai B, Zhang G, Paterson JK, Rouzaud F, Berens W, Wincovitch SM, Garfield SH, Leapman RD, Hearing VJ, Gottesman MM (2006). Melanosomal sequestration of cytotoxic drugs contributes to the intractability of malignant melanomas. Proc Natl Acad Sci U S A  103, 9903-7.   https://doi.org/10.1073/pnas.0600213103




PubMed



        
     
Free Article


 


PubMed ID 16777967
         Pubmed Central ID 1502551 


 



4.
Hearing V, Valencia J, Hu Z, Watabe H, Yamaguchi H, Mangini N, Huang H, Canfield V, Cheng K, Yang F, Abe R, Yamagishi S, Shabanowitz J, Wu C, Appella E, Hunt D   (2006) Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes.  J. Prot. Res, in press.




 



5.
Hoashi T, Muller J, Vieira WD, Rouzaud F, Kikuchi K, Tamaki K, Hearing VJ (2006). The repeat domain of the melanosomal matrix protein PMEL17/GP100 is required for the formation of organellar fibers. J Biol Chem  281, 21198-208.   https://doi.org/10.1074/jbc.M601643200




PubMed


 


PubMed ID 16682408
    
     


 



6.
Rouzaud F, Costin GE, Yamaguchi Y, Valencia JC, Berens WF, Chen KG, Hoashi T, Böhm M, Abdel-Malek ZA, Hearing VJ (2006). Regulation of constitutive and UVR-induced skin pigmentation by melanocortin 1 receptor isoforms. FASEB J  20, 1927-9.   https://doi.org/10.1096/fj.06-5922fje




PubMed


 


PubMed ID 16877522
    
     


 



7.
Rouzaud F, Hearing VJ (2006). Analysis of the transcriptional regulation of melanocytic genes by alphaMSH using the cDNA microarray technique. Cell Mol Biol (Noisy-le-grand)  52, 21-31.




PubMed


 


PubMed ID 16914083
    
     


 



8.
Takahashi K, Hoashi T, Yamaguchi Y, Mutsuga N, Suzuki I, Vieira WD, Hearing VJ (2006). UV increases the nuclear localization of apurinic/apyrimidinic endonuclease/redox effector factor-1 in human skin. J Invest Dermatol  126, 2723-6.   https://doi.org/10.1038/sj.jid.5700466




PubMed


 


PubMed ID 16810294
    
     


 



9.
Valencia JC, Hoashi T, Pawelek JM, Solano F, Hearing VJ (2006). Pmel17: controversial indeed but critical to melanocyte function. Pigment Cell Res  19, 250-2; author reply 253-7.   https://doi.org/10.1111/j.1600-0749.2006.00308.x




PubMed


 


PubMed ID 16704461
    
     


 



10.
Valencia JC, Watabe H, Chi A, Rouzaud F, Chen KG, Vieira WD, Takahashi K, Yamaguchi Y, Berens W, Nagashima K, Shabanowitz J, Hunt DF, Appella E, Hearing VJ (2006). Sorting of Pmel17 to melanosomes through the plasma membrane by AP1 and AP2: evidence for the polarized nature of melanocytes. J Cell Sci  119, 1080-91.   https://doi.org/10.1242/jcs.02804




PubMed



        
     
Free Article


 


PubMed ID 16492709
         Pubmed Central ID 4629779 


 



11.
Watabe H, Valencia JC, Le Pape E, Yamaguchi Y, Nakamura M, Rouzaud F, Hoashi T, Kawa Y, Mizoguchi M, Hearing VJ (2008). Involvement of dynein and spectrin with early melanosome transport and melanosomal protein trafficking. J Invest Dermatol  128, 162-74.   https://doi.org/10.1038/sj.jid.5701019




PubMed



        
     
Free Article


 


PubMed ID 17687388
         Pubmed Central ID 2167631 


 



12.
Wolber R, Schlenz K, Wakamatsu K, Smuda C, Nakanishi Y, Hearing VJ, Ito S (2008). Pigmentation effects of solar-simulated radiation as compared with UVA and UVB radiation. Pigment Cell Melanoma Res  21, 487-91.   https://doi.org/10.1111/j.1755-148X.2008.00470.x




PubMed



        
     
Free Article


 


PubMed ID 18627527
         Pubmed Central ID 2593890 


 



13.
Yamaguchi Y, Hearing VJ, Itami S, Yoshikawa K, Katayama I (2005). Mesenchymal-epithelial interactions in the skin: aiming for site-specific tissue regeneration. J Dermatol Sci  40, 1-9.   https://doi.org/10.1016/j.jdermsci.2005.04.006




PubMed


 


PubMed ID 16157476
    
     


 



14.
Yamaguchi Y, Takahashi K, Zmudzka BZ, Kornhauser A, Miller SA, Tadokoro T, Berens W, Beer JZ, Hearing VJ (2006). Human skin responses to UV radiation: pigment in the upper epidermis protects against DNA damage in the lower epidermis and facilitates apoptosis. FASEB J  20, 1486-8.   https://doi.org/10.1096/fj.06-5725fje




PubMed


 


PubMed ID 16793869
    
     


 



15.
Zmudzka BZ, Hearing VJ, Beer JZ (2006). Photobiologic role of melanin distribution in the epidermis. J Photochem Photobiol B  84, 231.   https://doi.org/10.1016/j.jphotobiol.2006.05.008




PubMed


 


PubMed ID 16857378",https://intramural.nih.gov/search/searchview.taf?ipid=43652
93,BC009101-14,"October 01, 2005 -  September 30, 2006",Design of Antiviral Drugs Effective Against the HIV-1 Virus,"Ettore  Appella; MD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Marco L Schito



Lisa Marie Jenkins","Cecilia  Cheng-Mayer
(The Aaron Diamond AIDS Research Center, Rockefeller University)




James G. Omichinski; PhD
(Department of Biochemistry, University of Montreal)




Robin  Shattock; PhD
(St George's Hospital Medical School)",NULL,NULL,"Ordered by publication type and then author name.



1.
Jenkins LM, Durell SR, Maynard AT, Stahl SJ, Inman JK, Appella E, Legault P, Omichinski JG (2006). Comparison of the specificity of interaction of cellular and viral zinc-binding domains with 2-mercaptobenzamide thioesters. J Am Chem Soc  128, 11964-76.   https://doi.org/10.1021/ja063329e




PubMed


 


PubMed ID 16953638
    
     


 



2.
Schito ML, Soloff AC, Slovitz D, Trichel A, Inman JK, Appella E, Turpin JA, Barratt-Boyes SM (2006). Preclinical evaluation of a zinc finger inhibitor targeting lentivirus nucleocapsid protein in SIV-infected monkeys. Curr HIV Res  4, 379-86.   https://doi.org/10.2174/157016206777709492




PubMed


 


PubMed ID 16842089",https://intramural.nih.gov/search/searchview.taf?ipid=43653
94,BC009254-32,"October 01, 2005 -  September 30, 2006",Innate Immunity,David M Segal; PhD,NULL,"Experimental Immunology Branch, NCI","Alessandra  Mazzoni



Joshua  Leonard



Mikhael  Wallowitz",NULL,NULL,David R Davies; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Bell JK, Askins J, Hall PR, Davies DR, Segal DM (2006). The dsRNA binding site of human Toll-like receptor 3. Proc Natl Acad Sci U S A  103, 8792-7.   https://doi.org/10.1073/pnas.0603245103




PubMed



        
     
Free Article


 


PubMed ID 16720699
         Pubmed Central ID 1482657 


 



2.
Rallabhandi P, Bell J, Boukhvalova MS, Medvedev A, Lorenz E, Arditi M, Hemming VG, Blanco JC, Segal DM, Vogel SN (2006). Analysis of TLR4 polymorphic variants: new insights into TLR4/MD-2/CD14 stoichiometry, structure, and signaling. J Immunol  177, 322-32.   https://doi.org/10.4049/jimmunol.177.1.322




PubMed


 


PubMed ID 16785528
    
     


 



3.
Wang ZY, Yang D, Chen Q, Leifer CA, Segal DM, Su SB, Caspi RR, Howard ZO, Oppenheim JJ (2006). Induction of dendritic cell maturation by pertussis toxin and its B subunit differentially initiate Toll-like receptor 4-dependent signal transduction pathways. Exp Hematol  34, 1115-24.   https://doi.org/10.1016/j.exphem.2006.04.025




PubMed


 


PubMed ID 16863919",https://intramural.nih.gov/search/searchview.taf?ipid=43656
95,BC009255-31,"October 01, 2005 -  September 30, 2006",Application of Flow Cytometry to Cell Biology,Susan  Sharrow,Alfred  Singer; MD,"Experimental Immunology Branch, NCI","Anthony J Adams



Larry  Granger



Don  Plugge",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Chiang YJ, Nguyen ML, Gurunathan S, Kaminker P, Tessarollo L, Campisi J, Hodes RJ (2006). Generation and characterization of telomere length maintenance in tankyrase 2-deficient mice. Mol Cell Biol  26, 2037-43.   https://doi.org/10.1128/MCB.26.6.2037-2043.2006




PubMed



        
     
Free Article


 


PubMed ID 16507984
         Pubmed Central ID 1430286 


 



2.
Collier-Hyams LS, Sloane V, Batten BC, Neish AS   (2005) Cutting edge: bacterial modulation of epithelial signaling via changes in neddylation of cullin-1.  J Immunol 175:4194-8.




PubMed


 


PubMed ID 16177058
    
     


 



3.
Difilippantonio S, Celeste A, Fernandez-Capetillo O, Chen HT, Reina San Martin B, Van Laethem F, Yang YP, Petukhova GV, Eckhaus M, Feigenbaum L, Manova K, Kruhlak M, Camerini-Otero RD, Sharan S, Nussenzweig M, Nussenzweig A (2005). Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models. Nat Cell Biol  7, 675-85.   https://doi.org/10.1038/ncb1270




PubMed


 


PubMed ID 15965469
    
     


 



4.
Dubois S, Waldmann TA, Müller JR (2006). ITK and IL-15 support two distinct subsets of CD8+ T cells. Proc Natl Acad Sci U S A  103, 12075-80.   https://doi.org/10.1073/pnas.0605212103




PubMed



        
     
Free Article


 


PubMed ID 16880398
         Pubmed Central ID 1567699 


 



5.
Dubois SP, Waldmann TA, Müller JR (2005). Survival adjustment of mature dendritic cells by IL-15. Proc Natl Acad Sci U S A  102, 8662-7.   https://doi.org/10.1073/pnas.0503360102




PubMed



        
     
Free Article


 


PubMed ID 15932944
         Pubmed Central ID 1150852 


 



6.
Leifer CA, Brooks JC, Hoelzer K, Lopez J, Kennedy MN, Mazzoni A, Segal DM (2006). Cytoplasmic targeting motifs control localization of toll-like receptor 9. J Biol Chem  281, 35585-92.   https://doi.org/10.1074/jbc.M607511200




PubMed



        
     
Free Article


 


PubMed ID 16990271
         Pubmed Central ID 2758030 


 



7.
Liu K, Caldwell SA, Abrams SI (2005). Cooperative disengagement of Fas and intercellular adhesion molecule-1 function in neoplastic cells confers enhanced colonization efficiency. Cancer Res  65, 1045-54.




PubMed


 


PubMed ID 15705906
    
     


 



8.
Mazzoni A, Siraganian RP, Leifer CA, Segal DM (2006). Dendritic cell modulation by mast cells controls the Th1/Th2 balance in responding T cells. J Immunol  177, 3577-81.   https://doi.org/10.4049/jimmunol.177.6.3577




PubMed


 


PubMed ID 16951316
    
     


 



9.
Pellegrini M, Celeste A, Difilippantonio S, Guo R, Wang W, Feigenbaum L, Nussenzweig A (2006). Autophosphorylation at serine 1987 is dispensable for murine Atm activation in vivo. Nature  443, 222-5.   https://doi.org/10.1038/nature05112




PubMed


 


PubMed ID 16906133
    
     


 



10.
Reina-San-Martin B, Nussenzweig MC, Nussenzweig A, Difilippantonio S (2005). Genomic instability, endoreduplication, and diminished Ig class-switch recombination in B cells lacking Nbs1. Proc Natl Acad Sci U S A  102, 1590-5.   https://doi.org/10.1073/pnas.0406289102




PubMed



        
     
Free Article


 


PubMed ID 15668392
         Pubmed Central ID 547831 


 



11.
Sarafova SD, Erman B, Yu Q, Van Laethem F, Guinter T, Sharrow SO, Feigenbaum L, Wildt KF, Ellmeier W, Singer A (2005). Modulation of coreceptor transcription during positive selection dictates lineage fate independently of TCR/coreceptor specificity. Immunity  23, 75-87.   https://doi.org/10.1016/j.immuni.2005.05.011




PubMed


 


PubMed ID 16039581
    
     


 



12.
Tai X, Cowan M, Feigenbaum L, Singer A (2005). CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat Immunol  6, 152-62.   https://doi.org/10.1038/ni1160




PubMed


 


PubMed ID 15640801
    
     


 



13.
Vacchio MS, Hodes RJ (2005). Fetal expression of Fas ligand is necessary and sufficient for induction of CD8 T cell tolerance to the fetal antigen H-Y during pregnancy. J Immunol  174, 4657-61.   https://doi.org/10.4049/jimmunol.174.8.4657




PubMed


 


PubMed ID 15814689
    
     


 



14.
Williams JA, Hathcock KS, Klug D, Harada Y, Choudhury B, Allison JP, Abe R, Hodes RJ (2005). Regulated costimulation in the thymus is critical for T cell development: dysregulated CD28 costimulation can bypass the pre-TCR checkpoint. J Immunol  175, 4199-207.   https://doi.org/10.4049/jimmunol.175.7.4199




PubMed



        
     
Free Article


 


PubMed ID 16177059
         Pubmed Central ID 1343453 


 



15.
Yu Q, Park JH, Doan LL, Erman B, Feigenbaum L, Singer A (2006). Cytokine signal transduction is suppressed in preselection double-positive thymocytes and restored by positive selection. J Exp Med  203, 165-75.   https://doi.org/10.1084/jem.20051836




PubMed



        
     
Free Article


 


PubMed ID 16390939
         Pubmed Central ID 2118084",https://intramural.nih.gov/search/searchview.taf?ipid=43554
96,BC009257-31,"October 01, 2005 -  September 30, 2006",Mechanisms of Cellular Immune Responses,"James Stephen Shaw; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Ruchika  Nijhara



Yin  Liu



Natalya  Belkina



Khadija  Ben-aissa",NULL,"Alfred  Singer; MD (National Cancer Institute)



Michael John Kruhlak; PhD (National Cancer Institute)



Philip J Lucas; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Liu Y, Belkina NV, Graham C, Shaw S   (2006) Independence of protein kinase C-delta activity from activation loop phosphorylation: structural basis and altered functions in cells.  J Biol Chem 281:12102-11.




PubMed


 


PubMed ID 16505477
    
     


 



2.
Salganik MP, Milford EL, Hardie DL, Shaw S, Wands MP   (2005) Classifying antibodies using flow cytometry data: class prediction and class discovery.  Biom J 47:740-54.




PubMed


 


PubMed ID 16385913
    
     


 



3.
Sarkar K, Kruhlak MJ, Erlandsen SL, Shaw S (2005). Selective inhibition by rottlerin of macropinocytosis in monocyte-derived dendritic cells. Immunology  116, 513-24.   https://doi.org/10.1111/j.1365-2567.2005.02253.x




PubMed



        
     
Free Article


 


PubMed ID 16313365
         Pubmed Central ID 1802442 


 



4.
Thuille N, Heit I, Fresser F, Krumböck N, Bauer B, Leuthaeusser S, Dammeier S, Graham C, Copeland TD, Shaw S, Baier G (2005). Critical role of novel Thr-219 autophosphorylation for the cellular function of PKCtheta in T lymphocytes. EMBO J  24, 3869-80.   https://doi.org/10.1038/sj.emboj.7600856




PubMed



        
     
Free Article


 


PubMed ID 16252004
         Pubmed Central ID 1283955",https://intramural.nih.gov/search/searchview.taf?ipid=43658
97,BC009264-23,"October 01, 2005 -  September 30, 2006",Cytokine Regulation of Normal and Neoplastic Hematopoietic Cell Growth,Francis W Ruscetti; PhD,NULL,"Laboratory of Experimental Immunology, NCI","Daniel C Bertolette



Maria  Birchenall-Roberts



Tao  Fu



Yi  Huang



Cari  Sadowski","Steven  Bartelmez
(stem cell biology, Betastem Therapeutics)




David  Danielpour
(NCI)




John  Letterio
(Division of Pediatric Hematology/Oncology, Case Western Reserve University)","Seong-Jin  Kim; PhD (National Cancer Institute)



Lalage  Wakefield; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Ruscetti F   (2006) Role of TGF-beta in myeloid and lympoid homeostatis, in TGF-beta Biology. Derynck R, ed., Cold Spring Harbor Press (NY), in press.




 



2.
Birchenall-Roberts MC, Fu T, Kim SG, Huang YK, Dambach M, Resau JH, Ruscetti FW (2006). K-Ras4B proteins are expressed in the nucleolus: Interaction with nucleolin. Biochem Biophys Res Commun  348, 540-9.   https://doi.org/10.1016/j.bbrc.2006.07.094




PubMed


 


PubMed ID 16889753
    
     


 



3.
Jones KS, Akel S, Petrow-Sadowski C, Huang Y, Bertolette DC, Ruscetti FW (2005). Induction of human T cell leukemia virus type I receptors on quiescent naive T lymphocytes by TGF-beta. J Immunol  174, 4262-70.   https://doi.org/10.4049/jimmunol.174.7.4262




PubMed


 


PubMed ID 15778389",https://intramural.nih.gov/search/searchview.taf?ipid=43660
98,BC009265-24,"October 01, 2005 -  September 30, 2006",Analysis of the T Cell Repertoire,"Richard J Hodes; MD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Karen  Hathcock



Melanie S Vacchio; PhD



Joy A Williams



Lila A Farrington",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43661
99,BC009267-24,"October 01, 2005 -  September 30, 2006",Immune ProtectionDysregulation in HIVAIDS,"Gene  Shearer; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Adriano  Boasso



Andrew W Hardy","Jan  Andersson
(Medicine, Karolinska Institutet)




Claire  Chougnet
(CHRF, Children's Hospital)




Fuchs  Dietmar
(Chemestry and Biochemestry, Innsbruck Medical University)




Matthew  Dolan
(AIDS, Wilford Hall Med Inst)




Maria  Rugeles
(Immunovirology, Unversidad de Antioquia)",Genoveffa  Franchini; MD (National Cancer Institute),Jean Charles  Grivel; PhD (NICHD),"Ordered by publication type and then author name.



1.
Andersson J, Boasso A, Nilsson J, Zhang R, Shire NJ, Lindback S, Shearer GM, Chougnet CA (2005). The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J Immunol  174, 3143-7.   https://doi.org/10.4049/jimmunol.174.6.3143




PubMed


 


PubMed ID 15749840
    
     


 



2.
Bedoya VI, Boasso A, Hardy AW, Rybak S, Shearer GM, Rugeles MT (2006). Ribonucleases in HIV type 1 inhibition: effect of recombinant RNases on infection of primary T cells and immune activation-induced RNase gene and protein expression. AIDS Res Hum Retroviruses  22, 897-907.   https://doi.org/10.1089/aid.2006.22.897




PubMed


 


PubMed ID 16989616
    
     


 



3.
Herbeuval JP, Nilsson J, Boasso A, Hardy AW, Kruhlak MJ, Anderson SA, Dolan MJ, Dy M, Andersson J, Shearer GM   (2006) Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients.  Proc Natl Acad Sci U S A 103:7000-5.




PubMed



        
     
Free Article


 


PubMed ID 16632604
         Pubmed Central ID 1444883 


 



4.
Herbeuval JP, Shearer GM (2006). Are blockers of gp120/CD4 interaction effective inhibitors of HIV-1 immunopathogenesis? AIDS Rev  8, 3-8.




PubMed


 


PubMed ID 16736946
    
     


 



5.
Hryniewicz A, Boasso A, Edghill-Smith Y, Vaccari M, Fuchs D, Venzon D, Nacsa J, Betts MR, Tsai WP, Heraud JM, Beer B, Blanset D, Chougnet C, Lowy I, Shearer GM, Franchini G (2006). CTLA-4 blockade decreases TGF-beta, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques. Blood  108, 3834-42.   https://doi.org/10.1182/blood-2006-04-010637




PubMed



        
     
Free Article


 


PubMed ID 16896154
         Pubmed Central ID 1895471 


 



6.
Nilsson J, Boasso A, Velilla PA, Zhang R, Vaccari M, Franchini G, Shearer GM, Andersson J, Chougnet C (2006). HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. Blood  108, 3808-17.   https://doi.org/10.1182/blood-2006-05-021576




PubMed



        
     
Free Article


 


PubMed ID 16902147
         Pubmed Central ID 1895475",https://intramural.nih.gov/search/searchview.taf?ipid=43663
100,BC009273-19,"October 01, 2005 -  September 30, 2006",T Cell Differentiation and Repertoire Selection,"Alfred  Singer; MD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Amala Shenai Alag



Terry I Guinter



Sophia D Sarafova



Jung-Hyun  Park



Xuguang C Tai



Francois  Van Laethem



Show all 10",NULL,NULL,"Paul E Love; MD, PhD (NICHD)","Ordered by publication type and then author name.



1.
Graham DB, Bell MP, Huntoon CJ, Griffin MD, Tai X, Singer A, McKean DJ (2006). CD28 ligation costimulates cell death but not maturation of double-positive thymocytes due to defective ERK MAPK signaling. J Immunol  177, 6098-107.   https://doi.org/10.4049/jimmunol.177.9.6098




PubMed


 


PubMed ID 17056536
    
     


 



2.
Yu Q, Park JH, Doan LL, Erman B, Feigenbaum L, Singer A (2006). Cytokine signal transduction is suppressed in preselection double-positive thymocytes and restored by positive selection. J Exp Med  203, 165-75.   https://doi.org/10.1084/jem.20051836




PubMed



        
     
Free Article


 


PubMed ID 16390939
         Pubmed Central ID 2118084",https://intramural.nih.gov/search/searchview.taf?ipid=43664
101,BC009279-21,"October 01, 2005 -  September 30, 2006",Regulation of Expression of MHC Class I Genes,"Dinah  Singer; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Jocelyn D Weissman



Aparna  Kotekar



Helit  Cohen



Shankar  Iyer",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Mozes E, Lovchik J, Zinger H, Singer DS (2005). MHC class I expression regulates susceptibility to spontaneous autoimmune disease in (NZBxNZW)F1 mice. Lupus  14, 308-14.   https://doi.org/10.1191/0961203305lu2079oa




PubMed


 


PubMed ID 15864917",https://intramural.nih.gov/search/searchview.taf?ipid=43665
102,BC009281-20,"October 01, 2005 -  September 30, 2006",Receptor Mediated T and B Cell Activation,"Richard J Hodes; MD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Haifeng  Song



Sumeena  Bhatia",NULL,NULL,"Reuben P Siraganian; MD, PhD (NIDCR)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43666
103,BC009283-22,"October 01, 2005 -  September 30, 2006",Control of Cytokine Gene Expression in LymphoidMyeloid Cells,"Howard A Young; PhD



IRP Faculty Profile",Robert  Wiltrout; PhD,"Laboratory of Experimental Immunology, NCI","Deborah L Hodge



Della A Reynolds



Michael E Sanford



Kevin P Lock



Hong T Dang



Ram  Savan



Show all 8","Thomas  Aune
(Vanderbilt Univ.)




Rivkah  Gonsky
(UCLA)","Thomas Joseph Sayers; PhD (National Cancer Institute)



Daniel  McVicar; PhD (National Cancer Institute)



Victor  Marquez; PhD (ORGANIC CHEMSTRY SECT)



Nancy H Colburn; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Gonsky R, Deem RL, Bream JH, Young HA, Targan SR (2006). An IFNG SNP with an estrogen-like response element selectively enhances promoter expression in peripheral but not lamina propria T cells. Genes Immun  7, 342-51.   https://doi.org/10.1038/sj.gene.6364305




PubMed


 


PubMed ID 16724074
    
     


 



2.
Khabar KS, Young HA (2007). Post-transcriptional control of the interferon system. Biochimie  89, 761-9.   https://doi.org/10.1016/j.biochi.2007.02.008




PubMed



        
     
Free Article


 


PubMed ID 17408842
         Pubmed Central ID 1994070 


 



3.
Ortaldo JR, Winkler-Pickett R, Wigginton J, Horner M, Bere EW, Mason AT, Bhat N, Cherry J, Sanford M, Hodge DL, Young HA (2006). Regulation of ITAM-positive receptors: role of IL-12 and IL-18. Blood  107, 1468-75.   https://doi.org/10.1182/blood-2005-04-1579




PubMed



        
     
Free Article


 


PubMed ID 16249390
         Pubmed Central ID 1895416 


 



4.
Ortaldo JR, Young HA (2005). Mouse Ly49 NK receptors: balancing activation and inhibition. Mol Immunol  42, 445-50.   https://doi.org/10.1016/j.molimm.2004.07.024




PubMed


 


PubMed ID 15607796
    
     


 



5.
Ortaldo JR, Young HA (2006). IL-18 as critical co-stimulatory molecules in modulating the immune response of ITAM bearing lymphocytes. Semin Immunol  18, 193-6.   https://doi.org/10.1016/j.smim.2006.03.014




PubMed


 


PubMed ID 16678434
    
     


 



6.
Rodriguez-Galán MC, Bream JH, Farr A, Young HA (2005). Synergistic effect of IL-2, IL-12, and IL-18 on thymocyte apoptosis and Th1/Th2 cytokine expression. J Immunol  174, 2796-804.   https://doi.org/10.4049/jimmunol.174.5.2796




PubMed


 


PubMed ID 15728489
    
     


 



7.
Young H   (2006) IL-18 as critical co-stimulatory molecules in modulating the immune response of ITAM bearing lymphocytes.  Sem. Immunol, in press.




 



8.
Young HA (2006). Unraveling the pros and cons of interferon-gamma gene regulation. Immunity  24, 506-7.   https://doi.org/10.1016/j.immuni.2006.05.004




PubMed


 


PubMed ID 16713967
    
     


 



9.
Young HA, Ortaldo J (2006). Cytokines as critical co-stimulatory molecules in modulating the immune response of natural killer cells. Cell Res  16, 20-4.   https://doi.org/10.1038/sj.cr.7310004




PubMed


 


PubMed ID 16467872",https://intramural.nih.gov/search/searchview.taf?ipid=43667
104,BC009285-20,"October 01, 2005 -  September 30, 2006",Responses of MHC Class I Genes to Exogeneous Stimuli,"Dinah  Singer; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Jocelyn D Weissman



Shankar  Iyer",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Giuliani C, Saji M, Bucci I, Fiore G, Liberatore M, Singer DS, Monaco F, Kohn LD, Napolitano G (2006). Transcriptional regulation of major histocompatibility complex class I gene by insulin and IGF-I in FRTL-5 thyroid cells. J Endocrinol  189, 605-15.   https://doi.org/10.1677/joe.1.06486




PubMed


 


PubMed ID 16731791
    
     


 



2.
Mozes E, Lovchik J, Zinger H, Singer DS (2005). MHC class I expression regulates susceptibility to spontaneous autoimmune disease in (NZBxNZW)F1 mice. Lupus  14, 308-14.   https://doi.org/10.1191/0961203305lu2079oa




PubMed


 


PubMed ID 15864917",https://intramural.nih.gov/search/searchview.taf?ipid=43668
105,BC009287-22,"October 01, 2005 -  September 30, 2006",Cytokines and T Cell Development,"Scott K Durum; PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI","Annette R Khaled



Qiong  Jiang



Wenqing  Li



Benyam  Asefa



Renata I Mazzucchelli



Arthur A Hurwitz",NULL,Jonathan  Keller; PhD (Cancer and Developmental Biology Laboratory),NULL,"Ordered by publication type and then author name.



1.
Jiang Q, Li WQ, Aiello FB, Klarmann KD, Keller JR, Durum SK (2005). Retroviral transduction of IL-7Ralpha into IL-7Ralpha-/- bone marrow progenitors: correction of lymphoid deficiency and induction of neutrophilia. Gene Ther  12, 1761-8.   https://doi.org/10.1038/sj.gt.3302558




PubMed


 


PubMed ID 16208423
    
     


 



2.
Khaled AR, Bulavin DV, Kittipatarin C, Li WQ, Alvarez M, Kim K, Young HA, Fornace AJ, Durum SK (2005). Cytokine-driven cell cycling is mediated through Cdc25A. J Cell Biol  169, 755-63.   https://doi.org/10.1083/jcb.200409099




PubMed



        
     
Free Article


 


PubMed ID 15928203
         Pubmed Central ID 2171622 


 



3.
Kittipatarin C, Li WQ, Bulavin DV, Durum SK, Khaled AR (2006). Cell cycling through Cdc25A: transducer of cytokine proliferative signals. Cell Cycle  5, 907-12.   https://doi.org/10.4161/cc.5.9.2693




PubMed


 


PubMed ID 16628013
    
     


 



4.
Leviton A, Dammann O, Durum SK (2005). The adaptive immune response in neonatal cerebral white matter damage. Ann Neurol  58, 821-8.   https://doi.org/10.1002/ana.20662




PubMed


 


PubMed ID 16250014
    
     


 



5.
Li WQ, Jiang Q, Aleem E, Kaldis P, Khaled AR, Durum SK (2006). IL-7 promotes T cell proliferation through destabilization of p27Kip1. J Exp Med  203, 573-82.   https://doi.org/10.1084/jem.20051520




PubMed



        
     
Free Article


 


PubMed ID 16492801
         Pubmed Central ID 2118250 


 



6.
Takase H, Yu CR, Ham DI, Chan CC, Chen J, Vistica BP, Wawrousek EF, Durum SK, Egwuagu CE, Gery I (2006). Inflammatory processes triggered by TCR engagement or by local cytokine expression: differences in profiles of gene expression and infiltrating cell populations. J Leukoc Biol  80, 538-45.   https://doi.org/10.1189/jlb.1205719




PubMed


 


PubMed ID 16793919
    
     


 



7.
Yao Z, Cui Y, Watford WT, Bream JH, Yamaoka K, Hissong BD, Li D, Durum SK, Jiang Q, Bhandoola A, Hennighausen L, O'Shea JJ (2006). Stat5a/b are essential for normal lymphoid development and differentiation. Proc Natl Acad Sci U S A  103, 1000-5.   https://doi.org/10.1073/pnas.0507350103




PubMed



        
     
Free Article


 


PubMed ID 16418296
         Pubmed Central ID 1327727",https://intramural.nih.gov/search/searchview.taf?ipid=43669
106,BC009290-21,"October 01, 2005 -  September 30, 2006",T Cell Activation and Apoptosis,"Jonathan D Ashwell; MD



IRP Faculty Profile",NULL,"Laboratory of Immune Cell Biology, NCI","Valerie J Brantley



Chuanjin  Wu



Dietrich B Conze



Paul  Mittelstadt; PhD



Bei  Dong



Yongge  Zhao



Show all 9","Albert J Fornace; MD
(NCI)




David  Fushman
(Biochemistry, University of Maryland)",NULL,"John Allan Hanover; PhD (NIDDK) 



David Harvey Margulies; MD, PhD (NIAID) 



Ethan M Shevach; MD (NIAID)","Ordered by publication type and then author name.



1.
Ashwell JD (2006). The many paths to p38 mitogen-activated protein kinase activation in the immune system. Nat Rev Immunol  6, 532-40.   https://doi.org/10.1038/nri1865




PubMed


 


PubMed ID 16799472
    
     


 



2.
Mittelstadt PR, Salvador JM, Fornace AJ, Ashwell JD (2005). Activating p38 MAPK: new tricks for an old kinase. Cell Cycle  4, 1189-92.   https://doi.org/10.4161/cc.4.9.2043




PubMed


 


PubMed ID 16103752
    
     


 



3.
Munitic I, Ryan PE, Ashwell JD (2005). T cells in G1 provide a memory-like response to secondary stimulation. J Immunol  174, 4010-8.   https://doi.org/10.4049/jimmunol.174.7.4010




PubMed


 


PubMed ID 15778358
    
     


 



4.
Salvador JM, Mittelstadt PR, Belova GI, Fornace AJ, Ashwell JD (2005). The autoimmune suppressor Gadd45alpha inhibits the T cell alternative p38 activation pathway. Nat Immunol  6, 396-402.   https://doi.org/10.1038/ni1176




PubMed


 


PubMed ID 15735649
    
     


 



5.
Salvador JM, Mittelstadt PR, Guszczynski T, Copeland TD, Yamaguchi H, Appella E, Fornace AJ, Ashwell JD (2005). Alternative p38 activation pathway mediated by T cell receptor-proximal tyrosine kinases. Nat Immunol  6, 390-5.   https://doi.org/10.1038/ni1177




PubMed


 


PubMed ID 15735648
    
     


 



6.
Schito ML, Demidov ON, Saito S, Ashwell JD, Appella E (2006). Wip1 phosphatase-deficient mice exhibit defective T cell maturation due to sustained p53 activation. J Immunol  176, 4818-25.   https://doi.org/10.4049/jimmunol.176.8.4818




PubMed


 


PubMed ID 16585576
    
     


 



7.
Wu CJ, Conze DB, Li T, Srinivasula SM, Ashwell JD (2006). Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected]. Nat Cell Biol  8, 398-406.   https://doi.org/10.1038/ncb1384




PubMed


 


PubMed ID 16547522
    
     


 



8.
Wu CJ, Conze DB, Li X, Ying SX, Hanover JA, Ashwell JD (2005). TNF-alpha induced c-IAP1/TRAF2 complex translocation to a Ubc6-containing compartment and TRAF2 ubiquitination. EMBO J  24, 1886-98.   https://doi.org/10.1038/sj.emboj.7600649




PubMed



        
     
Free Article


 


PubMed ID 15861135
         Pubmed Central ID 1142588",https://intramural.nih.gov/search/searchview.taf?ipid=43670
107,BC009297-15,"October 01, 2005 -  September 30, 2006",SENP1 and SUMO in mouse development,Michael Robert Kuehn; PhD,NULL,"Laboratory of Protein Dynamics and Signaling, NCI","Yasuhiro  Ozawa



Prashant  Sharma",NULL,Allan M Weissman; MD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Kuehn MR (2005). Mouse Ubc9 knockout: many path(way)s to ruin. Dev Cell  9, 727-8.   https://doi.org/10.1016/j.devcel.2005.11.008




PubMed


 


PubMed ID 16326385",https://intramural.nih.gov/search/searchview.taf?ipid=43671
108,BC009304-12,"October 01, 2005 -  September 30, 2006",Glycosyltransferases: Structure-Function Studies and Structure-Based Design,Pradman  Qasba; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI","Elizabeth  Boeggeman



Boopathy  Ramakrishna



Marta  Pasek",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Ramakrishnan B, Ramasamy V, Qasba PK (2006). Structural snapshots of beta-1,4-galactosyltransferase-I along the kinetic pathway. J Mol Biol  357, 1619-33.   https://doi.org/10.1016/j.jmb.2006.01.088




PubMed


 


PubMed ID 16497331",https://intramural.nih.gov/search/searchview.taf?ipid=43672
109,BC009369-16,"October 01, 2005 -  September 30, 2006",Consequences of Chemokine-Receptor Interactions with Chemokines and Chemokine Mi,"Joost J Oppenheim; MD



IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI","Hui-Fang  Dong



Ola Mae Zack Howard



Ruth  Neta



De  Yang



Tiziana  Cavinato



Kahori  Kurosaka



Show all 8","Robert D Goldman; PhD
(CMS Biology, Northwestern University Medical School)




Kouji  Matsushima
(Molecular Preventive Medicine, University of Toyko)




Finn  Olivera
(Department of Immunology, University of Pittsburgh School of Medicine)




Kevin  Tracey
(Ctr Patient Oriented Res, North Shore-Long Island Jewish Res Inst)




David  Wade
(Rutgers University)","Qian  Chen (Office Of The Director)



Jacek Tadeusz Lubkowski (National Cancer Institute)



Howard A Young; PhD (National Cancer Institute)



Michael  Bustin; PhD (National Cancer Institute)



David M Segal; PhD (National Cancer Institute)","Rachel R Caspi; PhD (NEI) 



Helene Fischer Rosenberg; PhD, MD (NIAID)","Ordered by publication type and then author name.



1.
Oppenheim J   (2006) Neuropeptides that regulate immune responses, in The Handbook of Biologically Active Peptides. Kastin A, ed., Academic Press Elsevier (London), pp. 579-584.




 



2.
Oppenheim J, Wang Z, Gao P   (2006) Biology of Chmokines: Lymphocyte trafficking in health and disease, in Progress in Inflammation Research. Badolato R, Sozzani S, eds., Birkhauser Verlag AG (Boston), pp. 7-38.




 



3.
Chute JP, Saini AA, Chute DJ, Wells MR, Clark WB, Harlan DM, Park J, Stull MK, Civin C, Davis TA   (2002) Ex vivo culture with human brain endothelial cells increases the SCID-repopulating capacity of adult human bone marrow.  Blood .




PubMed



        
     
Free Article


 


PubMed ID 16522819
         Pubmed Central ID 1895822 


 



4.
Hu PQ, Oppenheim JJ, Medsger TA, Wright TM (2006). T cell lines from systemic sclerosis patients and healthy controls recognize multiple epitopes on DNA topoisomerase I. J Autoimmun  26, 258-67.   https://doi.org/10.1016/j.jaut.2006.03.004




PubMed


 


PubMed ID 16735104
    
     


 



5.
Wang ZY, Yang D, Chen Q, Leifer CA, Segal DM, Su SB, Caspi RR, Howard ZO, Oppenheim JJ (2006). Induction of dendritic cell maturation by pertussis toxin and its B subunit differentially initiate Toll-like receptor 4-dependent signal transduction pathways. Exp Hematol  34, 1115-24.   https://doi.org/10.1016/j.exphem.2006.04.025




PubMed


 


PubMed ID 16863919",https://intramural.nih.gov/search/searchview.taf?ipid=43675
110,BC009392-13,"October 01, 2005 -  September 30, 2006",Determining the Fate of Transmembrane Proteins,"Allan M Weissman; MD



IRP Faculty Profile",NULL,"Laboratory of Protein Dynamics and Signaling, NCI","Jennifer B Mariano



Yien-Che  Tsai



Zlatka  Kostova-Lenard



Mickael M Cohen



Guillaume  Leboucher



Tiesong  Shang","Robert  Gemmill
(Medical Oncology, UCHSC)




Michael  Glickman





Willian  Lennarz
(Biochemistry, Stony Brook University)","Robert Andrew Byrd (National Cancer Institute)



Lee Jay Helman; MD (National Cancer Institute)



Walter M Kuehl; MD, PhD (National Cancer Institute)



Barry R O'Keefe (National Cancer Institute)



John A Beutler (National Cancer Institute)



Chand  Khanna; MD (Pediatric Oncology Br)",NULL,"Ordered by publication type and then author name.



1.
Weissman A, Yang Y, Jensen J, Iwai K   (2006) Studies of the ubiquitin proteasome system, in Current Protocols in Cell Biology. Bonifacino x, Dasso x, Lippincott-Schwartz x, Harford x, Yamada x, Bonafacino x, eds.,  John Wiley and Sons, in press.




 



2.
Kostova Z, Tsai YC, Weissman AM (2007). Ubiquitin ligases, critical mediators of endoplasmic reticulum-associated degradation. Semin Cell Dev Biol  18, 770-9.   https://doi.org/10.1016/j.semcdb.2007.09.002




PubMed



        
     
Free Article


 


PubMed ID 17950636
         Pubmed Central ID 2200800 


 



3.
Weissman A, Lorick K, Jason L, Tsai Y, Chen D, Drabkin H, Gemmill R   (2006) RING-dependent tumor suppression and G2/M arrest induced by the TCR8 hereditary kidney cancer gene.  Oncogene, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=43533
111,BC009404-12,"October 01, 2005 -  September 30, 2006",Protein Trafficking in Lymphocytes,"Paul A Roche; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Niti  Puri



Neil J Poloso



Even  Walseng","Lisa  Denzin
(Immunology Program, Sloan-Kettering Institute)




Sidney  Whiteheart
(Mol. and Cellular Biochemistry, Univ. of Kentucky)",NULL,NULL,"Ordered by publication type and then author name.



1.
Puri N, Roche PA (2006). Ternary SNARE complexes are enriched in lipid rafts during mast cell exocytosis. Traffic  7, 1482-94.   https://doi.org/10.1111/j.1600-0854.2006.00490.x




PubMed


 


PubMed ID 16984405
    
     


 



2.
Roche PA (2006). Gold-plating MHC class II molecules. Nat Chem Biol  2, 178-9.   https://doi.org/10.1038/nchembio0406-178




PubMed


 


PubMed ID 16547476",https://intramural.nih.gov/search/searchview.taf?ipid=43677
112,BC009405-12,"October 01, 2005 -  September 30, 2006",Regulation of Lymphocyte Proliferation and Replicative Capacity,"Richard J Hodes; MD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI",Karen  Hathcock,NULL,"Steven Aaron Rosenberg; MD, PhD (National Cancer Institute)



James Carl Barrett; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Chiang YJ, Nguyen ML, Gurunathan S, Kaminker P, Tessarollo L, Campisi J, Hodes RJ (2006). Generation and characterization of telomere length maintenance in tankyrase 2-deficient mice. Mol Cell Biol  26, 2037-43.   https://doi.org/10.1128/MCB.26.6.2037-2043.2006




PubMed



        
     
Free Article


 


PubMed ID 16507984
         Pubmed Central ID 1430286 


 



2.
Fritsch RD, Shen X, Illei GG, Yarboro CH, Prussin C, Hathcock KS, Hodes RJ, Lipsky PE (2006). Abnormal differentiation of memory T cells in systemic lupus erythematosus. Arthritis Rheum  54, 2184-97.   https://doi.org/10.1002/art.21943




PubMed


 


PubMed ID 16802356
    
     


 



3.
Hadley EC, Lakatta EG, Morrison-Bogorad M, Warner HR, Hodes RJ (2005). The future of aging therapies. Cell  120, 557-67.   https://doi.org/10.1016/j.cell.2005.01.030




PubMed


 


PubMed ID 15734687
    
     


 



4.
Horikawa I, Chiang YJ, Patterson T, Feigenbaum L, Leem SH, Michishita E, Larionov V, Hodes RJ, Barrett JC (2005). Differential cis-regulation of human versus mouse TERT gene expression in vivo: identification of a human-specific repressive element. Proc Natl Acad Sci U S A  102, 18437-42.   https://doi.org/10.1073/pnas.0508964102




PubMed



        
     
Free Article


 


PubMed ID 16344462
         Pubmed Central ID 1317953 


 



5.
Zhou J, Shen X, Huang J, Hodes RJ, Rosenberg SA, Robbins PF (2005). Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy. J Immunol  175, 7046-52.   https://doi.org/10.4049/jimmunol.175.10.7046




PubMed



        
     
Free Article


 


PubMed ID 16272366
         Pubmed Central ID 1351312",https://intramural.nih.gov/search/searchview.taf?ipid=43678
113,BC010001-11,"October 01, 2005 -  September 30, 2006",MolecularCellular Regulation of Hematopoiesis,Jonathan  Keller; PhD,NULL,"Cancer and Developmental Biology Laboratory, NCI","Kimberly D Klarmann



Kristbjorn O Gudmundsson; MSc, PhD



Ming  Ji",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Drutskaya MS, Ortiz M, Liepinsh DJ, Kuprash DV, Nedospasov SA, Keller JR (2005). Inhibitory effects of tumor necrosis factor on hematopoiesis seen in vitro are translated to increased numbers of both committed and multipotent progenitors in TNF-deficient mice. Exp Hematol  33, 1348-56.   https://doi.org/10.1016/j.exphem.2005.08.001




PubMed


 


PubMed ID 16263419",https://intramural.nih.gov/search/searchview.taf?ipid=43679
114,BC010003-11,"October 01, 2005 -  September 30, 2006",Retrovirus Gene Regulation: HTLV-1 Transmission and Replication,David  Derse; PhD,NULL,"Retroviral Replication Laboratory, NCI","Shawn A Hill



Patricia  Lloyd



Gerald L Princler



Michael S Mitchell



Anna N Ilinskaya



Leslie  Gee



Show all 7","Paul  Bieniasz
(Rockefeller University, Aaron Diamond AIDS Research Center)




Madeleine  Duc Dodon
(-, Ecole Normale Superieure de Lyon)




Thomas M Folks; PhD
(HIV and Retrovirology Branch, CDC)




Louis  Gazzolo
(-, Ecole Normale Superieure de Lyon)




Chou-Zen  Giam
(-, Uniformed Services University of the Health Sciences)




Walid  Heneine
(-, Centers for Disease Control and Prevention)


Show all 12",Stephen H Hughes; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Derse D   (2006) HTLV tax tails.  Blood 107:1740-1741.




 



2.
Mitchell MS, Tözsér J, Princler G, Lloyd PA, Auth A, Derse D (2006). Synthesis, processing, and composition of the virion-associated HTLV-1 reverse transcriptase. J Biol Chem  281, 3964-71.   https://doi.org/10.1074/jbc.M507660200




PubMed


 


PubMed ID 16368688",https://intramural.nih.gov/search/searchview.taf?ipid=43680
115,BC010006-11,"October 01, 2005 -  September 30, 2006",Developmental Signal Transduction in Xenopus Oocytes and Embryos,"Ira  Daar; PhD



IRP Faculty Profile",NULL,"Laboratory of Cell and Developmental Signaling, NCI","Kathleen T Soria



Yong-Sik  Bong



Hyun-Shik  Lee



Zongjian  Jia","Sally  Moody
(Anatomy and Cell Biology, George washington University)




Morag  Park
(Dept. Biochemistry and Oncology, McGill University)",NULL,NULL,"Ordered by publication type and then author name.



1.
Ishimura A, Lee HS, Bong YS, Saucier C, Mood K, Park EK, Daar IO (2006). Oncogenic Met receptor induces ectopic structures in Xenopus embryos. Oncogene  25, 4286-99.   https://doi.org/10.1038/sj.onc.1209463




PubMed


 


PubMed ID 16518409
    
     


 



2.
Lee HS, Bong YS, Moore KB, Soria K, Moody SA, Daar IO (2006). Dishevelled mediates ephrinB1 signalling in the eye field through the planar cell polarity pathway. Nat Cell Biol  8, 55-63.   https://doi.org/10.1038/ncb1344




PubMed


 


PubMed ID 16362052
    
     


 



3.
Mood K, Saucier C, Bong YS, Lee HS, Park M, Daar IO (2006). Gab1 is required for cell cycle transition, cell proliferation, and transformation induced by an oncogenic met receptor. Mol Biol Cell  17, 3717-28.   https://doi.org/10.1091/mbc.e06-03-0244




PubMed



        
     
Free Article


 


PubMed ID 16775003
         Pubmed Central ID 1556377 


 



4.
Mood K, Saucier C, Ishimura A, Bong YS, Lee HS, Park M, Daar IO (2006). Oncogenic Met receptor induces cell-cycle progression in Xenopus oocytes independent of direct Grb2 and Shc binding or Mos synthesis, but requires phosphatidylinositol 3-kinase and Raf signaling. J Cell Physiol  207, 271-85.   https://doi.org/10.1002/jcp.20564




PubMed


 


PubMed ID 16331688",https://intramural.nih.gov/search/searchview.taf?ipid=43682
116,BC010008-11,"October 01, 2005 -  September 30, 2006",The Genetics of Susceptibility to Mouse Plasma Cell Tumors,"Beverly  Mock; PhD



IRP Faculty Profile",NULL,"Laboratory of Genetics, NCI","Shuling  Zhang; MD, PhD



Valery  Bliskovsky; PhD



Wendy Dianne Du Bois De Vroylande



Richard C Robinson



Jyoti  Patel



Daniel R Kagan



Show all 7",NULL,"Neal G Copeland; PhD (National Cancer Institute)



Carole A Parent; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43683
117,BC010012-11,"October 01, 2005 -  September 30, 2006",Mechanisms of Immune-mediated Tumor Cell Destruction,Thomas Joseph Sayers; PhD,NULL,"Laboratory of Experimental Immunology, NCI","Alan  Brooks



Anil  Shanker



Teresa  Ramirez","Avi  Ashkenazi
(Genentech, Inc.)




Mark  Smyth
(Cancer Immunology Program, Peter MacCallum Cancer Center)




Hideo  Yagita
(Immunology, Juntendo University)",NULL,William T Murphy (OD),"Ordered by publication type and then author name.



1.
Cretney E, Shanker A, Yagita H, Smyth MJ, Sayers TJ (2006). TNF-related apoptosis-inducing ligand as a therapeutic agent in autoimmunity and cancer. Immunol Cell Biol  84, 87-98.   https://doi.org/10.1111/j.1440-1711.2005.01413.x




PubMed


 


PubMed ID 16405656
    
     


 



2.
Khan T, Stauffer JK, Williams R, Hixon JA, Salcedo R, Lincoln E, Back TC, Powell D, Lockett S, Arnold AC, Sayers TJ, Wigginton JM (2006). Proteasome inhibition to maximize the apoptotic potential of cytokine therapy for murine neuroblastoma tumors. J Immunol  176, 6302-12.   https://doi.org/10.4049/jimmunol.176.10.6302




PubMed


 


PubMed ID 16670342
    
     


 



3.
Sayers TJ, Murphy WJ (2006). Combining proteasome inhibition with TNF-related apoptosis-inducing ligand (Apo2L/TRAIL) for cancer therapy. Cancer Immunol Immunother  55, 76-84.   https://doi.org/10.1007/s00262-005-0676-3




PubMed


 


PubMed ID 15864587",https://intramural.nih.gov/search/searchview.taf?ipid=43684
118,BC010013-11,"October 01, 2005 -  September 30, 2006",Molecular Studies of Cellular Cytotoxicity,Stephen K Anderson; PhD,NULL,"Laboratory of Experimental Immunology, NCI","Paul  Wright



Veronique  Pascal



Michael J Stulberg","Andrew  Makrigiannis
(Molecular Immunology, Clinical Research Institute of Montreal)




Jeffrey  Miller
(Division of Hematology, Oncology and Transplantation, University of Minnesota Cancer Center)",NULL,NULL,"Ordered by publication type and then author name.



1.
Anderson S   (2006) Killer cell lectin-like receptor, subfamily A, member 9; Klra9; Ly49I.  AfCS-Nature Molecule Pages, in press.




 



2.
Anderson S   (2006) Ly49G.  AfCS-Nature Molecule Pages  1 pp.




 



3.
Anderson S   (2006) Ly49H.  AfCS-Nature Molecule Pages  1 pp.




 



4.
Anderson S   (2006) Ly49J.  AfCS-Nature Molecule Pages  1 pp.




 



5.
Anderson S   (2006) Ly49Q.  AfCS-Nature Molecule Pages  1 pp.




 



6.
Anderson S   (2006) Ly49T.  AfCS-Nature Molecule Pages  1 pp.




 



7.
Anderson S, Makrigiannis A   (2006) Ly49E.  AfCS-Nature Molecule Pages  1 pp.




 



8.
Anderson S, Makrigiannis A   (2006) Ly49F.  AfCS-Nature Molecule Pages  1 pp.




 



9.
Anderson SK (2006). Transcriptional regulation of NK cell receptors. Curr Top Microbiol Immunol  298, 59-75.   https://doi.org/10.1007/3-540-27743-9_3




PubMed


 


PubMed ID 16329185",https://intramural.nih.gov/search/searchview.taf?ipid=43685
119,BC010014-11,"October 01, 2005 -  September 30, 2006",Epigenetic control during embryogenesis,Kathrin  Muegge; MD,NULL,"Laboratory of Cancer Prevention, NCI","Heming  Zhu



Anja  Schmidtmann



Theresa M Geiman



Sichuan  Xi","Rabindranath  de la Fuente





Ina  Dobrinski",NULL,NULL,"Ordered by publication type and then author name.



1.
Fan T, Hagan JP, Kozlov SV, Stewart CL, Muegge K (2005). Lsh controls silencing of the imprinted Cdkn1c gene. Development  132, 635-44.   https://doi.org/10.1242/dev.01612




PubMed


 


PubMed ID 15647320
    
     


 



2.
Zhu H, Geiman TM, Xi S, Jiang Q, Schmidtmann A, Chen T, Li E, Muegge K (2006). Lsh is involved in de novo methylation of DNA. EMBO J  25, 335-45.   https://doi.org/10.1038/sj.emboj.7600925




PubMed



        
     
Free Article


 


PubMed ID 16395332
         Pubmed Central ID 1383509",https://intramural.nih.gov/search/searchview.taf?ipid=43686
120,BC010015-11,"October 01, 2005 -  September 30, 2006",The Role of Cellular Receptors Involved in Inflammation and Tumor Progression,"Ji Ming  Wang; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI","Wang-Hua  Gong



Jian  Huang","Xiuwu  Bian
(Southwest Hospital, Institute of Pathology)




Gert  Schmid-Schonbein
(Whitaker Institute, UC San Diego)




Chunfu  Wu
(Medicinal Chemistry, Shenyang Pharmaceutical University)",Keqiang  Chen (Laboratory of Molecular Immunoregulation),Philip M Murphy; MD (NIAID),"Ordered by publication type and then author name.



1.
Wang J   (2006) Chemotactic peptide ligands for formylpeptide receptors influencing inflammation, in The Handbook of Biologically Active Peptides. Kastin A, ed., Academic Press Elsevier (London), in press.




 



2.
Bian XW, Jiang XF, Chen JH, Bai JS, Dai C, Wang QL, Lu JY, Zhao W, Xin R, Liu MY, Shi JQ, Wang JM (2006). Increased angiogenic capabilities of endothelial cells from microvessels of malignant human gliomas. Int Immunopharmacol  6, 90-9.   https://doi.org/10.1016/j.intimp.2005.08.004




PubMed


 


PubMed ID 16332517
    
     


 



3.
Bian XW, Wang QL, Xiao HL, Wang JM (2006). Tumor microvascular architecture phenotype (T-MAP) as a new concept for studies of angiogenesis and oncology. J Neurooncol  80, 211-3.   https://doi.org/10.1007/s11060-006-9167-4




PubMed


 


PubMed ID 16708278
    
     


 



4.
Chen K, Iribarren P, Gong W, Wang JM (2005). The essential role of phosphoinositide 3-kinases (PI3Ks) in regulating pro-inflammatory responses and the progression of cancer. Cell Mol Immunol  2, 241-52.




PubMed


 


PubMed ID 16274621
    
     


 



5.
Chen K, Iribarren P, Hu J, Chen J, Gong W, Cho EH, Lockett S, Dunlop NM, Wang JM (2006). Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide. J Biol Chem  281, 3651-9.   https://doi.org/10.1074/jbc.M508125200




PubMed


 


PubMed ID 16339765
    
     


 



6.
Kitazawa H, Yonezawa K, Tohno M, Shimosato T, Kawai Y, Saito T, Wang JM (2007). Enzymatic digestion of the milk protein beta-casein releases potent chemotactic peptide(s) for monocytes and macrophages. Int Immunopharmacol  7, 1150-9.   https://doi.org/10.1016/j.intimp.2007.04.008




PubMed



               Available in future as a Free Article 


 


PubMed ID 17630193
         Pubmed Central ID 3205927 


 



7.
Le Y, Yu X, Ruan L, Wang O, Qi D, Zhu J, Lu X, Kong Y, Cai K, Pang S, Shi X, Wang JM (2005). The immunopharmacological properties of transforming growth factor beta. Int Immunopharmacol  5, 1771-82.   https://doi.org/10.1016/j.intimp.2005.07.006




PubMed


 


PubMed ID 16275614",https://intramural.nih.gov/search/searchview.taf?ipid=43687
121,BC010017-11,"October 01, 2005 -  September 30, 2006","The Use of Bacteriophage in the Prevention, Diagnosis, and Treatment of Human Di","Sankar  Adhya; PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Rotem  Edgar



Catherine  Bair",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Adhya S, Lin J, Bair C   (2006) Recognition of the tumor supressor p53 and other protein targets by the calcium binding protein S100B.  Molec Cell Res, in press.




 



2.
Edgar R, McKinstry M, Hwang J, Oppenheim AB, Fekete RA, Giulian G, Merril C, Nagashima K, Adhya S (2006). High-sensitivity bacterial detection using biotin-tagged phage and quantum-dot nanocomplexes. Proc Natl Acad Sci U S A  103, 4841-5.   https://doi.org/10.1073/pnas.0601211103




PubMed



        
     
Free Article


 


PubMed ID 16549760
         Pubmed Central ID 1458757",https://intramural.nih.gov/search/searchview.taf?ipid=43688
122,BC010020-11,"October 01, 2005 -  September 30, 2006",Clinical Trials with Immunotoxins,"Ira H Pastan; MD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Mitchell  Ho



Satoshi  Nagata; PhD



Dawn A Walker",NULL,"Wyndham H Wilson; MD, PhD (National Cancer Institute)



Alan S Wayne; MD (National Cancer Institute)



Raffit  Hassan (National Cancer Institute)



Robert J Kreitman; MD, PhD (National Cancer Institute)



David J Fitzgerald; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Arons E, Margulies I, Sorbara L, Raffeld M, Stetler-Stevenson M, Pastan I, Kreitman RJ (2006). Minimal residual disease in hairy cell leukemia patients assessed by clone-specific polymerase chain reaction. Clin Cancer Res  12, 2804-11.   https://doi.org/10.1158/1078-0432.CCR-05-2315




PubMed


 


PubMed ID 16675574
    
     


 



2.
Arons E, Sorbara L, Raffeld M, Stetler-Stevenson M, Steinberg SM, Liewehr DJ, Pastan I, Kreitman RJ (2006). Characterization of T-cell repertoire in hairy cell leukemia patients before and after recombinant immunotoxin BL22 therapy. Cancer Immunol Immunother  55, 1100-10.   https://doi.org/10.1007/s00262-005-0099-1




PubMed


 


PubMed ID 16311729
    
     


 



3.
Hassan R, Kreitman RJ, Pastan I, Willingham MC (2005). Localization of mesothelin in epithelial ovarian cancer. Appl Immunohistochem Mol Morphol  13, 243-7.   https://doi.org/10.1097/01.pai.00000141545.36485.d6




PubMed


 


PubMed ID 16082249
    
     


 



4.
Hassan R, Remaley AT, Sampson ML, Zhang J, Cox DD, Pingpank J, Alexander R, Willingham M, Pastan I, Onda M (2006). Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer. Clin Cancer Res  12, 447-53.   https://doi.org/10.1158/1078-0432.CCR-05-1477




PubMed


 


PubMed ID 16428485
    
     


 



5.
Ise T, Kreitman RJ, Pastan I, Nagata S (2006). Sandwich ELISAs for soluble immunoglobulin superfamily receptor translocation-associated 2 (IRTA2)/FcRH5 (CD307) proteins in human sera. Clin Chem Lab Med  44, 594-602.   https://doi.org/10.1515/CCLM.2006.115




PubMed


 


PubMed ID 16681430
    
     


 



6.
Kreitman RJ, Squires DR, Stetler-Stevenson M, Noel P, FitzGerald DJ, Wilson WH, Pastan I (2005). Phase I trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with B-cell malignancies. J Clin Oncol  23, 6719-29.   https://doi.org/10.1200/JCO.2005.11.437




PubMed


 


PubMed ID 16061911
    
     


 



7.
Onda M, Nagata S, Ho M, Bera TK, Hassan R, Alexander RH, Pastan I (2006). Megakaryocyte potentiation factor cleaved from mesothelin precursor is a useful tumor marker in the serum of patients with mesothelioma. Clin Cancer Res  12, 4225-31.   https://doi.org/10.1158/1078-0432.CCR-06-0472




PubMed


 


PubMed ID 16857795
    
     


 



8.
Pastan I, Raghavan R, Brady M, Provenzale J, Lally-Gross D, Tansey L, McGehee S, Petry N, Croteau D, Grahn A, Sherman J, Reardon D, Friedman A, Friedman H, Coleman R, Wong T, Greer K, Rodriguez-Ponce M, Bigner D, Puri R, Pedain C   (2006) Intracerebral infusate distribution by convection-enhanced delivery in humans with malignant gliomas: descriptive effects of target anatomy and catheter positioning.  Neurosurgery, in press.




 



9.
Steinbach D, Schramm A, Eggert A, Onda M, Dawczynski K, Rump A, Pastan I, Wittig S, Pfaffendorf N, Voigt A, Zintl F, Gruhn B (2006). Identification of a set of seven genes for the monitoring of minimal residual disease in pediatric acute myeloid leukemia. Clin Cancer Res  12, 2434-41.   https://doi.org/10.1158/1078-0432.CCR-05-2552




PubMed


 


PubMed ID 16638849",https://intramural.nih.gov/search/searchview.taf?ipid=43689
123,BC010021-11,"October 01, 2005 -  September 30, 2006",Biology of Mammary Gland Development and Tumorigenesis,"Gilbert  Smith; PhD



IRP Faculty Profile",NULL,"Mammary Biology and Tumorigenesis Laboratory, NCI","Corinne A Boulanger-Espeut



David L Mack



Brian  Booth",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43690
124,BC010022-11,"October 01, 2005 -  September 30, 2006",Genetics of Renal Disease in African Americans,Cheryl Ann Winkler,NULL,"Laboratory of Genomic Diversity, NCI","Shawn R Palmer



Michael J Malasky



Ping  An; PhD



Elizabeth  Binns-Roemer



Mary A Thompson



Michael E Weedon



Show all 9","David  Gasser
(Department of Genetics, University of Pennsylvania)




Sudha  Iyengar
(Division of Genetic and Molecular Epidemiology, Case Western Reserve University)",NULL,Jeffrey Burnett Kopp; MD (NIDDK),"Ordered by publication type and then author name.



1.
Franceschini N, North KE, Kopp JB, McKenzie L, Winkler C (2006). NPHS2 gene, nephrotic syndrome and focal segmental glomerulosclerosis: a HuGE review. Genet Med  8, 63-75.   https://doi.org/10.1097/01.gim.0000200947.09626.1c




PubMed


 


PubMed ID 16481888",https://intramural.nih.gov/search/searchview.taf?ipid=43691
125,BC010025-11,"October 01, 2005 -  September 30, 2006",The Role of AP-1 and Other Transcription Factors in Cancer Cause and Prevention,"Nancy H Colburn; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Prevention, NCI","Glenn  Hegamyer



Alyson R Baker



Connie P Matthews



Moon-Il  Kang",NULL,"Terry D Copeland (National Cancer Institute)



Melinda  Hollingshead (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Chang SH, Yu KN, Lee YS, An GH, Beck GR, Colburn NH, Lee KH, Cho MH (2006). Elevated inorganic phosphate stimulates Akt-ERK1/2-Mnk1 signaling in human lung cells. Am J Respir Cell Mol Biol  35, 528-39.   https://doi.org/10.1165/rcmb.2005-0477OC




PubMed



        
     
Free Article


 


PubMed ID 16763222
         Pubmed Central ID 2643273 


 



2.
Shen Q, Zhang Y, Uray IP, Hill JL, Kim HT, Lu C, Young MR, Gunther EJ, Hilsenbeck SG, Chodosh LA, Colburn NH, Brown PH (2006). The AP-1 transcription factor regulates postnatal mammary gland development. Dev Biol  295, 589-603.   https://doi.org/10.1016/j.ydbio.2006.03.042




PubMed


 


PubMed ID 16678816
    
     


 



3.
Weber TJ, Siegel RW, Markillie LM, Chrisler WB, Lei XC, Colburn NH (2005). A paracrine signal mediates the cell transformation response to low dose gamma radiation in JB6 cells. Mol Carcinog  43, 31-7.   https://doi.org/10.1002/mc.20092




PubMed


 


PubMed ID 15800926
    
     


 



4.
Young MR, Colburn NH (2006). Fra-1 a target for cancer prevention or intervention. Gene  379, 1-11.   https://doi.org/10.1016/j.gene.2006.05.001




PubMed


 


PubMed ID 16784822
    
     


 



5.
Zhao Y, Chaiswing L, Velez JM, Batinic-Haberle I, Colburn NH, Oberley TD, St Clair DK (2005). p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase. Cancer Res  65, 3745-50.   https://doi.org/10.1158/0008-5472.CAN-04-3835




PubMed


 


PubMed ID 15867370",https://intramural.nih.gov/search/searchview.taf?ipid=43693
126,BC010026-11,"October 01, 2005 -  September 30, 2006",Genes Differentially Expressed During Tumor Promotion and Progression,"Nancy H Colburn; PhD



IRP Faculty Profile",NULL,"Laboratory of Cancer Prevention, NCI","Glenn  Hegamyer



Aaron P Jansen



Alyson R Baker



Arti  Santhanam



Tobias  Schmid","Heike  Allgayer
(University of Munich)




Myung  Cho
(Laboratory of Toxicology, Seoul National University)




Robert  Rhoads
(LSU Shreveport)","Lee Jay Helman; MD (National Cancer Institute)



Bruce Allen Shapiro; PhD (National Cancer Institute)



Alexander  Wlodawer; PhD (National Cancer Institute)



Chand  Khanna; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Colburn N, Peschiaroli A, Guardavaccaro D, Sherman N, Pagano M   (2006) S6K1- and BetaTRCP-Mediated Degradation of PDCD4 Promotes Protein Translation and Cell Growth.  Science, in press.




 



2.
Colburn N, Santhanam A, Baker A, Wlodawer A   (2006) Structural basis for inhibition of translation by the tumor suppressor Pdcd4.  Mole Cell Biol, in press.




 



3.
Jin H, Kim TH, Hwang SK, Chang SH, Kim HW, Anderson HK, Lee HW, Lee KH, Colburn NH, Yang HS, Cho MH, Cho CS (2006). Aerosol delivery of urocanic acid-modified chitosan/programmed cell death 4 complex regulated apoptosis, cell cycle, and angiogenesis in lungs of K-ras null mice. Mol Cancer Ther  5, 1041-9.   https://doi.org/10.1158/1535-7163.MCT-05-0433




PubMed


 


PubMed ID 16648576
    
     


 



4.
Yang HS, Matthews CP, Clair T, Wang Q, Baker AR, Li CC, Tan TH, Colburn NH (2006). Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion. Mol Cell Biol  26, 1297-306.   https://doi.org/10.1128/MCB.26.4.1297-1306.2006




PubMed



        
     
Free Article


 


PubMed ID 16449643
         Pubmed Central ID 1367180",https://intramural.nih.gov/search/searchview.taf?ipid=43694
127,BC010027-12,"October 01, 2005 -  September 30, 2006",Function of Steroid Receptors in Subcellular Compartments,"Gordon Lee Hager; PhD



IRP Faculty Profile",NULL,"Laboratory of Receptor Biology and Gene Expression, NCI","Carol T Comlish



Anindya P Hendarwanto",NULL,Angie  Dull (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43695
128,BC010030-11,"October 01, 2005 -  September 30, 2006",Biochemical Analysis of Multidrug Resistance-linked Transport Proteins,"Suresh V Ambudkar; PhD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI",Michael Marc Gottesman; MD,"Maria  Baer
(Medicine, Roswell Park Cancer Institute)




Margery  Barrand
(Pharamacology, University of Cambridge)




Stephen  Hladky
(Pharmacology, University of Cambridge)




Rajendra  Prasad
(Membrane Biology Laboratory, Jawaharlal Nehru University)","Susan  Bates; MD (National Cancer Institute)



Michael  Dean; PhD (National Cancer Institute)



Peter C Fitzgerald (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Ambudkar SV, Kim IW, Sauna ZE (2006). The power of the pump: mechanisms of action of P-glycoprotein (ABCB1). Eur J Pharm Sci  27, 392-400.   https://doi.org/10.1016/j.ejps.2005.10.010




PubMed


 


PubMed ID 16352426
    
     


 



2.
Ambudkar SV, Kim IW, Xia D, Sauna ZE (2006). The A-loop, a novel conserved aromatic acid subdomain upstream of the Walker A motif in ABC transporters, is critical for ATP binding. FEBS Lett  580, 1049-55.   https://doi.org/10.1016/j.febslet.2005.12.051




PubMed


 


PubMed ID 16412422
    
     


 



3.
Calcagno AM, Chewning KJ, Wu CP, Ambudkar SV (2006). Plasma membrane calcium ATPase (PMCA4): a housekeeper for RT-PCR relative quantification of polytopic membrane proteins. BMC Mol Biol  7, 29.   https://doi.org/10.1186/1471-2199-7-29




PubMed



        
     
Free Article


 


PubMed ID 16978418
         Pubmed Central ID 1586022 


 



4.
Calcagno AM, Ludwig JA, Fostel JM, Gottesman MM, Ambudkar SV (2006). Comparison of drug transporter levels in normal colon, colon cancer, and Caco-2 cells: impact on drug disposition and discovery. Mol Pharm  3, 87-93.   https://doi.org/10.1021/mp050090k




PubMed


 


PubMed ID 16686373
    
     


 



5.
Chearwae W, Shukla S, Limtrakul P, Ambudkar SV (2006). Modulation of the function of the multidrug resistance-linked ATP-binding cassette transporter ABCG2 by the cancer chemopreventive agent curcumin. Mol Cancer Ther  5, 1995-2006.   https://doi.org/10.1158/1535-7163.MCT-06-0087




PubMed


 


PubMed ID 16928820
    
     


 



6.
Chearwae W, Wu CP, Chu HY, Lee TR, Ambudkar SV, Limtrakul P (2006). Curcuminoids purified from turmeric powder modulate the function of human multidrug resistance protein 1 (ABCC1). Cancer Chemother Pharmacol  57, 376-88.   https://doi.org/10.1007/s00280-005-0052-1




PubMed


 


PubMed ID 16021489
    
     


 



7.
Kim IW, Peng XH, Sauna ZE, FitzGerald PC, Xia D, Müller M, Nandigama K, Ambudkar SV (2006). The conserved tyrosine residues 401 and 1044 in ATP sites of human P-glycoprotein are critical for ATP binding and hydrolysis: evidence for a conserved subdomain, the A-loop in the ATP-binding cassette. Biochemistry  45, 7605-16.   https://doi.org/10.1021/bi060308o




PubMed


 


PubMed ID 16768456
    
     


 



8.
Limtrakul P, Chearwae W, Shukla S, Phisalphong C, Ambudkar SV (2007). Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin. Mol Cell Biochem  296, 85-95.   https://doi.org/10.1007/s11010-006-9302-8




PubMed


 


PubMed ID 16960658
    
     


 



9.
Ludwig JA, Szakács G, Martin SE, Chu BF, Cardarelli C, Sauna ZE, Caplen NJ, Fales HM, Ambudkar SV, Weinstein JN, Gottesman MM (2006). Selective toxicity of NSC73306 in MDR1-positive cells as a new strategy to circumvent multidrug resistance in cancer. Cancer Res  66, 4808-15.   https://doi.org/10.1158/0008-5472.CAN-05-3322




PubMed



        
     
Free Article


 


PubMed ID 16651436
         Pubmed Central ID 1474781 


 



10.
Sauna ZE, Nandigama K, Ambudkar SV (2006). Exploiting reaction intermediates of the ATPase reaction to elucidate the mechanism of transport by P-glycoprotein (ABCB1). J Biol Chem  281, 26501-11.   https://doi.org/10.1074/jbc.M601917200




PubMed


 


PubMed ID 16844693
    
     


 



11.
Shukla S, Robey RW, Bates SE, Ambudkar SV (2006). The calcium channel blockers, 1,4-dihydropyridines, are substrates of the multidrug resistance-linked ABC drug transporter, ABCG2. Biochemistry  45, 8940-51.   https://doi.org/10.1021/bi060552f




PubMed


 


PubMed ID 16846237
    
     


 



12.
Shukla S, Wu CP, Nandigama K, Ambudkar SV (2007). The naphthoquinones, vitamin K3 and its structural analogue plumbagin, are substrates of the multidrug resistance linked ATP binding cassette drug transporter ABCG2. Mol Cancer Ther  6, 3279-86.   https://doi.org/10.1158/1535-7163.MCT-07-0564




PubMed



        
     
Free Article


 


PubMed ID 18065489
         Pubmed Central ID 2398729 


 



13.
Wu CP, Calcagno AM, Hladky SB, Ambudkar SV, Barrand MA (2005). Modulatory effects of plant phenols on human multidrug-resistance proteins 1, 4 and 5 (ABCC1, 4 and 5). FEBS J  272, 4725-40.   https://doi.org/10.1111/j.1742-4658.2005.04888.x




PubMed



        
     
Free Article


 


PubMed ID 16156793
         Pubmed Central ID 1350838 


 



14.
Wu CP, Shukla S, Calcagno AM, Hall MD, Gottesman MM, Ambudkar SV (2007). Evidence for dual mode of action of a thiosemicarbazone, NSC73306: a potent substrate of the multidrug resistance linked ABCG2 transporter. Mol Cancer Ther  6, 3287-96.   https://doi.org/10.1158/1535-7163.MCT-07-2005




PubMed



        
     
Free Article


 


PubMed ID 18089722
         Pubmed Central ID 2268031",https://intramural.nih.gov/search/searchview.taf?ipid=43697
129,BC010033-11,"October 01, 2005 -  September 30, 2006",Inflammation and  Cancer,"Curtis  Harris; MD



IRP Faculty Profile",Robert  Wiltrout; PhD,"Laboratory of Human Carcinogenesis, NCI","Elise Dawn Bowman



Mary G Mcmenamin



Elisa A Spillare



Glennwood E Trivers



Gerald N Wogan



Hideaki  Shiga



Show all 9",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Hofseth LJ, Robles AI, Espey MG, Harris CC (2005). Nitric oxide is a signaling molecule that regulates gene expression. Methods Enzymol  396, 326-40.   https://doi.org/10.1016/S0076-6879(05)96027-8




PubMed


 


PubMed ID 16291242
    
     


 



2.
Thomas DD, Ridnour LA, Espey MG, Donzelli S, Ambs S, Hussain SP, Harris CC, DeGraff W, Roberts DD, Mitchell JB, Wink DA (2006). Superoxide fluxes limit nitric oxide-induced signaling. J Biol Chem  281, 25984-93.   https://doi.org/10.1074/jbc.M602242200




PubMed


 


PubMed ID 16829532
    
     


 



3.
Ying L, Marino J, Hussain SP, Khan MA, You S, Hofseth AB, Trivers GE, Dixon DA, Harris CC, Hofseth LJ (2005). Chronic inflammation promotes retinoblastoma protein hyperphosphorylation and E2F1 activation. Cancer Res  65, 9132-6.   https://doi.org/10.1158/0008-5472.CAN-05-1358




PubMed


 


PubMed ID 16230367",https://intramural.nih.gov/search/searchview.taf?ipid=43698
130,BC010036-11,"October 01, 2005 -  September 30, 2006",Comparative functional genomics approach to identify best-fit models to study hu,"Snorri S. Thorgeirsson; MD, PhD",Robert  Wiltrout; PhD,"Laboratory of Experimental Carcinogenesis, NCI","Timothy V Benjamin



Elizabeth A Conner



Marian E Durkin



Anita  Ton



Tanya N Hoang



Joe W Grisham



Show all 9","Marcello  Arsura
(Department of Pharmacology &Therapeutic, University of Tennessee)




Diego F Calvisi
(NCI)




Nelson  Fausto
(Pathology, University of Washington School of Medicine)




Gen-Sheng  Feng
(Program in Signal Transduction and Stem Cells& Regeneration, Burnham Institute for Medical Research)




Stefan  Karlsson; MD, PhD
(University of Lund)




Sara  Kozma
(Genome Research Institute, University of Cincinnati)


Show all 11","Valentina  Factor (Cellular and Molecular Biology Section)



Frank Jess Gonzalez; PhD (National Cancer Institute)



Glenn  Merlino; PhD (National Cancer Institute)



Douglas  Lowy; MD (National Cancer Institute)



Nicolae C Popescu; PhD (National Cancer Institute)","Irwin Monroe Arias; BS, MD (NICHD)","Ordered by publication type and then author name.



1.
Calvisi DF, Thorgeirsson SS (2005). Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer. Toxicol Pathol  33, 181-4.   https://doi.org/10.1080/01926230590522095




PubMed


 


PubMed ID 15805070
    
     


 



2.
Cavin LG, Wang F, Factor VM, Kaur S, Venkatraman M, Thorgeirsson SS, Arsura M (2005). Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas. Mol Cancer Res  3, 403-12.   https://doi.org/10.1158/1541-7786.MCR-04-0186




PubMed


 


PubMed ID 16046551
    
     


 



3.
Durkin ME, Avner MR, Huh CG, Yuan BZ, Thorgeirsson SS, Popescu NC (2005). DLC-1, a Rho GTPase-activating protein with tumor suppressor function, is essential for embryonic development. FEBS Lett  579, 1191-6.   https://doi.org/10.1016/j.febslet.2004.12.090




PubMed


 


PubMed ID 15710412
    
     


 



4.
Karlsson G, Liu Y, Larsson J, Goumans MJ, Lee JS, Thorgeirsson SS, Ringnér M, Karlsson S (2005). Gene expression profiling demonstrates that TGF-beta1 signals exclusively through receptor complexes involving Alk5 and identifies targets of TGF-beta signaling. Physiol Genomics  21, 396-403.   https://doi.org/10.1152/physiolgenomics.00303.2004




PubMed


 


PubMed ID 15769904
    
     


 



5.
Martin J, Magnino F, Schmidt K, Piguet AC, Lee JS, Semela D, St-Pierre MV, Ziemiecki A, Cassio D, Brenner C, Thorgeirsson SS, Dufour JF (2006). Hint2, a mitochondrial apoptotic sensitizer down-regulated in hepatocellular carcinoma. Gastroenterology  130, 2179-88.   https://doi.org/10.1053/j.gastro.2006.03.024




PubMed



        
     
Free Article


 


PubMed ID 16762638
         Pubmed Central ID 2569837 


 



6.
Thorgeirsson S, Gomez-Quiroz L, Lee J, Kaposi-Novak P, Conner E, Goldina T, Onishchenko G, Factor V   (2006) Oncogene-specific gene expression signatures at preneoplastic stage define distinct mechanisms of hepatocarcinogenesis.  Hepatology, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=43699
131,BC010038-11,"October 01, 2005 -  September 30, 2006",Molecular Cytogenetics of Solid Tumors,Nicolae C Popescu; PhD,NULL,"Laboratory of Experimental Carcinogenesis, NCI","Xiaoling  Zhou



Drazen  Zimonjic; PhD



Ming  Guan



Veronika  Ullmannova","Steve  Goodison
(Department of Pathology, University of Florida)




Hector  Martinez Valdez
(Department of Immunology, The University of Texas, MD Anderson Cancer Center)




Demetrios  Spandidos
(Laboratory of Clinical Virology, University of Crete Medical School)




May  Thassabehji
(Academic Unit of Medical Genetics, University of Manchester)




Chuan-Ging  Wu","Sheueyann  Cheng; PhD (National Cancer Institute)



Ira H Pastan; MD (National Cancer Institute)



Snorri S. Thorgeirsson; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bera TK, Saint Fleur A, Lee Y, Kydd A, Hahn Y, Popescu NC, Zimonjic DB, Lee B, Pastan I (2006). POTE paralogs are induced and differentially expressed in many cancers. Cancer Res  66, 52-6.   https://doi.org/10.1158/0008-5472.CAN-05-3014




PubMed


 


PubMed ID 16397215
    
     


 



2.
Erdreich-Epstein A, Ganguly AK, Shi XH, Zimonjic DB, Shackleford GM   (2006) Androgen inducibility of Fgf8 in Shionogi carcinoma 115 cells correlates with an adjacent t(5;19) translocation.  Genes Chromosomes Cancer 45:169-81.




PubMed


 


PubMed ID 16252261
    
     


 



3.
Guan M, Zhou X, Soulitzis N, Spandidos DA, Popescu NC (2006). Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications. Clin Cancer Res  12, 1412-9.   https://doi.org/10.1158/1078-0432.CCR-05-1906




PubMed


 


PubMed ID 16533763
    
     


 



4.
Popescu N   (2006) Expression profile of the tumor suppressor genes DLC-1 and DLC-2 in solid tumors.  Int. J. Oncology, in press.




 



5.
Tassabehji M, Hammond P, Karmiloff-Smith A, Thompson P, Thorgeirsson SS, Durkin ME, Popescu NC, Hutton T, Metcalfe K, Rucka A, Stewart H, Read AP, Maconochie M, Donnai D (2005). GTF2IRD1 in craniofacial development of humans and mice. Science  310, 1184-7.   https://doi.org/10.1126/science.1116142




PubMed


 


PubMed ID 16293761
    
     


 



6.
Wu CG, Budhu A, Chen S, Zhou X, Popescu NC, Valerie K, Wang XW (2006). Effect of hepatitis C virus core protein on the molecular profiling of human B lymphocytes. Mol Med  12, 47-53.   https://doi.org/10.2119/2006-00020.Wu




PubMed



        
     
Free Article


 


PubMed ID 16838065
         Pubmed Central ID 1514550",https://intramural.nih.gov/search/searchview.taf?ipid=43701
132,BC010041-11,"October 01, 2005 -  September 30, 2006","Oligosaccharide Inhibitor Interactions with beta-1,4-Galactosyltransferase-1",Pradman  Qasba; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI","Elizabeth  Boeggeman



Boopathy  Ramakrishna



Velavan  Ramasamy","Jeffrey  Esko; PhD
(Cellular & Molecular Medicine, University of Califonia)




Peter  Seeberger
(Chemistry, MIT/)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43702
133,BC010251-11,"October 01, 2005 -  September 30, 2006",Secreted Frizzled-Related Proteins and Wnt Signaling,"Jeffrey S Rubin; MD, PhD",NULL,"Laboratory of Cellular and Molecular Biology, NCI","William G Taylor



Michal  Barshishat-Kupper



Bolormaa  Baljinnyam



Osler A Andres



Shengjian  Li","Paul  Marker
(University of Minnesota Cancer Center)




Bart  Williams
(Laboratory of Cell Signaling and Carcinogenesis, Van Andel Research Institute)","Alan O Perantoni; PhD (National Cancer Institute)



Donald P Bottaro; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Joesting MS, Perrin S, Elenbaas B, Fawell SE, Rubin JS, Franco OE, Hayward SW, Cunha GR, Marker PC (2005). Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer. Cancer Res  65, 10423-30.   https://doi.org/10.1158/0008-5472.CAN-05-0824




PubMed


 


PubMed ID 16288033
    
     


 



2.
Liu X, Rubin JS, Kimmel AR (2005). Rapid, Wnt-induced changes in GSK3beta associations that regulate beta-catenin stabilization are mediated by Galpha proteins. Curr Biol  15, 1989-97.   https://doi.org/10.1016/j.cub.2005.10.050




PubMed


 


PubMed ID 16303557
    
     


 



3.
Rubin JS, Barshishat-Kupper M, Feroze-Merzoug F, Xi ZF (2006). Secreted WNT antagonists as tumor suppressors: pro and con. Front Biosci  11, 2093-105.   https://doi.org/10.2741/1952




PubMed


 


PubMed ID 16720296
    
     


 



4.
Tchou-Wong KM, Fok SY, Rubin JS, Pixley F, Condeelis J, Braet F, Rom W, Soon LL (2006). Rapid chemokinetic movement and the invasive potential of lung cancer cells; a functional molecular study. BMC Cancer  6, 151.   https://doi.org/10.1186/1471-2407-6-151




PubMed



        
     
Free Article


 


PubMed ID 16756685
         Pubmed Central ID 1501041 


 



5.
Wang H, Charles PC, Wu Y, Ren R, Pi X, Moser M, Barshishat-Kupper M, Rubin JS, Perou C, Bautch V, Patterson C (2006). Gene expression profile signatures indicate a role for Wnt signaling in endothelial commitment from embryonic stem cells. Circ Res  98, 1331-9.   https://doi.org/10.1161/01.RES.0000220650.26555.1d




PubMed


 


PubMed ID 16601226",https://intramural.nih.gov/search/searchview.taf?ipid=43703
134,BC010252-11,"October 01, 2005 -  September 30, 2006",Pathogenic Effects of Human Retroviruses on Hematopoietic and Adherent Cells.,Francis W Ruscetti; PhD,NULL,"Laboratory of Experimental Immunology, NCI","Daniel C Bertolette



Yi  Huang



Kathryn  Jones; PhD



Cari  Sadowski",NULL,"Robert  Blumenthal; PhD (National Cancer Institute)



Gene  Shearer; PhD (National Cancer Institute)",Samuel W Cushman; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Jones KS, Fugo K, Petrow-Sadowski C, Huang Y, Bertolette DC, Lisinski I, Cushman SW, Jacobson S, Ruscetti FW (2006). Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells. J Virol  80, 8291-302.   https://doi.org/10.1128/JVI.00389-06




PubMed



        
     
Free Article


 


PubMed ID 16912281
         Pubmed Central ID 1563841 


 



2.
Jones KS, Petrow-Sadowski C, Bertolette DC, Huang Y, Ruscetti FW (2005). Heparan sulfate proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4+ T cells. J Virol  79, 12692-702.   https://doi.org/10.1128/JVI.79.20.12692-12702.2005




PubMed



        
     
Free Article


 


PubMed ID 16188972
         Pubmed Central ID 1235841 


 



3.
Ruscetti FW, Akel S, Bartelmez SH (2005). Autocrine transforming growth factor-beta regulation of hematopoiesis: many outcomes that depend on the context. Oncogene  24, 5751-63.   https://doi.org/10.1038/sj.onc.1208921




PubMed


 


PubMed ID 16123808",https://intramural.nih.gov/search/searchview.taf?ipid=43704
135,BC010253-11,"October 01, 2005 -  September 30, 2006",Molecular Mechanisms of Growth Factor Modulated Proliferation,William  Farrar,NULL,"Laboratory of Cancer Prevention, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Hodge DR, Hurt EM, Farrar WL (2005). The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer  41, 2502-12.   https://doi.org/10.1016/j.ejca.2005.08.016




PubMed


 


PubMed ID 16199153
    
     


 



2.
Hodge DR, Peng B, Cherry JC, Hurt EM, Fox SD, Kelley JA, Munroe DJ, Farrar WL (2005). Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation. Cancer Res  65, 4673-82.   https://doi.org/10.1158/0008-5472.CAN-04-3589




PubMed


 


PubMed ID 15930285
    
     


 



3.
Hodge DR, Peng B, Pompeia C, Thomas S, Cho E, Clausen PA, Marquez VE, Farrar WL (2005). Epigenetic silencing of manganese superoxide dismutase (SOD-2) in KAS 6/1 human multiple myeloma cells increases cell proliferation. Cancer Biol Ther  4, 585-92.   https://doi.org/10.4161/cbt.4.5.1704




PubMed


 


PubMed ID 15908783
    
     


 



4.
Hurt EM, Thomas SB, Peng B, Farrar WL (2006). Reversal of p53 epigenetic silencing in multiple myeloma permits apoptosis by a p53 activator. Cancer Biol Ther  5, 1154-60.   https://doi.org/10.4161/cbt.5.9.3001




PubMed


 


PubMed ID 16855375
    
     


 



5.
Peng B, Hodge DR, Thomas SB, Cherry JM, Munroe DJ, Pompeia C, Xiao W, Farrar WL (2005). Epigenetic silencing of the human nucleotide excision repair gene, hHR23B, in interleukin-6-responsive multiple myeloma KAS-6/1 cells. J Biol Chem  280, 4182-7.   https://doi.org/10.1074/jbc.M412566200




PubMed


 


PubMed ID 15550378
    
     


 



6.
Wang LH, Yang XY, Zhang X, Farrar WL (2005). Nuclear receptors as negative modulators of STAT3 in multiple myeloma. Cell Cycle  4, 242-5.




PubMed


 


PubMed ID 15655377",https://intramural.nih.gov/search/searchview.taf?ipid=43705
136,BC010256-11,"October 01, 2005 -  September 30, 2006",Analysis of the function of the nodal gene during embryonic development,Michael Robert Kuehn; PhD,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",George T Lezin,NULL,NULL,Amit  Kumar; PhD (NIDDK),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43706
137,BC010262-10,"October 01, 2005 -  September 30, 2006",Molecular Genetics of the MHC,"Mary  Carrington; MS, PhD",NULL,"Laboratory of Genomic Diversity, NCI","Maureen P Martin



Xiaojiang  Gao



Amy E Poisson



Yalun  Liu","Kidd  Judith
(Department of Genetics, Yale University)




Kenneth  Kidd
(Yale University)




John  Rioux
(Department of Medicine, Universit de Montral)




Richard  Single
(Department of Mathematics and Statistics, University of Vermont)




John  Trowsdale
(Cambridge Institute for Medical Research, University of Cambridge)",Robert H Stephens (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Gao X, Single RM, Karacki P, Marti D, O'Brien SJ, Carrington M (2006). Diversity of MICA and linkage disequilibrium with HLA-B in two North American populations. Hum Immunol  67, 152-8.   https://doi.org/10.1016/j.humimm.2006.02.009




PubMed


 


PubMed ID 16698437
    
     


 



2.
Traherne JA, Horton R, Roberts AN, Miretti MM, Hurles ME, Stewart CA, Ashurst JL, Atrazhev AM, Coggill P, Palmer S, Almeida J, Sims S, Wilming LG, Rogers J, de Jong PJ, Carrington M, Elliott JF, Sawcer S, Todd JA, Trowsdale J, Beck S (2006). Genetic analysis of completely sequenced disease-associated MHC haplotypes identifies shuffling of segments in recent human history. PLoS Genet  2, e9.   https://doi.org/10.1371/journal.pgen.0020009




PubMed



        
     
Free Article


 


PubMed ID 16440057
         Pubmed Central ID 1331980",https://intramural.nih.gov/search/searchview.taf?ipid=43709
138,BC010263-10,"October 01, 2005 -  September 30, 2006",Comparative Feline Genomics: High-Throughput BACPACFosmid Mapping of the MHC,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI","Naoya  Yuhki; MD



Thomas  Beck



Joan C Menninger



Lisa  Maslan



Emily L Howe



Katherine M Kelley



Show all 7","Carsten  Muenk
(Div. of Medical Biotechnology, Paul-Ehrlich-Institute)




William J. Murphy
(NCI-FCRDC, NCI)




Douglas U Smith",Robert H Stephens (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43710
139,BC010265-10,"October 01, 2005 -  September 30, 2006",Developing the Feline Radiation Hybrid Map,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI","Victor A David



Joan C Menninger



Alfred L Roca",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
O'Brien S, David B, David V, Agarwala R, Schaffer A, Pearks-Wilkerson A, Neelam B, Menotti-Raymond M   (2006) A 15 megabase resolution radiation hybrid map of the cat genome and comparative analysis with the canine and human genomes.  Genomics, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=43711
140,BC010269-10,"October 01, 2005 -  September 30, 2006",Effects of genetic variation on infectious disease,"Mary  Carrington; MS, PhD",NULL,"Laboratory of Genomic Diversity, NCI","Maureen P Martin



Darlene M Marti



Xiaojiang  Gao



Amy E Poisson



George  Nelson



Yalun  Liu



Show all 8","Marcus  Altfeld
(Infectious Disease Unit, Partners AIDS Research Center)




Howard  Strickler
(Albert Einstein College of Medicine)




Amalio  Telenti
(University Hospital of Lausanne)




Chloe  Thio
(University Medicine, Johns Hopkins University)




David  Thomas
(Department of Medicine, Johns Hopkins University)




Judith  Torimiro
(Johns Hopkins School of Public Health)


Show all 7","Sophia S Wang; PhD (National Cancer Institute)



Allan  Hildesheim; PhD (National Cancer Institute)



Frank  Maldarelli (National Cancer Institute)",Barbara  Rehermann; MD (NIDDK),"Ordered by publication type and then author name.



1.
Bashirova AA, Bleiber G, Qi Y, Hutcheson H, Yamashita T, Johnson RC, Cheng J, Alter G, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, May M, Maldarelli F, Jacobson L, O'brien SJ, Telenti A, Carrington M (2006). Consistent effects of TSG101 genetic variability on multiple outcomes of exposure to human immunodeficiency virus type 1. J Virol  80, 6757-63.   https://doi.org/10.1128/jvi.00094-06




PubMed



        
     
Free Article


 


PubMed ID 16809281
         Pubmed Central ID 1489017 


 



2.
Frahm N, Kiepiela P, Adams S, Linde CH, Hewitt HS, Sango K, Feeney ME, Addo MM, Lichterfeld M, Lahaie MP, Pae E, Wurcel AG, Roach T, St John MA, Altfeld M, Marincola FM, Moore C, Mallal S, Carrington M, Heckerman D, Allen TM, Mullins JI, Korber BT, Goulder PJ, Walker BD, et al. [1 more author] (2006). Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes. Nat Immunol  7, 173-8.   https://doi.org/10.1038/ni1281




PubMed


 


PubMed ID 16369537
    
     


 



3.
Liu H, Carrington M, Wang C, Holte S, Lee J, Greene B, Hladik F, Koelle DM, Wald A, Kurosawa K, Rinaldo CR, Celum C, Detels R, Corey L, McElrath MJ, Zhu T (2006). Repeat-region polymorphisms in the gene for the dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related molecule: effects on HIV-1 susceptibility. J Infect Dis  193, 698-702.   https://doi.org/10.1086/499820




PubMed


 


PubMed ID 16453266
    
     


 



4.
Qi Y, Martin MP, Gao X, Jacobson L, Goedert JJ, Buchbinder S, Kirk GD, O'Brien SJ, Trowsdale J, Carrington M (2006). KIR/HLA pleiotropism: protection against both HIV and opportunistic infections. PLoS Pathog  2, e79.   https://doi.org/10.1371/journal.ppat.0020079




PubMed



        
     
Free Article


 


PubMed ID 16933987
         Pubmed Central ID 1550271 


 



5.
Torimiro JN, Carr JK, Wolfe ND, Karacki P, Martin MP, Gao X, Tamoufe U, Thomas A, Ngole EM, Birx DL, McCutchan FE, Burke DS, Carrington M (2006). HLA class I diversity among rural rainforest inhabitants in Cameroon: identification of A*2612-B*4407 haplotype. Tissue Antigens  67, 30-7.   https://doi.org/10.1111/j.1399-0039.2005.00527.x




PubMed


 


PubMed ID 16451198
    
     


 



6.
Yant LJ, Friedrich TC, Johnson RC, May GE, Maness NJ, Enz AM, Lifson JD, O'Connor DH, Carrington M, Watkins DI (2006). The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication. J Virol  80, 5074-7.   https://doi.org/10.1128/JVI.80.10.5074-5077.2006




PubMed



        
     
Free Article


 


PubMed ID 16641299
         Pubmed Central ID 1472056",https://intramural.nih.gov/search/searchview.taf?ipid=43712
141,BC010270-10,"October 01, 2005 -  September 30, 2006",High-Throughput Genotyping for Genetic Epidemiology,Michael W Smith,NULL,"Laboratory of Genomic Diversity, NCI","Shawn R Palmer



Michael J Malasky



Taras K Oleksyk



Ann  Truelove



Mary  Mcnally



Bailey D Kessing



Show all 9","Anthony  Alberg
(Dept. of Epidemiology, Johns Hopkins University)




Josef  Coresh; MD, PhD
(Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health)




Linda  Kao
(Dept. of Epidemiology, Johns Hopkins University)




Elizabeth  Platz; PhD
(School of Public Health, Johns Hopkins University)




Sadeep  Shrestha





Paul  Strickland
(Dept. of Environmental Health Sciences, Johns Hopkins University)",Stephen J O'Brien; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Chretien JP, Coresh J, Berthier-Schaad Y, Kao WH, Fink NE, Klag MJ, Marcovina SM, Giaculli F, Smith MW (2006). Three single-nucleotide polymorphisms in LPA account for most of the increase in lipoprotein(a) level elevation in African Americans compared with European Americans. J Med Genet  43, 917-23.   https://doi.org/10.1136/jmg.2006.042119




PubMed



        
     
Free Article


 


PubMed ID 16840570
         Pubmed Central ID 2563202 


 



2.
Laud K, Marian C, Avril MF, Barrois M, Chompret A, Goldstein AM, Tucker MA, Clark PA, Peters G, Chaudru V, Demenais F, Spatz A, Smith MW, Lenoir GM, Bressac-de Paillerets B, French Hereditary Melanoma Study Group (2006). Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma. J Med Genet  43, 39-47.   https://doi.org/10.1136/jmg.2005.033498




PubMed



        
     
Free Article


 


PubMed ID 15937071
         Pubmed Central ID 2564502 


 



3.
Liu Y, Berthier-Schaad Y, Fallin MD, Fink NE, Tracy RP, Klag MJ, Smith MW, Coresh J (2006). IL-6 haplotypes, inflammation, and risk for cardiovascular disease in a multiethnic dialysis cohort. J Am Soc Nephrol  17, 863-70.   https://doi.org/10.1681/ASN.2005050465




PubMed


 


PubMed ID 16467451
    
     


 



4.
Shrestha S, Strathdee SA, Galai N, Oleksyk T, Fallin MD, Mehta S, Schaid D, Vlahov D, O'Brien SJ, Smith MW (2006). Behavioral risk exposure and host genetics of susceptibility to HIV-1 infection. J Infect Dis  193, 16-26.   https://doi.org/10.1086/498532




PubMed


 


PubMed ID 16323127
    
     


 



5.
Smith M, Broman K, Farzadegan H, Vlahov D, Strathdee S   (2006) Multiperson Use of Syringes Among Injection Drug Users in a Needle Exchange Program.  JAIDS, in press.




 



6.
Smith M, Hutcheson-Dilks H, Williams S, Moore J, Essex M, Ruiz-Pesini E, Wallace D, Tishkoff S, O'Brien S   (2006) Elevated male European and female African contributions to the genomes of African American individuals.  Human Genetics, in press.




 



7.
Zhang L, Kao WH, Berthier-Schaad Y, Liu Y, Plantinga L, Jaar BG, Fink N, Powe N, Klag MJ, Smith MW, Coresh J   (2006) Haplotype of signal transducer and activator of transcription 3 gene predicts cardiovascular disease in dialysis patients.  J Am Soc Nephrol 17:2285-92.




PubMed


 


PubMed ID 16807407",https://intramural.nih.gov/search/searchview.taf?ipid=43713
142,BC010271-10,"October 01, 2005 -  September 30, 2006","Identification of Genes Involved in HIV-1AIDS, HBV and HCV",Michael W Smith,NULL,"Laboratory of Genomic Diversity, NCI","Taras K Oleksyk



Ann  Truelove



Efe  Sezgin



Cheryl Ann Winkler","Gregory D Kirk





Sadeep  Shrestha





David  Vlahov
(Center for Urban Epidemiologic Studies, New York Academy of Medicine)","Stephen J O'Brien; PhD (National Cancer Institute)



James Jerome Goedert; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Shrestha S, Smith MW, Beaty TH, Strathdee SA (2005). Theory and methodology for utilizing genes as biomarkers to determine potential biological mixtures. Ann Epidemiol  15, 29-38.   https://doi.org/10.1016/j.annepidem.2004.05.006




PubMed


 


PubMed ID 15571991
    
     


 



2.
Shrestha S, Strathdee SA, Broman KW, Smith MW (2006). Unknown biological mixtures evaluation using STR analytical quantification. Electrophoresis  27, 409-15.   https://doi.org/10.1002/elps.200500502




PubMed


 


PubMed ID 16437418
    
     


 



3.
Shrestha S, Strathdee SA, Galai N, Oleksyk T, Fallin MD, Mehta S, Schaid D, Vlahov D, O'Brien SJ, Smith MW (2006). Behavioral risk exposure and host genetics of susceptibility to HIV-1 infection. J Infect Dis  193, 16-26.   https://doi.org/10.1086/498532




PubMed


 


PubMed ID 16323127
    
     


 



4.
Smith M, Broman K, Farzadegan H, Vlahov D, Strathdee S   (2006) Multiperson Use of Syringes Among Injection Drug Users in a Needle Exchange Program.  JAIDS, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=43714
143,BC010272-10,"October 01, 2005 -  September 30, 2006",Facilitating Access to Information on Human Proteins and Their Phosphorylation,"James Stephen Shaw; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI",Natalya  Belkina,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Zhu G, Fujii K, Liu Y, Codrea V, Herrero J, Shaw S (2005). A single pair of acidic residues in the kinase major groove mediates strong substrate preference for P-2 or P-5 arginine in the AGC, CAMK, and STE kinase families. J Biol Chem  280, 36372-9.   https://doi.org/10.1074/jbc.M505031200




PubMed


 


PubMed ID 16131491",https://intramural.nih.gov/search/searchview.taf?ipid=43715
144,BC010275-09,"October 01, 2005 -  September 30, 2006",Neuronal Cell Death Regulation in Drosophila,"Florence M Davidson; MS, PhD, BA",NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI","Nadia  Urban



Moyi  Li



Robert  Padilla



Nancy  Wong",NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=43716
145,BC010276-09,"October 01, 2005 -  September 30, 2006",Protein Folding Mechanism,"Yawen  Bai; PhD



IRP Faculty Profile",NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI","Ngoc Diep T Vu



Hangiao  Feng



Zheng  Zhou



Hidenori  Kato",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Ai X, Zhou Z, Bai Y, Choy WY (2006). 15N NMR spin relaxation dispersion study of the molecular crowding effects on protein folding under native conditions. J Am Chem Soc  128, 3916-7.   https://doi.org/10.1021/ja057832n




PubMed


 


PubMed ID 16551092
    
     


 



2.
Bai Y (2006). Energy barriers, cooperativity, and hidden intermediates in the folding of small proteins. Biochem Biophys Res Commun  340, 976-83.   https://doi.org/10.1016/j.bbrc.2005.12.093




PubMed


 


PubMed ID 16405866
    
     


 



3.
Bai Y (2006). Protein folding pathways studied by pulsed- and native-state hydrogen exchange. Chem Rev  106, 1757-68.   https://doi.org/10.1021/cr040432i




PubMed


 


PubMed ID 16683753
    
     


 



4.
Bai Y, Feng H   (2006) Detection of a hidden folding intermediate in the focal adhesion target domain: Implications for its folding and function.  Proteins, in press.




 



5.
Choy WY, Zhou Z, Bai Y, Kay LE (2005). An 15N NMR spin relaxation dispersion study of the folding of a pair of engineered mutants of apocytochrome b562. J Am Chem Soc  127, 5066-72.   https://doi.org/10.1021/ja042560u




PubMed


 


PubMed ID 15810841
    
     


 



6.
Feng H, Vu ND, Bai Y (2005). Detection of a hidden folding intermediate of the third domain of PDZ. J Mol Biol  346, 345-53.   https://doi.org/10.1016/j.jmb.2004.11.040




PubMed


 


PubMed ID 15663949
    
     


 



7.
Korzhnev DM, Bezsonova I, Evanics F, Taulier N, Zhou Z, Bai Y, Chalikian TV, Prosser RS, Kay LE (2006). Probing the transition state ensemble of a protein folding reaction by pressure-dependent NMR relaxation dispersion. J Am Chem Soc  128, 5262-9.   https://doi.org/10.1021/ja0601540




PubMed


 


PubMed ID 16608362
    
     


 



8.
Zhou Z, Feng H, Zhou H, Zhou Y, Bai Y (2005). Design and folding of a multidomain protein. Biochemistry  44, 12107-12.   https://doi.org/10.1021/bi050785r




PubMed


 


PubMed ID 16142908
    
     


 



9.
Zhou Z, Huang Y, Bai Y (2005). An on-pathway hidden intermediate and the early rate-limiting transition state of Rd-apocytochrome b562 characterized by protein engineering. J Mol Biol  352, 757-64.   https://doi.org/10.1016/j.jmb.2005.07.057




PubMed


 


PubMed ID 16125200",https://intramural.nih.gov/search/searchview.taf?ipid=43717
146,BC010277-09,"October 01, 2005 -  September 30, 2006",Mechanisms of Chromosome Maintenance in Bacteria,"Dhruba K Chattoraj; PhD



IRP Faculty Profile",NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI","Preeti  Srivastava



Tatiana B Venkova-Canova



Ryosuke  Kadoya



Ranajit Kumar Ghosh



Gaelle  Demarre","Chanchal  Dasgupta
(Biophysics, Mol Biol & Genetics, U of Calcutta)




Johan  Paulsson
(Appl Math and Theoretical Physics, U of Cambridge)",NULL,NULL,"Ordered by publication type and then author name.



1.
Das N, Valjavec-Gratian M, Basuray AN, Fekete RA, Papp PP, Paulsson J, Chattoraj DK (2005). Multiple homeostatic mechanisms in the control of P1 plasmid replication. Proc Natl Acad Sci U S A  102, 2856-61.   https://doi.org/10.1073/pnas.0409790102




PubMed



        
     
Free Article


 


PubMed ID 15708977
         Pubmed Central ID 549481 


 



2.
Fekete RA, Chattoraj DK (2005). A cis-acting sequence involved in chromosome segregation in Escherichia coli. Mol Microbiol  55, 175-83.   https://doi.org/10.1111/j.1365-2958.2004.04392.x




PubMed


 


PubMed ID 15612926
    
     


 



3.
Pal D, Venkova-Canova T, Srivastava P, Chattoraj DK (2005). Multipartite regulation of rctB, the replication initiator gene of Vibrio cholerae chromosome II. J Bacteriol  187, 7167-75.   https://doi.org/10.1128/JB.187.21.7167-7175.2005




PubMed



        
     
Free Article


 


PubMed ID 16237000
         Pubmed Central ID 1272990 


 



4.
Srivastava P, Fekete RA, Chattoraj DK (2006). Segregation of the replication terminus of the two Vibrio cholerae chromosomes. J Bacteriol  188, 1060-70.   https://doi.org/10.1128/JB.188.3.1060-1070.2006




PubMed



        
     
Free Article


 


PubMed ID 16428410
         Pubmed Central ID 1347332",https://intramural.nih.gov/search/searchview.taf?ipid=43718
147,BC010278-09,"October 01, 2005 -  September 30, 2006",Imaging cellular assemblies with three-dimensional electron microscopy,"Sriram  Subramaniam; PhD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Jurgen A Heymann



Teruhisa  Hirai



Martin  Kessel; BSc, PhD



Jeffrey S Lengyel



Alberto  Bartesaghi



Adam  Bennett



Show all 12","Ben  Lich
(FEI Inc.)




Terry P Lybrand





Mark  McBride
(Microbiology, University of Wisconsin)




Robert  Morrison
(GATAN Inc.)




Guillermo  Sapiro
(Electrical Engineering, Uinversity of Minnesota)




Robert  Weis
(Chemistry, University of Masachusetts)","Jeffrey D Lifson; MD (National Cancer Institute)



Robert  Blumenthal; PhD (National Cancer Institute)



Dimiter Stanchev Dimitrov; PhD (National Cancer Institute)



Eric O Freed; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Subramaniam S, Weis R, Peters P   (2006) Electron tomography of bacterial chemotaxis receptor assemblies, in Methods in Cell Biology, in press.




 



2.
Heymann JA, Hayles M, Gestmann I, Giannuzzi LA, Lich B, Subramaniam S (2006). Site-specific 3D imaging of cells and tissues with a dual beam microscope. J Struct Biol  155, 63-73.   https://doi.org/10.1016/j.jsb.2006.03.006




PubMed



        
     
Free Article


 


PubMed ID 16713294
         Pubmed Central ID 1647295 


 



3.
Lefman J, Morrison R, Subramaniam S (2007). Automated 100-position specimen loader and image acquisition system for transmission electron microscopy. J Struct Biol  158, 318-26.   https://doi.org/10.1016/j.jsb.2006.11.007




PubMed



        
     
Free Article


 


PubMed ID 17240161
         Pubmed Central ID 1952209 


 



4.
Milne JL, Wu X, Borgnia MJ, Lengyel JS, Brooks BR, Shi D, Perham RN, Subramaniam S (2006). Molecular structure of a 9-MDa icosahedral pyruvate dehydrogenase subcomplex containing the E2 and E3 enzymes using cryoelectron microscopy. J Biol Chem  281, 4364-70.   https://doi.org/10.1074/jbc.M504363200




PubMed



        
     
Free Article


 


PubMed ID 16308322
         Pubmed Central ID 1647297 


 



5.
Subramaniam S (2006). The SIV surface spike imaged by electron tomography: one leg or three? PLoS Pathog  2, e91.   https://doi.org/10.1371/journal.ppat.0020091




PubMed



        
     
Free Article


 


PubMed ID 16933994
         Pubmed Central ID 1557834 


 



6.
Subramaniam S, Bartesaghi A, Liu J, Bennett AE, Sougrat R (2007). Electron tomography of viruses. Curr Opin Struct Biol  17, 596-602.   https://doi.org/10.1016/j.sbi.2007.09.009




PubMed



        
     
Free Article


 


PubMed ID 17964134
         Pubmed Central ID 2121662",https://intramural.nih.gov/search/searchview.taf?ipid=43719
148,BC010279-09,"October 01, 2005 -  December 31, 1899",Interaction of Progesterone Receptor with Chromatin,Catharine L Smith; PhD,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI","Angeliki  Magklara



Anne  Gussow",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43720
149,BC010283-09,"October 01, 2005 -  September 30, 2006",DNA Repair,"Andre A Nussenzweig; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI","Arkady  Celeste



Simone  Difilippantonio



Hua Tang (Henry)  Chen



Maria Elsa  Callen Moreu



Samuel  Bunting",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Kruhlak MJ, Celeste A, Dellaire G, Fernandez-Capetillo O, Müller WG, McNally JG, Bazett-Jones DP, Nussenzweig A (2006). Changes in chromatin structure and mobility in living cells at sites of DNA double-strand breaks. J Cell Biol  172, 823-34.   https://doi.org/10.1083/jcb.200510015




PubMed



        
     
Free Article


 


PubMed ID 16520385
         Pubmed Central ID 2063727 


 



2.
Kruhlak MJ, Celeste A, Nussenzweig A (2006). Spatio-temporal dynamics of chromatin containing DNA breaks. Cell Cycle  5, 1910-2.   https://doi.org/10.4161/cc.5.17.3169




PubMed


 


PubMed ID 16929171
    
     


 



3.
Lou Z, Minter-Dykhouse K, Franco S, Gostissa M, Rivera MA, Celeste A, Manis JP, van Deursen J, Nussenzweig A, Paull TT, Alt FW, Chen J (2006). MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals. Mol Cell  21, 187-200.   https://doi.org/10.1016/j.molcel.2005.11.025




PubMed


 


PubMed ID 16427009
    
     


 



4.
Nussenzweig A, Paull T (2006). DNA repair: tails of histones lost. Nature  439, 406-7.   https://doi.org/10.1038/439406a




PubMed


 


PubMed ID 16437102
    
     


 



5.
Pellegrini M, Celeste A, Difilippantonio S, Guo R, Wang W, Feigenbaum L, Nussenzweig A (2006). Autophosphorylation at serine 1987 is dispensable for murine Atm activation in vivo. Nature  443, 222-5.   https://doi.org/10.1038/nature05112




PubMed


 


PubMed ID 16906133
    
     


 



6.
Ramiro AR, Jankovic M, Callen E, Difilippantonio S, Chen HT, McBride KM, Eisenreich TR, Chen J, Dickins RA, Lowe SW, Nussenzweig A, Nussenzweig MC (2006). Role of genomic instability and p53 in AID-induced c-myc-Igh translocations. Nature  440, 105-9.   https://doi.org/10.1038/nature04495




PubMed



        
     
Free Article


 


PubMed ID 16400328
         Pubmed Central ID 4601098 


 



7.
Ramiro AR, Nussenzweig MC, Nussenzweig A (2006). Switching on chromosomal translocations. Cancer Res  66, 7837-9.   https://doi.org/10.1158/0008-5472.CAN-06-0863




PubMed


 


PubMed ID 16912154
    
     


 



8.
Ward IM, Difilippantonio S, Minn K, Mueller MD, Molina JR, Yu X, Frisk CS, Ried T, Nussenzweig A, Chen J (2005). 53BP1 cooperates with p53 and functions as a haploinsufficient tumor suppressor in mice. Mol Cell Biol  25, 10079-86.   https://doi.org/10.1128/MCB.25.22.10079-10086.2005




PubMed



        
     
Free Article


 


PubMed ID 16260621
         Pubmed Central ID 1280262",https://intramural.nih.gov/search/searchview.taf?ipid=43721
150,BC010289-09,"October 01, 2005 -  September 30, 2006",Chromatin Targets of Cyclic Nucleotide Signaling Pathways,Catharine L Smith; PhD,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI","Sara K Snyder



Erin  Bressler","Jackie  Dudley; PhD
(University of Texas)




Hans-Gottfried  Genieser
(BIOLOG Life Science Institute)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43722
151,BC010292-08,"October 01, 2005 -  September 30, 2006",Enzymes and Substrates of the Ubiquitin Conjugating System,"Allan M Weissman; MD



IRP Faculty Profile",NULL,"Laboratory of Protein Dynamics and Signaling, NCI","Jane P Jensen



Kevin L Lorick; PhD



Jennifer B Mariano



Yien-Che  Tsai



Jirouta  Kitagaki



Andrew  Fotia",NULL,"Yves  Pommier; PhD (National Cancer Institute)



Michael Robert Kuehn; PhD (National Cancer Institute)



Barry R O'Keefe (National Cancer Institute)












Karen H Vousden  (Regulation of Cell Growth Laboratory)","Juan S Bonifacino; PhD (NICHD) 



James H Hurley; PhD (NIDDK)","Ordered by publication type and then author name.



1.
Lee S, Tsai YC, Mattera R, Smith WJ, Kostelansky MS, Weissman AM, Bonifacino JS, Hurley JH (2006). Structural basis for ubiquitin recognition and autoubiquitination by Rabex-5. Nat Struct Mol Biol  13, 264-71.   https://doi.org/10.1038/nsmb1064




PubMed



        
     
Free Article


 


PubMed ID 16462746
         Pubmed Central ID 1578505 


 



2.
Lorick KL, Jensen JP, Weissman AM (2005). Expression, purification, and properties of the Ubc4/5 family of E2 enzymes. Methods Enzymol  398, 54-68.   https://doi.org/10.1016/S0076-6879(05)98006-3




PubMed


 


PubMed ID 16275319
    
     


 



3.
Mattera R, Tsai YC, Weissman AM, Bonifacino JS (2006). The Rab5 guanine nucleotide exchange factor Rabex-5 binds ubiquitin (Ub) and functions as a Ub ligase through an atypical Ub-interacting motif and a zinc finger domain. J Biol Chem  281, 6874-83.   https://doi.org/10.1074/jbc.M509939200




PubMed


 


PubMed ID 16407276
    
     


 



4.
Weissman A, Oh A, Bowden E, Lahusen T, Lorick K, Schlegel R, Wellstein A, Riegel A   (2006) E6-AP mediates regulated proteasomal degradation of the nuclear receptor coactivator AIB1/SRC-3 in immortalized cells.  Cancer Research, in press.




 



5.
Yang Y, Lorick KL, Jensen JP, Weissman AM (2005). Expression and evaluation of RING finger proteins. Methods Enzymol  398, 103-12.   https://doi.org/10.1016/S0076-6879(05)98010-5




PubMed


 


PubMed ID 16275323
    
     


 



6.
Weissman AM, Yang YM (submitted in 2006) Highly Soluble Pyrimido-dione-quinoline Compounds And Their Use In The Treatment Of Cancer. Patent issued: 8,877,765 (US in 2015). Patent pending: PCT/US2007/013952 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=43534
152,BC010297-09,"October 01, 2005 -  September 30, 2006",Identification of Candidate Gene Polymorphisms Associated with Infectious Diseas,Cheryl Ann Winkler,NULL,"Laboratory of Genomic Diversity, NCI","Michael J Malasky



Ping  An; PhD



Elizabeth  Binns-Roemer



Mary A Thompson



Michael E Weedon



Mary  Mcnally



Show all 9","Sharyne  Donfield
(Hemophilia Growth and Development Study, Rho, Inc.)




Max  Essex
(Department of Immuology and Infectious Diseases, Harvard Medical School)




Gregory D Kirk





John P Phair





Joseph  Sodroski
(Harvard University)","James Jerome Goedert; MD (National Cancer Institute)



Michael  Dean; PhD (National Cancer Institute)



Stephen J O'Brien; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Guo XC, O'Brien SJ, Winkler C, Scott K, Hutcheson H, David V, Kessing B, Zheng YM, Liao J, Lui Y, Guy de T, Zeng Y (2006). [Association study of chromosome 4 STRs polymorphisms with nasopharyngeal carcinoma]. Yi Chuan  28, 783-90.




PubMed


 


PubMed ID 16825163
    
     


 



2.
Guo XC, Scott K, Liu Y, Dean M, David V, Nelson GW, Johnson RC, Dilks HH, Lautenberger J, Kessing B, Martenson J, Guan L, Sun S, Deng H, Zheng Y, de The G, Liao J, Zeng Y, O'Brien SJ, Winkler CA (2006). Genetic factors leading to chronic Epstein-Barr virus infection and nasopharyngeal carcinoma in South East China: study design, methods and feasibility. Hum Genomics  2, 365-75.   https://doi.org/10.1186/1479-7364-2-6-365




PubMed



        
     
Free Article


 


PubMed ID 16848974
         Pubmed Central ID 3525159 


 



3.
Javanbakht H, An P, Gold B, Petersen DC, O'Huigin C, Nelson GW, O'Brien SJ, Kirk GD, Detels R, Buchbinder S, Donfield S, Shulenin S, Song B, Perron MJ, Stremlau M, Sodroski J, Dean M, Winkler C (2006). Effects of human TRIM5alpha polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection. Virology  354, 15-27.   https://doi.org/10.1016/j.virol.2006.06.031




PubMed


 


PubMed ID 16887163
    
     


 



4.
Modi WS, Lautenberger J, An P, Scott K, Goedert JJ, Kirk GD, Buchbinder S, Phair J, Donfield S, O'Brien SJ, Winkler C (2006). Genetic variation in the CCL18-CCL3-CCL4 chemokine gene cluster influences HIV Type 1 transmission and AIDS disease progression. Am J Hum Genet  79, 120-8.   https://doi.org/10.1086/505331




PubMed



        
     
Free Article


 


PubMed ID 16773571
         Pubmed Central ID 1474130 


 



5.
Modi WS, Scott K, Goedert JJ, Vlahov D, Buchbinder S, Detels R, Donfield S, O'brien SJ, Winkler C (2005). Haplotype analysis of the SDF-1 (CXCL12) gene in a longitudinal HIV-1/AIDS cohort study. Genes Immun  6, 691-8.   https://doi.org/10.1038/sj.gene.6364258




PubMed


 


PubMed ID 16177829
    
     


 



6.
Walsh EC, Sabeti P, Hutcheson HB, Fry B, Schaffner SF, de Bakker PI, Varilly P, Palma AA, Roy J, Cooper R, Winkler C, Zeng Y, de The G, Lander ES, O'Brien S, Altshuler D (2006). Searching for signals of evolutionary selection in 168 genes related to immune function. Hum Genet  119, 92-102.   https://doi.org/10.1007/s00439-005-0090-0




PubMed


 


PubMed ID 16362345",https://intramural.nih.gov/search/searchview.taf?ipid=43723
153,BC010298-09,"October 01, 2005 -  September 30, 2006",Gene Discovery,"Ira H Pastan; MD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Richard A Beers



Satoshi  Nagata; PhD



Laiman  Xiang



Tapan K Bera



Sudipto  Das



Xiu-Fen  Liu



Show all 7",NULL,"Robert J Kreitman; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bera TK, Saint Fleur A, Lee Y, Kydd A, Hahn Y, Popescu NC, Zimonjic DB, Lee B, Pastan I (2006). POTE paralogs are induced and differentially expressed in many cancers. Cancer Res  66, 52-6.   https://doi.org/10.1158/0008-5472.CAN-05-3014




PubMed


 


PubMed ID 16397215
    
     


 



2.
Das S, Ise T, Nagata S, Maeda H, Bera TK, Pastan I (2007). Palmitoylation of POTE family proteins for plasma membrane targeting. Biochem Biophys Res Commun  363, 751-6.   https://doi.org/10.1016/j.bbrc.2007.09.045




PubMed



        
     
Free Article


 


PubMed ID 17904529
         Pubmed Central ID 2170890 


 



3.
Egland KA, Liu XF, Squires S, Nagata S, Man YG, Bera TK, Onda M, Vincent JJ, Strausberg RL, Lee B, Pastan I (2006). High expression of a cytokeratin-associated protein in many cancers. Proc Natl Acad Sci U S A  103, 5929-34.   https://doi.org/10.1073/pnas.0601296103




PubMed



        
     
Free Article


 


PubMed ID 16585525
         Pubmed Central ID 1458675 


 



4.
Hahn Y, Bera TK, Pastan IH, Lee B (2006). Duplication and extensive remodeling shaped POTE family genes encoding proteins containing ankyrin repeat and coiled coil domains. Gene  366, 238-45.   https://doi.org/10.1016/j.gene.2005.07.045




PubMed


 


PubMed ID 16364570
    
     


 



5.
Korherr C, Gille H, Schäfer R, Koenig-Hoffmann K, Dixelius J, Egland KA, Pastan I, Brinkmann U (2006). Identification of proangiogenic genes and pathways by high-throughput functional genomics: TBK1 and the IRF3 pathway. Proc Natl Acad Sci U S A  103, 4240-5.   https://doi.org/10.1073/pnas.0511319103




PubMed



        
     
Free Article


 


PubMed ID 16537515
         Pubmed Central ID 1449677 


 



6.
Schlom J, Pastan I, Tsang K (submitted in 2006) Immunogenic Peptides And Methods Of Use. Patents issued: 1989224 (BE in 2011); 1989224 (CH in 2011); 1989224 (DE in 2011); 1989224 (DK in 2011); 1989224 (EP in 2011); 1989224 (ES in 2011); 1989224 (FR in 2011); 1989224 (GB in 2011); 1989224 (IT in 2011); 1989224 (NL in 2011); 1989224 (SE in 2011); ATE485305T1 (AT in 2011); 7,910,692 (US in 2011); 2007221255 (AU in 2012); 2642994 (CA in 2015); 9,175,057 (US in 2016). Patent pending: PCT/US2007/004603 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=43724
154,BC010300-09,"October 01, 2005 -  September 30, 2006",Signal Transduction of Paired Inhibitory Receptors of NK Cells and Macrophages,"Daniel  McVicar; PhD



IRP Faculty Profile",NULL,"Laboratory of Experimental Immunology, NCI","Gillian C Whittaker



Eriko  Yamada","Thomas  Yankee
(Microbiology, Univ. Kansas Medical Center)




Weiguo  Zhang
(NICHHD)",Stephen K Anderson; PhD (National Cancer Institute),"Ivo  Francischetti; MD, PhD (NIAID) 



Pamela Lee Schwartzberg; MD, PhD (NHGRI)","Ordered by publication type and then author name.



1.
Gattis JL, Washington AV, Chisholm MM, Quigley L, Szyk A, McVicar DW, Lubkowski J (2006). The structure of the extracellular domain of triggering receptor expressed on myeloid cells like transcript-1 and evidence for a naturally occurring soluble fragment. J Biol Chem  281, 13396-403.   https://doi.org/10.1074/jbc.M600489200




PubMed


 


PubMed ID 16505478
    
     


 



2.
Mason LH, Willette-Brown J, Taylor LS, McVicar DW (2006). Regulation of Ly49D/DAP12 signal transduction by Src-family kinases and CD45. J Immunol  176, 6615-23.   https://doi.org/10.4049/jimmunol.176.11.6615




PubMed


 


PubMed ID 16709819",https://intramural.nih.gov/search/searchview.taf?ipid=43725
155,BC010301-09,"October 01, 2005 -  September 30, 2006",Development of Recombinant Toxins for Treatment of Patients with Hematologic Mal,"Robert J Kreitman; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Evgeny  Arons



Linda  Ellison-Dejewski



Inger M Margulies



Barbara  Debrah



Karen  Bergeron



Kit S Beane",NULL,Alan S Wayne; MD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Arons E, Margulies I, Sorbara L, Raffeld M, Stetler-Stevenson M, Pastan I, Kreitman RJ (2006). Minimal residual disease in hairy cell leukemia patients assessed by clone-specific polymerase chain reaction. Clin Cancer Res  12, 2804-11.   https://doi.org/10.1158/1078-0432.CCR-05-2315




PubMed


 


PubMed ID 16675574
    
     


 



2.
Arons E, Sorbara L, Raffeld M, Stetler-Stevenson M, Steinberg SM, Liewehr DJ, Pastan I, Kreitman RJ (2006). Characterization of T-cell repertoire in hairy cell leukemia patients before and after recombinant immunotoxin BL22 therapy. Cancer Immunol Immunother  55, 1100-10.   https://doi.org/10.1007/s00262-005-0099-1




PubMed


 


PubMed ID 16311729
    
     


 



3.
Arons E, Sunshine J, Suntum T, Kreitman RJ (2006). Somatic hypermutation and VH gene usage in hairy cell leukaemia. Br J Haematol  133, 504-12.   https://doi.org/10.1111/j.1365-2141.2006.06066.x




PubMed


 


PubMed ID 16681637
    
     


 



4.
Pastan I, Hassan R, Fitzgerald DJ, Kreitman RJ (2006). Immunotoxin therapy of cancer. Nat Rev Cancer  6, 559-65.   https://doi.org/10.1038/nrc1891




PubMed


 


PubMed ID 16794638",https://intramural.nih.gov/search/searchview.taf?ipid=43726
156,BC010303-08,"October 01, 2005 -  September 30, 2006",MicroArray Explorer:  Data Mining the Expression Profiles of DNA Microarrays,Peter F Lemkin; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Gregory  Thornwall,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43727
157,BC010304-08,"October 01, 2005 -  September 30, 2006",Biochemical Basis of T Cell Activation,"Lawrence Elliot Samelson; MD



IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI","Mira  Barda-Saad



Alex  Braiman



Jon  Houtman



Connie  Sommers; PhD



Kelsie M Bernot



Aparna  Kishor



Show all 9",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Barr VA, Balagopalan L, Barda-Saad M, Polishchuk R, Boukari H, Bunnell SC, Bernot KM, Toda Y, Nossal R, Samelson LE (2006). T-cell antigen receptor-induced signaling complexes: internalization via a cholesterol-dependent endocytic pathway. Traffic  7, 1143-62.   https://doi.org/10.1111/j.1600-0854.2006.00464.x




PubMed


 


PubMed ID 16919152
    
     


 



2.
Braiman A, Barda-Saad M, Sommers CL, Samelson LE (2006). Recruitment and activation of PLCgamma1 in T cells: a new insight into old domains. EMBO J  25, 774-84.   https://doi.org/10.1038/sj.emboj.7600978




PubMed



        
     
Free Article


 


PubMed ID 16467851
         Pubmed Central ID 1383559 


 



3.
Bunnell SC, Singer AL, Hong DI, Jacque BH, Jordan MS, Seminario MC, Barr VA, Koretzky GA, Samelson LE (2006). Persistence of cooperatively stabilized signaling clusters drives T-cell activation. Mol Cell Biol  26, 7155-66.   https://doi.org/10.1128/MCB.00507-06




PubMed



        
     
Free Article


 


PubMed ID 16980618
         Pubmed Central ID 1592897 


 



4.
Houtman JC, Barda-Saad M, Samelson LE (2005). Examining multiprotein signaling complexes from all angles. FEBS J  272, 5426-35.   https://doi.org/10.1111/j.1742-4658.2005.04972.x




PubMed



        
     
Free Article


 


PubMed ID 16262684
         Pubmed Central ID 1431607 


 



5.
Houtman JC, Yamaguchi H, Barda-Saad M, Braiman A, Bowden B, Appella E, Schuck P, Samelson LE (2006). Oligomerization of signaling complexes by the multipoint binding of GRB2 to both LAT and SOS1. Nat Struct Mol Biol  13, 798-805.   https://doi.org/10.1038/nsmb1133




PubMed


 


PubMed ID 16906159",https://intramural.nih.gov/search/searchview.taf?ipid=43728
158,BC010305-08,"October 01, 2005 -  September 30, 2006",Genetic effects of the MHC and KIR locus on autoimmune disease and cancer,"Mary  Carrington; MS, PhD",NULL,"Laboratory of Genomic Diversity, NCI","Shawn R Palmer



Maureen P Martin



Darlene M Marti



Xiaojiang  Gao



Amy E Poisson



Michael J Malasky



Show all 11","James  Elder
(University of Michigan)




Rajan  Nair
(University of Michigan)




Metka  Ravnik-Glavac
(University of Lubljana)




John  Rioux
(Department of Medicine, Universit de Montral)




Kathy  Siminovitch
(MEDICAL GENETICS & MICROBIOLOGY, University of Toronto)","Sophia S Wang; PhD (National Cancer Institute)



Maria Teresa Pia Landi; MD, PhD (National Cancer Institute)



Allan  Hildesheim; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Carrington M, Martin MP (2006). The impact of variation at the KIR gene cluster on human disease. Curr Top Microbiol Immunol  298, 225-57.   https://doi.org/10.1007/3-540-27743-9_12




PubMed


 


PubMed ID 16329188
    
     


 



2.
Frahm N, Kiepiela P, Adams S, Linde CH, Hewitt HS, Sango K, Feeney ME, Addo MM, Lichterfeld M, Lahaie MP, Pae E, Wurcel AG, Roach T, St John MA, Altfeld M, Marincola FM, Moore C, Mallal S, Carrington M, Heckerman D, Allen TM, Mullins JI, Korber BT, Goulder PJ, Walker BD, et al. [1 more author] (2006). Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes. Nat Immunol  7, 173-8.   https://doi.org/10.1038/ni1281




PubMed


 


PubMed ID 16369537
    
     


 



3.
Moffett A, Hiby S, Carrington M (2006). The incidence of pre-eclampsia among couples consisting of Japanese women and Caucasian men'. J Reprod Immunol  71, 132-3; author reply 134.   https://doi.org/10.1016/j.jri.2006.04.003




PubMed


 


PubMed ID 16860398
    
     


 



4.
O'Hanlon TP, Carrick DM, Targoff IN, Arnett FC, Reveille JD, Carrington M, Gao X, Oddis CV, Morel PA, Malley JD, Malley K, Shamim EA, Rider LG, Chanock SJ, Foster CB, Bunch T, Blackshear PJ, Plotz PH, Love LA, Miller FW (2006). Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies. Medicine (Baltimore)  85, 111-27.   https://doi.org/10.1097/01.md.0000217525.82287.eb




PubMed


 


PubMed ID 16609350",https://intramural.nih.gov/search/searchview.taf?ipid=43732
159,BC010306-08,"October 01, 2005 -  September 30, 2006",Identification of Needle Sharing: A Risk Factor for Viral Infection,Michael W Smith,NULL,"Laboratory of Genomic Diversity, NCI",Ann  Truelove,"Karl  Broman
(University of Michigan)




Homayoon  Farzadegan
(Dept. of Epidemiology, Johns Hopkins University)




Sadeep  Shrestha





Steffanie  Strathdee
(Dept. of Epidemiology, Johns Hopkins University)",NULL,NULL,"Ordered by publication type and then author name.



1.
Shrestha S, Strathdee SA, Broman KW, Smith MW (2006). Unknown biological mixtures evaluation using STR analytical quantification. Electrophoresis  27, 409-15.   https://doi.org/10.1002/elps.200500502




PubMed


 


PubMed ID 16437418
    
     


 



2.
Shrestha S, Strathdee SA, Galai N, Oleksyk T, Fallin MD, Mehta S, Schaid D, Vlahov D, O'Brien SJ, Smith MW (2006). Behavioral risk exposure and host genetics of susceptibility to HIV-1 infection. J Infect Dis  193, 16-26.   https://doi.org/10.1086/498532




PubMed


 


PubMed ID 16323127
    
     


 



3.
Smith M, Broman K, Farzadegan H, Vlahov D, Strathdee S   (2006) Multiperson Use of Syringes Among Injection Drug Users in a Needle Exchange Program.  JAIDS, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=43733
160,BC010307-07,"October 01, 2005 -  September 30, 2006",Cell Growth Control In Vivo by CEBPbeta and CEBPdelta,"Gisela Esta Sterneck; PhD



IRP Faculty Profile",NULL,"Laboratory of Cell and Developmental Signaling, NCI","Shikha  Sharan



Snehalata Anil Pawar



Jun  Wang



Youhong  Zhang","Lane  Christenson
(Center for Research on Reproduction and Women's Health, University of Pennsylvania)




Zdenek  Kleibel
(Dept. of Biochemistry and Experimental Oncology, Charles University in Prague)




Robert  Smart
(Department of Environmental and Molecular Toxicology, NCSU)",Mark  Raffeld; MD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43555
161,BC010308-08,"October 01, 2005 -  September 30, 2006",In vivo Imaging Analysis of SteroidNuclear Receptor Function,"Gordon Lee Hager; PhD



IRP Faculty Profile",NULL,"Laboratory of Receptor Biology and Gene Expression, NCI","Carol T Comlish



Ty Cole Voss","Donald  DeFranco; PhD

(Department of Pharmacology)




Miroslav  Dundr





Dean  Edwards
(Pharmacology, Univ Colorado Hlth Sciences Center)




Brian  Freeman
(University of Illinois, Dept. of Cell and Developmental Biology)




Donald  McDonnell
(Pharmacology and Cancer Biology, Duke University Medical Center)




Fahri  Saatcioglu
(Department of Biology, University of Oslo)


Show all 8",James G McNally; PhD (National Cancer Institute),S Stoney  Simons; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Becker M, Becker A, Miyara F, Han Z, Kihara M, Brown DT, Hager GL, Latham K, Adashi EY, Misteli T (2005). Differential in vivo binding dynamics of somatic and oocyte-specific linker histones in oocytes and during ES cell nuclear transfer. Mol Biol Cell  16, 3887-95.   https://doi.org/10.1091/mbc.e05-04-0350




PubMed



        
     
Free Article


 


PubMed ID 15944219
         Pubmed Central ID 1182324 


 



2.
Hager G   (2006) Development of assays for nuclear receptor modulators using fluorescently tagged proteins in Measuring Biological Responses with Automated Microscopy.  Methods Enyzmol.  37-50 pp.




 



3.
Hager G, Dull A, Beutler J   (2006) High-content fluorescence-based screening for epigenetic modulators in Measuring Biological Responses with Automated Microscopy.  Methods Enyzmol.  21-36 pp.




 



4.
Martinez ED, Rayasam GV, Dull AB, Walker DA, Hager GL (2005). An estrogen receptor chimera senses ligands by nuclear translocation. J Steroid Biochem Mol Biol  97, 307-21.   https://doi.org/10.1016/j.jsbmb.2005.06.033




PubMed


 


PubMed ID 16162406
    
     


 



5.
Voss TC, John S, Hager GL (2006). Single-cell analysis of glucocorticoid receptor action reveals that stochastic post-chromatin association mechanisms regulate ligand-specific transcription. Mol Endocrinol  20, 2641-55.   https://doi.org/10.1210/me.2006-0091




PubMed


 


PubMed ID 16873444",https://intramural.nih.gov/search/searchview.taf?ipid=43734
162,BC010309-08,"October 01, 2005 -  September 30, 2006",Nuclear Architecture and Disease,"Thomas A Misteli; PhD



IRP Faculty Profile",NULL,"Laboratory of Receptor Biology and Gene Expression, NCI","Stan  Gorski



Stephen A Mabon



Paola  Scaffidi



Manjari  Mazumdar



Eran  Meshorer



Evi  Soutoglou



Show all 10","David  Brown
(University of Mississippi)




Kris  Dahl
(Bioengineering, Carnegie Mellon)




Amanda  Fisher





Tom  Gingeras
(Array Technology, Affymetrix)




Ingrid  Grummt
(Cancer Biology, DKFZ)




Tina  Izard
(St. Jude's Research Hospital)


Show all 8","Karl Thomas Ried; MD (National Cancer Institute)



Andre A Nussenzweig; PhD (National Cancer Institute)



Stephen J Lockett; PhD (National Cancer Institute)



James G McNally; PhD (National Cancer Institute)","Sushil Gopal Rane; MS, PhD (NIDDK)","Ordered by publication type and then author name.



1.
Gorski S, Misteli T (2005). Systems biology in the cell nucleus. J Cell Sci  118, 4083-92.   https://doi.org/10.1242/jcs.02596




PubMed


 


PubMed ID 16155251
    
     


 



2.
Mazumdar M, Lee JH, Sengupta K, Ried T, Rane S, Misteli T (2006). Tumor formation via loss of a molecular motor protein. Curr Biol  16, 1559-64.   https://doi.org/10.1016/j.cub.2006.06.029




PubMed



        
     
Free Article


 


PubMed ID 16890532
         Pubmed Central ID 1853379 


 



3.
Meshorer E, Yellajoshula D, George E, Scambler PJ, Brown DT, Misteli T (2006). Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Dev Cell  10, 105-16.   https://doi.org/10.1016/j.devcel.2005.10.017




PubMed



        
     
Free Article


 


PubMed ID 16399082
         Pubmed Central ID 1868458 


 



4.
Scaffidi P, Misteli T (2006). Lamin A-dependent nuclear defects in human aging. Science  312, 1059-63.   https://doi.org/10.1126/science.1127168




PubMed



        
     
Free Article


 


PubMed ID 16645051
         Pubmed Central ID 1855250 


 



5.
Soutoglou E, Misteli T (2007). Mobility and immobility of chromatin in transcription and genome stability. Curr Opin Genet Dev  17, 435-42.   https://doi.org/10.1016/j.gde.2007.08.004




PubMed



        
     
Free Article


 


PubMed ID 17905579
         Pubmed Central ID 2118061",https://intramural.nih.gov/search/searchview.taf?ipid=43735
163,BC010313-08,"October 01, 2005 -  September 30, 2006",Molecular profiling of human hepatocellular cancer,"Xin Wei Wang; PhD



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","Anuradha Samantha Budhu



Marshonna J Forgues



Brian Daniel Zipser



Vivian A Takafuji



Chuan-Ging  Wu



Hu-Liang  Jia



Show all 7","Ping  He





Zhao-You  Tang
(Liver Cancer Institute)




Chuan-Ging  Wu",Udai S Kammula (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Budhu A, Forgues M, Ye QH, Jia HL, He P, Zanetti KA, Kammula US, Chen Y, Qin LX, Tang ZY, Wang XW (2006). Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell  10, 99-111.   https://doi.org/10.1016/j.ccr.2006.06.016




PubMed


 


PubMed ID 16904609
    
     


 



2.
Staib F, Robles AI, Varticovski L, Wang XW, Zeeberg BR, Sirotin M, Zhurkin VB, Hofseth LJ, Hussain SP, Weinstein JN, Galle PR, Harris CC (2005). The p53 tumor suppressor network is a key responder to microenvironmental components of chronic inflammatory stress. Cancer Res  65, 10255-64.   https://doi.org/10.1158/0008-5472.CAN-05-1714




PubMed



        
     
Free Article


 


PubMed ID 16288013
         Pubmed Central ID 1421332",https://intramural.nih.gov/search/searchview.taf?ipid=43738
164,BC010317-08,"October 01, 2005 -  September 30, 2006",Rapid Analysis of Single Nucleotide Polymorphism Genotypes in AIDS Cohorts,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI","Shawn R Palmer



Michael J Malasky



Guan  Li



Mary  Mcnally



James  Lautenberger; PhD



Bailey D Kessing



Show all 11",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Modi WS, Lautenberger J, An P, Scott K, Goedert JJ, Kirk GD, Buchbinder S, Phair J, Donfield S, O'Brien SJ, Winkler C (2006). Genetic variation in the CCL18-CCL3-CCL4 chemokine gene cluster influences HIV Type 1 transmission and AIDS disease progression. Am J Hum Genet  79, 120-8.   https://doi.org/10.1086/505331




PubMed



        
     
Free Article


 


PubMed ID 16773571
         Pubmed Central ID 1474130 


 



2.
Nelson GW, O'Brien SJ (2006). Using mutual information to measure the impact of multiple genetic factors on AIDS. J Acquir Immune Defic Syndr  42, 347-54.   https://doi.org/10.1097/01.qai.0000219786.88786.d8




PubMed


 


PubMed ID 16763524",https://intramural.nih.gov/search/searchview.taf?ipid=43739
165,BC010319-08,"October 01, 2005 -  September 30, 2006",Structural Analysis of Biological Membrane Proteins,"Di S Xia; PhD, MS, BS



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Lothar  Esser



Jichun  Ma



Kazuya  Nishio



Michael Marc Gottesman; MD",NULL,Susan  Bates; MD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Ambudkar SV, Kim IW, Xia D, Sauna ZE (2006). The A-loop, a novel conserved aromatic acid subdomain upstream of the Walker A motif in ABC transporters, is critical for ATP binding. FEBS Lett  580, 1049-55.   https://doi.org/10.1016/j.febslet.2005.12.051




PubMed


 


PubMed ID 16412422
    
     


 



2.
Kim IW, Peng XH, Sauna ZE, FitzGerald PC, Xia D, Müller M, Nandigama K, Ambudkar SV (2006). The conserved tyrosine residues 401 and 1044 in ATP sites of human P-glycoprotein are critical for ATP binding and hydrolysis: evidence for a conserved subdomain, the A-loop in the ATP-binding cassette. Biochemistry  45, 7605-16.   https://doi.org/10.1021/bi060308o




PubMed


 


PubMed ID 16768456
    
     


 



3.
Xia D, Gong X, Yang S, Yu L, Yu C   (2006) Surface Modulated Motion Switch: the Capture and Release of Iron-Sulfur Protein in the Cytochrome bc1 Complex.  Proc. Natl. Acad. Sci. USA  13045-13050 pp.




 



4.
Xia D, Polgar O, Okada M, Esser L, Bates S   (2006) Towards understanding the mechanism of action of the multidrug resistance-linked half-ABC transporter ABCG2: A molecular modeling study.  J. Mol Graphics Modeling  In press pp.




 



5.
Xia D, Xiao K, Esser L, Yu L, Yu C   (2006) Gneration, characterization and crystallization of a highly active and stable cytochrome bc1 complex mutant from Rhodobacter sphaeroides.  Biochim Biophys Acta  835-840 pp.",https://intramural.nih.gov/search/searchview.taf?ipid=43741
166,BC010326-07,"October 01, 2005 -  September 30, 2006",Structural Chemistry of Biomolecular Systems and Structure-Based Drug Design,"Xinhua  Ji; PhD



IRP Faculty Profile",NULL,"Macromolecular Crystallography Laboratory, NCI","Jianhua  Gan



Gary X Shaw



Chao  Tu



Hehua  Liu","Shivendra  Singh
(Pharmacology, U of Pittsburgh)




Honggao  Yan","Dimiter Stanchev Dimitrov; PhD (National Cancer Institute)



Ding Jun Jin (National Cancer Institute)



Larry K Keefer; PhD (National Cancer Institute)



Christopher J Michejda; PhD (National Cancer Institute)



Joseph Edward Tropea (National Cancer Institute)



David S Waugh; PhD (Protein Engineering Section)",NULL,"Ordered by publication type and then author name.



1.
Ji X   (2006) The mechanism of RNase III action: How Dicer dices, in RNAi edition of Current Topics in Microbiology and Immunology. Springer Publishers (New York), in press.




 



2.
Gan J, Gu Y, Li Y, Yan H, Ji X (2006). Crystal structure of Mycobacterium tuberculosis shikimate kinase in complex with shikimic acid and an ATP analogue. Biochemistry  45, 8539-45.   https://doi.org/10.1021/bi0606290




PubMed


 


PubMed ID 16834327
    
     


 



3.
Gan J, Tropea JE, Austin BP, Court DL, Waugh DS, Ji X (2006). Structural insight into the mechanism of double-stranded RNA processing by ribonuclease III. Cell  124, 355-66.   https://doi.org/10.1016/j.cell.2005.11.034




PubMed


 


PubMed ID 16439209
    
     


 



4.
Ji X (2006). Structural basis for non-catalytic and catalytic activities of ribonuclease III. Acta Crystallogr D Biol Crystallogr  62, 933-40.   https://doi.org/10.1107/S090744490601153X




PubMed


 


PubMed ID 16855311
    
     


 



5.
Prabakaran P, Gan J, Feng Y, Zhu Z, Choudhry V, Xiao X, Ji X, Dimitrov DS (2006). Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody. J Biol Chem  281, 15829-36.   https://doi.org/10.1074/jbc.M600697200




PubMed


 


PubMed ID 16597622
    
     


 



6.
Prabakaran P, Gan J, Wu YQ, Zhang MY, Dimitrov DS, Ji X (2006). Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs. J Mol Biol  357, 82-99.   https://doi.org/10.1016/j.jmb.2005.12.062




PubMed


 


PubMed ID 16426633
    
     


 



7.
Saavedra JE, Srinivasan A, Buzard GS, Davies KM, Waterhouse DJ, Inami K, Wilde TC, Citro ML, Cuellar M, Deschamps JR, Parrish D, Shami PJ, Findlay VJ, Townsend DM, Tew KD, Singh S, Jia L, Ji X, Keefer LK (2006). PABA/NO as an anticancer lead: analogue synthesis, structure revision, solution chemistry, reactivity toward glutathione, and in vitro activity. J Med Chem  49, 1157-64.   https://doi.org/10.1021/jm050700k




PubMed



        
     
Free Article


 


PubMed ID 16451080
         Pubmed Central ID 6522251 


 



8.
Shami PJ, Saavedra JE, Bonifant CL, Chu J, Udupi V, Malaviya S, Carr BI, Kar S, Wang M, Jia L, Ji X, Keefer LK (2006). Antitumor activity of JS-K [O2-(2,4-dinitrophenyl) 1-[(4-ethoxycarbonyl)piperazin-1-yl]diazen-1-ium-1,2-diolate] and related O2-aryl diazeniumdiolates in vitro and in vivo. J Med Chem  49, 4356-66.   https://doi.org/10.1021/jm060022h




PubMed


 


PubMed ID 16821795
    
     


 



9.
Townsend DM, Findlay VJ, Fazilev F, Ogle M, Fraser J, Saavedra JE, Ji X, Keefer LK, Tew KD (2006). A glutathione S-transferase pi-activated prodrug causes kinase activation concurrent with S-glutathionylation of proteins. Mol Pharmacol  69, 501-8.   https://doi.org/10.1124/mol.105.018523




PubMed



        
     
Free Article


 


PubMed ID 16288082
         Pubmed Central ID 6522256",https://intramural.nih.gov/search/searchview.taf?ipid=43742
167,BC010328-07,"October 01, 2005 -  September 30, 2006",Role of CEBP transcription factors in regulating cell growth and tumorigenesis,"Peter F Johnson; PhD



IRP Faculty Profile",NULL,"Laboratory of Protein Dynamics and Signaling, NCI","Thomas  Sebastian



Nancy C Martin



Sook  Lee



Barbara L Shankle



Carlton J Briggs



Radek  Malik



Show all 9","Richard  Schwartz
(Department of Microbiology and Molecular Genetics, Michigan State University)




Robert  Smart
(Department of Environmental and Molecular Toxicology, North Carolina State University)","Jonathan  Keller; PhD (National Cancer Institute)



Maria  Miller (National Cancer Institute)



Alexander  Wlodawer; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Mantena SR, Kannan A, Cheon YP, Li Q, Johnson PF, Bagchi IC, Bagchi MK (2006). C/EBPbeta is a critical mediator of steroid hormone-regulated cell proliferation and differentiation in the uterine epithelium and stroma. Proc Natl Acad Sci U S A  103, 1870-5.   https://doi.org/10.1073/pnas.0507261103




PubMed



        
     
Free Article


 


PubMed ID 16439483
         Pubmed Central ID 1413629 


 



2.
Sebastian T, Johnson PF (2006). Stop and go: anti-proliferative and mitogenic functions of the transcription factor C/EBPbeta. Cell Cycle  5, 953-7.   https://doi.org/10.4161/cc.5.9.2733




PubMed


 


PubMed ID 16687924
    
     


 



3.
Suh HC, Gooya J, Renn K, Friedman AD, Johnson PF, Keller JR (2006). C/EBPalpha determines hematopoietic cell fate in multipotential progenitor cells by inhibiting erythroid differentiation and inducing myeloid differentiation. Blood  107, 4308-16.   https://doi.org/10.1182/blood-2005-06-2216




PubMed



        
     
Free Article


 


PubMed ID 16469877
         Pubmed Central ID 1895788",https://intramural.nih.gov/search/searchview.taf?ipid=43743
168,BC010329-07,"October 01, 2005 -  September 30, 2006",Regulation of Ras-Dependent Signal Transduction Pathways,"Deborah K Morrison



IRP Faculty Profile",NULL,"Laboratory of Cell and Developmental Signaling, NCI","Michele Kathleen Dougherty



Carolyn B McGill



Junghwa  Lim



Melissa M Mckay","Kun-Ping  Lu
(Cancer Biology Program, Harvard Medical School)




J.  Sweatt
(Department of Neurobiology, Univerisity of Alabama at Birmingham)",NULL,NULL,"Ordered by publication type and then author name.



1.
Morrison D   (2006) Ras and the Raf-MEK-ERK Cascade, in Ras GTPases. Der C, ed., Kluwer Academic Publishers (Norwell), in press.




 



2.
Ritt DA, Daar IO, Morrison DK (2006). KSR regulation of the Raf-MEK-ERK cascade. Methods Enzymol  407, 224-37.   https://doi.org/10.1016/S0076-6879(05)07019-9




PubMed


 


PubMed ID 16757327
    
     


 



3.
Shalin SC, Hernandez CM, Dougherty MK, Morrison DK, Sweatt JD (2006). Kinase suppressor of Ras1 compartmentalizes hippocampal signal transduction and subserves synaptic plasticity and memory formation. Neuron  50, 765-79.   https://doi.org/10.1016/j.neuron.2006.04.029




PubMed


 


PubMed ID 16731514",https://intramural.nih.gov/search/searchview.taf?ipid=43744
169,BC010331-07,"October 01, 2005 -  September 30, 2006",Phospholipid and Sphingolipid Signaling in Drosophila,"Jairaj K Acharya; MBBS, PhD



IRP Faculty Profile",NULL,"Laboratory of Cell and Developmental Signaling, NCI","Chang-Qing  Yuan



Pralhada Rao  Raghavendra



Nicholas Benjamin Daar



Lindsey Meredith Draper",NULL,"Lino  Tessarollo (National Cancer Institute)



Shyam K Sharan (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Acharya U, Edwards MB, Jorquera RA, Silva H, Nagashima K, Labarca P, Acharya JK (2006). Drosophila melanogaster Scramblases modulate synaptic transmission. J Cell Biol  173, 69-82.   https://doi.org/10.1083/jcb.200506159




PubMed



        
     
Free Article


 


PubMed ID 16606691
         Pubmed Central ID 2063791",https://intramural.nih.gov/search/searchview.taf?ipid=43745
170,BC010333-07,"October 01, 2005 -  September 30, 2006",The Segregation of Bacterial Chromosomes to Daughter Cells,"Stuart J Austin



IRP Faculty Profile",NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Therese G Brendler; BS, PhD



Lucretia D Reaves



Brenda L Youngren



Alena V Dabrazhynetskaya



Manjistha  Sengupta",NULL,Donald L Court; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Austin S, Youngren B, Ottesen J, Hansen F   (2006) The Escherichia coli chromosome is organized with each chromosome arm in separate cell halves.  Molecular Microbiology, in press.




 



2.
Camara JE, Breier AM, Brendler T, Austin S, Cozzarelli NR, Crooke E (2005). Hda inactivation of DnaA is the predominant mechanism preventing hyperinitiation of Escherichia coli DNA replication. EMBO Rep  6, 736-41.   https://doi.org/10.1038/sj.embor.7400467




PubMed



        
     
Free Article


 


PubMed ID 16041320
         Pubmed Central ID 1369143 


 



3.
Nielsen HJ, Li Y, Youngren B, Hansen FG, Austin S (2006). Progressive segregation of the Escherichia coli chromosome. Mol Microbiol  61, 383-93.   https://doi.org/10.1111/j.1365-2958.2006.05245.x




PubMed


 


PubMed ID 16771843",https://intramural.nih.gov/search/searchview.taf?ipid=43746
171,BC010334-07,"October 01, 2005 -  September 30, 2006",Posttranscriptional control of gene expression,"Barbara K Felber



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Jenifer L Bear



Andrei S Zolotukhin



Irina V Tretyakova","George  Panayotou
(Molecular Oncology, Alexander Fleming Biomedicine Sciences Research Center)




Friedrich  Propst
(Molecular Cell Biology, University of Austria)




Gordon  Ruthel
(USAMRI)




Ralf  Schneider
(GSF-National Research Center for Environment and Health)","Neal G Copeland; PhD (National Cancer Institute)



Nancy  Jenkins-Copeland; PhD (National Cancer Institute)



George N Pavlakis; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Lindtner S, Zolotukhin AS, Uranishi H, Bear J, Kulkarni V, Smulevitch S, Samiotaki M, Panayotou G, Felber BK, Pavlakis GN (2006). RNA-binding motif protein 15 binds to the RNA transport element RTE and provides a direct link to the NXF1 export pathway. J Biol Chem  281, 36915-28.   https://doi.org/10.1074/jbc.M608745200




PubMed


 


PubMed ID 17001072
    
     


 



2.
Smulevitch S, Bear J, Alicea C, Rosati M, Jalah R, Zolotukhin AS, von Gegerfelt A, Michalowski D, Moroni C, Pavlakis GN, Felber BK (2006). RTE and CTE mRNA export elements synergistically increase expression of unstable, Rev-dependent HIV and SIV mRNAs. Retrovirology  3, 6.   https://doi.org/10.1186/1742-4690-3-6




PubMed



        
     
Free Article


 


PubMed ID 16412225
         Pubmed Central ID 1363727 


 



3.
Smulevitch S, Michalowski D, Zolotukhin AS, Schneider R, Bear J, Roth P, Pavlakis GN, Felber BK (2005). Structural and functional analysis of the RNA transport element, a member of an extensive family present in the mouse genome. J Virol  79, 2356-65.   https://doi.org/10.1128/JVI.79.4.2356-2365.2005




PubMed



        
     
Free Article


 


PubMed ID 15681436
         Pubmed Central ID 546579 


 



4.
Tretyakova I, Zolotukhin AS, Tan W, Bear J, Propst F, Ruthel G, Felber BK (2005). Nuclear export factor family protein participates in cytoplasmic mRNA trafficking. J Biol Chem  280, 31981-90.   https://doi.org/10.1074/jbc.M502736200




PubMed


 


PubMed ID 16014633",https://intramural.nih.gov/search/searchview.taf?ipid=43747
172,BC010336-07,"October 01, 2005 -  September 30, 2006",Genetic Networks and Red-mediated Recombination,"Donald L Court; PhD



IRP Faculty Profile",NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Nina C Costantino



Lynn C Thomason



James A Sawitzke



Teresa L Baker



Simanti  Datta



Hanna  Wierzchoslawska","Gloria  Culver
(Biochemistry, biophysics, and Molecular Biology, Iowa State University)




David  Friedman
(Microbiology and Immunology, University of Michigan School of Medicine)




Max  Gottesman
(Institute of Cancer Research, Columbia University)




Kenon  Murphy
(Molecular Genetics and Microbiology, University of Massachusetts Med. School)




Amos  Oppenheim





Joel  Stavans
(Physics of Complex Systems, Weizmann Institute of Science)","Neal G Copeland; PhD (National Cancer Institute)



Mikhail V Kashlev (National Cancer Institute)



Sankar  Adhya; PhD (National Cancer Institute)



Ding Jun Jin (National Cancer Institute)



Xinhua  Ji; PhD (National Cancer Institute)



David S Waugh; PhD (Protein Engineering Section)",Nancy L Jenkins (CC),"Ordered by publication type and then author name.



1.
Court D   (2006) Regulation of Gene Expression by Transcription Termination and Antitermination, in The Bacteriophages. Oxford University Press (New York), pp. 83-103.




 



2.
Bubunenko M, Korepanov A, Court DL, Jagannathan I, Dickinson D, Chaudhuri BR, Garber MB, Culver GM (2006). 30S ribosomal subunits can be assembled in vivo without primary binding ribosomal protein S15. RNA  12, 1229-39.   https://doi.org/10.1261/rna.2262106




PubMed



        
     
Free Article


 


PubMed ID 16682557
         Pubmed Central ID 1484426 


 



3.
Datta S, Costantino N, Court DL (2006). A set of recombineering plasmids for gram-negative bacteria. Gene  379, 109-15.   https://doi.org/10.1016/j.gene.2006.04.018




PubMed


 


PubMed ID 16750601
    
     


 



4.
Gan J, Tropea JE, Austin BP, Court DL, Waugh DS, Ji X (2005). Intermediate states of ribonuclease III in complex with double-stranded RNA. Structure  13, 1435-42.   https://doi.org/10.1016/j.str.2005.06.014




PubMed


 


PubMed ID 16216575
    
     


 



5.
Gan J, Tropea JE, Austin BP, Court DL, Waugh DS, Ji X (2006). Structural insight into the mechanism of double-stranded RNA processing by ribonuclease III. Cell  124, 355-66.   https://doi.org/10.1016/j.cell.2005.11.034




PubMed


 


PubMed ID 16439209
    
     


 



6.
Kobiler O, Rokney A, Friedman N, Court DL, Stavans J, Oppenheim AB (2005). Quantitative kinetic analysis of the bacteriophage lambda genetic network. Proc Natl Acad Sci U S A  102, 4470-5.   https://doi.org/10.1073/pnas.0500670102




PubMed



        
     
Free Article


 


PubMed ID 15728384
         Pubmed Central ID 549295 


 



7.
Oppenheim AB, Kobiler O, Stavans J, Court DL, Adhya S (2005). Switches in bacteriophage lambda development. Annu Rev Genet  39, 409-29.   https://doi.org/10.1146/annurev.genet.39.073003.113656




PubMed


 


PubMed ID 16285866
    
     


 



8.
Svenningsen SL, Costantino N, Court DL, Adhya S (2005). On the role of Cro in lambda prophage induction. Proc Natl Acad Sci U S A  102, 4465-9.   https://doi.org/10.1073/pnas.0409839102




PubMed



        
     
Free Article


 


PubMed ID 15728734
         Pubmed Central ID 555511",https://intramural.nih.gov/search/searchview.taf?ipid=43748
173,BC010337-07,"October 01, 2005 -  September 30, 2006",Identifying Protein Factors and Pathways Leading to the Active Chromatin State,"Mikhail V Kashlev



IRP Faculty Profile",NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Maria L Kireeva



Lucyna E Lubkowska



Yuri  Purtov","Brad  Cairns
(Oncological Sciences, University of Utah School of Medicine)




Tim  Formosa
(Department of Biochemistry and Molecular Biology, University of Utah School of Medicine)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43749
174,BC010338-07,"October 01, 2005 -  September 30, 2006",The Role of Fgf Signaling in Vertebrate Development,"Mark B Lewandoski



IRP Faculty Profile",NULL,"Cancer and Developmental Biology Laboratory, NCI","Catherine P Wilson



Samuel T Waters



Cindy  Elder



Nakisha D Moore","Gregg  Duester
(Department of OncoDevelopmental Biology, Burnham Institute)




Martyn  Goulding
(Molecular Neurobiology Laborator, Salk Institute)","Terence P Yamaguchi; PhD (National Cancer Institute)



Alan O Perantoni; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Lewandoski M, Jun Liao J, Bondarev A, Schimmang T, Locker J, Shanske A, Campione M, Morrow B   (2006) Dissection of Tbx1 and Fgf interactions in mouse models of 22q11DS suggests functional redundancy.  Hum Mol Genet, in press.




 



2.
Perantoni AO, Timofeeva O, Naillat F, Richman C, Pajni-Underwood S, Wilson C, Vainio S, Dove LF, Lewandoski M (2005). Inactivation of FGF8 in early mesoderm reveals an essential role in kidney development. Development  132, 3859-71.   https://doi.org/10.1242/dev.01945




PubMed


 


PubMed ID 16049111
    
     


 



3.
Waters ST, Lewandoski M (2006). A threshold requirement for Gbx2 levels in hindbrain development. Development  133, 1991-2000.   https://doi.org/10.1242/dev.02364




PubMed


 


PubMed ID 16651541",https://intramural.nih.gov/search/searchview.taf?ipid=43750
175,BC010339-07,"October 01, 2005 -  September 30, 2006",The Role of Rx in the Adult Retina,"Mark B Lewandoski



IRP Faculty Profile",NULL,"Cancer and Developmental Biology Laboratory, NCI","Catherine P Wilson



Cindy  Elder",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43751
176,BC010340-07,"October 01, 2005 -  September 30, 2006",Ty Element Retrotransposition in Saccharomyces cerevisiae,David J. Garfinkel; PhD,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Sharon P Moore



Karen Marie Stefanisko



Arun  Dakshinamurthy



Emiko  Matsuda



Mary Ann  Checkley",NULL,Dwight V Nissley (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Garfinkel DJ (2005). Genome evolution mediated by Ty elements in Saccharomyces. Cytogenet Genome Res  110, 63-9.   https://doi.org/10.1159/000084939




PubMed


 


PubMed ID 16093659
    
     


 



2.
Nissley DV, Halvas EK, Hoppman NL, Garfinkel DJ, Mellors JW, Strathern JN (2005). Sensitive phenotypic detection of minor drug-resistant human immunodeficiency virus type 1 reverse transcriptase variants. J Clin Microbiol  43, 5696-704.   https://doi.org/10.1128/JCM.43.11.5696-5704.2005




PubMed



        
     
Free Article


 


PubMed ID 16272507
         Pubmed Central ID 1287775",https://intramural.nih.gov/search/searchview.taf?ipid=43752
177,BC010341-07,"October 01, 2005 -  September 30, 2006",Protein Expression and Purification in the Fast Lane,"David S Waugh; PhD



IRP Faculty Profile",NULL,"Macromolecular Crystallography Laboratory, NCI","Sreedevi  Nallamsetty



Brian P Austin



Di  Zhang",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Nallamsetty S, Austin BP, Penrose KJ, Waugh DS (2005). Gateway vectors for the production of combinatorially-tagged His6-MBP fusion proteins in the cytoplasm and periplasm of Escherichia coli. Protein Sci  14, 2964-71.   https://doi.org/10.1110/ps.051718605




PubMed



        
     
Free Article


 


PubMed ID 16322578
         Pubmed Central ID 2253240 


 



2.
Nallamsetty S, Waugh DS (2006). Solubility-enhancing proteins MBP and NusA play a passive role in the folding of their fusion partners. Protein Expr Purif  45, 175-82.   https://doi.org/10.1016/j.pep.2005.06.012




PubMed


 


PubMed ID 16168669
    
     


 



3.
Nallamsetty S, Waugh DS (2007). Mutations that alter the equilibrium between open and closed conformations of Escherichia coli maltose-binding protein impede its ability to enhance the solubility of passenger proteins. Biochem Biophys Res Commun  364, 639-44.   https://doi.org/10.1016/j.bbrc.2007.10.060




PubMed



        
     
Free Article


 


PubMed ID 17964542
         Pubmed Central ID 2129132",https://intramural.nih.gov/search/searchview.taf?ipid=43753
178,BC010342-07,"October 01, 2005 -  September 30, 2006",Structural Proteomics of the Yersinia Yop Virulon,"David S Waugh; PhD



IRP Faculty Profile",NULL,"Macromolecular Crystallography Laboratory, NCI","Brian P Austin



George T Lountos



Ping  Sun



Di  Zhang","Gregory  Plano; PhD
(Microbiology and Immunology, University of Miami School of Medicine)




Robert  Ulrich
(Molecular Immunology, USAMRIID)",Terrence R Burke; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Lee K, Boovanahalli SK, Nam KY, Kang SU, Lee M, Phan J, Wu L, Waugh DS, Zhang ZY, No KT, Lee JJ, Burke TR (2005). Synthesis of tripeptides as potent Yersinia protein tyrosine phosphatase inhibitors. Bioorg Med Chem Lett  15, 4037-42.   https://doi.org/10.1016/j.bmcl.2005.06.027




PubMed


 


PubMed ID 16039123
    
     


 



2.
Phan J, Austin BP, Waugh DS (2005). Crystal structure of the Yersinia type III secretion protein YscE. Protein Sci  14, 2759-63.   https://doi.org/10.1110/ps.051706105




PubMed



        
     
Free Article


 


PubMed ID 16195558
         Pubmed Central ID 2253283",https://intramural.nih.gov/search/searchview.taf?ipid=43754
179,BC010345-07,"October 01, 2005 -  September 30, 2006",The Role of Wnt Genes in Vertebrate Development and Cancer,"Terence P Yamaguchi; PhD



IRP Faculty Profile",NULL,"Cancer and Developmental Biology Laboratory, NCI","Kristin K Biris



Jaime  Greear



William C Dunty",NULL,"Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43756
180,BC010346-07,"October 01, 2005 -  September 30, 2006",Structural Biology of Proteins Involved in Signal Transduction and Regulation of,"Robert Andrew Byrd



IRP Faculty Profile",NULL,"Structural Biophysics Laboratory, NCI","Amanda S Altieri; PhD



Jess R Li



Robert L Mcfeeters



Hana  Krizova



Ranabir  Das



Walter C Thompson",NULL,"Allan M Weissman; MD (National Cancer Institute)



Barry R O'Keefe (National Cancer Institute)



Donald L Court; PhD (National Cancer Institute)



Donald P Bottaro; PhD (National Cancer Institute)



David S Waugh; PhD (Protein Engineering Section)",John J Kuszewski; PhD (CIT),"Ordered by publication type and then author name.



1.
Hamel DJ, Zhou H, Starich MR, Byrd RA, Dahlquist FW (2006). Chemical-shift-perturbation mapping of the phosphotransfer and catalytic domain interaction in the histidine autokinase CheA from Thermotoga maritima. Biochemistry  45, 9509-17.   https://doi.org/10.1021/bi060798k




PubMed


 


PubMed ID 16878985
    
     


 



2.
Xiong C, O'Keefe BR, Byrd RA, McMahon JB (2006). Potent anti-HIV activity of scytovirin domain 1 peptide. Peptides  27, 1668-75.   https://doi.org/10.1016/j.peptides.2006.03.018




PubMed


 


PubMed ID 16647158",https://intramural.nih.gov/search/searchview.taf?ipid=43757
181,BC010347-07,"October 01, 2005 -  September 30, 2006",Design of Drugs Against Cancer and Viral Diseases,Christopher J Michejda; PhD,NULL,"Structural Biophysics Laboratory, NCI","Nadya I Tarasova; PhD



Teresa  Kosakowska Cholo



David W Farnsworth



Susan  Keay



Marilyn B Kroeger-Smith



Elwood  Labrosse



Show all 9","Edward  Arnold
(BIOCHEMISTRY, Rutgers University)




Brian  Carr
(SURGERY, University of Pittsburgh)




William  Jorgensen
(CHEMISTRY, Yale University)




Susan  Keay





Anne  Monks
(STB, SAIC-Frederick)




Veenstra  Timothy
(RTP, SAIC-Frederick)","Stuart F J Le Grice; PhD (National Cancer Institute)



Stephen H Hughes; PhD (National Cancer Institute)



Michael Marc Gottesman; MD (Laboratory of Cell Biology)



Michael  Dean; PhD (National Cancer Institute)



Melinda  Hollingshead (National Cancer Institute)



Xinhua  Ji; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Cholody WM, Kosakowska-Cholody T, Hollingshead MG, Hariprakasha HK, Michejda CJ (2005). A new synthetic agent with potent but selective cytotoxic activity against cancer. J Med Chem  48, 4474-81.   https://doi.org/10.1021/jm048946x




PubMed


 


PubMed ID 15974599
    
     


 



2.
Michejda C, Dyba M, Kosakowska-Cholody T, Tarasova N   (2006) Synthesis and biological activity of 5-aza-ellipticine derivatives.  Bioorganic and Medicinal Chemistry Letters, in press.




 



3.
Michejda C, Tocci G, Hood B, Zhang C, Guo L, Koch K, Veenstra T, Keay S   (2006) CKAP4/p63 is a cell membrane receptor for a frizzled-8 protein-related antiproliferative factor from interstitial cystitis patients.  J. Biol. Chem, in press.




 



4.
Michejda C, Wang M, Yao W, Carr B   (2006) PM-20, a novel inhibitor of Cdc25A, induces ERK1/2 phosphorylation and inhibits tumor growth in vitro and in vivo.  Mol. Cancer Ther.  1511-1519 pp.




 



5.
Morningstar ML, Roth T, Farnsworth D, Kroeger-Smith M, Watson K, Buckheit, Jr. R, Das K, Zhang W, Arnold E, Hughes S, Michejda C   (2007) Synthesis, biological activity, and crystal structure of potent non-nucleoside inhibitors of HIV-1 reverse transcriptase that retain activity against mutant forms of the enzyme.  J Med Chem, in press.




 



6.
Tarasova NI, Seth R, Tarasov SG, Kosakowska-Cholody T, Hrycyna CA, Gottesman MM, Michejda CJ (2005). Transmembrane inhibitors of P-glycoprotein, an ABC transporter. J Med Chem  48, 3768-75.   https://doi.org/10.1021/jm049065t




PubMed


 


PubMed ID 15916428
    
     


 



7.
Tarasova NI, Dyba MI, Michejda CI (submitted in 2006) Azonafide Derived Tumor And Cancer Targeting Compounds. Patents issued: 8,008,316 (US in 2011); 2069308 (FR in 2017); 2069308 (GB in 2017); 2069308 (DE in 2017); 2069308 (EP in 2017). Patent pending: PCT/US2007/078233 (PC application).




 



8.
Tarasova NI, Michejda CI, Tarasov SI (submitted in 2006) Self-assembling Nanoparticles Composed Of Transmembrane Peptides And Their Application For Specific Intra-tumor Delivery Of Anti-cancer Drugs. Patents issued: 2009/03125 (SA in 2010); 576769 (NZ in 2012); 152018 (SG in 2012); 9,326,950 (US in 2016). Patents pending: 200780045937.9 (CN application); 07868671.4 (EP application); 2947/DELNP/2009 (IN application); 2009-535502 (JP application); PCT/US2007/083772 (PC application); 2007316416 (AU application); 2668638 (CA application).",https://intramural.nih.gov/search/searchview.taf?ipid=43758
182,BC010348-07,"October 01, 2005 -  September 30, 2006",Protein Structure,"Alexander  Wlodawer; PhD



IRP Faculty Profile",NULL,"Macromolecular Crystallography Laboratory, NCI","Alla E Gustchina



Alexander S Zdanov



Natasza Ewa Ziolkowska



Tinoush  Moulaei","Ben  Dunn
(Biochem. & Mol. Biol., University of Florida)




Hong  Guo; PhD





Mariusz  Jaskolski





Toru  Nakayama
(Biomolecular Engineering, Tohoku University)




Kohei  Oda
(Dept. Applied Biology, Kyoto Inst. of Technology)","Nancy H Colburn; PhD (National Cancer Institute)



Barry R O'Keefe (National Cancer Institute)



Zbigniew  Dauter (National Cancer Institute)",Maria E Miller (CIT),"Ordered by publication type and then author name.



1.
Botos I, Wlodawer A (2007). The expanding diversity of serine hydrolases. Curr Opin Struct Biol  17, 683-90.   https://doi.org/10.1016/j.sbi.2007.08.003




PubMed



        
     
Free Article


 


PubMed ID 17890078
         Pubmed Central ID 2173878 


 



2.
Guo H, Wlodawer A, Guo H (2005). A general acid-base mechanism for the stabilization of a tetrahedral adduct in a serine-carboxyl peptidase: a computational study. J Am Chem Soc  127, 15662-3.   https://doi.org/10.1021/ja0520565




PubMed


 


PubMed ID 16277482
    
     


 



3.
Guo H, Wlodawer A, Nakayama T, Xu Q, Guo H (2006). Catalytic role of proton transfers in the formation of a tetrahedral adduct in a serine carboxyl peptidase. Biochemistry  45, 9129-37.   https://doi.org/10.1021/bi060461i




PubMed


 


PubMed ID 16866358
    
     


 



4.
Gustchina A, Jaskólski M, Wlodawer A (2006). Lessons learned fighting HIV can be applied to anti-cancer drug design. Cell Cycle  5, 463-4.   https://doi.org/10.4161/cc.5.5.2490




PubMed


 


PubMed ID 16479175
    
     


 



5.
Jaskólski M, Li M, Laco G, Gustchina A, Wlodawer A (2006). Molecular replacement with pseudosymmetry and model dissimilarity: a case study. Acta Crystallogr D Biol Crystallogr  62, 208-15.   https://doi.org/10.1107/S0907444905040655




PubMed


 


PubMed ID 16421452
    
     


 



6.
LaRonde-LeBlanc N, Wlodawer A (2005). A family portrait of the RIO kinases. J Biol Chem  280, 37297-300.   https://doi.org/10.1074/jbc.R500013200




PubMed


 


PubMed ID 16183636
    
     


 



7.
LaRonde-LeBlanc N, Wlodawer A (2005). The RIO kinases: an atypical protein kinase family required for ribosome biogenesis and cell cycle progression. Biochim Biophys Acta  1754, 14-24.   https://doi.org/10.1016/j.bbapap.2005.07.037




PubMed


 


PubMed ID 16182620
    
     


 



8.
Li M, Laco GS, Jaskolski M, Rozycki J, Alexandratos J, Wlodawer A, Gustchina A (2005). Crystal structure of human T cell leukemia virus protease, a novel target for anticancer drug design. Proc Natl Acad Sci U S A  102, 18332-7.   https://doi.org/10.1073/pnas.0509335102




PubMed



        
     
Free Article


 


PubMed ID 16352712
         Pubmed Central ID 1317974 


 



9.
Li M, Rasulova F, Melnikov EE, Rotanova TV, Gustchina A, Maurizi MR, Wlodawer A (2005). Crystal structure of the N-terminal domain of E. coli Lon protease. Protein Sci  14, 2895-900.   https://doi.org/10.1110/ps.051736805




PubMed



        
     
Free Article


 


PubMed ID 16199667
         Pubmed Central ID 2253230 


 



10.
Okubo A, Li M, Ashida M, Oyama H, Gustchina A, Oda K, Dunn BM, Wlodawer A, Nakayama T (2006). Processing, catalytic activity and crystal structures of kumamolisin-As with an engineered active site. FEBS J  273, 2563-76.   https://doi.org/10.1111/j.1742-4658.2006.05266.x




PubMed


 


PubMed ID 16704427
    
     


 



11.
Oyama H, Fujisawa T, Suzuki T, Dunn BM, Wlodawer A, Oda K (2005). Catalytic residues and substrate specificity of recombinant human tripeptidyl peptidase I (CLN2). J Biochem  138, 127-34.   https://doi.org/10.1093/jb/mvi110




PubMed


 


PubMed ID 16091586
    
     


 



12.
Prasanna MD, Vondrasek J, Wlodawer A, Rodriguez H, Bhat TN (2006). Chemical compound navigator: a web-based chem-BLAST, chemical taxonomy-based search engine for browsing compounds. Proteins  63, 907-17.   https://doi.org/10.1002/prot.20914




PubMed


 


PubMed ID 16508960
    
     


 



13.
Rotanova TV, Botos I, Melnikov EE, Rasulova F, Gustchina A, Maurizi MR, Wlodawer A (2006). Slicing a protease: structural features of the ATP-dependent Lon proteases gleaned from investigations of isolated domains. Protein Sci  15, 1815-28.   https://doi.org/10.1110/ps.052069306




PubMed



        
     
Free Article


 


PubMed ID 16877706
         Pubmed Central ID 2242575 


 



14.
Snásel J, Krejcík Z, Jencová V, Rosenberg I, Ruml T, Alexandratos J, Gustchina A, Pichová I (2005). Integrase of Mason-Pfizer monkey virus. FEBS J  272, 203-16.   https://doi.org/10.1111/j.1432-1033.2004.04386.x




PubMed


 


PubMed ID 15634344
    
     


 



15.
Wünschmann S, Gustchina A, Chapman MD, Pomés A (2005). Cockroach allergen Bla g 2: an unusual aspartic proteinase. J Allergy Clin Immunol  116, 140-5.   https://doi.org/10.1016/j.jaci.2005.04.024




PubMed


 


PubMed ID 15990787
    
     


 



16.
Wlodawer A (2005). Giving credit where credit is due. Nat Struct Mol Biol  12, 634; discussion 634.   https://doi.org/10.1038/nsmb0805-634a




PubMed


 


PubMed ID 16077721
    
     


 



17.
Xiong C, O'Keefe BR, Botos I, Wlodawer A, McMahon JB (2006). Overexpression and purification of scytovirin, a potent, novel anti-HIV protein from the cultured cyanobacterium Scytonema varium. Protein Expr Purif  46, 233-9.   https://doi.org/10.1016/j.pep.2005.09.019




PubMed


 


PubMed ID 16289703
    
     


 



18.
Xu Q, Guo H, Wlodawer A, Guo H (2006). The importance of dynamics in substrate-assisted catalysis and specificity. J Am Chem Soc  128, 5994-5.   https://doi.org/10.1021/ja058831y




PubMed



        
     
Free Article


 


PubMed ID 16669642
         Pubmed Central ID 2530918 


 



19.
Zdanov A   (2006) Membrane-bound receptors of the interleukin-10 family of cytokines.  Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry  207-214 pp.




 



20.
Ziółkowska NE, O'Keefe BR, Mori T, Zhu C, Giomarelli B, Vojdani F, Palmer KE, McMahon JB, Wlodawer A (2006). Domain-swapped structure of the potent antiviral protein griffithsin and its mode of carbohydrate binding. Structure  14, 1127-35.   https://doi.org/10.1016/j.str.2006.05.017




PubMed


 


PubMed ID 16843894",https://intramural.nih.gov/search/searchview.taf?ipid=43759
183,BC010349-07,"October 01, 2005 -  September 30, 2006",Genomic Imprinting in Development and Disease,Colin L Stewart; PhD,NULL,"Cancer and Developmental Biology Laboratory, NCI","Serguei V Kozlov



Leonid  Belayev",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43760
184,BC010350-07,"October 01, 2005 -  September 30, 2006",Prevention of AIDS,"Barbara K Felber



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Jenifer L Bear



Candido  Alicea; PhD



Rashmi  Jalah



Viraj M Kulkarni","J. Thomas  August
(Molecular Biology and Genetics Department, Johns Hopkins University School of Medicine)




Ronald  Desrosiers
(New England Primate Research Center)




Michael F Egan; MD
(NIMH)




John  Eldridge
(Wyeth Lederle Vaccines)




Zimra  Israel
(Wyeth Lederle Vaccines)




R. Paul  Johnson
(New England Primate Research Center)


Show all 12","Antonio L Valentin (National Cancer Institute)



George N Pavlakis; MD, PhD (National Cancer Institute)



Genoveffa  Franchini; MD (National Cancer Institute)



Marjorie  Robert-Guroff; PhD (National Cancer Institute)",David C Montefiori; PhD (NIAID),"Ordered by publication type and then author name.



1.
Egan MA, Megati S, Roopchand V, Garcia-Hand D, Luckay A, Chong SY, Rosati M, Sackitey S, Weiner DB, Felber BK, Pavlakis GN, Israel ZR, Eldridge JH, Sidhu MK (2006). Rational design of a plasmid DNA vaccine capable of eliciting cell-mediated immune responses to multiple HIV antigens in mice. Vaccine  24, 4510-23.   https://doi.org/10.1016/j.vaccine.2005.08.024




PubMed


 


PubMed ID 16140439
    
     


 



2.
Hel Z, Tsai WP, Tryniszewska E, Nacsa J, Markham PD, Lewis MG, Pavlakis GN, Felber BK, Tartaglia J, Franchini G (2006). Improved vaccine protection from simian AIDS by the addition of nonstructural simian immunodeficiency virus genes. J Immunol  176, 85-96.   https://doi.org/10.4049/jimmunol.176.1.85




PubMed


 


PubMed ID 16365399
    
     


 



3.
Kaur A, Sanford HB, Garry D, Lang S, Klumpp SA, Watanabe D, Bronson RT, Lifson JD, Rosati M, Pavlakis GN, Felber BK, Knipe DM, Desrosiers RC (2007). Ability of herpes simplex virus vectors to boost immune responses to DNA vectors and to protect against challenge by simian immunodeficiency virus. Virology  357, 199-214.   https://doi.org/10.1016/j.virol.2006.08.007




PubMed



        
     
Free Article


 


PubMed ID 16962628
         Pubmed Central ID 1819472 


 



4.
Kumar S, Yan J, Muthumani K, Ramanathan MP, Yoon H, Pavlakis GN, Felber BK, Sidhu M, Boyer JD, Weiner DB (2006). Immunogenicity testing of a novel engineered HIV-1 envelope gp140 DNA vaccine construct. DNA Cell Biol  25, 383-92.   https://doi.org/10.1089/dna.2006.25.383




PubMed


 


PubMed ID 16848679
    
     


 



5.
Schadeck EB, Sidhu M, Egan MA, Chong SY, Piacente P, Masood A, Garcia-Hand D, Cappello S, Roopchand V, Megati S, Quiroz J, Boyer JD, Felber BK, Pavlakis GN, Weiner DB, Eldridge JH, Israel ZR (2006). A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIVgag-plasmid DNA vaccine in rhesus macaques. Vaccine  24, 4677-87.   https://doi.org/10.1016/j.vaccine.2005.10.035




PubMed


 


PubMed ID 16288822
    
     


 



6.
von Gegerfelt AS, Alicea C, Valentin A, Morrow M, van Rompay KK, Ayash-Rashkovsky M, Markham P, Else JG, Marthas ML, Pavlakis GN, Ruprecht RM, Felber BK (2006). Long lasting control and lack of pathogenicity of the attenuated Rev-independent SIV in rhesus macaques. AIDS Res Hum Retroviruses  22, 516-28.   https://doi.org/10.1089/aid.2006.22.516




PubMed


 


PubMed ID 16796527
    
     


 



7.
Watanabe D, Brockman MA, Ndung'u T, Mathews L, Lucas WT, Murphy CG, Felber BK, Pavlakis GN, Deluca NA, Knipe DM (2007). Properties of a herpes simplex virus multiple immediate-early gene-deleted recombinant as a vaccine vector. Virology  357, 186-98.   https://doi.org/10.1016/j.virol.2006.08.015




PubMed


 


PubMed ID 16996101",https://intramural.nih.gov/search/searchview.taf?ipid=43761
185,BC010376-07,"October 01, 2005 -  September 30, 2006",Leukemia Inhibitory Factor and Embryo Development,Colin L Stewart; PhD,NULL,"Cancer and Developmental Biology Laboratory, NCI","Tatiana Vilenskaya Cohen



Jianbo  Hu",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Ishibashi T, Dakin KA, Stevens B, Lee PR, Kozlov SV, Stewart CL, Fields RD (2006). Astrocytes promote myelination in response to electrical impulses. Neuron  49, 823-32.   https://doi.org/10.1016/j.neuron.2006.02.006




PubMed



        
     
Free Article


 


PubMed ID 16543131
         Pubmed Central ID 1474838 


 



2.
Makishima T, Rodriguez CI, Robertson NG, Morton CC, Stewart CL, Griffith AJ (2005). Targeted disruption of mouse Coch provides functional evidence that DFNA9 hearing loss is not a COCH haploinsufficiency disorder. Hum Genet  118, 29-34.   https://doi.org/10.1007/s00439-005-0001-4




PubMed


 


PubMed ID 16078052
    
     


 



3.
Rodriguez CI, Stewart CL (2007). Disruption of the ubiquitin ligase HERC4 causes defects in spermatozoon maturation and impaired fertility. Dev Biol  312, 501-8.   https://doi.org/10.1016/j.ydbio.2007.09.053




PubMed


 


PubMed ID 17967448",https://intramural.nih.gov/search/searchview.taf?ipid=43762
186,BC010377-07,"October 01, 2005 -  September 30, 2006","The Nuclear Envelope in Development, Disease and Ageing",Colin L Stewart; PhD,NULL,"Cancer and Developmental Biology Laboratory, NCI","Lidia F Hernandez



Serguei V Kozlov



Tatiana Vilenskaya Cohen



Leonid  Belayev



Ourania  Kosti","Brian  Burke
(Cell Biology, University of Florida)




Roland  Foisner
(Medical Biochemistry, Medical University of Vienna)




Didier  Hodzic
(Cell Biology and Physiology, Washington University School of Medicine)




Eric  Hoffman
(Research Center for Genetic Medicine, Children's National Medical Center)




Jan  Lammerding
(Cardiovascular Division, Harvard Medical School)




Richard  Lee
(Cardiovascular Division, Brigham and Womens Hospital Harvard)


Show all 8",NULL,NULL,"Ordered by publication type and then author name.



1.
Boguslavsky RL, Stewart CL, Worman HJ (2006). Nuclear lamin A inhibits adipocyte differentiation: implications for Dunnigan-type familial partial lipodystrophy. Hum Mol Genet  15, 653-63.   https://doi.org/10.1093/hmg/ddi480




PubMed


 


PubMed ID 16415042
    
     


 



2.
Burke B, Stewart CL (2006). The laminopathies: the functional architecture of the nucleus and its contribution to disease. Annu Rev Genomics Hum Genet  7, 369-405.   https://doi.org/10.1146/annurev.genom.7.080505.115732




PubMed


 


PubMed ID 16824021
    
     


 



3.
Fong LG, Ng JK, Lammerding J, Vickers TA, Meta M, Coté N, Gavino B, Qiao X, Chang SY, Young SR, Yang SH, Stewart CL, Lee RT, Bennett CF, Bergo MO, Young SG (2006). Prelamin A and lamin A appear to be dispensable in the nuclear lamina. J Clin Invest  116, 743-52.   https://doi.org/10.1172/JCI27125




PubMed



        
     
Free Article


 


PubMed ID 16511604
         Pubmed Central ID 1386109 


 



4.
Lammerding J, Fong LG, Ji JY, Reue K, Stewart CL, Young SG, Lee RT (2006). Lamins A and C but not lamin B1 regulate nuclear mechanics. J Biol Chem  281, 25768-80.   https://doi.org/10.1074/jbc.M513511200




PubMed


 


PubMed ID 16825190
    
     


 



5.
Melcon G, Kozlov S, Cutler DA, Sullivan T, Hernandez L, Zhao P, Mitchell S, Nader G, Bakay M, Rottman JN, Hoffman EP, Stewart CL (2006). Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and MyoD pathways during muscle regeneration. Hum Mol Genet  15, 637-51.   https://doi.org/10.1093/hmg/ddi479




PubMed


 


PubMed ID 16403804
    
     


 



6.
Ostlund C, Sullivan T, Stewart CL, Worman HJ (2006). Dependence of diffusional mobility of integral inner nuclear membrane proteins on A-type lamins. Biochemistry  45, 1374-82.   https://doi.org/10.1021/bi052156n




PubMed



        
     
Free Article


 


PubMed ID 16445279
         Pubmed Central ID 2527696",https://intramural.nih.gov/search/searchview.taf?ipid=43763
187,BC010378-07,"October 01, 2005 -  September 30, 2006",Macromolecular Crystallography Research with Synchrotron Radiation,"Zbigniew  Dauter



IRP Faculty Profile",NULL,"Macromolecular Crystallography Laboratory, NCI","John  Cobuzzi



Sergei V Pletnev



Robert P Jedrzejczak



Elzbieta  Nowak



Jiawei  Wang","Zygmunt  Derewenda
(Dept. of Molecular Physiology and Biophysics, University of Virginia)




Andrzej  Joachimiak
(Biosciences, Argonne Natl. Lab.)




Jozef  Kur
(Microbiology, University of Technology)




Wladek  Minor





Zbyszek  Otwinowski
(Biomedical Sciences, Southwestern Medical School)




Piotr  Stepien
(Genetics, University of Warsaw)",Alexander  Wlodawer; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Bielnicki J, Devedjiev Y, Derewenda U, Dauter Z, Joachimiak A, Derewenda ZS (2006). B. subtilis ykuD protein at 2.0 A resolution: insights into the structure and function of a novel, ubiquitous family of bacterial enzymes. Proteins  62, 144-51.   https://doi.org/10.1002/prot.20702




PubMed



        
     
Free Article


 


PubMed ID 16287140
         Pubmed Central ID 2792008 


 



2.
Dauter Z (2006). Current state and prospects of macromolecular crystallography. Acta Crystallogr D Biol Crystallogr  62, 1-11.   https://doi.org/10.1107/S0907444905034050




PubMed


 


PubMed ID 16369088
    
     


 



3.
Dauter Z (2006). Estimation of anomalous signal in diffraction data. Acta Crystallogr D Biol Crystallogr  62, 867-76.   https://doi.org/10.1107/S0907444906023481




PubMed


 


PubMed ID 16855302
    
     


 



4.
Dauter Z, Dauter Z, Gayathri D, Banumathi B, Yamane T, Sekar K   (2006) Ab initio structure determination of the triple mutant (k53,56,121M) of bovine pancreatic phospholipase A2 at atomic and high resolution using ACORN.  Current Science  1091-1099 pp.




 



5.
Jedrzejczak R, Dauter Z, Dauter M, Piatek R, Zalewska B, Mróz M, Bury K, Nowicki B, Kur J (2006). Structure of DraD invasin from uropathogenic Escherichia coli: a dimer with swapped beta-tails. Acta Crystallogr D Biol Crystallogr  62, 157-64.   https://doi.org/10.1107/S0907444905036747




PubMed


 


PubMed ID 16421447
    
     


 



6.
Liu Y, Cheney MD, Gaudet JJ, Chruszcz M, Lukasik SM, Sugiyama D, Lary J, Cole J, Dauter Z, Minor W, Speck NA, Bushweller JH (2006). The tetramer structure of the Nervy homology two domain, NHR2, is critical for AML1/ETO's activity. Cancer Cell  9, 249-60.   https://doi.org/10.1016/j.ccr.2006.03.012




PubMed


 


PubMed ID 16616331
    
     


 



7.
Ramagopal UA, Dauter Z, Thirumuruhan R, Fedorov E, Almo SC (2005). Radiation-induced site-specific damage of mercury derivatives: phasing and implications. Acta Crystallogr D Biol Crystallogr  61, 1289-98.   https://doi.org/10.1107/S0907444905022316




PubMed


 


PubMed ID 16131763
    
     


 



8.
Sekar K, Yogavel M, Gayathri D, Velmurugan D, Krishna R, Poi MJ, Dauter Z, Dauter M, Tsai MD (2006). Atomic resolution structure of the double mutant (K53,56M) of bovine pancreatic phospholipase A2. Acta Crystallogr Sect F Struct Biol Cryst Commun  62, 1-5.   https://doi.org/10.1107/S1744309105040984




PubMed



        
     
Free Article


 


PubMed ID 16511247
         Pubmed Central ID 2150930 


 



9.
Sekar K, Yogavel M, Kanaujia SP, Sharma A, Velmurugan D, Poi MJ, Dauter Z, Tsai MD (2006). Suggestive evidence for the involvement of the second calcium and surface loop in interfacial binding: monoclinic and trigonal crystal structures of a quadruple mutant of phospholipase A2. Acta Crystallogr D Biol Crystallogr  62, 717-24.   https://doi.org/10.1107/S0907444906014855




PubMed


 


PubMed ID 16790927",https://intramural.nih.gov/search/searchview.taf?ipid=43764
188,BC010379-07,"October 01, 2005 -  September 30, 2006",Search for the Structural Basis of Biomacromolecular Function and Activity,Yun  Wang,NULL,"Nucleic Acid NMR Section, NCI",Donghan  Lee,"Susan  Krueger
(NIST Center for Neutron Research, National Institute of Standards and Technology)




Dudley  Strickland; PhD
(American Red Cross)",NULL,NULL,"Ordered by publication type and then author name.



1.
Lee D, Walsh JD, Mikhailenko I, Yu P, Migliorini M, Wu Y, Krueger S, Curtis JE, Harris B, Lockett S, Blacklow SC, Strickland DK, Wang YX (2006). RAP uses a histidine switch to regulate its interaction with LRP in the ER and Golgi. Mol Cell  22, 423-30.   https://doi.org/10.1016/j.molcel.2006.04.011




PubMed


 


PubMed ID 16678114
    
     


 



2.
Wang Y, Lee D, Yu P, Migliorini M, Strickland D   (2006) NMR assignment of domain 2 of the receptor-associated protein.  J. Biomol. NMR, in press.




 



3.
Wang Y, Walsh J, Yu P, Migliorini M, Wu Y, Strickland D   (2006) NMR assignment of domain 3 of the receptor-associated protein (RAP).  J. Biomol. NMR, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=43765
189,BC010380-07,"October 01, 2005 -  September 30, 2006",Recombination and Regulation,Jeffrey N Strathern,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Alison J Rattray



Brenda K Shafer



Deanna R Gotte



Gustavo S Santoyo Pizano



Jordan D Irvin",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43766
190,BC010381-07,"October 01, 2005 -  September 30, 2006",Studies on Silencing,Amar J S Klar; PhD,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Gurjeet  Singh



Michael J Bonaduce",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43767
191,BC010382-07,"October 01, 2005 -  September 30, 2006",Chemotherapy Adjuvants,Robert C Moschel; PhD,NULL,"Laboratory of Comparative Carcinogenesis, NCI","Gary T Pauly



Sahar  Javanmard



Magdalena Katarzyna Krajewska



Jason A Lagona



Xiaojin  Li","Henry  Friedman
(Oncology, Duke University Medical Center)




Anthony  Pegg
(Department of Physiology, Penn State College of Medicine)","Melinda  Hollingshead (National Cancer Institute)



Michael  Alley (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Fishel ML, Gamcsik MP, Delaney SM, Zuhowski EG, Maher VM, Karrison T, Moschel RC, Egorin MJ, Dolan ME (2005). Role of glutathione and nucleotide excision repair in modulation of cisplatin activity with O6-benzylguanine. Cancer Chemother Pharmacol  55, 333-342.   https://doi.org/10.1007/s00280-004-0901-3




PubMed


 


PubMed ID 15723259
    
     


 



2.
Fishel ML, Newell DR, Griffin RJ, Davison R, Wang LZ, Curtin NJ, Zuhowski EG, Kasza K, Egorin MJ, Moschel RC, Dolan ME (2005). Effect of cell cycle inhibition on Cisplatin-induced cytotoxicity. J Pharmacol Exp Ther  312, 206-13.   https://doi.org/10.1124/jpet.104.073924




PubMed


 


PubMed ID 15304523
    
     


 



3.
Fishel ML, Rabik CA, Bleibel WK, Li X, Moschel RC, Dolan ME (2006). Role of GADD34 in modulation of cisplatin cytotoxicity. Biochem Pharmacol  71, 239-47.   https://doi.org/10.1016/j.bcp.2005.10.039




PubMed


 


PubMed ID 16325149
    
     


 



4.
Wei G, Loktionova NA, Pegg AE, Moschel RC (2005). Beta-glucuronidase-cleavable prodrugs of O6-benzylguanine and O6-benzyl-2'-deoxyguanosine. J Med Chem  48, 256-61.   https://doi.org/10.1021/jm0493865




PubMed


 


PubMed ID 15634019",https://intramural.nih.gov/search/searchview.taf?ipid=43768
192,BC010385-07,"October 01, 2005 -  September 30, 2006",Studies on mat1 Imprinting,Amar J S Klar; PhD,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",Gurjeet  Singh,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43769
193,BC010386-07,"October 01, 2005 -  September 30, 2006",Human Handedness Psychosis Etiology Studies,Amar J S Klar; PhD,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Gurjeet  Singh



Deepak  Sidhu",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Armakolas A, Klar AJ (2006). Cell type regulates selective segregation of mouse chromosome 7 DNA strands in mitosis. Science  311, 1146-9.   https://doi.org/10.1126/science.1120519




PubMed


 


PubMed ID 16497932
    
     


 



2.
Klar A   (2006) Response to Comment on Cell Type Regulates Selective Segregation of Mouse Chromosome 7 DNA Strands in Mitosis.  Science  1045c pp.",https://intramural.nih.gov/search/searchview.taf?ipid=43770
194,BC010387-07,"October 01, 2005 -  September 30, 2006",Functional Analysis of Breast Cancer Susceptibility Genes in Mice,"Shyam K Sharan



IRP Faculty Profile",NULL,"Mouse Cancer Genetics Program, NCI","Sergey  Kuznetsov



Subha  Philip



Kajal  Biswas



Suhwan  Chang",NULL,Andre A Nussenzweig; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43771
195,BC010390-07,"October 01, 2005 -  September 30, 2006",Role of Neurotrophins and Their Receptors in the Development of the Mammalian Ne,"Lino  Tessarollo



IRP Faculty Profile",NULL,"Mouse Cancer Genetics Program, NCI","Vincenzo  Coppola



Mary Ellen  Palko



Paola  Caprari



Sudhirkumar U Yanpallewar



Jodi L Becker",NULL,"Paul A Randazzo; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Dorsey SG, Renn CL, Carim-Todd L, Barrick CA, Bambrick L, Krueger BK, Ward CW, Tessarollo L (2006). In vivo restoration of physiological levels of truncated TrkB.T1 receptor rescues neuronal cell death in a trisomic mouse model. Neuron  51, 21-8.   https://doi.org/10.1016/j.neuron.2006.06.009




PubMed


 


PubMed ID 16815329
    
     


 



2.
Esteban PF, Yoon HY, Becker J, Dorsey SG, Caprari P, Palko ME, Coppola V, Saragovi HU, Randazzo PA, Tessarollo L (2006). A kinase-deficient TrkC receptor isoform activates Arf6-Rac1 signaling through the scaffold protein tamalin. J Cell Biol  173, 291-9.   https://doi.org/10.1083/jcb.200512013




PubMed



        
     
Free Article


 


PubMed ID 16636148
         Pubmed Central ID 2063819 


 



3.
Garcia-Fresco GP, Sousa AD, Pillai AM, Moy SS, Crawley JN, Tessarollo L, Dupree JL, Bhat MA (2006). Disruption of axo-glial junctions causes cytoskeletal disorganization and degeneration of Purkinje neuron axons. Proc Natl Acad Sci U S A  103, 5137-42.   https://doi.org/10.1073/pnas.0601082103




PubMed



        
     
Free Article


 


PubMed ID 16551741
         Pubmed Central ID 1405910",https://intramural.nih.gov/search/searchview.taf?ipid=43772
196,BC010391-07,"October 01, 2005 -  September 30, 2006",Role of Trk receptors in the development and function of non-neuronal structures,"Lino  Tessarollo



IRP Faculty Profile",NULL,"Mouse Cancer Genetics Program, NCI","Vincenzo  Coppola



Mary Ellen  Palko



Paola  Caprari



Jodi L Becker",NULL,"Paul A Randazzo; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Coppola V, Barrick CA, Bobisse S, Rodriguez-Galan MC, Pivetta M, Reynolds D, Howard OM, Palko ME, Esteban PF, Young HA, Rosato A, Tessarollo L (2006). The scaffold protein Cybr is required for cytokine-modulated trafficking of leukocytes in vivo. Mol Cell Biol  26, 5249-58.   https://doi.org/10.1128/MCB.02473-05




PubMed



        
     
Free Article


 


PubMed ID 16809763
         Pubmed Central ID 1592701 


 



2.
Esteban PF, Yoon HY, Becker J, Dorsey SG, Caprari P, Palko ME, Coppola V, Saragovi HU, Randazzo PA, Tessarollo L (2006). A kinase-deficient TrkC receptor isoform activates Arf6-Rac1 signaling through the scaffold protein tamalin. J Cell Biol  173, 291-9.   https://doi.org/10.1083/jcb.200512013




PubMed



        
     
Free Article


 


PubMed ID 16636148
         Pubmed Central ID 2063819",https://intramural.nih.gov/search/searchview.taf?ipid=43773
197,BC010411-07,"October 01, 2005 -  September 30, 2006",Initiation of DNA replication in Mammalian Cells,"Mirit I Aladjem; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Chiimei (Cindy) L Tseng



Tsutomu  Shimura



Melvenia  Martin",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Feng YQ, Desprat R, Fu H, Olivier E, Lin CM, Lobell A, Gowda SN, Aladjem MI, Bouhassira EE (2006). DNA methylation supports intrinsic epigenetic memory in mammalian cells. PLoS Genet  2, e65.   https://doi.org/10.1371/journal.pgen.0020065




PubMed



        
     
Free Article


 


PubMed ID 16683039
         Pubmed Central ID 1449906 


 



2.
Feng YQ, Warin R, Li T, Olivier E, Besse A, Lobell A, Fu H, Lin CM, Aladjem MI, Bouhassira EE (2005). The human beta-globin locus control region can silence as well as activate gene expression. Mol Cell Biol  25, 3864-74.   https://doi.org/10.1128/MCB.25.10.3864-3874.2005




PubMed



        
     
Free Article


 


PubMed ID 15870261
         Pubmed Central ID 1087713 


 



3.
Fu H, Wang L, Lin CM, Singhania S, Bouhassira EE, Aladjem MI (2006). Preventing gene silencing with human replicators. Nat Biotechnol  24, 572-6.   https://doi.org/10.1038/nbt1202




PubMed


 


PubMed ID 16604060
    
     


 



4.
Wang J, Liu H, Lin CM, Aladjem MI, Epner EM (2005). Targeted deletion of the chicken beta-globin regulatory elements reveals a cooperative gene silencing activity. J Biol Chem  280, 23340-8.   https://doi.org/10.1074/jbc.M501161200




PubMed


 


PubMed ID 15824098
    
     


 



5.
Wang L, Lin CM, Lopreiato JO, Aladjem MI (2006). Cooperative sequence modules determine replication initiation sites at the human beta-globin locus. Hum Mol Genet  15, 2613-22.   https://doi.org/10.1093/hmg/ddl187




PubMed


 


PubMed ID 16877501",https://intramural.nih.gov/search/searchview.taf?ipid=43779
198,BC010412-07,"October 01, 2005 -  September 30, 2006",Structural Analysis of Macromolecular Complexes by Electron Microscopy,Jacqueline L Milne,NULL,"Laboratory of Cell Biology, NCI","Mario J Borgnia; PhD



Dan  Shi



Paul  Youn",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43780
199,BC010413-06,"October 01, 2005 -  September 30, 2006",Comparative Analysis of Cancer-Associated Genes and Development of a Gene Delive,"Vladimir L Larionov; PhD, DSc",Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI","Natalay  Kouprina



Vladimir  Noskov; PhD



Hiroshi  Masumoto","William  Earnshaw
(Laboratory of Cell Biology, Wellcome Trust Centre for Cell Biology)




Mitsuo  Oshimura
(Graduate Program, Tottori University)",Richard J Hodes; MD (Immune Regulation Section),NULL,"Ordered by publication type and then author name.



1.
Kim J, Ebersole T, Larionov V (submitted in 2006) Gamma Satellite Insulator Sequences And Their Use In Preventing Gene Silencing. Patent issued: 9,018,011 (US in 2015). Patent pending: PCT/US2008/054170 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=43556
200,BC010418-07,"October 01, 2005 -  September 30, 2006",Signaling events regulating chemotaxis,Carole A Parent; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI","Frank I Comer



Paul W Kriebel



Dana C Mahadeo



Anna  Bagorda



Mirkka Maarit Janka-junttila",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Bagorda A, Mihaylov VA, Parent CA (2006). Chemotaxis: moving forward and holding on to the past. Thromb Haemost  95, 12-21.




PubMed


 


PubMed ID 16543956
    
     


 



2.
Mahadeo DC, Parent CA (2006). Signal relay during the life cycle of Dictyostelium. Curr Top Dev Biol  73, 115-40.   https://doi.org/10.1016/S0070-2153(05)73004-0




PubMed


 


PubMed ID 16782457",https://intramural.nih.gov/search/searchview.taf?ipid=43782
201,BC010419-07,"October 01, 2005 -  September 30, 2006",Molecular Mechanisms of TGF-beta Signaling Pathway,"Ying  Zhang



IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI","Mary E Heller



Yu-an  Yang



Motozo  Yamashita



Caroline  Millet



Chaoyang  Jin","Chu-Xia  Deng
(NIDDK)
















Zhigang  He
(Program in Neurobiology, Children's Hospital Boston, Harvard Medical School)




Emmanuel  Lemichez
(Faculté de Médecine de Nice, INSERM U627)




Lianping  Xing
(Department of Pathology, University of Rochester)",NULL,NULL,"Ordered by publication type and then author name.



1.
Boyer L, Turchi L, Desnues B, Doye A, Ponzio G, Mege JL, Yamashita M, Zhang YE, Bertoglio J, Flatau G, Boquet P, Lemichez E (2006). CNF1-induced ubiquitylation and proteasome destruction of activated RhoA is impaired in Smurf1-/- cells. Mol Biol Cell  17, 2489-97.   https://doi.org/10.1091/mbc.e05-09-0876




PubMed



        
     
Free Article


 


PubMed ID 16540523
         Pubmed Central ID 1474842 


 



2.
Kaneki H, Guo R, Chen D, Yao Z, Schwarz EM, Zhang YE, Boyce BF, Xing L (2006). Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts. J Biol Chem  281, 4326-33.   https://doi.org/10.1074/jbc.M509430200




PubMed



        
     
Free Article


 


PubMed ID 16373342
         Pubmed Central ID 2647592 


 



3.
Yang YA, Zhang GM, Feigenbaum L, Zhang YE (2006). Smad3 reduces susceptibility to hepatocarcinoma by sensitizing hepatocytes to apoptosis through downregulation of Bcl-2. Cancer Cell  9, 445-57.   https://doi.org/10.1016/j.ccr.2006.04.025




PubMed



        
     
Free Article


 


PubMed ID 16766264
         Pubmed Central ID 2708973",https://intramural.nih.gov/search/searchview.taf?ipid=43783
202,BC010425-07,"October 01, 2005 -  September 30, 2006",Human T-Cell Responses to Tumor Antigens,"Jeffrey  Schlom; PhD



IRP Faculty Profile",NULL,"Laboratory of Tumor Immunology and Biology, NCI","Marjorie P Duberstein



Diane J Poole



Nirmolini D Soares



Kwong Yok Tsang



Helen B Sabzevari



Sixun  Yang



Show all 13","Kenneth  Foon
(Hematology-Oncology, University of Pittsburgh Cancer Institute)




Andrei  Kozlov
(biology, The Biomedical Center/St. Petersburg University)




Ronald  Levy
(Division of Oncology, Stanford University School of Medicine)




John  Yannelli
(Microbiology and Immunology, University of Kentucky--Markey Cancer Center)","Ira H Pastan; MD (National Cancer Institute)



Vladimir L Larionov; PhD, DSc (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Tsang KY, Palena C, Yokokawa J, Arlen PM, Gulley JL, Mazzara GP, Gritz L, Yafal AG, Ogueta S, Greenhalgh P, Manson K, Panicali D, Schlom J (2005). Analyses of recombinant vaccinia and fowlpox vaccine vectors expressing transgenes for two human tumor antigens and three human costimulatory molecules. Clin Cancer Res  11, 1597-607.   https://doi.org/10.1158/1078-0432.CCR-04-1609




PubMed


 


PubMed ID 15746065
    
     


 



2.
Yang S, Tsang KY, Schlom J (2005). Induction of higher-avidity human CTLs by vector-mediated enhanced costimulation of antigen-presenting cells. Clin Cancer Res  11, 5603-15.   https://doi.org/10.1158/1078-0432.CCR-05-0670




PubMed



        
     
Free Article


 


PubMed ID 16061879
         Pubmed Central ID 1351007",https://intramural.nih.gov/search/searchview.taf?ipid=43785
203,BC010435-06,"October 01, 2005 -  September 30, 2006",Developmental Therapeutics,Sandra M Swain; MD,NULL,"Medical Oncology Branch, NCI","Diana A Nguyen



Arlene Wendy Berman



Neelima  Denduluri



Margarita R Velarde; CRNP



Chia  Portera",NULL,"Stephen M Hewitt; MD, PhD (National Cancer Institute)



Seth M Steinberg; PhD (Biostatistics and Data Management Section)



Stanley  Lipkowitz; MD, PhD (National Cancer Institute)



Antonio  Fojo; MD, PhD (National Cancer Institute)",Douglas R Rosing; MD (NHLBI),"Ordered by publication type and then author name.



1.
Denduluri N, Lee JJ, Walshe J, Berman AW, Vatas U, Chow CK, Steinberg SM, Cox MC, Low JA, Swain SM (2007). Phase II trial of ixabepilone, an epothilone B analog, given daily for three days every three weeks, in metastatic breast cancer. Invest New Drugs  25, 63-7.   https://doi.org/10.1007/s10637-006-9006-7




PubMed


 


PubMed ID 16933153
    
     


 



2.
Lee JJ, Low JA, Croarkin E, Parks R, Berman AW, Mannan N, Steinberg SM, Swain SM (2006). Changes in neurologic function tests may predict neurotoxicity caused by ixabepilone. J Clin Oncol  24, 2084-91.   https://doi.org/10.1200/JCO.2005.04.2820




PubMed


 


PubMed ID 16648510
    
     


 



3.
Swain S, Dan T   (2006) Emerging drugs to replace current leaders in first-line therapy for breast cancer.  Expert Opin Emerging Drugs  489-501 pp.




 



4.
Swain S, Low J, Lee J, Walshe J, Denduluri N, Berman A, Permenter M, Petros W, Price D, Figg W, Sparreboom A   (2006) Influence of garlic (allium sativum) on the pharmacokinetics of docetaxel.  Clinical Cancer Research  4636-40 pp.




 



5.
Walshe JM, Denduluri N, Berman AW, Rosing DR, Swain SM (2006). A phase II trial with trastuzumab and pertuzumab in patients with HER2-overexpressed locally advanced and metastatic breast cancer. Clin Breast Cancer  6, 535-9.   https://doi.org/10.3816/CBC.2006.n.009




PubMed


 


PubMed ID 16595039",https://intramural.nih.gov/search/searchview.taf?ipid=43790
204,BC010439-05,"October 01, 2005 -  September 30, 2006",Maryland Breast Cancer Case-Control Study,"Stefan  Ambs



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","Brenda Jean Boersma-Maland



Tiffany Marie Howe



Damali Nzinga Martin",NULL,"Stephen J Chanock; MD, PhD (National Cancer Institute)



David Anderson Wink (National Cancer Institute)



Kent W Hunter; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Boersma BJ, Howe TM, Goodman JE, Yfantis HG, Lee DH, Chanock SJ, Ambs S (2006). Association of breast cancer outcome with status of p53 and MDM2 SNP309. J Natl Cancer Inst  98, 911-9.   https://doi.org/10.1093/jnci/djj245




PubMed


 


PubMed ID 16818855",https://intramural.nih.gov/search/searchview.taf?ipid=43729
205,BC010440-05,"October 01, 2005 -  September 30, 2006","Protein Structure, Stability, and Amyloid Formation",Ruth  Nussinov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI","Gunasakaran  Kannan



Buyong  Ma



Yongping  Pan



Hyunbum  Jang



Jie  Zheng



Jin  Liu","Carlos  Aleman
(Engineering, Univ. Barcelona)




Carlos  Cativiela
(Chemistry, Univ. Zaragoza)




Antonio  del Sol
(Research & Development, Fujirebio Inc)




S.  Gnanakaran
(T10, Los Alamos national Laboratory)




Haim  Wolfson
(Computer Science Dept., Tel Aviv University)",NULL,NULL,"Ordered by publication type and then author name.



1.
Nussinov R, Nussinov R, Wolfson H (2006) Algorithms for multiple protein, in Protein structure prediction: methods and protocols. Zaki M, Bystroff C, eds, Humana, in press.




 



2.
Alemán C, Zanuy D, Jiménez AI, Cativiela C, Haspel N, Zheng J, Casanovas J, Wolfson H, Nussinov R (2006). Concepts and schemes for the re-engineering of physical protein modules: generating nanodevices via targeted replacements with constrained amino acids. Phys Biol  3, S54-62.   https://doi.org/10.1088/1478-3975/3/1/S06




PubMed


 


PubMed ID 16582465
    
     


 



3.
Haliloglu T, Keskin O, Ma B, Nussinov R (2005). How similar are protein folding and protein binding nuclei? Examination of vibrational motions of energy hot spots and conserved residues. Biophys J  88, 1552-9.   https://doi.org/10.1529/biophysj.104.051342




PubMed



        
     
Free Article


 


PubMed ID 15596504
         Pubmed Central ID 1305212 


 



4.
Haspel N, Zanuy D, Alemán C, Wolfson H, Nussinov R (2006). De novo tubular nanostructure design based on self-assembly of beta-helical protein motifs. Structure  14, 1137-48.   https://doi.org/10.1016/j.str.2006.05.016




PubMed


 


PubMed ID 16843895
    
     


 



5.
Ma B, Nussinov R (2006). The stability of monomeric intermediates controls amyloid formation: Abeta25-35 and its N27Q mutant. Biophys J  90, 3365-74.   https://doi.org/10.1529/biophysj.105.075309




PubMed



        
     
Free Article


 


PubMed ID 16500972
         Pubmed Central ID 1440722 


 



6.
Ma B, Pan Y, Gunasekaran K, Venkataraghavan RB, Levine AJ, Nussinov R (2005). Comparison of the protein-protein interfaces in the p53-DNA crystal structures: towards elucidation of the biological interface. Proc Natl Acad Sci U S A  102, 3988-93.   https://doi.org/10.1073/pnas.0500215102




PubMed



        
     
Free Article


 


PubMed ID 15738397
         Pubmed Central ID 554805 


 



7.
Nussinov R   (2006) Nanobiology: from physics and engineering to biology.  Physical Biology  1 pp.




 



8.
Nussinov R, Zanuy D, Aleman C   (2006) Identification of the intrinsic conformational properties of 1-aminocyclobutane-1-carboxylic acid.  Chemical Physics Letters  558-62 pp.




 



9.
Pan Y, Ma B, Levine AJ, Nussinov R (2006). Comparison of the human and worm p53 structures suggests a way for enhancing stability. Biochemistry  45, 3925-33.   https://doi.org/10.1021/bi052242n




PubMed


 


PubMed ID 16548519
    
     


 



10.
Tsai CJ, Nussinov R (2005). The implications of higher (or lower) success in secondary structure prediction of chain fragments. Protein Sci  14, 1943-4.   https://doi.org/10.1110/ps.051581805




PubMed



        
     
Free Article


 


PubMed ID 16046621
         Pubmed Central ID 2279305 


 



11.
Tsai CJ, Zheng J, Nussinov R (2006). Designing a nanotube using naturally occurring protein building blocks. PLoS Comput Biol  2, e42.   https://doi.org/10.1371/journal.pcbi.0020042




PubMed



        
     
Free Article


 


PubMed ID 16683021
         Pubmed Central ID 1447657 


 



12.
Tsai HH, Gunasekaran K, Nussinov R (2006). Sequence and structure analysis of parallel beta helices: implication for constructing amyloid structural models. Structure  14, 1059-72.   https://doi.org/10.1016/j.str.2006.03.015




PubMed


 


PubMed ID 16765899
    
     


 



13.
Wainreb G, Haspel N, Wolfson HJ, Nussinov R (2006). A permissive secondary structure-guided superposition tool for clustering of protein fragments toward protein structure prediction via fragment assembly. Bioinformatics  22, 1343-52.   https://doi.org/10.1093/bioinformatics/btl098




PubMed


 


PubMed ID 16543273
    
     


 



14.
Zanuy D, Gunasekaran K, Lesk AM, Nussinov R (2006). Computational study of the fibril organization of polyglutamine repeats reveals a common motif identified in beta-helices. J Mol Biol  358, 330-45.   https://doi.org/10.1016/j.jmb.2006.01.070




PubMed


 


PubMed ID 16503338
    
     


 



15.
Zanuy D, Nussinov R, Alemán C (2006). From peptide-based material science to protein fibrils: discipline convergence in nanobiology. Phys Biol  3, S80-90.   https://doi.org/10.1088/1478-3975/3/1/S08




PubMed


 


PubMed ID 16582467
    
     


 



16.
Zheng J, Ma B, Tsai CJ, Nussinov R (2006). Structural stability and dynamics of an amyloid-forming peptide GNNQQNY from the yeast prion sup-35. Biophys J  91, 824-33.   https://doi.org/10.1529/biophysj.106.083246




PubMed



        
     
Free Article


 


PubMed ID 16679374
         Pubmed Central ID 1563778",https://intramural.nih.gov/search/searchview.taf?ipid=43730
206,BC010441-05,"October 01, 2005 -  September 30, 2006",Biomolecular Recognition and Binding Mechanisms,Ruth  Nussinov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI","Gunasakaran  Kannan



Chung  Tsai



Hui-Hsu (Gavin)  Tsai



Buyong  Ma



Yongping  Pan



Hyunbum  Jang



Show all 7","Carlos  Aleman
(Engineering, Univ. Barcelona)




Carlos  Cativiela
(Chemistry, Univ. Zaragoza)




S.  Gnanakaran
(T10, Los Alamos national Laboratory)




Attila  Gursoy
(Computer Science Dept., Koc University)




Turkan  Haliloglu





Ozlem  Keskin
(College of Engineering, Koc University)


Show all 7",NULL,NULL,"Ordered by publication type and then author name.



1.
Alemán C, Zanuy D, Jiménez AI, Cativiela C, Haspel N, Zheng J, Casanovas J, Wolfson H, Nussinov R (2006). Concepts and schemes for the re-engineering of physical protein modules: generating nanodevices via targeted replacements with constrained amino acids. Phys Biol  3, S54-62.   https://doi.org/10.1088/1478-3975/3/1/S06




PubMed


 


PubMed ID 16582465
    
     


 



2.
Benyamini H, Gunasekaran K, Wolfson H, Nussinov R (2005). Fibril modelling by sequence and structure conservation analysis combined with protein docking techniques: beta(2)-microglobulin amyloidosis. Biochim Biophys Acta  1753, 121-30.   https://doi.org/10.1016/j.bbapap.2005.07.012




PubMed


 


PubMed ID 16107326
    
     


 



3.
Halperin I, Wolfson H, Nussinov R (2006). Correlated mutations: advances and limitations. A study on fusion proteins and on the Cohesin-Dockerin families. Proteins  63, 832-45.   https://doi.org/10.1002/prot.20933




PubMed


 


PubMed ID 16508975
    
     


 



4.
Haspel N, Zanuy D, Alemán C, Wolfson H, Nussinov R (2006). De novo tubular nanostructure design based on self-assembly of beta-helical protein motifs. Structure  14, 1137-48.   https://doi.org/10.1016/j.str.2006.05.016




PubMed


 


PubMed ID 16843895
    
     


 



5.
Haspel N, Zanuy D, Ma B, Wolfson H, Nussinov R (2005). A comparative study of amyloid fibril formation by residues 15-19 of the human calcitonin hormone: a single beta-sheet model with a small hydrophobic core. J Mol Biol  345, 1213-27.   https://doi.org/10.1016/j.jmb.2004.11.002




PubMed


 


PubMed ID 15644216
    
     


 



6.
Inbar Y, Benyamini H, Nussinov R, Wolfson HJ (2005). Combinatorial docking approach for structure prediction of large proteins and multi-molecular assemblies. Phys Biol  2, S156-65.   https://doi.org/10.1088/1478-3975/2/4/S10




PubMed


 


PubMed ID 16280621
    
     


 



7.
Inbar Y, Benyamini H, Nussinov R, Wolfson HJ (2005). Prediction of multimolecular assemblies by multiple docking. J Mol Biol  349, 435-47.   https://doi.org/10.1016/j.jmb.2005.03.039




PubMed


 


PubMed ID 15890207
    
     


 



8.
Inbar Y, Schneidman-Duhovny D, Halperin I, Oron A, Nussinov R, Wolfson HJ (2005). Approaching the CAPRI challenge with an efficient geometry-based docking. Proteins  60, 217-23.   https://doi.org/10.1002/prot.20561




PubMed


 


PubMed ID 15981251
    
     


 



9.
Keskin O, Ma B, Rogale K, Gunasekaran K, Nussinov R (2005). Protein-protein interactions: organization, cooperativity and mapping in a bottom-up Systems Biology approach. Phys Biol  2, S24-35.   https://doi.org/10.1088/1478-3975/2/2/S03




PubMed


 


PubMed ID 16204846
    
     


 



10.
Ma B, Pan Y, Gunasekaran K, Keskin O, Venkataraghavan RB, Levine AJ, Nussinov R (2005). The contribution of the Trp/Met/Phe residues to physical interactions of p53 with cellular proteins. Phys Biol  2, S56-66.   https://doi.org/10.1088/1478-3975/2/2/S06




PubMed


 


PubMed ID 16204849
    
     


 



11.
Mintz S, Shulman-Peleg A, Wolfson HJ, Nussinov R (2005). Generation and analysis of a protein-protein interface data set with similar chemical and spatial patterns of interactions. Proteins  61, 6-20.   https://doi.org/10.1002/prot.20580




PubMed


 


PubMed ID 16184518
    
     


 



12.
Ogmen U, Keskin O, Aytuna AS, Nussinov R, Gursoy A (2005). PRISM: protein interactions by structural matching. Nucleic Acids Res  33, W331-6.   https://doi.org/10.1093/nar/gki585




PubMed



        
     
Free Article


 


PubMed ID 15991339
         Pubmed Central ID 1160261 


 



13.
Pan Y, Ma B, Nussinov R (2005). CD4 binding partially locks the bridging sheet in gp120 but leaves the beta2/3 strands flexible. J Mol Biol  350, 514-27.   https://doi.org/10.1016/j.jmb.2005.05.009




PubMed


 


PubMed ID 15946678
    
     


 



14.
Schneidman-Duhovny D, Inbar Y, Nussinov R, Wolfson HJ (2005). Geometry-based flexible and symmetric protein docking. Proteins  60, 224-31.   https://doi.org/10.1002/prot.20562




PubMed


 


PubMed ID 15981269
    
     


 



15.
Schneidman-Duhovny D, Inbar Y, Nussinov R, Wolfson HJ (2005). PatchDock and SymmDock: servers for rigid and symmetric docking. Nucleic Acids Res  33, W363-7.   https://doi.org/10.1093/nar/gki481




PubMed



        
     
Free Article


 


PubMed ID 15980490
         Pubmed Central ID 1160241 


 



16.
Tsai CJ, Zheng J, Nussinov R (2006). Designing a nanotube using naturally occurring protein building blocks. PLoS Comput Biol  2, e42.   https://doi.org/10.1371/journal.pcbi.0020042




PubMed



        
     
Free Article


 


PubMed ID 16683021
         Pubmed Central ID 1447657 


 



17.
Tsai HH, Gunasekaran K, Nussinov R (2006). Sequence and structure analysis of parallel beta helices: implication for constructing amyloid structural models. Structure  14, 1059-72.   https://doi.org/10.1016/j.str.2006.03.015




PubMed


 


PubMed ID 16765899
    
     


 



18.
Wolfson HJ, Shatsky M, Schneidman-Duhovny D, Dror O, Shulman-Peleg A, Ma B, Nussinov R (2005). From structure to function: methods and applications. Curr Protein Pept Sci  6, 171-83.   https://doi.org/10.2174/1389203053545435




PubMed


 


PubMed ID 15853653
    
     


 



19.
Zanuy D, Nussinov R, Alemán C (2006). From peptide-based material science to protein fibrils: discipline convergence in nanobiology. Phys Biol  3, S80-90.   https://doi.org/10.1088/1478-3975/3/1/S08




PubMed


 


PubMed ID 16582467
    
     


 



20.
Zheng J, Ma B, Tsai CJ, Nussinov R (2006). Structural stability and dynamics of an amyloid-forming peptide GNNQQNY from the yeast prion sup-35. Biophys J  91, 824-33.   https://doi.org/10.1529/biophysj.106.083246




PubMed



        
     
Free Article


 


PubMed ID 16679374
         Pubmed Central ID 1563778",https://intramural.nih.gov/search/searchview.taf?ipid=43731
207,BC010442-05,"October 01, 2005 -  September 30, 2006",Method Development: Efficient Computer Vision Based Algorithms,Ruth  Nussinov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI","Chung  Tsai



Hui-Hsu (Gavin)  Tsai","Attila  Gursoy
(Computer Science Dept., Koc University)




Roded  Sharan
(Computer Science Dept., Tel Aviv University)




Haim  Wolfson
(Computer Science Dept., Tel Aviv University)",NULL,NULL,"Ordered by publication type and then author name.



1.
Nussinov R, Wolfson H   (2006) Algorithms for multiple protein, in Protein structure prediction: methods and protocols. Zaki x, Bystroff x, eds.,  Humana, in press.




 



2.
Dror O, Nussinov R, Wolfson H (2005). ARTS: alignment of RNA tertiary structures. Bioinformatics  21 Suppl 2, ii47-53.   https://doi.org/10.1093/bioinformatics/bti1108




PubMed


 


PubMed ID 16204124
    
     


 



3.
Dror O, Nussinov R, Wolfson HJ (2006). The ARTS web server for aligning RNA tertiary structures. Nucleic Acids Res  34, W412-5.   https://doi.org/10.1093/nar/gkl312




PubMed



        
     
Free Article


 


PubMed ID 16845038
         Pubmed Central ID 1538835 


 



4.
Inbar Y, Benyamini H, Nussinov R, Wolfson HJ (2005). Combinatorial docking approach for structure prediction of large proteins and multi-molecular assemblies. Phys Biol  2, S156-65.   https://doi.org/10.1088/1478-3975/2/4/S10




PubMed


 


PubMed ID 16280621
    
     


 



5.
Mintz S, Shulman-Peleg A, Wolfson HJ, Nussinov R (2005). Generation and analysis of a protein-protein interface data set with similar chemical and spatial patterns of interactions. Proteins  61, 6-20.   https://doi.org/10.1002/prot.20580




PubMed


 


PubMed ID 16184518
    
     


 



6.
Ogmen U, Keskin O, Aytuna AS, Nussinov R, Gursoy A (2005). PRISM: protein interactions by structural matching. Nucleic Acids Res  33, W331-6.   https://doi.org/10.1093/nar/gki585




PubMed



        
     
Free Article


 


PubMed ID 15991339
         Pubmed Central ID 1160261 


 



7.
Shatsky M, Nussinov R, Wolfson HJ (2006). Optimization of multiple-sequence alignment based on multiple-structure alignment. Proteins  62, 209-17.   https://doi.org/10.1002/prot.20665




PubMed


 


PubMed ID 16294339
    
     


 



8.
Shatsky M, Shulman-Peleg A, Nussinov R, Wolfson HJ (2006). The multiple common point set problem and its application to molecule binding pattern detection. J Comput Biol  13, 407-28.   https://doi.org/10.1089/cmb.2006.13.407




PubMed


 


PubMed ID 16597249
    
     


 



9.
Wainreb G, Haspel N, Wolfson HJ, Nussinov R (2006). A permissive secondary structure-guided superposition tool for clustering of protein fragments toward protein structure prediction via fragment assembly. Bioinformatics  22, 1343-52.   https://doi.org/10.1093/bioinformatics/btl098




PubMed


 


PubMed ID 16543273",https://intramural.nih.gov/search/searchview.taf?ipid=43736
208,BC010446-05,"October 01, 2005 -  September 30, 2006",DNA Double Strand Break Repair in Drosophila Melanogaster,Yikang  Rong,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI","Min  Gong



Xiao-Feng  Zheng



Xiaolin  Bi



Rui  Lin",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Bandyopadhyay PK, Clark K, Stevenson BJ, Rivier JE, Olivera BM, Golic KG, Rong YS (2006). Biochemical characterization of Drosophila gamma-glutamyl carboxylase and its role in fly development. Insect Mol Biol  15, 147-56.   https://doi.org/10.1111/j.1365-2583.2006.00619.x




PubMed


 


PubMed ID 16640725
    
     


 



2.
Bi X, Srikanta D, Fanti L, Pimpinelli S, Badugu R, Kellum R, Rong YS (2005). Drosophila ATM and ATR checkpoint kinases control partially redundant pathways for telomere maintenance. Proc Natl Acad Sci U S A  102, 15167-72.   https://doi.org/10.1073/pnas.0504981102




PubMed



        
     
Free Article


 


PubMed ID 16203987
         Pubmed Central ID 1257705",https://intramural.nih.gov/search/searchview.taf?ipid=43740
209,BC010447-04,"October 01, 2005 -  September 30, 2006",Cell Cycle and Cancer,"Sushil Gopal Rane; MS, PhD



IRP Faculty Profile",NULL,"Diabetes, Endocrinology, and Obesity Branch, NCI",NULL,NULL,NULL,"Wan  Jiao (NCI) 



Ji Hyeon  Lee (NCI) 



Huei-Min  Lin (NCI)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43557
210,BC010448-05,"October 01, 2005 -  September 30, 2006",Genetic Alterations in Lung Cancer,Jonathan S Wiest; PhD,NULL,"Laboratory of Cellular Carcinogenesis and Tumor Promotion, NCI","Zhihong  Shan



Jyotsna  Pandey",NULL,"Phillip A Dennis; MD, PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43791
211,BC010449-05,"October 01, 2005 -  September 30, 2006",Role of Uteroglobin-Related Protein (UGRP) 1 in Lung Inflammation,"Shioko  Kimura; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI","Reiko  Kurotani



Takeshi  Tomita",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Cheung C, Ma X, Krausz KW, Kimura S, Feigenbaum L, Dalton TP, Nebert DW, Idle JR, Gonzalez FJ (2005). Differential metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in mice humanized for CYP1A1 and CYP1A2. Chem Res Toxicol  18, 1471-8.   https://doi.org/10.1021/tx050136g




PubMed


 


PubMed ID 16167840
    
     


 



2.
Chiba Y, Kurotani R, Kusakabe T, Miura T, Link BW, Misawa M, Kimura S (2006). Uteroglobin-related protein 1 expression suppresses allergic airway inflammation in mice. Am J Respir Crit Care Med  173, 958-64.   https://doi.org/10.1164/rccm.200503-456OC




PubMed



        
     
Free Article


 


PubMed ID 16456148
         Pubmed Central ID 2582904 


 



3.
Niimi T, Kurotani R, Kimura S, Kitagawa Y (2006). Identification and expression of alternative splice variants of the mouse Ppp1r3b gene in lung epithelial cells. Biochem Biophys Res Commun  349, 588-96.   https://doi.org/10.1016/j.bbrc.2006.08.091




PubMed


 


PubMed ID 16949035
    
     


 



4.
Ueda R, Iketaki H, Nagata K, Kimura S, Gonzalez FJ, Kusano K, Yoshimura T, Yamazoe Y (2006). A common regulatory region functions bidirectionally in transcriptional activation of the human CYP1A1 and CYP1A2 genes. Mol Pharmacol  69, 1924-30.   https://doi.org/10.1124/mol.105.021220




PubMed


 


PubMed ID 16505155
    
     


 



5.
Yang Q, Kurotani R, Yamada A, Kimura S, Gonzalez FJ (2006). Peroxisome proliferator-activated receptor alpha activation during pregnancy severely impairs mammary lobuloalveolar development in mice. Endocrinology  147, 4772-80.   https://doi.org/10.1210/en.2006-0437




PubMed



        
     
Free Article


 


PubMed ID 16857745
         Pubmed Central ID 1570154 


 



6.
Yang Q, Yamada A, Kimura S, Peters JM, Gonzalez FJ (2006). Alterations in skin and stratified epithelia by constitutively activated PPARalpha. J Invest Dermatol  126, 374-85.   https://doi.org/10.1038/sj.jid.5700056




PubMed


 


PubMed ID 16374467
    
     


 



7.
Kimura S, Kurotani R (submitted in 2006) Therapeutic Use Of Scgb3a2. Patents issued: 8,133,859 (US in 2012); 8,501,688 (US in 2013); 8,828,936 (US in 2014). Patent pending: PCT/US2007/079771 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=43792
212,BC010450-05,"October 01, 2005 -  September 30, 2006",Development of Akt Inhibitors,"Phillip A Dennis; MD, PhD",NULL,"Medical Oncology Branch, NCI","Chunyu  Zhang



Joell J Gills",NULL,"Susan L Holbeck (National Cancer Institute)



Melinda  Hollingshead (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Carón RW, Yacoub A, Li M, Zhu X, Mitchell C, Hong Y, Hawkins W, Sasazuki T, Shirasawa S, Kozikowski AP, Dennis PA, Hagan MP, Grant S, Dent P (2005). Activated forms of H-RAS and K-RAS differentially regulate membrane association of PI3K, PDK-1, and AKT and the effect of therapeutic kinase inhibitors on cell survival. Mol Cancer Ther  4, 257-70.




PubMed


 


PubMed ID 15713897
    
     


 



2.
Gills JJ, Holbeck S, Hollingshead M, Hewitt SM, Kozikowski AP, Dennis PA (2006). Spectrum of activity and molecular correlates of response to phosphatidylinositol ether lipid analogues, novel lipid-based inhibitors of Akt. Mol Cancer Ther  5, 713-22.   https://doi.org/10.1158/1535-7163.MCT-05-0484




PubMed


 


PubMed ID 16546986
    
     


 



3.
Granville CA, Memmott RM, Gills JJ, Dennis PA (2006). Handicapping the race to develop inhibitors of the phosphoinositide 3-kinase/Akt/mammalian target of rapamycin pathway. Clin Cancer Res  12, 679-89.   https://doi.org/10.1158/1078-0432.CCR-05-1654




PubMed


 


PubMed ID 16467077",https://intramural.nih.gov/search/searchview.taf?ipid=43793
213,BC010451-05,"October 01, 2005 -  September 30, 2006",NMR Group Project: Preparation and Properties of Novel Multivalent Nanoparticles,"Joseph John Barchi



IRP Faculty Profile",NULL,"Laboratory of Medicinal Chemistry, NCI",Andreas  Sundgren,"Vladislav  Glinskii
(Biochemistry, University of Missouri)




Kate  Rittenhouse-Olson
(Biotechnical and Clinical Laboratory Science, University of Buffalo)",Robert  Blumenthal; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Svarovsky S, Barchi Jr J   (2006) De Novo Synthesis of Biofunctional Carbohydrate-Encapsulated Quantum Dots.  ACS Symposium Series: Frontiers in Carbohydrate Chemisrtry, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=43969
214,BC010453-05,"October 01, 2005 -  September 30, 2006",Identify SNPs and Polymorphisms Involved in the Development of Prostate Cancer,"William D Figg; PharmD



IRP Faculty Profile",NULL,"Medical Oncology Branch, NCI","Nicola F Smith



Cindy Huong-Bich Chau



Haiqing  Li



Akinobu  Hamada



Douglas K Price



Erika K Smith",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Ahlers CM, Figg WD (2006). ETS-TMPRSS2 fusion gene products in prostate cancer. Cancer Biol Ther  5, 254-5.   https://doi.org/10.4161/cbt.5.3.2603




PubMed


 


PubMed ID 16575200
    
     


 



2.
Best CJ, Gillespie JW, Yi Y, Chandramouli GV, Perlmutter MA, Gathright Y, Erickson HS, Georgevich L, Tangrea MA, Duray PH, González S, Velasco A, Linehan WM, Matusik RJ, Price DK, Figg WD, Emmert-Buck MR, Chuaqui RF (2005). Molecular alterations in primary prostate cancer after androgen ablation therapy. Clin Cancer Res  11, 6823-34.   https://doi.org/10.1158/1078-0432.CCR-05-0585




PubMed



        
     
Free Article


 


PubMed ID 16203770
         Pubmed Central ID 1432092 


 



3.
Chau CH, Figg WD (2005). Molecular and phenotypic heterogeneity of metastatic prostate cancer. Cancer Biol Ther  4, 166-7.   https://doi.org/10.4161/cbt.4.2.1571




PubMed


 


PubMed ID 15738648
    
     


 



4.
Figg W   (2006) Prostate Cancer Chemoprevention (letter).  Pharmacotherapy, in press.




 



5.
Hamada A, Danesi R, Price DK, Sissung T, Chau C, Venzon D, Sparreboom A, Dahut WL, Figg WD (2007). Association of a CYP17 polymorphism with overall survival in Caucasian patients with androgen-independent prostate cancer. Urology  70, 217-20.   https://doi.org/10.1016/j.urology.2007.06.1097




PubMed



        
     
Free Article


 


PubMed ID 17826473
         Pubmed Central ID 1994899 


 



6.
Singh AS, Chau CH, Price DK, Figg WD (2005). Mechanisms of disease: Polymorphisms of androgen regulatory genes in the development of prostate cancer. Nat Clin Pract Urol  2, 101-7.   https://doi.org/10.1038/ncpuro0091




PubMed


 


PubMed ID 16474655
    
     


 



7.
Sissung TM, Price DK, Sparreboom A, Figg WD (2006). Pharmacogenetics and regulation of human cytochrome P450 1B1: implications in hormone-mediated tumor metabolism and a novel target for therapeutic intervention. Mol Cancer Res  4, 135-50.   https://doi.org/10.1158/1541-7786.MCR-05-0101




PubMed


 


PubMed ID 16547151",https://intramural.nih.gov/search/searchview.taf?ipid=43794
215,BC010455-05,"October 01, 2005 -  September 30, 2006",The Role of Wnts in the Formation of the Vertebrate Body Plan,"Terence P Yamaguchi; PhD



IRP Faculty Profile",NULL,"Cancer and Developmental Biology Laboratory, NCI","Kristin K Biris



Jaime  Greear



William C Dunty



Rieko  Ajima



Ravindra Babu  Chalamalasetty","Ernest  Arenas
(CEDB, Karolinska Institute)




Raymond  Habas





Xi  He
(NCI)




Ryoichiro  Kageyama
(Institute for Virus Research, Kyoto University)




Kenro  Kusumi
(School of Life Sciences, Arizona State U.)




Sarah E. Millar; PhD
(University of Pennsylvania)


Show all 9",Mark B Lewandoski (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Nakaya MA, Biris K, Tsukiyama T, Jaime S, Rawls JA, Yamaguchi TP (2005). Wnt3a links left-right determination with segmentation and anteroposterior axis elongation. Development  132, 5425-36.   https://doi.org/10.1242/dev.02149




PubMed



        
     
Free Article


 


PubMed ID 16291790
         Pubmed Central ID 1389788",https://intramural.nih.gov/search/searchview.taf?ipid=43795
216,BC010459-05,"October 01, 2005 -  September 30, 2006",Gene Methylation in Prostate Cancer,Karen  Woodson,NULL,"Cancer Genetics Branch, NCI",NULL,"Mark  Lawler
(Molecular Medicine, St James Hospital, Trinity College)




Keith  O'Reilly





David  Ward
(Pathology, Madigan Army Medical Center)","Michael R Emmert-Buck; MD, PhD (National Cancer Institute)



Joseph A Tangrea (National Cancer Institute)



John W Gillespie (National Cancer Institute)



William Marston Linehan; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Grover AC, Tangrea MA, Woodson KG, Wallis BS, Hanson JC, Chuaqui RF, Gillespie JW, Erickson HS, Bonner RF, Pohida TJ, Emmert-Buck MR, Libutti SK (2006). Tumor-associated endothelial cells display GSTP1 and RARbeta2 promoter methylation in human prostate cancer. J Transl Med  4, 13.   https://doi.org/10.1186/1479-5876-4-13




PubMed



        
     
Free Article


 


PubMed ID 16512911
         Pubmed Central ID 1420331 


 



2.
Hanson JA, Gillespie JW, Grover A, Tangrea MA, Chuaqui RF, Emmert-Buck MR, Tangrea JA, Libutti SK, Linehan WM, Woodson KG (2006). Gene promoter methylation in prostate tumor-associated stromal cells. J Natl Cancer Inst  98, 255-61.   https://doi.org/10.1093/jnci/djj051




PubMed


 


PubMed ID 16478744
    
     


 



3.
Perry AS, Foley R, Woodson K, Lawler M (2006). The emerging roles of DNA methylation in the clinical management of prostate cancer. Endocr Relat Cancer  13, 357-77.   https://doi.org/10.1677/erc.1.01184




PubMed


 


PubMed ID 16728568",https://intramural.nih.gov/search/searchview.taf?ipid=43797
217,BC010465-03,"October 01, 2005 -  September 30, 2006",Protemics Bioinformatics Tools,Peter F Lemkin; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Gregory  Thornwall,"Gregory  Alvord
(Data Management Services)
















John  Cornell
(Center Epidemiology & Biostatistics, Univ. Texas Health Science Center)




Jai A Evans





Howard  Gutstein
(UT-MD Anderson Cancer Center)




Djamel None Medjahed





Arlan G Richardson



Show all 9",Scott E McNeil (Office Of The Director),"Mark A Knepper; PhD, MD (NHLBI) 



Donita  Garland; PhD (NEI)",There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=43541
218,BC010468-04,"October 01, 2005 -  September 30, 2006",The Role of Cytopathology in Biomedical Research,"Andrea  Abati; BS, MD",Elaine S Jaffe; MD,"Laboratory of Pathology, NCI","Armando  Filie



Keith R Brosky



Dana K Erickson



Patricia A Fetsch



Anna-Maria  Wilder",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Abati A, Greene MH, Filie A, Loud J, Prindiville S, Danforth D, Giusti RM (2006). Quantification of the cellular components of breast duct lavage samples. Diagn Cytopathol  34, 78-81.   https://doi.org/10.1002/dc.20371




PubMed


 


PubMed ID 16355383
    
     


 



2.
Fetsch PA, Simsir A, Abati A (2006). There may be ""madness in the methods,"" but the devil is in the details. Diagn Cytopathol  34, 590-3; author reply 594-5.   https://doi.org/10.1002/dc.20461




PubMed


 


PubMed ID 16850490
    
     


 



3.
Lindsey KR, Gritz L, Sherry R, Abati A, Fetsch PA, Goldfeder LC, Gonzales MI, Zinnack KA, Rogers-Freezer L, Haworth L, Mavroukakis SA, White DE, Steinberg SM, Restifo NP, Panicali DL, Rosenberg SA, Topalian SL (2006). Evaluation of prime/boost regimens using recombinant poxvirus/tyrosinase vaccines for the treatment of patients with metastatic melanoma. Clin Cancer Res  12, 2526-37.   https://doi.org/10.1158/1078-0432.CCR-05-2061




PubMed



        
     
Free Article


 


PubMed ID 16638862
         Pubmed Central ID 2151202 


 



4.
Schinstine M, Abati A, Tsokos M, Fox E, Filie AC (2006). Cytological identification of metastatic epithelial nephroblastoma in pleural fluid: report of a case and review of literature. Diagn Cytopathol  34, 621-5.   https://doi.org/10.1002/dc.20535




PubMed


 


PubMed ID 16900470
    
     


 



5.
Schinstine M, Filie AC, Wilson W, Stetler-Stevenson M, Abati A (2006). Detection of malignant hematopoietic cells in cerebral spinal fluid previously diagnosed as atypical or suspicious. Cancer  108, 157-62.   https://doi.org/10.1002/cncr.21915




PubMed


 


PubMed ID 16649227",https://intramural.nih.gov/search/searchview.taf?ipid=43798
219,BC010469-04,"October 01, 2005 -  September 30, 2006",Molecular Targets Development Program,James  McMahon; PhD,NULL,"Molecular Targets Development Program, NCI","Kirk R Gustafson; PhD



John A Beutler



Heidi  Bokesch



Laura  Cartner



Richard W Fuller



Roberta  Gardella



Show all 24","Edward  Arnold
(BIOCHEMISTRY, Rutgers University)




U.A.  Baltayev
(Natural Product, Industrial Biotechnology)




John W Blunt; PhD
(Chemistry Department, Natural products group)




Anders  Bolmstedt
(Glycovirology, Univ. of Goteborg)




Emma/Barry  Bowman
(V-ATPase, UC Santa Barbara)




Ihsan  Calis
(Natural product diversity librarires, Hacteppe University)


Show all 25","Gordon Lee Hager; PhD (National Cancer Institute)



Daniel  McVicar; PhD (National Cancer Institute)



Giovanni  Melillo (National Cancer Institute)



William Marston Linehan; MD (National Cancer Institute)



Lalage  Wakefield; PhD (National Cancer Institute)



Stanley  Lipkowitz; MD, PhD (National Cancer Institute)",Michael P Bray (NIAID),"Ordered by publication type and then author name.



1.
Giomarelli B, Schumacher KM, Taylor TE, Sowder RC, Hartley JL, McMahon JB, Mori T (2006). Recombinant production of anti-HIV protein, griffithsin, by auto-induction in a fermentor culture. Protein Expr Purif  47, 194-202.   https://doi.org/10.1016/j.pep.2005.10.014




PubMed


 


PubMed ID 16300962
    
     


 



2.
Henrich CJ, Bokesch HR, Dean M, Bates SE, Robey RW, Goncharova EI, Wilson JA, McMahon JB (2006). A high-throughput cell-based assay for inhibitors of ABCG2 activity. J Biomol Screen  11, 176-83.   https://doi.org/10.1177/1087057105284576




PubMed


 


PubMed ID 16490770
    
     


 



3.
Krumpe LR, Atkinson AJ, Smythers GW, Kandel A, Schumacher KM, McMahon JB, Makowski L, Mori T (2006). T7 lytic phage-displayed peptide libraries exhibit less sequence bias than M13 filamentous phage-displayed peptide libraries. Proteomics  6, 4210-22.   https://doi.org/10.1002/pmic.200500606




PubMed


 


PubMed ID 16819727
    
     


 



4.
Martinez ED, Rayasam GV, Dull AB, Walker DA, Hager GL (2005). An estrogen receptor chimera senses ligands by nuclear translocation. J Steroid Biochem Mol Biol  97, 307-21.   https://doi.org/10.1016/j.jsbmb.2005.06.033




PubMed


 


PubMed ID 16162406
    
     


 



5.
Xiong C, O'Keefe BR, Botos I, Wlodawer A, McMahon JB (2006). Overexpression and purification of scytovirin, a potent, novel anti-HIV protein from the cultured cyanobacterium Scytonema varium. Protein Expr Purif  46, 233-9.   https://doi.org/10.1016/j.pep.2005.09.019




PubMed


 


PubMed ID 16289703
    
     


 



6.
Xiong C, O'Keefe BR, Byrd RA, McMahon JB (2006). Potent anti-HIV activity of scytovirin domain 1 peptide. Peptides  27, 1668-75.   https://doi.org/10.1016/j.peptides.2006.03.018




PubMed


 


PubMed ID 16647158
    
     


 



7.
Ziółkowska NE, O'Keefe BR, Mori T, Zhu C, Giomarelli B, Vojdani F, Palmer KE, McMahon JB, Wlodawer A (2006). Domain-swapped structure of the potent antiviral protein griffithsin and its mode of carbohydrate binding. Structure  14, 1127-35.   https://doi.org/10.1016/j.str.2006.05.017




PubMed


 


PubMed ID 16843894
    
     


 



8.
O'Keefe BR, McMahon JR (submitted in 2006) Anti-h5n1 Influenza Activity Of The Antiviral Protein Cyanovirin-n (cv-n). Patent issued: 2051730 (EP in 2012). Patent pending: 12/377,875 (US application).




 



9.
O'Keefe BR, McMahon JR, Mori TR (submitted in 2006) Anti-viral Griffithsin Compounds, Compositions, And Methods. Patents issued: 8,088,729 (US in 2012); 1976596 (EP in 2013); 1976596 (FR in 2013); 1976596 (GB in 2013); 1976596 (IE in 2013); 1976596 (CH in 2013); 1976596 (DE in 2013); 2314349 (EP in 2016). Patents pending: 10014894.9 (EP application); 10014893.1 (EP application).",https://intramural.nih.gov/search/searchview.taf?ipid=43843
220,BC010470-04,"October 01, 2005 -  September 30, 2006",Bioinformatic Tools in Cancer Research,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI","Michael N Edmonson



William L Rowe



Peisen  Zhang",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Zhang J, Finney RP, Clifford RJ, Derr LK, Buetow KH (2005). Detecting false expression signals in high-density oligonucleotide arrays by an in silico approach. Genomics  85, 297-308.   https://doi.org/10.1016/j.ygeno.2004.11.004




PubMed


 


PubMed ID 15718097
    
     


 



2.
Zhang J, Hunter KW, Gandolph M, Rowe WL, Finney RP, Kelley JM, Edmonson M, Buetow KH (2005). A high-resolution multistrain haplotype analysis of laboratory mouse genome reveals three distinctive genetic variation patterns. Genome Res  15, 241-9.   https://doi.org/10.1101/gr.2901705




PubMed



        
     
Free Article


 


PubMed ID 15687287
         Pubmed Central ID 546525",https://intramural.nih.gov/search/searchview.taf?ipid=43801
221,BC010472-04,"October 01, 2005 -  September 30, 2006",High-Density Marker Studies Near Founder BRCA12 Mutations,"Jeffery P Struewing; MS, MD",NULL,"Laboratory of Population Genetics, NCI",Lutecia  Pereira,"Andrew  Collins
(Genetics, University of Southampton)




Kenneth  Offit",Mark H Greene; MD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43842
222,BC010474-04,"October 01, 2005 -  September 30, 2006",Signal Transduction Mechanisms of Type I IFNs,Ana M Gamero,Giorgio  Trinchieri,"Laboratory of Experimental Immunology, NCI","Anthony J Scarzello



Ana L Romero



Christy D Bieber



Hsiang-Wen  Wang","Graham  Foster
(Hepatology, Queen Mary's School of Medicine)




Michael  Jacobs





Mark  Walter
(Microbiology, University of Alabama)","Nancy H Colburn; PhD (National Cancer Institute)



Howard A Young; PhD (National Cancer Institute)



Paul  Goldsmith; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43808
223,BC010476-04,"October 01, 2005 -  September 30, 2006",Time Domian Electron Paramagnetic Resonance Imaging,"Murali  Krishna; PhD



IRP Faculty Profile",NULL,"Radiation Biology Branch, NCI","Nallathamby  Devasahayam



Sankaran  Subramanian; MD



Fuminori  Hyodo



Shingo  Matsumoto",NULL,NULL,Calvin A Johnson; PhD (CIT),"Ordered by publication type and then author name.



1.
Matsumoto K, Subramanian S, Devasahayam N, Aravalluvan T, Murugesan R, Cook JA, Mitchell JB, Krishna MC (2006). Electron paramagnetic resonance imaging of tumor hypoxia: enhanced spatial and temporal resolution for in vivo pO2 determination. Magn Reson Med  55, 1157-63.   https://doi.org/10.1002/mrm.20872




PubMed


 


PubMed ID 16596636
    
     


 



2.
Pursley RH, Salem G, Devasahayam N, Subramanian S, Koscielniak J, Krishna MC, Pohida TJ (2006). Integration of digital signal processing technologies with pulsed electron paramagnetic resonance imaging. J Magn Reson  178, 220-7.   https://doi.org/10.1016/j.jmr.2005.10.001




PubMed



        
     
Free Article


 


PubMed ID 16243552
         Pubmed Central ID 1847784",https://intramural.nih.gov/search/searchview.taf?ipid=43824
224,BC010477-04,"October 01, 2005 -  September 30, 2006",Overhauser Enhanced Magnetic Resonance Imaging (OMRI),"Murali  Krishna; PhD



IRP Faculty Profile",NULL,"Radiation Biology Branch, NCI","Nallathamby  Devasahayam



Sankaran  Subramanian; MD



Fuminori  Hyodo



Shingo  Matsumoto",NULL,NULL,Alan Paul Koretsky; PhD (NINDS),"Ordered by publication type and then author name.



1.
Matsumoto K, Bernardo M, Subramanian S, Choyke P, Mitchell JB, Krishna MC, Lizak MJ (2006). MR assessment of changes of tumor in response to hyperbaric oxygen treatment. Magn Reson Med  56, 240-6.   https://doi.org/10.1002/mrm.20961




PubMed


 


PubMed ID 16795082",https://intramural.nih.gov/search/searchview.taf?ipid=43822
225,BC010478-04,"October 01, 2005 -  September 30, 2006",Continuous Wave Electron Paramagnetic Resonance Imaging,"Murali  Krishna; PhD



IRP Faculty Profile",NULL,"Radiation Biology Branch, NCI","Nallathamby  Devasahayam



Sankaran  Subramanian; MD



Fuminori  Hyodo



Shingo  Matsumoto",NULL,"David Anderson Wink (National Cancer Institute)



Jeffrey S Isenberg (National Cancer Institute)",Thomas J Pohida; MS (CIT),"Ordered by publication type and then author name.



1.
Matsumoto K, Hyodo F, Matsumoto A, Koretsky AP, Sowers AL, Mitchell JB, Krishna MC (2006). High-resolution mapping of tumor redox status by magnetic resonance imaging using nitroxides as redox-sensitive contrast agents. Clin Cancer Res  12, 2455-62.   https://doi.org/10.1158/1078-0432.CCR-05-2747




PubMed


 


PubMed ID 16638852
    
     


 



2.
Matsumoto K, Okajo A, Kobayashi T, Mitchell JB, Krishna MC, Endo K (2005). Estimation of free radical formation by beta-ray irradiation in rat liver. J Biochem Biophys Methods  63, 79-90.   https://doi.org/10.1016/j.jbbm.2005.03.004




PubMed


 


PubMed ID 15896849
    
     


 



3.
Okajo A, Matsumoto K, Mitchell JB, Krishna MC, Endo K (2006). Competition of nitroxyl contrast agents as an in vivo tissue redox probe: comparison of pharmacokinetics by the bile flow monitoring (BFM) and blood circulating monitoring (BCM) methods using X-band EPR and simulation of decay profiles. Magn Reson Med  56, 422-31.   https://doi.org/10.1002/mrm.20958




PubMed


 


PubMed ID 16810697",https://intramural.nih.gov/search/searchview.taf?ipid=43823
226,BC010479-04,"October 01, 2005 -  September 30, 2006",Regulation of Melanocyte Development and Differentiation,Thomas J Hornyak,NULL,"Dermatology Branch, NCI",Deming  Zhang,"David  Dolan
(Otolaryngology, The University of Michigan)




Yehoash  Raphael; PhD
(Department of Otolaryngology, University of Michigan)




Faith  Strickland
(Department of Dermatology, Henry Ford Health System)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43812
227,BC010481-04,"October 01, 2005 -  September 30, 2006",Structure and Function of HIV-1 Reverse Transcriptase,"Stephen H Hughes; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Paul L Boyer



Linda L Dunn



Andrea L Ferris



Edward  Wu



Rafal  Wierzchoslawski



Gunnar  Gunnarsson



Show all 7","Eddy  Arnold; PhD
(Chemistry and Chemical Biology, CABM and Rutgers University)




Michael  Parniak; PhD
(Department of Medicine, McGill University)","Dwight V Nissley (National Cancer Institute)



Victor  Marquez; PhD (National Cancer Institute)



David  Derse; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Boyer PL, Sarafianos SG, Clark PK, Arnold E, Hughes SH (2006). Why do HIV-1 and HIV-2 use different pathways to develop AZT resistance? PLoS Pathog  2, e10.   https://doi.org/10.1371/journal.ppat.0020010




PubMed



        
     
Free Article


 


PubMed ID 16485036
         Pubmed Central ID 1364504 


 



2.
Das K, Clark A, Lewi P, Hughes S, Arnold E   (2007) Detection of non-nucleoside inhibitor binding to HIV-1 reverse transcriptase by dynamic light scattering.  Biophys J, in press.




 



3.
Hughes S, Roth T, Farnsworth D, Kroeger-Smith M, Watson K, Buckheit Jr R, Das K, Zhang W, Arnold E, Michejda C   (2006) Synthesis, biological activity, and crystal structure of potent non-nucleoside inhibitors of HIV-1 reverse transcriptase that retain activity against mutant forms of the enzyme.  J Med Chem, in press.




 



4.
Hughes S, Sarafianos S, Clark A, Boyer P, Arnold E   (2006) Crystal structures of clinically relevant Lys103Asn/Tyr181Cys double mutant HIV-1 reverse transcriptase in complexes with ATP and non-nucleoside inhibitor HBY 097.  J Mol Biol, in press.




 



5.
Marquez VE, Hughes SH, Sei S, Agbaria R (2006). The history of N-methanocarbathymidine: the investigation of a conformational concept leads to the discovery of a potent and selective nucleoside antiviral agent. Antiviral Res  71, 268-75.   https://doi.org/10.1016/j.antiviral.2006.04.012




PubMed


 


PubMed ID 16730077",https://intramural.nih.gov/search/searchview.taf?ipid=43817
228,BC010482-04,"October 01, 2005 -  September 30, 2006",Retroviral Replication and Vector Design,"Stephen H Hughes; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Linda L Dunn



Andrea L Ferris



Mary J McWilliams



Kevin W Chang



John G Julias



Jangsuk  Oh; PhD



Show all 7","Jerry  Dodgson
(Michigan State University)




Mamuka  Kvaratskhelia; PhD
(College of Pharmacy, Ohio State University)




John W Mellors","Sarah E Palmer (National Cancer Institute)



Frank  Maldarelli (National Cancer Institute)



Jeffrey D Lifson; MD (National Cancer Institute)



Vineet Narain KewalRamani; PhD (National Cancer Institute)



John Miller Coffin; PhD (National Cancer Institute)



David J. Garfinkel; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Hughes SH, Crise B   (2007) Using viral vectors in animal research , in Anthology of Biosafety X: Animal Issues, in press.




 



2.
Ambrose Z, Julias JG, Boyer PL, Kewalramani VN, Hughes SH (2006). The level of reverse transcriptase (RT) in human immunodeficiency virus type 1 particles affects susceptibility to nonnucleoside RT inhibitors but not to lamivudine. J Virol  80, 2578-81.   https://doi.org/10.1128/JVI.80.5.2578-2581.2006




PubMed



        
     
Free Article


 


PubMed ID 16474164
         Pubmed Central ID 1395365 


 



3.
Garfinkel DJ, Stefanisko KM, Nyswaner KM, Moore SP, Oh J, Hughes SH (2006). Retrotransposon suicide: formation of Ty1 circles and autointegration via a central DNA flap. J Virol  80, 11920-34.   https://doi.org/10.1128/JVI.01483-06




PubMed



        
     
Free Article


 


PubMed ID 17005648
         Pubmed Central ID 1676259 


 



4.
McWilliams MJ, Julias JG, Sarafianos SG, Alvord WG, Arnold E, Hughes SH (2006). Combining mutations in HIV-1 reverse transcriptase with mutations in the HIV-1 polypurine tract affects RNase H cleavages involved in PPT utilization. Virology  348, 378-88.   https://doi.org/10.1016/j.virol.2005.12.042




PubMed


 


PubMed ID 16473384
    
     


 



5.
Oh J, Chang KW, Alvord WG, Hughes SH (2006). Alternate polypurine tracts affect rous sarcoma virus integration in vivo. J Virol  80, 10281-4.   https://doi.org/10.1128/JVI.00361-06




PubMed



        
     
Free Article


 


PubMed ID 17005708
         Pubmed Central ID 1617299 


 



6.
Oh J, Chang KW, Hughes SH (2006). Mutations in the U5 sequences adjacent to the primer binding site do not affect tRNA cleavage by rous sarcoma virus RNase H but do cause aberrant integrations in vivo. J Virol  80, 451-9.   https://doi.org/10.1128/JVI.80.1.451-459.2006




PubMed



        
     
Free Article


 


PubMed ID 16352569
         Pubmed Central ID 1317513",https://intramural.nih.gov/search/searchview.taf?ipid=43816
229,BC010483-04,"October 01, 2005 -  September 30, 2006",TEM5 Ligand Hunt,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI","Steven  Seaman



Janine P Stevens",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43838
230,BC010484-04,"October 01, 2005 -  September 30, 2006",Functional Analysis of TEM5 and TEM8,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI","Steven  Seaman



Michael G Cullen",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43839
231,BC010485-04,"October 01, 2005 -  September 30, 2006",Mechanism of DC-SIGNMediated Transmission of HIV,"Vineet Narain KewalRamani; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI",NULL,"Derya  Unutmaz
(Vanderbilt University)




Li  Wu",Alan  Rein; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
García-Piñeres AJ, Hildesheim A, Trivett M, Williams M, Wu L, Kewalramani VN, Pinto LA (2006). Role of DC-SIGN in the activation of dendritic cells by HPV-16 L1 virus-like particle vaccine. Eur J Immunol  36, 437-45.   https://doi.org/10.1002/eji.200535068




PubMed


 


PubMed ID 16385626
    
     


 



2.
KewalRamani V   (2006) Dendritic-cell interactions with HIV: Infection and viral dissemination.  Nat Rev Immunol, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=43819
232,BC010486-04,"October 01, 2005 -  September 30, 2006",Search for New Tumor Endothelial Markers,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI",Steven  Seaman,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Seaman S, Stevens J, Yang MY, Logsdon D, Graff-Cherry C, St Croix B (2007). Genes that distinguish physiological and pathological angiogenesis. Cancer Cell  11, 539-54.   https://doi.org/10.1016/j.ccr.2007.04.017




PubMed



        
     
Free Article


 


PubMed ID 17560335
         Pubmed Central ID 2039723 


 



2.
St Croix BD, Seaman SD (submitted in 2006) Differential Gene Expression In Physiological And Pathological Angiogenesis. Patents issued: 8,440,411 (US in 2013); 2007317753 (AU in 2014); 2014200453 (AU in 2016). Patents pending: 2,669,260 (CA application); 12/514,297 (US application); 13/863,674 (US application); 14/954,509 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=43840
233,BC010487-04,"October 01, 2005 -  September 30, 2006",Postentry Factors That Positively or Negatively Impact HIVSIV Replication,"Vineet Narain KewalRamani; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Zandrea  Ambrose



Kyeongeun  Lee



Taichiro  Takemura



Alok  Mulky","Paul  Bieniasz
(Rockefeller University, Aaron Diamond AIDS Research Center)




John  Coffin
(Tufts University School of Medicine)




Alan  Engelman; PhD
(Dana-Farber, Harvard University)




Dan  Littman
(New York University Medical Center)




Michael W Miller; DVM
(Colorado Division of Wildlife)




Ronald  Montelaro; MD
(Molecular Genetics and Biochemistry, University of Pittsburg School of Medicine)


Show all 7",Stephen H Hughes; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43820
234,BC010488-04,"October 01, 2005 -  September 30, 2006",A Macaque Model to Study HIV-1 RT Antiviral Therapy and Resistance,"Vineet Narain KewalRamani; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Zandrea  Ambrose



Matthew A Bess","Paul  Bieniasz
(Rockefeller University, Aaron Diamond AIDS Research Center)




John  Coffin
(Tufts University School of Medicine)




Shiu-Lok  Hu
(National Primate Research Center, University of Washington)




Jason  Kimata
(Southwest Foundation)




John W Mellors","Sarah E Palmer (National Cancer Institute)



Stephen H Hughes; PhD (National Cancer Institute)



Jeffrey D Lifson; MD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43821
235,BC010492-04,"October 01, 2005 -  September 30, 2006",Modified Nucleosides as Probes of Replication Complexes,"Stuart F J Le Grice; PhD



IRP Faculty Profile",NULL,"Resistance Mechanisms Laboratory, NCI","Chandravanu  Dash



Jason William Rausch","Mary  Barkley
(Case Western Reserve University)




Dan  Fabris
(Chemistry and Biochemistry, University of Maryland, Baltimore County)




Matthias  Goette
(McGill University)




Myron F Goodman; PhD
(University of Southern California)




John  Marino
(DEpartment of Structural Biology, Center for Advanced Research in Biotechnology)




Vinayaka  Prasad
(Albert Einstein University)",Victor  Marquez; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Dash C, Fisher TS, Prasad VR, Le Grice SF   (2006) Examining interactions of HIV-1 reverse transcriptase with single-stranded template nucleotides by nucleoside analog interference.  J Biol Chem 281:27873-81.




PubMed


 


PubMed ID 16867979
    
     


 



2.
Ignatov ME, Berdis AJ, Le Grice SF, Barkley MD (2005). Attenuation of DNA replication by HIV-1 reverse transcriptase near the central termination sequence. Biochemistry  44, 5346-56.   https://doi.org/10.1021/bi048000p




PubMed


 


PubMed ID 15807528
    
     


 



3.
Le Grice S, Rausch JW   (2006) Using nucleoside analogs to explore HIV-1 reverse transcriptase function.  Curr HIV Res, in press.




 



4.
Mandal D, Dash C, Le Grice SF, Prasad VR (2006). Analysis of HIV-1 replication block due to substitutions at F61 residue of reverse transcriptase reveals additional defects involving the RNase H function. Nucleic Acids Res  34, 2853-63.   https://doi.org/10.1093/nar/gkl360




PubMed



        
     
Free Article


 


PubMed ID 16723431
         Pubmed Central ID 1474072",https://intramural.nih.gov/search/searchview.taf?ipid=43827
236,BC010493-04,"October 01, 2005 -  September 30, 2006",High-Resolution Protein and Nucleic Acid Footprinting,"Stuart F J Le Grice; PhD



IRP Faculty Profile",NULL,"Resistance Mechanisms Laboratory, NCI","Jennifer T Miller



Jason William Rausch



Victoria  Mcparland



Michaela  Wendeler



Christopher S Badorrek","Michael  Bowser
(Department of Chemistry, University of Minnesota)




Dan  Fabris
(Chemistry and Biochemistry, University of Maryland, Baltimore County)




Matthias  Goette
(McGill University)




Sidney  Hecht
(Lady Davis Institute-Jewish General Hospital, University of Virginia)




John  Marino
(DEpartment of Structural Biology, Center for Advanced Research in Biotechnology)




David  Rekosh
(Myles Thayler AIDS Institute, University of Virginia)


Show all 7",NULL,"Robert Joseph Crouch; PhD (NICHD) 



Robert  Craigie; PhD (NIDDK)","Ordered by publication type and then author name.



1.
Bampi C, Bibillo A, Wendeler M, Divita G, Gorelick RJ, Le Grice SF, Darlix JL (2006). Nucleotide excision repair and template-independent addition by HIV-1 reverse transcriptase in the presence of nucleocapsid protein. J Biol Chem  281, 11736-43.   https://doi.org/10.1074/jbc.M600290200




PubMed


 


PubMed ID 16500895
    
     


 



2.
Bibillo A, Lener D, Tewari A, Le Grice SF (2005). Interaction of the Ty3 reverse transcriptase thumb subdomain with template-primer. J Biol Chem  280, 30282-90.   https://doi.org/10.1074/jbc.M502457200




PubMed


 


PubMed ID 15944162
    
     


 



3.
Kvaratskhelia M, LeGrice S   (2006) Structural analysis of protein-RNA interactions with mass spectrometry.  Methods Mol Biol, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=43828
237,BC010494-04,"October 01, 2005 -  September 30, 2006",HIV-1 RNase H as a Therapeutic Target,"Stuart F J Le Grice; PhD



IRP Faculty Profile",NULL,"Resistance Mechanisms Laboratory, NCI","Marion Karla Bona; PhD



Jason William Rausch



Victoria  Mcparland","Robert J. Gorelick; PhD
(AIDS and Cancer Virus Program, SAIC-Frederick, Inc.)
















Eric  Arts
(Infectious Diseases, Case Western Reserve)




Matthias  Goette
(McGill University)




John  Marino
(DEpartment of Structural Biology, Center for Advanced Research in Biotechnology)




Michael  Parniak; PhD
(Department of Medicine, McGill University)




David  Stammers
(Division of Structural Biology, University of Oxford)


Show all 7","Victor  Marquez; PhD (National Cancer Institute)



John A Beutler (National Cancer Institute)



Vinay K Pathak; PhD (National Cancer Institute)","Henry L Levin; PhD (NICHD) 



Robert Joseph Crouch; PhD (NICHD)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43825
238,BC010495-04,"October 01, 2005 -  September 30, 2006",Unnatural Amino Acids as Probes of RT Structure and Function,"Stuart F J Le Grice; PhD



IRP Faculty Profile",NULL,"Resistance Mechanisms Laboratory, NCI","George J Klarmann



Michaela  Wendeler



Bridget  Dixon","Matthias  Goette
(McGill University)




Sidney  Hecht
(Lady Davis Institute-Jewish General Hospital, University of Virginia)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43826
239,BC010496-04,"October 01, 2005 -  September 30, 2006",Molecular genetics of the KIR gene complex,"Mary  Carrington; MS, PhD",NULL,"Laboratory of Genomic Diversity, NCI","Maureen P Martin



Megan E Boon



Ying  Qi","Stephan  Beck
(Sanger Centre)




Kidd  Judith
(Department of Genetics, Yale University)




Kenneth  Kidd
(Yale University)




Richard  Single
(Department of Mathematics and Statistics, University of Vermont)




John  Trowsdale
(Cambridge Institute for Medical Research, University of Cambridge)",NULL,NULL,"Ordered by publication type and then author name.



1.
Bashirova AA, Martin MP, McVicar DW, Carrington M (2006). The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu Rev Genomics Hum Genet  7, 277-300.   https://doi.org/10.1146/annurev.genom.7.080505.115726




PubMed


 


PubMed ID 16824023
    
     


 



2.
Sambrook JG, Bashirova A, Andersen H, Piatak M, Vernikos GS, Coggill P, Lifson JD, Carrington M, Beck S (2006). Identification of the ancestral killer immunoglobulin-like receptor gene in primates. BMC Genomics  7, 209.   https://doi.org/10.1186/1471-2164-7-209




PubMed



        
     
Free Article


 


PubMed ID 16911775
         Pubmed Central ID 1559706",https://intramural.nih.gov/search/searchview.taf?ipid=43802
240,BC010499-04,"October 01, 2005 -  September 30, 2006",Maryland Prostate Cancer Case-Control Study,"Stefan  Ambs



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI",Tiffany Marie Howe,NULL,"Neil Edward Caporaso; MS, MD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43799
241,BC010500-04,"October 01, 2005 -  September 30, 2006",The Molecular Profile of Inflammatory Breast Cancer,"Stefan  Ambs



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI",Brenda Jean Boersma-Maland,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=43800
242,BC010504-04,"October 01, 2005 -  September 30, 2006",Genetic Recombination in Retroviruses,"Wei-Shau  Hu; PhD



IRP Faculty Profile",NULL,"Resistance Mechanisms Laboratory, NCI","Olga A Nikolaitchik



Jianbo  Chen



Mario  Chin



Kazushi  Motomura



Michael D Moore","David  Ott
(SAIC-Frederick)
















Marcelo  Soares; PhD
(Instituto Nacional de Cancer do Brasil)","Vinay K Pathak; PhD (National Cancer Institute)



Matthew  Fivash (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Chen J, Powell D, Hu WS (2006). High frequency of genetic recombination is a common feature of primate lentivirus replication. J Virol  80, 9651-8.   https://doi.org/10.1128/JVI.00936-06




PubMed



        
     
Free Article


 


PubMed ID 16973569
         Pubmed Central ID 1617242 


 



2.
Nikolaitchik O, Rhodes TD, Ott D, Hu WS (2006). Effects of mutations in the human immunodeficiency virus type 1 Gag gene on RNA packaging and recombination. J Virol  80, 4691-7.   https://doi.org/10.1128/JVI.80.10.4691-4697.2006




PubMed



        
     
Free Article


 


PubMed ID 16641262
         Pubmed Central ID 1472086",https://intramural.nih.gov/search/searchview.taf?ipid=43814
243,BC010505-04,"October 01, 2005 -  September 30, 2006",Retroviral Double Infection and Its Relationship to Recombination,"Wei-Shau  Hu; PhD



IRP Faculty Profile",NULL,"Resistance Mechanisms Laboratory, NCI","Jianbo  Chen



Vitaly P Boyko



Kazushi  Motomura",NULL,"Vinay K Pathak; PhD (National Cancer Institute)



John Miller Coffin; PhD (National Cancer Institute)



Frank  Maldarelli (National Cancer Institute)



Sarah E Palmer (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43815
244,BC010506-04,"October 01, 2005 -  September 30, 2006","Mechanisms of Virus Assembly, RNA Packaging, and Replication","Wei-Shau  Hu; PhD



IRP Faculty Profile",NULL,"Resistance Mechanisms Laboratory, NCI","Olga A Nikolaitchik



Jianbo  Chen



Vitaly P Boyko



Michael D Moore","David  Ott
(SAIC-Frederick)





Robert J. Gorelick; PhD
(AIDS and Cancer Virus Program, SAIC-Frederick, Inc.)","Vinay K Pathak; PhD (National Cancer Institute)



Alan  Rein; PhD (National Cancer Institute)



Eric O Freed; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Boyko V, Leavitt M, Gorelick R, Fu W, Nikolaitchik O, Pathak VK, Nagashima K, Hu WS (2006). Coassembly and complementation of Gag proteins from HIV-1 and HIV-2, two distinct human pathogens. Mol Cell  23, 281-7.   https://doi.org/10.1016/j.molcel.2006.05.028




PubMed


 


PubMed ID 16857594
    
     


 



2.
Fu W, Dang Q, Nagashima K, Freed EO, Pathak VK, Hu WS (2006). Effects of Gag mutation and processing on retroviral dimeric RNA maturation. J Virol  80, 1242-9.   https://doi.org/10.1128/JVI.80.3.1242-1249.2006




PubMed



        
     
Free Article


 


PubMed ID 16415001
         Pubmed Central ID 1346957 


 



3.
Nikolaitchik O, Rhodes TD, Ott D, Hu WS (2006). Effects of mutations in the human immunodeficiency virus type 1 Gag gene on RNA packaging and recombination. J Virol  80, 4691-7.   https://doi.org/10.1128/JVI.80.10.4691-4697.2006




PubMed



        
     
Free Article


 


PubMed ID 16641262
         Pubmed Central ID 1472086",https://intramural.nih.gov/search/searchview.taf?ipid=43813
245,BC010510-04,"October 01, 2005 -  September 30, 2006",Targeted Therapy of Mesothelioma and Development of Blood Tests for Diagnosis,"Raffit  Hassan



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI","Jingli  Zhang



Barbara S Schuler",NULL,Kevin A Camphausen; MD (National Cancer Institute),"Alan T Remaley; MD, PhD (CC)",Ordered by publication type and then author name.,https://intramural.nih.gov/search/searchview.taf?ipid=43811
246,BC010511-04,"October 01, 2005 -  September 30, 2006",Retrovirus Assembly and Maturation,"Alan  Rein; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Siddhartha  Datta; PhD



Demetria P Harvin



Jane  Mirro



Samuel J Rulli



Shilpa  Kulkarni



Rachael M Crist



Show all 7","Susan  Krueger
(Center for Neutron Research, NIST)




Mamuka  Kvaratskhelia; PhD
(College of Pharmacy, Ohio State University)




John W Mellors





Delphine  Muriaux
(National Institute of Standards and Technology, Unité de Virologie Humaine)




Massimo  Palmarini
(Veterinary School, University of Glasgow)","Robert J Fisher (National Cancer Institute)



Sergey G Tarasov (National Cancer Institute)



Alexander  Wlodawer; PhD (National Cancer Institute)



Vineet Narain KewalRamani; PhD (National Cancer Institute)



David  Derse; PhD (National Cancer Institute)



Wei-Shau  Hu; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Rulli SJ, Muriaux D, Nagashima K, Mirro J, Oshima M, Baumann JG, Rein A (2006). Mutant murine leukemia virus Gag proteins lacking proline at the N-terminus of the capsid domain block infectivity in virions containing wild-type Gag. Virology  347, 364-71.   https://doi.org/10.1016/j.virol.2005.12.012




PubMed


 


PubMed ID 16427108
    
     


 



2.
Shkriabai N, Datta SA, Zhao Z, Hess S, Rein A, Kvaratskhelia M (2006). Interactions of HIV-1 Gag with assembly cofactors. Biochemistry  45, 4077-83.   https://doi.org/10.1021/bi052308e




PubMed


 


PubMed ID 16566581",https://intramural.nih.gov/search/searchview.taf?ipid=43836
247,BC010512-04,"October 01, 2005 -  September 30, 2006",Interactions of Retroviral Proteins with Nucleic Acids,"Alan  Rein; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Demetria P Harvin



Jane  Mirro



Samuel J Rulli","Shyam  Biswal
(School of Public Health, Johns Hopkins University)




Delphine  Muriaux
(National Institute of Standards and Technology, Unité de Virologie Humaine)




Karin  Musier-Forsyth
(-, University of Minnesota)","Robert J Fisher (National Cancer Institute)



Robert  Shoemaker (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Cruceanu M, Urbaneja MA, Hixson CV, Johnson DG, Datta SA, Fivash MJ, Stephen AG, Fisher RJ, Gorelick RJ, Casas-Finet JR, Rein A, Rouzina I, Williams MC (2006). Nucleic acid binding and chaperone properties of HIV-1 Gag and nucleocapsid proteins. Nucleic Acids Res  34, 593-605.   https://doi.org/10.1093/nar/gkj458




PubMed



        
     
Free Article


 


PubMed ID 16449201
         Pubmed Central ID 1356529 


 



2.
Fisher RJ, Fivash MJ, Stephen AG, Hagan NA, Shenoy SR, Medaglia MV, Smith LR, Worthy KM, Simpson JT, Shoemaker R, McNitt KL, Johnson DG, Hixson CV, Gorelick RJ, Fabris D, Henderson LE, Rein A (2006). Complex interactions of HIV-1 nucleocapsid protein with oligonucleotides. Nucleic Acids Res  34, 472-84.   https://doi.org/10.1093/nar/gkj442




PubMed



        
     
Free Article


 


PubMed ID 16434700
         Pubmed Central ID 1351370 


 



3.
Kol N, Gladnikoff M, Barlam D, Shneck RZ, Rein A, Rousso I (2006). Mechanical properties of murine leukemia virus particles: effect of maturation. Biophys J  91, 767-74.   https://doi.org/10.1529/biophysj.105.079657




PubMed



        
     
Free Article


 


PubMed ID 16632508
         Pubmed Central ID 1483117 


 



4.
Kovaleski BJ, Kennedy R, Hong MK, Datta SA, Kleiman L, Rein A, Musier-Forsyth K (2006). In vitro characterization of the interaction between HIV-1 Gag and human lysyl-tRNA synthetase. J Biol Chem  281, 19449-56.   https://doi.org/10.1074/jbc.M601189200




PubMed


 


PubMed ID 16702215",https://intramural.nih.gov/search/searchview.taf?ipid=43837
248,BC010516-04,"October 01, 2005 -  September 30, 2006",Gated Optical DetectorsDose Guided Radiotherapy,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI","George  Li



Hu-Chen  Xie



Holly  Ning



Frank S Harrington



Barbara Chin Arora","Paul  Falkenstein
(Optical Sciences Division, Naval Research Laboratory)




Alan  Huston
(Optical Sciences Division, Naval Research Laboratory)




Brian  Justus
(Optical Sciences Division, Naval Research Lab (NRL))




Maria  Plazas
(Departmento de Fiscia, Universidad Nacional de Colombia)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43844
249,BC010517-04,"October 01, 2005 -  September 30, 2006",Large Databases of Small Molecules - Drug Development Tool and Public Resource,"Marc C Nicklaus



IRP Faculty Profile",NULL,"Laboratory of Medicinal Chemistry, NCI","Megan L Peach



Markus  Sitzmann",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Nicklaus M, Sitzmann M, Ihlenfeldt W   (2006) Chemicals and Chemoinformatics Tools and User Services.  CADD Group Web Server  0 pp.




 



2.
Richard AM, Gold LS, Nicklaus MC (2006). Chemical structure indexing of toxicity data on the internet: moving toward a flat world. Curr Opin Drug Discov Devel  9, 314-25.




PubMed


 


PubMed ID 16729727",https://intramural.nih.gov/search/searchview.taf?ipid=43847
250,BC010518-04,"October 01, 2005 -  September 30, 2006",Role of BMP and FGF signaling during limb development,"Mark B Lewandoski



IRP Faculty Profile",NULL,"Cancer and Developmental Biology Laboratory, NCI","Catherine P Wilson



Cindy  Elder",NULL,NULL,Yuji  Mishina; PhD (NIEHS),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43852
251,BC010519-04,"October 01, 2005 -  September 30, 2006",Development of Novel Therapeutic Strategies for Thoracic Malignancies by Targeti,"Dao M Nguyen; MD, MS",NULL,"Surgery Branch, NCI","Jingtong  Zuo



Wen-Shuz  Yeow","Avi  Ashkenazi
(Genentech, Inc.)




Marc  Dupuis
(Oncology, Apoxis SA)




Bing Liang  Fang
(Thoracic and Cardiovascular Surgery, MD Anderson Cancer Center)","Peter L Choyke; MD (National Cancer Institute)



Steven  Libutti; MD (National Cancer Institute)



Stanley  Lipkowitz; MD, PhD (National Cancer Institute)



David  Schrump; MD (National Cancer Institute)



William Marston Linehan; MD (National Cancer Institute)



John R Wunderlich (National Cancer Institute)",Bradford J Wood; MD (CC),"Ordered by publication type and then author name.



1.
Guo ZS, Hong JA, Irvine KR, Chen GA, Spiess PJ, Liu Y, Zeng G, Wunderlich JR, Nguyen DM, Restifo NP, Schrump DS (2006). De novo induction of a cancer/testis antigen by 5-aza-2'-deoxycytidine augments adoptive immunotherapy in a murine tumor model. Cancer Res  66, 1105-13.   https://doi.org/10.1158/0008-5472.CAN-05-3020




PubMed



        
     
Free Article


 


PubMed ID 16424047
         Pubmed Central ID 2242843 


 



2.
Kassis ES, Zhao M, Hong JA, Chen GA, Nguyen DM, Schrump DS (2006). Depletion of DNA methyltransferase 1 and/or DNA methyltransferase 3b mediates growth arrest and apoptosis in lung and esophageal cancer and malignant pleural mesothelioma cells. J Thorac Cardiovasc Surg  131, 298-306.   https://doi.org/10.1016/j.jtcvs.2005.05.022




PubMed


 


PubMed ID 16434257
    
     


 



3.
Nguyen D   (2006) Lung cancer staging in the genomic era.  Thoracic Surgery Clinics, in press.




 



4.
Nguyen D, Nguyen D, Chua A, Baras A, Ziauddin M, Shamimi-Noori S, Maxhimer J, Schrump D   (2006) Rapid and profound potentiation of Apo2L/TRAIL-mediated cytotoxicity and apoptosis in thoracic cancer cells by the histone deacetylase inhibitor Trichostatin A: the essential role of the mitochondria-mediated caspase activation cascade.  Apoptosis, in press.




 



5.
Nguyen D, Nguyen D, Chua A, Reddy R, Schrump D   (2006) ENHANCEMENT OF APO2L/TRAIL-MEDIATED CYTOTOXICITY IN ESOPHAGEAL CANCER CELLS BY CISPLATIN: RECRUITMENT OF THE MITOCHONDRIA-DEPENDENT DEATH SIGNALING PATHWAY.  Molecular Cancer Therapeutics, in press.




 



6.
Nguyen D, Nguyen D, Chua A, Sehgal S, Schrump D   (2006) Gossypol, a phytochemical with BH3-mimetic property, sensitizes cultured thoracic cancer cells to Apo2L/TRAIL.  Journal of Thoracic and Cardiovascular Surgery, in press.




 



7.
Schrump DS, Nguyen DM (2005). Targeting the epigenome for the treatment and prevention of lung cancer. Semin Oncol  32, 488-502.   https://doi.org/10.1053/j.seminoncol.2005.07.007




PubMed


 


PubMed ID 16210090
    
     


 



8.
Yeow WS, Ziauddin MF, Maxhimer JB, Shamimi-Noori S, Baras A, Chua A, Schrump DS, Nguyen DM (2006). Potentiation of the anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the kinase inhibitor Staurosporine or its clinically relevant analogue UCN-01. Br J Cancer  94, 1436-45.   https://doi.org/10.1038/sj.bjc.6603132




PubMed



        
     
Free Article


 


PubMed ID 16705314
         Pubmed Central ID 2361280 


 



9.
Ziauddin MF, Yeow WS, Maxhimer JB, Baras A, Chua A, Reddy RM, Tsai W, Cole GW, Schrump DS, Nguyen DM (2006). Valproic acid, an antiepileptic drug with histone deacetylase inhibitory activity, potentiates the cytotoxic effect of Apo2L/TRAIL on cultured thoracic cancer cells through mitochondria-dependent caspase activation. Neoplasia  8, 446-57.   https://doi.org/10.1593/neo.05823




PubMed



        
     
Free Article


 


PubMed ID 16820090
         Pubmed Central ID 1601472",https://intramural.nih.gov/search/searchview.taf?ipid=43845
252,BC010520-04,"October 01, 2005 -  September 30, 2006","Characterization of PBIP1, a novel polo-box-interacting protein at the kinetocho","Kyung  Lee; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI",Su Jung  Song,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Kang YH, Park JE, Yu LR, Soung NK, Yun SM, Bang JK, Seong YS, Yu H, Garfield S, Veenstra TD, Lee KS (2006). Self-regulated Plk1 recruitment to kinetochores by the Plk1-PBIP1 interaction is critical for proper chromosome segregation. Mol Cell  24, 409-22.   https://doi.org/10.1016/j.molcel.2006.10.016




PubMed


 


PubMed ID 17081991",https://intramural.nih.gov/search/searchview.taf?ipid=43829
253,BC010521-04,"October 01, 2005 -  September 30, 2006",Regulation of G2M transition in budding yeast,"Kyung  Lee; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI",Jung Eun  Park,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Asano S, Park JE, Yu LR, Zhou M, Sakchaisri K, Park CJ, Kang YH, Thorner J, Veenstra TD, Lee KS (2006). Direct phosphorylation and activation of a Nim1-related kinase Gin4 by Elm1 in budding yeast. J Biol Chem  281, 27090-8.   https://doi.org/10.1074/jbc.M601483200




PubMed


 


PubMed ID 16861226
    
     


 



2.
Kang YH, Park JE, Yu LR, Soung NK, Yun SM, Bang JK, Seong YS, Yu H, Garfield S, Veenstra TD, Lee KS (2006). Self-regulated Plk1 recruitment to kinetochores by the Plk1-PBIP1 interaction is critical for proper chromosome segregation. Mol Cell  24, 409-22.   https://doi.org/10.1016/j.molcel.2006.10.016




PubMed


 


PubMed ID 17081991",https://intramural.nih.gov/search/searchview.taf?ipid=43830
254,BC010523-03,"October 01, 2005 -  September 30, 2006",RNAi and Epigenetic Control of Higher-Order Chromatin Assembly,"Shivinder Singh Grewal



IRP Faculty Profile",NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI","Songtao  Jia



Estelle  Nicolas



Tomoyasu  Sugiyama



Martin  Zofall



Hugh P Cam



Ee Sin  Chen



Show all 9",NULL,Peter C Fitzgerald (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Noma K, Cam HP, Maraia RJ, Grewal SI (2006). A role for TFIIIC transcription factor complex in genome organization. Cell  125, 859-72.   https://doi.org/10.1016/j.cell.2006.04.028




PubMed


 


PubMed ID 16751097
    
     


 



2.
Yamada T, Fischle W, Sugiyama T, Allis CD, Grewal SI (2005). The nucleation and maintenance of heterochromatin by a histone deacetylase in fission yeast. Mol Cell  20, 173-85.   https://doi.org/10.1016/j.molcel.2005.10.002




PubMed


 


PubMed ID 16246721
    
     


 



3.
Zofall M, Grewal SI (2006). Swi6/HP1 recruits a JmjC domain protein to facilitate transcription of heterochromatic repeats. Mol Cell  22, 681-92.   https://doi.org/10.1016/j.molcel.2006.05.010




PubMed


 


PubMed ID 16762840",https://intramural.nih.gov/search/searchview.taf?ipid=43538
255,BC010524-04,"October 01, 2005 -  September 30, 2006",HIV Integrase Modeling and Computer-Aided Inhibitor Development,"Marc C Nicklaus



IRP Faculty Profile",NULL,"Laboratory of Medicinal Chemistry, NCI",Chenzhong  Liao,NULL,"Yves  Pommier; PhD (National Cancer Institute)



Vinay K Pathak; PhD (National Cancer Institute)



Terrence R Burke; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Nicklaus M, Semenova E, Liao C, Pommier Y, Burke T   (2006) Biotinylated biphenyl ketone-containing 2,4-dioxobutanoic acids designed as HIV-1 integrase photoaffinity ligands.  Bioorg. Med. Chem, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=43846
256,BC010525-04,"October 01, 2005 -  September 30, 2006",Immune Reconstitution,"Ronald E Gress; MD



IRP Faculty Profile",NULL,"Experimental Transplantation and Immunology Branch, NCI","Sarfraz A Memon



Francis  Flomerfelt; PhD



James N Kochenderfer



Philip J Lucas; PhD



Yu-Waye (Wayne)  Chu



Catherine Virginia Bare



Show all 8","Bruce  Blazar
(Department of Pediatrics, University of Minnesota)




Gregory  Hadley
(Immunology, University of Maryland)




Robert  Korngold
(Cancer Center, Hackensack University)




Andrew  Pecora
(Cancer Center, Hackensack University)




Wayne  Streilein
(Ophthamology, Yale)","Martin  Gutierrez (National Cancer Institute)



Shivaani  Kummar; PhD (National Cancer Institute)



Steven Aaron Rosenberg; MD, PhD (National Cancer Institute)



Alfred  Singer; MD (National Cancer Institute)



James Stephen Shaw; PhD (National Cancer Institute)",Daniel C Douek; MD (NIAID),"Ordered by publication type and then author name.



1.
El-Asady R, Yuan R, Liu K, Wang D, Gress RE, Lucas PJ, Drachenberg CB, Hadley GA (2005). TGF-{beta}-dependent CD103 expression by CD8(+) T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease. J Exp Med  201, 1647-57.   https://doi.org/10.1084/jem.20041044




PubMed



        
     
Free Article


 


PubMed ID 15897278
         Pubmed Central ID 2212926 


 



2.
Gress R, Ng T, Lucas P, Streilein J   (2006) B7-expressing iris pigment epithelium, and the regulatory CD8+ T cells they induce, suppress bystander CTLA-4+ T cells via membrane- bound TGF-beta.  J Immunol  118-127 pp.




 



3.
Gress R, Sportes C, Ahmadzadeh M, Fry T, Ngo L, Schwartz S, Stetler-Stevenson M, Morton K, Mavroukakis S, Morre M, Buffet R, Mackall C   (2006) IL-7 administration to humans leads to homeostatic expansion of CD8+ and CD4+ cells but not CD4+ T-regulatory cells.  J. Immunotherapy  313-319 pp.




 



4.
Hakim FT, Gress RE (2005). Reconstitution of the lymphocyte compartment after lymphocyte depletion: a key issue in clinical immunology. Eur J Immunol  35, 3099-102.   https://doi.org/10.1002/eji.200535385




PubMed


 


PubMed ID 16231288
    
     


 



5.
Hakim FT, Memon SA, Cepeda R, Jones EC, Chow CK, Kasten-Sportes C, Odom J, Vance BA, Christensen BL, Mackall CL, Gress RE (2005). Age-dependent incidence, time course, and consequences of thymic renewal in adults. J Clin Invest  115, 930-9.   https://doi.org/10.1172/JCI22492




PubMed



        
     
Free Article


 


PubMed ID 15776111
         Pubmed Central ID 1064981 


 



6.
Lucas PJ, Kim SJ, Mackall CL, Telford WG, Chu YW, Hakim FT, Gress RE (2006). Dysregulation of IL-15-mediated T-cell homeostasis in TGF-beta dominant-negative receptor transgenic mice. Blood  108, 2789-95.   https://doi.org/10.1182/blood-2006-05-025676




PubMed



        
     
Free Article


 


PubMed ID 16788095
         Pubmed Central ID 1895588 


 



7.
Sportès C, McCarthy NJ, Hakim F, Steinberg SM, Liewehr DJ, Weng D, Kummar S, Gea-Banacloche J, Chow CK, Dean RM, Castro KM, Marchigiani D, Bishop MR, Fowler DH, Gress RE (2005). Establishing a platform for immunotherapy: clinical outcome and study of immune reconstitution after high-dose chemotherapy with progenitor cell support in breast cancer patients. Biol Blood Marrow Transplant  11, 472-83.   https://doi.org/10.1016/j.bbmt.2005.03.010




PubMed


 


PubMed ID 15931636
    
     


 



8.
Vance BA, Harley PH, Backlund PS, Ward Y, Phelps TL, Gress RE (2005). Human CD69 associates with an N-terminal fragment of calreticulin at the cell surface. Arch Biochem Biophys  438, 11-20.   https://doi.org/10.1016/j.abb.2005.04.009




PubMed


 


PubMed ID 15893733
    
     


 



9.
Williams KM, Hakim FT, Gress RE (2007). T cell immune reconstitution following lymphodepletion. Semin Immunol  19, 318-30.   https://doi.org/10.1016/j.smim.2007.10.004




PubMed



        
     
Free Article


 


PubMed ID 18023361
         Pubmed Central ID 2180244",https://intramural.nih.gov/search/searchview.taf?ipid=43809
257,BC010526-04,"October 01, 2005 -  September 30, 2006",Investigation of Persistent Viremia in Patients on Antiretroviral Therapy,John Miller Coffin; PhD,NULL,"Host Virus Interaction Branch, NCI",Frank  Maldarelli,"Scott  Brun
(-, Abbott Laboratories)




George  Hanna
(-, Abbott Laboratories)




Dale  Kempf





David M Margolis





John W Mellors





Deborah  Persaud
(Johns Hopkins University)


Show all 7",NULL,H. Clifford  Lane; MD (NIAID),"Ordered by publication type and then author name.



1.
Halvas EK, Aldrovandi GM, Balfe P, Beck IA, Boltz VF, Coffin JM, Frenkel LM, Hazelwood JD, Johnson VA, Kearney M, Kovacs A, Kuritzkes DR, Metzner KJ, Nissley DV, Nowicki M, Palmer S, Ziermann R, Zhao RY, Jennings CL, Bremer J, Brambilla D, Mellors JW (2006). Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency. J Clin Microbiol  44, 2612-4.   https://doi.org/10.1128/JCM.00449-06




PubMed



        
     
Free Article


 


PubMed ID 16825395
         Pubmed Central ID 1489464 


 



2.
Hazra R, Gafni RI, Maldarelli F, Balis FM, Tullio AN, DeCarlo E, Worrell CJ, Steinberg SM, Flaherty J, Yale K, Kearney BP, Zeichner SL (2005). Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy for pediatric HIV infection. Pediatrics  116, e846-54.   https://doi.org/10.1542/peds.2005-0975




PubMed


 


PubMed ID 16291735
    
     


 



3.
Palmer S, Boltz V, Maldarelli F, Kearney M, Halvas EK, Rock D, Falloon J, Davey RT, Dewar RL, Metcalf JA, Mellors JW, Coffin JM (2006). Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy. AIDS  20, 701-10.   https://doi.org/10.1097/01.aids.0000216370.69066.7f




PubMed


 


PubMed ID 16514300
    
     


 



4.
Palmer S, Boltz V, Martinson N, Maldarelli F, Gray G, McIntyre J, Mellors J, Morris L, Coffin J (2006). Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission. Proc Natl Acad Sci U S A  103, 7094-9.   https://doi.org/10.1073/pnas.0602033103




PubMed



        
     
Free Article


 


PubMed ID 16641095
         Pubmed Central ID 1459023 


 



5.
Palmer S, Kearney M, Maldarelli F, Halvas EK, Bixby CJ, Bazmi H, Rock D, Falloon J, Davey RT, Dewar RL, Metcalf JA, Hammer S, Mellors JW, Coffin JM (2005). Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis. J Clin Microbiol  43, 406-13.   https://doi.org/10.1128/JCM.43.1.406-413.2005




PubMed



        
     
Free Article


 


PubMed ID 15635002
         Pubmed Central ID 540111",https://intramural.nih.gov/search/searchview.taf?ipid=43804
258,BC010527-04,"October 01, 2005 -  September 30, 2006",Characterization of the Genetic Diversity of HIV-1 in Infected Individuals,John Miller Coffin; PhD,NULL,"Host Virus Interaction Branch, NCI",Frank  Maldarelli,"John W Mellors





Lynn  Morris
(National Institute for Communicable Diseases)




Pat  Robertson
(-, Boehringer Ingelheim)","Eric O Freed; PhD (National Cancer Institute)



Vineet Narain KewalRamani; PhD (National Cancer Institute)



Wei-Shau  Hu; PhD (National Cancer Institute)",H. Clifford  Lane; MD (NIAID),"Ordered by publication type and then author name.



1.
Bashirova AA, Bleiber G, Qi Y, Hutcheson H, Yamashita T, Johnson RC, Cheng J, Alter G, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, May M, Maldarelli F, Jacobson L, O'brien SJ, Telenti A, Carrington M (2006). Consistent effects of TSG101 genetic variability on multiple outcomes of exposure to human immunodeficiency virus type 1. J Virol  80, 6757-63.   https://doi.org/10.1128/jvi.00094-06




PubMed



        
     
Free Article


 


PubMed ID 16809281
         Pubmed Central ID 1489017 


 



2.
Halvas EK, Aldrovandi GM, Balfe P, Beck IA, Boltz VF, Coffin JM, Frenkel LM, Hazelwood JD, Johnson VA, Kearney M, Kovacs A, Kuritzkes DR, Metzner KJ, Nissley DV, Nowicki M, Palmer S, Ziermann R, Zhao RY, Jennings CL, Bremer J, Brambilla D, Mellors JW (2006). Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency. J Clin Microbiol  44, 2612-4.   https://doi.org/10.1128/JCM.00449-06




PubMed



        
     
Free Article


 


PubMed ID 16825395
         Pubmed Central ID 1489464 


 



3.
Palmer S, Boltz V, Maldarelli F, Kearney M, Halvas EK, Rock D, Falloon J, Davey RT, Dewar RL, Metcalf JA, Mellors JW, Coffin JM (2006). Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy. AIDS  20, 701-10.   https://doi.org/10.1097/01.aids.0000216370.69066.7f




PubMed


 


PubMed ID 16514300
    
     


 



4.
Palmer S, Boltz V, Martinson N, Maldarelli F, Gray G, McIntyre J, Mellors J, Morris L, Coffin J (2006). Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission. Proc Natl Acad Sci U S A  103, 7094-9.   https://doi.org/10.1073/pnas.0602033103




PubMed



        
     
Free Article


 


PubMed ID 16641095
         Pubmed Central ID 1459023",https://intramural.nih.gov/search/searchview.taf?ipid=43805
259,BC010528-04,"October 01, 2005 -  September 30, 2006",Characterization of the Genetic Diversity of HIV-1 in Infected Individuals,John Miller Coffin; PhD,NULL,"Host Virus Interaction Branch, NCI",Frank  Maldarelli,"Anuradha  Ganesan; MD
(Uniform Services University of the Health Sciences)




Sybil  Tasker
(-, National Naval Medical Center)",NULL,"H. Clifford  Lane; MD (NIAID) 



Richard T Davey; MD (NIAID)","Ordered by publication type and then author name.



1.
Halvas EK, Aldrovandi GM, Balfe P, Beck IA, Boltz VF, Coffin JM, Frenkel LM, Hazelwood JD, Johnson VA, Kearney M, Kovacs A, Kuritzkes DR, Metzner KJ, Nissley DV, Nowicki M, Palmer S, Ziermann R, Zhao RY, Jennings CL, Bremer J, Brambilla D, Mellors JW (2006). Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency. J Clin Microbiol  44, 2612-4.   https://doi.org/10.1128/JCM.00449-06




PubMed



        
     
Free Article


 


PubMed ID 16825395
         Pubmed Central ID 1489464 


 



2.
Palmer S, Boltz V, Maldarelli F, Kearney M, Halvas EK, Rock D, Falloon J, Davey RT, Dewar RL, Metcalf JA, Mellors JW, Coffin JM (2006). Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy. AIDS  20, 701-10.   https://doi.org/10.1097/01.aids.0000216370.69066.7f




PubMed


 


PubMed ID 16514300
    
     


 



3.
Palmer S, Boltz V, Martinson N, Maldarelli F, Gray G, McIntyre J, Mellors J, Morris L, Coffin J (2006). Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission. Proc Natl Acad Sci U S A  103, 7094-9.   https://doi.org/10.1073/pnas.0602033103




PubMed



        
     
Free Article


 


PubMed ID 16641095
         Pubmed Central ID 1459023",https://intramural.nih.gov/search/searchview.taf?ipid=43803
260,BC010529-04,"October 01, 2005 -  September 30, 2006",Regulated proteolysis in developmental signaling,Mark E Fortini,NULL,"Basic Research Laboratory, NCI","Ritu  Kanwar



Casper  Groth



Nikolaos  Tountas



Takeshi  Sasamura",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Doglio LE, Kanwar R, Jackson GR, Perez M, Avila J, Dingwall C, Dotti CG, Fortini ME, Feiguin F (2006). gamma-cleavage-independent functions of presenilin, nicastrin, and Aph-1 regulate cell-junction organization and prevent tau toxicity in vivo. Neuron  50, 359-75.   https://doi.org/10.1016/j.neuron.2006.03.038




PubMed


 


PubMed ID 16675392
    
     


 



2.
Seidner GA, Ye Y, Faraday MM, Alvord WG, Fortini ME (2006). Modeling clinically heterogeneous presenilin mutations with transgenic Drosophila. Curr Biol  16, 1026-33.   https://doi.org/10.1016/j.cub.2006.04.004




PubMed


 


PubMed ID 16713961",https://intramural.nih.gov/search/searchview.taf?ipid=43807
261,BC010530-04,"October 01, 2005 -  September 30, 2006",Molecular Therapeutics for HIVAIDS,"Dean H. Hamer; PhD



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Louise L Mchugh



Tao  Wang



Christopher J Richards



Kevin  Schully



Margaret Edgington Mckinney",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43810
262,BC010532-04,"October 01, 2005 -  September 30, 2006",Mechanisms of RT Template Switching and Role of RNase H in Drug Resistance,"Vinay K Pathak; PhD



IRP Faculty Profile",NULL,"Resistance Mechanisms Laboratory, NCI","Galina  Nikolenko



Yeshitila  Friew","Robert J. Gorelick; PhD
(AIDS and Cancer Virus Program, SAIC-Frederick, Inc.)
















Jeffrey  Anderson





John W Mellors





Deborah  Persaud
(Johns Hopkins University)




Marcelo  Soares; PhD
(Instituto Nacional de Cancer do Brasil)




Ronald I Swanstrom



Show all 7","Wei-Shau  Hu; PhD (National Cancer Institute)



John Miller Coffin; PhD (National Cancer Institute)



Sarah E Palmer (National Cancer Institute)



David  Derse; PhD (National Cancer Institute)



Vineet Narain KewalRamani; PhD (National Cancer Institute)



Frank  Maldarelli (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Krajewski K, Zhang Y, Parrish D, Deschamps J, Roller PP, Pathak VK (2006). New HIV-1 reverse transcriptase inhibitors based on a tricyclic benzothiophene scaffold: synthesis, resolution, and inhibitory activity. Bioorg Med Chem Lett  16, 3034-8.   https://doi.org/10.1016/j.bmcl.2006.02.049




PubMed


 


PubMed ID 16527484
    
     


 



2.
Voronin YA, Sidorov IA, Pathak VK (2006). A probability model predicting initiation efficiency of retroviral vectors with two primer-binding sites. J Theor Biol  242, 347-55.   https://doi.org/10.1016/j.jtbi.2006.03.003




PubMed


 


PubMed ID 16631208",https://intramural.nih.gov/search/searchview.taf?ipid=43849
263,BC010533-04,"October 01, 2005 -  September 30, 2006",Structural Determinants of RT That Influence Fidelity of Reverse Transcription,"Vinay K Pathak; PhD



IRP Faculty Profile",NULL,"Resistance Mechanisms Laboratory, NCI",Jean L Mbisa,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43850
264,BC010534-04,"October 01, 2005 -  September 30, 2006",Development and Characterization of Antiviral Drugs That Target HIV-1 Integrase,"Vinay K Pathak; PhD



IRP Faculty Profile",NULL,"Resistance Mechanisms Laboratory, NCI","Patricia A Henry; PhD



Abhay  Jere","Mamuka  Kvaratskhelia; PhD
(College of Pharmacy, Ohio State University)




Vladimir  Poroikov
(Lab. of Structure-Function Based Drug Design, Russian Academy of Medical Sciences)","Yves  Pommier; PhD (National Cancer Institute)



Terrence R Burke; PhD (National Cancer Institute)



Marc C Nicklaus (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43851
265,BC010537-04,"October 01, 2005 -  September 30, 2006",Molecular and Genetic Characterization of Mammalian MHC,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI","Naoya  Yuhki; MD



Thomas  Beck



Joan C Menninger



Lisa  Maslan



Emily L Howe



Katherine M Kelley



Show all 7","C. Scott  Baker
(School of Biological Sciences, University of Auckland)




Carsten  Muenk
(Div. of Medical Biotechnology, Paul-Ehrlich-Institute)




William J. Murphy
(NCI-FCRDC, NCI)




Douglas U Smith","Robert H Stephens (National Cancer Institute)



Howard A Young; PhD (National Cancer Institute)



Benjamin G Luttge (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43848
266,BC010538-04,"October 01, 2005 -  September 30, 2006",Molecular Analysis of Breast Cancer Metastasis to the Brain,"Patricia  Steeg; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Diane  Palmieri



Julie L Mason



Aamir  Ahmad



Brunilde M Gril","Kenneth Dean Aldape; MD
(Laboratory Of Pathology)




Raffael  Kurek
(Department of Obstetrics and Gynecology, University of Tuebingen)




Victoria  Richon
(Cancer Biology and Therapeutics, Merck)




Steven  Rubin
(Oncology, GlaxoSmithKline)




Andreas  Stark
(Department of Neurosurgery, Univeristy of Kiel)




Robert  Weil; MD
(NINDS)


Show all 7","Jeanne  Herring (National Cancer Institute)



Seth M Steinberg; PhD (National Cancer Institute)",Alexander Oliver Vortmeyer; MD (NINDS),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43841
267,BC010539-04,"October 01, 2005 -  September 30, 2006",Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma,"Karlyne M Reilly; BS, PhD",NULL,"Mouse Cancer Genetics Program, NCI","Krishan  Kumar



Jessica J Hawes","Karl  Broman
(University of Michigan)




Frederik  Mertens
(Clinical Genetics, Lund University)",David  Munroe (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43834
268,BC010540-04,"October 01, 2005 -  September 30, 2006",Molecular Mechanisms of Proliferation and Infiltration of Astrocytoma,"Karlyne M Reilly; BS, PhD",NULL,"Mouse Cancer Genetics Program, NCI","Demirkan B Gursel



Krishan  Kumar



Jessica J Hawes



Yvette Simone Connell-Albert","Ancha  Baranov
(Molecular and Microbiology, George Mason University)




Ken  McCarthy
(Pharmacology, U. North Carolina-Chapel Hill)","Thomas J Turbyville (National Cancer Institute)



Colin L Stewart; PhD (National Cancer Institute)



David  Munroe (National Cancer Institute)



John A Beutler (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43835
269,BC010541-04,"October 01, 2005 -  September 30, 2006",Development of Mouse Astrocytoma Model for Preclinical Testing of Experimental T,"Karlyne M Reilly; BS, PhD",NULL,"Mouse Cancer Genetics Program, NCI",Jessica J Hawes,NULL,"Melinda  Hollingshead (National Cancer Institute)



Peter L Choyke; MD (National Cancer Institute)



Marcelino  Bernardo (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43833
270,BC010542-04,"October 01, 2005 -  September 30, 2006",Biology of Keratinocyte and Cancer Stem Cells,Jonathan  Vogel; MD,NULL,"Dermatology Branch, NCI","Carole L Yee



Atsushi  Terunuma



Girish  Patel



Renuka  Pudi



Jennifer  Warner



Justin William Cross",NULL,"Mark  Udey; MD (National Cancer Institute)



John N Brady; PhD (National Cancer Institute)



William G Telford (National Cancer Institute)



Christoph  Rader; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Fan Q, Yee CL, Ohyama M, Tock C, Zhang G, Darling TN, Vogel JC (2006). Bone marrow-derived keratinocytes are not detected in normal skin and only rarely detected in wounded skin in two different murine models. Exp Hematol  34, 672-9.   https://doi.org/10.1016/j.exphem.2006.02.002




PubMed


 


PubMed ID 16647573
    
     


 



2.
Ohyama M, Terunuma A, Tock CL, Radonovich MF, Pise-Masison CA, Hopping SB, Brady JN, Udey MC, Vogel JC (2006). Characterization and isolation of stem cell-enriched human hair follicle bulge cells. J Clin Invest  116, 249-60.   https://doi.org/10.1172/JCI26043




PubMed



        
     
Free Article


 


PubMed ID 16395407
         Pubmed Central ID 1323261",https://intramural.nih.gov/search/searchview.taf?ipid=43831
271,BC010543-03,"October 01, 2005 -  September 30, 2006",HSP90 as a Molecular Target for Ionizing Radiation,"David R Gius; MD, PhD",NULL,"Radiation Oncology Branch, NCI","Kheem Singh Bisht



Lunching  Sun



Lei  Huang",NULL,Leonard  Neckers; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43535
272,BC010544-03,"October 01, 2005 -  September 30, 2006",Epigenetic regulation of of Gene Expression and multi-modality resistance in tum,"David R Gius; MD, PhD",NULL,"Radiation Oncology Branch, NCI","Kheem Singh Bisht



Lunching  Sun



Lei  Huang",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Fitzpatrick MA, Funk MC, Gius D, Huettner PC, Zhang Z, Bidder M, Ma D, Powell MA, Rader JS (2006). Identification of chromosomal alterations important in the development of cervical intraepithelial neoplasia and invasive carcinoma using alignment of DNA microarray data. Gynecol Oncol  103, 458-62.   https://doi.org/10.1016/j.ygyno.2006.03.020




PubMed


 


PubMed ID 16647105
    
     


 



2.
Gius D, Bradbury CM, Sun L, Awwad RT, Huang L, Smart DD, Bisht KS, Ho AS, Nguyen P (2005). The epigenome as a molecular marker and target. Cancer  104, 1789-93.   https://doi.org/10.1002/cncr.21395




PubMed


 


PubMed ID 16149092
    
     


 



3.
Nguyen P, Awwad RT, Smart DD, Spitz DR, Gius D (2006). Thioredoxin reductase as a novel molecular target for cancer therapy. Cancer Lett  236, 164-74.   https://doi.org/10.1016/j.canlet.2005.04.028




PubMed


 


PubMed ID 15955621
    
     


 



4.
Zhao W, Chuang EY, Mishra M, Awwad R, Bisht K, Sun L, Nguyen P, Pennington JD, Wang TJ, Bradbury CM, Huang L, Chen Z, Bar-Sela G, Robbins ME, Gius D (2006). Distinct effects of ionizing radiation on in vivo murine kidney and brain normal tissue gene expression. Clin Cancer Res  12, 3823-30.   https://doi.org/10.1158/1078-0432.CCR-05-2418




PubMed


 


PubMed ID 16778110",https://intramural.nih.gov/search/searchview.taf?ipid=43536
273,BC010547-04,"October 01, 2005 -  September 30, 2006",Development of Drugs That Target Prostate Cancer,"William D Figg; PharmD



IRP Faculty Profile",NULL,"Medical Oncology Branch, NCI","Nicola F Smith



Cindy Huong-Bich Chau



Haiqing  Li



Kristina  Cook



Christoph M Ahlers



Douglas K Price



Show all 7","Anthony  D'Amico
(Radiation Oncology, Harvard Medical School)




Sylvia  Ng
(Advanced Therapeutics, BC Cancer Research Centre)","William Laurence Dahut; MD (National Cancer Institute)



Mustafa  Hussain (National Cancer Institute)



John J Wright (National Cancer Institute)



Philip M Arlen; MD (National Cancer Institute)



James L Gulley; MD, PhD (National Cancer Institute)



Howard  Parnes (National Cancer Institute)",Clara Chi Chen; MD (CC),"Ordered by publication type and then author name.



1.
D'Amico AV, Chen MH, Cox MC, Dahut W, Figg WD (2005). Prostate-specific antigen response duration and risk of death for patients with hormone-refractory metastatic prostate cancer. Urology  66, 571-6.   https://doi.org/10.1016/j.urology.2005.03.083




PubMed


 


PubMed ID 16140080
    
     


 



2.
Figg WD, Liu Y, Arlen P, Gulley J, Steinberg SM, Liewehr DJ, Cox MC, Zhai S, Cremers S, Parr A, Yang X, Chen CC, Jones E, Dahut WL (2005). A randomized, phase II trial of ketoconazole plus alendronate versus ketoconazole alone in patients with androgen independent prostate cancer and bone metastases. J Urol  173, 790-6.   https://doi.org/10.1097/01.ju.0000147013.09157.8e




PubMed


 


PubMed ID 15711271
    
     


 



3.
Gulley JL, Figg WD, Steinberg SM, Carter J, Sartor O, Higano CS, Petrylak DP, Chatta G, Hussain MH, Dahut WL (2005). A prospective analysis of the time to normalization of serum androgens following 6 months of androgen deprivation therapy in patients on a randomized phase III clinical trial using limited hormonal therapy. J Urol  173, 1567-71.   https://doi.org/10.1097/01.ju.0000154780.72631.85




PubMed


 


PubMed ID 15821487
    
     


 



4.
Rozhansky F, Chen MH, Cox MC, Dahut W, Figg WD, D'Amico AV (2006). Prostate-specific antigen velocity and survival for patients with hormone-refractory metastatic prostate carcinoma. Cancer  106, 63-7.   https://doi.org/10.1002/cncr.21576




PubMed


 


PubMed ID 16333854
    
     


 



5.
Sharifi N, Dahut WL, Steinberg SM, Figg WD, Tarassoff C, Arlen P, Gulley JL (2005). A retrospective study of the time to clinical endpoints for advanced prostate cancer. BJU Int  96, 985-9.   https://doi.org/10.1111/j.1464-410X.2005.05798.x




PubMed


 


PubMed ID 16225513
    
     


 



6.
Singh AS, Figg WD (2005). In vivo models of prostate cancer metastasis to bone. J Urol  174, 820-6.   https://doi.org/10.1097/01.ju.0000169133.82167.aa




PubMed


 


PubMed ID 16093963
    
     


 



7.
Singh AS, Macpherson GR, Price DK, Schimel D, Figg WD (2006). Evaluation of human fetal bone implants in SCID mice as a model of prostate cancer bone metastasis. Oncol Rep  15, 519-24.




PubMed


 


PubMed ID 16465406",https://intramural.nih.gov/search/searchview.taf?ipid=43806
274,BC010549-03,"October 01, 2005 -  September 30, 2006",Zebrafish models of human leukemia and sarcoma,"Dennis D Hickstein



IRP Faculty Profile",NULL,"Experimental Transplantation and Immunology Branch, NCI","Lisa J Embree



Hatem E Sabaawy



Mizuki  Azuma",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43539
275,BC010555-04,"October 01, 2005 -  September 30, 2006",Generation of T-cell Responses by Dendritic Cell Presentation of Tumor Cells,"James Chung-Yin Yang; MD, PhD



IRP Faculty Profile",NULL,"Surgery Branch, NCI","Cynthia  Liu



Takashi  Inozume



Qiong J Wang",NULL,Nicholas Phillip Restifo; MD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43832
276,BC010558-03,"October 01, 2005 -  September 30, 2006",The Maintenance of Plasmids in Pathogenic Organisms,"Stuart J Austin



IRP Faculty Profile",NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Alena V Dabrazhynetskaya



Manjistha  Sengupta



Therese G Brendler; BS, PhD



Lucretia D Reaves



Brenda L Youngren",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43964
277,BC010559-03,"October 01, 2005 -  September 30, 2006",Identification of Non-BRCA12 Susceptibility Genes in Special Populations,"Jeffery P Struewing; MS, MD",NULL,"Laboratory of Population Genetics, NCI","Marbin A Pineda



Lutecia  Pereira","Mahmoud  Al-Masri
(Surgical Oncology, King Hussein Cancer Center)




James  Coyne
(Psychiatry, University of Pennsylvania)




Emmanualle  Genin
(Genetic Epidemiology, INSERM)","Kathleen A Calzone (National Cancer Institute)



Margaret Anne Tucker (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43853
278,BC010560-03,"October 01, 2005 -  September 30, 2006",Adjuvant Therapy of Breast Cancer,Sandra M Swain; MD,NULL,"Medical Oncology Branch, NCI",NULL,"Charles  Geyer
(NSABP)




Norman  Wolmark
(National Surgical Adjuvant Breast and Bowel Project)",NULL,Sherry M Yang (NINDS),"Ordered by publication type and then author name.



1.
Gradishar WJ, Wedam SB, Jahanzeb M, Erban J, Limentani SA, Tsai KT, Olsen SR, Swain SM (2005). Neoadjuvant docetaxel followed by adjuvant doxorubicin and cyclophosphamide in patients with stage III breast cancer. Ann Oncol  16, 1297-304.   https://doi.org/10.1093/annonc/mdi254




PubMed


 


PubMed ID 15905305
    
     


 



2.
Orzano JA, Swain SM (2005). Concepts and clinical trials of dose-dense chemotherapy for breast cancer . Clin Breast Cancer  6, 402-11.   https://doi.org/10.3816/CBC.2005.n.044




PubMed


 


PubMed ID 16381623
    
     


 



3.
Swain S, Berman A, Vatas U, Steinberg S, Anderson W, Lippman M   (2006) A prospective study of adjuvant CMF in males with node positive breast cancer: 20 year follow-up.  Breast Cancer Res Treat, in press.




 



4.
Swain S, Denduluri N   (2006) Amenorrhea in premenopausal women following adjuvant chemotherapy for breast cancer.  J Clin Oncol, in press.




 



5.
Swain SM (2005). Aromatase inhibitors--a triumph of translational oncology. N Engl J Med  353, 2807-9.   https://doi.org/10.1056/NEJMe058273




PubMed


 


PubMed ID 16382068
    
     


 



6.
Tan-Chiu E, Yothers G, Romond E, Geyer CE, Ewer M, Keefe D, Shannon RP, Swain SM, Brown A, Fehrenbacher L, Vogel VG, Seay TE, Rastogi P, Mamounas EP, Wolmark N, Bryant J (2005). Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31. J Clin Oncol  23, 7811-9.   https://doi.org/10.1200/JCO.2005.02.4091




PubMed


 


PubMed ID 16258083
    
     


 



7.
Wedam SB, Swain SM (2005). Contralateral breast cancer: where does it all begin? J Clin Oncol  23, 4585-7.   https://doi.org/10.1200/JCO.2005.01.910




PubMed


 


PubMed ID 15837973",https://intramural.nih.gov/search/searchview.taf?ipid=43855
279,BC010561-03,"October 01, 2005 -  September 30, 2006",Transcription factor mobility,James G McNally; PhD,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI","Rebekah L Halkyard



Tatiana  Karpova



Florian  Mueller","David  Auble
(Univ. Virginia)




Paul  Wach
(Biophysics, Graz University of Technology)",NULL,NULL,"Ordered by publication type and then author name.



1.
Sprague BL, Müller F, Pego RL, Bungay PM, Stavreva DA, McNally JG (2006). Analysis of binding at a single spatially localized cluster of binding sites by fluorescence recovery after photobleaching. Biophys J  91, 1169-91.   https://doi.org/10.1529/biophysj.105.073676




PubMed



        
     
Free Article


 


PubMed ID 16679358
         Pubmed Central ID 1518639 


 



2.
Stavreva DA, McNally JG (2006). Role of H1 phosphorylation in rapid GR exchange and function at the MMTV promoter. Histochem Cell Biol  125, 83-9.   https://doi.org/10.1007/s00418-005-0086-9




PubMed


 


PubMed ID 16397795",https://intramural.nih.gov/search/searchview.taf?ipid=43901
280,BC010562-03,"October 01, 2005 -  September 30, 2006",Molecular Interaction Maps and Analysis of Bioregulatory Networks,"Mirit I Aladjem; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI",NULL,NULL,Yves  Pommier; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Kohn KW, Aladjem MI (2006). Circuit diagrams for biological networks. Mol Syst Biol  2, 2006.0002.   https://doi.org/10.1038/msb4100044




PubMed



        
     
Free Article


 


PubMed ID 16738549
         Pubmed Central ID 1681476 


 



2.
Kohn KW, Aladjem MI, Weinstein JN, Pommier Y (2006). Molecular interaction maps of bioregulatory networks: a general rubric for systems biology. Mol Biol Cell  17, 1-13.   https://doi.org/10.1091/mbc.e05-09-0824




PubMed



        
     
Free Article


 


PubMed ID 16267266
         Pubmed Central ID 1345641 


 



3.
Pommier Y, Weinstein JN, Aladjem MI, Kohn KW (2006). Chk2 molecular interaction map and rationale for Chk2 inhibitors. Clin Cancer Res  12, 2657-61.   https://doi.org/10.1158/1078-0432.CCR-06-0743




PubMed


 


PubMed ID 16675556",https://intramural.nih.gov/search/searchview.taf?ipid=43869
281,BC010563-03,"October 01, 2005 -  September 30, 2006",Modulating T cell tolerance to elicit tumor immunity and autoimmunity,Arthur A Hurwitz,NULL,"Laboratory of Molecular Immunoregulation, NCI","Jami D Willette brown



Vinod  Singh



Thomas Y Wuest","Vincenzo  Bronte





Protul  Shrikant
(Department of Immunology, Roswell Park Cancer Institute)","Lionel  Feigenbaum (Office Of The Director)



Scott K Durum; PhD (National Cancer Institute)



Joost J Oppenheim; MD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43887
282,BC010564-03,"October 01, 2005 -  September 30, 2006",Large Scale Chromatin Structure,James G McNally; PhD,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",Hillary  Mueller,NULL,Andre A Nussenzweig; PhD (Experimental Immunology Branch),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43902
283,BC010565-03,"October 01, 2005 -  September 30, 2006",Determinants of Melanocyte Transformation and Melanoma Progression,Thomas J Hornyak,NULL,"Dermatology Branch, NCI",Shunlin  Jiang,NULL,Leonard  Neckers; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43884
284,BC010566-03,"October 01, 2005 -  September 30, 2006",Tumor and Metastasis Biology,Chand  Khanna; MD,NULL,"Pediatric Oncology Branch, NCI","Ling  Ren



Sung-Hyeok  Hong



Joseph  Briggs","Tim  Veenstra
(Laboratory of Systems Biology, SAIC Frederick)
















Mark  Berryman
(Department of Biomedical Sciences, Ohio University College of Osteopathic Medicine)




Anthony  Bretscher
(Cell Biology, Cornell University)




Richard  Gorlick
(Laboratory of Cellular Carcinogenesis and Tumor Promotion, Albert Einstein College of Medicine)




Timothy  Green
(Preclinical, AstraZeneca)




Eugenie  Kleinerman
(Pediatric Oncology, MD Anderson Cancer Center)


Show all 10","Lee Jay Helman; MD (National Cancer Institute)



Jeffrey E Green; MD (National Cancer Institute)



Nancy H Colburn; PhD (National Cancer Institute)



Joseph John Barchi (National Cancer Institute)



John A Beutler (National Cancer Institute)



Bruce Allen Shapiro; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Khanna C, Helman LJ (2006). Molecular approaches in pediatric oncology. Annu Rev Med  57, 83-97.   https://doi.org/10.1146/annurev.med.57.121304.131247




PubMed


 


PubMed ID 16409138
    
     


 



2.
Krishnan K, Khanna C, Helman LJ (2006). The molecular biology of pulmonary metastasis. Thorac Surg Clin  16, 115-24.   https://doi.org/10.1016/j.thorsurg.2005.12.003




PubMed


 


PubMed ID 16805200
    
     


 



3.
Riss J, Khanna C, Koo S, Chandramouli GV, Yang HH, Hu Y, Kleiner DE, Rosenwald A, Schaefer CF, Ben-Sasson SA, Yang L, Powell J, Kane DW, Star RA, Aprelikova O, Bauer K, Vasselli JR, Maranchie JK, Kohn KW, Buetow KH, Linehan WM, Weinstein JN, Lee MP, Klausner RD, Barrett JC (2006). Cancers as wounds that do not heal: differences and similarities between renal regeneration/repair and renal cell carcinoma. Cancer Res  66, 7216-24.   https://doi.org/10.1158/0008-5472.CAN-06-0040




PubMed


 


PubMed ID 16849569
    
     


 



4.
Terabe M, Khanna C, Bose S, Melchionda F, Mendoza A, Mackall CL, Helman LJ, Berzofsky JA (2006). CD1d-restricted natural killer T cells can down-regulate tumor immunosurveillance independent of interleukin-4 receptor-signal transducer and activator of transcription 6 or transforming growth factor-beta. Cancer Res  66, 3869-75.   https://doi.org/10.1158/0008-5472.CAN-05-3421




PubMed


 


PubMed ID 16585215
    
     


 



5.
Wan X, Shen N, Mendoza A, Khanna C, Helman LJ (2006). CCI-779 inhibits rhabdomyosarcoma xenograft growth by an antiangiogenic mechanism linked to the targeting of mTOR/Hif-1alpha/VEGF signaling. Neoplasia  8, 394-401.   https://doi.org/10.1593/neo.05820




PubMed



        
     
Free Article


 


PubMed ID 16790088
         Pubmed Central ID 1592447",https://intramural.nih.gov/search/searchview.taf?ipid=43897
285,BC010567-03,"October 01, 2005 -  September 30, 2006",Malignant Progression in Human Melanoma,Thomas J Hornyak,NULL,"Dermatology Branch, NCI","Mirza Ali Alikhan



Shunlin  Jiang



Nancy M Chung



Nitin  Sharma",NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=43885
286,BC010569-03,"October 01, 2005 -  September 30, 2006",Comparative Oncology Program,Chand  Khanna; MD,NULL,"Pediatric Oncology Branch, NCI","Ling  Ren



Christina  Mazcko



Melissa C Paoloni","Tim  Veenstra
(Laboratory of Systems Biology, SAIC Frederick)
















Lisa  Barber
(Veterinary Medicine, Tufts University)




Philip  Bergman
(Veterinary Medicine, The Animal Medical Center)




Matthew  Breen; PhD
(Veterinary Medicine, North Carolina State University)




Kenine  Comstock
(Cancer Center, Univeristy of MIchigan)




Timothy  Fan
(Veterinary Clinical Medicine, University of Illinois)


Show all 23","Steven  Libutti; MD (National Cancer Institute)



Stephen M Hewitt; MD, PhD (National Cancer Institute)



Paul S Meltzer; MD, PhD (Cancer Genetics Branch)



Howard A Fine; MD, PhD (National Cancer Institute)



Caryn  Steakley; BA, BSN, MSW (National Cancer Institute)












Daryl  Brooks  (Pharmaceutical Management Branch)",NULL,"Ordered by publication type and then author name.



1.
Khanna C   (2006) Cancer biology and metastases, in Small Animal Clinical Oncology. Vail x, Wtihrow x, eds., W.B. Saunders (Philadelphia), in press.




 



2.
Khanna C   (2006) Cancer Biology and Therapy in Dogs, in The Dog: Canine Genome Release. Linblad-Toh x, Ostrander x, eds., Cold Spring Harbor (New York), pp. 1-30.




 



3.
Khanna C   (2006) Molecular Diagnostics, in Small Animal Clinical Oncology. Vail x, Withrow x, eds., W.B. Saunders (Philadelphia), in press.




 



4.
Khanna C, Lindblad-Toh K, Vail D, London C, Bergman P, Barber L, Breen M, Kitchell B, McNeil E, Modiano JF, Niemi S, Comstock KE, Ostrander E, Westmoreland S, Withrow S (2006). The dog as a cancer model. Nat Biotechnol  24, 1065-6.   https://doi.org/10.1038/nbt0906-1065b




PubMed


 


PubMed ID 16964204
    
     


 



5.
Paoloni MC, Khanna C (2007). Comparative oncology today. Vet Clin North Am Small Anim Pract  37, 1023-32; v.   https://doi.org/10.1016/j.cvsm.2007.08.003




PubMed



        
     
Free Article


 


PubMed ID 17950880
         Pubmed Central ID 2174910",https://intramural.nih.gov/search/searchview.taf?ipid=43898
287,BC010571-03,"October 01, 2005 -  September 30, 2006",Fluorescence Imaging Facility,James G McNally; PhD,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",Tatiana  Karpova,NULL,Leonard  Neckers; PhD (National Cancer Institute),"Mary C Dasso; BA, PhD (NICHD)","Ordered by publication type and then author name.



1.
Koga F, Xu W, Karpova TS, McNally JG, Baron R, Neckers L (2006). Hsp90 inhibition transiently activates Src kinase and promotes Src-dependent Akt and Erk activation. Proc Natl Acad Sci U S A  103, 11318-22.   https://doi.org/10.1073/pnas.0604705103




PubMed



        
     
Free Article


 


PubMed ID 16844778
         Pubmed Central ID 1544084 


 



2.
Laricchia-Robbio L, Tamura T, Karpova T, Sprague BL, McNally JG, Ozato K (2005). Partner-regulated interaction of IFN regulatory factor 8 with chromatin visualized in live macrophages. Proc Natl Acad Sci U S A  102, 14368-73.   https://doi.org/10.1073/pnas.0504014102




PubMed



        
     
Free Article


 


PubMed ID 16183743
         Pubmed Central ID 1242294",https://intramural.nih.gov/search/searchview.taf?ipid=43900
288,BC010572-03,"October 01, 2005 -  September 30, 2006",Thyroid NodulesCancer and Radiation,"Jeffery P Struewing; MS, MD",NULL,"Laboratory of Population Genetics, NCI","Marbin A Pineda



Denise L Stredrick",NULL,"Charles E. Land; PhD (National Cancer Institute)



Alice  Sigurdson; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43854
289,BC010575-03,"October 01, 2005 -  September 30, 2006",Identification of New  Markers for Ovarian Cancer,"Maria  Merino; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI",Linda S Wrathall,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Torres-Cabala C, Bibbo M, Panizo-Santos A, Barazi H, Krutzsch H, Roberts DD, Merino MJ   (2006) Proteomic identification of new biomarkers and application in thyroid cytology.  Acta Cytol 50:518-28.




PubMed


 


PubMed ID 17017437",https://intramural.nih.gov/search/searchview.taf?ipid=43903
290,BC010578-03,"October 01, 2005 -  September 30, 2006",Targeting TEMs in Preclinical Tumor Models,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI","Steven  Seaman



Jill M Dunty",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43547
291,BC010579-03,"October 01, 2005 -  September 30, 2006",Papillomavirus Virion Proteins and Vaccines,"Douglas  Lowy; MD



IRP Faculty Profile",NULL,"Laboratory of Cellular Oncology, NCI","Alex  Papageorge



William C Vass","Joel  Palefsky
(Department of Medicine, University of California at San Francisco)




Richard  Roden
(Department of Pathology, Johns Hopkins School of Medicine)","Allan  Hildesheim; PhD (National Cancer Institute)



Ligia  Pinto (Interdisciplinary Studies Sect)



John  Schiller; PhD (National Cancer Institute)



Lauren V Wood; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Lowy D   (2006) History of Papillomavirus Research, in The Papillomaviruses. Garcea R, DiMaio D, eds., Springer (New York), in press.




 



2.
Lowy D   (2006) Perspectives on HPV Virus-Like Particle Vaccine Efficacy, in Emerging Issues of HPV Infections: From Science to Practice. Monsenego J, ed., Karger (Basel), pp. 217-226.




 



3.
Lowy D   (2006) The Papillomaviruses, in Fields Virology. Knipe K, Howley P, eds.,  Lippincott Williams and Wilkens, in press.




 



4.
Lowy D (2006) History of Papillomavirus Research, in The Papillomaviruses. Garcea R, DiMaio D, eds, Springer (New York), in press.




 



5.
Lowy D, Lowy D (2006) The Papillomaviruses, in Fields Virology. Knipe K, Howley P, eds, Lippincott Williams and Wilkens, in press.




 



6.
Buck CB, Day PM, Thompson CD, Lubkowski J, Lu W, Lowy DR, Schiller JT (2006). Human alpha-defensins block papillomavirus infection. Proc Natl Acad Sci U S A  103, 1516-21.   https://doi.org/10.1073/pnas.0508033103




PubMed



        
     
Free Article


 


PubMed ID 16432216
         Pubmed Central ID 1360544 


 



7.
Buck CB, Pastrana DV, Lowy DR, Schiller JT (2005). Generation of HPV pseudovirions using transfection and their use in neutralization assays. Methods Mol Med  119, 445-62.   https://doi.org/10.1385/1-59259-982-6:445




PubMed


 


PubMed ID 16350417
    
     


 



8.
Buck CB, Thompson CD, Roberts JN, Müller M, Lowy DR, Schiller JT (2006). Carrageenan is a potent inhibitor of papillomavirus infection. PLoS Pathog  2, e69.   https://doi.org/10.1371/journal.ppat.0020069




PubMed



        
     
Free Article


 


PubMed ID 16839203
         Pubmed Central ID 1500806 


 



9.
Lowy D   (2006) Prospects for Cervical Cancer Prevention by HPV Vaccination.  Cancer Research, in press.




 



10.
Lowy DR, Schiller JT (2006). Prophylactic human papillomavirus vaccines. J Clin Invest  116, 1167-73.   https://doi.org/10.1172/JCI28607




PubMed



        
     
Free Article


 


PubMed ID 16670757
         Pubmed Central ID 1451224 


 



11.
Richards RM, Lowy DR, Schiller JT, Day PM (2006). Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection. Proc Natl Acad Sci U S A  103, 1522-7.   https://doi.org/10.1073/pnas.0508815103




PubMed



        
     
Free Article


 


PubMed ID 16432208
         Pubmed Central ID 1360554",https://intramural.nih.gov/search/searchview.taf?ipid=43899
292,BC010580-03,"October 01, 2005 -  September 30, 2006",Phase II Trial of PEG-Intron in Children with Diffuse Pontine Gliomas,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Neuro-Oncology Branch, NCI","Karna L Robinson



David D Draper",NULL,"Frank M Balis; MD, PhD (National Cancer Institute)



Paul Stuart Albert (National Cancer Institute)



Pamela  Wolters (National Cancer Institute)



Howard A Fine; MD, PhD (National Cancer Institute)","John Anthony Butman; MD, PhD (CC)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43863
293,BC010581-03,"October 01, 2005 -  September 30, 2006",1H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients who,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Neuro-Oncology Branch, NCI","Karna L Robinson



David D Draper",NULL,"Frank M Balis; MD, PhD (National Cancer Institute)



Paul Stuart Albert (National Cancer Institute)



Pamela  Wolters (National Cancer Institute)



Howard A Fine; MD, PhD (National Cancer Institute)",Nicholas  Patronas; MD (CC),"Ordered by publication type and then author name.



1.
Steffen-Smith EA, Wolters PL, Albert PS, Baker EH, Shimoda KC, Barnett AS, Warren KE (2008). Detection and characterization of neurotoxicity in cancer patients using proton MR spectroscopy. Childs Nerv Syst  24, 807-13.   https://doi.org/10.1007/s00381-007-0576-2




PubMed



        
     
Free Article


 


PubMed ID 18293002
         Pubmed Central ID 2398763",https://intramural.nih.gov/search/searchview.taf?ipid=43864
294,BC010582-03,"October 01, 2005 -  September 30, 2006",A Comparative Study of Pediatric CNS Tumor Activity as Assessed by18F-- FDG PET,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Neuro-Oncology Branch, NCI","Karna L Robinson



David D Draper",NULL,NULL,"John Anthony Butman; MD, PhD (CC) 



Nicholas  Patronas; MD (CC)",There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=43865
295,BC010583-03,"October 01, 2005 -  September 30, 2006",Phase I Trial and Pharmacokinetic Study of Temozolomide and O6-Benzylguanine in,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Neuro-Oncology Branch, NCI",NULL,NULL,"Frank M Balis; MD, PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43862
296,BC010584-03,"October 01, 2005 -  September 30, 2006",A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatri,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Neuro-Oncology Branch, NCI",David D Draper,NULL,NULL,"Joseph A Frank; MD, MS (CC)",There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=43968
297,BC010585-03,"October 01, 2005 -  September 30, 2006",A Phase I Trial of CC-5013 (lenalidomide) in Pediatric Patients with Recurrent o,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Neuro-Oncology Branch, NCI",David D Draper,"Susan  Blaney
(Ped Onc, Baylor University/TCCC)




Larry  Kun
(Radiation Oncology, St. Jude Children's Research Hospital)




Roger  Packer
(Neurology, Children's Natl. Med. Ctr.)","Howard A Fine; MD, PhD (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=43967
298,BC010586-03,"October 01, 2005 -  September 30, 2006",Evaluation of the Natural History of Patients with Tumors of the Central Nervous,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Neuro-Oncology Branch, NCI",David D Draper,NULL,"Kevin A Camphausen; MD (National Cancer Institute)



Howard A Fine; MD, PhD (National Cancer Institute)",Russell R Lonser; MD (NINDS),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43861
299,BC010589-03,"October 01, 2005 -  September 30, 2006",Imaging characteristics of Diffuse Pontine Gliomas after Radiation Therapy,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Neuro-Oncology Branch, NCI",David D Draper,NULL,NULL,"John Anthony Butman; MD, PhD (CC)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43859
300,BC010590-03,"October 01, 2005 -  September 30, 2006",Phase II Trial of O6-Benzylguanine and Temozolomide in Pediatric Patients with H,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Neuro-Oncology Branch, NCI","Karna L Robinson



David D Draper","Susan  Blaney
(Ped Onc, Baylor University/TCCC)




Larry  Kun
(Radiation Oncology, St. Jude Children's Research Hospital)




Roger  Packer
(Neurology, Children's Natl. Med. Ctr.)","Frank M Balis; MD, PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43860
301,BC010591-03,"October 01, 2005 -  September 30, 2006",Characterization of Xenograft Models of Childhood Cancers,"Javed  Khan; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Jun S Wei



Sven  Bilke



Qingrong  Chen



Xinyu  Wen",NULL,Malcolm A Smith (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43895
302,BC010592-03,"October 01, 2005 -  September 30, 2006",Comparative Genomic Hybridization of Neuroblastoma,"Javed  Khan; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Jun S Wei



Sven  Bilke



Qingrong  Chen



Xinyu  Wen



Steffen  Durinck","John  Maris
(Pharmacology, Children's Hospital of Philadelphia)




Andrew  Pearson
(Paediatric Section, Institute of Cancer Research)




Manfred  Schwab
(Division Tumour Genetics, German Cancer Research Center)",NULL,NULL,"Ordered by publication type and then author name.



1.
Bilke S, Chen QR, Westerman F, Schwab M, Catchpoole D, Khan J (2005). Inferring a tumor progression model for neuroblastoma from genomic data. J Clin Oncol  23, 7322-31.   https://doi.org/10.1200/JCO.2005.03.2821




PubMed


 


PubMed ID 16145061
    
     


 



2.
Chen QR, Bilke S, Khan J (2005). High-resolution cDNA microarray-based comparative genomic hybridization analysis in neuroblastoma. Cancer Lett  228, 71-81.   https://doi.org/10.1016/j.canlet.2004.12.056




PubMed


 


PubMed ID 15951107
    
     


 



3.
Chen QR, Bilke S, Wei JS, Greer BT, Steinberg SM, Westermann F, Schwab M, Khan J (2006). Increased WSB1 copy number correlates with its over-expression which associates with increased survival in neuroblastoma. Genes Chromosomes Cancer  45, 856-62.   https://doi.org/10.1002/gcc.20349




PubMed


 


PubMed ID 16804916",https://intramural.nih.gov/search/searchview.taf?ipid=43896
303,BC010593-03,"October 01, 2005 -  September 30, 2006",Gene Expression Profiling of Normal Tissues,"Javed  Khan; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Jun S Wei



Sven  Bilke



Qingrong  Chen



Xinyu  Wen",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43893
304,BC010594-03,"October 01, 2005 -  September 30, 2006",Molecular Mechanisms of Drugs,"Javed  Khan; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Jun S Wei



Sven  Bilke



Quangeng  Zhang



Patricia S Tsang; PhD",NULL,Carol J Thiele (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43894
305,BC010595-03,"October 01, 2005 -  September 30, 2006",Host Genes That Influence HIV-1 Replication: APOBEC3G and TRIM5alpha,"Vinay K Pathak; PhD



IRP Faculty Profile",NULL,"Resistance Mechanisms Laboratory, NCI","Jean L Mbisa



Rebekah A Thorick



Hongzhan  Xu



Patricia A Henry; PhD



Yeshitila  Friew



Rebecca A Russell","Robert J. Gorelick; PhD
(AIDS and Cancer Virus Program, SAIC-Frederick, Inc.)





David  Ott
(SAIC-Frederick)





Dominic  Esposito
(Protein Expression Laboratory, SAIC-Frederick)
















Alan  Engelman; PhD
(Dana-Farber, Harvard University)




Reuben  Harris
(Biochemistry, University of Minnesota)




Mamuka  Kvaratskhelia; PhD
(College of Pharmacy, Ohio State University)


Show all 9","Wei-Shau  Hu; PhD (National Cancer Institute)



Eric O Freed; PhD (National Cancer Institute)



Elena  Chertova (National Cancer Institute)



William  Gillette (National Cancer Institute)",Klaus  Strebel; PhD (NIAID),"Ordered by publication type and then author name.



1.
Boyko V, Leavitt M, Gorelick R, Fu W, Nikolaitchik O, Pathak VK, Nagashima K, Hu WS (2006). Coassembly and complementation of Gag proteins from HIV-1 and HIV-2, two distinct human pathogens. Mol Cell  23, 281-7.   https://doi.org/10.1016/j.molcel.2006.05.028




PubMed


 


PubMed ID 16857594
    
     


 



2.
Fu W, Dang Q, Nagashima K, Freed EO, Pathak VK, Hu WS (2006). Effects of Gag mutation and processing on retroviral dimeric RNA maturation. J Virol  80, 1242-9.   https://doi.org/10.1128/JVI.80.3.1242-1249.2006




PubMed



        
     
Free Article


 


PubMed ID 16415001
         Pubmed Central ID 1346957",https://intramural.nih.gov/search/searchview.taf?ipid=43907
306,BC010596-03,"October 01, 2005 -  September 30, 2006",Pediatric Graft-vs-Host Disease,Alan S Wayne; MD,NULL,"Pediatric Oncology Branch, NCI","Cynthia P Love



Paula K Layton



Kristin  Baird",NULL,"Michael R Bishop; MD (National Cancer Institute)



Steven  Pavletic; MD, MS (National Cancer Institute)



Terry J Fry (National Cancer Institute)



Ronald E Gress; MD (National Cancer Institute)



Frances  Hakim; PhD (National Cancer Institute)



Daniel H Fowler (National Cancer Institute)",Austin John Barrett; MD (NHLBI),"Ordered by publication type and then author name.



1.
Couriel D, Carpenter PA, Cutler C, Bolaños-Meade J, Treister NS, Gea-Banacloche J, Shaughnessy P, Hymes S, Kim S, Wayne AS, Chien JW, Neumann J, Mitchell S, Syrjala K, Moravec CK, Abramovitz L, Liebermann J, Berger A, Gerber L, Schubert M, Filipovich AH, Weisdorf D, Schubert MM, Shulman H, Schultz K, et al. [6 more authors] (2006). Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant  12, 375-96.   https://doi.org/10.1016/j.bbmt.2006.02.003




PubMed


 


PubMed ID 16545722
    
     


 



2.
Yamashita K, Horwitz ME, Kwatemaa A, Nomicos E, Castro K, Sokolic R, Foster SF, Garofalo M, Choi U, Ryherd M, Brown MR, Leitman SF, Wayne AS, Fowler DH, Bishop MR, Childs RW, Barrett AJ, Pavletic SZ, Malech HL (2006). Unique abnormalities of CD4(+) and CD8(+) central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis. Biol Blood Marrow Transplant  12, 22-30.   https://doi.org/10.1016/j.bbmt.2005.11.004




PubMed


 


PubMed ID 16399598",https://intramural.nih.gov/search/searchview.taf?ipid=43866
307,BC010598-03,"October 01, 2005 -  September 30, 2006",Development of Novel Vaccine Strategies,"Jeffrey  Schlom; PhD



IRP Faculty Profile",NULL,"Laboratory of Tumor Immunology and Biology, NCI","Diane J Poole



Marion G Taylor



Garland M Davis



Judith M Dipietro



James W Hodge; PhD



Mala  Chakraborty; PhD



Show all 17","Tyler  Curiel
(Medical Oncology, University of Texas Health Science Center)




Alex  Franzusoff
(Research and Development, GlobeImmune)




Yang-Xin  Fu
(Pathology, University of Chicago)




Chandan  Guha
(Radiation Oncology, Montefiore Medical Center)




Stephen D Hursting; PhD, MPH
(Epidemiology and Carcinogenesis, NCI)




Howard  Kaufman
(Surgical Oncology, Columbia University College of Physicians and Surgeons)


Show all 10","Kevin A Camphausen; MD (National Cancer Institute)



Yutaka  Tagaya; MD, PhD (National Cancer Institute)","J Silvio  Gutkind; PhD (NIDCR) 



Marta Liliana Catalfamo; PhD (NIAID) 



Roshanak  Tolouei Semnani; PhD (NIAID)","Ordered by publication type and then author name.



1.
Gulley JL, Arlen PM, Bastian A, Morin S, Marte J, Beetham P, Tsang KY, Yokokawa J, Hodge JW, Ménard C, Camphausen K, Coleman CN, Sullivan F, Steinberg SM, Schlom J, Dahut W (2005). Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer. Clin Cancer Res  11, 3353-62.   https://doi.org/10.1158/1078-0432.CCR-04-2062




PubMed


 


PubMed ID 15867235
    
     


 



2.
Kudo-Saito C, Hodge JW, Kwak H, Kim-Schulze S, Schlom J, Kaufman HL (2006). 4-1BB ligand enhances tumor-specific immunity of poxvirus vaccines. Vaccine  24, 4975-86.   https://doi.org/10.1016/j.vaccine.2006.03.042




PubMed



        
     
Free Article


 


PubMed ID 16621183
         Pubmed Central ID 1865095 


 



3.
Kudo-Saito C, Schlom J, Camphausen K, Coleman CN, Hodge JW (2005). The requirement of multimodal therapy (vaccine, local tumor radiation, and reduction of suppressor cells) to eliminate established tumors. Clin Cancer Res  11, 4533-44.   https://doi.org/10.1158/1078-0432.CCR-04-2237




PubMed


 


PubMed ID 15958639
    
     


 



4.
Tsang KY, Palena C, Yokokawa J, Arlen PM, Gulley JL, Mazzara GP, Gritz L, Yafal AG, Ogueta S, Greenhalgh P, Manson K, Panicali D, Schlom J (2005). Analyses of recombinant vaccinia and fowlpox vaccine vectors expressing transgenes for two human tumor antigens and three human costimulatory molecules. Clin Cancer Res  11, 1597-607.   https://doi.org/10.1158/1078-0432.CCR-04-1609




PubMed


 


PubMed ID 15746065
    
     


 



5.
Yang S, Hodge JW, Grosenbach DW, Schlom J (2005). Vaccines with enhanced costimulation maintain high avidity memory CTL. J Immunol  175, 3715-23.   https://doi.org/10.4049/jimmunol.175.6.3715




PubMed



        
     
Free Article


 


PubMed ID 16148117
         Pubmed Central ID 1350817 


 



6.
Schlom J, Pastan I, Tsang K (submitted in 2006) Immunogenic Peptides And Methods Of Use. Patents issued: 1989224 (BE in 2011); 1989224 (CH in 2011); 1989224 (DE in 2011); 1989224 (DK in 2011); 1989224 (EP in 2011); 1989224 (ES in 2011); 1989224 (FR in 2011); 1989224 (GB in 2011); 1989224 (IT in 2011); 1989224 (NL in 2011); 1989224 (SE in 2011); ATE485305T1 (AT in 2011); 7,910,692 (US in 2011); 2007221255 (AU in 2012); 2642994 (CA in 2015); 9,175,057 (US in 2016). Patent pending: PCT/US2007/004603 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=43543
308,BC010599-03,"October 01, 2005 -  September 30, 2006",Mechanisms of Transcriptional Repression by Histone Deacetylase Inhibitors,Catharine L Smith; PhD,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI","Angeliki  Magklara



Sang  Lee



Anne  Gussow",NULL,Carol J Thiele (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43544
309,BC010600-03,"October 01, 2005 -  September 30, 2006",Study of AAA proteins by X-ray protein crystallography,"Di S Xia; PhD, MS, BS



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Lothar  Esser



Dongyang  Li",NULL,Michael  Maurizi; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43868
310,BC010603-03,"October 01, 2005 -  September 30, 2006",Receptor -directed therapy,John  Janik; MD,"Thomas Alexander Waldmann; MD, PhD","Lymphoid Malignancies Branch, NCI","Wendy W Gao



Diana  O'Hagan



Leslie S Moses



Cathryn C Lee



Neelam  Gulati



Helen  Matthews



Show all 7",NULL,John N Brady; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43888
311,BC010604-03,"October 01, 2005 -  September 30, 2006",Epigenetic Studies of Gastro-Intestinal Cancers,Karen  Woodson,NULL,"Cancer Genetics Branch, NCI",NULL,NULL,"Sanford Martin Dawsey; MD (National Cancer Institute)



Christian Cormac Abnet; PhD, MPH (National Cancer Institute)



Mark J Roth (National Cancer Institute)



Philip  Taylor; MD, ScD (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=43867
312,BC010607-03,"October 01, 2005 -  September 30, 2006",Ras-mediated signals in human epithelial cell transformation and metastasis,"Kathleen  Kelly; PhD



IRP Faculty Profile",NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Ivy (Juan Juan)  Yin



Michael David Oberst



Kathleen E Romero



Orla Majella Casey",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43892
313,BC010608-02,"October 01, 2005 -  September 30, 2006",CCR RNAi Initiative:  Overview,"Natasha  Caplen



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Konrad  Huppi; MD, PhD



Mark  Mackiewicz



Scott E Martin",NULL,Paul  Goldsmith; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Griesenbach U, Kitson C, Escudero Garcia S, Farley R, Singh C, Somerton L, Painter H, Smith RL, Gill DR, Hyde SC, Chow YH, Hu J, Gray M, Edbrooke M, Ogilvie V, MacGregor G, Scheule RK, Cheng SH, Caplen NJ, Alton EW (2006). Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo. Respir Res  7, 26.   https://doi.org/10.1186/1465-9921-7-26




PubMed



        
     
Free Article


 


PubMed ID 16480492
         Pubmed Central ID 1420290 


 



2.
Huppi K, Martin SE, Caplen NJ (2005). Defining and assaying RNAi in mammalian cells. Mol Cell  17, 1-10.   https://doi.org/10.1016/j.molcel.2004.12.017




PubMed


 


PubMed ID 15629712
    
     


 



3.
Ludwig JA, Szakács G, Martin SE, Chu BF, Cardarelli C, Sauna ZE, Caplen NJ, Fales HM, Ambudkar SV, Weinstein JN, Gottesman MM (2006). Selective toxicity of NSC73306 in MDR1-positive cells as a new strategy to circumvent multidrug resistance in cancer. Cancer Res  66, 4808-15.   https://doi.org/10.1158/0008-5472.CAN-05-3322




PubMed



        
     
Free Article


 


PubMed ID 16651436
         Pubmed Central ID 1474781",https://intramural.nih.gov/search/searchview.taf?ipid=43920
314,BC010609-02,"October 01, 2005 -  September 30, 2006",RNAi Analysis of the ATP-binding Cassette (ABC) Family of Proteins,"Natasha  Caplen



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI",Scott E Martin,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Calcagno AM, Fostel JM, To KK, Salcido CD, Martin SE, Chewning KJ, Wu CP, Varticovski L, Bates SE, Caplen NJ, Ambudkar SV (2008). Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes. Br J Cancer  98, 1515-24.   https://doi.org/10.1038/sj.bjc.6604334




PubMed



        
     
Free Article


 


PubMed ID 18382425
         Pubmed Central ID 2386965",https://intramural.nih.gov/search/searchview.taf?ipid=43921
315,BC010611-02,"October 01, 2005 -  September 30, 2006",RNAi Analysis of the IGF Pathway,"Natasha  Caplen



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI",Scott E Martin,NULL,"James  McMahon; PhD (National Cancer Institute)



Paul  Goldsmith; PhD (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=43923
316,BC010612-02,"October 01, 2005 -  September 30, 2006",The Role of MicroRNAs in the Regulation of Gene Expression,"Natasha  Caplen



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Konrad  Huppi; MD, PhD



Scott E Martin



Mark  Mackiewicz",NULL,Robert H Stephens (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Martin SE, Caplen NJ (2006). Mismatched siRNAs downregulate mRNAs as a function of target site location. FEBS Lett  580, 3694-8.   https://doi.org/10.1016/j.febslet.2006.05.056




PubMed


 


PubMed ID 16764866
    
     


 



2.
Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC (2006). Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell  9, 189-98.   https://doi.org/10.1016/j.ccr.2006.01.025




PubMed


 


PubMed ID 16530703",https://intramural.nih.gov/search/searchview.taf?ipid=43924
317,BC010613-02,"October 01, 2005 -  September 30, 2006",CCR RNAi Initiative: Validation of siRNAs Against Cancer-Associated Genes,"Natasha  Caplen



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Konrad  Huppi; MD, PhD



Scott E Martin",NULL,Paul  Goldsmith; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Ludwig JA, Szakács G, Martin SE, Chu BF, Cardarelli C, Sauna ZE, Caplen NJ, Fales HM, Ambudkar SV, Weinstein JN, Gottesman MM (2006). Selective toxicity of NSC73306 in MDR1-positive cells as a new strategy to circumvent multidrug resistance in cancer. Cancer Res  66, 4808-15.   https://doi.org/10.1158/0008-5472.CAN-05-3322




PubMed



        
     
Free Article


 


PubMed ID 16651436
         Pubmed Central ID 1474781 


 



2.
Lorenzi PL, Caplen NL, Weinstein JL (submitted in 2006) Materials And Methods Directed To Asparagine Synthetase And Asparaginase Therapies. Patents issued: 7,985,548 (US in 2011); 9,181,552 (US in 2016). Patent pending: PCT/US2007/005555 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=43925
318,BC010614-02,"October 01, 2005 -  September 30, 2006",CCR RNAi Initiative: Establishment of shRNA RNAi Library Screens,"Natasha  Caplen



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI",NULL,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=43926
319,BC010615-02,"October 01, 2005 -  September 30, 2006",CCR RNAi Initiative: Technology and Assay Development,"Natasha  Caplen



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Tamara L Jones



Konrad  Huppi; MD, PhD



Scott E Martin",NULL,Paul  Goldsmith; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Ludwig JA, Szakács G, Martin SE, Chu BF, Cardarelli C, Sauna ZE, Caplen NJ, Fales HM, Ambudkar SV, Weinstein JN, Gottesman MM (2006). Selective toxicity of NSC73306 in MDR1-positive cells as a new strategy to circumvent multidrug resistance in cancer. Cancer Res  66, 4808-15.   https://doi.org/10.1158/0008-5472.CAN-05-3322




PubMed



        
     
Free Article


 


PubMed ID 16651436
         Pubmed Central ID 1474781 


 



2.
Martin SE, Caplen NJ (2006). Mismatched siRNAs downregulate mRNAs as a function of target site location. FEBS Lett  580, 3694-8.   https://doi.org/10.1016/j.febslet.2006.05.056




PubMed


 


PubMed ID 16764866",https://intramural.nih.gov/search/searchview.taf?ipid=43927
320,BC010619-03,"October 01, 2005 -  September 30, 2006",Assembly and Release of HIV-1 and Other Retroviruses,"Eric O Freed; PhD



IRP Faculty Profile",NULL,"Retroviral Replication Laboratory, NCI","Catherine  Adamson



Karine  Gousset



Benjamin G Luttge



Anjali  Joshi



Ken  Fujii","Tim  Veenstra
(Laboratory of Systems Biology, SAIC Frederick)
















Javad  Aman
(Medicine, USAMRID)




Sina  Bavari
(-, USAMRIID)




Louis  Mansky
(-, University of Minnesota)




Tsutomu  Murakami
(Nishihara, University of the Ryukyus)




Karl  Salzwedel; PhD



Show all 9","Vinay K Pathak; PhD (National Cancer Institute)



Frank  Maldarelli (National Cancer Institute)



John Miller Coffin; PhD (National Cancer Institute)



Sarah E Palmer (National Cancer Institute)



Robert  Blumenthal; PhD (National Cancer Institute)



Terrence R Burke; PhD (National Cancer Institute)","Judith Goldstein Levin; PhD (NICHD) 



Alasdair C Steven; PhD (NIAMS) 



James H Hurley; PhD (NIDDK)","Ordered by publication type and then author name.



1.
Adamson CS, Ablan SD, Boeras I, Goila-Gaur R, Soheilian F, Nagashima K, Li F, Salzwedel K, Sakalian M, Wild CT, Freed EO (2006). In vitro resistance to the human immunodeficiency virus type 1 maturation inhibitor PA-457 (Bevirimat). J Virol  80, 10957-71.   https://doi.org/10.1128/JVI.01369-06




PubMed



        
     
Free Article


 


PubMed ID 16956950
         Pubmed Central ID 1642185 


 



2.
Davis MR, Jiang J, Zhou J, Freed EO, Aiken C (2006). A mutation in the human immunodeficiency virus type 1 Gag protein destabilizes the interaction of the envelope protein subunits gp120 and gp41. J Virol  80, 2405-17.   https://doi.org/10.1128/JVI.80.5.2405-2417.2006




PubMed



        
     
Free Article


 


PubMed ID 16474147
         Pubmed Central ID 1395406 


 



3.
Freed EO (2006). HIV-1 Gag: flipped out for PI(4,5)P(2). Proc Natl Acad Sci U S A  103, 11101-2.   https://doi.org/10.1073/pnas.0604715103




PubMed



        
     
Free Article


 


PubMed ID 16847255
         Pubmed Central ID 1544048 


 



4.
Fu W, Dang Q, Nagashima K, Freed EO, Pathak VK, Hu WS (2006). Effects of Gag mutation and processing on retroviral dimeric RNA maturation. J Virol  80, 1242-9.   https://doi.org/10.1128/JVI.80.3.1242-1249.2006




PubMed



        
     
Free Article


 


PubMed ID 16415001
         Pubmed Central ID 1346957 


 



5.
Joshi A, Nagashima K, Freed EO (2006). Mutation of dileucine-like motifs in the human immunodeficiency virus type 1 capsid disrupts virus assembly, gag-gag interactions, gag-membrane binding, and virion maturation. J Virol  80, 7939-51.   https://doi.org/10.1128/JVI.00355-06




PubMed



        
     
Free Article


 


PubMed ID 16873251
         Pubmed Central ID 1563813 


 



6.
Li F, Zoumplis D, Matallana C, Kilgore NR, Reddick M, Yunus AS, Adamson CS, Salzwedel K, Martin DE, Allaway GP, Freed EO, Wild CT (2006). Determinants of activity of the HIV-1 maturation inhibitor PA-457. Virology  356, 217-24.   https://doi.org/10.1016/j.virol.2006.07.023




PubMed


 


PubMed ID 16930665
    
     


 



7.
Ono A, Freed EO (2005). Role of lipid rafts in virus replication. Adv Virus Res  64, 311-58.   https://doi.org/10.1016/S0065-3527(05)64010-9




PubMed


 


PubMed ID 16139599
    
     


 



8.
Ono A, Waheed AA, Joshi A, Freed EO (2005). Association of human immunodeficiency virus type 1 gag with membrane does not require highly basic sequences in the nucleocapsid: use of a novel Gag multimerization assay. J Virol  79, 14131-40.   https://doi.org/10.1128/JVI.79.22.14131-14140.2005




PubMed



        
     
Free Article


 


PubMed ID 16254348
         Pubmed Central ID 1280195",https://intramural.nih.gov/search/searchview.taf?ipid=43881
321,BC010620-03,"October 01, 2005 -  September 30, 2006",Clinical Studies of Multidrug Resistance Reversal,Susan  Bates; MD,NULL,"Medical Oncology Branch, NCI","Robert W Robey



Zhirong  Zhan



Kenneth A Steadman",NULL,"Antonio  Fojo; MD, PhD (National Cancer Institute)



William D Figg; PharmD (National Cancer Institute)",Clara Chi Chen; MD (CC),"Ordered by publication type and then author name.



1.
Dean M, Fojo T, Bates S (2005). Tumour stem cells and drug resistance. Nat Rev Cancer  5, 275-84.   https://doi.org/10.1038/nrc1590




PubMed


 


PubMed ID 15803154
    
     


 



2.
Dong D, Ko B, Baumeister P, Swenson S, Costa F, Markland F, Stiles C, Patterson JB, Bates SE, Lee AS (2005). Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironment. Cancer Res  65, 5785-91.   https://doi.org/10.1158/0008-5472.CAN-05-0754




PubMed


 


PubMed ID 15994954
    
     


 



3.
Lepper ER, Baker SD, Permenter M, Ries N, van Schaik RH, Schenk PW, Price DK, Ahn D, Smith NF, Cusatis G, Ingersoll RG, Bates SE, Mathijssen RH, Verweij J, Figg WD, Sparreboom A (2005). Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients. Clin Cancer Res  11, 7398-404.   https://doi.org/10.1158/1078-0432.CCR-05-0520




PubMed


 


PubMed ID 16243813
    
     


 



4.
Nesterova MV, Johnson N, Cheadle C, Bates SE, Mani S, Stratakis CA, Khan IU, Kahn I, Gupta RK, Cho-Chung YS (2006). Autoantibody cancer biomarker: extracellular protein kinase A. Cancer Res  66, 8971-4.   https://doi.org/10.1158/0008-5472.CAN-06-1049




PubMed


 


PubMed ID 16982736
    
     


 



5.
Robey RW, Zhan Z, Piekarz RL, Kayastha GL, Fojo T, Bates SE (2006). Increased MDR1 expression in normal and malignant peripheral blood mononuclear cells obtained from patients receiving depsipeptide (FR901228, FK228, NSC630176). Clin Cancer Res  12, 1547-55.   https://doi.org/10.1158/1078-0432.CCR-05-1423




PubMed


 


PubMed ID 16533780
    
     


 



6.
Sisodiya SM, Bates SE (2006). Treatment of drug resistance in epilepsy: one step at a time. Lancet Neurol  5, 380-1.   https://doi.org/10.1016/S1474-4422(06)70422-7




PubMed


 


PubMed ID 16632304
    
     


 



7.
Stein WD, Litman T, Fojo T, Bates SE (2005). Differential expression of cell adhesion genes: implications for drug resistance. Int J Cancer  113, 861-5.   https://doi.org/10.1002/ijc.20671




PubMed


 


PubMed ID 15514970",https://intramural.nih.gov/search/searchview.taf?ipid=43874
322,BC010621-03,"October 01, 2005 -  September 30, 2006",II. Clinical and Laboratory Studies of the Histone Deacetylase Inhibitor Depsipe,Susan  Bates; MD,NULL,"Medical Oncology Branch, NCI","Robert W Robey



Zhirong  Zhan



Richard Lawrence Piekarz



Kenneth A Steadman",NULL,"Antonio  Fojo; MD, PhD (National Cancer Institute)



Seth M Steinberg; PhD (National Cancer Institute)



Maria L Turner; MD (National Cancer Institute)



William D Figg; PharmD (National Cancer Institute)



Elaine S Jaffe; MD (National Cancer Institute)","Danny L Sackett; PhD (NICHD) 



Douglas R Rosing; MD (NHLBI) 



April R Robbins; PhD (NIDDK)","Ordered by publication type and then author name.



1.
Bates SE, Rosing DR, Fojo T, Piekarz RL (2006). Challenges of evaluating the cardiac effects of anticancer agents. Clin Cancer Res  12, 3871-4.   https://doi.org/10.1158/1078-0432.CCR-06-1017




PubMed


 


PubMed ID 16818679
    
     


 



2.
Piekarz RL, Frye AR, Wright JJ, Steinberg SM, Liewehr DJ, Rosing DR, Sachdev V, Fojo T, Bates SE (2006). Cardiac studies in patients treated with depsipeptide, FK228, in a phase II trial for T-cell lymphoma. Clin Cancer Res  12, 3762-73.   https://doi.org/10.1158/1078-0432.CCR-05-2095




PubMed


 


PubMed ID 16778104
    
     


 



3.
Robbins AR, Jablonski SA, Yen TJ, Yoda K, Robey R, Bates SE, Sackett DL (2005). Inhibitors of histone deacetylases alter kinetochore assembly by disrupting pericentromeric heterochromatin. Cell Cycle  4, 717-26.   https://doi.org/10.4161/cc.4.5.1690




PubMed


 


PubMed ID 15846093
    
     


 



4.
Robey RW, Zhan Z, Piekarz RL, Kayastha GL, Fojo T, Bates SE (2006). Increased MDR1 expression in normal and malignant peripheral blood mononuclear cells obtained from patients receiving depsipeptide (FR901228, FK228, NSC630176). Clin Cancer Res  12, 1547-55.   https://doi.org/10.1158/1078-0432.CCR-05-1423




PubMed


 


PubMed ID 16533780",https://intramural.nih.gov/search/searchview.taf?ipid=43872
323,BC010622-03,"October 01, 2005 -  September 30, 2006",III. Investigation of the ABC Half-Transporter ABCG2,Susan  Bates; MD,NULL,"Medical Oncology Branch, NCI","Robert W Robey



Orsolya  Polgar



Kin Wah  To



John F Deeken","Gary  Kruh; MD, PhD
(Medical Science Division, Fox Chase Cancer Center)




Balazs  Sarkadi
(Dept Cell Metabolism, National Insitute of Hematology and Immunology)","Patricia A Fetsch (National Cancer Institute)



Michael  Dean; PhD (National Cancer Institute)



Andrea  Abati; BS, MD (National Cancer Institute)



Alexander  Sparreboom (National Cancer Institute)



Curtis  Henrich (National Cancer Institute)



William D Figg; PharmD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Henrich CJ, Bokesch HR, Dean M, Bates SE, Robey RW, Goncharova EI, Wilson JA, McMahon JB (2006). A high-throughput cell-based assay for inhibitors of ABCG2 activity. J Biomol Screen  11, 176-83.   https://doi.org/10.1177/1087057105284576




PubMed


 


PubMed ID 16490770
    
     


 



2.
Polgar O, Ozvegy-Laczka C, Robey RW, Morisaki K, Okada M, Tamaki A, Koblos G, Elkind NB, Ward Y, Dean M, Sarkadi B, Bates SE (2006). Mutational studies of G553 in TM5 of ABCG2: a residue potentially involved in dimerization. Biochemistry  45, 5251-60.   https://doi.org/10.1021/bi0521590




PubMed



        
     
Free Article


 


PubMed ID 16618113
         Pubmed Central ID 2548280 


 



3.
Robey RW, Fetsch PA, Polgar O, Dean M, Bates SE (2006). The livestock photosensitizer, phytoporphyrin (phylloerythrin), is a substrate of the ATP-binding cassette transporter ABCG2. Res Vet Sci  81, 345-9.   https://doi.org/10.1016/j.rvsc.2006.04.003




PubMed


 


PubMed ID 16808938
    
     


 



4.
Shukla S, Robey RW, Bates SE, Ambudkar SV (2006). The calcium channel blockers, 1,4-dihydropyridines, are substrates of the multidrug resistance-linked ABC drug transporter, ABCG2. Biochemistry  45, 8940-51.   https://doi.org/10.1021/bi060552f




PubMed


 


PubMed ID 16846237
    
     


 



5.
To KK, Zhan Z, Bates SE (2006). Aberrant promoter methylation of the ABCG2 gene in renal carcinoma. Mol Cell Biol  26, 8572-85.   https://doi.org/10.1128/MCB.00650-06




PubMed



        
     
Free Article


 


PubMed ID 16954373
         Pubmed Central ID 1636795",https://intramural.nih.gov/search/searchview.taf?ipid=43873
324,BC010623-03,"October 01, 2005 -  September 30, 2006",The molecular recognition of proteins by antibodies: A model for rational design,"Sandra  Smith-Gill; MS, PhD, BS",NULL,"Structural Biophysics Laboratory, NCI","Claudia A Lipschultz



Mauro  Acchione



Morgan  Desantis","Peter  Hinterdorfer
(University of Linz)




Roy  Mariuzza
(W.M. Keck Laboratory for Structural Biology, University of Maryland Biotechnology Institute)




Neeti  Sinha





Richard  Willson
(Chemical Engineering, University of Houston)",Yun  Wang (Nucleic Acid NMR Section),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43545
325,BC010624-02,"October 01, 2005 -  September 30, 2006",The Molecular Profile of Prostate Tumors in African-American Men,"Stefan  Ambs



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","Tiffany Marie Howe



Robyn  Prueitt



Tiffany A Wallace



Robert Scott Hudson","Carlo M Croce





Chris  Loffredo
(Cancer Genetics and Epidemiology Program, Georgetown University)","Neil Edward Caporaso; MS, MD (National Cancer Institute)



James Jerome Goedert; MD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43913
326,BC010625-03,"October 01, 2005 -  September 30, 2006",Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance,"Antonio  Fojo; MD, PhD",NULL,"Medical Oncology Branch, NCI","Marianne  Poruchynsky



Shana Y Trostel



Masaki  Okada",NULL,"Susan  Bates; MD (National Cancer Institute)



William D Figg; PharmD (National Cancer Institute)



Frank M Balis; MD, PhD (National Cancer Institute)



Yvona  Ward; PhD (National Cancer Institute)



Sandra M Swain; MD (National Cancer Institute)",Danny L Sackett; PhD (NICHD),"Ordered by publication type and then author name.



1.
Fojo AT, Menefee M (2005). Microtubule targeting agents: basic mechanisms of multidrug resistance (MDR). Semin Oncol  32, S3-8.   https://doi.org/10.1053/j.seminoncol.2005.09.010




PubMed


 


PubMed ID 16360716
    
     


 



2.
Niederhuber JE, Fojo T   (2006) Treatment of metastatic disease in patients with neuroendocrine tumors.  Surg Oncol Clin N Am 15:511-33, viii.




PubMed


 


PubMed ID 16882495
    
     


 



3.
Trostel SY, Sackett DL, Fojo T (2006). Oligomerization of p53 precedes its association with dynein and nuclear accumulation. Cell Cycle  5, 2253-9.   https://doi.org/10.4161/cc.5.19.3291




PubMed


 


PubMed ID 16969106",https://intramural.nih.gov/search/searchview.taf?ipid=43876
327,BC010627-03,"October 01, 2005 -  September 30, 2006",Clinical Pharmacogenetics,"William D Figg; PharmD



IRP Faculty Profile",NULL,"Medical Oncology Branch, NCI","Nicola F Smith



Tristan  Sissung



Akinobu  Hamada",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Baker SD, Li J, ten Tije AJ, Figg WD, Graveland W, Verweij J, Sparreboom A (2005). Relationship of systemic exposure to unbound docetaxel and neutropenia. Clin Pharmacol Ther  77, 43-53.   https://doi.org/10.1016/j.clpt.2004.09.005




PubMed


 


PubMed ID 15637530
    
     


 



2.
Figg WD, Chau CH (2006). Heterogeneity in drug disposition determines interindividual variability of docetaxel pharmacokinetics. Cancer Biol Ther  5, 840-1.   https://doi.org/10.4161/cbt.5.7.3025




PubMed


 


PubMed ID 16880730
    
     


 



3.
Gardner ER, Burger H, van Schaik RH, van Oosterom AT, de Bruijn EA, Guetens G, Prenen H, de Jong FA, Baker SD, Bates SE, Figg WD, Verweij J, Sparreboom A, Nooter K (2006). Association of enzyme and transporter genotypes with the pharmacokinetics of imatinib. Clin Pharmacol Ther  80, 192-201.   https://doi.org/10.1016/j.clpt.2006.05.003




PubMed


 


PubMed ID 16890580
    
     


 



4.
Lepper ER, Baker SD, Permenter M, Ries N, van Schaik RH, Schenk PW, Price DK, Ahn D, Smith NF, Cusatis G, Ingersoll RG, Bates SE, Mathijssen RH, Verweij J, Figg WD, Sparreboom A (2005). Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients. Clin Cancer Res  11, 7398-404.   https://doi.org/10.1158/1078-0432.CCR-05-0520




PubMed


 


PubMed ID 16243813
    
     


 



5.
Scripture CD, Figg WD, Sparreboom A (2006). The role of drug-metabolising enzymes in clinical responses to chemotherapy. Expert Opin Drug Metab Toxicol  2, 17-25.   https://doi.org/10.1517/17425255.2.1.17




PubMed


 


PubMed ID 16863465
    
     


 



6.
Sissung TM, Mross K, Steinberg SM, Behringer D, Figg WD, Sparreboom A, Mielke S (2006). Association of ABCB1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropenia. Eur J Cancer  42, 2893-6.   https://doi.org/10.1016/j.ejca.2006.06.017




PubMed



        
     
Free Article


 


PubMed ID 16950614
         Pubmed Central ID 1647318 


 



7.
Sissung TM, Price DK, Sparreboom A, Figg WD (2006). Pharmacogenetics and regulation of human cytochrome P450 1B1: implications in hormone-mediated tumor metabolism and a novel target for therapeutic intervention. Mol Cancer Res  4, 135-50.   https://doi.org/10.1158/1541-7786.MCR-05-0101




PubMed


 


PubMed ID 16547151
    
     


 



8.
Smith NF, Figg WD, Sparreboom A (2006). Pharmacogenetics of irinotecan metabolism and transport: an update. Toxicol In Vitro  20, 163-75.   https://doi.org/10.1016/j.tiv.2005.06.045




PubMed


 


PubMed ID 16271446
    
     


 



9.
Sparreboom A, Loos WJ, Burger H, Sissung TM, Verweij J, Figg WD, Nooter K, Gelderblom H (2005). Effect of ABCG2 genotype on the oral bioavailability of topotecan. Cancer Biol Ther  4, 650-8.   https://doi.org/10.4161/cbt.4.6.1731




PubMed


 


PubMed ID 15908806
    
     


 



10.
Figg WD, Behringer DD, Mielke SD, Mross KD, Sissung TD, Sparreboom AD (submitted in 2006) Abcb1 Genotyping To Predict Microtubule-stabalizing-agent-iduced Toxicity. Patents issued: 2041312 (ES in 2011); 2041312 (FR in 2011); 2041312 (GB in 2011); 2041312 (IT in 2011); 602007010939 (DE in 2011); 2041312 (EP in 2011); 8,835,115 (US in 2014). Patent pending: PCT/US2007/073497 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=43875
328,BC010628-03,"October 01, 2005 -  September 30, 2006",Epigenetic control of mammalian retrotransposons,David E Symer,NULL,"Mouse Cancer Genetics Program, NCI",NULL,"Jef  Boeke
(Molecular Biology and Genetics, Johns Hopkins University)




Giovanni  Parmigiani
(The Sydney Kimmel Comprehensive Cancer Center)




Gerald  Schumann
(Federal Agency for Sera and Vaccines, Paul Ehrlich Institute)","Robert H Stephens (National Cancer Institute)



Keiko  Akagi (National Cancer Institute)



Karl Thomas Ried; MD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43856
329,BC010629-03,"October 01, 2005 -  September 30, 2006",Characterization of Signaling Pathways involved in Cell Death and Survival,Srinivasa M Srinivasula,NULL,"Laboratory of Immune Cell Biology, NCI","Wentao  Liao



Qi  Xiao



Zhiyong  Liao","Wafik  El-Deiry
(Department of Medicine, University of Pennsylvania)




Melissa  Spencer
(Dept of Neurology, UCLA)",Susan H Garfield (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Wu CJ, Conze DB, Li T, Srinivasula SM, Ashwell JD (2006). Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected]. Nat Cell Biol  8, 398-406.   https://doi.org/10.1038/ncb1384




PubMed


 


PubMed ID 16547522",https://intramural.nih.gov/search/searchview.taf?ipid=43546
330,BC010630-03,"October 01, 2005 -  September 30, 2006",Cancer Vaccines and Modulation of Checkpoint Controls in Immunization,John  Janik; MD,"Thomas Alexander Waldmann; MD, PhD","Lymphoid Malignancies Branch, NCI","Wendy W Gao



Arlethia J Spencer



Diana  O'Hagan



Leslie S Moses



Neelam  Gulati



Kamal  Sharma",NULL,"Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43889
331,BC010631-03,"October 01, 2005 -  September 30, 2006",Characterization of candidate histone methyltransferases,David E Symer,NULL,"Mouse Cancer Genetics Program, NCI",Elizabeth K Flynn,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43857
332,BC010632-03,"October 01, 2005 -  September 30, 2006",Tancription Machinery and  Regulation in E. coli,Ding Jun Jin,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Julio E Cabrera



Huijun  Zhi



Anne-Marie  Hansen",NULL,Xinhua  Ji; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Cabrera JE, Jin DJ (2006). Active transcription of rRNA operons is a driving force for the distribution of RNA polymerase in bacteria: effect of extrachromosomal copies of rrnB on the in vivo localization of RNA polymerase. J Bacteriol  188, 4007-14.   https://doi.org/10.1128/JB.01893-05




PubMed



        
     
Free Article


 


PubMed ID 16707692
         Pubmed Central ID 1482923 


 



2.
Jin DJ, Cabrera JE (2006). Coupling the distribution of RNA polymerase to global gene regulation and the dynamic structure of the bacterial nucleoid in Escherichia coli. J Struct Biol  156, 284-91.   https://doi.org/10.1016/j.jsb.2006.07.005




PubMed


 


PubMed ID 16934488",https://intramural.nih.gov/search/searchview.taf?ipid=43890
333,BC010633-03,"October 01, 2005 -  September 30, 2006",Transcription Regulation and Pathogenesis in H. pylori,Ding Jun Jin,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",Yi  Yang,NULL,NULL,William G Coleman; PhD (NIDDK),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43891
334,BC010638-03,"October 01, 2005 -  September 30, 2006",The role of c-met in liver biology,"Snorri S. Thorgeirsson; MD, PhD",Robert  Wiltrout; PhD,"Laboratory of Experimental Carcinogenesis, NCI","Joe W Grisham



Sharla L Mcdonald



Taro  Takami



Anita  Ton



Tanya N Hoang



Pal  Kaposi-Novak



Show all 8","Sanjoy  Das
(Pediatrics and Cancer Biology, Vanderbilt University Medical Center)




Anthony  Demetris
(Transplantation Pathology, University of Pittsburgh Medical Center)




Ju-Seog  Lee; PhD
(NCI)




Hiroyuki  Nakai
(Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine)




Enid  Neptune
(Pulmonary and Critical Care Medicine, Johns Hopkins School of Medicine)




Alexander  Nikitin
(Biomedical Sciences, Cornell University)


Show all 10","Valentina  Factor (Cellular and Molecular Biology Section)



Glenn  Merlino; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Kaposi-Novak P, Lee JS, Gòmez-Quiroz L, Coulouarn C, Factor VM, Thorgeirsson SS (2006). Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype. J Clin Invest  116, 1582-95.   https://doi.org/10.1172/JCI27236




PubMed



        
     
Free Article


 


PubMed ID 16710476
         Pubmed Central ID 1462944",https://intramural.nih.gov/search/searchview.taf?ipid=43858
335,BC010639-03,"October 01, 2005 -  September 30, 2006",In Silico Screening for Cancer Targets,"Marc C Nicklaus



IRP Faculty Profile",NULL,"Laboratory of Medicinal Chemistry, NCI","Chenzhong  Liao



Megan L Peach



Markus  Sitzmann



Iwona Elzbieta Weidlich",NULL,"Phillip A Dennis; MD, PhD (National Cancer Institute)



Donald P Bottaro; PhD (National Cancer Institute)



Kyung  Lee; PhD (National Cancer Institute)



Yves  Pommier; PhD (National Cancer Institute)



Christopher J Michejda; PhD (National Cancer Institute)



Stuart F J Le Grice; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Baleja JD, Cherry JJ, Liu Z, Gao H, Nicklaus MC, Voigt JH, Chen JJ, Androphy EJ (2006). Identification of inhibitors to papillomavirus type 16 E6 protein based on three-dimensional structures of interacting proteins. Antiviral Res  72, 49-59.   https://doi.org/10.1016/j.antiviral.2006.03.014




PubMed



        
     
Free Article


 


PubMed ID 16690141
         Pubmed Central ID 2776632 


 



2.
Choi WJ, Shi ZD, Worthy KM, Bindu L, Karki RG, Nicklaus MC, Fisher RJ, Burke TR (2006). Application of azide-alkyne cycloaddition 'click chemistry' for the synthesis of Grb2 SH2 domain-binding macrocycles. Bioorg Med Chem Lett  16, 5265-9.   https://doi.org/10.1016/j.bmcl.2006.08.004




PubMed



        
     
Free Article


 


PubMed ID 16908148
         Pubmed Central ID 1624856 


 



3.
Kang JH, Peach ML, Pu Y, Lewin NE, Nicklaus MC, Blumberg PM, Marquez VE (2005). Conformationally constrained analogues of diacylglycerol (DAG). 25. Exploration of the sn-1 and sn-2 carbonyl functionality reveals the essential role of the sn-1 carbonyl at the lipid interface in the binding of DAG-lactones to protein kinase C. J Med Chem  48, 5738-48.   https://doi.org/10.1021/jm050352m




PubMed



        
     
Free Article


 


PubMed ID 16134942
         Pubmed Central ID 2563800 


 



4.
Lung FD, Chang CW, Chong MC, Liou CC, Li P, Peach ML, Nicklaus MC, Lou BS, Roller PP (2005). Small nonphosphorylated Grb2-SH2 domain antagonists evaluated by surface plasmon resonance technology. Biopolymers  80, 628-35.   https://doi.org/10.1002/bip.20209




PubMed


 


PubMed ID 15660381
    
     


 



5.
Oishi S, Karki RG, Kang SU, Wang X, Worthy KM, Bindu LK, Nicklaus MC, Fisher RJ, Burke TR (2005). Design and synthesis of conformationally constrained Grb2 SH2 domain binding peptides employing alpha-methylphenylalanyl based phosphotyrosyl mimetics. J Med Chem  48, 764-72.   https://doi.org/10.1021/jm0492709




PubMed


 


PubMed ID 15689160
    
     


 



6.
Oishi S, Karki RG, Shi ZD, Worthy KM, Bindu L, Chertov O, Esposito D, Frank P, Gillette WK, Maderia M, Hartley J, Nicklaus MC, Barchi JJ, Fisher RJ, Burke TR (2005). Evaluation of macrocyclic Grb2 SH2 domain-binding peptide mimetics prepared by ring-closing metathesis of C-terminal allylglycines with an N-terminal beta-vinyl-substituted phosphotyrosyl mimetic. Bioorg Med Chem  13, 2431-8.   https://doi.org/10.1016/j.bmc.2005.01.052




PubMed


 


PubMed ID 15755645
    
     


 



7.
Shi ZD, Karki RG, Oishi S, Worthy KM, Bindu LK, Dharmawardana PG, Nicklaus MC, Bottaro DP, Fisher RJ, Burke TR (2005). Utilization of a nitrobenzoxadiazole (NBD) fluorophore in the design of a Grb2 SH2 domain-binding peptide mimetic. Bioorg Med Chem Lett  15, 1385-8.   https://doi.org/10.1016/j.bmcl.2005.01.017




PubMed


 


PubMed ID 15713392",https://intramural.nih.gov/search/searchview.taf?ipid=43906
336,BC010641-03,"October 01, 2005 -  September 30, 2006",Molecular Oncology,"Patricia  Steeg; PhD



IRP Faculty Profile",NULL,"Molecular Therapeutics Program, NCI",Maria  Zajac-Kaye; PhD,NULL,"Melinda  Hollingshead (National Cancer Institute)



Stanley  Lipkowitz; MD, PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43548
337,BC010642-03,"October 01, 2005 -  September 30, 2006",Chemistry,"Patricia  Steeg; PhD



IRP Faculty Profile",NULL,"Molecular Therapeutics Program, NCI",Richard  Cysyk; PhD,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Cysyk RL, Parker RJ, Barchi JJ, Steeg PS, Hartman NR, Strong JM (2006). Reaction of geldanamycin and C17-substituted analogues with glutathione: product identifications and pharmacological implications. Chem Res Toxicol  19, 376-81.   https://doi.org/10.1021/tx050237e




PubMed


 


PubMed ID 16544941
    
     


 



2.
Klecker RW, Cysyk RL, Collins JM   (2006) Zebularine metabolism by aldehyde oxidase in hepatic cytosol from humans, monkeys, dogs, rats, and mice: influence of sex and inhibitors.  Bioorg Med Chem 14:62-6.




PubMed


 


PubMed ID 16143537",https://intramural.nih.gov/search/searchview.taf?ipid=43965
338,BC010643-03,"October 01, 2005 -  September 30, 2006",Molecular Technologies,"Patricia  Steeg; PhD



IRP Faculty Profile",NULL,"Molecular Therapeutics Program, NCI",Satoshi  Nishizuka,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Bussey KJ, Chin K, Lababidi S, Reimers M, Reinhold WC, Kuo WL, Gwadry F, Ajay, Kouros-Mehr H, Fridlyand J, Jain A, Collins C, Nishizuka S, Tonon G, Roschke A, Gehlhaus K, Kirsch I, Scudiero DA, Gray JW, Weinstein JN (2006). Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel. Mol Cancer Ther  5, 853-67.   https://doi.org/10.1158/1535-7163.MCT-05-0155




PubMed



        
     
Free Article


 


PubMed ID 16648555
         Pubmed Central ID 2733874 


 



2.
Homma N, Tamura G, Honda T, Matsumoto Y, Nishizuka S, Kawata S, Motoyama T   (2006) Spreading of methylation within RUNX3 CpG island in gastric cancer.  Cancer Sci 97:51-6.




PubMed


 


PubMed ID 16367921
    
     


 



3.
Honda T, Tamura G, Endoh Y, Nishizuka S, Kawata S, Motoyama T (2005). Expression of tumor suppressor and tumor-related proteins in differentiated carcinoma, undifferentiated carcinoma with tubular component and pure undifferentiated carcinoma of the stomach. Jpn J Clin Oncol  35, 580-6.   https://doi.org/10.1093/jjco/hyi166




PubMed


 


PubMed ID 16254038
    
     


 



4.
Major SM, Nishizuka S, Morita D, Rowland R, Sunshine M, Shankavaram U, Washburn F, Asin D, Kouros-Mehr H, Kane D, Weinstein JN (2006). AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. BMC Bioinformatics  7, 192.   https://doi.org/10.1186/1471-2105-7-192




PubMed



        
     
Free Article


 


PubMed ID 16600027
         Pubmed Central ID 1524995 


 



5.
Nishizuka S   (2006) Profiling cancer stem cells using protein array technology.  Eur J Cancer 42:1273-82.




PubMed


 


PubMed ID 16644205
    
     


 



6.
Nishizuka S, Washburn NR, Munson PJ (2006). Evaluation method of ordinary flatbed scanners for quantitative density analysis. Biotechniques  40, 442, 444, 446 passim.   https://doi.org/10.2144/000112144




PubMed


 


PubMed ID 16629390
    
     


 



7.
Rudelius M, Pittaluga S, Nishizuka S, Pham TH, Fend F, Jaffe ES, Quintanilla-Martinez L, Raffeld M (2006). Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma. Blood  108, 1668-76.   https://doi.org/10.1182/blood-2006-04-015586




PubMed



        
     
Free Article


 


PubMed ID 16645163
         Pubmed Central ID 1895501 


 



8.
So K, Tamura G, Honda T, Homma N, Endoh M, Togawa N, Nishizuka S, Motoyama T   (2006) Quantitative assessment of RUNX3 methylation in neoplastic and non-neoplastic gastric epithelia using a DNA microarray.  Pathol Int 56:571-5.




PubMed


 


PubMed ID 16984612
    
     


 



9.
So K, Tamura G, Honda T, Homma N, Waki T, Togawa N, Nishizuka S, Motoyama T   (2006) Multiple tumor suppressor genes are increasingly methylated with age in non-neoplastic gastric epithelia.  Cancer Sci 97:1155-8.




PubMed


 


PubMed ID 16952303",https://intramural.nih.gov/search/searchview.taf?ipid=43549
339,BC010644-03,"October 01, 2005 -  September 30, 2006",Preclinical Models Strategy Team,"Patricia  Steeg; PhD



IRP Faculty Profile",NULL,"Molecular Therapeutics Program, NCI",Lyuba  Varticovski,NULL,"Melinda  Hollingshead (National Cancer Institute)



Glenn  Merlino; PhD (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=43966
340,BC010646-03,"October 01, 2005 -  September 30, 2006",Chromatin Remodeling Proteins,"Gordon Lee Hager; PhD



IRP Faculty Profile",NULL,"Laboratory of Receptor Biology and Gene Expression, NCI","Sam  John



Ronit  Salomon",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Marom R, Shur I, Hager GL, Benayahu D (2006). Expression and regulation of CReMM, a chromodomain helicase-DNA-binding (CHD), in marrow stroma derived osteoprogenitors. J Cell Physiol  207, 628-35.   https://doi.org/10.1002/jcp.20611




PubMed


 


PubMed ID 16523501",https://intramural.nih.gov/search/searchview.taf?ipid=43883
341,BC010647-02,"October 01, 2005 -  September 30, 2006",Antibody Engineering for Therapy and Diagnosis of Hematologic Malignancies,Christoph  Rader; PhD,NULL,"Experimental Transplantation and Immunology Branch, NCI","Ka Yin  Kwong



Sivasubramanian  Baskar



Thomas  Hofer",NULL,"Jeffrey D Lifson; MD (National Cancer Institute)



Terrence R Burke; PhD (National Cancer Institute)



Crystal L. Mackall; MD (National Cancer Institute)



Jonathan  Vogel; MD (National Cancer Institute)



Alan S Wayne; MD (National Cancer Institute)",Rose G Mage; PhD (NIAID),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43952
342,BC010648-02,"October 01, 2005 -  September 30, 2006","Discovery of Drugs, Targets, and Target Strategies for Immunotherapy of CLL",Christoph  Rader; PhD,NULL,"Experimental Transplantation and Immunology Branch, NCI","Ka Yin  Kwong



Sivasubramanian  Baskar



Jessica M Levy",NULL,"Wyndham H Wilson; MD, PhD (National Cancer Institute)



Michael R Bishop; MD (National Cancer Institute)



Steven  Pavletic; MD, MS (National Cancer Institute)","Adrian U Wiestner; MD, PhD (NHLBI)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43953
343,BC010649-02,"October 01, 2005 -  September 30, 2006",Development of Immunotherapy Strategies for Gastrointestinal Cancers with focus,Udai S Kammula,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",Diana L Caragacianu,NULL,"Snorri S. Thorgeirsson; MD, PhD (National Cancer Institute)



Xin Wei Wang; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Attia P, Phan GQ, Maker AV, Robinson MR, Quezado MM, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Restifo NP, Haworth LR, Levy C, Mavroukakis SA, Nichol G, Yellin MJ, Rosenberg SA (2005). Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4. J Clin Oncol  23, 6043-53.   https://doi.org/10.1200/JCO.2005.06.205




PubMed



        
     
Free Article


 


PubMed ID 16087944
         Pubmed Central ID 1473965 


 



2.
Beck KE, Blansfield JA, Tran KQ, Feldman AL, Hughes MS, Royal RE, Kammula US, Topalian SL, Sherry RM, Kleiner D, Quezado M, Lowy I, Yellin M, Rosenberg SA, Yang JC (2006). Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4. J Clin Oncol  24, 2283-9.   https://doi.org/10.1200/JCO.2005.04.5716




PubMed



        
     
Free Article


 


PubMed ID 16710025
         Pubmed Central ID 2140223 


 



3.
Blansfield JA, Beck KE, Tran K, Yang JC, Hughes MS, Kammula US, Royal RE, Topalian SL, Haworth LR, Levy C, Rosenberg SA, Sherry RM (2005). Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer. J Immunother  28, 593-8.   https://doi.org/10.1097/01.cji.0000178913.41256.06




PubMed



        
     
Free Article


 


PubMed ID 16224277
         Pubmed Central ID 2154350 


 



4.
Budhu A, Forgues M, Ye QH, Jia HL, He P, Zanetti KA, Kammula US, Chen Y, Qin LX, Tang ZY, Wang XW (2006). Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell  10, 99-111.   https://doi.org/10.1016/j.ccr.2006.06.016




PubMed


 


PubMed ID 16904609
    
     


 



5.
Kammula US, Kuntz EJ, Francone TD, Zeng Z, Shia J, Landmann RG, Paty PB, Weiser MR (2007). Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome. Cancer Lett  248, 219-28.   https://doi.org/10.1016/j.canlet.2006.07.007




PubMed


 


PubMed ID 16945480
    
     


 



6.
Maker AV, Phan GQ, Attia P, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Haworth LR, Levy C, Kleiner D, Mavroukakis SA, Yellin M, Rosenberg SA (2005). Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study. Ann Surg Oncol  12, 1005-16.   https://doi.org/10.1245/ASO.2005.03.536




PubMed



        
     
Free Article


 


PubMed ID 16283570
         Pubmed Central ID 1473970 


 



7.
Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, Sherry RM, Royal RE, Topalian SL, Kammula US, Restifo NP, Zheng Z, Nahvi A, de Vries CR, Rogers-Freezer LJ, Mavroukakis SA, Rosenberg SA (2006). Cancer regression in patients after transfer of genetically engineered lymphocytes. Science  314, 126-9.   https://doi.org/10.1126/science.1129003




PubMed



        
     
Free Article


 


PubMed ID 16946036
         Pubmed Central ID 2267026 


 



8.
Rosenberg SA, Sherry RM, Morton KE, Scharfman WJ, Yang JC, Topalian SL, Royal RE, Kammula U, Restifo NP, Hughes MS, Schwartzentruber D, Berman DM, Schwarz SL, Ngo LT, Mavroukakis SA, White DE, Steinberg SM (2005). Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma. J Immunol  175, 6169-76.   https://doi.org/10.4049/jimmunol.175.9.6169




PubMed


 


PubMed ID 16237114",https://intramural.nih.gov/search/searchview.taf?ipid=43942
344,BC010651-02,"October 01, 2005 -  September 30, 2006",Robo4: Function and Signaling Mechanisms in Vascular Development,Ramani I Ramchandran,Elaine S Jaffe; MD,"Laboratory of Pathology, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Kaur S, Castellone MD, Bedell VM, Konar M, Gutkind JS, Ramchandran R (2006). Robo4 signaling in endothelial cells implies attraction guidance mechanisms. J Biol Chem  281, 11347-56.   https://doi.org/10.1074/jbc.M508853200




PubMed


 


PubMed ID 16481322",https://intramural.nih.gov/search/searchview.taf?ipid=43954
345,BC010652-02,"October 01, 2005 -  September 30, 2006",Lipid-Based Nanocapsules and Nano Fusion Machines,"Robert  Blumenthal; PhD



IRP Faculty Profile",NULL,"Center for Cancer Research Nanobiology Program, NCI","Shrikant  Tele



Nicholas  Francella



Benitra T Johnson



Himanshu  Garg



Amy L Jacobs



Anu  Puri; PhD



Show all 8","Mark  Kester
(Pharmacology, Penn State College of Medicine)




Radha  Maheshwari
(Dept of Pathology, Uniformed Services University of the Health Sciences)




Alok  Singh
(Center for Bio/Molecular Science & Engineering, Naval Research Laboratory)","Joseph John Barchi (National Cancer Institute)



Jacek  Capala; PhD (National Cancer Institute)



Scott E McNeil (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Blumenthal R, Dimitrov D   (2006) A model of drug delivery to normal and cancer cells by antibody-targeted nanoliposomes.  J. Comp. and Theor. Nanosci.  405-11 pp.",https://intramural.nih.gov/search/searchview.taf?ipid=43918
346,BC010653-02,"October 01, 2005 -  September 30, 2006",Inflammation and Prostatic Carcinogenesis,Arthur A Hurwitz,NULL,"Laboratory of Molecular Immunoregulation, NCI","Jami D Willette brown



Fran  Dorsey",NULL,"William  Farrar (National Cancer Institute)



Lionel  Feigenbaum (Office Of The Director)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43939
347,BC010654-02,"October 01, 2005 -  September 30, 2006",Lymphatic Imaging,"Peter L Choyke; MD



IRP Faculty Profile",NULL,"Molecular Imaging Program, NCI","Yukihiro  Hama



Hisataka  Kobayashi



Yoshinori  Koyama



Tristan  Barrett",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Kobayashi H, Kawamoto S, Bernardo M, Brechbiel MW, Knopp MV, Choyke PL (2006). Delivery of gadolinium-labeled nanoparticles to the sentinel lymph node: comparison of the sentinel node visualization and estimations of intra-nodal gadolinium concentration by the magnetic resonance imaging. J Control Release  111, 343-51.   https://doi.org/10.1016/j.jconrel.2005.12.019




PubMed


 


PubMed ID 16490277
    
     


 



2.
Talanov VS, Regino CA, Kobayashi H, Bernardo M, Choyke PL, Brechbiel MW (2006). Dendrimer-based nanoprobe for dual modality magnetic resonance and fluorescence imaging. Nano Lett  6, 1459-63.   https://doi.org/10.1021/nl060765q




PubMed


 


PubMed ID 16834429",https://intramural.nih.gov/search/searchview.taf?ipid=43933
348,BC010655-02,"October 01, 2005 -  September 30, 2006",Prostate Cancer Imaging,"Peter L Choyke; MD



IRP Faculty Profile",NULL,"Molecular Imaging Program, NCI","Marcelino  Bernardo



Iclal  Ocak



Tristan  Barrett",NULL,"William Marston Linehan; MD (National Cancer Institute)



Kevin A Camphausen; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Susil RC, Ménard C, Krieger A, Coleman JA, Camphausen K, Choyke P, Fichtinger G, Whitcomb LL, Coleman CN, Atalar E (2006). Transrectal prostate biopsy and fiducial marker placement in a standard 1.5T magnetic resonance imaging scanner. J Urol  175, 113-20.   https://doi.org/10.1016/S0022-5347(05)00065-0




PubMed



        
     
Free Article


 


PubMed ID 16406885
         Pubmed Central ID 3299542",https://intramural.nih.gov/search/searchview.taf?ipid=43934
349,BC010656-02,"October 01, 2005 -  September 30, 2006",Growth Factor Imaging,"Peter L Choyke; MD



IRP Faculty Profile",NULL,"Molecular Imaging Program, NCI",NULL,NULL,Sandra M Swain; MD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43935
350,BC010657-02,"October 01, 2005 -  September 30, 2006",Intracellular In vivo Imaging,"Peter L Choyke; MD



IRP Faculty Profile",NULL,"Molecular Imaging Program, NCI","Yoshinori  Koyama



Tristan  Barrett



Yukihiro  Hama



Karen J Wong



Hisataka  Kobayashi



Marcelino  Bernardo",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Hama Y, Urano Y, Koyama Y, Choyke PL, Kobayashi H (2006). Targeted optical imaging of cancer cells using lectin-binding BODIPY conjugated avidin. Biochem Biophys Res Commun  348, 807-13.   https://doi.org/10.1016/j.bbrc.2006.07.169




PubMed


 


PubMed ID 16904640
    
     


 



2.
Hama Y, Urano Y, Koyama Y, Kamiya M, Bernardo M, Paik RS, Krishna MC, Choyke PL, Kobayashi H (2006). In vivo spectral fluorescence imaging of submillimeter peritoneal cancer implants using a lectin-targeted optical agent. Neoplasia  8, 607-12.   https://doi.org/10.1593/neo.06268




PubMed



        
     
Free Article


 


PubMed ID 16867223
         Pubmed Central ID 1601930",https://intramural.nih.gov/search/searchview.taf?ipid=43936
351,BC010658-02,"October 01, 2005 -  September 30, 2006",Combination of radiation with multi-target molecular therapy for cancer,Jacek  Capala; PhD,NULL,"Radiation Oncology Branch, NCI","Alesia J Holly



Sang  Lee



Jung Shin  Byun",NULL,NULL,"Teresa M Przytycka (NLM) 



Martin  Meier-Schellersheim; PhD (NIAID)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43919
352,BC010659-02,"October 01, 2005 -  September 30, 2006",p53 and its cancer-causing mutants,"Yawen  Bai; PhD



IRP Faculty Profile",NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Hangiao  Feng,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=43909
353,BC010660-02,"October 01, 2005 -  September 30, 2006",The Molecular Profile of Prostate Tumors in Smokers,"Stefan  Ambs



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI","Tiffany Marie Howe



Robyn  Prueitt



Robert Scott Hudson",NULL,"Neil Edward Caporaso; MS, MD (National Cancer Institute)



James Jerome Goedert; MD (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=43914
354,BC010661-02,"October 01, 2005 -  September 30, 2006",The Use of Cancer Vaccines and Combination Therapies,"James W Hodge; PhD



IRP Faculty Profile",NULL,"Laboratory of Tumor Immunology and Biology, NCI","Elizabeth K Wansley



Michael B Bernstein



Marion G Taylor



Mala  Chakraborty; PhD



Charlese T Garnett","Jorge A Carrasquillo; MD
(CC)




Tyler  Curiel
(Medical Oncology, University of Texas Health Science Center)




Alex  Franzusoff
(Research and Development, GlobeImmune)




Yang-Xin  Fu
(Pathology, University of Chicago)




Chandan  Guha
(Radiation Oncology, Montefiore Medical Center)




Howard  Kaufman
(Surgical Oncology, Columbia University College of Physicians and Surgeons)


Show all 9",Kevin A Camphausen; MD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Garnett CT, Greiner JW, Tsang KY, Kudo-Saito C, Grosenbach DW, Chakraborty M, Gulley JL, Arlen PM, Schlom J, Hodge JW (2006). TRICOM vector based cancer vaccines. Curr Pharm Des  12, 351-61.   https://doi.org/10.2174/138161206775201929




PubMed


 


PubMed ID 16454749
    
     


 



2.
Gelbard A, Garnett CT, Abrams SI, Patel V, Gutkind JS, Palena C, Tsang KY, Schlom J, Hodge JW (2006). Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysis. Clin Cancer Res  12, 1897-905.   https://doi.org/10.1158/1078-0432.CCR-05-1761




PubMed



        
     
Free Article


 


PubMed ID 16551875
         Pubmed Central ID 1865094 


 



3.
Gulley JL, Arlen PM, Bastian A, Morin S, Marte J, Beetham P, Tsang KY, Yokokawa J, Hodge JW, Ménard C, Camphausen K, Coleman CN, Sullivan F, Steinberg SM, Schlom J, Dahut W (2005). Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer. Clin Cancer Res  11, 3353-62.   https://doi.org/10.1158/1078-0432.CCR-04-2062




PubMed


 


PubMed ID 15867235
    
     


 



4.
Hodge JW, Chakraborty M, Kudo-Saito C, Garnett CT, Schlom J (2005). Multiple costimulatory modalities enhance CTL avidity. J Immunol  174, 5994-6004.   https://doi.org/10.4049/jimmunol.174.10.5994




PubMed



        
     
Free Article


 


PubMed ID 15879092
         Pubmed Central ID 1924685 


 



5.
Hodge JW, Greiner JW, Tsang KY, Sabzevari H, Kudo-Saito C, Grosenbach DW, Gulley JL, Arlen PM, Marshall JL, Panicali D, Schlom J (2006). Costimulatory molecules as adjuvants for immunotherapy. Front Biosci  11, 788-803.   https://doi.org/10.2741/1837




PubMed


 


PubMed ID 16146771
    
     


 



6.
Kudo-Saito C, Hodge JW, Kwak H, Kim-Schulze S, Schlom J, Kaufman HL (2006). 4-1BB ligand enhances tumor-specific immunity of poxvirus vaccines. Vaccine  24, 4975-86.   https://doi.org/10.1016/j.vaccine.2006.03.042




PubMed



        
     
Free Article


 


PubMed ID 16621183
         Pubmed Central ID 1865095 


 



7.
Kudo-Saito C, Schlom J, Hodge JW (2005). Induction of an antigen cascade by diversified subcutaneous/intratumoral vaccination is associated with antitumor responses. Clin Cancer Res  11, 2416-26.   https://doi.org/10.1158/1078-0432.CCR-04-1380




PubMed


 


PubMed ID 15788693
    
     


 



8.
Marshall JL, Gulley JL, Arlen PM, Beetham PK, Tsang KY, Slack R, Hodge JW, Doren S, Grosenbach DW, Hwang J, Fox E, Odogwu L, Park S, Panicali D, Schlom J (2005). Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomas. J Clin Oncol  23, 720-31.   https://doi.org/10.1200/JCO.2005.10.206




PubMed


 


PubMed ID 15613691
    
     


 



9.
Reits EA, Hodge JW, Herberts CA, Groothuis TA, Chakraborty M, Wansley EK, Camphausen K, Luiten RM, de Ru AH, Neijssen J, Griekspoor A, Mesman E, Verreck FA, Spits H, Schlom J, van Veelen P, Neefjes JJ (2006). Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J Exp Med  203, 1259-71.   https://doi.org/10.1084/jem.20052494




PubMed



        
     
Free Article


 


PubMed ID 16636135
         Pubmed Central ID 3212727 


 



10.
Yang S, Hodge JW, Grosenbach DW, Schlom J (2005). Vaccines with enhanced costimulation maintain high avidity memory CTL. J Immunol  175, 3715-23.   https://doi.org/10.4049/jimmunol.175.6.3715




PubMed



        
     
Free Article


 


PubMed ID 16148117
         Pubmed Central ID 1350817",https://intramural.nih.gov/search/searchview.taf?ipid=43960
355,BC010662-02,"October 01, 2005 -  September 30, 2006",Vaccine Clinical Trials,Philip M Arlen; MD,NULL,"Laboratory of Tumor Immunology and Biology, NCI","Sandra  Doren



James L Gulley; MD, PhD



Theresa A Ferrara



Myrna B Rauckhorst



Bonnie L Casey



Carolyn L Smith



Show all 7","Jorge A Carrasquillo; MD
(CC)




Robert  DiPaola
(Medicine, Cancer Institute of New Jersey)




Guido  Francini
(Human pathology and oncology, Siena University School of Medicine)




Donald  Kufe
(Medical Oncology, Dana-Farber Cancer Institute)




Edmund  Lattime
(Surgery, molecular genetics, microbiology & immunology, Cancer Institute of New Jersey)




Albert  LoBuglio
(Office of the Director, University of Alabama Comprehensive Cancer Center)


Show all 10","William Marston Linehan; MD (National Cancer Institute)



William Laurence Dahut; MD (National Cancer Institute)



Michael R Bishop; MD (National Cancer Institute)



Howard Z Streicher (National Cancer Institute)



Peter A Pinto; MD (National Cancer Institute)



Jonathan A Coleman (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Arlen PM, Gulley JL (2005). Docetaxel-based regimens, the standard of care for metastatic androgen-insensitive prostate cancer. Future Oncol  1, 19-22.   https://doi.org/10.1517/14796694.1.1.19




PubMed


 


PubMed ID 16555972
    
     


 



2.
Arlen PM, Gulley JL (2005). Therapeutic vaccines for prostate cancer: a review of clinical data. Curr Opin Investig Drugs  6, 592-6.




PubMed


 


PubMed ID 15988910
    
     


 



3.
Arlen PM, Gulley JL, Parker C, Skarupa L, Pazdur M, Panicali D, Beetham P, Tsang KY, Grosenbach DW, Feldman J, Steinberg SM, Jones E, Chen C, Marte J, Schlom J, Dahut W (2006). A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer. Clin Cancer Res  12, 1260-9.   https://doi.org/10.1158/1078-0432.CCR-05-2059




PubMed



        
     
Free Article


 


PubMed ID 16489082
         Pubmed Central ID 1526707 


 



4.
Arlen PM, Madan RA, Hodge JW, Schlom J, Gulley JL (2007). Combining Vaccines with Conventional Therapies for Cancer. Update Cancer Ther  2, 33-39.   https://doi.org/10.1016/j.uct.2007.04.004




PubMed



        
     
Free Article


 


PubMed ID 17948067
         Pubmed Central ID 2034272 


 



5.
Arlen PM, Pazdur M, Skarupa L, Rauckhorst M, Gulley JL (2006). A randomized phase II study of docetaxel alone or in combination with PANVAC-V (vaccinia) and PANVAC-F (fowlpox) in patients with metastatic breast cancer (NCI 05-C-0229). Clin Breast Cancer  7, 176-9.   https://doi.org/10.3816/CBC.2006.n.032




PubMed


 


PubMed ID 16800982
    
     


 



6.
Garnett CT, Greiner JW, Tsang KY, Kudo-Saito C, Grosenbach DW, Chakraborty M, Gulley JL, Arlen PM, Schlom J, Hodge JW (2006). TRICOM vector based cancer vaccines. Curr Pharm Des  12, 351-61.   https://doi.org/10.2174/138161206775201929




PubMed


 


PubMed ID 16454749
    
     


 



7.
Hodge JW, Greiner JW, Tsang KY, Sabzevari H, Kudo-Saito C, Grosenbach DW, Gulley JL, Arlen PM, Marshall JL, Panicali D, Schlom J (2006). Costimulatory molecules as adjuvants for immunotherapy. Front Biosci  11, 788-803.   https://doi.org/10.2741/1837




PubMed


 


PubMed ID 16146771
    
     


 



8.
Madan RA, Gulley JL, Arlen PM (2006). PSA-based vaccines for the treatment of prostate cancer. Expert Rev Vaccines  5, 199-209.   https://doi.org/10.1586/14760584.5.2.199




PubMed


 


PubMed ID 16608420
    
     


 



9.
Tarassoff CP, Arlen PM, Gulley JL (2006). Therapeutic vaccines for prostate cancer. Oncologist  11, 451-62.   https://doi.org/10.1634/theoncologist.11-5-451




PubMed


 


PubMed ID 16720845
    
     


 



10.
Todd NF, Lieberman R, Gulley JL, Dahut W, Arlen PM (2005). Prolonged response to nilutamide in a patient with stage D0.5 prostate cancer who previously failed androgen deprivation therapy. Am J Ther  12, 172-4.   https://doi.org/10.1097/01.mjt.0000144497.85706.e6




PubMed


 


PubMed ID 15767834
    
     


 



11.
Tsang KY, Palena C, Yokokawa J, Arlen PM, Gulley JL, Mazzara GP, Gritz L, Yafal AG, Ogueta S, Greenhalgh P, Manson K, Panicali D, Schlom J (2005). Analyses of recombinant vaccinia and fowlpox vaccine vectors expressing transgenes for two human tumor antigens and three human costimulatory molecules. Clin Cancer Res  11, 1597-607.   https://doi.org/10.1158/1078-0432.CCR-04-1609




PubMed


 


PubMed ID 15746065
    
     


 



12.
Yokokawa J, Palena C, Arlen P, Hassan R, Ho M, Pastan I, Schlom J, Tsang KY (2005). Identification of novel human CTL epitopes and their agonist epitopes of mesothelin. Clin Cancer Res  11, 6342-51.   https://doi.org/10.1158/1078-0432.CCR-05-0596




PubMed



        
     
Free Article


 


PubMed ID 16144939
         Pubmed Central ID 1351144",https://intramural.nih.gov/search/searchview.taf?ipid=43908
356,BC010663-02,"October 01, 2005 -  September 30, 2006",The Role of JAM-C  in Adhesive Interactions of Immune Cells,Triantafyllos  Chavakis,NULL,"Experimental Immunology Branch, NCI","Valeria  Orlova



Eun-Young  Choi",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Chavakis T, Orlova V (2006). The role of junctional adhesion molecules in interactions between vascular cells. Methods Mol Biol  341, 37-50.   https://doi.org/10.1385/1-59745-113-4:37




PubMed


 


PubMed ID 16799187
    
     


 



2.
Keiper T, Al-Fakhri N, Chavakis E, Athanasopoulos AN, Isermann B, Herzog S, Saffrich R, Hersemeyer K, Bohle RM, Haendeler J, Preissner KT, Santoso S, Chavakis T (2005). The role of junctional adhesion molecule-C (JAM-C) in oxidized LDL-mediated leukocyte recruitment. FASEB J  19, 2078-80.   https://doi.org/10.1096/fj.05-4196fje




PubMed


 


PubMed ID 16195363",https://intramural.nih.gov/search/searchview.taf?ipid=43930
357,BC010664-02,"October 01, 2005 -  September 30, 2006",Crosstalk between inflammation and angiogenesis,Triantafyllos  Chavakis,NULL,"Experimental Immunology Branch, NCI","Valeria  Orlova



Eun-Young  Choi","Douglas  Cines
(Dept. Pathology and Laboratory medicine, University of Pennsylvania)




Carl  Gahmberg
(Biochemistry, University of Helsinki)




Tom  Quertermous
(Cardiovascular Medicine, Stanford University)",NULL,NULL,"Ordered by publication type and then author name.



1.
Economopoulou M, Bdeir K, Cines DB, Fogt F, Bdeir Y, Lubkowski J, Lu W, Preissner KT, Hammes HP, Chavakis T (2005). Inhibition of pathologic retinal neovascularization by alpha-defensins. Blood  106, 3831-8.   https://doi.org/10.1182/blood-2005-03-0889




PubMed



        
     
Free Article


 


PubMed ID 16123222
         Pubmed Central ID 1895098 


 



2.
Hoffmann J, Alt A, Lin J, Lochnit G, Schubert U, Schleicher E, Chavakis T, Brownlee M, Van der Woude FJ, Preissner KT, Hammes HP (2006). Tenilsetam prevents early diabetic retinopathy without correcting pericyte loss. Thromb Haemost  95, 689-95.




PubMed


 


PubMed ID 16601840
    
     


 



3.
Lange-Sperandio B, Schimpgen K, Rodenbeck B, Chavakis T, Bierhaus A, Nawroth P, Thornhill B, Schaefer F, Chevalier RL (2006). Distinct roles of Mac-1 and its counter-receptors in neonatal obstructive nephropathy. Kidney Int  69, 81-8.   https://doi.org/10.1038/sj.ki.5000017




PubMed


 


PubMed ID 16374427
    
     


 



4.
Schmidt R, Bültmann A, Ungerer M, Joghetaei N, Bülbül O, Thieme S, Chavakis T, Toole BP, Gawaz M, Schömig A, May AE (2006). Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction. Circulation  113, 834-41.   https://doi.org/10.1161/CIRCULATIONAHA.105.568162




PubMed


 


PubMed ID 16461815
    
     


 



5.
Sotiriou SN, Orlova VV, Al-Fakhri N, Ihanus E, Economopoulou M, Isermann B, Bdeir K, Nawroth PP, Preissner KT, Gahmberg CG, Koschinsky ML, Chavakis T (2006). Lipoprotein(a) in atherosclerotic plaques recruits inflammatory cells through interaction with Mac-1 integrin. FASEB J  20, 559-61.   https://doi.org/10.1096/fj.05-4857fje




PubMed


 


PubMed ID 16403785",https://intramural.nih.gov/search/searchview.taf?ipid=43931
358,BC010666-02,"October 01, 2005 -  September 30, 2006",Vaccine Clinical Trials,"James L Gulley; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Tumor Immunology and Biology, NCI","Sandra  Doren



Philip M Arlen; MD



Lisa M Skarupa



Mary P Pazdur



Jacquin L Jones



Bonnie L Casey



Show all 7","Jorge A Carrasquillo; MD
(CC)




Robert  DiPaola
(Medicine, Cancer Institute of New Jersey)




Guido  Francini
(Human pathology and oncology, Siena University School of Medicine)




Donlad  Kufe
(Medical oncology, Dana-Farber Cancer Institute)




Edmund  Lattime
(Surgery, molecular genetics, microbiology & immunology, Cancer Institute of New Jersey)




Albert  LoBuglio
(Office of the Director, University of Alabama Comprehensive Cancer Center)


Show all 10","William Laurence Dahut; MD (National Cancer Institute)



Howard Z Streicher (National Cancer Institute)



Claude  Sportes (National Cancer Institute)



William Marston Linehan; MD (National Cancer Institute)



Michael R Bishop; MD (National Cancer Institute)



Peter A Pinto; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Arlen PM, Gulley JL (2005). Docetaxel-based regimens, the standard of care for metastatic androgen-insensitive prostate cancer. Future Oncol  1, 19-22.   https://doi.org/10.1517/14796694.1.1.19




PubMed


 


PubMed ID 16555972
    
     


 



2.
Arlen PM, Gulley JL, Parker C, Skarupa L, Pazdur M, Panicali D, Beetham P, Tsang KY, Grosenbach DW, Feldman J, Steinberg SM, Jones E, Chen C, Marte J, Schlom J, Dahut W (2006). A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer. Clin Cancer Res  12, 1260-9.   https://doi.org/10.1158/1078-0432.CCR-05-2059




PubMed



        
     
Free Article


 


PubMed ID 16489082
         Pubmed Central ID 1526707 


 



3.
Arlen PM, Pazdur M, Skarupa L, Rauckhorst M, Gulley JL (2006). A randomized phase II study of docetaxel alone or in combination with PANVAC-V (vaccinia) and PANVAC-F (fowlpox) in patients with metastatic breast cancer (NCI 05-C-0229). Clin Breast Cancer  7, 176-9.   https://doi.org/10.3816/CBC.2006.n.032




PubMed


 


PubMed ID 16800982
    
     


 



4.
Garnett CT, Greiner JW, Tsang KY, Kudo-Saito C, Grosenbach DW, Chakraborty M, Gulley JL, Arlen PM, Schlom J, Hodge JW (2006). TRICOM vector based cancer vaccines. Curr Pharm Des  12, 351-61.   https://doi.org/10.2174/138161206775201929




PubMed


 


PubMed ID 16454749
    
     


 



5.
Madan RA, Gulley JL, Arlen PM (2006). PSA-based vaccines for the treatment of prostate cancer. Expert Rev Vaccines  5, 199-209.   https://doi.org/10.1586/14760584.5.2.199




PubMed


 


PubMed ID 16608420
    
     


 



6.
Tarassoff CP, Arlen PM, Gulley JL (2006). Therapeutic vaccines for prostate cancer. Oncologist  11, 451-62.   https://doi.org/10.1634/theoncologist.11-5-451




PubMed


 


PubMed ID 16720845
    
     


 



7.
Tsang KY, Palena C, Yokokawa J, Arlen PM, Gulley JL, Mazzara GP, Gritz L, Yafal AG, Ogueta S, Greenhalgh P, Manson K, Panicali D, Schlom J (2005). Analyses of recombinant vaccinia and fowlpox vaccine vectors expressing transgenes for two human tumor antigens and three human costimulatory molecules. Clin Cancer Res  11, 1597-607.   https://doi.org/10.1158/1078-0432.CCR-04-1609




PubMed


 


PubMed ID 15746065",https://intramural.nih.gov/search/searchview.taf?ipid=43959
359,BC010668-02,"October 01, 2005 -  September 30, 2006",Instrumentation for microSPECT and microPET imaging,"Peter L Choyke; MD



IRP Faculty Profile",NULL,"Molecular Imaging Program, NCI","Jurgen  Seidel; PhD



Wenze  Xi",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43932
360,BC010669-02,"October 01, 2005 -  September 30, 2006",Role of Gene Methylation in Tumor Microenvironment,Karen  Woodson,NULL,"Cancer Genetics Branch, NCI",NULL,NULL,"Michael R Emmert-Buck; MD, PhD (National Cancer Institute)



Steven  Libutti; MD (National Cancer Institute)



John W Gillespie (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Grover AC, Tangrea MA, Woodson KG, Wallis BS, Hanson JC, Chuaqui RF, Gillespie JW, Erickson HS, Bonner RF, Pohida TJ, Emmert-Buck MR, Libutti SK (2006). Tumor-associated endothelial cells display GSTP1 and RARbeta2 promoter methylation in human prostate cancer. J Transl Med  4, 13.   https://doi.org/10.1186/1479-5876-4-13




PubMed



        
     
Free Article


 


PubMed ID 16512911
         Pubmed Central ID 1420331 


 



2.
Hanson JA, Gillespie JW, Grover A, Tangrea MA, Chuaqui RF, Emmert-Buck MR, Tangrea JA, Libutti SK, Linehan WM, Woodson KG (2006). Gene promoter methylation in prostate tumor-associated stromal cells. J Natl Cancer Inst  98, 255-61.   https://doi.org/10.1093/jnci/djj051




PubMed


 


PubMed ID 16478744",https://intramural.nih.gov/search/searchview.taf?ipid=43957
361,BC010670-02,"October 01, 2005 -  September 30, 2006",Molecular-targeted Radiation Therapy,"Norman Norman Coleman; MD



IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI",Sanjeewani T Palayoor,NULL,"James B Mitchell; PhD (National Cancer Institute)



Stephen  Yoo (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43912
362,BC010671-02,"October 01, 2005 -  September 30, 2006",Genetic analysis of T-cell differentiation,"Remy J Bosselut; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Immune Cell Biology, NCI","Kathryn F Wildt



Lie  Wang



Monica B Zamisch","Marc  Ehlers
(Tolerance & auto-immunity, DRFZ)




I-Cheng  Ho
(Rheumatology, Immunology and Allergy, Harvard (Brigham and Women's))




Steven  Reiner
(Abramson, U Penn)",Lionel  Feigenbaum (Office Of The Director),William E Paul; MD (NIAID),"Ordered by publication type and then author name.



1.
Bosselut R (2006). Retroviral TCR gene transduction: 2A for two. Nat Methods  3, 162-4.   https://doi.org/10.1038/nmeth0306-162




PubMed


 


PubMed ID 16489331
    
     


 



2.
Sun G, Liu X, Mercado P, Jenkinson SR, Kypriotou M, Feigenbaum L, Galéra P, Bosselut R (2005). The zinc finger protein cKrox directs CD4 lineage differentiation during intrathymic T cell positive selection. Nat Immunol  6, 373-81.   https://doi.org/10.1038/ni1183




PubMed


 


PubMed ID 15750595",https://intramural.nih.gov/search/searchview.taf?ipid=43910
363,BC010672-02,"October 01, 2005 -  September 30, 2006",KIR gene polymorphism and its role in HIV-1 pathogenesis,"Mary  Carrington; MS, PhD",NULL,"Laboratory of Genomic Diversity, NCI","Maureen P Martin



Darlene M Marti



Xiaojiang  Gao



Amy E Poisson



Yalun  Liu



Megan E Boon



Show all 7","Marcus  Altfeld
(Infectious Disease Unit, Partners AIDS Research Center)




Howard  Strickler
(Albert Einstein College of Medicine)




Bruce D. Walker; MD
(Partners AIDS Research Center, Massachusetts General Hospital)","Daniel  McVicar; PhD (National Cancer Institute)



Stephen K Anderson; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Carrington M   (2006) Natural killer cells and HIV-1 disease.  Current Opinion in HIV and AIDS  226-231 pp.",https://intramural.nih.gov/search/searchview.taf?ipid=43929
364,BC010673-02,"October 01, 2005 -  September 30, 2006",Regulation of Metastasis and Angiogenesis by Autotaxin,"David D Roberts; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Russell William Bandle



Malgorzata  Ptaszynska



Elliott  Schiffman",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Baker DL, Fujiwara Y, Pigg KR, Tsukahara R, Kobayashi S, Murofushi H, Uchiyama A, Murakami-Murofushi K, Koh E, Bandle RW, Byun HS, Bittman R, Fan D, Murph M, Mills GB, Tigyi G   (2006) Carba analogs of cyclic phosphatidic acid are selective inhibitors of autotaxin and cancer cell invasion and metastasis.  J Biol Chem 281:22786-93.




PubMed



        
     
Free Article


 


PubMed ID 16782709
         Pubmed Central ID 3505596 


 



2.
Roberts D, Bandle R, Clair T, Stracke M   (2006) Trichostatin A and 5-aza-2'-deoxycytidine switch S1P from an inhibitor to a stimulator of motility through epigenetic modification of S1P receptors.  Cancer Lett, in press.




 



3.
Song J, Jie C, Polk P, Shridhar R, Clair T, Zhang J, Yin L, Keppler D   (2006) The candidate tumor suppressor CST6 alters the gene expression profile of human breast carcinoma cells: down-regulation of the potent mitogenic, motogenic, and angiogenic factor autotaxin.  Biochem Biophys Res Commun 340:175-82.




PubMed


 


PubMed ID 16356477
    
     


 



4.
Yang HS, Matthews CP, Clair T, Wang Q, Baker AR, Li CC, Tan TH, Colburn NH (2006). Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion. Mol Cell Biol  26, 1297-306.   https://doi.org/10.1128/MCB.26.4.1297-1306.2006




PubMed



        
     
Free Article


 


PubMed ID 16449643
         Pubmed Central ID 1367180",https://intramural.nih.gov/search/searchview.taf?ipid=43955
365,BC010675-02,"October 01, 2005 -  September 30, 2006",Development of a Carbohydrate Microarray,"Jeffrey  Gildersleeve



IRP Faculty Profile",NULL,"Laboratory of Medicinal Chemistry, NCI","Zhitao  Li



Joseph C Manimala



Anthony S Stapon



Oyindasola O Oyelaran",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Li Z, Gildersleeve JC (2006). Mechanistic studies and methods to prevent aglycon transfer of thioglycosides. J Am Chem Soc  128, 11612-9.   https://doi.org/10.1021/ja063247q




PubMed


 


PubMed ID 16939286",https://intramural.nih.gov/search/searchview.taf?ipid=43938
366,BC010676-02,"October 01, 2005 -  September 30, 2006",Clinical Proteomics and Laser Capture Microdissection,"Elaine S Jaffe; MD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","David  Levens; PhD



Katherine Rainsford Calvo



Andrew L Feldman; MD



Paul C Herrmann



Joy A Aquino



Mary  Winters



Show all 7","Lance  Liotta
(Life Sciences, George Mason Univ)




Emanuel  Petricoin
(Life Sciences, George Mason University)","Michael R Emmert-Buck; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Alessandro R, Belluco C, Kohn EC (2005). Proteomic approaches in colon cancer: promising tools for new cancer markers and drug target discovery. Clin Colorectal Cancer  4, 396-402.   https://doi.org/10.3816/ccc.2005.n.012




PubMed


 


PubMed ID 15807933
    
     


 



2.
Azad NS, Rasool N, Annunziata CM, Minasian L, Whiteley G, Kohn EC (2006). Proteomics in clinical trials and practice: present uses and future promise. Mol Cell Proteomics  5, 1819-29.   https://doi.org/10.1074/mcp.R600008-MCP200




PubMed


 


PubMed ID 16737951
    
     


 



3.
Campbell MJ, Esserman LJ, Zhou Y, Shoemaker M, Lobo M, Borman E, Baehner F, Kumar AS, Adduci K, Marx C, Petricoin EF, Liotta LA, Winters M, Benz S, Benz CC   (2006) Breast cancer growth prevention by statins.  Cancer Res 66:8707-14.




PubMed


 


PubMed ID 16951186
    
     


 



4.
Davidson B, Espina V, Steinberg SM, Flørenes VA, Liotta LA, Kristensen GB, Tropé CG, Berner A, Kohn EC (2006). Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling. Clin Cancer Res  12, 791-9.   https://doi.org/10.1158/1078-0432.CCR-05-2516




PubMed


 


PubMed ID 16467090
    
     


 



5.
Feldman AL, Berthold F, Arceci RJ, Abramowsky C, Shehata BM, Mann KP, Lauer SJ, Pritchard J, Raffeld M, Jaffe ES (2005). Clonal relationship between precursor T-lymphoblastic leukaemia/lymphoma and Langerhans-cell histiocytosis. Lancet Oncol  6, 435-7.   https://doi.org/10.1016/S1470-2045(05)70211-4




PubMed


 


PubMed ID 15925822
    
     


 



6.
Kobrin C, Cha SC, Qin H, Raffeld M, Fend F, Quintanilla-Martinez L, Grove S, Jaffe ES, Kwak LW (2006). Molecular analysis of light-chain switch and acute lymphoblastic leukemia transformation in two follicular lymphomas: implications for lymphomagenesis. Leuk Lymphoma  47, 1523-34.   https://doi.org/10.1080/10428190600612909




PubMed


 


PubMed ID 16966263
    
     


 



7.
Petricoin EF, Bichsel VE, Calvert VS, Espina V, Winters M, Young L, Belluco C, Trock BJ, Lippman M, Fishman DA, Sgroi DC, Munson PJ, Esserman LJ, Liotta LA (2005). Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy. J Clin Oncol  23, 3614-21.   https://doi.org/10.1200/JCO.2005.02.509




PubMed


 


PubMed ID 15908672
    
     


 



8.
Posadas EM, Simpkins F, Liotta LA, MacDonald C, Kohn EC (2005). Proteomic analysis for the early detection and rational treatment of cancer--realistic hope? Ann Oncol  16, 16-22.   https://doi.org/10.1093/annonc/mdi004




PubMed


 


PubMed ID 15598930
    
     


 



9.
Quintanilla-Martinez L, Pittaluga S, Miething C, Klier M, Rudelius M, Davies-Hill T, Anastasov N, Martinez A, Vivero A, Duyster J, Jaffe ES, Fend F, Raffeld M (2006). NPM-ALK-dependent expression of the transcription factor CCAAT/enhancer binding protein beta in ALK-positive anaplastic large cell lymphoma. Blood  108, 2029-36.   https://doi.org/10.1182/blood-2005-10-014258




PubMed


 


PubMed ID 16709933
    
     


 



10.
Rudelius M, Pittaluga S, Nishizuka S, Pham TH, Fend F, Jaffe ES, Quintanilla-Martinez L, Raffeld M (2006). Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma. Blood  108, 1668-76.   https://doi.org/10.1182/blood-2006-04-015586




PubMed



        
     
Free Article


 


PubMed ID 16645163
         Pubmed Central ID 1895501 


 



11.
Srinivasan R, Daniels J, Fusaro V, Lundqvist A, Killian JK, Geho D, Quezado M, Kleiner D, Rucker S, Espina V, Whiteley G, Liotta L, Petricoin E, Pittaluga S, Hitt B, Barrett AJ, Rosenblatt K, Childs RW (2006). Accurate diagnosis of acute graft-versus-host disease using serum proteomic pattern analysis. Exp Hematol  34, 796-801.   https://doi.org/10.1016/j.exphem.2006.02.013




PubMed


 


PubMed ID 16728285
    
     


 



12.
Tchabo NE, Liel MS, Kohn EC (2005). Applying proteomics in clinical trials: assessing the potential and practical limitations in ovarian cancer. Am J Pharmacogenomics  5, 141-8.   https://doi.org/10.2165/00129785-200505030-00001




PubMed


 


PubMed ID 15952868
    
     


 



13.
Traverse-Glehen A, Pittaluga S, Gaulard P, Sorbara L, Alonso MA, Raffeld M, Jaffe ES (2005). Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma. Am J Surg Pathol  29, 1411-21.   https://doi.org/10.1097/01.pas.0000180856.74572.73




PubMed


 


PubMed ID 16224207
    
     


 



14.
Winters ME, Mehta AI, Petricoin EF, Kohn EC, Liotta LA (2005). Supra-additive growth inhibition by a celecoxib analogue and carboxyamido-triazole is primarily mediated through apoptosis. Cancer Res  65, 3853-60.   https://doi.org/10.1158/0008-5472.CAN-04-1989




PubMed


 


PubMed ID 15867384",https://intramural.nih.gov/search/searchview.taf?ipid=43940
367,BC010677-02,"October 01, 2005 -  September 30, 2006",NADPH Oxidase 1: A Novel Target for Colon Cancer Therapy,"James Halpern Doroshow



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Acharya MR, Sparreboom A, Sausville EA, Conley BA, Doroshow JH, Venitz J, Figg WD (2006). Interspecies differences in plasma protein binding of MS-275, a novel histone deacetylase inhibitor. Cancer Chemother Pharmacol  57, 275-81.   https://doi.org/10.1007/s00280-005-0058-8




PubMed


 


PubMed ID 16028097
    
     


 



2.
Doroshow JH (2005). Targeting EGFR in non-small-cell lung cancer. N Engl J Med  353, 200-2.   https://doi.org/10.1056/NEJMe058113




PubMed


 


PubMed ID 16014890
    
     


 



3.
Doroshow JH (2006). Redox modulation of chemotherapy-induced tumor cell killing and normal tissue toxicity. J Natl Cancer Inst  98, 223-5.   https://doi.org/10.1093/jnci/djj065




PubMed


 


PubMed ID 16478735
    
     


 



4.
Doroshow JH, McCoy S, Macdonald JS, Issell BF, Patel T, Cobb PW, Yost KJ, Abbruzzese JL (2006). Phase II trial of PN401, 5-FU, and leucovorin in unresectable or metastatic adenocarcinoma of the stomach: a Southwest Oncology Group study. Invest New Drugs  24, 537-42.   https://doi.org/10.1007/s10637-006-9244-8




PubMed


 


PubMed ID 16832602
    
     


 



5.
Kummar S, Gutierrez M, Doroshow JH, Murgo AJ (2006). Drug development in oncology: classical cytotoxics and molecularly targeted agents. Br J Clin Pharmacol  62, 15-26.   https://doi.org/10.1111/j.1365-2125.2006.02713.x




PubMed



        
     
Free Article


 


PubMed ID 16842375
         Pubmed Central ID 1885070 


 



6.
Lara PN, Law LY, Wright JJ, Frankel P, Twardowski P, Lenz HJ, Lau DH, Kawaguchi T, Gumerlock PH, Doroshow JH, Gandara DR   (2005) Intermittent dosing of the farnesyl transferase inhibitor tipifarnib (R115777) in advanced malignant solid tumors: a phase I California Cancer Consortium Trial.  Anticancer Drugs 16:317-21.




PubMed


 


PubMed ID 15711184
    
     


 



7.
Lara PN, Mack PC, Synold T, Frankel P, Longmate J, Gumerlock PH, Doroshow JH, Gandara DR (2005). The cyclin-dependent kinase inhibitor UCN-01 plus cisplatin in advanced solid tumors: a California cancer consortium phase I pharmacokinetic and molecular correlative trial. Clin Cancer Res  11, 4444-50.   https://doi.org/10.1158/1078-0432.CCR-04-2602




PubMed


 


PubMed ID 15958629
    
     


 



8.
Lara PN, Stadler WM, Longmate J, Quinn DI, Wexler J, Van Loan M, Twardowski P, Gumerlock PH, Vogelzang NJ, Vokes EE, Lenz HJ, Doroshow JH, Gandara DR (2006). A randomized phase II trial of the matrix metalloproteinase inhibitor BMS-275291 in hormone-refractory prostate cancer patients with bone metastases. Clin Cancer Res  12, 1556-63.   https://doi.org/10.1158/1078-0432.CCR-05-2074




PubMed


 


PubMed ID 16533781
    
     


 



9.
Lim D, Morgan RJ, Akman S, Margolin K, Carr BI, Leong L, Odujinrin O, Doroshow JH (2005). Phase I trial of menadiol diphosphate (vitamin K3) in advanced malignancy. Invest New Drugs  23, 235-9.   https://doi.org/10.1007/s10637-005-6731-2




PubMed


 


PubMed ID 15868379
    
     


 



10.
Margolin KA, Doroshow JH, Frankel P, Chow W, Leong LA, Lim D, McNamara M, Morgan RJ, Shibata S, Somlo G, Twardowski P, Yen Y, Kogut N, Schriber J, Alvarnas J, Stalter S (2005). Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell cancer. Biol Blood Marrow Transplant  11, 903-11.   https://doi.org/10.1016/j.bbmt.2005.07.010




PubMed


 


PubMed ID 16275593",https://intramural.nih.gov/search/searchview.taf?ipid=43937
368,BC010678-02,"October 01, 2005 -  September 30, 2006",Keratinocyte Growth Factor:  Epithelial Homeostatic Factor with Clinical Applica,"Jeffrey S Rubin; MD, PhD",NULL,"Laboratory of Cellular and Molecular Biology, NCI",NULL,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=43962
369,BC010679-02,"October 01, 2005 -  September 30, 2006",Characterization of novel substrates of budding yeast polo kinase Cdc5,"Kyung  Lee; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI",Jung Eun  Park,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Kang YH, Park JE, Yu LR, Soung NK, Yun SM, Bang JK, Seong YS, Yu H, Garfield S, Veenstra TD, Lee KS (2006). Self-regulated Plk1 recruitment to kinetochores by the Plk1-PBIP1 interaction is critical for proper chromosome segregation. Mol Cell  24, 409-22.   https://doi.org/10.1016/j.molcel.2006.10.016




PubMed


 


PubMed ID 17081991",https://intramural.nih.gov/search/searchview.taf?ipid=43946
370,BC010680-02,"October 01, 2005 -  September 30, 2006",Characterization of the hCenexin-Plk1 interaction at the centrosomes of cultured,"Kyung  Lee; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Kang YH, Park JE, Yu LR, Soung NK, Yun SM, Bang JK, Seong YS, Yu H, Garfield S, Veenstra TD, Lee KS (2006). Self-regulated Plk1 recruitment to kinetochores by the Plk1-PBIP1 interaction is critical for proper chromosome segregation. Mol Cell  24, 409-22.   https://doi.org/10.1016/j.molcel.2006.10.016




PubMed


 


PubMed ID 17081991
    
     


 



2.
Soung N   (2006) Requirement of hCenexin for proper mitotic functions of polo-like kinase 1 at the centrosomes.  Mol. Cell. Biol, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=43947
371,BC010681-02,"October 01, 2005 -  September 30, 2006",Development of anti-polo-box therapeutic agents,"Kyung  Lee; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI",NULL,NULL,"Marc C Nicklaus (National Cancer Institute)



James  McMahon; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Kang YH, Park JE, Yu LR, Soung NK, Yun SM, Bang JK, Seong YS, Yu H, Garfield S, Veenstra TD, Lee KS (2006). Self-regulated Plk1 recruitment to kinetochores by the Plk1-PBIP1 interaction is critical for proper chromosome segregation. Mol Cell  24, 409-22.   https://doi.org/10.1016/j.molcel.2006.10.016




PubMed


 


PubMed ID 17081991",https://intramural.nih.gov/search/searchview.taf?ipid=43948
372,BC010683-02,"October 01, 2005 -  September 30, 2006",Role of FH loss in development of HLRCC heriditary kidney cancer,"Leonard  Neckers; PhD



IRP Faculty Profile",NULL,"Urologic Oncology Branch, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43950
373,BC010684-02,"October 01, 2005 -  September 30, 2006",Anatomic Pathology Residency Program,"Elaine S Jaffe; MD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Andrea  Abati; BS, MD



Diane Carol Arthur; MD



David Erwin Kleiner; MD, PhD



David  Levens; PhD



Susan  Mackem; MD



Maria  Merino; PhD



Show all 26",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Aisner DL, Maker A, Rosenberg SA, Berman DM (2005). Loss of S100 antigenicity in metastatic melanoma. Hum Pathol  36, 1016-9.   https://doi.org/10.1016/j.humpath.2005.07.010




PubMed



        
     
Free Article


 


PubMed ID 16153466
         Pubmed Central ID 2656365 


 



2.
Fountaine TJ, Wincovitch SM, Geho DH, Garfield SH, Pittaluga S   (2006) Multispectral imaging of clinically relevant cellular targets in tonsil and lymphoid tissue using semiconductor quantum dots.  Mod Pathol 19:1181-91.




PubMed


 


PubMed ID 16778828
    
     


 



3.
Gulmann C, Espina V, Petricoin E, Longo DL, Santi M, Knutsen T, Raffeld M, Jaffe ES, Liotta LA, Feldman AL (2005). Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma. Clin Cancer Res  11, 5847-55.   https://doi.org/10.1158/1078-0432.CCR-05-0637




PubMed


 


PubMed ID 16115925
    
     


 



4.
Ingkanisorn WP, Paterson DI, Calvo KR, Rosing DR, Schwartzentruber DJ, Fuisz AR, Arai AE (2006). Cardiac magnetic resonance appearance of myocarditis caused by high dose IL-2: similarities to community-acquired myocarditis. J Cardiovasc Magn Reson  8, 353-60.   https://doi.org/10.1080/10976640500452000




PubMed


 


PubMed ID 16669178
    
     


 



5.
Mojica WD, Rapkiewicz AV, Liotta LA, Espina V (2005). Manual exfoliation of fresh tissue obviates the need for frozen sections for molecular profiling. Cancer  105, 483-91.   https://doi.org/10.1002/cncr.21347




PubMed


 


PubMed ID 16015639
    
     


 



6.
Nijdam AJ, Ming-Cheng Cheng M, Geho DH, Fedele R, Herrmann P, Killian K, Espina V, Petricoin EF, Liotta LA, Ferrari M   (2007) Physicochemically modified silicon as a substrate for protein microarrays.  Biomaterials 28:550-8.




PubMed


 


PubMed ID 16987550
    
     


 



7.
Politei J   (2006) Schiffmann R, Rapkiewicz A, Abu-Asab M, Ries M, Askari H, Tsokos M, Quezado M Pathological findings in a patient with Fabry disease, who died after 25 years of enzyme replacement Virchows Arch 2005 Nov 29; 1-7.  Virchows Arch 448:873.




PubMed


 


PubMed ID 16523259
    
     


 



8.
Rapkiewicz AV, Hawk A, Noe A, Berman DM (2005). Surgical pathology in the era of the Civil War: the remarkable life and accomplishments of Joseph Janvier Woodward, MD. Arch Pathol Lab Med  129, 1313-6.   https://doi.org/10.1043/1543-2165(2005)129[1313:SPITEO]2.0.CO;2




PubMed


 


PubMed ID 16196522
    
     


 



9.
Schiffmann R, Rapkiewicz A, Abu-Asab M, Ries M, Askari H, Tsokos M, Quezado M (2006). Pathological findings in a patient with Fabry disease who died after 2.5 years of enzyme replacement. Virchows Arch  448, 337-43.   https://doi.org/10.1007/s00428-005-0089-x




PubMed



        
     
Free Article


 


PubMed ID 16315019
         Pubmed Central ID 2288734 


 



10.
Srinivasan R, Daniels J, Fusaro V, Lundqvist A, Killian JK, Geho D, Quezado M, Kleiner D, Rucker S, Espina V, Whiteley G, Liotta L, Petricoin E, Pittaluga S, Hitt B, Barrett AJ, Rosenblatt K, Childs RW (2006). Accurate diagnosis of acute graft-versus-host disease using serum proteomic pattern analysis. Exp Hematol  34, 796-801.   https://doi.org/10.1016/j.exphem.2006.02.013




PubMed


 


PubMed ID 16728285",https://intramural.nih.gov/search/searchview.taf?ipid=43941
374,BC010685-02,"October 01, 2005 -  September 30, 2006",Postmortem Pathology,"David Erwin Kleiner; MD, PhD",Elaine S Jaffe; MD,"Laboratory of Pathology, NCI","David  Levens; PhD



Susan  Mackem; MD



Martha Maria Nicacio Quezado; MD



James C Rainey



Willie J Young



Sedric V Cade",NULL,NULL,"Theo  Heller; MD (NIDDK) 



Steven M Holland; MD (NIAID)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43943
375,BC010686-02,"October 01, 2005 -  September 30, 2006",Clinical Operations for Laboratory of Pathology,"David Erwin Kleiner; MD, PhD",Elaine S Jaffe; MD,"Laboratory of Pathology, NCI","Earle J Barnes



Kevin L Nellis",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43944
376,BC010687-02,"October 01, 2005 -  September 30, 2006",Histology Core Laboratory,"David Erwin Kleiner; MD, PhD",Elaine S Jaffe; MD,"Laboratory of Pathology, NCI","Helen G Lynch



Martha A Pruden



Kathy A Kalinyak



John A Polite","Elizabeth  Brunt
(Pathology, St. Louis University)




Hari  Conjeevaram
(Gastroenterology, The University of Michigan)




Robert  Fontana
(Gastroenterology, The University of Michigan)




Joel  Lavine
(Pediatrics, University of California San Diego Medical Center)




Arthur  Mccullough
(Gastroenterology/Hepatology, Cleveland Clinic Foundation)




Arun  Sanyal
(Hepatology, Virginia Commonwealth University Medical Center)


Show all 8","Steven  Pavletic; MD, MS (National Cancer Institute)","Jay  Hoofnagle; MD (NIDDK) 



Theo  Heller; MD (NIDDK) 



Linda C Cendales (NIAMS) 



Allan Douglas Kirk; MD, PhD (NIDDK) 



Roslyn B Mannon; MD (NIDDK) 



Marc Gregory Ghany; MD (NIDDK)","Ordered by publication type and then author name.



1.
Beck KE, Blansfield JA, Tran KQ, Feldman AL, Hughes MS, Royal RE, Kammula US, Topalian SL, Sherry RM, Kleiner D, Quezado M, Lowy I, Yellin M, Rosenberg SA, Yang JC (2006). Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4. J Clin Oncol  24, 2283-9.   https://doi.org/10.1200/JCO.2005.04.5716




PubMed



        
     
Free Article


 


PubMed ID 16710025
         Pubmed Central ID 2140223 


 



2.
Conjeevaram HS, Fried MW, Jeffers LJ, Terrault NA, Wiley-Lucas TE, Afdhal N, Brown RS, Belle SH, Hoofnagle JH, Kleiner DE, Howell CD, Virahep-C Study Group (2006) Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1. Gastroenterology 131:470-7.




PubMed


 


PubMed ID 16890601
    
     


 



3.
De Ravin SS, Naumann N, Robinson MR, Barron KS, Kleiner DE, Ulrick J, Friend J, Anderson VL, Darnell D, Kang EM, Malech HL (2006). Sarcoidosis in chronic granulomatous disease. Pediatrics  117, e590-5.   https://doi.org/10.1542/peds.2005-1349




PubMed


 


PubMed ID 16452321
    
     


 



4.
Greenberg DE, Ding L, Zelazny AM, Stock F, Wong A, Anderson VL, Miller G, Kleiner DE, Tenorio AR, Brinster L, Dorward DW, Murray PR, Holland SM (2006). A novel bacterium associated with lymphadenitis in a patient with chronic granulomatous disease. PLoS Pathog  2, e28.   https://doi.org/10.1371/journal.ppat.0020028




PubMed



        
     
Free Article


 


PubMed ID 16617373
         Pubmed Central ID 1435791 


 



5.
Hoffmann SC, Hale DA, Kleiner DE, Mannon RB, Kampen RL, Jacobson LM, Cendales LC, Swanson SJ, Becker BN, Kirk AD (2005). Functionally significant renal allograft rejection is defined by transcriptional criteria. Am J Transplant  5, 573-81.   https://doi.org/10.1111/j.1600-6143.2005.00719.x




PubMed


 


PubMed ID 15707413
    
     


 



6.
Javor ED, Ghany MG, Cochran EK, Oral EA, DePaoli AM, Premkumar A, Kleiner DE, Gorden P (2005). Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy. Hepatology  41, 753-60.   https://doi.org/10.1002/hep.20672




PubMed


 


PubMed ID 15791619
    
     


 



7.
Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ, Nonalcoholic Steatohepatitis Clinical Research Network (2005). Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology  41, 1313-21.   https://doi.org/10.1002/hep.20701




PubMed


 


PubMed ID 15915461
    
     


 



8.
Lutchman G, Promrat K, Kleiner DE, Heller T, Ghany MG, Yanovski JA, Liang TJ, Hoofnagle JH (2006). Changes in serum adipokine levels during pioglitazone treatment for nonalcoholic steatohepatitis: relationship to histological improvement. Clin Gastroenterol Hepatol  4, 1048-52.   https://doi.org/10.1016/j.cgh.2006.05.005




PubMed


 


PubMed ID 16814613
    
     


 



9.
Maker AV, Phan GQ, Attia P, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Haworth LR, Levy C, Kleiner D, Mavroukakis SA, Yellin M, Rosenberg SA (2005). Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study. Ann Surg Oncol  12, 1005-16.   https://doi.org/10.1245/ASO.2005.03.536




PubMed



        
     
Free Article


 


PubMed ID 16283570
         Pubmed Central ID 1473970 


 



10.
O'Brien K, Hussain N, Warady BA, Kleiner DE, Kleta R, Bernardini I, Heller T, Gahl WA (2006). Nodular regenerative hyperplasia and severe portal hypertension in cystinosis. Clin Gastroenterol Hepatol  4, 387-94.   https://doi.org/10.1016/j.cgh.2005.12.013




PubMed


 


PubMed ID 16527704
    
     


 



11.
Perumalswami P, Kleiner DE, Lutchman G, Heller T, Borg B, Park Y, Liang TJ, Hoofnagle JH, Ghany MG (2006). Steatosis and progression of fibrosis in untreated patients with chronic hepatitis C infection. Hepatology  43, 780-7.   https://doi.org/10.1002/hep.21078




PubMed


 


PubMed ID 16557550",https://intramural.nih.gov/search/searchview.taf?ipid=43945
377,BC010688-02,"October 01, 2005 -  September 30, 2006",Dermatology Consultation Clinic and Clinical Research,Maria L Turner; MD,NULL,"Dermatology Branch, NCI","Susan L Booher



Edward W Cowen



Rachel T Fitten



Jatin Raj Matta



Heidi H Kong",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Chan JL, Ehrlich A, Lawrence RC, Moshell AN, Turner ML, Kimball AB (2005). Assessing the role of race in quantitative measures of skin pigmentation and clinical assessments of photosensitivity. J Am Acad Dermatol  52, 609-15.   https://doi.org/10.1016/j.jaad.2004.03.051




PubMed


 


PubMed ID 15793510
    
     


 



2.
Ehrlich A, Koch T, Amin B, Liewehr DJ, Steinberg SM, Turner ML, Blauvelt A (2006). Development and reliability testing of a standardized questionnaire to assess psoriasis phenotype. J Am Acad Dermatol  54, 987.e1-14.   https://doi.org/10.1016/j.jaad.2006.02.003




PubMed


 


PubMed ID 16713452
    
     


 



3.
Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, Martin P, Chien J, Przepiorka D, Couriel D, Cowen EW, Dinndorf P, Farrell A, Hartzman R, Henslee-Downey J, Jacobsohn D, McDonald G, Mittleman B, Rizzo JD, Robinson M, Schubert M, Schultz K, Shulman H, Turner M, Vogelsang G, et al. [1 more author] (2005). National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant  11, 945-56.   https://doi.org/10.1016/j.bbmt.2005.09.004




PubMed


 


PubMed ID 16338616
    
     


 



4.
Goldbach-Mansky R, Dailey NJ, Canna SW, Gelabert A, Jones J, Rubin BI, Kim HJ, Brewer C, Zalewski C, Wiggs E, Hill S, Turner ML, Karp BI, Aksentijevich I, Pucino F, Penzak SR, Haverkamp MH, Stein L, Adams BS, Moore TL, Fuhlbrigge RC, Shaham B, Jarvis JN, O'Neil K, Vehe RK, et al. [15 more authors] (2006). Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med  355, 581-92.   https://doi.org/10.1056/NEJMoa055137




PubMed



        
     
Free Article


 


PubMed ID 16899778
         Pubmed Central ID 4178954 


 



5.
Jacob SE, Cowen EW, Goldbach-Mansky R, Kastner D, Turner ML (2006). A recurrent rash with fever and arthropathy. J Am Acad Dermatol  54, 318-21.   https://doi.org/10.1016/j.jaad.2005.07.007




PubMed


 


PubMed ID 16443062
    
     


 



6.
Katz KA, Yan AC, Turner ML (2005). Aquagenic wrinkling of the palms in patients with cystic fibrosis homozygous for the delta F508 CFTR mutation. Arch Dermatol  141, 621-4.   https://doi.org/10.1001/archderm.141.5.621




PubMed


 


PubMed ID 15897385
    
     


 



7.
Kimball AB, Ehrlich A, Lawrence RC, Moshell AN, Turner ML (2006). Validating standardized acquisition of digital dermatologic images for use in the national health and nutrition examination survey. Arch Dermatol  142, 110-2.   https://doi.org/10.1001/archderm.142.1.110-b




PubMed


 


PubMed ID 16415399
    
     


 



8.
Pavletic SZ, Martin P, Lee SJ, Mitchell S, Jacobsohn D, Cowen EW, Turner ML, Akpek G, Gilman A, McDonald G, Schubert M, Berger A, Bross P, Chien JW, Couriel D, Dunn JP, Fall-Dickson J, Farrell A, Flowers ME, Greinix H, Hirschfeld S, Gerber L, Kim S, Knobler R, Lachenbruch PA, Response Criteria Working Group, et al. [13 more authors] (2006). Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. Biol Blood Marrow Transplant  12, 252-66.   https://doi.org/10.1016/j.bbmt.2006.01.008




PubMed


 


PubMed ID 16503494
    
     


 



9.
Pimpinelli N, Olsen EA, Santucci M, Vonderheid E, Haeffner AC, Stevens S, Burg G, Cerroni L, Dreno B, Glusac E, Guitart J, Heald PW, Kempf W, Knobler R, Lessin S, Sander C, Smoller BS, Telang G, Whittaker S, Iwatsuki K, Obitz E, Takigawa M, Turner ML, Wood GS, International Society for Cutaneous Lymphoma (2005). Defining early mycosis fungoides. J Am Acad Dermatol  53, 1053-63.   https://doi.org/10.1016/j.jaad.2005.08.057




PubMed


 


PubMed ID 16310068
    
     


 



10.
Schmidt LS, Nickerson ML, Warren MB, Glenn GM, Toro JR, Merino MJ, Turner ML, Choyke PL, Sharma N, Peterson J, Morrison P, Maher ER, Walther MM, Zbar B, Linehan WM (2005). Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dubé syndrome. Am J Hum Genet  76, 1023-33.   https://doi.org/10.1086/430842




PubMed



        
     
Free Article


 


PubMed ID 15852235
         Pubmed Central ID 1196440 


 



11.
Shulman HM, Kleiner D, Lee SJ, Morton T, Pavletic SZ, Farmer E, Moresi JM, Greenson J, Janin A, Martin PJ, McDonald G, Flowers ME, Turner M, Atkinson J, Lefkowitch J, Washington MK, Prieto VG, Kim SK, Argenyi Z, Diwan AH, Rashid A, Hiatt K, Couriel D, Schultz K, Hymes S, et al. [1 more author] (2006). Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report. Biol Blood Marrow Transplant  12, 31-47.   https://doi.org/10.1016/j.bbmt.2005.10.023




PubMed


 


PubMed ID 16399567
    
     


 



12.
Wei MH, Toure O, Glenn GM, Pithukpakorn M, Neckers L, Stolle C, Choyke P, Grubb R, Middelton L, Turner ML, Walther MM, Merino MJ, Zbar B, Linehan WM, Toro JR (2006). Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet  43, 18-27.   https://doi.org/10.1136/jmg.2005.033506




PubMed



        
     
Free Article


 


PubMed ID 15937070
         Pubmed Central ID 2564499",https://intramural.nih.gov/search/searchview.taf?ipid=43911
378,BC010692-02,"October 01, 2005 -  September 30, 2006",Significance of Bone Marrow Karyotypes in Patients with Inherited Bone Marrow Fa,Diane Carol Arthur; MD,NULL,"Laboratory of Pathology, NCI",Shannon I Skarshaug,NULL,Blanche P Alter (National Cancer Institute),NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=43915
379,BC010693-02,"October 01, 2005 -  September 30, 2006",Legume Inflammation Study,Elaine L Lanza,NULL,"Laboratory of Cancer Prevention, NCI","Gerd  Bobe



Roycelynn  Mentor-Marcel","Maurice  Bennink
(Michigan State University)




Terryl  Hartman
(DCEG, NCI, NIH)",Paul Stuart Albert (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43961
380,BC010694-02,"October 01, 2005 -  September 30, 2006",Clinical Cancer Cytogenetics,Diane Carol Arthur; MD,NULL,"Laboratory of Pathology, NCI","Jack  Hicks



Shannon I Skarshaug



Valerie M Zgonc



Alexander Cm Smith",NULL,"Alan S Wayne; MD (National Cancer Institute)



Blanche P Alter (National Cancer Institute)



Michael R Bishop; MD (National Cancer Institute)



Daniel H Fowler (National Cancer Institute)



Elaine S Jaffe; MD (National Cancer Institute)



Stefania  Pittaluga (National Cancer Institute)","Adrian U Wiestner; MD, PhD (NHLBI) 



Gerald Ernest Marti (OD)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43916
381,BC010695-02,"October 01, 2005 -  September 30, 2006",Prostate stem cells and cancer stem cells,Jonathan  Vogel; MD,NULL,"Dermatology Branch, NCI","Carole L Yee



Jianjun  Zhou



Renuka  Pudi","Jason  Engel
(Transgenic Core, George Washington Univ)




Johng  Rhim
(Pathology, CPDR, USUHS)","Lionel  Feigenbaum (Office Of The Director)



William G Telford (National Cancer Institute)



Michael R Emmert-Buck; MD, PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43963
382,BC010696-02,"October 01, 2005 -  September 30, 2006",Study of Hereditary Renal Syndromes,"Maria  Merino; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI",Linda S Wrathall,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Isaacs JS, Jung YJ, Mole DR, Lee S, Torres-Cabala C, Chung YL, Merino M, Trepel J, Zbar B, Toro J, Ratcliffe PJ, Linehan WM, Neckers L (2005). HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell  8, 143-53.   https://doi.org/10.1016/j.ccr.2005.06.017




PubMed


 


PubMed ID 16098467
    
     


 



2.
Schmidt LS, Nickerson ML, Warren MB, Glenn GM, Toro JR, Merino MJ, Turner ML, Choyke PL, Sharma N, Peterson J, Morrison P, Maher ER, Walther MM, Zbar B, Linehan WM (2005). Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dubé syndrome. Am J Hum Genet  76, 1023-33.   https://doi.org/10.1086/430842




PubMed



        
     
Free Article


 


PubMed ID 15852235
         Pubmed Central ID 1196440 


 



3.
Vocke CD, Yang Y, Pavlovich CP, Schmidt LS, Nickerson ML, Torres-Cabala CA, Merino MJ, Walther MM, Zbar B, Linehan WM (2005). High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dubé-associated renal tumors. J Natl Cancer Inst  97, 931-5.   https://doi.org/10.1093/jnci/dji154




PubMed


 


PubMed ID 15956655
    
     


 



4.
Wei MH, Toure O, Glenn GM, Pithukpakorn M, Neckers L, Stolle C, Choyke P, Grubb R, Middelton L, Turner ML, Walther MM, Merino MJ, Zbar B, Linehan WM, Toro JR (2006). Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet  43, 18-27.   https://doi.org/10.1136/jmg.2005.033506




PubMed



        
     
Free Article


 


PubMed ID 15937070
         Pubmed Central ID 2564499",https://intramural.nih.gov/search/searchview.taf?ipid=43949
383,BC010698-02,"October 01, 2005 -  September 30, 2006",Developing Immunoablative Regimens for the Engraftment of Allogeneic HSTC,Michael R Bishop; MD,NULL,"Experimental Transplantation and Immunology Branch, NCI","Nancy M Hardy



Jennifer Sproul Wilder",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Bevans MF, Marden S, Leidy NK, Soeken K, Cusack G, Rivera P, Mayberry H, Bishop MR, Childs R, Barrett AJ (2006). Health-related quality of life in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant  38, 101-9.   https://doi.org/10.1038/sj.bmt.1705406




PubMed


 


PubMed ID 16751786
    
     


 



2.
Dean RM, Fowler DH, Wilson WH, Odom J, Steinberg SM, Chow C, Kasten-Sportes C, Gress RE, Bishop MR (2005). Efficacy of reduced-intensity allogeneic stem cell transplantation in chemotherapy-refractory non-hodgkin lymphoma. Biol Blood Marrow Transplant  11, 593-9.   https://doi.org/10.1016/j.bbmt.2005.04.005




PubMed


 


PubMed ID 16041309
    
     


 



3.
Hardy NM, Fowler DH, Bishop MR (2006). Immunotherapy of metastatic breast cancer: phase I trail of reduced-intensity allogeneic hematopoietic stem cell transplantation with Th2/Tc2 T-cell exchange. Clin Breast Cancer  7, 87-9.   https://doi.org/10.3816/cbc.2006.n.019




PubMed


 


PubMed ID 16764750
    
     


 



4.
O'Mahony D, Bishop MR (2006). Monoclonal antibody therapy. Front Biosci  11, 1620-35.   https://doi.org/10.2741/1909




PubMed


 


PubMed ID 16368542
    
     


 



5.
Pavletic SZ, Smith LM, Bishop MR, Lynch JC, Tarantolo SR, Vose JM, Bierman PJ, Hadi A, Armitage JO, Kessinger A (2005). Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation. Am J Hematol  78, 265-74.   https://doi.org/10.1002/ajh.20275




PubMed


 


PubMed ID 15795914
    
     


 



6.
Tallman MS, Pérez WS, Lazarus HM, Gale RP, Maziarz RT, Rowe JM, Marks DI, Cahn JY, Bashey A, Bishop MR, Christiansen N, Frankel SR, García JJ, Ilhan O, Laughlin MJ, Liesveld J, Linker C, Litzow MR, Luger S, McCarthy PL, Milone GA, Pavlovsky S, Phillips GL, Russell JA, Saez RA, et al. [8 more authors] (2006). Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission. Biol Blood Marrow Transplant  12, 204-16.   https://doi.org/10.1016/j.bbmt.2005.10.013




PubMed


 


PubMed ID 16443518
    
     


 



7.
Yamashita K, Horwitz ME, Kwatemaa A, Nomicos E, Castro K, Sokolic R, Foster SF, Garofalo M, Choi U, Ryherd M, Brown MR, Leitman SF, Wayne AS, Fowler DH, Bishop MR, Childs RW, Barrett AJ, Pavletic SZ, Malech HL (2006). Unique abnormalities of CD4(+) and CD8(+) central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis. Biol Blood Marrow Transplant  12, 22-30.   https://doi.org/10.1016/j.bbmt.2005.11.004




PubMed


 


PubMed ID 16399598",https://intramural.nih.gov/search/searchview.taf?ipid=43917
384,BC010701-01,"October 01, 2005 -  September 30, 2006",Human Monoclonal Antibodies and Antibody-Guided Nanoparticles,Dimiter Stanchev Dimitrov; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI","Yang  Feng



Vidita  Choudhry



Igor A Sidorov



Xiaodong  Xiao



Mei-Yun  Zhang



Prabakaran  Ponraj



Show all 9","Christopher  Broder
(Immunology and Microbiology, USUHS)




Shibo  Jiang
(Virology, New York Blood Center)




George  Shaw
(University of Alabama)","Xinhua  Ji; PhD (National Cancer Institute)



Robert  Blumenthal; PhD (National Cancer Institute)



Ira H Pastan; MD (National Cancer Institute)","Michael P Bray (NIAID) 



Peter D Kwong; PhD (NIAID)","Ordered by publication type and then author name.



1.
Bonaparte MI, Dimitrov AS, Bossart KN, Crameri G, Mungall BA, Bishop KA, Choudhry V, Dimitrov DS, Wang LF, Eaton BT, Broder CC (2005). Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. Proc Natl Acad Sci U S A  102, 10652-7.   https://doi.org/10.1073/pnas.0504887102




PubMed



        
     
Free Article


 


PubMed ID 15998730
         Pubmed Central ID 1169237 


 



2.
Choudhry V, Zhang MY, Dimitrova D, Prabakaran P, Dimitrov AS, Fouts TR, Dimitrov DS (2006). Antibody-based inhibitors of HIV infection. Expert Opin Biol Ther  6, 523-31.   https://doi.org/10.1517/14712598.6.5.523




PubMed


 


PubMed ID 16610981
    
     


 



3.
Feng Y, Zhu Z, Xiao X, Choudhry V, Barrett JC, Dimitrov DS (2006). Novel human monoclonal antibodies to insulin-like growth factor (IGF)-II that potently inhibit the IGF receptor type I signal transduction function. Mol Cancer Ther  5, 114-20.   https://doi.org/10.1158/1535-7163.MCT-05-0252




PubMed


 


PubMed ID 16432169
    
     


 



4.
Huang CC, Tang M, Zhang MY, Majeed S, Montabana E, Stanfield RL, Dimitrov DS, Korber B, Sodroski J, Wilson IA, Wyatt R, Kwong PD (2005). Structure of a V3-containing HIV-1 gp120 core. Science  310, 1025-8.   https://doi.org/10.1126/science.1118398




PubMed



        
     
Free Article


 


PubMed ID 16284180
         Pubmed Central ID 2408531 


 



5.
Prabakaran P, Gan J, Feng Y, Zhu Z, Choudhry V, Xiao X, Ji X, Dimitrov DS (2006). Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody. J Biol Chem  281, 15829-36.   https://doi.org/10.1074/jbc.M600697200




PubMed


 


PubMed ID 16597622
    
     


 



6.
Prabakaran P, Gan J, Wu YQ, Zhang MY, Dimitrov DS, Ji X (2006). Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs. J Mol Biol  357, 82-99.   https://doi.org/10.1016/j.jmb.2005.12.062




PubMed


 


PubMed ID 16426633
    
     


 



7.
Zhu Z, Dimitrov AS, Bossart KN, Crameri G, Bishop KA, Choudhry V, Mungall BA, Feng YR, Choudhary A, Zhang MY, Feng Y, Wang LF, Xiao X, Eaton BT, Broder CC, Dimitrov DS (2006). Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies. J Virol  80, 891-9.   https://doi.org/10.1128/JVI.80.2.891-899.2006




PubMed



        
     
Free Article


 


PubMed ID 16378991
         Pubmed Central ID 1346873 


 



8.
Zhu Z, Dimitrov AS, Chakraborti S, Dimitrova D, Xiao X, Broder CC, Dimitrov DS (2006). Development of human monoclonal antibodies against diseases caused by emerging and biodefense-related viruses. Expert Rev Anti Infect Ther  4, 57-66.   https://doi.org/10.1586/14787210.4.1.57




PubMed


 


PubMed ID 16441209",https://intramural.nih.gov/search/searchview.taf?ipid=44193
385,BC010702-01,"October 01, 2005 -  September 30, 2006",HIV-1 Integrase Inhibitors,Peter P Roller; PhD,NULL,"Laboratory of Medicinal Chemistry, NCI",Krzysztof A Krajewski,NULL,Yves  Pommier; PhD (National Cancer Institute),NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=44535
386,BC010703-01,"October 01, 2005 -  September 30, 2006",Matriptase Inhibitory Agents as Anti-metastatics,Peter P Roller; PhD,NULL,"Laboratory of Medicinal Chemistry, NCI",Sheng  Jiang,"Robert  Dickson
(Duke University)




Michael Anthony Johnson
(Information Technology Branch)",NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=44536
387,BC010704-01,"October 01, 2005 -  September 30, 2006",Inhibition of Grb2 mediated cellular signaling,Peter P Roller; PhD,NULL,"Laboratory of Medicinal Chemistry, NCI",Sheng  Jiang,"Robert  Fisher
(Protein Chemistry, Saic-Frederick)




Dajun  Yang
(School of Medicine, Univ. of Michigan)",Marc C Nicklaus (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Shi YH, Song YL, Lin DH, Tan J, Roller PP, Li Q, Long YQ, Song GQ (2005). Binding affinity difference induced by the stereochemistry of the sulfoxide bridge of the cyclic peptide inhibitors of Grb2-SH2 domain: NMR studies for the structural origin. Biochem Biophys Res Commun  330, 1254-61.   https://doi.org/10.1016/j.bbrc.2005.03.110




PubMed


 


PubMed ID 15823578
    
     


 



2.
Song YL, Peach ML, Roller PP, Qiu S, Wang S, Long YQ (2006). Discovery of a novel nonphosphorylated pentapeptide motif displaying high affinity for Grb2-SH2 domain by the utilization of 3'-substituted tyrosine derivatives. J Med Chem  49, 1585-96.   https://doi.org/10.1021/jm050910x




PubMed


 


PubMed ID 16509576",https://intramural.nih.gov/search/searchview.taf?ipid=44537
388,BC010705-01,"October 01, 2005 -  September 30, 2006",Role of Cytokines in NK & NK leukemia survival or apoptosis,"Howard A Young; PhD



IRP Faculty Profile",NULL,"Laboratory of Experimental Immunology, NCI","Deborah L Hodge



Della A Reynolds



Michael E Sanford



Matthew D Buschman



Hong T Dang



Anit  Sharma



Show all 7",NULL,Philipp  Kaldis; PhD (Mouse Cancer Genetics Program),NULL,"Ordered by publication type and then author name.



1.
Young H, Subleski J, Reynolds D, Buschman M, Schill W, Burkett M, Malyguine A   (2006) The proinflammatory cytokine interelukin 18 alters multiple signaling pathways to inhibit natural killer cell death.  J. Interferon and Cytokine Res, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=44413
389,BC010706-01,"October 01, 2005 -  September 30, 2006",The immunomodulatory role of bacterial proteins,Triantafyllos  Chavakis,NULL,"Experimental Immunology Branch, NCI","Valeria  Orlova



Eun-Young  Choi","Brian  Geisbrecht
(Biology, University of Kansas)




Matthias  Herrmann
(Microbiology, University of Saarland)




Francis  Luscinskas
(Pathology, Harvard Medical School)




Klaus  Preissner
(Biochemistry, University Giessen)",NULL,NULL,"Ordered by publication type and then author name.



1.
Athanasopoulos AN, Economopoulou M, Orlova VV, Sobke A, Schneider D, Weber H, Augustin HG, Eming SA, Schubert U, Linn T, Nawroth PP, Hussain M, Hammes HP, Herrmann M, Preissner KT, Chavakis T (2006). The extracellular adherence protein (Eap) of Staphylococcus aureus inhibits wound healing by interfering with host defense and repair mechanisms. Blood  107, 2720-7.   https://doi.org/10.1182/blood-2005-08-3140




PubMed



        
     
Free Article


 


PubMed ID 16317095
         Pubmed Central ID 1895382 


 



2.
Chavakis T, Wiechmann K, Preissner KT, Herrmann M (2005). Staphylococcus aureus interactions with the endothelium: the role of bacterial ""secretable expanded repertoire adhesive molecules"" (SERAM) in disturbing host defense systems. Thromb Haemost  94, 278-85.   https://doi.org/10.1160/TH05-05-0306




PubMed


 


PubMed ID 16113816
    
     


 



3.
Xie C, Alcaide P, Geisbrecht BV, Schneider D, Herrmann M, Preissner KT, Luscinskas FW, Chavakis T (2006). Suppression of experimental autoimmune encephalomyelitis by extracellular adherence protein of Staphylococcus aureus. J Exp Med  203, 985-94.   https://doi.org/10.1084/jem.20051681




PubMed



        
     
Free Article


 


PubMed ID 16585266
         Pubmed Central ID 2118278",https://intramural.nih.gov/search/searchview.taf?ipid=44454
390,BC010707-01,"October 01, 2005 -  September 30, 2006",Role of T regulatory suppression in autoimmunity and cancer,"Joost J Oppenheim; MD



IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI","Xin  Chen



Hui-Fang  Dong



Ola Mae Zack Howard



Ruth  Neta



De  Yang



Ning  Zhang



Show all 8","Nick  Carbonetti
(Dept. of Immunology, University of Maryland)




Robert D Goldman; PhD
(CMS Biology, Northwestern University Medical School)




Michael  Kron
(Michigan State University, East Lansing, MI)




Daniela  Maennel
(Immunology, University of Regensburg)




Kouji  Matsushima
(Molecular Preventive Medicine, University of Toyko)




Finn  Olivera
(Department of Immunology, University of Pittsburgh School of Medicine)


Show all 7","Ana M Gamero (National Cancer Institute)



John R Ortaldo; PhD (National Cancer Institute)



Howard A Young; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Carlos CA, Dong HF, Howard OM, Oppenheim JJ, Hanisch FG, Finn OJ (2005). Human tumor antigen MUC1 is chemotactic for immature dendritic cells and elicits maturation but does not promote Th1 type immunity. J Immunol  175, 1628-35.   https://doi.org/10.4049/jimmunol.175.3.1628




PubMed


 


PubMed ID 16034102
    
     


 



2.
Chen X, Murakami T, Oppenheim JJ, Howard OM (2005). Triptolide, a constituent of immunosuppressive Chinese herbal medicine, is a potent suppressor of dendritic-cell maturation and trafficking. Blood  106, 2409-16.   https://doi.org/10.1182/blood-2005-03-0854




PubMed



        
     
Free Article


 


PubMed ID 15956285
         Pubmed Central ID 1569904 


 



3.
Chen X, Oppenheim JJ, Winkler-Pickett RT, Ortaldo JR, Howard OM (2006). Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3(+)CD4(+)CD25(+) T regulatory cells in vivo and enhances their capacity to suppress EAE. Eur J Immunol  36, 2139-49.   https://doi.org/10.1002/eji.200635873




PubMed


 


PubMed ID 16841298
    
     


 



4.
Chen X, Winkler-Pickett RT, Carbonetti NH, Ortaldo JR, Oppenheim JJ, Howard OM (2006). Pertussis toxin as an adjuvant suppresses the number and function of CD4+CD25+ T regulatory cells. Eur J Immunol  36, 671-80.   https://doi.org/10.1002/eji.200535353




PubMed



        
     
Free Article


 


PubMed ID 16479542
         Pubmed Central ID 3153960 


 



5.
Howard OM, Dong HF, Su SB, Caspi RR, Chen X, Plotz P, Oppenheim JJ (2005). Autoantigens signal through chemokine receptors: uveitis antigens induce CXCR3- and CXCR5-expressing lymphocytes and immature dendritic cells to migrate. Blood  105, 4207-14.   https://doi.org/10.1182/blood-2004-07-2697




PubMed



        
     
Free Article


 


PubMed ID 15713799
         Pubmed Central ID 1895027 


 



6.
Krakauer T, Chen X, Howard OM, Young HA (2005). Triptolide attenuates endotoxin- and staphylococcal exotoxin-induced T-cell proliferation and production of cytokines and chemokines. Immunopharmacol Immunotoxicol  27, 53-66.   https://doi.org/10.1081/iph-51294




PubMed


 


PubMed ID 15803859
    
     


 



7.
Kurosaka K, Chen Q, Yarovinsky F, Oppenheim JJ, Yang D (2005). Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant. J Immunol  174, 6257-65.   https://doi.org/10.4049/jimmunol.174.10.6257




PubMed


 


PubMed ID 15879124",https://intramural.nih.gov/search/searchview.taf?ipid=44293
391,BC010708-01,"October 01, 2005 -  September 30, 2006",Consequences of receptor cross talk on inflammation and algesia,"Joost J Oppenheim; MD



IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI","Hui-Fang  Dong



Ola Mae Zack Howard



Ruth  Neta



Ning  Zhang



Takeo  Edamatsu



Ping  Gao","Michael  Cateria
(Neurology, John Hopkins University)




Robert D Goldman; PhD
(CMS Biology, Northwestern University Medical School)




Michael  Kron
(Michigan State University, East Lansing, MI)




Kouji  Matsushima
(Molecular Preventive Medicine, University of Toyko)




Thomas  Rogers
( Department of Microbiology and Immunology, Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine)",Howard A Young; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Gao P, Wange RL, Zhang N, Oppenheim JJ, Howard OM (2005). Negative regulation of CXCR4-mediated chemotaxis by the lipid phosphatase activity of tumor suppressor PTEN. Blood  106, 2619-26.   https://doi.org/10.1182/blood-2004-08-3362




PubMed



        
     
Free Article


 


PubMed ID 15994292
         Pubmed Central ID 1895312 


 



2.
Jiao X, Zhang N, Xu X, Oppenheim JJ, Jin T (2005). Ligand-induced partitioning of human CXCR1 chemokine receptors with lipid raft microenvironments facilitates G-protein-dependent signaling. Mol Cell Biol  25, 5752-62.   https://doi.org/10.1128/MCB.25.13.5752-5762.2005




PubMed



        
     
Free Article


 


PubMed ID 15964828
         Pubmed Central ID 1156970 


 



3.
Sun R, Gao P, Chen L, Ma D, Wang J, Oppenheim JJ, Zhang N (2005). Protein kinase C zeta is required for epidermal growth factor-induced chemotaxis of human breast cancer cells. Cancer Res  65, 1433-41.   https://doi.org/10.1158/0008-5472.CAN-04-1163




PubMed


 


PubMed ID 15735031
    
     


 



4.
Zhang N, Inan S, Inan S, Cowan A, Sun R, Wang JM, Rogers TJ, Caterina M, Oppenheim JJ (2005). A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1. Proc Natl Acad Sci U S A  102, 4536-41.   https://doi.org/10.1073/pnas.0406030102




PubMed



        
     
Free Article


 


PubMed ID 15764707
         Pubmed Central ID 555471",https://intramural.nih.gov/search/searchview.taf?ipid=44294
392,BC010709-01,"October 01, 2005 -  September 30, 2006",An Exploratory Study of Biologic and Pathophysiologic Efects of Radiation Therap,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Neuro-Oncology Branch, NCI","Karna L Robinson



David D Draper","Gerard  Gioia
(Neuropschology, CNMC)




Roger  Packer
(Neurology, Children's Natl. Med. Ctr.)","Paul Stuart Albert (National Cancer Institute)



Pamela  Wolters (National Cancer Institute)



Kevin A Camphausen; MD (National Cancer Institute)



Stephen J Chanock; MD, PhD (National Cancer Institute)



Howard A Fine; MD, PhD (National Cancer Institute)



Steven  Libutti; MD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44553
393,BC010712-01,"October 01, 2005 -  September 30, 2006",Breast Cancer Prevention,Sandra M Swain; MD,NULL,"Medical Oncology Branch, NCI","Guinevere Joy Ng Chun



Jennifer  Eng Wong



Tyane Marcia Calhoun



Michele E Nehrebecky","Robert  Chatterton
(Robert H. Lurie Comprehensive Cancer Center, Northwestern University)




Stephen D Hursting; PhD, MPH
(Epidemiology and Carcinogenesis, NCI)




V.  Jordan
(Medical Oncology, Fox Chase Cancer Center)","Larissa A Korde (National Cancer Institute)



Barbara V Vonderhaar; PhD (National Cancer Institute)



Katherine Rainsford Calvo (National Cancer Institute)



David J Venzon; PhD (National Cancer Institute)



Ashley W Smith (National Cancer Institute)



Jo Anne N Zujewski (National Cancer Institute)","Catherine K Chow; MD (CC) 



Pamela  Stratton; MD (NICHD)","Ordered by publication type and then author name.



1.
Chatterton R, Zujewski J, Mateo E, Eng-Wong J, Inderyas F, Jordan V   (2006) Effect of raloxifene on salivary sex steroid concentrations.  Journal of Endocrinology, in press.




 



2.
Eng-Wong J, Reynolds J, Venzon D, Liewehr D, Gantz S, Danforth D, Liu E, Chow C, Zujewski J   (2006) Effect of raloxifene on bone mineral density in premenopausal women at increased risk for breast cancer.  Journal of Clinical Endocrinology and Metabolism  e-pub pp.




 



3.
Faupel-Badger J, Prindiville S, Venzon D, Vonderhaar B, Zujewski J, Eng-Wong J   (2006) Effects of raloxifene on circulating prolactin and estradiol levels in premenopausal women at high risk for developing breast cancer.  Cancer Epidemiology, Biomarkers and Prevention  1153-58 pp.",https://intramural.nih.gov/search/searchview.taf?ipid=44353
394,BC010714-01,"October 01, 2005 -  September 30, 2006",Angiogenesis imaging,"Peter L Choyke; MD



IRP Faculty Profile",NULL,"Molecular Imaging Program, NCI","Tristan  Barrett



Karen J Wong



Marcelino  Bernardo



Iclal  Ocak",NULL,"William Marston Linehan; MD (National Cancer Institute)



Sandra M Swain; MD (National Cancer Institute)



Kevin A Camphausen; MD (National Cancer Institute)","Robert  Star; MD (NIDDK) 



David M Thomasson; PhD (CC)","Ordered by publication type and then author name.



1.
Ménard C, Susil RC, Choyke P, Coleman J, Grubb R, Gharib A, Krieger A, Guion P, Thomasson D, Ullman K, Gupta S, Espina V, Liotta L, Petricoin E, Fitchtinger G, Whitcomb LL, Atalar E, Coleman CN, Camphausen K (2005). An interventional magnetic resonance imaging technique for the molecular characterization of intraprostatic dynamic contrast enhancement. Mol Imaging  4, 63-6.




PubMed



        
     
Free Article


 


PubMed ID 15967127
         Pubmed Central ID 3299492 


 



2.
Talanov VS, Regino CA, Kobayashi H, Bernardo M, Choyke PL, Brechbiel MW (2006). Dendrimer-based nanoprobe for dual modality magnetic resonance and fluorescence imaging. Nano Lett  6, 1459-63.   https://doi.org/10.1021/nl060765q




PubMed


 


PubMed ID 16834429
    
     


 



3.
Tang JS, Choy G, Bernardo M, Thomasson D, Libutti SK, Choyke PL (2006). Dynamic contrast-enhanced magnetic resonance imaging in the assessment of early response to tumor necrosis factor alpha in a colon carcinoma model. Invest Radiol  41, 691-6.   https://doi.org/10.1097/01.rli.0000233882.83800.fb




PubMed


 


PubMed ID 16896304
    
     


 



4.
Wedam SB, Low JA, Yang SX, Chow CK, Choyke P, Danforth D, Hewitt SM, Berman A, Steinberg SM, Liewehr DJ, Plehn J, Doshi A, Thomasson D, McCarthy N, Koeppen H, Sherman M, Zujewski J, Camphausen K, Chen H, Swain SM (2006). Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer. J Clin Oncol  24, 769-77.   https://doi.org/10.1200/JCO.2005.03.4645




PubMed


 


PubMed ID 16391297",https://intramural.nih.gov/search/searchview.taf?ipid=44473
395,BC010715-01,"October 01, 2005 -  September 30, 2006",Phase II study of flavopiridol in mantle cell lymphoma and DLBCL,"Wyndham H Wilson; MD, PhD



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Kieron Michael Dunleavy,NULL,"Elaine S Jaffe; MD (National Cancer Institute)



John  Janik; MD (National Cancer Institute)



Stefania  Pittaluga (National Cancer Institute)","Adrian U Wiestner; MD, PhD (NHLBI)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44573
396,BC010716-01,"October 01, 2005 -  September 30, 2006",Phase III study of BCL-family inhibitors in lymphoma,"Wyndham H Wilson; MD, PhD



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Kieron Michael Dunleavy,NULL,"Louis  Staudt; MD (Lymphoid Malignancies Branch)



Elaine S Jaffe; MD (National Cancer Institute)



John  Janik; MD (National Cancer Institute)



Stefania  Pittaluga (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44574
397,BC010717-01,"October 01, 2005 -  September 30, 2006",Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,"Wyndham H Wilson; MD, PhD



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Kieron Michael Dunleavy,NULL,"Louis  Staudt; MD (Lymphoid Malignancies Branch)



Elaine S Jaffe; MD (National Cancer Institute)



Stefania  Pittaluga (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44575
398,BC010719-01,"October 01, 2005 -  September 30, 2006",Randomized Phase II study of borteozmibEPOCH-R in Mantle cell lymphoma,"Wyndham H Wilson; MD, PhD



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Kieron Michael Dunleavy,NULL,"Elaine S Jaffe; MD (National Cancer Institute)



John  Janik; MD (National Cancer Institute)



Stefania  Pittaluga (National Cancer Institute)","Adrian U Wiestner; MD, PhD (NHLBI)","Ordered by publication type and then author name.



1.
Fu K, Weisenburger DD, Greiner TC, Dave S, Wright G, Rosenwald A, Chiorazzi M, Iqbal J, Gesk S, Siebert R, De Jong D, Jaffe ES, Wilson WH, Delabie J, Ott G, Dave BJ, Sanger WG, Smith LM, Rimsza L, Braziel RM, Müller-Hermelink HK, Campo E, Gascoyne RD, Staudt LM, Chan WC, Lymphoma/Leukemia Molecular Profiling Project (2005). Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. Blood  106, 4315-21.   https://doi.org/10.1182/blood-2005-04-1753




PubMed



        
     
Free Article


 


PubMed ID 16123218
         Pubmed Central ID 1895253",https://intramural.nih.gov/search/searchview.taf?ipid=44576
399,BC010720-01,"October 01, 2005 -  September 30, 2006","Isolation, Characterization, and Behavior of Melanocyte and Melanoma Stem Cells",Thomas J Hornyak,NULL,"Dermatology Branch, NCI","Deming  Zhang



Ha-Young  Hwang",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44513
400,BC010721-01,"October 01, 2005 -  September 30, 2006",Modeling of the structure and functional mechanisms of voltage-gated channels,Homer Robert Guy; PhD,NULL,"Laboratory of Cell Biology, NCI",Yinon  Shafrir,"Steffen  Hering
(Institut für Pharmakologie und Toxikologie, Universität Wien)




Gea-Ny  Tseng
(Biology, Virginia Commonwealth University)




Heike  Wulff
(Genome/Biomed Sci, Univ Calif, Davis)",NULL,NULL,"Ordered by publication type and then author name.



1.
Tseng GN, Guy HR (2005). Structure-function studies of the outer mouth and voltage sensor domain of hERG. Novartis Found Symp  266, 19-35; discussion 35-45.




PubMed


 


PubMed ID 16050260",https://intramural.nih.gov/search/searchview.taf?ipid=44493
401,BC010722-01,"October 01, 2005 -  September 30, 2006",Modeling of amyloid peptides and proteins,Homer Robert Guy; PhD,NULL,"Laboratory of Cell Biology, NCI",Yinon  Shafrir,"Nelson  Arispe
(Anat/Physiol/Genet, Uniformed Serv Univ Hlth Sci)




Harvey B Pollard; MD, PhD
(Anatomy, USUHS)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44494
402,BC010723-01,"October 01, 2005 -  September 30, 2006",Role chemoattractant receptors in inflammatory aspects of neurodegenerative Dise,"Ji Ming  Wang; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI","Wang-Hua  Gong



Keqiang  Chen",NULL,NULL,Philip M Murphy; MD (NIAID),"Ordered by publication type and then author name.



1.
Wang J   (2006) Chemotactic peptide ligands for formylpeptide receptors influencing inflammation, in The Handbook of Biologically Active Peptides. Kastin A, ed., Academic Press Elsevier (London), in press.




 



2.
Chen K, Iribarren P, Hu J, Chen J, Gong W, Cho EH, Lockett S, Dunlop NM, Wang JM (2006). Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide. J Biol Chem  281, 3651-9.   https://doi.org/10.1074/jbc.M508125200




PubMed


 


PubMed ID 16339765
    
     


 



3.
Iribarren P, Chen K, Hu J, Zhang X, Gong W, Wang JM (2005). IL-4 inhibits the expression of mouse formyl peptide receptor 2, a receptor for amyloid beta1-42, in TNF-alpha-activated microglia. J Immunol  175, 6100-6.   https://doi.org/10.4049/jimmunol.175.9.6100




PubMed


 


PubMed ID 16237106
    
     


 



4.
Le Y, Ye RD, Gong W, Li J, Iribarren P, Wang JM (2005). Identification of functional domains in the formyl peptide receptor-like 1 for agonist-induced cell chemotaxis. FEBS J  272, 769-78.   https://doi.org/10.1111/j.1742-4658.2004.04514.x




PubMed


 


PubMed ID 15670157",https://intramural.nih.gov/search/searchview.taf?ipid=44373
403,BC010724-01,"October 01, 2005 -  September 30, 2006",Chemotactic Formylpeptide Receptor DevelopmentProgression Malignant Human Gliom,"Ji Ming  Wang; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI","Wang-Hua  Gong



Ye  Zhou



Jian  Huang","Xiuwu  Bian
(Southwest Hospital, Institute of Pathology)




Chunfu  Wu
(Medicinal Chemistry, Shenyang Pharmaceutical University)",NULL,NULL,"Ordered by publication type and then author name.



1.
Hu J, Li G, Tong Y, Li Y, Zhou G, He X, Xie P, Wang JM, Sun Q (2005). Transduction of the gene coding for a human G-protein coupled receptor FPRL1 in mouse tumor cells increases host anti-tumor immunity. Int Immunopharmacol  5, 971-80.   https://doi.org/10.1016/j.intimp.2005.01.011




PubMed


 


PubMed ID 15829413",https://intramural.nih.gov/search/searchview.taf?ipid=44374
404,BC010725-01,"October 01, 2005 -  September 30, 2006",Role of Formylpeptide Receptors in Host Defense,"Ji Ming  Wang; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI",Wang-Hua  Gong,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Wang J, Chen K (2006) Chemotactic peptide ligands for formylpeptide receptors influencing inflammation, in The Handbook of Biologically Active Peptides. Kastin A, ed, Academic Press Elsevier (London), in press.",https://intramural.nih.gov/search/searchview.taf?ipid=44375
405,BC010727-01,"October 01, 2005 -  September 30, 2006",Molecular Imaging and Targeted Therapy of HER2-Positive Breast Cancers,Jacek  Capala; PhD,NULL,"Radiation Oncology Branch, NCI","Alesia J Holly



Sang  Lee



Gabriela  Kramer-Marek","Wei  Chen; PhD
(Department of Physics, The University of Texas at Arlington)




Fredrik  Nilsson
(Affibody AB)




Alok  Singh
(Center for Bio/Molecular Science & Engineering, Naval Research Laboratory)",Robert  Blumenthal; PhD (National Cancer Institute),"Dale Oscar Kiesewetter; BS, PhD (NIBIB)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44453
406,BC010728-01,"October 01, 2005 -  September 30, 2006",Phase III Study of R-CHOP v DA-EPOCH-R with microarray,"Wyndham H Wilson; MD, PhD



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Kieron Michael Dunleavy,"Bruce Allan Chabner





Bruce  Cheson
(NCI)




Myron  Czuczman
(Oncology, Roswell Park Cancer Institute)




Andrew  Zelenetz
(Medicine, MSKCC)","Louis  Staudt; MD (Lymphoid Malignancies Branch)



Elaine S Jaffe; MD (National Cancer Institute)



John  Janik; MD (National Cancer Institute)



Stefania  Pittaluga (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bea S, Zettl A, Wright G, Salaverria I, Jehn P, Moreno V, Burek C, Ott G, Puig X, Yang L, Lopez-Guillermo A, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Gascoyne RD, Connors JM, Grogan TM, Braziel R, Fisher RI, Smeland EB, Kvaloy S, Holte H, Delabie J, Simon R, Lymphoma/Leukemia Molecular Profiling Project, et al. [8 more authors] (2005). Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. Blood  106, 3183-90.   https://doi.org/10.1182/blood-2005-04-1399




PubMed



        
     
Free Article


 


PubMed ID 16046532
         Pubmed Central ID 1895326 


 



2.
Dunleavy K, Hakim F, Kim HK, Janik JE, Grant N, Nakayama T, White T, Wright G, Kwak L, Gress R, Tosato G, Wilson WH (2005). B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasis. Blood  106, 795-802.   https://doi.org/10.1182/blood-2004-08-3198




PubMed



        
     
Free Article


 


PubMed ID 15718416
         Pubmed Central ID 1895166",https://intramural.nih.gov/search/searchview.taf?ipid=44577
407,BC010729-01,"October 01, 2005 -  September 30, 2006",Technology Development,"Michael R Emmert-Buck; MD, PhD",NULL,"Laboratory of Pathology, NCI",NULL,"Jon  Cohen
(Diagnostics, 2020 GeneSystems, Inc)




Benjamin  Shapiro
(Engineering, University of Maryland)




Elisabeth  Smela
(Engineering, University of Maryland)",NULL,Robert F Bonner; PhD (NICHD),"Ordered by publication type and then author name.



1.
Gannot G, Gillespie JW, Chuaqui RF, Tangrea MA, Linehan WM, Emmert-Buck MR (2005). Histomathematical analysis of clinical specimens: challenges and progress. J Histochem Cytochem  53, 177-85.   https://doi.org/10.1369/jhc.4A6457.2005




PubMed


 


PubMed ID 15684330
    
     


 



2.
Grover AC, Tangrea MA, Woodson KG, Wallis BS, Hanson JC, Chuaqui RF, Gillespie JW, Erickson HS, Bonner RF, Pohida TJ, Emmert-Buck MR, Libutti SK (2006). Tumor-associated endothelial cells display GSTP1 and RARbeta2 promoter methylation in human prostate cancer. J Transl Med  4, 13.   https://doi.org/10.1186/1479-5876-4-13




PubMed



        
     
Free Article


 


PubMed ID 16512911
         Pubmed Central ID 1420331 


 



3.
Hanson JA, Gillespie JW, Grover A, Tangrea MA, Chuaqui RF, Emmert-Buck MR, Tangrea JA, Libutti SK, Linehan WM, Woodson KG (2006). Gene promoter methylation in prostate tumor-associated stromal cells. J Natl Cancer Inst  98, 255-61.   https://doi.org/10.1093/jnci/djj051




PubMed


 


PubMed ID 16478744",https://intramural.nih.gov/search/searchview.taf?ipid=44213
408,BC010730-01,"October 01, 2005 -  September 30, 2006",HIV Genetic Variation in HIV-Infected Individuals,John Miller Coffin; PhD,NULL,"Host Virus Interaction Branch, NCI",Frank  Maldarelli,"Peter  Sklar; MD
(Drexel University)
















Eric  Daar
(Infectious Diseases, Harbor-UCL Medical Center)




Anuradha  Ganesan; MD
(Uniform Services University of the Health Sciences)




Joseph  Margolick
(School of Public Health, Johns Hopkins University)




John W Mellors





Sybil  Tasker
(-, National Naval Medical Center)","Eric O Freed; PhD (National Cancer Institute)



Wei-Shau  Hu; PhD (National Cancer Institute)



Vinay K Pathak; PhD (National Cancer Institute)



Robert  Yarchoan; MD (National Cancer Institute)



Steven Leonard Zeichner; MD, PhD (Center for Cancer Research)",H. Clifford  Lane; MD (NIAID),"Ordered by publication type and then author name.



1.
Bashirova AA, Bleiber G, Qi Y, Hutcheson H, Yamashita T, Johnson RC, Cheng J, Alter G, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, May M, Maldarelli F, Jacobson L, O'brien SJ, Telenti A, Carrington M (2006). Consistent effects of TSG101 genetic variability on multiple outcomes of exposure to human immunodeficiency virus type 1. J Virol  80, 6757-63.   https://doi.org/10.1128/jvi.00094-06




PubMed



        
     
Free Article


 


PubMed ID 16809281
         Pubmed Central ID 1489017 


 



2.
Chen J, Dang Q, Unutmaz D, Pathak VK, Maldarelli F, Powell D, Hu WS (2005). Mechanisms of nonrandom human immunodeficiency virus type 1 infection and double infection: preference in virus entry is important but is not the sole factor. J Virol  79, 4140-9.   https://doi.org/10.1128/JVI.79.7.4140-4149.2005




PubMed



        
     
Free Article


 


PubMed ID 15767415
         Pubmed Central ID 1061529 


 



3.
Gafni RI, Hazra R, Reynolds JC, Maldarelli F, Tullio AN, DeCarlo E, Worrell CJ, Flaherty JF, Yale K, Kearney BP, Zeichner SL   (2006) Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: impact on bone mineral density in HIV-infected children.  Pediatrics 118:e711-8.




PubMed


 


PubMed ID 16923923
    
     


 



4.
Halvas EK, Aldrovandi GM, Balfe P, Beck IA, Boltz VF, Coffin JM, Frenkel LM, Hazelwood JD, Johnson VA, Kearney M, Kovacs A, Kuritzkes DR, Metzner KJ, Nissley DV, Nowicki M, Palmer S, Ziermann R, Zhao RY, Jennings CL, Bremer J, Brambilla D, Mellors JW (2006). Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency. J Clin Microbiol  44, 2612-4.   https://doi.org/10.1128/JCM.00449-06




PubMed



        
     
Free Article


 


PubMed ID 16825395
         Pubmed Central ID 1489464 


 



5.
Hazra R, Gafni RI, Maldarelli F, Balis FM, Tullio AN, DeCarlo E, Worrell CJ, Steinberg SM, Flaherty J, Yale K, Kearney BP, Zeichner SL (2005). Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy for pediatric HIV infection. Pediatrics  116, e846-54.   https://doi.org/10.1542/peds.2005-0975




PubMed


 


PubMed ID 16291735
    
     


 



6.
Nikolenko GN, Palmer S, Maldarelli F, Mellors JW, Coffin JM, Pathak VK (2005). Mechanism for nucleoside analog-mediated abrogation of HIV-1 replication: balance between RNase H activity and nucleotide excision. Proc Natl Acad Sci U S A  102, 2093-8.   https://doi.org/10.1073/pnas.0409823102




PubMed



        
     
Free Article


 


PubMed ID 15684061
         Pubmed Central ID 548555 


 



7.
Palmer S, Boltz V, Maldarelli F, Kearney M, Halvas EK, Rock D, Falloon J, Davey RT, Dewar RL, Metcalf JA, Mellors JW, Coffin JM (2006). Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy. AIDS  20, 701-10.   https://doi.org/10.1097/01.aids.0000216370.69066.7f




PubMed


 


PubMed ID 16514300
    
     


 



8.
Palmer S, Boltz V, Martinson N, Maldarelli F, Gray G, McIntyre J, Mellors J, Morris L, Coffin J (2006). Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission. Proc Natl Acad Sci U S A  103, 7094-9.   https://doi.org/10.1073/pnas.0602033103




PubMed



        
     
Free Article


 


PubMed ID 16641095
         Pubmed Central ID 1459023 


 



9.
Sklar PA, Masur H, Grubb JR, Voell J, Witek J, Ono A, Freed EO, Maldarelli F (2005). Pravastatin does not have a consistent antiviral effect in chronically HIV-infected individuals on antiretroviral therapy. AIDS  19, 1109-11.   https://doi.org/10.1097/01.aids.0000174461.31794.50




PubMed


 


PubMed ID 15958846",https://intramural.nih.gov/search/searchview.taf?ipid=44474
409,BC010731-01,"October 01, 2005 -  September 30, 2006",In Vivo MRI imaging of single metastatic cells,"Kathleen  Kelly; PhD



IRP Faculty Profile",NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Ivy (Juan Juan)  Yin



Kirsten  Tracy",NULL,NULL,Alan Paul Koretsky; PhD (NINDS),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44253
410,BC010732-01,"October 01, 2005 -  September 30, 2006",The Drosophilia Lgl tumor model as a functional screen for metastasis genes,"Kathleen  Kelly; PhD



IRP Faculty Profile",NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",NULL,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=44254
411,BC010733-01,"October 01, 2005 -  September 30, 2006",Dermatoscopy in the Management of Xeroderma Pigmentosum,Thomas J Hornyak,NULL,"Dermatology Branch, NCI",Mirza Ali Alikhan,NULL,"Kenneth H Kraemer; MD (National Cancer Institute)



John  Digiovanna (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44514
412,BC010734-01,"October 01, 2005 -  September 30, 2006",Growth of Dermal Neurofibromas in Neurofibromatosis Type I,Thomas J Hornyak,NULL,"Dermatology Branch, NCI",NULL,NULL,NULL,"Douglas Russell Stewart; BA, MD (NHGRI)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44515
413,BC010735-01,"October 01, 2005 -  September 30, 2006",Structural studies of fimbriae of enterotoxigenic E. coli (ETEC),"Di S Xia; PhD, MS, BS



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Lothar  Esser



Kazuya  Nishio",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44393
414,BC010736-01,"October 01, 2005 -  September 30, 2006",Using mouse knockouts to unravel endothelial gene function,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44538
415,BC010737-01,"October 01, 2005 -  September 30, 2006",IFN-lambda signal transduction,Ana M Gamero,Giorgio  Trinchieri,"Laboratory of Experimental Immunology, NCI","Anthony J Scarzello



Stephen G Maher",NULL,"Howard A Young; PhD (National Cancer Institute)



Paul  Goldsmith; PhD (National Cancer Institute)",Raymond  Donnelly (OD),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44475
416,BC010738-01,"October 01, 2005 -  September 30, 2006","Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging","Steven X Hou



IRP Faculty Profile",NULL,"Mouse Cancer Genetics Program, NCI",Grace Zhiyu  Zheng,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Singh SR, Liu W, Hou SX (2007). The adult Drosophila malpighian tubules are maintained by multipotent stem cells. Cell Stem Cell  1, 191-203.   https://doi.org/10.1016/j.stem.2007.07.003




PubMed



        
     
Free Article


 


PubMed ID 18371350
         Pubmed Central ID 2040309 


 



2.
Singh SR, Oh SW, Liu W, Chen X, Zheng Z, Hou SX   (2006) Rap-GEF/Rap signaling restricts the formation of supernumerary spermathecae in Drosophila melanogaster.  Dev Growth Differ 48:169-75.




PubMed


 


PubMed ID 16573734
    
     


 



3.
Singh SR, Zhen W, Zheng Z, Wang H, Oh SW, Liu W, Zbar B, Schmidt LS, Hou SX   (2006) The Drosophila homolog of the human tumor suppressor gene BHD interacts with the JAK-STAT and Dpp signaling pathways in regulating male germline stem cell maintenance.  Oncogene 25:5933-41.




PubMed


 


PubMed ID 16636660
    
     


 



4.
Wang H, Singh SR, Zheng Z, Oh SW, Chen X, Edwards K, Hou SX (2006). Rap-GEF signaling controls stem cell anchoring to their niche through regulating DE-cadherin-mediated cell adhesion in the Drosophila testis. Dev Cell  10, 117-26.   https://doi.org/10.1016/j.devcel.2005.11.004




PubMed


 


PubMed ID 16399083",https://intramural.nih.gov/search/searchview.taf?ipid=44516
417,BC010739-01,"October 01, 2005 -  September 30, 2006",Structural Studies of Drug Agents by Nuclear Magnetic Resonance Spectroscopy,"Joseph John Barchi



IRP Faculty Profile",NULL,"Laboratory of Medicinal Chemistry, NCI",Yi-Chien  Lee,NULL,Christopher J Michejda; PhD (National Cancer Institute),Adriaan  Bax; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Cysyk RL, Parker RJ, Barchi JJ, Steeg PS, Hartman NR, Strong JM (2006). Reaction of geldanamycin and C17-substituted analogues with glutathione: product identifications and pharmacological implications. Chem Res Toxicol  19, 376-81.   https://doi.org/10.1021/tx050237e




PubMed


 


PubMed ID 16544941
    
     


 



2.
Furrer J, Luy B, Basrur V, Roberts D, Barchi Jr J   (2006) Conformational Analysis of an 31 Integrin-Binding Peptide from Thrombospondin-1: Implications for Antiangiogenic Drug Design.  Journal of Medicinal Chemistry  Article ASAP pp.




 



3.
Oishi S, Karki RG, Shi ZD, Worthy KM, Bindu L, Chertov O, Esposito D, Frank P, Gillette WK, Maderia M, Hartley J, Nicklaus MC, Barchi JJ, Fisher RJ, Burke TR (2005). Evaluation of macrocyclic Grb2 SH2 domain-binding peptide mimetics prepared by ring-closing metathesis of C-terminal allylglycines with an N-terminal beta-vinyl-substituted phosphotyrosyl mimetic. Bioorg Med Chem  13, 2431-8.   https://doi.org/10.1016/j.bmc.2005.01.052




PubMed


 


PubMed ID 15755645
    
     


 



4.
Showalter BM, Reynolds MM, Valdez CA, Saavedra JE, Davies KM, Klose JR, Chmurny GN, Citro ML, Barchi JJ, Merz SI, Meyerhoff ME, Keefer LK (2005). Diazeniumdiolate ions as leaving groups in anomeric displacement reactions: a protection-deprotection strategy for ionic diazeniumdiolates. J Am Chem Soc  127, 14188-9.   https://doi.org/10.1021/ja054510a




PubMed


 


PubMed ID 16218605
    
     


 



5.
Wu Z, Maderia M, Barchi JJ, Marquez VE, Bax A (2005). Changes in DNA bending induced by restricting nucleotide ring pucker studied by weak alignment NMR spectroscopy. Proc Natl Acad Sci U S A  102, 24-8.   https://doi.org/10.1073/pnas.0408498102




PubMed



        
     
Free Article


 


PubMed ID 15618396
         Pubmed Central ID 544063",https://intramural.nih.gov/search/searchview.taf?ipid=44433
418,BC010740-01,"October 01, 2005 -  September 30, 2006",Carbohydrate Microarray Profiling of Glycan-Binding Antibodies and Lectins,"Jeffrey  Gildersleeve



IRP Faculty Profile",NULL,"Laboratory of Medicinal Chemistry, NCI","Joseph C Manimala



Oyindasola O Oyelaran","Daniel  Devine
(Company, Acceptys)




Lara  Mahal
(Chemistry, University of Texas at Austin)",Christoph  Rader; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Manimala JC, Roach TA, Li Z, Gildersleeve JC (2006). High-throughput carbohydrate microarray analysis of 24 lectins. Angew Chem Int Ed Engl  45, 3607-10.   https://doi.org/10.1002/anie.200600591




PubMed


 


PubMed ID 16639753",https://intramural.nih.gov/search/searchview.taf?ipid=44476
419,BC010742-01,"October 01, 2005 -  September 30, 2006",Using Glycosyltransferase Mutants to Develop Effective Contrast Agents,Pradman  Qasba; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI","Elizabeth  Boeggeman



Boopathy  Ramakrishna



Maria Rita Manzoni",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44533
420,BC010743-01,"October 01, 2005 -  September 30, 2006",Metabolic Mechanisms for Programmed Cell Death,"James Ming Phang; MD



IRP Faculty Profile",NULL,"Laboratory of Comparative Carcinogenesis, NCI","Gregory L Borchert



Yongmin  Liu



Carlos A Tristan","Chien-An  Hu
(Biochemistry & Molecular Biology, U. New Mexico School of Medicine)




David  Valle
(Human Genetics, Johns Hopkins University School of Medicine)",NULL,NULL,"Ordered by publication type and then author name.



1.
Hu CA, Donald SP, Yu J, Lin WW, Liu Z, Steel G, Obie C, Valle D, Phang JM (2007). Overexpression of proline oxidase induces proline-dependent and mitochondria-mediated apoptosis. Mol Cell Biochem  295, 85-92.   https://doi.org/10.1007/s11010-006-9276-6




PubMed


 


PubMed ID 16874462
    
     


 



2.
Liu Y, Borchert GL, Surazynski A, Hu CA, Phang JM (2006). Proline oxidase activates both intrinsic and extrinsic pathways for apoptosis: the role of ROS/superoxides, NFAT and MEK/ERK signaling. Oncogene  25, 5640-7.   https://doi.org/10.1038/sj.onc.1209564




PubMed


 


PubMed ID 16619034",https://intramural.nih.gov/search/searchview.taf?ipid=44333
421,BC010744-01,"October 01, 2005 -  September 30, 2006",Regulation of Proline Oxidase for Bioenergetics during Nutrient Stress,"James Ming Phang; MD



IRP Faculty Profile",NULL,"Laboratory of Comparative Carcinogenesis, NCI","Steven  Donald



Jui  Pandhare",NULL,NULL,Sandra D White (NIAID),"Ordered by publication type and then author name.



1.
Pandhare J, Cooper SK, Phang JM (2006). Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms. J Biol Chem  281, 2044-52.   https://doi.org/10.1074/jbc.M507867200




PubMed


 


PubMed ID 16303758",https://intramural.nih.gov/search/searchview.taf?ipid=44334
422,BC010746-01,"October 01, 2005 -  September 30, 2006",Extracellular Matrix and Stress Substrates: the Role of Prolidase,"James Ming Phang; MD



IRP Faculty Profile",NULL,"Laboratory of Comparative Carcinogenesis, NCI","Steven  Donald



Yongmin  Liu",NULL,Konstantin V Salnikow (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Surazynski A, Liu Y, Miltyk W, Phang JM (2005). Nitric oxide regulates prolidase activity by serine/threonine phosphorylation. J Cell Biochem  96, 1086-94.   https://doi.org/10.1002/jcb.20631




PubMed


 


PubMed ID 16167338",https://intramural.nih.gov/search/searchview.taf?ipid=44335
423,BC010747-01,"October 01, 2005 -  September 30, 2006",Charaterization of the Expression and Ligands of KIR3DS1,"Daniel  McVicar; PhD



IRP Faculty Profile",NULL,"Laboratory of Experimental Immunology, NCI","Gillian C Whittaker



Eriko  Yamada",NULL,Stephen K Anderson; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
McVicar D, Bashirova A, Dong T, Rowland-Jones S, Carrington M   (2006) Lack of KIR3DS1 binding to MHC class I Bw4 tetramers in complex with HIV-derived T cell epitopes.  ARHR, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=44273
424,BC010748-01,"October 01, 2005 -  September 30, 2006",Clinical investigation of signal transduction inhibitors,"Phillip A Dennis; MD, PhD",NULL,"Medical Oncology Branch, NCI",Marc S Ballas,NULL,"Ilona  Linnoila; MD (National Cancer Institute)



Stephen M Hewitt; MD, PhD (National Cancer Institute)



William D Figg; PharmD (National Cancer Institute)



Seth M Steinberg; PhD (National Cancer Institute)



Joanna H Shih (National Cancer Institute)



Frederic  Kaye; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
O'Mahony D, Dennis PA (2006). Using immunotherapy to target EGF in patients with NSCLC. Cancer Biol Ther  5, 150-1.   https://doi.org/10.4161/cbt.5.2.2557




PubMed


 


PubMed ID 16552172
    
     


 



2.
Tsurutani J, Ballas M, Steinberg SM, Egilsson V, Dennis PA (2006). Gefitinib for refractory advanced non-small-cell lung cancer. Lancet  367, 300.   https://doi.org/10.1016/S0140-6736(06)68064-1




PubMed


 


PubMed ID 16443034
    
     


 



3.
Tsurutani J, Ballas MS, Dennis PA (2006). Overestimating the influence of the 1999 WHO classification of lung tumors on survival in bronchioloalveloar carcinoma. J Clin Oncol  24, 1963; author reply 1963-4.   https://doi.org/10.1200/JCO.2005.05.1318




PubMed


 


PubMed ID 16622278
    
     


 



4.
Tsurutani J, Fukuoka J, Tsurutani H, Shih JH, Hewitt SM, Travis WD, Jen J, Dennis PA (2006). Evaluation of two phosphorylation sites improves the prognostic significance of Akt activation in non-small-cell lung cancer tumors. J Clin Oncol  24, 306-14.   https://doi.org/10.1200/JCO.2005.02.4133




PubMed


 


PubMed ID 16330671",https://intramural.nih.gov/search/searchview.taf?ipid=44173
425,BC010749-01,"October 01, 2005 -  September 30, 2006",DNA Vaccines,"George N Pavlakis; MD, PhD



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Agneta S Von Gegerfelt



Margherita  Rosati



Antonio L Valentin



Cristina  Bergamaschi



Gen-Mu  Zhang","J. Thomas  August
(Molecular Biology and Genetics Department, Johns Hopkins University School of Medicine)




Ronald  Desrosiers
(New England Primate Research Center)




Michael F Egan; MD
(NIMH)




John  Eldridge
(Wyeth Lederle Vaccines)




Zimra  Israel
(Wyeth Lederle Vaccines)




R. Paul  Johnson
(New England Primate Research Center)


Show all 13","Marjorie  Robert-Guroff; PhD (National Cancer Institute)



Genoveffa  Franchini; MD (National Cancer Institute)



Barbara K Felber (National Cancer Institute)",David C Montefiori; PhD (NIAID),"Ordered by publication type and then author name.



1.
Boyer JD, Robinson TM, Kutzler MA, Parkinson R, Calarota SA, Sidhu MK, Muthumani K, Lewis M, Pavlakis G, Felber B, Weiner D (2005). SIV DNA vaccine co-administered with IL-12 expression plasmid enhances CD8 SIV cellular immune responses in cynomolgus macaques. J Med Primatol  34, 262-70.   https://doi.org/10.1111/j.1600-0684.2005.00124.x




PubMed


 


PubMed ID 16128921
    
     


 



2.
Boyer JD, Robinson TM, Maciag PC, Peng X, Johnson RS, Pavlakis G, Lewis MG, Shen A, Siliciano R, Brown CR, Weiner DB, Paterson Y (2005). DNA prime Listeria boost induces a cellular immune response to SIV antigens in the rhesus macaque model that is capable of limited suppression of SIV239 viral replication. Virology  333, 88-101.   https://doi.org/10.1016/j.virol.2004.12.026




PubMed


 


PubMed ID 15708595
    
     


 



3.
Egan MA, Chong SY, Megati S, Montefiori DC, Rose NF, Boyer JD, Sidhu MK, Quiroz J, Rosati M, Schadeck EB, Pavlakis GN, Weiner DB, Rose JK, Israel ZR, Udem SA, Eldridge JH (2005). Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virus. AIDS Res Hum Retroviruses  21, 629-43.   https://doi.org/10.1089/aid.2005.21.629




PubMed


 


PubMed ID 16060834
    
     


 



4.
Egan MA, Megati S, Roopchand V, Garcia-Hand D, Luckay A, Chong SY, Rosati M, Sackitey S, Weiner DB, Felber BK, Pavlakis GN, Israel ZR, Eldridge JH, Sidhu MK (2006). Rational design of a plasmid DNA vaccine capable of eliciting cell-mediated immune responses to multiple HIV antigens in mice. Vaccine  24, 4510-23.   https://doi.org/10.1016/j.vaccine.2005.08.024




PubMed


 


PubMed ID 16140439
    
     


 



5.
Kaur A, Sanford HB, Garry D, Lang S, Klumpp SA, Watanabe D, Bronson RT, Lifson JD, Rosati M, Pavlakis GN, Felber BK, Knipe DM, Desrosiers RC (2007). Ability of herpes simplex virus vectors to boost immune responses to DNA vectors and to protect against challenge by simian immunodeficiency virus. Virology  357, 199-214.   https://doi.org/10.1016/j.virol.2006.08.007




PubMed



        
     
Free Article


 


PubMed ID 16962628
         Pubmed Central ID 1819472 


 



6.
Kumar S, Yan J, Muthumani K, Ramanathan MP, Yoon H, Pavlakis GN, Felber BK, Sidhu M, Boyer JD, Weiner DB (2006). Immunogenicity testing of a novel engineered HIV-1 envelope gp140 DNA vaccine construct. DNA Cell Biol  25, 383-92.   https://doi.org/10.1089/dna.2006.25.383




PubMed


 


PubMed ID 16848679
    
     


 



7.
Kutzler MA, Robinson TM, Chattergoon MA, Choo DK, Choo AY, Choe PY, Ramanathan MP, Parkinson R, Kudchodkar S, Tamura Y, Sidhu M, Roopchand V, Kim JJ, Pavlakis GN, Felber BK, Waldmann TA, Boyer JD, Weiner DB (2005). Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help. J Immunol  175, 112-23.   https://doi.org/10.4049/jimmunol.175.1.112




PubMed


 


PubMed ID 15972637
    
     


 



8.
Rosati M, von Gegerfelt A, Roth P, Alicea C, Valentin A, Robert-Guroff M, Venzon D, Montefiori DC, Markham P, Felber BK, Pavlakis GN (2005). DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge. J Virol  79, 8480-92.   https://doi.org/10.1128/JVI.79.13.8480-8492.2005




PubMed



        
     
Free Article


 


PubMed ID 15956591
         Pubmed Central ID 1143718 


 



9.
Schadeck EB, Sidhu M, Egan MA, Chong SY, Piacente P, Masood A, Garcia-Hand D, Cappello S, Roopchand V, Megati S, Quiroz J, Boyer JD, Felber BK, Pavlakis GN, Weiner DB, Eldridge JH, Israel ZR (2006). A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIVgag-plasmid DNA vaccine in rhesus macaques. Vaccine  24, 4677-87.   https://doi.org/10.1016/j.vaccine.2005.10.035




PubMed


 


PubMed ID 16288822
    
     


 



10.
Smulevitch S, Bear J, Alicea C, Rosati M, Jalah R, Zolotukhin AS, von Gegerfelt A, Michalowski D, Moroni C, Pavlakis GN, Felber BK (2006). RTE and CTE mRNA export elements synergistically increase expression of unstable, Rev-dependent HIV and SIV mRNAs. Retrovirology  3, 6.   https://doi.org/10.1186/1742-4690-3-6




PubMed



        
     
Free Article


 


PubMed ID 16412225
         Pubmed Central ID 1363727 


 



11.
von Gegerfelt AS, Alicea C, Valentin A, Morrow M, van Rompay KK, Ayash-Rashkovsky M, Markham P, Else JG, Marthas ML, Pavlakis GN, Ruprecht RM, Felber BK (2006). Long lasting control and lack of pathogenicity of the attenuated Rev-independent SIV in rhesus macaques. AIDS Res Hum Retroviruses  22, 516-28.   https://doi.org/10.1089/aid.2006.22.516




PubMed


 


PubMed ID 16796527
    
     


 



12.
Watanabe D, Brockman MA, Ndung'u T, Mathews L, Lucas WT, Murphy CG, Felber BK, Pavlakis GN, Deluca NA, Knipe DM (2007). Properties of a herpes simplex virus multiple immediate-early gene-deleted recombinant as a vaccine vector. Virology  357, 186-98.   https://doi.org/10.1016/j.virol.2006.08.015




PubMed


 


PubMed ID 16996101",https://intramural.nih.gov/search/searchview.taf?ipid=44313
426,BC010750-01,"October 01, 2005 -  September 30, 2006",HIV Molecular Biology and Pathogenic Mechanisms of AIDS,"George N Pavlakis; MD, PhD



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Antonio L Valentin



Susan L Lindtner



Vainav Vikram Patel



Hiroaki  Uranishi","Angelos  Hatzakis
(University of Athens Medical School)




George  Panayotou
(Molecular Oncology, Alexander Fleming Biomedicine Sciences Research Center)




Ralf  Schneider
(GSF-National Research Center for Environment and Health)","Robert  Yarchoan; MD (National Cancer Institute)



Neal G Copeland; PhD (National Cancer Institute)



Nancy  Jenkins-Copeland; PhD (National Cancer Institute)



Barbara K Felber (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Daelemans D, Costes SV, Lockett S, Pavlakis GN (2005). Kinetic and molecular analysis of nuclear export factor CRM1 association with its cargo in vivo. Mol Cell Biol  25, 728-39.   https://doi.org/10.1128/MCB.25.2.728-739.2005




PubMed



        
     
Free Article


 


PubMed ID 15632073
         Pubmed Central ID 543413 


 



2.
Kino T, Gragerov A, Valentin A, Tsopanomihalou M, Ilyina-Gragerova G, Erwin-Cohen R, Chrousos GP, Pavlakis GN (2005). Vpr protein of human immunodeficiency virus type 1 binds to 14-3-3 proteins and facilitates complex formation with Cdc25C: implications for cell cycle arrest. J Virol  79, 2780-7.   https://doi.org/10.1128/JVI.79.5.2780-2787.2005




PubMed



        
     
Free Article


 


PubMed ID 15708996
         Pubmed Central ID 548435 


 



3.
Kutzler MA, Robinson TM, Chattergoon MA, Choo DK, Choo AY, Choe PY, Ramanathan MP, Parkinson R, Kudchodkar S, Tamura Y, Sidhu M, Roopchand V, Kim JJ, Pavlakis GN, Felber BK, Waldmann TA, Boyer JD, Weiner DB (2005). Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help. J Immunol  175, 112-23.   https://doi.org/10.4049/jimmunol.175.1.112




PubMed


 


PubMed ID 15972637
    
     


 



4.
Lindtner S, Zolotukhin AS, Uranishi H, Bear J, Kulkarni V, Smulevitch S, Samiotaki M, Panayotou G, Felber BK, Pavlakis GN (2006). RNA-binding motif protein 15 binds to the RNA transport element RTE and provides a direct link to the NXF1 export pathway. J Biol Chem  281, 36915-28.   https://doi.org/10.1074/jbc.M608745200




PubMed


 


PubMed ID 17001072
    
     


 



5.
Smulevitch S, Bear J, Alicea C, Rosati M, Jalah R, Zolotukhin AS, von Gegerfelt A, Michalowski D, Moroni C, Pavlakis GN, Felber BK (2006). RTE and CTE mRNA export elements synergistically increase expression of unstable, Rev-dependent HIV and SIV mRNAs. Retrovirology  3, 6.   https://doi.org/10.1186/1742-4690-3-6




PubMed



        
     
Free Article


 


PubMed ID 16412225
         Pubmed Central ID 1363727 


 



6.
Smulevitch S, Michalowski D, Zolotukhin AS, Schneider R, Bear J, Roth P, Pavlakis GN, Felber BK (2005). Structural and functional analysis of the RNA transport element, a member of an extensive family present in the mouse genome. J Virol  79, 2356-65.   https://doi.org/10.1128/JVI.79.4.2356-2365.2005




PubMed



        
     
Free Article


 


PubMed ID 15681436
         Pubmed Central ID 546579 


 



7.
von Gegerfelt AS, Alicea C, Valentin A, Morrow M, van Rompay KK, Ayash-Rashkovsky M, Markham P, Else JG, Marthas ML, Pavlakis GN, Ruprecht RM, Felber BK (2006). Long lasting control and lack of pathogenicity of the attenuated Rev-independent SIV in rhesus macaques. AIDS Res Hum Retroviruses  22, 516-28.   https://doi.org/10.1089/aid.2006.22.516




PubMed


 


PubMed ID 16796527
    
     


 



8.
Yuste E, Johnson W, Pavlakis GN, Desrosiers RC (2005). Virion envelope content, infectivity, and neutralization sensitivity of simian immunodeficiency virus. J Virol  79, 12455-63.   https://doi.org/10.1128/JVI.79.19.12455-12463.2005




PubMed



        
     
Free Article


 


PubMed ID 16160173
         Pubmed Central ID 1211544",https://intramural.nih.gov/search/searchview.taf?ipid=44314
427,BC010752-01,"October 01, 2005 -  September 30, 2006",Anti-angiogenesis targeted vaccine therapy,Samir N. Khleif; MD,NULL,"Vaccine Branch, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44517
428,BC010755-01,"October 01, 2005 -  September 30, 2006",Enhancing immune response strategies:,Samir N. Khleif; MD,NULL,"Vaccine Branch, NCI",NULL,NULL,"Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)



Yuk Ying S Pang (National Cancer Institute)



Franklin R Grollman (National Cancer Institute)



David J Venzon; PhD (National Cancer Institute)



John  Schiller; PhD (National Cancer Institute)



Masaki  Terabe (National Cancer Institute)","Francesco M. Marincola; MD (CC) 



Susan L Goodman (NIAID)","Ordered by publication type and then author name.



1.
Ibrahim R, Frederickson H, Parr A, Ward Y, Moncur J, Khleif SN (2006). Expression of FasL in squamous cell carcinomas of the cervix and cervical intraepithelial neoplasia and its role in tumor escape mechanism. Cancer  106, 1065-77.   https://doi.org/10.1002/cncr.21697




PubMed


 


PubMed ID 16456813
    
     


 



2.
Qian J, Dong Y, Pang YY, Ibrahim R, Berzofsky JA, Schiller JT, Khleif SN (2006). Combined prophylactic and therapeutic cancer vaccine: enhancing CTL responses to HPV16 E2 using a chimeric VLP in HLA-A2 mice. Int J Cancer  118, 3022-9.   https://doi.org/10.1002/ijc.21781




PubMed


 


PubMed ID 16425257",https://intramural.nih.gov/search/searchview.taf?ipid=44518
429,BC010756-01,"October 01, 2005 -  September 30, 2006",Development a combined prophylactic and therapeutic cervical cancer vaccine u,Samir N. Khleif; MD,NULL,"Vaccine Branch, NCI",NULL,NULL,"Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)



John  Schiller; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44519
430,BC010757-01,"October 01, 2005 -  September 30, 2006",Clinical trial development in cancer vaccines,Samir N. Khleif; MD,NULL,"Vaccine Branch, NCI",NULL,"Vincent  Herrin; MD





Charles  Levenbach
(Gynecologic Oncology, MD Anderson)




Joe  Lucci
(Gynecologic Oncology, University of Florida)




Therresa  Whiteside
(Immuunoligy, University of Pittsburg)","Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)



Franklin R Grollman (National Cancer Institute)



David J Venzon; PhD (National Cancer Institute)",Susan L Goodman (NIAID),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44520
431,BC010758-01,"October 01, 2005 -  September 30, 2006",Monitoring of Basic Biochemical Processes at Single Molecule Level Using Light-e,"Mikhail V Kashlev



IRP Faculty Profile",NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Maria L Kireeva



Lucyna E Lubkowska



Vitaly  Chasov",NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=44233
432,BC010759-01,"October 01, 2005 -  September 30, 2006",Functional genomics of cancer,"Paul S Meltzer; MD, PhD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Sarah L Anzick; PhD



John E Lueders



Yidong  Chen; PhD



John R Cornelison



Robert L Walker; BS



Sylvia W Wong



Show all 12","Rosemary  Balleine
(Translational Oncology, Westmead Hospital)




Michael  Choti
(Surgery, Johns Hopkins University)","Sheueyann  Cheng; PhD (National Cancer Institute)



Chand  Khanna; MD (National Cancer Institute)



Gordon Lee Hager; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Crawford GE, Davis S, Scacheri PC, Renaud G, Halawi MJ, Erdos MR, Green R, Meltzer PS, Wolfsberg TG, Collins FS (2006). DNase-chip: a high-resolution method to identify DNase I hypersensitive sites using tiled microarrays. Nat Methods  3, 503-9.   https://doi.org/10.1038/nmeth888




PubMed



        
     
Free Article


 


PubMed ID 16791207
         Pubmed Central ID 2698431 


 



2.
Davis S, Meltzer PS (2006). Ewing's sarcoma: general insights from a rare model. Cancer Cell  9, 331-2.   https://doi.org/10.1016/j.ccr.2006.05.003




PubMed


 


PubMed ID 16697953
    
     


 



3.
Li HM, Man C, Jin Y, Deng W, Yip YL, Feng HC, Cheung YC, Lo KW, Meltzer PS, Wu ZG, Kwong YL, Yuen AP, Tsao SW (2006). Molecular and cytogenetic changes involved in the immortalization of nasopharyngeal epithelial cells by telomerase. Int J Cancer  119, 1567-76.   https://doi.org/10.1002/ijc.22032




PubMed


 


PubMed ID 16688717
    
     


 



4.
Scacheri PC, Davis S, Odom DT, Crawford GE, Perkins S, Halawi MJ, Agarwal SK, Marx SJ, Spiegel AM, Meltzer PS, Collins FS (2006). Genome-wide analysis of menin binding provides insights into MEN1 tumorigenesis. PLoS Genet  2, e51.   https://doi.org/10.1371/journal.pgen.0020051




PubMed



        
     
Free Article


 


PubMed ID 16604156
         Pubmed Central ID 1428788 


 



5.
Seftor EA, Meltzer PS, Kirschmann DA, Margaryan NV, Seftor RE, Hendrix MJ (2006). The epigenetic reprogramming of poorly aggressive melanoma cells by a metastatic microenvironment. J Cell Mol Med  10, 174-96.   https://doi.org/10.1111/j.1582-4934.2006.tb00299.x




PubMed



        
     
Free Article


 


PubMed ID 16563230
         Pubmed Central ID 3933110",https://intramural.nih.gov/search/searchview.taf?ipid=44523
433,BC010760-01,"October 01, 2005 -  September 30, 2006",Study of the urokinase plasminogen activator signalling pathway,Jacek Tadeusz Lubkowski,NULL,"Macromolecular Crystallography Laboratory, NCI",Cyril  Barinka,"Douglas  Cines
(Dept. Pathology and Laboratory medicine, University of Pennsylvania)




Anrew  Mazar
(Biopharm-development company, Attenuon, LLC)",NULL,NULL,"Ordered by publication type and then author name.



1.
Barinka C, Hlouchova K, Rovenska M, Majer P, Dauter M, Hin N, Ko YS, Tsukamoto T, Slusher BS, Konvalinka J, Lubkowski J (2008). Structural basis of interactions between human glutamate carboxypeptidase II and its substrate analogs. J Mol Biol  376, 1438-50.   https://doi.org/10.1016/j.jmb.2007.12.066




PubMed



        
     
Free Article


 


PubMed ID 18234225
         Pubmed Central ID 2753231",https://intramural.nih.gov/search/searchview.taf?ipid=44521
434,BC010761-01,"October 01, 2005 -  September 30, 2006",Structural studies of teh TREM family of proteins,Jacek Tadeusz Lubkowski,NULL,"Macromolecular Crystallography Laboratory, NCI",James L Gattis,NULL,Daniel  McVicar; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44522
435,BC010762-01,"October 01, 2005 -  September 30, 2006",Molecular Alterations of Primary Breast Cancer and Metastasis,"Maria  Merino; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI",Linda S Wrathall,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44524
436,BC010763-01,"October 01, 2005 -  September 30, 2006",Building on the success of the adoptive immunotherapy of cancer,"Nicholas Phillip Restifo; MD



IRP Faculty Profile",NULL,"Surgery Branch, NCI","Luca  Gattinoni



Claudia  Wrzesinski



Chrystal  Paulos



Zhiya  Yu



Nadrian F Teclar



Douglas  Palmer",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Antony PA, Paulos CM, Ahmadzadeh M, Akpinarli A, Palmer DC, Sato N, Kaiser A, Hinrichs CS, Heinrichs C, Klebanoff CA, Tagaya Y, Restifo NP (2006). Interleukin-2-dependent mechanisms of tolerance and immunity in vivo. J Immunol  176, 5255-66.   https://doi.org/10.4049/jimmunol.176.9.5255




PubMed



        
     
Free Article


 


PubMed ID 16621991
         Pubmed Central ID 1473163 


 



2.
Antony PA, Piccirillo CA, Akpinarli A, Finkelstein SE, Speiss PJ, Surman DR, Palmer DC, Chan CC, Klebanoff CA, Overwijk WW, Rosenberg SA, Restifo NP (2005). CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells. J Immunol  174, 2591-601.   https://doi.org/10.4049/jimmunol.174.5.2591




PubMed



        
     
Free Article


 


PubMed ID 15728465
         Pubmed Central ID 1403291 


 



3.
Antony PA, Restifo NP (2005). CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2. J Immunother  28, 120-8.   https://doi.org/10.1097/01.cji.0000155049.26787.45




PubMed



        
     
Free Article


 


PubMed ID 15725955
         Pubmed Central ID 1242172 


 



4.
Attia P, Phan GQ, Maker AV, Robinson MR, Quezado MM, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Restifo NP, Haworth LR, Levy C, Mavroukakis SA, Nichol G, Yellin MJ, Rosenberg SA (2005). Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4. J Clin Oncol  23, 6043-53.   https://doi.org/10.1200/JCO.2005.06.205




PubMed



        
     
Free Article


 


PubMed ID 16087944
         Pubmed Central ID 1473965 


 



5.
Borbulevych OY, Baxter TK, Yu Z, Restifo NP, Baker BM (2005). Increased immunogenicity of an anchor-modified tumor-associated antigen is due to the enhanced stability of the peptide/MHC complex: implications for vaccine design. J Immunol  174, 4812-20.   https://doi.org/10.4049/jimmunol.174.8.4812




PubMed



        
     
Free Article


 


PubMed ID 15814707
         Pubmed Central ID 2241749 


 



6.
Borbulevych OY, Insaidoo FK, Baxter TK, Powell DJ, Johnson LA, Restifo NP, Baker BM (2007). Structures of MART-126/27-35 Peptide/HLA-A2 complexes reveal a remarkable disconnect between antigen structural homology and T cell recognition. J Mol Biol  372, 1123-36.   https://doi.org/10.1016/j.jmb.2007.07.025




PubMed



        
     
Free Article


 


PubMed ID 17719062
         Pubmed Central ID 2134917 


 



7.
Chang CC, Campoli M, Restifo NP, Wang X, Ferrone S (2005). Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy. J Immunol  174, 1462-71.   https://doi.org/10.4049/jimmunol.174.3.1462




PubMed



        
     
Free Article


 


PubMed ID 15661905
         Pubmed Central ID 2245899 


 



8.
Charo J, Finkelstein SE, Grewal N, Restifo NP, Robbins PF, Rosenberg SA (2005). Bcl-2 overexpression enhances tumor-specific T-cell survival. Cancer Res  65, 2001-8.   https://doi.org/10.1158/0008-5472.CAN-04-2006




PubMed



        
     
Free Article


 


PubMed ID 15753400
         Pubmed Central ID 2174600 


 



9.
Cohen AD, Diab A, Perales MA, Wolchok JD, Rizzuto G, Merghoub T, Huggins D, Liu C, Turk MJ, Restifo NP, Sakaguchi S, Houghton AN   (2006) Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunity.  Cancer Res 66:4904-12.




PubMed



        
     
Free Article


 


PubMed ID 16651447
         Pubmed Central ID 2242844 


 



10.
Donohue KB, Grant JM, Tewalt EF, Palmer DC, Theoret MR, Restifo NP, Norbury CC (2006). Cross-priming utilizes antigen not available to the direct presentation pathway. Immunology  119, 63-73.   https://doi.org/10.1111/j.1365-2567.2006.02406.x




PubMed



        
     
Free Article


 


PubMed ID 16764686
         Pubmed Central ID 1782342 


 



11.
Dudley ME, Wunderlich JR, Yang JC, Sherry RM, Topalian SL, Restifo NP, Royal RE, Kammula U, White DE, Mavroukakis SA, Rogers LJ, Gracia GJ, Jones SA, Mangiameli DP, Pelletier MM, Gea-Banacloche J, Robinson MR, Berman DM, Filie AC, Abati A, Rosenberg SA (2005). Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol  23, 2346-57.   https://doi.org/10.1200/JCO.2005.00.240




PubMed



        
     
Free Article


 


PubMed ID 15800326
         Pubmed Central ID 1475951 


 



12.
Gattinoni L, Finkelstein SE, Klebanoff CA, Antony PA, Palmer DC, Spiess PJ, Hwang LN, Yu Z, Wrzesinski C, Heimann DM, Surh CD, Rosenberg SA, Restifo NP (2005). Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells. J Exp Med  202, 907-12.   https://doi.org/10.1084/jem.20050732




PubMed



        
     
Free Article


 


PubMed ID 16203864
         Pubmed Central ID 1397916 


 



13.
Gattinoni L, Klebanoff CA, Palmer DC, Wrzesinski C, Kerstann K, Yu Z, Finkelstein SE, Theoret MR, Rosenberg SA, Restifo NP (2005). Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells. J Clin Invest  115, 1616-26.   https://doi.org/10.1172/JCI24480




PubMed



        
     
Free Article


 


PubMed ID 15931392
         Pubmed Central ID 1137001 


 



14.
Gattinoni L, Powell DJ, Rosenberg SA, Restifo NP (2006). Adoptive immunotherapy for cancer: building on success. Nat Rev Immunol  6, 383-93.   https://doi.org/10.1038/nri1842




PubMed



        
     
Free Article


 


PubMed ID 16622476
         Pubmed Central ID 1473162 


 



15.
Gattinoni L, Ranganathan A, Surman DR, Palmer DC, Antony PA, Theoret MR, Heimann DM, Rosenberg SA, Restifo NP (2006). CTLA-4 dysregulation of self/tumor-reactive CD8+ T-cell function is CD4+ T-cell dependent. Blood  108, 3818-23.   https://doi.org/10.1182/blood-2006-07-034066




PubMed



        
     
Free Article


 


PubMed ID 16882704
         Pubmed Central ID 1679662 


 



16.
Guo ZS, Hong JA, Irvine KR, Chen GA, Spiess PJ, Liu Y, Zeng G, Wunderlich JR, Nguyen DM, Restifo NP, Schrump DS (2006). De novo induction of a cancer/testis antigen by 5-aza-2'-deoxycytidine augments adoptive immunotherapy in a murine tumor model. Cancer Res  66, 1105-13.   https://doi.org/10.1158/0008-5472.CAN-05-3020




PubMed



        
     
Free Article


 


PubMed ID 16424047
         Pubmed Central ID 2242843 


 



17.
Hinrichs CS, Gattinoni L, Restifo NP (2006). Programming CD8+ T cells for effective immunotherapy. Curr Opin Immunol  18, 363-70.   https://doi.org/10.1016/j.coi.2006.03.009




PubMed



        
     
Free Article


 


PubMed ID 16616471
         Pubmed Central ID 1540013 


 



18.
Hinrichs CS, Palmer DC, Rosenberg SA, Restifo NP (2005). Glucocorticoids do not inhibit antitumor activity of activated CD8+ T cells. J Immunother  28, 517-24.   https://doi.org/10.1097/01.cji.0000177999.95831.7b




PubMed



        
     
Free Article


 


PubMed ID 16224268
         Pubmed Central ID 1484506 


 



19.
Hwang LN, Yu Z, Palmer DC, Restifo NP (2006). The in vivo expansion rate of properly stimulated transferred CD8+ T cells exceeds that of an aggressively growing mouse tumor. Cancer Res  66, 1132-8.   https://doi.org/10.1158/0008-5472.CAN-05-1679




PubMed



        
     
Free Article


 


PubMed ID 16424050
         Pubmed Central ID 1550975 


 



20.
Klebanoff CA, Gattinoni L, Restifo NP (2006). CD8+ T-cell memory in tumor immunology and immunotherapy. Immunol Rev  211, 214-24.   https://doi.org/10.1111/j.0105-2896.2006.00391.x




PubMed



        
     
Free Article


 


PubMed ID 16824130
         Pubmed Central ID 1501075 


 



21.
Klebanoff CA, Gattinoni L, Torabi-Parizi P, Kerstann K, Cardones AR, Finkelstein SE, Palmer DC, Antony PA, Hwang ST, Rosenberg SA, Waldmann TA, Restifo NP (2005). Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. Proc Natl Acad Sci U S A  102, 9571-6.   https://doi.org/10.1073/pnas.0503726102




PubMed



        
     
Free Article


 


PubMed ID 15980149
         Pubmed Central ID 1172264 


 



22.
Klebanoff CA, Khong HT, Antony PA, Palmer DC, Restifo NP (2005). Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy. Trends Immunol  26, 111-7.   https://doi.org/10.1016/j.it.2004.12.003




PubMed



        
     
Free Article


 


PubMed ID 15668127
         Pubmed Central ID 1388277 


 



23.
Lee CH, Kakinuma T, Wang J, Zhang H, Palmer DC, Restifo NP, Hwang ST (2006). Sensitization of B16 tumor cells with a CXCR4 antagonist increases the efficacy of immunotherapy for established lung metastases. Mol Cancer Ther  5, 2592-9.   https://doi.org/10.1158/1535-7163.MCT-06-0310




PubMed



        
     
Free Article


 


PubMed ID 17041104
         Pubmed Central ID 2228334 


 



24.
Leitner WW, Bergmann-Leitner ES, Hwang LN, Restifo NP (2006). Type I Interferons are essential for the efficacy of replicase-based DNA vaccines. Vaccine  24, 5110-8.   https://doi.org/10.1016/j.vaccine.2006.04.059




PubMed



        
     
Free Article


 


PubMed ID 16725231
         Pubmed Central ID 1484849 


 



25.
Lindsey KR, Gritz L, Sherry R, Abati A, Fetsch PA, Goldfeder LC, Gonzales MI, Zinnack KA, Rogers-Freezer L, Haworth L, Mavroukakis SA, White DE, Steinberg SM, Restifo NP, Panicali DL, Rosenberg SA, Topalian SL (2006). Evaluation of prime/boost regimens using recombinant poxvirus/tyrosinase vaccines for the treatment of patients with metastatic melanoma. Clin Cancer Res  12, 2526-37.   https://doi.org/10.1158/1078-0432.CCR-05-2061




PubMed



        
     
Free Article


 


PubMed ID 16638862
         Pubmed Central ID 2151202 


 



26.
Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, Sherry RM, Royal RE, Topalian SL, Kammula US, Restifo NP, Zheng Z, Nahvi A, de Vries CR, Rogers-Freezer LJ, Mavroukakis SA, Rosenberg SA (2006). Cancer regression in patients after transfer of genetically engineered lymphocytes. Science  314, 126-9.   https://doi.org/10.1126/science.1129003




PubMed



        
     
Free Article


 


PubMed ID 16946036
         Pubmed Central ID 2267026 


 



27.
Muranski P, Boni A, Wrzesinski C, Citrin DE, Rosenberg SA, Childs R, Restifo NP (2006). Increased intensity lymphodepletion and adoptive immunotherapy--how far can we go? Nat Clin Pract Oncol  3, 668-81.   https://doi.org/10.1038/ncponc0666




PubMed



        
     
Free Article


 


PubMed ID 17139318
         Pubmed Central ID 1773008 


 



28.
Overwijk WW, de Visser KE, Tirion FH, de Jong LA, Pols TW, van der Velden YU, van den Boorn JG, Keller AM, Buurman WA, Theoret MR, Blom B, Restifo NP, Kruisbeek AM, Kastelein RA, Haanen JB (2006). Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant. J Immunol  176, 5213-22.   https://doi.org/10.4049/jimmunol.176.9.5213




PubMed



        
     
Free Article


 


PubMed ID 16621986
         Pubmed Central ID 2242845 


 



29.
Paulos CM, Kaiser A, Wrzesinski C, Hinrichs CS, Cassard L, Boni A, Muranski P, Sanchez-Perez L, Palmer DC, Yu Z, Antony PA, Gattinoni L, Rosenberg SA, Restifo NP (2007). Toll-like receptors in tumor immunotherapy. Clin Cancer Res  13, 5280-9.   https://doi.org/10.1158/1078-0432.CCR-07-1378




PubMed



        
     
Free Article


 


PubMed ID 17875756
         Pubmed Central ID 2131730 


 



30.
Paulos CM, Wrzesinski C, Kaiser A, Hinrichs CS, Chieppa M, Cassard L, Palmer DC, Boni A, Muranski P, Yu Z, Gattinoni L, Antony PA, Rosenberg SA, Restifo NP (2007). Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling. J Clin Invest  117, 2197-204.   https://doi.org/10.1172/JCI32205




PubMed



        
     
Free Article


 


PubMed ID 17657310
         Pubmed Central ID 1924500 


 



31.
Restifo NP, Rosenberg SA (2005). Use of standard criteria for assessment of cancer vaccines. Lancet Oncol  6, 3-4.   https://doi.org/10.1016/S1470-2045(04)01693-6




PubMed



        
     
Free Article


 


PubMed ID 15629270
         Pubmed Central ID 1484507 


 



32.
Rosenberg SA, Sherry RM, Morton KE, Scharfman WJ, Yang JC, Topalian SL, Royal RE, Kammula U, Restifo NP, Hughes MS, Schwartzentruber D, Berman DM, Schwarz SL, Ngo LT, Mavroukakis SA, White DE, Steinberg SM (2005). Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma. J Immunol  175, 6169-76.   https://doi.org/10.4049/jimmunol.175.9.6169




PubMed


 


PubMed ID 16237114
    
     


 



33.
Rosenberg SA, Sherry RM, Morton KE, Yang JC, Topalian SL, Royal RE, Kammula US, Restifo NP, Hughes MS, Schwarz SL, Ngo LT, Mavroukakis SA, White DE (2006). Altered CD8(+) T-cell responses when immunizing with multiepitope peptide vaccines. J Immunother  29, 224-31.   https://doi.org/10.1097/01.cji.0000190399.98802.10




PubMed



        
     
Free Article


 


PubMed ID 16531823
         Pubmed Central ID 1473975 


 



34.
Schiavo R, Baatar D, Olkhanud P, Indig FE, Restifo N, Taub D, Biragyn A (2006). Chemokine receptor targeting efficiently directs antigens to MHC class I pathways and elicits antigen-specific CD8+ T-cell responses. Blood  107, 4597-605.   https://doi.org/10.1182/blood-2005-08-3207




PubMed



        
     
Free Article


 


PubMed ID 16514063
         Pubmed Central ID 1895803 


 



35.
Wang LX, Li R, Yang G, Lim M, O'Hara A, Chu Y, Fox BA, Restifo NP, Urba WJ, Hu HM (2005). Interleukin-7-dependent expansion and persistence of melanoma-specific T cells in lymphodepleted mice lead to tumor regression and editing. Cancer Res  65, 10569-77.   https://doi.org/10.1158/0008-5472.CAN-05-2117




PubMed



        
     
Free Article


 


PubMed ID 16288050
         Pubmed Central ID 2241747 


 



36.
Wrzesinski C, Paulos CM, Gattinoni L, Palmer DC, Kaiser A, Yu Z, Rosenberg SA, Restifo NP (2007). Hematopoietic stem cells promote the expansion and function of adoptively transferred antitumor CD8 T cells. J Clin Invest  117, 492-501.   https://doi.org/10.1172/JCI30414




PubMed



        
     
Free Article


 


PubMed ID 17273561
         Pubmed Central ID 1783812 


 



37.
Wrzesinski C, Restifo NP (2005). Less is more: lymphodepletion followed by hematopoietic stem cell transplant augments adoptive T-cell-based anti-tumor immunotherapy. Curr Opin Immunol  17, 195-201.   https://doi.org/10.1016/j.coi.2005.02.002




PubMed



        
     
Free Article


 


PubMed ID 15766681
         Pubmed Central ID 2254579 


 



38.
Zeng R, Spolski R, Finkelstein SE, Oh S, Kovanen PE, Hinrichs CS, Pise-Masison CA, Radonovich MF, Brady JN, Restifo NP, Berzofsky JA, Leonard WJ (2005). Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. J Exp Med  201, 139-48.   https://doi.org/10.1084/jem.20041057




PubMed



        
     
Free Article


 


PubMed ID 15630141
         Pubmed Central ID 2212766 


 



39.
Zhao Y, Parkhurst MR, Zheng Z, Cohen CJ, Riley JP, Gattinoni L, Restifo NP, Rosenberg SA, Morgan RA (2007). Extrathymic generation of tumor-specific T cells from genetically engineered human hematopoietic stem cells via Notch signaling. Cancer Res  67, 2425-9.   https://doi.org/10.1158/0008-5472.CAN-06-3977




PubMed



        
     
Free Article


 


PubMed ID 17363559
         Pubmed Central ID 2100408 


 



40.
Zhao Y, Zheng Z, Cohen CJ, Gattinoni L, Palmer DC, Restifo NP, Rosenberg SA, Morgan RA (2006). High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation. Mol Ther  13, 151-9.   https://doi.org/10.1016/j.ymthe.2005.07.688




PubMed



        
     
Free Article


 


PubMed ID 16140584
         Pubmed Central ID 1473967",https://intramural.nih.gov/search/searchview.taf?ipid=44534
437,BC010764-01,"October 01, 2005 -  September 30, 2006",Pediatric Oncology Branch Clinical Care and Education,Alan S Wayne; MD,NULL,"Pediatric Oncology Branch, NCI","Kristin  Baird



Joanne A Derdak



Barbara V Wise",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44376
438,CP000101-02,"October 01, 2005 -  September 30, 2006",Human Studies of Diet and Nutrition,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI",NULL,"David  Baer
(BHNRC, USDA)




Beverly  Clevidence
(BHNRC, USDA)




Jerry  Combs
(USDA)




Joanne  Dorgan; PhD
(NCI)




Terryl  Hartman
(DCEG, NCI, NIH)




Joseph  Judd
(BHNRC, USDA)


Show all 7",Blossom  Patterson (Biometry Research Group),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44032
439,CP000112-02,"October 01, 2005 -  September 30, 2006",Nutrition Intervention Trials in Linxian China,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI",Nan  Hu,"Zhi-Wei  Dong
(CICAMS)




You-Lin  Qiao
(Cancer Institute of the Chinese Academy of Science)




Guo-Qing  Wang
(CICAMS)




Wen-Qiang  Wei
(EPIDEMIOLOGY, CICAMS)","Farin  Kamangar (Nutritional Epidemiology Branch)



Mark J Roth (Nutritional Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Abnet C, Taylor P, Dawsey S, Kamangar F, Fraumeni J   (2006) Self-reported goiter is associated with a significantly increased risk of gastric noncardia adenocarcinoma in a large population-based Chinese cohort.  Int J Cancer  1508-1510 pp.




 



2.
Abnet CC, Fan JH, Kamangar F, Sun XD, Taylor PR, Ren JS, Mark SD, Zhao P, Fraumeni JF, Qiao YL, Dawsey SM (2006). Self-reported goiter is associated with a significantly increased risk of gastric noncardia adenocarcinoma in a large population-based Chinese cohort. Int J Cancer  119, 1508-10.   https://doi.org/10.1002/ijc.21993




PubMed


 


PubMed ID 16642482
    
     


 



3.
Kamangar F, Qiao YL, Yu B, Sun XD, Abnet CC, Fan JH, Mark SD, Zhao P, Dawsey SM, Taylor PR (2006). Lung cancer chemoprevention: a randomized, double-blind trial in Linxian, China. Cancer Epidemiol Biomarkers Prev  15, 1562-4.   https://doi.org/10.1158/1055-9965.EPI-06-0316




PubMed


 


PubMed ID 16896051",https://intramural.nih.gov/search/searchview.taf?ipid=44030
440,CP000150-02,"October 01, 2005 -  September 30, 2006",UGI Cancer Genetic Studies,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI","Nan  Hu



Chaoyu C Wang",NULL,"Maxwell P Lee; PhD (Laboratory of Population Genetics)



Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)



Stephen M Hewitt; MD, PhD (Laboratory of Pathology)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44031
441,CP000176-02,"October 01, 2005 -  September 30, 2006",Biologic Specimen Bank for Early Lung Cancer Markers in Chinese Tin Miners,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI",NULL,NULL,Ping  Hu; MS (Biometry Research Group),NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=44033
442,CP000185-02,"October 01, 2005 -  September 30, 2006",Upper Gastrointestinal Cancer Studies,"Sanford Martin Dawsey; MD



IRP Faculty Profile",NULL,"Nutritional Epidemiology Branch, NCI","Christian Cormac Abnet; PhD, MPH



Mark J Roth



Farin  Kamangar","Paolo  Boffetta
(International Agency for Research on Cancer)




Paul  Brennan
(International Agency for Research on Cancer, Lyon, France)




Zhi-Wei  Dong
(CICAMS)




Renato  Fagundes





David  Fleischer
(Mayo Clinic (Scottsdale))




Paul J Limburg



Show all 13","Philip  Taylor; MD, ScD (Genetic Epidemiology Branch)



Nan  Hu (Genetic Epidemiology Branch)



Edward L Korn (Clinical Trials Section)



Karen  Woodson (Cancer Genetics Branch)",NULL,"Ordered by publication type and then author name.



1.
Akbari MR, Malekzadeh R, Nasrollahzadeh D, Amanian D, Sun P, Islami F, Sotoudeh M, Semnani S, Boffeta P, Dawsey SM, Ghadirian P, Narod SA (2006). Familial risks of esophageal cancer among the Turkmen population of the Caspian littoral of Iran. Int J Cancer  119, 1047-51.   https://doi.org/10.1002/ijc.21906




PubMed


 


PubMed ID 16570268
    
     


 



2.
Fagundes R, Abnet C, Roth M, Taylor P, Dawsey S, Kamangar F   (2006) Higher urine 1-hydroxy pyrene glucuronide (1-OHPG) is associated with tobacco smoke exposure and drinking mate in healthy subjects from Rio Grande do Sul, Brazil.  BMC Cancer  39 pp.




 



3.
Fagundes RB, Abnet CC, Strickland PT, Kamangar F, Roth MJ, Taylor PR, Dawsey SM (2006). Higher urine 1-hydroxy pyrene glucuronide (1-OHPG) is associated with tobacco smoke exposure and drinking maté in healthy subjects from Rio Grande do Sul, Brazil. BMC Cancer  6, 139.   https://doi.org/10.1186/1471-2407-6-139




PubMed



        
     
Free Article


 


PubMed ID 16729889
         Pubmed Central ID 1539013 


 



4.
Gao GF, Roth MJ, Wei WQ, Abnet CC, Chen F, Lu N, Zhao FH, Li XQ, Wang GQ, Taylor PR, Pan QJ, Chen W, Dawsey SM, Qiao YL (2006). No association between HPV infection and the neoplastic progression of esophageal squamous cell carcinoma: result from a cross-sectional study in a high-risk region of China. Int J Cancer  119, 1354-9.   https://doi.org/10.1002/ijc.21980




PubMed


 


PubMed ID 16615110
    
     


 



5.
Joshi N, Johnson LL, Wei WQ, Abnet CC, Dong ZW, Taylor PR, Limburg PJ, Dawsey SM, Hawk ET, Qiao YL, Kirsch IR (2006). Gene expression differences in normal esophageal mucosa associated with regression and progression of mild and moderate squamous dysplasia in a high-risk Chinese population. Cancer Res  66, 6851-60.   https://doi.org/10.1158/0008-5472.CAN-06-0662




PubMed


 


PubMed ID 16818663
    
     


 



6.
Joshi N, Johnson LL, Wei WQ, Abnet CC, Dong ZW, Taylor PR, Limburg PJ, Dawsey SM, Hawk ET, Qiao YL, Kirsch IR (2006). Selenomethionine treatment does not alter gene expression in normal squamous esophageal mucosa in a high-risk Chinese population. Cancer Epidemiol Biomarkers Prev  15, 1046-7.   https://doi.org/10.1158/1055-9965.EPI-06-0135




PubMed


 


PubMed ID 16702392
    
     


 



7.
Malekshah AF, Kimiagar M, Saadatian-Elahi M, Pourshams A, Nouraie M, Goglani G, Hoshiarrad A, Sadatsafavi M, Golestan B, Yoonesi A, Rakhshani N, Fahimi S, Nasrollahzadeh D, Salahi R, Ghafarpour A, Semnani S, Steghens JP, Abnet CC, Kamangar F, Dawsey SM, Brennan P, Boffetta P, Malekzadeh R (2006). Validity and reliability of a new food frequency questionnaire compared to 24 h recalls and biochemical measurements: pilot phase of Golestan cohort study of esophageal cancer. Eur J Clin Nutr  60, 971-7.   https://doi.org/10.1038/sj.ejcn.1602407




PubMed


 


PubMed ID 16465196
    
     


 



8.
McGruder BM, Atha DH, Wang W, Huppi K, Wei WQ, Abnet CC, Qiao YL, Dawsey SM, Taylor PR, Jakupciak JP (2006). Real-time telomerase assay of less-invasively collected esophageal cell samples. Cancer Lett  244, 91-100.   https://doi.org/10.1016/j.canlet.2005.12.012




PubMed


 


PubMed ID 16569479
    
     


 



9.
Roth MJ, Abnet CC, Hu N, Wang QH, Wei WQ, Green L, D'Alelio M, Qiao YL, Dawsey SM, Taylor PR, Woodson K (2006). p16, MGMT, RARbeta2, CLDN3, CRBP and MT1G gene methylation in esophageal squamous cell carcinoma and its precursor lesions. Oncol Rep  15, 1591-7.




PubMed


 


PubMed ID 16685400",https://intramural.nih.gov/search/searchview.taf?ipid=44036
443,CP004410-30,"October 01, 2005 -  September 30, 2006",Family Studies,"Margaret Anne Tucker



IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI","Gladys M. Glenn; MD, PhD



Mary C Fraser



Mary Louise McMaster; MD



Dilys  Parry; PhD



Kimberly F Kerstann



David  Ng; AB, MD



Show all 8","Janis  Beach
(Information Management Systems)




Giovanna  Bianchi-Scarra
(University of Genova)




Tim  Bishop
(Institute for Cancer Research)




Donato  Calista
(Bufalini Hospital)




Florence  Demenais
(Institut National de la Sante et de la Recherche Medicale)




David  Elder
(University of Pennsylvania School of Medicine, Philadelphia, PA)


Show all 12","June  Peters (Clinical Genetics Branch)



Jeffery P Struewing; MS, MD (Laboratory of Population Genetics)



Kenneth H Kraemer; MD (DNA Repair Section)",NULL,"Ordered by publication type and then author name.



1.
Baser ME, Mautner VF, Parry DM, Evans DG (2005). Methodological issues in longitudinal studies: vestibular schwannoma growth rates in neurofibromatosis 2. J Med Genet  42, 903-6.   https://doi.org/10.1136/jmg.2005.031302




PubMed



        
     
Free Article


 


PubMed ID 15831594
         Pubmed Central ID 1735973 


 



2.
Buckel TB, Goldstein AM, Fraser MC, Rogers B, Tucker MA (2006). Recent tanning bed use: a risk factor for melanoma. Arch Dermatol  142, 485-8.   https://doi.org/10.1001/archderm.142.4.485




PubMed


 


PubMed ID 16618869
    
     


 



3.
Goldstein AM, Tucker MA (2005). A piece of the melanoma puzzle. J Natl Cancer Inst  97, 1486-7.   https://doi.org/10.1093/jnci/dji359




PubMed


 


PubMed ID 16234555
    
     


 



4.
Laud K, Marian C, Avril MF, Barrois M, Chompret A, Goldstein AM, Tucker MA, Clark PA, Peters G, Chaudru V, Demenais F, Spatz A, Smith MW, Lenoir GM, Bressac-de Paillerets B, French Hereditary Melanoma Study Group (2006). Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma. J Med Genet  43, 39-47.   https://doi.org/10.1136/jmg.2005.033498




PubMed



        
     
Free Article


 


PubMed ID 15937071
         Pubmed Central ID 2564502 


 



5.
Pithukpakorn M, Wei MH, Toure O, Steinbach PJ, Glenn GM, Zbar B, Linehan WM, Toro JR (2006). Fumarate hydratase enzyme activity in lymphoblastoid cells and fibroblasts of individuals in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet  43, 755-62.   https://doi.org/10.1136/jmg.2006.041087




PubMed



        
     
Free Article


 


PubMed ID 16597677
         Pubmed Central ID 2564577 


 



6.
Stewart L, Glenn G, Toro JR (2006). Cutaneous leiomyomas: a clinical marker of risk for hereditary leiomyomatosis and renal cell cancer. Dermatol Nurs  18, 335-41; quiz 342.




PubMed


 


PubMed ID 16948378
    
     


 



7.
Wei MH, Toure O, Glenn GM, Pithukpakorn M, Neckers L, Stolle C, Choyke P, Grubb R, Middelton L, Turner ML, Walther MM, Merino MJ, Zbar B, Linehan WM, Toro JR (2006). Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet  43, 18-27.   https://doi.org/10.1136/jmg.2005.033506




PubMed



        
     
Free Article


 


PubMed ID 15937070
         Pubmed Central ID 2564499",https://intramural.nih.gov/search/searchview.taf?ipid=43988
444,CP005782-12,"October 01, 2005 -  September 30, 2006",Epidemiology of Oncogenic Viruses,"Thomas R O'Brien; BA, MPH, MD



IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Kachapati K, O'Brien TR, Bergeron J, Zhang M, Dean M (2006). Population distribution of the functional caspase-12 allele. Hum Mutat  27, 975.   https://doi.org/10.1002/humu.9448




PubMed


 


PubMed ID 16917906
    
     


 



2.
Zhang M, Rosenberg P, Zhang M   (2006) Correlates of spontaneous clearance of hepatitis C virus among HIV-infected people with hemophilia.  Blood  892-897 pp.",https://intramural.nih.gov/search/searchview.taf?ipid=43986
445,CP005803-12,"October 01, 2005 -  September 30, 2006",Genetic Epidemiology,"Alisa  Goldstein; PhD



IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI","Neil Edward Caporaso; MS, MD



Mary C Fraser



Gladys M. Glenn; MD, PhD



Lynn Rachel Goldin; PhD



Naoko  Ishibe; ScD



Maria Teresa Pia Landi; MD, PhD



Show all 13","Tim  Bishop
(Institute for Cancer Research)




Julianne  Byrne
(Washington Children's hospital)




Donato  Calista
(Bufalini Hospital)




Florence  Demenais
(Institut National de la Sante et de la Recherche Medicale)




Kari  Hemminki; PhD
(Department of Biosciences, Karolinska Institute)




David  Hogg
(University of Toronto)


Show all 9","Martha S Linet; PhD (Radiation Epidemiology Branch)



Roni T Falk (Hormonal and Reproductive Epidemiology Branch)



Gloria L Gridley (Biostatistics Branch)



Mitchell Henry Gail; PhD, MD (Biostatistics Branch)



Ruth  Pfeiffer; PhD (Biostatistics Branch)



Thomas  Fears; PhD (Biostatistics Branch)",NULL,"Ordered by publication type and then author name.



1.
Fears TR, Guerry D, Pfeiffer RM, Sagebiel RW, Elder DE, Halpern A, Holly EA, Hartge P, Tucker MA (2006). Identifying individuals at high risk of melanoma: a practical predictor of absolute risk. J Clin Oncol  24, 3590-6.   https://doi.org/10.1200/JCO.2005.04.1277




PubMed


 


PubMed ID 16728488
    
     


 



2.
Goldin LR, Landgren O, McMaster ML, Gridley G, Hemminki K, Li X, Mellemkjaer L, Olsen JH, Linet MS (2005). Familial aggregation and heterogeneity of non-Hodgkin lymphoma in population-based samples. Cancer Epidemiol Biomarkers Prev  14, 2402-6.   https://doi.org/10.1158/1055-9965.EPI-05-0346




PubMed


 


PubMed ID 16214923
    
     


 



3.
Goldstein AM, Dondon MG, Andrieu N (2006). Unconditional analyses can increase efficiency in assessing gene-environment interaction of the case-combined-control design. Int J Epidemiol  35, 1067-73.   https://doi.org/10.1093/ije/dyl048




PubMed



        
     
Free Article


 


PubMed ID 16556643
         Pubmed Central ID 2080880 


 



4.
Landgren O, Engels EA, Caporaso NE, Gridley G, Mellemkjaer L, Hemminki K, Linet MS, Goldin LR (2006). Patterns of autoimmunity and subsequent chronic lymphocytic leukemia in Nordic countries. Blood  108, 292-6.   https://doi.org/10.1182/blood-2005-11-4620




PubMed



        
     
Free Article


 


PubMed ID 16527887
         Pubmed Central ID 1895837 


 



5.
Landgren O, Goldin L, Gridley G, Linet M   (2006) Familial characteristics of hematologic and autoimmune disorders in 8,406 multiple myeloma patients: a population-based case-control study.  Int J Cancer  3095-3098 pp.




 



6.
Landgren O, Linet MS, McMaster ML, Gridley G, Hemminki K, Goldin LR (2006). Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study. Int J Cancer  118, 3095-8.   https://doi.org/10.1002/ijc.21745




PubMed


 


PubMed ID 16395700
    
     


 



7.
Parry DM (2006). NF2 and spinal tumors. J Neurosurg Spine  5, 179; author reply 179.   https://doi.org/10.3171/spi.2006.5.2.179




PubMed


 


PubMed ID 16925089
    
     


 



8.
R Yang X, Pfeiffer RM, Goldstein AM (2006). Influence of glutathione-S-transferase (GSTM1, GSTP1, GSTT1) and cytochrome p450 (CYP1A1, CYP2D6) polymorphisms on numbers of basal cell carcinomas (BCCs) in families with the naevoid basal cell carcinoma syndrome. J Med Genet  43, e16.   https://doi.org/10.1136/jmg.2005.035006




PubMed



        
     
Free Article


 


PubMed ID 16582078
         Pubmed Central ID 2563218 


 



9.
Yang X, Pfeiffer R   (2006) Influence of glutathione-S-transferase (GSTM1, GSTP1, GSTT1) and cytochrome p450 (CYP1A1, CYP2D6) polymorphisms on numbers of basal cell carcinomas (BCCs) in families with the nevoid basal cell carcinoma syndrome (NBCCS).  Journal of Medical Genetics  1-5 pp.




 



10.
Yang XR, Charette LA, Garcia-Closas M, Lissowska J, Paal E, Sidawy M, Hewitt SM, Rimm DL, Sherman ME (2006). Construction and validation of tissue microarrays of ductal carcinoma in situ and terminal duct lobular units associated with invasive breast carcinoma. Diagn Mol Pathol  15, 157-61.   https://doi.org/10.1097/01.pdm.0000213453.45398.e0




PubMed


 


PubMed ID 16932071",https://intramural.nih.gov/search/searchview.taf?ipid=43984
446,CP005804-12,"October 01, 2005 -  September 30, 2006",Pharmacogenetic Studies,"Neil Edward Caporaso; MS, MD



IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI","Alisa  Goldstein; PhD



Lynn Rachel Goldin; PhD



Naoko  Ishibe; ScD



Maria Teresa Pia Landi; MD, PhD



Margaret Anne Tucker",NULL,Andrew Wells Bergen (Office of the Director),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43983
447,CP010119-11,"October 01, 2005 -  September 30, 2006",Studies of Occupational Cancer (Pesticides),Michael  Alavanja; PhD,NULL,"Occupational and Environmental Epidemiology Branch, NCI","Aaron E Blair; PhD, MPH



Dalsu  Baris



Joanne S Colt



Mary Helen Ward; MS, PhD



Debra  Silverman; ScD, ScM



Mustafa  Dosemeci; PhD



Show all 8","Lisbeth  Lopez-Carrillo
(Mexican National Institute of Public Health)




Andrew  Olshan
(University of North Carolina)




Sandra  Petralia
(Roche Laboratories)




Dennis  Weisenburger
(University of Nebraska Medical Center)","Shelia K Zahm; ScM, ScD (Office of the Director)



Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)



Jay  Lubin; PhD (Biostatistics Branch)",NULL,"Ordered by publication type and then author name.



1.
Beane Freeman LE, Bonner MR, Blair A, Hoppin JA, Sandler DP, Lubin JH, Dosemeci M, Lynch CF, Knott C, Alavanja MC (2005). Cancer incidence among male pesticide applicators in the Agricultural Health Study cohort exposed to diazinon. Am J Epidemiol  162, 1070-9.   https://doi.org/10.1093/aje/kwi321




PubMed


 


PubMed ID 16236997
    
     


 



2.
Hou L, Lee WJ, Rusiecki J, Hoppin JA, Blair A, Bonner MR, Lubin JH, Samanic C, Sandler DP, Dosemeci M, Alavanja MC (2006). Pendimethalin exposure and cancer incidence among pesticide applicators. Epidemiology  17, 302-7.   https://doi.org/10.1097/01.ede.0000201398.82658.50




PubMed



        
     
Free Article


 


PubMed ID 16452832
         Pubmed Central ID 1513643 


 



3.
Lee W, Baccarelli A   (2006) Pesticide exposure and lung cancer mortality in Russia.  Environ Int  412-416 pp.




 



4.
Lee WJ, Baccarelli A, Tretiakova M, Gorbanev S, Lomtev A, Klimkina I, Tchibissov V, Averkina O, Dosemeci M (2006). Pesticide exposure and lung cancer mortality in Leningrad province in Russia. Environ Int  32, 412-6.   https://doi.org/10.1016/j.envint.2005.10.001




PubMed


 


PubMed ID 16280162
    
     


 



5.
Lee WJ, Colt JS, Heineman EF, McComb R, Weisenburger DD, Lijinsky W, Ward MH (2005). Agricultural pesticide use and risk of glioma in Nebraska, United States. Occup Environ Med  62, 786-92.   https://doi.org/10.1136/oem.2005.020230




PubMed



        
     
Free Article


 


PubMed ID 16234405
         Pubmed Central ID 1740883 


 



6.
Lynch SM, Rusiecki JA, Blair A, Dosemeci M, Lubin J, Sandler D, Hoppin JA, Lynch CF, Alavanja MC (2006). Cancer incidence among pesticide applicators exposed to cyanazine in the agricultural health study. Environ Health Perspect  114, 1248-52.   https://doi.org/10.1289/ehp.8997




PubMed



        
     
Free Article


 


PubMed ID 16882534
         Pubmed Central ID 1552023 


 



7.
Mahajan R, Blair A, Lynch C, Schroeder P, Hoppin J, Sandler D, Alavanja M (2006) Fonofos Exposure and Incidence of Cancer in the Agricultural Health Study. Environmental Health Perspectives 114:1838-42




 



8.
Mahajan R, Bonner MR, Hoppin JA, Alavanja MC (2006). Phorate exposure and incidence of cancer in the agricultural health study. Environ Health Perspect  114, 1205-9.   https://doi.org/10.1289/ehp.8911




PubMed



        
     
Free Article


 


PubMed ID 16882526
         Pubmed Central ID 1551990 


 



9.
Rusiecki JA, Hou L, Lee WJ, Blair A, Dosemeci M, Lubin JH, Bonner M, Samanic C, Hoppin JA, Sandler DP, Alavanja MC (2006). Cancer incidence among pesticide applicators exposed to metolachlor in the Agricultural Health Study. Int J Cancer  118, 3118-23.   https://doi.org/10.1002/ijc.21758




PubMed


 


PubMed ID 16425265
    
     


 



10.
Sallmén M, Baird DD, Hoppin JA, Blair A, Sandler DP (2006). Fertility and exposure to solvents among families in the Agricultural Health Study. Occup Environ Med  63, 469-75.   https://doi.org/10.1136/oem.2005.021337




PubMed



        
     
Free Article


 


PubMed ID 16698811
         Pubmed Central ID 2092515 


 



11.
Sallmén M, Sandler DP, Hoppin JA, Blair A, Baird DD (2006). Reduced fertility among overweight and obese men. Epidemiology  17, 520-3.   https://doi.org/10.1097/01.ede.0000229953.76862.e5




PubMed


 


PubMed ID 16837825
    
     


 



12.
Ward MH, Heineman EF, McComb RD, Weisenburger DD (2005). Drinking water and dietary sources of nitrate and nitrite and risk of glioma. J Occup Environ Med  47, 1260-7.   https://doi.org/10.1097/01.jom.0000184879.67736.ae




PubMed


 


PubMed ID 16340707",https://intramural.nih.gov/search/searchview.taf?ipid=43978
448,CP010120-11,"October 01, 2005 -  September 30, 2006",Studies of Occupational Cancer,"Aaron E Blair; PhD, MPH",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris



Joanne S Colt



Bu Tian  Ji



Mary Helen Ward; MS, PhD



Joseph B Coble



Debra  Silverman; ScD, ScM



Show all 21","Paolo  Boffetta
(International Agency for Research on Cancer)




Paul  Brennan
(International Agency for Research on Cancer, Lyon, France)




Leon  Burmeister
(University of Iowa)




Brian  Chiu
(Northwestern University)




Pierluigi  Cocco
(University of Cagliari)




Larwence  Figgs
(St. Louis University)


Show all 21","Jay  Lubin; PhD (Biostatistics Branch)



Louise  Brinton; PhD (Hormonal and Reproductive Epidemiology Branch)



Montserrat  Garcia-Closas; MD, PhD (Hormonal and Reproductive Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Baccarelli A, Khmelnitskii O, Tretiakova M, Gorbanev S, Lomtev A, Klimkina I, Tchibissov V, Averkina O, Rice C, Dosemeci M (2006). Risk of lung cancer from exposure to dusts and fibers in Leningrad Province, Russia. Am J Ind Med  49, 460-7.   https://doi.org/10.1002/ajim.20316




PubMed


 


PubMed ID 16586409
    
     


 



2.
Blair A (2006). Occupational exposures and non-Hodgkin lymphoma: where do we stand? Occup Environ Med  63, 1-3.   https://doi.org/10.1136/oem.2005.023978




PubMed



        
     
Free Article


 


PubMed ID 16361397
         Pubmed Central ID 1351383 


 



3.
Cantor KP (2006). Feasibility of conducting human studies to address bromate risks. Toxicology  221, 197-204.   https://doi.org/10.1016/j.tox.2005.11.009




PubMed


 


PubMed ID 16352386
    
     


 



4.
Chiu BC, Dave BJ, Blair A, Gapstur SM, Zahm SH, Weisenburger DD (2006). Agricultural pesticide use and risk of t(14;18)-defined subtypes of non-Hodgkin lymphoma. Blood  108, 1363-9.   https://doi.org/10.1182/blood-2005-12-008755




PubMed



        
     
Free Article


 


PubMed ID 16621961
         Pubmed Central ID 1566872 


 



5.
Fortuny J, Kogevinas M, Garcia-Closas M, Real FX, Tardón A, Garcia-Closas R, Serra C, Carrato A, Lloreta J, Rothman N, Villanueva C, Dosemeci M, Malats N, Silverman D (2006). Use of analgesics and nonsteroidal anti-inflammatory drugs, genetic predisposition, and bladder cancer risk in Spain. Cancer Epidemiol Biomarkers Prev  15, 1696-702.   https://doi.org/10.1158/1055-9965.EPI-06-0038




PubMed


 


PubMed ID 16985032
    
     


 



6.
Fortuny J, Silverman D, Dosemeci M, Rothman N, Garcia-Closas M   (2006) Use of analgesics and NSAIDS,genetic predisposition and bladder cancer risk in Spain.  Cancer Epidemiol Biomarkers Prev  1696-1702 pp.




 



7.
García-Closas M, Malats N, Real FX, Welch R, Kogevinas M, Chatterjee N, Pfeiffer R, Silverman D, Dosemeci M, Tardón A, Serra C, Carrato A, García-Closas R, Castaño-Vinyals G, Chanock S, Yeager M, Rothman N (2006). Genetic variation in the nucleotide excision repair pathway and bladder cancer risk. Cancer Epidemiol Biomarkers Prev  15, 536-42.   https://doi.org/10.1158/1055-9965.EPI-05-0749




PubMed


 


PubMed ID 16537713
    
     


 



8.
Kogevinas M, Fernandez F, Garcia-Closas M, Tardon A, Garcia-Closas R, Serra C, Carrato A, Castano-Vinyals G, Yeager M, Chanock SJ, Lloreta J, Rothman N, Real FX, Dosemeci M, Malats N, Silverman D (2006). Hair dye use is not associated with risk for bladder cancer: evidence from a case-control study in Spain. Eur J Cancer  42, 1448-54.   https://doi.org/10.1016/j.ejca.2006.02.009




PubMed


 


PubMed ID 16740387
    
     


 



9.
Liu Y, Lan Q, Siegfried JM, Luketich JD, Keohavong P (2006). Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patients. Neoplasia  8, 46-51.   https://doi.org/10.1593/neo.05586




PubMed



        
     
Free Article


 


PubMed ID 16533425
         Pubmed Central ID 1584289 


 



10.
Purdue MP, Järvholm B, Bergdahl IA, Hayes RB, Baris D (2006). Occupational exposures and head and neck cancers among Swedish construction workers. Scand J Work Environ Health  32, 270-5.   https://doi.org/10.5271/sjweh.1010




PubMed


 


PubMed ID 16932824
    
     


 



11.
Radican L, Wartenberg D, Rhoads GG, Schneider D, Wedeen R, Stewart P, Blair A (2006). A retrospective occupational cohort study of end-stage renal disease in aircraft workers exposed to trichloroethylene and other hydrocarbons. J Occup Environ Med  48, 1-12.   https://doi.org/10.1097/01.jom.0000190300.51629.e0




PubMed



        
     
Free Article


 


PubMed ID 16404204
         Pubmed Central ID 1351384 


 



12.
Raimondi S, Lan Q   (2006) Meta- and Pooled Analysis of GSTT1 and Lung Cancer: A Huge-GSEC Review.  Am J Epidemiol [Epub]  - pp.




 



13.
Raimondi S, Paracchini V, Autrup H, Barros-Dios JM, Benhamou S, Boffetta P, Cote ML, Dialyna IA, Dolzan V, Filiberti R, Garte S, Hirvonen A, Husgafvel-Pursiainen K, Imyanitov EN, Kalina I, Kang D, Kiyohara C, Kohno T, Kremers P, Lan Q, London S, Povey AC, Rannug A, Reszka E, Risch A, et al. [17 more authors] (2006). Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol  164, 1027-42.   https://doi.org/10.1093/aje/kwj321




PubMed


 


PubMed ID 17000715
    
     


 



14.
Shen M, Boffetta P, Olsen JH, Andersen A, Hemminki K, Pukkala E, Tracey E, Brewster DH, McBride ML, Pompe-Kirn V, Kliewer EV, Tonita JM, Chia KS, Martos C, Jonasson JG, Colin D, Scélo G, Brennan P (2006). A pooled analysis of second primary pancreatic cancer. Am J Epidemiol  163, 502-11.   https://doi.org/10.1093/aje/kwj073




PubMed


 


PubMed ID 16421239
    
     


 



15.
Villanueva CM, Cantor KP, Grimalt JO, Castaño-Vinyals G, Malats N, Silverman D, Tardon A, Garcia-Closas R, Serra C, Carrato A, Rothman N, Real FX, Dosemeci M, Kogevinas M (2006). Assessment of lifetime exposure to trihalomethanes through different routes. Occup Environ Med  63, 273-7.   https://doi.org/10.1136/oem.2005.023069




PubMed



        
     
Free Article


 


PubMed ID 16556748
         Pubmed Central ID 2078091 


 



16.
Villanueva CM, Cantor KP, King WD, Jaakkola JJ, Cordier S, Lynch CF, Porru S, Kogevinas M (2006). Total and specific fluid consumption as determinants of bladder cancer risk. Int J Cancer  118, 2040-7.   https://doi.org/10.1002/ijc.21587




PubMed


 


PubMed ID 16284957
    
     


 



17.
Zhang Y, Cantor KP, Dosemeci M, Lynch CF, Zhu Y, Zheng T (2006). Occupational and leisure-time physical activity and risk of colon cancer by subsite. J Occup Environ Med  48, 236-43.   https://doi.org/10.1097/01.jom.0000199521.72764.26




PubMed


 


PubMed ID 16531827",https://intramural.nih.gov/search/searchview.taf?ipid=43980
449,CP010121-11,"October 01, 2005 -  September 30, 2006",Molecular Epidemiology Studies of Occupational and Environmental Exposures,"Nathaniel C Rothman; MD



IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris



Mary Helen Ward; MS, PhD



Mustafa  Dosemeci; PhD



Michael  Alavanja; PhD



Kenneth  Cantor; PhD



Aaron E Blair; PhD, MPH



Show all 13","Robert  Branch
(University of Pittsburgh)




Paul  Brennan
(International Agency for Research on Cancer, Lyon, France)




David  DeMarini
(United States Environmental Protection Agency)




Manolis  Kogevinas





Nria  Malats
(Institut Municipal dInvestigaci Mdica)




Stephen  Rappaport
(University of North Carolina)


Show all 12","Shelia K Zahm; ScM, ScD (Office of the Director)



Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)",NULL,"Ordered by publication type and then author name.



1.
Beyerbach A, Rothman N, Bhatnagar VK, Kashyap R, Sabbioni G (2006). Hemoglobin adducts in workers exposed to benzidine and azo dyes. Carcinogenesis  27, 1600-6.   https://doi.org/10.1093/carcin/bgi362




PubMed


 


PubMed ID 16497705
    
     


 



2.
Choi JY, Lee KM, Noh DY, Ahn SH, Lee JE, Han W, Jang IJ, Shin SG, Yoo KY, Hayes RB, Kang D (2006). Genetic polymorphisms of eNOS, hormone receptor status, and survival of breast cancer. Breast Cancer Res Treat  100, 213-8.   https://doi.org/10.1007/s10549-006-9245-5




PubMed


 


PubMed ID 16821086
    
     


 



3.
De Roos AJ, Cooper GS, Alavanja MC, Sandler DP (2005). Rheumatoid arthritis among women in the Agricultural Health Study: risk associated with farming activities and exposures. Ann Epidemiol  15, 762-70.   https://doi.org/10.1016/j.annepidem.2005.08.001




PubMed


 


PubMed ID 16257361
    
     


 



4.
Fortuny J, Kogevinas M, Garcia-Closas M, Real FX, Tardón A, Garcia-Closas R, Serra C, Carrato A, Lloreta J, Rothman N, Villanueva C, Dosemeci M, Malats N, Silverman D (2006). Use of analgesics and nonsteroidal anti-inflammatory drugs, genetic predisposition, and bladder cancer risk in Spain. Cancer Epidemiol Biomarkers Prev  15, 1696-702.   https://doi.org/10.1158/1055-9965.EPI-06-0038




PubMed


 


PubMed ID 16985032
    
     


 



5.
Kang D   (2006) Genetic Polymorphisms of eNOS, Hormone Receptor Status, and Survival of Breast Cancer.  Breast Cancer Res Treat  - pp.




 



6.
Kim S, Vermeulen R, Waidyanatha S, Johnson BA, Lan Q, Rothman N, Smith MT, Zhang L, Li G, Shen M, Yin S, Rappaport SM (2006). Using urinary biomarkers to elucidate dose-related patterns of human benzene metabolism. Carcinogenesis  27, 772-81.   https://doi.org/10.1093/carcin/bgi297




PubMed


 


PubMed ID 16339183
    
     


 



7.
Kogevinas M, Fernandez F, Garcia-Closas M, Tardon A, Garcia-Closas R, Serra C, Carrato A, Castano-Vinyals G, Yeager M, Chanock SJ, Lloreta J, Rothman N, Real FX, Dosemeci M, Malats N, Silverman D (2006). Hair dye use is not associated with risk for bladder cancer: evidence from a case-control study in Spain. Eur J Cancer  42, 1448-54.   https://doi.org/10.1016/j.ejca.2006.02.009




PubMed


 


PubMed ID 16740387
    
     


 



8.
Lan Q, Zhang L, Shen M, Smith MT, Li G, Vermeulen R, Rappaport SM, Forrest MS, Hayes RB, Linet M, Dosemeci M, Alter BP, Weinberg RS, Yin S, Yeager M, Welch R, Waidyanatha S, Kim S, Chanock S, Rothman N (2005). Polymorphisms in cytokine and cellular adhesion molecule genes and susceptibility to hematotoxicity among workers exposed to benzene. Cancer Res  65, 9574-81.   https://doi.org/10.1158/0008-5472.CAN-05-1419




PubMed


 


PubMed ID 16230423
    
     


 



9.
Lan Q, Zheng T, Rothman N, Zhang Y, Wang SS, Shen M, Berndt SI, Zahm SH, Holford TR, Leaderer B, Yeager M, Welch R, Boyle P, Zhang B, Zou K, Zhu Y, Chanock S (2006). Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood  107, 4101-8.   https://doi.org/10.1182/blood-2005-10-4160




PubMed



        
     
Free Article


 


PubMed ID 16449530
         Pubmed Central ID 1895277 


 



10.
Liu Y, Lan Q, Siegfried JM, Luketich JD, Keohavong P (2006). Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patients. Neoplasia  8, 46-51.   https://doi.org/10.1593/neo.05586




PubMed



        
     
Free Article


 


PubMed ID 16533425
         Pubmed Central ID 1584289 


 



11.
Raimondi S, Lan Q   (2006) Meta- and Pooled Analysis of GSTT1 and Lung Cancer: A Huge-GSEC Review.  Am J Epidemiol [Epub]  - pp.




 



12.
Raimondi S, Paracchini V, Autrup H, Barros-Dios JM, Benhamou S, Boffetta P, Cote ML, Dialyna IA, Dolzan V, Filiberti R, Garte S, Hirvonen A, Husgafvel-Pursiainen K, Imyanitov EN, Kalina I, Kang D, Kiyohara C, Kohno T, Kremers P, Lan Q, London S, Povey AC, Rannug A, Reszka E, Risch A, et al. [17 more authors] (2006). Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol  164, 1027-42.   https://doi.org/10.1093/aje/kwj321




PubMed


 


PubMed ID 17000715
    
     


 



13.
Samanic C, Kogevinas M, Dosemeci M, Malats N, Real FX, Garcia-Closas M, Serra C, Carrato A, García-Closas R, Sala M, Lloreta J, Tardón A, Rothman N, Silverman DT (2006). Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender. Cancer Epidemiol Biomarkers Prev  15, 1348-54.   https://doi.org/10.1158/1055-9965.EPI-06-0021




PubMed


 


PubMed ID 16835335
    
     


 



14.
Shen M, Zheng T, Lan Q, Zhang Y, Zahm SH, Wang SS, Holford TR, Leaderer B, Yeager M, Welch R, Kang D, Boyle P, Zhang B, Zou K, Zhu Y, Chanock S, Rothman N (2006). Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut. Hum Genet  119, 659-68.   https://doi.org/10.1007/s00439-006-0177-2




PubMed


 


PubMed ID 16738949
    
     


 



15.
Vermeulen R, Lan Q, Zhang L, Gunn L, McCarthy D, Woodbury RL, McGuire M, Podust VN, Li G, Chatterjee N, Mu R, Yin S, Rothman N, Smith MT (2005). Decreased levels of CXC-chemokines in serum of benzene-exposed workers identified by array-based proteomics. Proc Natl Acad Sci U S A  102, 17041-6.   https://doi.org/10.1073/pnas.0508573102




PubMed



        
     
Free Article


 


PubMed ID 16286641
         Pubmed Central ID 1288009 


 



16.
Villanueva CM, Cantor KP, Grimalt JO, Castaño-Vinyals G, Malats N, Silverman D, Tardon A, Garcia-Closas R, Serra C, Carrato A, Rothman N, Real FX, Dosemeci M, Kogevinas M (2006). Assessment of lifetime exposure to trihalomethanes through different routes. Occup Environ Med  63, 273-7.   https://doi.org/10.1136/oem.2005.023069




PubMed



        
     
Free Article


 


PubMed ID 16556748
         Pubmed Central ID 2078091 


 



17.
Yokley K, Tran HT, Pekari K, Rappaport S, Riihimaki V, Rothman N, Waidyanatha S, Schlosser PM (2006). Physiologically-based pharmacokinetic modeling of benzene in humans: a Bayesian approach. Risk Anal  26, 925-43.   https://doi.org/10.1111/j.1539-6924.2006.00789.x




PubMed


 


PubMed ID 16948686",https://intramural.nih.gov/search/searchview.taf?ipid=43981
450,CP010122-11,"October 01, 2005 -  September 30, 2006",Occupational Exposure Assessment,Patricia S Stewart; PhD,NULL,"Occupational and Environmental Epidemiology Branch, NCI","Joseph B Coble



Mustafa  Dosemeci; PhD



Michael  Alavanja; PhD



Dalsu  Baris



Aaron E Blair; PhD, MPH



Kenneth  Cantor; PhD



Show all 19","Olufemi  Adegoke
(Meharry Medical College, Nashville, TN)




Wolfgang  Ahrens
(University of Bremen)




Ruth  Allen
(Environmental Protection Agency, Washington, DC)




Tye  Arbuckle
(Health Canada)




Michael  Attfield
(National Institute for Occupational Safety and Health, Morgantown, WV)




Berit  Bakke
(National Institute of Occupational Health)


Show all 52","Linda M Brown; MPH, DPhil (Biostatistics Branch)



Nilanjan  Chatterjee (Biostatistics Branch)



Montserrat  Garcia-Closas; MD, PhD (Hormonal and Reproductive Epidemiology Branch)



Gloria L Gridley (Biostatistics Branch)



Allan  Hildesheim; PhD (Hormonal and Reproductive Epidemiology Branch)



Peter D Inskip; ScD (Radiation Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Allen RH, Mage DT, Gondy G, Kodali A, Christensen C, Coble J, Stewart P (2006). Investigation of job-related pesticide exposure in the third national health and nutrition examination survey. Arch Environ Occup Health  61, 75-86.   https://doi.org/10.3200/AEOH.61.2.75-86




PubMed


 


PubMed ID 17649959
    
     


 



2.
Kelsey KT, Hirao T, Hirao S, Devi-Ashok T, Nelson HH, Andrew A, Colt J, Baris D, Morris JS, Schned A, Karagas M (2005). TP53 alterations and patterns of carcinogen exposure in a U.S. population-based study of bladder cancer. Int J Cancer  117, 370-5.   https://doi.org/10.1002/ijc.21195




PubMed


 


PubMed ID 15906354
    
     


 



3.
van Wijngaarden E, Dosemeci M (2006). Brain cancer mortality and potential occupational exposure to lead: findings from the National Longitudinal Mortality Study, 1979-1989. Int J Cancer  119, 1136-44.   https://doi.org/10.1002/ijc.21947




PubMed


 


PubMed ID 16570286",https://intramural.nih.gov/search/searchview.taf?ipid=43979
451,CP010123-11,"October 01, 2005 -  September 30, 2006",Studies of Occupational Cancer among Women and Minorities,Wong H Chow,NULL,"Occupational and Environmental Epidemiology Branch, NCI","Michael  Alavanja; PhD



Dalsu  Baris



Aaron E Blair; PhD, MPH



Kenneth  Cantor; PhD



Mustafa  Dosemeci; PhD



Richard  Hayes; PhD



Show all 11","Hans-Olov  Adami
(Karolinska Institute)




Eleuterio  Bravo-Otero
(University of Puerto Rico)




S.  Cooper
(The University of Texas)




Yu-Tang  Gao
(Shanghai Cancer Institute)




N.  Heyer
(University of Washington)




L.  Hoffman-Goetz
(University of Waterloo)


Show all 19","Linda M Brown; MPH, DPhil (Biostatistics Branch)



Gloria L Gridley (Biostatistics Branch)



Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)



Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)



Shelia K Zahm; ScM, ScD (Office of the Director)



Martha S Linet; PhD (Radiation Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Bonner MR, Bennett WP, Xiong W, Lan Q, Brownson RC, Harris CC, Field RW, Lubin JH, Alavanja MC (2006). Radon, secondhand smoke, glutathione-S-transferase M1 and lung cancer among women. Int J Cancer  119, 1462-7.   https://doi.org/10.1002/ijc.22002




PubMed


 


PubMed ID 16642467
    
     


 



2.
Zheng W, Chow WH, Yang G, Jin F, Rothman N, Blair A, Li HL, Wen W, Ji BT, Li Q, Shu XO, Gao YT (2005). The Shanghai Women's Health Study: rationale, study design, and baseline characteristics. Am J Epidemiol  162, 1123-31.   https://doi.org/10.1093/aje/kwi322




PubMed


 


PubMed ID 16236996",https://intramural.nih.gov/search/searchview.taf?ipid=43982
452,CP010124-11,"October 01, 2005 -  September 30, 2006",Cervical cancer and human papillomavirus (HPV) infection,"Mark  Schiffman; MD



IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI","Joseph  Carreon



Allan  Hildesheim; PhD



Jose A Jeronimo



James V Lacey; MPH, PhD



Mark E Sherman; MD



Sophia S Wang; PhD","Concepcion  Bratti
(Costa Rican Social Security)




Robert  Burk
(Albert Einstein College of Medicine)




Michael  Gold, MD
(University of Oklahoma Health Sciences Center)




Patti  Gravitt
(Johns Hopkins Blumberg School of Public Health)




Sharon  Hillier
(University of Pittsburgh)




Martha  Hutchinson
(Brown University)


Show all 13","Sholom  Wacholder; PhD (Biostatistics Branch)



Kenneth  Chu (Integrated Networks Branch)



Aimee Rebecca Kreimer (Office of Preventive Oncology)



Douglas  Lowy; MD (Laboratory of Cellular Oncology)



Miriam Christine Poirier; PhD (Carcinogen-DNA Interactions Section)



John  Schiller; PhD (Laboratory of Cellular Oncology)",NULL,"Ordered by publication type and then author name.



1.
Atkins KA, Jeronimo J, Stoler MH, ALTS Group (2006). Description of patients with squamous cell carcinoma in the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion triage study. Cancer  108, 212-21.   https://doi.org/10.1002/cncr.21940




PubMed


 


PubMed ID 16680733
    
     


 



2.
Castle PE, Walker JL, Schiffman M, Wheeler CM (2005). Hormonal contraceptive use, pregnancy and parity, and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA-positive women with equivocal or mildly abnormal cytology. Int J Cancer  117, 1007-12.   https://doi.org/10.1002/ijc.21279




PubMed


 


PubMed ID 15986443
    
     


 



3.
Gage JC, Hanson VW, Abbey K, Dippery S, Gardner S, Kubota J, Schiffman M, Solomon D, Jeronimo J, ASCUS LSIL Triage Study (ALTS) Group (2006). Number of cervical biopsies and sensitivity of colposcopy. Obstet Gynecol  108, 264-72.   https://doi.org/10.1097/01.AOG.0000220505.18525.85




PubMed


 


PubMed ID 16880294
    
     


 



4.
Guido RS, Jeronimo J, Schiffman M, Solomon D, ALTS Group (2005). The distribution of neoplasia arising on the cervix: results from the ALTS trial. Am J Obstet Gynecol  193, 1331-7.   https://doi.org/10.1016/j.ajog.2005.05.008




PubMed


 


PubMed ID 16202722
    
     


 



5.
Jeronimo J, Long LR, Neve L, Michael B, Antani S, Schiffman M (2006). Digital tools for collecting data from cervigrams for research and training in colposcopy. J Low Genit Tract Dis  10, 16-25.   https://doi.org/10.1097/01.lgt.0000194057.20485.5a




PubMed


 


PubMed ID 16378028
    
     


 



6.
Jeronimo J, Long R, Neve L, Ferris D, Noller K, Spitzer M, Mitra S, Guo J, Nutter B, Castle P, Herrero R, Rodriguez AC, Schiffman M (2006). Preparing digitized cervigrams for colposcopy research and education: determination of optimal resolution and compression parameters. J Low Genit Tract Dis  10, 39-44.   https://doi.org/10.1097/01.lgt.0000192696.93172.ae




PubMed


 


PubMed ID 16378030
    
     


 



7.
Schiffman M, Castle PE (2006). When to test women for human papillomavirus. BMJ  332, 61-2.   https://doi.org/10.1136/bmj.332.7533.61




PubMed



        
     
Free Article


 


PubMed ID 16410556
         Pubmed Central ID 1326915 


 



8.
Schiffman M, Wheeler CM, Dasgupta A, Solomon D, Castle PE, ALTS Group (2005). A comparison of a prototype PCR assay and hybrid capture 2 for detection of carcinogenic human papillomavirus DNA in women with equivocal or mildly abnormal papanicolaou smears. Am J Clin Pathol  124, 722-32.   https://doi.org/10.1309/E067-X0L1-U3CY-37NW




PubMed


 


PubMed ID 16203281
    
     


 



9.
Sengupta S, den Boon JA, Chen IH, Newton MA, Dahl DB, Chen M, Cheng YJ, Westra WH, Chen CJ, Hildesheim A, Sugden B, Ahlquist P (2006). Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma. Cancer Res  66, 7999-8006.   https://doi.org/10.1158/0008-5472.CAN-05-4399




PubMed


 


PubMed ID 16912175
    
     


 



10.
Sherman ME, Carreon JD, Schiffman M (2006). Performance of cytology and human papillomavirus testing in relation to the menstrual cycle. Br J Cancer  94, 1690-6.   https://doi.org/10.1038/sj.bjc.6603151




PubMed



        
     
Free Article


 


PubMed ID 16670716
         Pubmed Central ID 2361316 


 



11.
Sherman ME, Castle PE, Solomon D (2006). Cervical cytology of atypical squamous cells-cannot exclude high-grade squamous intraepithelial lesion (ASC-H): characteristics and histologic outcomes. Cancer  108, 298-305.   https://doi.org/10.1002/cncr.21844




PubMed


 


PubMed ID 16544318
    
     


 



12.
Walker JL, Wang SS, Schiffman M, Solomon D, ASCUS LSIL Triage Study Group (2006). Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS). Am J Obstet Gynecol  195, 341-8.   https://doi.org/10.1016/j.ajog.2006.02.047




PubMed


 


PubMed ID 16890545",https://intramural.nih.gov/search/searchview.taf?ipid=43971
453,CP010125-11,"October 01, 2005 -  September 30, 2006",Cancer Risk and Environmental Exposures,Kenneth  Cantor; PhD,NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris



Joanne S Colt



Mary Helen Ward; MS, PhD



Claudine M Samanic



Debra  Silverman; ScD, ScM



Michael  Alavanja; PhD



Show all 13","John W Brock
(CDC)




James  Cerhan
(Mayo Clinic)




R. William  Field
(University of Iowa, Iowa City, IO)




Margaret  Karagas
(Dartmouth University, Lebanon, NH)




Manolis  Kogevinas





Michele  Lynberg
(Centers for Disease Control and Prevention)


Show all 16","Daryl  Freedman (Radiation Epidemiology Branch)



Shelia K Zahm; ScM, ScD (Office of the Director)



Allan  Hildesheim; PhD (Hormonal and Reproductive Epidemiology Branch)



Peter D Inskip; ScD (Radiation Epidemiology Branch)



Jay  Lubin; PhD (Biostatistics Branch)



Rashmi P Sinha; PhD (Nutritional Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Cantor KP (2006). Feasibility of conducting human studies to address bromate risks. Toxicology  221, 197-204.   https://doi.org/10.1016/j.tox.2005.11.009




PubMed


 


PubMed ID 16352386
    
     


 



2.
Chiu BC, Gapstur SM, Chow WH, Kirby KA, Lynch CF, Cantor KP (2006). Body mass index, physical activity, and risk of renal cell carcinoma. Int J Obes (Lond)  30, 940-7.   https://doi.org/10.1038/sj.ijo.0803231




PubMed


 


PubMed ID 16446746
    
     


 



3.
Rusiecki JA, Kulldorff M, Nuckols JR, Song C, Ward MH (2006). Geographically based investigation of prostate cancer mortality in four U.S. Northern Plain states. Am J Prev Med  30, S101-8.   https://doi.org/10.1016/j.amepre.2005.09.005




PubMed


 


PubMed ID 16458784
    
     


 



4.
Villanueva CM, Cantor KP, King WD, Jaakkola JJ, Cordier S, Lynch CF, Porru S, Kogevinas M (2006). Total and specific fluid consumption as determinants of bladder cancer risk. Int J Cancer  118, 2040-7.   https://doi.org/10.1002/ijc.21587




PubMed


 


PubMed ID 16284957
    
     


 



5.
Ward MH, deKok TM, Levallois P, Brender J, Gulis G, Nolan BT, VanDerslice J, International Society for Environmental Epidemiology (2005). Workgroup report: Drinking-water nitrate and health--recent findings and research needs. Environ Health Perspect  113, 1607-14.   https://doi.org/10.1289/ehp.8043




PubMed



        
     
Free Article


 


PubMed ID 16263519
         Pubmed Central ID 1310926 


 



6.
Ward MH, Lubin J, Giglierano J, Colt JS, Wolter C, Bekiroglu N, Camann D, Hartge P, Nuckols JR (2006). Proximity to crops and residential exposure to agricultural herbicides in iowa. Environ Health Perspect  114, 893-7.   https://doi.org/10.1289/ehp.8770




PubMed



        
     
Free Article


 


PubMed ID 16759991
         Pubmed Central ID 1480526 


 



7.
Ward MH, Wartenberg D (2006). Invited commentary: on the road to improved exposure assessment using geographic information systems. Am J Epidemiol  164, 208-11.   https://doi.org/10.1093/aje/kwj183




PubMed


 


PubMed ID 16707652
    
     


 



8.
Zhang Y, Cantor KP, Dosemeci M, Lynch CF, Zhu Y, Zheng T (2006). Occupational and leisure-time physical activity and risk of colon cancer by subsite. J Occup Environ Med  48, 236-43.   https://doi.org/10.1097/01.jom.0000199521.72764.26




PubMed


 


PubMed ID 16531827",https://intramural.nih.gov/search/searchview.taf?ipid=43989
454,CP010126-11,"October 01, 2005 -  September 30, 2006",Hormone-Related Cancers,Louise  Brinton; PhD,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI","Patricia  Madigan



Mark E Sherman; MD



Roni T Falk



Allan  Hildesheim; PhD","David  Alberts
(University of Arizona Cancer Center)




Douglas  Bauer
(University of California at San Francisco)




Ralph  Coates
(Centers for Disease Control and Prevention)




Joanne  Dorgan; PhD
(NCI)




R. Loren  Erickson
(Department of Defense)




Jolanta  Lissowsaka
(Maria Sklodowsak-Curie Memorial Cancer Center)


Show all 10","Barry Ira Graubard; PhD (Biostatistics Branch)



Jeffery P Struewing; MS, MD (Laboratory of Population Genetics)



Stephen J Chanock; MD, PhD (Pediatric Oncology Branch)",Katharine D Egan (NIMH),"Ordered by publication type and then author name.



1.
Brinton LA, Sakoda LC, Frederiksen K, Sherman ME, Kjaer SK, Graubard BI, Olsen JH, Mellemkjaer L (2007). Relationships of uterine and ovarian tumors to pre-existing chronic conditions. Gynecol Oncol  107, 487-94.   https://doi.org/10.1016/j.ygyno.2007.08.002




PubMed



        
     
Free Article


 


PubMed ID 17825884
         Pubmed Central ID 2199881 


 



2.
Brinton LA, Sakoda LC, Sherman ME, Frederiksen K, Kjaer SK, Graubard BI, Olsen JH, Mellemkjaer L (2005). Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors. Cancer Epidemiol Biomarkers Prev  14, 2929-35.   https://doi.org/10.1158/1055-9965.EPI-05-0394




PubMed


 


PubMed ID 16365012
    
     


 



3.
Cantwell MM, Millen AE, Carroll R, Mittl BL, Hermansen S, Brinton LA, Potischman N (2006). A debriefing session with a nutritionist can improve dietary assessment using food diaries. J Nutr  136, 440-5.   https://doi.org/10.1093/jn/136.2.440




PubMed


 


PubMed ID 16424125
    
     


 



4.
García-Closas M, Egan KM, Newcomb PA, Brinton LA, Titus-Ernstoff L, Chanock S, Welch R, Lissowska J, Peplonska B, Szeszenia-Dabrowska N, Zatonski W, Bardin-Mikolajczak A, Struewing JP (2006). Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses. Hum Genet  119, 376-88.   https://doi.org/10.1007/s00439-006-0135-z




PubMed


 


PubMed ID 16485136
    
     


 



5.
Garcia-Closas M, Brinton L, Anderson W, Sherman M (2006) Reply to study design and statistics in epidemiology of breast cancer. Br J Cancer 95:1302-1303




 



6.
Gaudet MM, Chanock S, Lissowska J, Berndt SI, Yang XR, Peplonska B, Brinton LA, Welch R, Yeager M, Bardin-Mikolajczak A, Sherman ME, Sutter TR, Garcia-Closas M (2006). Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women. Pharmacogenet Genomics  16, 547-53.   https://doi.org/10.1097/01.fpc.0000215067.29342.6f




PubMed


 


PubMed ID 16847423
    
     


 



7.
Lissowska J, Brinton LA, Zatonski W, Blair A, Bardin-Mikolajczak A, Peplonska B, Sherman ME, Szeszenia-Dabrowska N, Chanock S, García-Closas M (2006). Tobacco smoking, NAT2 acetylation genotype and breast cancer risk. Int J Cancer  119, 1961-9.   https://doi.org/10.1002/ijc.22044




PubMed


 


PubMed ID 16721725
    
     


 



8.
Struewing JP, Pineda MA, Sherman ME, Lissowska J, Brinton LA, Peplonska B, Bardin-Mikolajczak A, Garcia-Closas M (2006). Skewed X chromosome inactivation and early-onset breast cancer. J Med Genet  43, 48-53.   https://doi.org/10.1136/jmg.2005.033134




PubMed



        
     
Free Article


 


PubMed ID 15923273
         Pubmed Central ID 1876702 


 



9.
Zhang Y, Chanock S, Peplonska B, Garcia-Closas M, Brinton L   (2006) Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer.  Cancer Epidemiol Biomarkers Prev  16492928 pp.




 



10.
Zhang Y, Longnecker M, Graubard B   (2006) Maternal Hormone Levels and Perinatal Characteristics: Implications for Testicular Cancer.  Ann Epidemiol [Epub]  - pp.




 



11.
Zhang Y, Newcomb PA, Egan KM, Titus-Ernstoff L, Chanock S, Welch R, Brinton LA, Lissowska J, Bardin-Mikolajczak A, Peplonska B, Szeszenia-Dabrowska N, Zatonski W, Garcia-Closas M (2006). Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiol Biomarkers Prev  15, 353-8.   https://doi.org/10.1158/1055-9965.EPI-05-0653




PubMed


 


PubMed ID 16492928",https://intramural.nih.gov/search/searchview.taf?ipid=43990
455,CP010127-11,"October 01, 2005 -  September 30, 2006",Etiologic Studies of Diet and Cancer,Arthur  Schatzkin; PhD,NULL,"Nutritional Epidemiology Branch, NCI","Stephanie Joan Weinstein



Rashmi P Sinha; PhD



Michael Fred Leitzmann



Rachael Zoe Solomon



Margaret E Wright



Amanda  Cross



Show all 17","Henry  Appelman
(University of Michigan)




Colin  Begg
(Memorial Sloan-Kettering Cancer Center)




Sheila  Bingham
(University of Cambridge)




M. Robert  Cooper
(Wake Forest University School of Medicine)




Stanley  Hamilton
(M.D. Anderson Cancer Center)




Frank  Iber
(Edward Hines Jr. Veterans Administration Hospital)


Show all 15","Demetrius  Albanes; MD (Office of the Director)



Amy F Subar (Risk Factor Monitoring and Methods Branch)



Victor  Kipnis (Biometry Research Group)



Frances E Thompson (Risk Factor Monitoring and Methods Branch)



Douglas N Midthune (Biometry Research Group)



Richard P Troiano (Risk Factor Monitoring and Methods Branch)",NULL,"Ordered by publication type and then author name.



1.
Cross A, Ward M, Sinha R, Hartge P, Cerhan J   (2006) Meat Intake and Risk of Non-Hodgkin Lymphoma: Results from a NCI-SEER case-control study.  carcinogenesis  293-297 pp.




 



2.
Cross AJ, Gunter MJ, Wood RJ, Pietinen P, Taylor PR, Virtamo J, Albanes D, Sinha R (2006). Iron and colorectal cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study. Int J Cancer  118, 3147-52.   https://doi.org/10.1002/ijc.21780




PubMed


 


PubMed ID 16425287
    
     


 



3.
Flood A, Subar AF, Hull SG, Zimmerman TP, Jenkins DJ, Schatzkin A (2006). Methodology for adding glycemic load values to the National Cancer Institute Diet History Questionnaire database. J Am Diet Assoc  106, 393-402.   https://doi.org/10.1016/j.jada.2005.12.008




PubMed


 


PubMed ID 16503230
    
     


 



4.
Lim U, Subar AF, Mouw T, Hartge P, Morton LM, Stolzenberg-Solomon R, Campbell D, Hollenbeck AR, Schatzkin A (2006). Consumption of aspartame-containing beverages and incidence of hematopoietic and brain malignancies. Cancer Epidemiol Biomarkers Prev  15, 1654-9.   https://doi.org/10.1158/1055-9965.EPI-06-0203




PubMed


 


PubMed ID 16985027
    
     


 



5.
Lim U, Weinstein S, Albanes D, Pietinen P, Teerenhovi L, Taylor PR, Virtamo J, Stolzenberg-Solomon R (2006). Dietary factors of one-carbon metabolism in relation to non-Hodgkin lymphoma and multiple myeloma in a cohort of male smokers. Cancer Epidemiol Biomarkers Prev  15, 1109-14.   https://doi.org/10.1158/1055-9965.EPI-05-0918




PubMed


 


PubMed ID 16775167",https://intramural.nih.gov/search/searchview.taf?ipid=44023
456,CP010128-11,"October 01, 2005 -  September 30, 2006",Therapeutic and Diagnostic Factors as Related to Cancer Risk,Louise  Brinton; PhD,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI","Allan  Hildesheim; PhD



Mark E Sherman; MD","Douglas  Bauer
(University of California at San Francisco)




Lenore  Buckley
(Virginia Commonwealth University)




Theodore  Colton
(Boston University School of Public Health)




Olga  Dvorkina
(SUNY Health Sciences Center)




Susanne  Kruger-Kjaer
(Danish Cancer Registry)




Emmet  Lamb
(Stanford University)


Show all 8","Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)



Catherine G Schairer (Biostatistics Branch)



Arthur  Schatzkin; PhD (Nutritional Epidemiology Branch)



Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)



Jay  Lubin; PhD (Biostatistics Branch)



Michael Fred Leitzmann (Nutritional Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Brinton L, Hoover R   (2006) Mortality Among Augmentation Mammoplasty Patients: An Update.  Epidemiology  162-169 pp.




 



2.
Brinton LA, Lubin JH, Murray MC, Colton T, Hoover RN (2006). Mortality rates among augmentation mammoplasty patients: an update. Epidemiology  17, 162-9.   https://doi.org/10.1097/01.ede.0000197056.84629.19




PubMed


 


PubMed ID 16477256
    
     


 



3.
Jeffrey T, Kanaya A, Hue T, Rubin S, Buist D, LaCroix A, Lacey J, Cauley J, Litwack S, Brinton L, Bauer D (2006) Risk factors for mortality in middle-aged women. Arch Intern 166:2469-2477",https://intramural.nih.gov/search/searchview.taf?ipid=43991
457,CP010131-11,"October 01, 2005 -  September 30, 2006",Studies of Medical Radiation and Other Therapeutic Agents,Elaine  Ron; PhD,NULL,"Radiation Epidemiology Branch, NCI","Rochelle E Curtis



Ruth Anne Kleinerman; MPH



Michele M Doody; MS



Peter D Inskip; ScD



Lois B Travis; PhD



Alice  Sigurdson; PhD



Show all 14","David  Abramson
(New York Presbyterian Hospital)




Michael  Andersson
(Danish Cancer Society)




Anneliese  Borresen
(The Norwegian Radium Hospital, Oslo, Norway)




Bengt  Glimelius
(Uppsala University)




Mary  Gospodarowicz
(Princess Margaret Hospital)




Deirdre A Hill



Show all 18",Margaret Anne Tucker (Genetic Epidemiology Branch),NULL,"Ordered by publication type and then author name.



1.
Brown LM, Chen BE, Pfeiffer RM, Schairer C, Hall P, Storm H, Pukkala E, Langmark F, Kaijser M, Andersson M, Joensuu H, Fosså SD, Travis LB (2007). Risk of second non-hematological malignancies among 376,825 breast cancer survivors. Breast Cancer Res Treat  106, 439-51.   https://doi.org/10.1007/s10549-007-9509-8




PubMed


 


PubMed ID 17277968
    
     


 



2.
Foster MC, Kleinerman RA, Abramson DH, Seddon JM, Tarone RE, Tucker MA (2006). Tobacco use in adult long-term survivors of retinoblastoma. Cancer Epidemiol Biomarkers Prev  15, 1464-8.   https://doi.org/10.1158/1055-9965.EPI-05-0783




PubMed


 


PubMed ID 16896033
    
     


 



3.
Hill DA, Gilbert E, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, Glimelius B, Andersson M, Wiklund T, Lynch CF, Van't Veer M, Storm H, Pukkala E, Stovall M, Curtis RE, Allan JM, Boice JD, Travis LB (2005). Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors. Blood  106, 3358-65.   https://doi.org/10.1182/blood-2005-04-1535




PubMed



        
     
Free Article


 


PubMed ID 16051739
         Pubmed Central ID 1895063 


 



4.
Kleinerman RA (2006). Cancer risks following diagnostic and therapeutic radiation exposure in children. Pediatr Radiol  36 Suppl 2, 121-5.   https://doi.org/10.1007/s00247-006-0191-5




PubMed



        
     
Free Article


 


PubMed ID 16862418
         Pubmed Central ID 2663653 


 



5.
Simon SL, Kleinerman RA, Ron E, Bouville A (2006). Uses of dosimetry in radiation epidemiology. Radiat Res  166, 125-7.   https://doi.org/10.1667/RR3385.1




PubMed


 


PubMed ID 16808601
    
     


 



6.
Stovall M, Weathers R, Kasper C, Smith SA, Travis L, Ron E, Kleinerman R (2006). Dose reconstruction for therapeutic and diagnostic radiation exposures: use in epidemiological studies. Radiat Res  166, 141-57.   https://doi.org/10.1667/RR3525.1




PubMed


 


PubMed ID 16808603",https://intramural.nih.gov/search/searchview.taf?ipid=43992
458,CP010132-11,"October 01, 2005 -  September 30, 2006",Studies of Populations Exposed to Environmental Sources of Radiation,"Martha S Linet; PhD



IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI","Ruth Anne Kleinerman; MPH



Andre  Bouville



Nickolas  Luckyanov



Ihor  Masnyk



Elaine  Ron; PhD



Charles E. Land; PhD



Show all 11","Bruce  Alexander
(University of Minnesota)




Aaron  Brill
(Vanderbilt University)




Boris  Gusev
(Kazakh Institute for Radiation Medicine and Ecology)




Terry  Hartman
(Pennsylvania State University)




Geoffrey  Howe
(Columbia University)




Margaret  Karagas
(Dartmouth University, Lebanon, NH)


Show all 13",Jay  Lubin; PhD (Biostatistics Branch),NULL,"Ordered by publication type and then author name.



1.
Hatch M (2006) Cancer Following the Chornobyl Nuclear Accident: The Ukrainian-American Studies of Thyroid and Leukemia. Journal of the Academy of Medical Sciences of Ukraine, in press.




 



2.
Likhtarov I, Kovgan L, Vavilov S, Chepurny M, Ron E, Lubin J, Bouville A, Tronko N, Bogdanova T, Gulak L, Zablotska L, Howe G (2006). Post-Chernobyl thyroid cancers in Ukraine. Report 2: risk analysis. Radiat Res  166, 375-86.   https://doi.org/10.1667/RR3593.1




PubMed


 


PubMed ID 16881739
    
     


 



3.
Tronko M, Kravchenko V, Fink D, Hatch M, Turchin V, McConnell R, Shpak V, Brenner A, Robbins J, Lusanchuk I, Howe G (2005). Iodine excretion in regions of Ukraine affected by the Chornobyl Accident: experience of the Ukrainian-American cohort study of thyroid cancer and other thyroid diseases. Thyroid  15, 1291-7.   https://doi.org/10.1089/thy.2005.15.1291




PubMed


 


PubMed ID 16356095",https://intramural.nih.gov/search/searchview.taf?ipid=43972
459,CP010133-11,"October 01, 2005 -  September 30, 2006",Studies of Populations Exposed to Occupational Sources of Radiation,Alice  Sigurdson; PhD,NULL,"Radiation Epidemiology Branch, NCI","Andre  Bouville



Michele M Doody; MS



Daryl  Freedman



Maureen Cusack Hatch; MD



Peter D Inskip; ScD



Elaine  Ron; PhD



Show all 10","Bruce  Alexander
(University of Minnesota)




Anssi P Auvinen





William  Bigbee
(University of Pittsburgh)




Timo  Hakulinen
(Finnish Cancer Registry)




Terry  Hartman
(Pennsylvania State University)




Geoffrey  Howe
(Columbia University)


Show all 19",NULL,NULL,"Ordered by publication type and then author name.



1.
Bhatti P, Sigurdson AJ, Wang SS, Chen J, Rothman N, Hartge P, Bergen AW, Landi MT (2005). Genetic variation and willingness to participate in epidemiologic research: data from three studies. Cancer Epidemiol Biomarkers Prev  14, 2449-53.   https://doi.org/10.1158/1055-9965.EPI-05-0463




PubMed


 


PubMed ID 16214931
    
     


 



2.
Freedman D, Sigurdson A, Linet M   (2006) Comparison between cancers identified by state cancer registry, self-report, and death certificate in a prospective cohort study of US radiologic technologists.  Int J Epidemiol  495-497 pp.




 



3.
Freedman DM, Ron E, Ballard-Barbash R, Doody MM, Linet MS (2006). Body mass index and all-cause mortality in a nationwide US cohort. Int J Obes (Lond)  30, 822-9.   https://doi.org/10.1038/sj.ijo.0803193




PubMed


 


PubMed ID 16404410
    
     


 



4.
Freedman DM, Sigurdson AJ, Doody MM, Love-Schnur S, Linet MS (2006). Comparison between cancers identified by state cancer registry, self-report, and death certificate in a prospective cohort study of US radiologic technologists. Int J Epidemiol  35, 495-7.   https://doi.org/10.1093/ije/dyi286




PubMed


 


PubMed ID 16330477
    
     


 



5.
Freedman DM, Sigurdson AJ, Rajaraman P, Doody MM, Linet MS, Ron E (2006). The mortality risk of smoking and obesity combined. Am J Prev Med  31, 355-62.   https://doi.org/10.1016/j.amepre.2006.07.022




PubMed


 


PubMed ID 17046405
    
     


 



6.
Rahu M, Rahu K, Auvinen A, Tekkel M, Stengrevics A, Hakulinen T, Boice JD, Inskip PD (2006). Cancer risk among Chernobyl cleanup workers in Estonia and Latvia, 1986-1998. Int J Cancer  119, 162-8.   https://doi.org/10.1002/ijc.21733




PubMed


 


PubMed ID 16432838
    
     


 



7.
Rajaraman P, Sigurdson A, Doody M, Freedman D, Hauptmann M, Ron E, Alexander B, Linet M (2006) Lung Cancer Incidence among U. S. Radiologic Technologists, 19831998. International Journal of Cancer 119:2481-2486




 



8.
Sigurdson AJ, Ha M, Cosentino M, Franklin T, Haque KA, Qi Y, Glaser C, Reid Y, Vaught JB, Bergen AW (2006). Long-term storage and recovery of buccal cell DNA from treated cards. Cancer Epidemiol Biomarkers Prev  15, 385-8.   https://doi.org/10.1158/1055-9965.EPI-05-0662




PubMed


 


PubMed ID 16492933
    
     


 



9.
Stredrick D, Pineda M, BHATTI P, Struewing J, Peplonska B, Garcia-Closas M, Doody M, Sigurdson A, Brinton L   (2006) The ATM missense mutation Ser49Cys and risk of breast cancer.  The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer.  538-544 pp.




 



10.
Stredrick DL, Garcia-Closas M, Pineda MA, Bhatti P, Alexander BH, Doody MM, Lissowska J, Peplonska B, Brinton LA, Chanock SJ, Struewing JP, Sigurdson AJ (2006). The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer. Hum Mutat  27, 538-44.   https://doi.org/10.1002/humu.20323




PubMed



        
     
Free Article


 


PubMed ID 16652348
         Pubmed Central ID 1850333 


 



11.
Zabel EW, Alexander BH, Mongin SJ, Doody MM, Sigurdson AJ, Linet MS, Freedman DM, Hauptmann M, Mabuchi K, Ron E (2006). Thyroid cancer and employment as a radiologic technologist. Int J Cancer  119, 1940-5.   https://doi.org/10.1002/ijc.22065




PubMed


 


PubMed ID 16736495",https://intramural.nih.gov/search/searchview.taf?ipid=43993
460,CP010134-11,"October 01, 2005 -  September 30, 2006",Studies of Atomic Bomb Survivors,Charles E. Land; PhD,NULL,"Radiation Epidemiology Branch, NCI","Kiyohiko  Mabuchi; MD, DPhil



Martha S Linet; PhD



Elaine  Ron; PhD



Alina V Brenner","Suminori  Akiba
(Kagoshima University)




Michinori  Kabuto
(National Institute for Environmental Studies)




Tim  Key
(Oxford University)




Kazunori  Kodama
(Radiation Effects Research Foundation, Japan)




Jun  Nagano
(Radiation Effects Research Foundation)




Dale  Preston
(Radiation Effects Research Foundation)


Show all 8",NULL,NULL,"Ordered by publication type and then author name.



1.
Inai K, Land C, Mabuchi K   (2006) Pathology study of malignant and benign ovarian tumors among atomic-bomb survivors; Case series.  J Radiat Res (Tokyo)  1198-1203 pp.




 



2.
Inai K, Shimizu Y, Kawai K, Tokunaga M, Soda M, Mabuchi K, Land CE, Tokuoka S (2006). A pathology study of malignant and benign ovarian tumors among atomic-bomb survivors--case series report. J Radiat Res  47, 49-59.   https://doi.org/10.1269/jrr.47.49




PubMed


 


PubMed ID 16571918",https://intramural.nih.gov/search/searchview.taf?ipid=44038
461,CP010135-11,"October 01, 2005 -  September 30, 2006",Studies of Non-Ionizing Radiation-Related Cancer,Peter D Inskip; ScD,NULL,"Radiation Epidemiology Branch, NCI","Ruth Anne Kleinerman; MPH



Alina V Brenner



Preetha  Rajaraman



Steven L Simon



Daryl  Freedman



Gabriel  Chodick","Bruce  Alexander
(University of Minnesota)




Peter  Black
(Brigham and Women's Hospital & Dana Farber Cancer Center)




W.  Bleyer
(Children's Cancer Group)




Anneclaire  De Roos
(University of Washington, Seattle, WA)




Howard  Fine
(Brigham and Women's Hospital)




Elizabeth  Hatch
(Boston University)


Show all 9","Joseph B Coble (Occupational and Environmental Epidemiology Branch)



Sholom  Wacholder; PhD (Biostatistics Branch)



Mustafa  Dosemeci; PhD (Occupational and Environmental Epidemiology Branch)



Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)



Thomas  Fears; PhD (Biostatistics Branch)



Elizabeth Carhart Bluhm (Office of Preventive Oncology)",NULL,"Ordered by publication type and then author name.



1.
De Roos AJ, Rothman N, Brown M, Bell DA, Pittman GS, Shapiro WR, Selker RG, Fine HA, Black PM, Inskip PD (2006). Variation in genes relevant to aromatic hydrocarbon metabolism and the risk of adult brain tumors. Neuro Oncol  8, 145-55.   https://doi.org/10.1215/15228517-2005-003




PubMed



        
     
Free Article


 


PubMed ID 16598069
         Pubmed Central ID 1871937",https://intramural.nih.gov/search/searchview.taf?ipid=43994
462,CP010136-11,"October 01, 2005 -  September 30, 2006",Cancer Risk in Human Populations,"Debra  Silverman; ScD, ScM



IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Bu Tian  Ji



Dalsu  Baris



Joanne S Colt



Mary Helen Ward; MS, PhD



Joseph B Coble



Claudine M Samanic



Show all 12",NULL,"Linda M Brown; MPH, DPhil (Biostatistics Branch)



Mark  Schiffman; MD (Hormonal and Reproductive Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Kelloff GJ, Lippman SM, Dannenberg AJ, Sigman CC, Pearce HL, Reid BJ, Szabo E, Jordan VC, Spitz MR, Mills GB, Papadimitrakopoulou VA, Lotan R, Aggarwal BB, Bresalier RS, Kim J, Arun B, Lu KH, Thomas ME, Rhodes HE, Brewer MA, Follen M, Shin DM, Parnes HL, Siegfried JM, Evans AA, AACR Task Force on Cancer Prevention, et al. [15 more authors] (2006). Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward. Clin Cancer Res  12, 3661-97.   https://doi.org/10.1158/1078-0432.CCR-06-1104




PubMed


 


PubMed ID 16778094
    
     


 



2.
Mayne ST, Risch HA, Dubrow R, Chow WH, Gammon MD, Vaughan TL, Borchardt L, Schoenberg JB, Stanford JL, West AB, Rotterdam H, Blot WJ, Fraumeni JF (2006). Carbonated soft drink consumption and risk of esophageal adenocarcinoma. J Natl Cancer Inst  98, 72-5.   https://doi.org/10.1093/jnci/djj007




PubMed


 


PubMed ID 16391374
    
     


 



3.
Savage SA, Hou L, Lissowska J, Chow WH, Zatonski W, Chanock SJ, Yeager M (2006). Interleukin-8 polymorphisms are not associated with gastric cancer risk in a Polish population. Cancer Epidemiol Biomarkers Prev  15, 589-91.   https://doi.org/10.1158/1055-9965.EPI-05-0887




PubMed


 


PubMed ID 16537722
    
     


 



4.
Yokley K, Rothman N   (2006) Physiologically based pharmacokinetic modeling of benzene in humans: a bayesian approach.  Risk Anal  925-943 pp.




 



5.
Yokley K, Tran HT, Pekari K, Rappaport S, Riihimaki V, Rothman N, Waidyanatha S, Schlosser PM (2006). Physiologically-based pharmacokinetic modeling of benzene in humans: a Bayesian approach. Risk Anal  26, 925-43.   https://doi.org/10.1111/j.1539-6924.2006.00789.x




PubMed


 


PubMed ID 16948686",https://intramural.nih.gov/search/searchview.taf?ipid=43995
463,CP010138-09,"October 01, 2005 -  September 30, 2006",Genetic Epidemiology of BRCA12,"Jeffery P Struewing; MS, MD",NULL,"Laboratory of Population Genetics, NCI","Marbin A Pineda



Denise L Stredrick



Lutecia  Pereira



Felicia E Mann","Georgia  Chenevix-Trench





Andrew  Collins
(Genetics, University of Southampton)




Douglas  Easton; PhD
(Oncology, Cambridge University)




Kenneth  Offit





Paul  Pharoah
(Oncology, Cambridge University)","Mark H Greene; MD (National Cancer Institute)



Albert M Gold (National Cancer Institute)



Alice  Sigurdson; PhD (National Cancer Institute)



Margaret Anne Tucker (National Cancer Institute)","Barbara B Biesecker; PhD, MS, CGC (NHGRI)","Ordered by publication type and then author name.



1.
Chodick G, Struewing JP, Ron E, Rutter JL, Iscovich J (2008). Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and non-Ashkenazi men with breast cancer: evidence from 261 cases in Israel, 1976-1999. Eur J Med Genet  51, 141-7.   https://doi.org/10.1016/j.ejmg.2007.11.001




PubMed



        
     
Free Article


 


PubMed ID 18158280
         Pubmed Central ID 2386175 


 



2.
Ellis NA, Kirchhoff T, Mitra N, Ye TZ, Chuai S, Huang H, Nafa K, Norton L, Neuhausen S, Gordon D, Struewing JP, Narod S, Offit K (2006). Localization of breast cancer susceptibility loci by genome-wide SNP linkage disequilibrium mapping. Genet Epidemiol  30, 48-61.   https://doi.org/10.1002/gepi.20101




PubMed


 


PubMed ID 16206141
    
     


 



3.
García-Closas M, Egan KM, Newcomb PA, Brinton LA, Titus-Ernstoff L, Chanock S, Welch R, Lissowska J, Peplonska B, Szeszenia-Dabrowska N, Zatonski W, Bardin-Mikolajczak A, Struewing JP (2006). Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses. Hum Genet  119, 376-88.   https://doi.org/10.1007/s00439-006-0135-z




PubMed


 


PubMed ID 16485136
    
     


 



4.
McInerney-Leo A, Biesecker BB, Hadley DW, Kase RG, Giambarresi TR, Johnson E, Lerman C, Struewing JP (2005). BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationships. Am J Med Genet A  133A, 165-9.   https://doi.org/10.1002/ajmg.a.30566




PubMed


 


PubMed ID 15633195
    
     


 



5.
Spurdle AB, Antoniou AC, Kelemen L, Holland H, Peock S, Cook MR, Smith PL, Greene MH, Simard J, Plourde M, Southey MC, Godwin AK, Beck J, Miron A, Daly MB, Santella RM, Hopper JL, John EM, Andrulis IL, Durocher F, Struewing JP, Easton DF, Chenevix-Trench G, Australian Breast Cancer Family Study, Australian Jewish Breast Cancer Study, Breast Cancer Family Registry, Interdisciplinary Health Research International Team on Breast Cancer Susceptibility, Kathleen Cunningham Foundation Consortium for Research into Familial Breast Cancer, Epidemiological Study of Familial Breast Cancer Study Collaborators (2006). The AIB1 polyglutamine repeat does not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev  15, 76-9.   https://doi.org/10.1158/1055-9965.EPI-05-0709




PubMed


 


PubMed ID 16434590
    
     


 



6.
Stredrick DL, Garcia-Closas M, Pineda MA, Bhatti P, Alexander BH, Doody MM, Lissowska J, Peplonska B, Brinton LA, Chanock SJ, Struewing JP, Sigurdson AJ (2006). The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer. Hum Mutat  27, 538-44.   https://doi.org/10.1002/humu.20323




PubMed



        
     
Free Article


 


PubMed ID 16652348
         Pubmed Central ID 1850333 


 



7.
Struewing JP, Pineda MA, Sherman ME, Lissowska J, Brinton LA, Peplonska B, Bardin-Mikolajczak A, Garcia-Closas M (2006). Skewed X chromosome inactivation and early-onset breast cancer. J Med Genet  43, 48-53.   https://doi.org/10.1136/jmg.2005.033134




PubMed



        
     
Free Article


 


PubMed ID 15923273
         Pubmed Central ID 1876702",https://intramural.nih.gov/search/searchview.taf?ipid=43996
464,CP010139-09,"October 01, 2005 -  September 30, 2006",Molecular Genetic Epidemiology of Primary Hepatocellular Carcinoma,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI","Hongen  Zhang



Ying  Hu; PhD



Daoud M Meerzaman



Jenny M Kelley",NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=43997
465,CP010140-09,"October 01, 2005 -  September 30, 2006",Molecular Genetic Epidemiology of leading  U.S. Cancers,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI","Daoud M Meerzaman



Jenny M Kelley",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43998
466,CP010141-09,"October 01, 2005 -  September 30, 2006",The Cancer Genome Anatomy Projects Genetic Annotation Initiative,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI","Robert  Clifford



Hongen  Zhang



Cu  Nguyen



Jenny M Kelley",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44022
467,CP010142-08,"October 01, 2005 -  September 30, 2006",Genetic and Pharmacogenetic Modifiers of Cancer Risk and Intervention Outcomes,"Mark H Greene; MD



IRP Faculty Profile",NULL,"Clinical Genetics Branch, NCI",Sharon Ann Savage,"John  Bryant
(National Surgical Adjuvant Breast and Bowel Project)




Joseph  Constantino
(National Surgical Adjuvant Breast & Bowel Project Statistical Center)




Chester  Douglass
(Harvard School of Dentistry)




Howard  McLeod
(Washington University)




Gareth  Morgan
(University of Leeds)




Michael  Pollak
(McGill University)


Show all 8","Barry Ira Graubard; PhD (Biostatistics Branch)



Richard  Hayes; PhD (Occupational and Environmental Epidemiology Branch)



Hormuzdiar Aspandiar Katki; MS (Biostatistics Branch)



Philip Samuel Rosenberg; PhD (Biostatistics Branch)



Kenneth  Buetow; PhD (Laboratory of Population Genetics)



Stephen J Chanock; MD, PhD (Pediatric Oncology Branch)",NULL,"Ordered by publication type and then author name.



1.
Savage S (2006) Genetic Association Studies: Where Are We Now?. Personalized Medicine 3:371-4




 



2.
Savage SA, Chanock SJ (2006). Genetic association studies in cancer: good, bad or no longer ugly? Hum Genomics  2, 415-21.   https://doi.org/10.1186/1479-7364-2-6-415




PubMed



        
     
Free Article


 


PubMed ID 16848979
         Pubmed Central ID 3525166",https://intramural.nih.gov/search/searchview.taf?ipid=43999
468,CP010144-08,"October 01, 2005 -  September 30, 2006",Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,"Mark H Greene; MD



IRP Faculty Profile",NULL,"Clinical Genetics Branch, NCI","Blanche P Alter



Neelam K Giri; MD



Jennifer T Loud



June  Peters","David  Alberts
(University of Arizona Cancer Center)




Tim  Bishop
(Institute for Cancer Research)




Robert  Brodsky
(Johns Hopkins University School of Medicine)




Joseph  Califano
(Johns Hopkins University School of Medicine)




George  Dover
(Johns Hopkins University School of Medicine)




Peter  Durie
(Toronto Hospital for Sick Children)


Show all 59","Thomas  Fears; PhD (Biostatistics Branch)



Mitchell Henry Gail; PhD, MD (Biostatistics Branch)



Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)



Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)



Katherine Ann McGlynn; PhD (Hormonal and Reproductive Epidemiology Branch)



Philip Samuel Rosenberg; PhD (Biostatistics Branch)",NULL,"Ordered by publication type and then author name.



1.
Giri N, Alter B (2006) Acquired Aplastic Anemia, in Current Pediatric Therapy, 18e., pp. 942-944.




 



2.
Lindor C, Greene M (2006) Chapter 28: Hereditary Neoplastic Syndromes, in Cancer Epidemiology and Prevention, Third Edition (D Schottenfeld, JF Fraumeni Jr, eds)., pp. 562-576.




 



3.
Aideen M, Hadley D, Kase R, Giambarresi T, Greene M, Struewing J, Biesecker B (2006) BRCA12 Testing in Hereditary Breast and Ovarian Cancer Families III: Risk Perception and Screening. American Journal of Medical Genetics 140A:2198-2206




 



4.
Al-Rahawan MM, Giri N, Alter BP (2006). Intensive immunosuppression therapy for aplastic anemia associated with dyskeratosis congenita. Int J Hematol  83, 275-6.   https://doi.org/10.1532/IJH97.06030




PubMed


 


PubMed ID 16720563
    
     


 



5.
Alter B (2006) Inherited Forms of Aplastic Anemia: the Inherited Bone Marrow Failure Syndromes (IBMFS). Current Pediatric Therapy, 18e 18:938-941




 



6.
Alter BP (2005). Fanconi's anemia, transplantation, and cancer. Pediatr Transplant  9 Suppl 7, 81-6.   https://doi.org/10.1111/j.1399-3046.2005.00440.x




PubMed


 


PubMed ID 16305622
    
     


 



7.
Alter BP (2006). The association between FANCD1/BRCA2 mutations and leukaemia. Br J Haematol  133, 446-8; author reply 448.   https://doi.org/10.1111/j.1365-2141.2006.06049.x




PubMed


 


PubMed ID 16643458
    
     


 



8.
Alter BP, Rosenberg PS, Brody LC   (2006) Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2.  J Med Genet, in press (e-pub ahead of print).




 



9.
Bagby GC, Alter BP (2006). Fanconi anemia. Semin Hematol  43, 147-56.   https://doi.org/10.1053/j.seminhematol.2006.04.005




PubMed


 


PubMed ID 16822457
    
     


 



10.
Braun M, Giri N, Alter BP, Cowen EW (2006). Thrombocytopenia, multiple mucosal squamous cell carcinomas, and dyspigmentation. J Am Acad Dermatol  54, 1056-9.   https://doi.org/10.1016/j.jaad.2006.02.065




PubMed


 


PubMed ID 16713462
    
     


 



11.
Crockford GP, Linger R, Hockley S, Dudakia D, Johnson L, Huddart R, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, Lohynska R, Daugaard G, Richard S, Chompret A, Bonaïti-Pellié C, Heidenreich A, Albers P, Olah E, Geczi L, Bodrogi I, Ormiston WJ, Daly PA, Guilford P, Fosså SD, et al. [18 more authors] (2006). Genome-wide linkage screen for testicular germ cell tumour susceptibility loci. Hum Mol Genet  15, 443-51.




PubMed


 


PubMed ID 16407372
    
     


 



12.
Dale DC, Bolyard AA, Schwinzer BG, Pracht G, Bonilla MA, Boxer L, Freedman MH, Donadieu J, Kannourakis G, Alter BP, Cham BP, Winkelstein J, Kinsey SE, Zeidler C, Welte K (2006). The Severe Chronic Neutropenia International Registry: 10-Year Follow-up Report. Support Cancer Ther  3, 220-31.   https://doi.org/10.3816/SCT.2006.n.020




PubMed


 


PubMed ID 18632498
    
     


 



13.
Dale DC, Rosenberg PS, Alter BP (2006). Lineage-specific hematopoietic growth factors. N Engl J Med  355, 526-7; author reply 527.




PubMed


 


PubMed ID 16888846
    
     


 



14.
Kazerouni N, Greene MH, Lacey JV, Mink PJ, Schairer C (2006). Family history of breast cancer as a risk factor for ovarian cancer in a prospective study. Cancer  107, 1075-83.   https://doi.org/10.1002/cncr.22082




PubMed


 


PubMed ID 16881078
    
     


 



15.
Loud JT, Weissman NE, Peters JA, Giusti RM, Wilfond BS, Burke W, Greene MH (2006). Deliberate deceit of family members: a challenge to providers of clinical genetics services. J Clin Oncol  24, 1643-6.   https://doi.org/10.1200/JCO.2005.02.6203




PubMed


 


PubMed ID 16575016
    
     


 



16.
Nathanson KL, Kanetsky PA, Hawes R, Vaughn DJ, Letrero R, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, Lohynska R, Daugaard G, Richard S, Chompret A, Bonaïti-Pellié C, Heidenreich A, Olah E, Geczi L, Bodrogi I, Ormiston WJ, Daly PA, Oosterhuis JW, Gillis AJ, Looijenga LH, Guilford P, et al. [24 more authors] (2005). The Y deletion gr/gr and susceptibility to testicular germ cell tumor. Am J Hum Genet  77, 1034-43.   https://doi.org/10.1086/498455




PubMed



        
     
Free Article


 


PubMed ID 16380914
         Pubmed Central ID 1285161 


 



17.
Peters J, Vadaparampil S, Kramer J, Moser R, PetersonCourt L, Greene M (2006) Familial Testicular Cancer: Interest in Genetic Testing Among High-Risk Family Members. Genetics in Medicine 8:760-770




 



18.
Rosenberg PS, Alter BP, Bolyard AA, Bonilla MA, Boxer LA, Cham B, Fier C, Freedman M, Kannourakis G, Kinsey S, Schwinzer B, Zeidler C, Welte K, Dale DC, Severe Chronic Neutropenia International Registry (2006). The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood  107, 4628-35.   https://doi.org/10.1182/blood-2005-11-4370




PubMed



        
     
Free Article


 


PubMed ID 16497969
         Pubmed Central ID 1895804 


 



19.
Savage SA, Stewart BJ, Weksler BB, Baerlocher GM, Lansdorp PM, Chanock SJ, Alter BP (2006). Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure. Blood Cells Mol Dis  37, 134-6.   https://doi.org/10.1016/j.bcmd.2006.07.001




PubMed


 


PubMed ID 16934504
    
     


 



20.
Spurdle AB, Antoniou AC, Kelemen L, Holland H, Peock S, Cook MR, Smith PL, Greene MH, Simard J, Plourde M, Southey MC, Godwin AK, Beck J, Miron A, Daly MB, Santella RM, Hopper JL, John EM, Andrulis IL, Durocher F, Struewing JP, Easton DF, Chenevix-Trench G, Australian Breast Cancer Family Study, Australian Jewish Breast Cancer Study, Breast Cancer Family Registry, Interdisciplinary Health Research International Team on Breast Cancer Susceptibility, Kathleen Cunningham Foundation Consortium for Research into Familial Breast Cancer, Epidemiological Study of Familial Breast Cancer Study Collaborators (2006). The AIB1 polyglutamine repeat does not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev  15, 76-9.   https://doi.org/10.1158/1055-9965.EPI-05-0709




PubMed


 


PubMed ID 16434590",https://intramural.nih.gov/search/searchview.taf?ipid=44000
469,CP010145-07,"October 01, 2005 -  September 30, 2006",Intervention Trials in Persons at Increased Genetic Risk of Cancer,"Mark H Greene; MD



IRP Faculty Profile",NULL,"Clinical Genetics Branch, NCI","Blanche P Alter



Neelam K Giri; MD



Ruthann  Giusti



Jennifer T Loud



Christine M Mueller



Larissa A Korde","David  Alberts
(University of Arizona Cancer Center)




Deborah A. Bell; MD
(Department of Laboratory Medicine and Pathology, Mayo Clinic)




Molly  Brewer
(Arizona Cancer Center)




Robert  Brodsky
(Johns Hopkins University School of Medicine)




Joseph  Califano
(Johns Hopkins University School of Medicine)




M.  Constenino
(BioTech Laboratories)


Show all 17","Philip E Castle; PhD, MPH (Hormonal and Reproductive Epidemiology Branch)



Mitchell Henry Gail; PhD, MD (Biostatistics Branch)



Alisa  Goldstein; PhD (Genetic Epidemiology Branch)



Allan  Hildesheim; PhD (Hormonal and Reproductive Epidemiology Branch)



Mark E Sherman; MD (Hormonal and Reproductive Epidemiology Branch)



Margaret Anne Tucker (Genetic Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
David A, Walker MD J, Rodriguez G, Garcia F, Mutter G, Plaxe S, Carlson J, Hensley M, Hess L, Method M, Greene M, Barakat R (2006) Chapter 9 - Prevention of Gynecologic Cancer, in The Gynecologic Oncology Group: Report of 35 Years of Excellence in Research (P DiSaia, ed)., pp. 60-72.




 



2.
Abati A, Greene MH, Filie A, Loud J, Prindiville S, Danforth D, Giusti RM (2006). Quantification of the cellular components of breast duct lavage samples. Diagn Cytopathol  34, 78-81.   https://doi.org/10.1002/dc.20371




PubMed


 


PubMed ID 16355383
    
     


 



3.
Peters J, Hoskins L, Prindiville S, Kenen R, Greene M (2006) Evolution of the Colored Eco Genetic Relationship Map (CEGRM) for Assessing Social Functioning in Women in Hereditary Breast-Ovarian (HBOC) Families. Journal of Genetic Counseling 15:477-489",https://intramural.nih.gov/search/searchview.taf?ipid=44001
470,CP010146-07,"October 01, 2005 -  September 30, 2006",Genetic Modifiers of Intitiation and Progression of Mammary Cancer,"Kent W Hunter; PhD



IRP Faculty Profile",NULL,"Laboratory of Population Genetics, NCI","Luanne M Lukes



Nigel P Crawford; MB ChB, PhD



Nicholas  Lintell



Szu-Min  Hsieh","Tim  Veenstra
(Laboratory of Systems Biology, SAIC Frederick)
















Hoda  Anton-Culver
(Department of Epidemiology, UCI)




Daniel  Pomp
(UNC)




David  Threadgill; PhD
(Department of Genetics, University of North Carolina School of Medicine)","Douglas  Lowy; MD (National Cancer Institute)



Chand  Khanna; MD (National Cancer Institute)



Stefan  Ambs (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Borowsky AD, Namba R, Young LJ, Hunter KW, Hodgson JG, Tepper CG, McGoldrick ET, Muller WJ, Cardiff RD, Gregg JP (2005). Syngeneic mouse mammary carcinoma cell lines: two closely related cell lines with divergent metastatic behavior. Clin Exp Metastasis  22, 47-59.   https://doi.org/10.1007/s10585-005-2908-5




PubMed


 


PubMed ID 16132578
    
     


 



2.
Crawford NP, Ziogas A, Peel DJ, Hess J, Anton-Culver H, Hunter KW (2006). Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer. Breast Cancer Res  8, R16.   https://doi.org/10.1186/bcr1389




PubMed



        
     
Free Article


 


PubMed ID 16563182
         Pubmed Central ID 1483843 


 



3.
Hunter K (2005). The intersection of inheritance and metastasis: the role and implications of germline polymorphism in tumor dissemination. Cell Cycle  4, 1719-21.   https://doi.org/10.4161/cc.4.12.2258




PubMed


 


PubMed ID 16294041
    
     


 



4.
Hunter K (2006). Host genetics influence tumour metastasis. Nat Rev Cancer  6, 141-6.   https://doi.org/10.1038/nrc1803




PubMed


 


PubMed ID 16491073
    
     


 



5.
Hunter KW, Crawford NP (2006). Germ line polymorphism in metastatic progression. Cancer Res  66, 1251-4.   https://doi.org/10.1158/0008-5472.CAN-05-3705




PubMed


 


PubMed ID 16452174
    
     


 



6.
Lancaster M, Rouse J, Hunter KW (2005). Modifiers of mammary tumor progression and metastasis on mouse chromosomes 7, 9, and 17. Mamm Genome  16, 120-6.   https://doi.org/10.1007/s00335-004-2432-y




PubMed


 


PubMed ID 15859357
    
     


 



7.
Park YG, Zhao X, Lesueur F, Lowy DR, Lancaster M, Pharoah P, Qian X, Hunter KW (2005). Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1. Nat Genet  37, 1055-62.   https://doi.org/10.1038/ng1635




PubMed



        
     
Free Article


 


PubMed ID 16142231
         Pubmed Central ID 2140048 


 



8.
Yang H, Yu LR, Yi M, Lucas DA, Lukes L, Lancaster M, Chan KC, Issaq HJ, Stephens RM, Conrads TP, Veenstra TD, Hunter KW (2006). Parallel analysis of transcript and translation profiles: identification of metastasis-related signal pathways differentially regulated by drug and genetic modifications. J Proteome Res  5, 1555-67.   https://doi.org/10.1021/pr0504283




PubMed



        
     
Free Article


 


PubMed ID 16823962
         Pubmed Central ID 1501083",https://intramural.nih.gov/search/searchview.taf?ipid=43976
471,CP010150-07,"October 01, 2005 -  September 30, 2006","Infections, immunity, and inflammation in cancer","Eric Andrew Engels; PhD



IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI","James Jerome Goedert; MD



Robert  Biggar; MD



Sam  Mbulaiteye



Anil Kumar Chaturvedi","Malcolm  Brock; MD
(Surgery, Johns Hopkins Medical Institutions)




Gregory  Fant





Thomas  Giordano
(Baylor College of Medicine)




Gregory D Kirk





Margaret R Spitz","Ruth  Pfeiffer; PhD (Biostatistics Branch)



Ola Anders Landgren (Genetic Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Brock MV, Hooker CM, Engels EA, Moore RD, Gillison ML, Alberg AJ, Keruly JC, Yang SC, Heitmiller RF, Baylin SB, Herman JG, Brahmer JR (2006). Delayed diagnosis and elevated mortality in an urban population with HIV and lung cancer: implications for patient care. J Acquir Immune Defic Syndr  43, 47-55.   https://doi.org/10.1097/01.qai.0000232260.95288.93




PubMed


 


PubMed ID 16936558
    
     


 



2.
Engels EA, Brock MV, Chen J, Hooker CM, Gillison M, Moore RD (2006). Elevated incidence of lung cancer among HIV-infected individuals. J Clin Oncol  24, 1383-8.   https://doi.org/10.1200/JCO.2005.03.4413




PubMed


 


PubMed ID 16549832
    
     


 



3.
Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, McNeel TS, Scoppa SM, Biggar RJ, HIV/AIDS Cancer Match Study (2006). Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS  20, 1645-54.   https://doi.org/10.1097/01.aids.0000238411.75324.59




PubMed


 


PubMed ID 16868446
    
     


 



4.
Goedert JJ, Rabkin CS, Ross SR (2006). Prevalence of serologic reactivity against four strains of mouse mammary tumour virus among US women with breast cancer. Br J Cancer  94, 548-51.   https://doi.org/10.1038/sj.bjc.6602977




PubMed



        
     
Free Article


 


PubMed ID 16449994
         Pubmed Central ID 2361179 


 



5.
Goedert JJ, Schairer C, McNeel TS, Hessol NA, Rabkin CS, Engels EA, HIV/AIDS Cancer Match Study (2006). Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS. Br J Cancer  95, 642-8.   https://doi.org/10.1038/sj.bjc.6603282




PubMed



        
     
Free Article


 


PubMed ID 16868538
         Pubmed Central ID 2360686 


 



6.
Kaae J, Wohlfahrt J, Boyd HA, Wulf HC, Biggar RJ, Melbye M (2007). The impact of autoimmune diseases on the incidence and prognosis of cutaneous malignant melanoma. Cancer Epidemiol Biomarkers Prev  16, 1840-4.   https://doi.org/10.1158/1055-9965.EPI-07-0459




PubMed


 


PubMed ID 17855703
    
     


 



7.
Mbulaiteye S, Marshall V, Bagni RK, Wang CD, Mbisa G, Bakaki PM, Owor AM, Ndugwa CM, Engels EA, Katongole-Mbidde E, Biggar RJ, Whitby D (2006). Molecular evidence for mother-to-child transmission of Kaposi sarcoma-associated herpesvirus in Uganda and K1 gene evolution within the host. J Infect Dis  193, 1250-7.   https://doi.org/10.1086/503052




PubMed


 


PubMed ID 16586362
    
     


 



8.
Mbulaiteye SM, Walters M, Engels EA, Bakaki PM, Ndugwa CM, Owor AM, Goedert JJ, Whitby D, Biggar RJ (2006). High levels of Epstein-Barr virus DNA in saliva and peripheral blood from Ugandan mother-child pairs. J Infect Dis  193, 422-6.   https://doi.org/10.1086/499277




PubMed


 


PubMed ID 16388490
    
     


 



9.
Rollison DE, Engels EA, Halsey NA, Shah KV, Viscidi RP, Helzlsouer KJ (2006). Prediagnostic circulating antibodies to JC and BK human polyomaviruses and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev  15, 543-50.   https://doi.org/10.1158/1055-9965.EPI-05-0728




PubMed


 


PubMed ID 16537714",https://intramural.nih.gov/search/searchview.taf?ipid=44003
472,CP010151-07,"October 01, 2005 -  September 30, 2006",KSHV and other oncogenic viruses,Denise  Whitby,NULL,"Office of the Director, NCI",NULL,"Bruce  Armstrong
(University of Sydney, Sydney, Australia)




Nikolaus  Becker
(German Cancer Research Center, Heidelberg, Germany)




Francis  Black
(Yale University School of Public Health)




Paolo  Boffeta
(International Agency for Research on Cancer, Lyon, France)




Paolo  Boffetta
(International Agency for Research on Cancer)




Paul  Brennan
(International Agency for Research on Cancer, Lyon, France)


Show all 30","James Jerome Goedert; MD (Infection & Immunoepidemiology Branch)



Robert  Biggar; MD (Infection & Immunoepidemiology Branch)



Thomas R O'Brien; BA, MPH, MD (Epidemiology and Biostatistics Program)



Charles  Rabkin (Infection & Immunoepidemiology Branch)



Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)



Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44004
473,CP010152-07,"October 01, 2005 -  September 30, 2006",Etiologic Studies in the PLCO Trial,Richard  Hayes; PhD,NULL,"Occupational and Environmental Epidemiology Branch, NCI","Wen-Yi  Huang



Bu Tian  Ji","Gerry  Andriole
(Washington University)




Thomas  Beck
(NCI)




Saundra  Buys
(Hunstman Cancer Institute, University of Utah)




Timothy R. Church; PhD
(Environ & Occup Health, University of Minnesota School of Public Health)




David T Crawford





Mona  Fouad
(University of Alabama, Birmingham)


Show all 11","Jimmie B Vaught (Office of the Director)



Christine Dorothy Berg (Early Detection Research Group)",NULL,"Ordered by publication type and then author name.



1.
Chang SC, Ziegler RG, Dunn B, Stolzenberg-Solomon R, Lacey JV, Huang WY, Schatzkin A, Reding D, Hoover RN, Hartge P, Leitzmann MF (2006). Association of energy intake and energy balance with postmenopausal breast cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev  15, 334-41.   https://doi.org/10.1158/1055-9965.EPI-05-0479




PubMed


 


PubMed ID 16492925
    
     


 



2.
Huang WY, Berndt SI, Kang D, Chatterjee N, Chanock SJ, Yeager M, Welch R, Bresalier RS, Weissfeld JL, Hayes RB (2006). Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: XPC polymorphisms modify smoking-related risk. Cancer Epidemiol Biomarkers Prev  15, 306-11.   https://doi.org/10.1158/1055-9965.EPI-05-0751




PubMed


 


PubMed ID 16492920
    
     


 



3.
Ji BT, Weissfeld JL, Chow WH, Huang WY, Schoen RE, Hayes RB (2006). Tobacco smoking and colorectal hyperplastic and adenomatous polyps. Cancer Epidemiol Biomarkers Prev  15, 897-901.   https://doi.org/10.1158/1055-9965.EPI-05-0883




PubMed


 


PubMed ID 16702367
    
     


 



4.
Kirsh VA, Hayes RB, Mayne ST, Chatterjee N, Subar AF, Dixon LB, Albanes D, Andriole GL, Urban DA, Peters U, PLCO Trial (2006). Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk. J Natl Cancer Inst  98, 245-54.   https://doi.org/10.1093/jnci/djj050




PubMed


 


PubMed ID 16478743
    
     


 



5.
Kirsh VA, Mayne ST, Peters U, Chatterjee N, Leitzmann MF, Dixon LB, Urban DA, Crawford ED, Hayes RB (2006). A prospective study of lycopene and tomato product intake and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev  15, 92-8.   https://doi.org/10.1158/1055-9965.EPI-05-0563




PubMed


 


PubMed ID 16434593
    
     


 



6.
Kraft P, Pharoah P, Chanock SJ, Albanes D, Kolonel LN, Hayes RB, Altshuler D, Andriole G, Berg C, Boeing H, Burtt NP, Bueno-de-Mesquita B, Calle EE, Cann H, Canzian F, Chen YC, Crawford DE, Dunning AM, Feigelson HS, Freedman ML, Gaziano JM, Giovannucci E, Gonzalez CA, Haiman CA, Hallmans G, et al. [21 more authors] (2005). Genetic variation in the HSD17B1 gene and risk of prostate cancer. PLoS Genet  1, e68.   https://doi.org/10.1371/journal.pgen.0010068




PubMed



        
     
Free Article


 


PubMed ID 16311626
         Pubmed Central ID 1287955 


 



7.
Michaud DS, Daugherty SE, Berndt SI, Platz EA, Yeager M, Crawford ED, Hsing A, Huang WY, Hayes RB (2006). Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer. Cancer Res  66, 4525-30.   https://doi.org/10.1158/0008-5472.CAN-05-3987




PubMed


 


PubMed ID 16618781
    
     


 



8.
Peters U, Chatterjee N, Church TR, Mayo C, Sturup S, Foster CB, Schatzkin A, Hayes RB (2006). High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program. Cancer Epidemiol Biomarkers Prev  15, 315-20.   https://doi.org/10.1158/1055-9965.EPI-05-0471




PubMed


 


PubMed ID 16492922
    
     


 



9.
Purdue MP, Mink PJ, Hartge P, Huang WY, Buys S, Hayes RB (2005). Hormone replacement therapy, reproductive history, and colorectal adenomas: data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial (United States). Cancer Causes Control  16, 965-73.   https://doi.org/10.1007/s10552-005-4500-3




PubMed


 


PubMed ID 16132805
    
     


 



10.
Rodriguez Ortner E, Hayes RB, Weissfeld J, Gelmann EP (2006). Effect of homeodomain protein NKX3.1 R52C polymorphism on prostate gland size. Urology  67, 311-5.   https://doi.org/10.1016/j.urology.2005.08.021




PubMed


 


PubMed ID 16442598",https://intramural.nih.gov/search/searchview.taf?ipid=44005
474,CP010153-07,"October 01, 2005 -  September 30, 2006","Cancer Risk and Environmental Exposures to Nitrate, Pesticides, and Industrial C","Mary Helen Ward; MS, PhD



IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Joanne S Colt



Kenneth  Cantor; PhD



Debra  Silverman; ScD, ScM



Dalsu  Baris



Adrienne  Katner","Patricia  Buffler
(Univerity of California at Berkeley)




David  Camann
(Southwest Research Institute)




James  Cerhan
(Mayo Clinic)




Anneclair  DeRoos
(University of Washington)




James  Giglierano
(Iowa Department of Natural Resources)




Martin  Kulldorf
(University of Connecticut)


Show all 13","Shelia K Zahm; ScM, ScD (Office of the Director)



Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)



Jay  Lubin; PhD (Biostatistics Branch)",NULL,"Ordered by publication type and then author name.



1.
Ward MH, Lubin J, Giglierano J, Colt JS, Wolter C, Bekiroglu N, Camann D, Hartge P, Nuckols JR (2006). Proximity to crops and residential exposure to agricultural herbicides in iowa. Environ Health Perspect  114, 893-7.   https://doi.org/10.1289/ehp.8770




PubMed



        
     
Free Article


 


PubMed ID 16759991
         Pubmed Central ID 1480526",https://intramural.nih.gov/search/searchview.taf?ipid=44028
475,CP010154-07,"October 01, 2005 -  September 30, 2006",Genetics and Epigenetics of Cancer,Maxwell P Lee; PhD,NULL,"Laboratory of Population Genetics, NCI","Sheryl A Gere



Mitsutaka  Kadota



Natacha  Diaz-Meyer",NULL,"Jeffery P Struewing; MS, MD (National Cancer Institute)



Kent W Hunter; PhD (National Cancer Institute)



Kenneth  Buetow; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44006
476,CP010155-07,"October 01, 2005 -  September 30, 2006",Informatics Solutions to Biomedical Research,Maxwell P Lee; PhD,NULL,"Laboratory of Population Genetics, NCI","Howard H Yang



Wei  Lin",NULL,"Philip  Taylor; MD, ScD (National Cancer Institute)



Alisa  Goldstein; PhD (National Cancer Institute)



Dinah  Singer; PhD (National Cancer Institute)



Kenneth  Buetow; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Riss J, Khanna C, Koo S, Chandramouli GV, Yang HH, Hu Y, Kleiner DE, Rosenwald A, Schaefer CF, Ben-Sasson SA, Yang L, Powell J, Kane DW, Star RA, Aprelikova O, Bauer K, Vasselli JR, Maranchie JK, Kohn KW, Buetow KH, Linehan WM, Weinstein JN, Lee MP, Klausner RD, Barrett JC (2006). Cancers as wounds that do not heal: differences and similarities between renal regeneration/repair and renal cell carcinoma. Cancer Res  66, 7216-24.   https://doi.org/10.1158/0008-5472.CAN-06-0040




PubMed


 


PubMed ID 16849569",https://intramural.nih.gov/search/searchview.taf?ipid=44007
477,CP010156-06,"October 01, 2005 -  September 30, 2006",Genetic Studies in Melanoma,"Jeffery P Struewing; MS, MD",NULL,"Laboratory of Population Genetics, NCI",Lutecia  Pereira,NULL,"Alisa  Goldstein; PhD (National Cancer Institute)



Margaret Anne Tucker (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43977
478,CP010157-06,"October 01, 2005 -  September 30, 2006","Genetic, Epidemiologic, and Biochemical Studies of DNA Damage Repair","Jeffery P Struewing; MS, MD",NULL,"Laboratory of Population Genetics, NCI",Marbin A Pineda,NULL,Alice  Sigurdson; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=43975
479,CP010158-06,"October 01, 2005 -  September 30, 2006",Studies of Rare Cancers,Louise  Brinton; PhD,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI","Gabriella  Andreotti



Kelly Jen-Yi Yu","Streamson  Chua
(Columbia University)




Scott  Davis
(Fred Hutchinson Cancer Research Center)




James  Dick
(Johns Hopkins Univeristy)




James  Fox
(MIT)




Yu-Tang  Gao
(Shanghai Cancer Institute)




Evelyene  Lennette
(Virolab, Inc.)


Show all 12","Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)



Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Yang X, Goldstein A, Hildesheim A, Rabkin C   (2006) Distribution of Epsein-Barr viral load in serum of individuals from nasopharyngeal carcinoma high-risk families in Taiwan.  International Journal of Cancer  780-784 pp.",https://intramural.nih.gov/search/searchview.taf?ipid=44008
480,CP010162-06,"October 01, 2005 -  September 30, 2006",Gene expression profiles in lung cancer using cDNA arrays,Jin  Jen,NULL,"Laboratory of Population Genetics, NCI","Tatiana V Dracheva



Rajbir K Gill



Hyo-Sung  Jeon



Megan  Hames



Abbas  Shakoori",NULL,"Curtis  Harris; MD (National Cancer Institute)



Neil Edward Caporaso; MS, MD (National Cancer Institute)



Kenneth  Buetow; PhD (National Cancer Institute)



Phillip A Dennis; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Tsurutani J, Fukuoka J, Tsurutani H, Shih JH, Hewitt SM, Travis WD, Jen J, Dennis PA (2006). Evaluation of two phosphorylation sites improves the prognostic significance of Akt activation in non-small-cell lung cancer tumors. J Clin Oncol  24, 306-14.   https://doi.org/10.1200/JCO.2005.02.4133




PubMed


 


PubMed ID 16330671",https://intramural.nih.gov/search/searchview.taf?ipid=44009
481,CP010163-06,"October 01, 2005 -  September 30, 2006",Genetic analysis in early age of onset lung cancer patients,Jin  Jen,NULL,"Laboratory of Population Genetics, NCI","Tatiana V Dracheva



Rajbir K Gill



Hyo-Sung  Jeon



Megan  Hames



Abbas  Shakoori","Teri  Franks
(pathology, Armed Forces Institute of Pathology)




William  Travis
(Pathology, Memorial Sloan Kettering Cancer Cancer)




Ping  Yang; MD, PhD
(Mayo Clinic)",Kenneth  Buetow; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44010
482,CP010164-06,"October 01, 2005 -  September 30, 2006",Development of non-small cell lung cancer tissue microarray for systematic analy,Jin  Jen,NULL,"Laboratory of Population Genetics, NCI","Tatiana V Dracheva



Rajbir K Gill



Hyo-Sung  Jeon



Megan  Hames



Abbas  Shakoori","Teri  Franks
(pathology, Armed Forces Institute of Pathology)




James  Herman
(Oncology, Johns Hopkins Medical School)




William  Travis
(Pathology, Memorial Sloan Kettering Cancer Cancer)




David  Yankelevitz
(Cornell Medical Center, Cornell University)","Curtis  Harris; MD (National Cancer Institute)



Kenneth  Buetow; PhD (National Cancer Institute)



Phillip A Dennis; MD, PhD (National Cancer Institute)



Karl Thomas Ried; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Tsurutani J, Fukuoka J, Tsurutani H, Shih JH, Hewitt SM, Travis WD, Jen J, Dennis PA (2006). Evaluation of two phosphorylation sites improves the prognostic significance of Akt activation in non-small-cell lung cancer tumors. J Clin Oncol  24, 306-14.   https://doi.org/10.1200/JCO.2005.02.4133




PubMed


 


PubMed ID 16330671",https://intramural.nih.gov/search/searchview.taf?ipid=44011
483,CP010165-06,"October 01, 2005 -  September 30, 2006",Mechanisms of gene expression changes in lung cancer,Jin  Jen,NULL,"Laboratory of Population Genetics, NCI","Tatiana V Dracheva



Rajbir K Gill



Hyo-Sung  Jeon



Megan  Hames



Abbas  Shakoori",NULL,"Ilona  Linnoila; MD (National Cancer Institute)



Kent W Hunter; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44012
484,CP010167-06,"October 01, 2005 -  September 30, 2006",General Studies of Epidemiology,"Robert  Hoover; MD, ScD



IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI","Rebecca  Troisi



Patricia  Hartge; ScD","Clark  Anderson
(University of Kansas School of Medicine)




Chester  Douglass
(Harvard School of Dentistry)




Sheila  McGuire
(Harvard School of Dentistry)",NULL,NULL,"Ordered by publication type and then author name.



1.
Puente D, Hartge P, Greiser E, Cantor KP, King WD, González CA, Cordier S, Vineis P, Lynge E, Chang-Claude J, Porru S, Tzonou A, Jöckel KH, Serra C, Hours M, Lynch CF, Ranft U, Wahrendorf J, Silverman D, Fernandez F, Boffetta P, Kogevinas M (2006). A pooled analysis of bladder cancer case-control studies evaluating smoking in men and women. Cancer Causes Control  17, 71-9.   https://doi.org/10.1007/s10552-005-0389-0




PubMed


 


PubMed ID 16411055",https://intramural.nih.gov/search/searchview.taf?ipid=44013
485,CP010168-06,"October 01, 2005 -  September 30, 2006",Early Life Exposures and Subsequent Cancer Risk,"Robert  Hoover; MD, ScD



IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI","Rebecca  Troisi



Nancy K Carter","Ervin  Adam
(Baylor College of Medicine)




Elizabeth  Hatch
(Boston University)




Arthur  Herbst
(University of Chicago)




Chung  Hsieh
(University of Massachuetts)




Michele  Lauria
(Dartmouth Hitchcock Medical Center)




Kenneth  Noller
(New England Medical Center)


Show all 15",NULL,NULL,"Ordered by publication type and then author name.



1.
Palmer JR, Wise LA, Hatch EE, Troisi R, Titus-Ernstoff L, Strohsnitter W, Kaufman R, Herbst AL, Noller KL, Hyer M, Hoover RN (2006). Prenatal diethylstilbestrol exposure and risk of breast cancer. Cancer Epidemiol Biomarkers Prev  15, 1509-14.   https://doi.org/10.1158/1055-9965.EPI-06-0109




PubMed


 


PubMed ID 16896041
    
     


 



2.
Perez KM, Titus-Ernstoff L, Hatch EE, Troisi R, Wactawski-Wende J, Palmer JR, Noller K, Hoover RN, National Cancer Institute''s DES Follow-up Study Group (2005). Reproductive outcomes in men with prenatal exposure to diethylstilbestrol. Fertil Steril  84, 1649-56.   https://doi.org/10.1016/j.fertnstert.2005.05.062




PubMed


 


PubMed ID 16359959
    
     


 



3.
Titus-Ernstoff L, Troisi R, Hatch EE, Palmer JR, Wise LA, Ricker W, Hyer M, Kaufman R, Noller K, Strohsnitter W, Herbst AL, Hartge P, Hoover RN (2006). Mortality in women given diethylstilbestrol during pregnancy. Br J Cancer  95, 107-11.   https://doi.org/10.1038/sj.bjc.6603221




PubMed



        
     
Free Article


 


PubMed ID 16786044
         Pubmed Central ID 2360488 


 



4.
Titus-Ernstoff L, Troisi R, Hatch EE, Wise LA, Palmer J, Hyer M, Kaufman R, Adam E, Strohsnitter W, Noller K, Herbst AL, Gibson-Chambers J, Hartge P, Hoover RN (2006). Menstrual and reproductive characteristics of women whose mothers were exposed in utero to diethylstilbestrol (DES). Int J Epidemiol  35, 862-8.   https://doi.org/10.1093/ije/dyl106




PubMed


 


PubMed ID 16723367
    
     


 



5.
Troisi R   (2006) Birth Weight and Breast Cancer Risk.  British Journal of Cancer  1734-7 pp.




 



6.
Troisi R, Hatch EE, Titus-Ernstoff L, Palmer JR, Hyer M, Strohsnitter WC, Robboy SJ, Kaufman R, Herbst A, Adam E, Hoover RN (2006). Birth weight and breast cancer risk. Br J Cancer  94, 1734-7.   https://doi.org/10.1038/sj.bjc.6603122




PubMed



        
     
Free Article


 


PubMed ID 16641898
         Pubmed Central ID 2361301 


 



7.
Troisi R, Vatten L, Roberts J, Cole B, Potischman N (2006) Maternal Androgen and Estrogen Concentrations Are Not Associated with Blood Pressure Changes in Uncomplicated Pregnancies. Cancer Epidemiology Biomarkers and Prevention 15:2013-2015




 



8.
Zhang Y, Longnecker M, Graubard B   (2006) Maternal Hormone Levels and Perinatal Characteristics: Implications for Testicular Cancer.  Ann Epidemiol [Epub]  - pp.",https://intramural.nih.gov/search/searchview.taf?ipid=44014
486,CP010169-05,"October 01, 2005 -  September 30, 2006","Nutrition, Metabolism, and Cancer","Regina Gale Ziegler; PhD, MPH



IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",Patricia  Hartge; ScD,"Ray  Greenberg
(University of South Carolina)




Rudolf  Kaaks
(International Agency for Research on Cancer)




Lawrence  Kolonel
(University of Hawaii)




Abraham  Nomura
(School of Public Health, University of Hawaii)




Emanuel  Petricoin, III
(Food and Drug Administration)




Malcolm  Pike
(University of Southern California)


Show all 11","Demetrius  Albanes; MD (Office of the Director)



Louise  Brinton; PhD (Hormonal and Reproductive Epidemiology Branch)



Roni T Falk (Hormonal and Reproductive Epidemiology Branch)



Mitchell Henry Gail; PhD, MD (Biostatistics Branch)



Gloria L Gridley (Biostatistics Branch)



Richard  Hayes; PhD (Occupational and Environmental Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Xu X, Roman JM, Veenstra TD, Van Anda J, Ziegler RG, Issaq HJ (2006). Analysis of fifteen estrogen metabolites using packed column supercritical fluid chromatography-mass spectrometry. Anal Chem  78, 1553-8.   https://doi.org/10.1021/ac051425c




PubMed


 


PubMed ID 16503607
    
     


 



2.
Xu X, Veenstra TD, Fox SD, Roman JM, Issaq HJ, Falk R, Saavedra JE, Keefer LK, Ziegler RG (2005). Measuring fifteen endogenous estrogens simultaneously in human urine by high-performance liquid chromatography-mass spectrometry. Anal Chem  77, 6646-54.   https://doi.org/10.1021/ac050697c




PubMed


 


PubMed ID 16223252",https://intramural.nih.gov/search/searchview.taf?ipid=44020
487,CP010170-06,"October 01, 2005 -  September 30, 2006",Multidisciplinary Studies of Lymphoma,Patricia  Hartge; ScD,NULL,"Epidemiology and Biostatistics Program, NCI",NULL,"Wendy  Cozen
(Norris Comprehensive Cancer Center)




Scott  Davis
(Fred Hutchinson Cancer Research Center)




Anneclaire  De Roos
(University of Washington, Seattle, WA)




Maryjean  Schenk
(Barbara Karmanos Cancer Institute)




Richard  Severson
(Barbara Karmanos Cancer Institute)","Joanne S Colt (Occupational and Environmental Epidemiology Branch)



Shelia K Zahm; ScM, ScD (Office of the Director)



Martha S Linet; PhD (Radiation Epidemiology Branch)



Aaron E Blair; PhD, MPH (Occupational and Environmental Epidemiology Branch)



Mary Helen Ward; MS, PhD (Occupational and Environmental Epidemiology Branch)



Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Cerhan JR, Bernstein L, Severson RK, Davis S, Colt JS, Blair A, Hartge P (2005). Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma. Cancer Causes Control  16, 1203-14.   https://doi.org/10.1007/s10552-005-0358-7




PubMed


 


PubMed ID 16215871
    
     


 



2.
Colt JS, Davis S, Severson RK, Lynch CF, Cozen W, Camann D, Engels EA, Blair A, Hartge P (2006). Residential insecticide use and risk of non-Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev  15, 251-7.   https://doi.org/10.1158/1055-9965.EPI-05-0556




PubMed


 


PubMed ID 16492912
    
     


 



3.
Cozen W, Gebregziabher M, Conti DV, Van Den Berg DJ, Coetzee GA, Wang SS, Rothman N, Bernstein L, Hartge P, Morhbacher A, Coetzee SG, Salam MT, Wang W, Zadnick J, Ingles SA (2006). Interleukin-6-related genotypes, body mass index, and risk of multiple myeloma and plasmacytoma. Cancer Epidemiol Biomarkers Prev  15, 2285-91.   https://doi.org/10.1158/1055-9965.EPI-06-0446




PubMed


 


PubMed ID 17119059
    
     


 



4.
De Roos AJ, Gold LS, Wang S, Hartge P, Cerhan JR, Cozen W, Yeager M, Chanock S, Rothman N, Severson RK (2006). Metabolic gene variants and risk of non-Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev  15, 1647-53.   https://doi.org/10.1158/1055-9965.EPI-06-0193




PubMed


 


PubMed ID 16985026
    
     


 



5.
De Roos AJ, Hartge P, Lubin JH, Colt JS, Davis S, Cerhan JR, Severson RK, Cozen W, Patterson DG, Needham LL, Rothman N (2005). Persistent organochlorine chemicals in plasma and risk of non-Hodgkin's lymphoma. Cancer Res  65, 11214-26.   https://doi.org/10.1158/0008-5472.CAN-05-1755




PubMed


 


PubMed ID 16322272
    
     


 



6.
Engel L, Blair A, Lan Q, Cantor K, Rothman N (2006) PCBs and non-Hodgkin lymphoma: Results from three cohorts. Epidemiology 17:S116-S116




 



7.
Ioannidis JP, Gwinn M, Little J, Higgins JP, Bernstein JL, Boffetta P, Bondy M, Bray MS, Brenchley PE, Buffler PA, Casas JP, Chokkalingam A, Danesh J, Smith GD, Dolan S, Duncan R, Gruis NA, Hartge P, Hashibe M, Hunter DJ, Jarvelin MR, Malmer B, Maraganore DM, Newton-Bishop JA, O'Brien TR, Human Genome Epidemiology Network and the Network of Investigator Networks, et al. [13 more authors] (2006). A road map for efficient and reliable human genome epidemiology. Nat Genet  38, 3-5.   https://doi.org/10.1038/ng0106-3




PubMed


 


PubMed ID 16468121
    
     


 



8.
Larry E, Blair A, Lan Q, Cantor K, Rothman N (2006) PCBs and non-Hodgkin lymphoma: Results from three cohorts. Epidemiology 17:S116-S116




 



9.
Lee W, Stewart T, Purdue M, Hartge P   (2006) Free in PMC Asthma history, occupational exposure to pesticides and the risk of non-Hodgkin's lymphoma.  Int J Cancer  3174-3176 pp.




 



10.
Lee WJ, Purdue MP, Stewart P, Schenk M, De Roos AJ, Cerhan JR, Severson RK, Cozen W, Hartge P, Blair A (2006). Asthma history, occupational exposure to pesticides and the risk of non-Hodgkin's lymphoma. Int J Cancer  118, 3174-6.   https://doi.org/10.1002/ijc.21755




PubMed



        
     
Free Article


 


PubMed ID 16395708
         Pubmed Central ID 1578637 


 



11.
Lim U, Schenk M, Kelemen LE, Davis S, Cozen W, Hartge P, Ward MH, Stolzenberg-Solomon R (2005). Dietary determinants of one-carbon metabolism and the risk of non-Hodgkin's lymphoma: NCI-SEER case-control study, 1998-2000. Am J Epidemiol  162, 953-64.   https://doi.org/10.1093/aje/kwi310




PubMed


 


PubMed ID 16221809
    
     


 



12.
Rothman N, Skibola CF, Wang SS, Morgan G, Lan Q, Smith MT, Spinelli JJ, Willett E, De Sanjose S, Cocco P, Berndt SI, Brennan P, Brooks-Wilson A, Wacholder S, Becker N, Hartge P, Zheng T, Roman E, Holly EA, Boffetta P, Armstrong B, Cozen W, Linet M, Bosch FX, Ennas MG, et al. [18 more authors] (2006). Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol  7, 27-38.   https://doi.org/10.1016/S1470-2045(05)70434-4




PubMed


 


PubMed ID 16389181
    
     


 



13.
Wang S, Cerhan J, Hartge P, Davis S, Severson R, Cozen W, Lan Q, Welch R, Chanock S, Rothman N (2006) Polymorphisms in Oxidative Stress Genes and Risk for Non-Hodgkin lymphoma. Cancer Research 27:1828-34




 



14.
Wang SS, Cozen W, Severson RK, Hartge P, Cerhan JR, Davis S, Welch R, Rothman N, Chanock SJ (2006). Cyclin D1 splice variant and risk for non-Hodgkin lymphoma. Hum Genet  120, 297-300.   https://doi.org/10.1007/s00439-006-0212-3




PubMed


 


PubMed ID 16783567
    
     


 



15.
Ward MH, Cerhan JR, Colt JS, Hartge P (2006). Risk of non-Hodgkin lymphoma and nitrate and nitrite from drinking water and diet. Epidemiology  17, 375-82.   https://doi.org/10.1097/01.ede.0000219675.79395.9f




PubMed


 


PubMed ID 16699473",https://intramural.nih.gov/search/searchview.taf?ipid=44015
488,CP010171-06,"October 01, 2005 -  September 30, 2006",Assessing the Risk of Breast and Ovarian Cancer,Patricia  Hartge; ScD,NULL,"Epidemiology and Biostatistics Program, NCI","Robert  Hoover; MD, ScD","Saundra  Buys
(Hunstman Cancer Institute, University of Utah)




Doug  Reding
(Marshfield Clinic Research Foundation)","Sholom  Wacholder; PhD (Biostatistics Branch)



James V Lacey; MPH, PhD (Hormonal and Reproductive Epidemiology Branch)



Mark E Sherman; MD (Hormonal and Reproductive Epidemiology Branch)



Ruth  Pfeiffer; PhD (Biostatistics Branch)



Richard  Hayes; PhD (Occupational and Environmental Epidemiology Branch)



Christine Dorothy Berg (Early Detection Research Group)",NULL,"Ordered by publication type and then author name.



1.
Chang S, Ziegler R, Lacey J, Solomon R, Dunn B, Hoover R, Leitzmann M, Schatzkin A, Hartge P   (2006) Association of energy intake, body size, and physical activity with postmenopausal breast cancer in the PLCO Screening Trial.  Cancer Epidemiol Biomarkers Prev  334-341 pp.",https://intramural.nih.gov/search/searchview.taf?ipid=44016
489,CP010175-06,"October 01, 2005 -  September 30, 2006",Molecular Targets - Colon Cancer,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI","Janet M Dipasquale



Robert  Clifford



Daoud M Meerzaman",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44017
490,CP010176-06,"October 01, 2005 -  September 30, 2006",Epidemiology and Natural History of Cancer-Associated Viruses,James Jerome Goedert; MD,NULL,"Infection & Immunoepidemiology Branch, NCI","Robert  Biggar; MD



Eric Andrew Engels; PhD



Charles  Rabkin



Sam  Mbulaiteye","M. Elaine  Eyster
(Pennsylvania State University)




Angelos  Hatzakis
(University of Athens Medical School)




Michael  Lederman; MD
(Case Western Reserve University)




Nino  Romano
(University of Palermo)




Cloe  Thio
(Dept of Medicine, Johns Hopkins University School of Medicine)




David  Thomas
(Johns Hopkins University)


Show all 7","Philip Samuel Rosenberg; PhD (Biostatistics Branch)



Thomas R O'Brien; BA, MPH, MD (Epidemiology and Biostatistics Program)



Denise  Whitby (Epidemiology and Biostatistics Program)



Barry Ira Graubard; PhD (Biostatistics Branch)



Stephen J Chanock; MD, PhD (Pediatric Oncology Branch)",NULL,"Ordered by publication type and then author name.



1.
Brown EE, Whitby D, Vitale F, Fei PC, Del Carpio C, Marshall V, Alberg AJ, Serraino D, Messina A, Gafa L, Goedert JJ (2005). Correlates of Human Herpesvirus-8 DNA detection among adults in Italy without Kaposi sarcoma. Int J Epidemiol  34, 1110-7.   https://doi.org/10.1093/ije/dyi131




PubMed


 


PubMed ID 16043440
    
     


 



2.
Goedert JJ, Rabkin CS, Ross SR (2006). Prevalence of serologic reactivity against four strains of mouse mammary tumour virus among US women with breast cancer. Br J Cancer  94, 548-51.   https://doi.org/10.1038/sj.bjc.6602977




PubMed



        
     
Free Article


 


PubMed ID 16449994
         Pubmed Central ID 2361179 


 



3.
Lleonart ME, Kirk GD, Villar S, Lesi OA, Dasgupta A, Goedert JJ, Mendy M, Hollstein MC, Montesano R, Groopman JD, Hainaut P, Friesen MD (2005). Quantitative analysis of plasma TP53 249Ser-mutated DNA by electrospray ionization mass spectrometry. Cancer Epidemiol Biomarkers Prev  14, 2956-62.   https://doi.org/10.1158/1055-9965.EPI-05-0612




PubMed


 


PubMed ID 16365016
    
     


 



4.
Mbulaiteye S, Marshall V, Bagni RK, Wang CD, Mbisa G, Bakaki PM, Owor AM, Ndugwa CM, Engels EA, Katongole-Mbidde E, Biggar RJ, Whitby D (2006). Molecular evidence for mother-to-child transmission of Kaposi sarcoma-associated herpesvirus in Uganda and K1 gene evolution within the host. J Infect Dis  193, 1250-7.   https://doi.org/10.1086/503052




PubMed


 


PubMed ID 16586362
    
     


 



5.
Mbulaiteye SM, Gold BD, Pfeiffer RM, Brubaker GR, Shao J, Biggar RJ, Hisada M (2006). H. pylori-infection and antibody immune response in a rural Tanzanian population. Infect Agent Cancer  1, 3.   https://doi.org/10.1186/1750-9378-1-3




PubMed



        
     
Free Article


 


PubMed ID 17150132
         Pubmed Central ID 1636024 


 



6.
Mbulaiteye SM, Katabira ET, Wabinga H, Parkin DM, Virgo P, Ochai R, Workneh M, Coutinho A, Engels EA (2006). Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study. Int J Cancer  118, 985-90.   https://doi.org/10.1002/ijc.21443




PubMed


 


PubMed ID 16106415
    
     


 



7.
Mbulaiteye SM, Walters M, Engels EA, Bakaki PM, Ndugwa CM, Owor AM, Goedert JJ, Whitby D, Biggar RJ (2006). High levels of Epstein-Barr virus DNA in saliva and peripheral blood from Ugandan mother-child pairs. J Infect Dis  193, 422-6.   https://doi.org/10.1086/499277




PubMed


 


PubMed ID 16388490
    
     


 



8.
Modi WS, Scott K, Goedert JJ, Vlahov D, Buchbinder S, Detels R, Donfield S, O'brien SJ, Winkler C (2005). Haplotype analysis of the SDF-1 (CXCL12) gene in a longitudinal HIV-1/AIDS cohort study. Genes Immun  6, 691-8.   https://doi.org/10.1038/sj.gene.6364258




PubMed


 


PubMed ID 16177829
    
     


 



9.
Newton R, Ribeiro T, Alvarez E, Ziegler J, Casabonne D, Carpenter L, Beral V, Mbidde E, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, Touzé A, Coursaget P, Uganda Kaposi''s and Sarcoma Study Group (2006). BK virus and cancer in Uganda. Eur J Cancer Prev  15, 285-9.   https://doi.org/10.1097/00008469-200608000-00002




PubMed


 


PubMed ID 16835499
    
     


 



10.
Rollison DE, Engels EA, Halsey NA, Shah KV, Viscidi RP, Helzlsouer KJ (2006). Prediagnostic circulating antibodies to JC and BK human polyomaviruses and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev  15, 543-50.   https://doi.org/10.1158/1055-9965.EPI-05-0728




PubMed


 


PubMed ID 16537714
    
     


 



11.
Shao W, Lazaryan A, Dorak MT, Penman-Aguilar A, Wilson CM, Margolick JB, Goedert JJ, Prins M, Tang J, Kaslow RA (2006). Cohort- and time-specific associations of CTLA4 genotypes with HIV-1 disease progression. AIDS  20, 1583-90.   https://doi.org/10.1097/01.aids.0000238403.08497.3f




PubMed


 


PubMed ID 16868438",https://intramural.nih.gov/search/searchview.taf?ipid=44018
491,CP010177-06,"October 01, 2005 -  September 30, 2006",HPV Vaccine Trials,"Allan  Hildesheim; PhD



IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Mark E Sherman; MD,"Concepcion  Bratti
(Costa Rican Social Security)




Clayton  Harro
(Johns Hopkins School of Medicine)




Rolando  Herrero
(Ministry of Health)




Ana Cecilia  Rodriguez
(Costa Rican Social Security)","Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)



Douglas  Lowy; MD (Laboratory of Cellular Oncology)



John  Schiller; PhD (Laboratory of Cellular Oncology)



Diane  Solomon; PhD (Breast and Gynecologic Cancer Research Group)",NULL,"Ordered by publication type and then author name.



1.
García-Piñeres AJ, Hildesheim A, Trivett M, Williams M, Wu L, Kewalramani VN, Pinto LA (2006). Role of DC-SIGN in the activation of dendritic cells by HPV-16 L1 virus-like particle vaccine. Eur J Immunol  36, 437-45.   https://doi.org/10.1002/eji.200535068




PubMed


 


PubMed ID 16385626",https://intramural.nih.gov/search/searchview.taf?ipid=44019
492,CP010178-05,"October 01, 2005 -  September 30, 2006",Core Genotyping Facility,"Stephen J Chanock; MD, PhD



IRP Faculty Profile",NULL,"Office of the Director, NCI",Andrew Wells Bergen,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44021
493,CP010180-05,"October 01, 2005 -  September 30, 2006",Prostate Cancer Studies,Ann  Hsing; PhD,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Gabriella  Andreotti,"Richard  Biritwum
(Univ of Ghana Medical School)




Peter  Carroll
(UCSF)




Chawnshang  Chang
(University of Rochester)




Chu  Chen
(University of Washington)




Streamson  Chua
(Columbia University)




Angelo  DeMarzo
(Johns Hopkins U)


Show all 15",Richard  Hayes; PhD (Occupational and Environmental Epidemiology Branch),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44040
494,CP010181-04,"October 01, 2005 -  September 30, 2006",Methods for Epidemiology Studies,"Mitchell Henry Gail; PhD, MD



IRP Faculty Profile",NULL,"Biostatistics Branch, NCI","Thomas  Fears; PhD



Nilanjan  Chatterjee



Joseph L Gastwirth



Hormuzdiar Aspandiar Katki; MS



Philip Samuel Rosenberg; PhD



Sholom  Wacholder; PhD



Show all 11","Jacques  Benichou
(University of Rouen Medical School)




Efstathia  Bura
(The George Washington University, Washington, DC)




Celia  Byrne
(George Washington University)




Raymond  Carroll
(Texas A&M University)




Sarah  Daugherty
(Johns Hopkins University)




Laure  El Ghormli
(GW Biostat)


Show all 14","Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)



Montserrat  Garcia-Closas; MD, PhD (Hormonal and Reproductive Epidemiology Branch)



Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)



Sam  Mbulaiteye (Infection & Immunoepidemiology Branch)



Mark H Greene; MD (Clinical Genetics Branch)



Edward L Korn (Clinical Trials Section)",NULL,"Ordered by publication type and then author name.



1.
Chen J, Pee D, Ayyagari R, Graubard B, Schairer C, Byrne C, Benichou J, Gail MH (2006). Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. J Natl Cancer Inst  98, 1215-26.   https://doi.org/10.1093/jnci/djj332




PubMed


 


PubMed ID 16954474
    
     


 



2.
Rosenberg PS, Alter BP, Bolyard AA, Bonilla MA, Boxer LA, Cham B, Fier C, Freedman M, Kannourakis G, Kinsey S, Schwinzer B, Zeidler C, Welte K, Dale DC, Severe Chronic Neutropenia International Registry (2006). The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood  107, 4628-35.   https://doi.org/10.1182/blood-2005-11-4370




PubMed



        
     
Free Article


 


PubMed ID 16497969
         Pubmed Central ID 1895804",https://intramural.nih.gov/search/searchview.taf?ipid=43974
495,CP010182-04,"October 01, 2005 -  September 30, 2006",Epidemiologic Field Studies,"Mitchell Henry Gail; PhD, MD



IRP Faculty Profile",NULL,"Biostatistics Branch, NCI","Linda M Brown; MPH, DPhil



Nilanjan  Chatterjee



Ruth  Pfeiffer; PhD



Catherine G Schairer



Thomas  Fears; PhD



Jay  Lubin; PhD



Show all 8","Joe  Ayotte
(US Geological Survey)




Farhat  Ben Ayed
(Institute Salah Azaiz, Tunis)




Tetyana  Bogdanova
(Institute of Endocrinology & Metabolism)




John  Boice, Jr.
(International Epidemiology Institute)




Aaron  Brill
(Vanderbilt University)




Raymond  Carroll
(Texas A&M University)


Show all 79","Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)



Mark H Greene; MD (Clinical Genetics Branch)



Joseph  Fraumeni; MD (Office of the Director)



Ruth Anne Kleinerman; MPH (Radiation Epidemiology Branch)



Debra  Silverman; ScD, ScM (Occupational and Environmental Epidemiology Branch)



Elaine  Ron; PhD (Radiation Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Brock KE, Gridley G, Brown LM, Yu MC, Schoenberg JB, Lynch CF, McLaughlin JK (2006). Dietary factors and cancers of the renal pelvis and ureter. Cancer Epidemiol Biomarkers Prev  15, 1051-3.   https://doi.org/10.1158/1055-9965.EPI-06-0056




PubMed


 


PubMed ID 16702394
    
     


 



2.
Gail MH, You WC (2006). A factorial trial including garlic supplements assesses effect in reducing precancerous gastric lesions. J Nutr  136, 813S-815S.   https://doi.org/10.1093/jn/136.3.813S




PubMed


 


PubMed ID 16484571
    
     


 



3.
You WC, Brown LM, Zhang L, Li JY, Jin ML, Chang YS, Ma JL, Pan KF, Liu WD, Hu Y, Crystal-Mansour S, Pee D, Blot WJ, Fraumeni JF, Xu GW, Gail MH (2006). Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst  98, 974-83.   https://doi.org/10.1093/jnci/djj264




PubMed


 


PubMed ID 16849680",https://intramural.nih.gov/search/searchview.taf?ipid=44024
496,CP010183-04,"October 01, 2005 -  September 30, 2006",Descriptive Studies and Record Linkage,Susan Shaw Devesa,NULL,"Biostatistics Branch, NCI","Gloria L Gridley



Linda M Brown; MPH, DPhil



Mitchell Henry Gail; PhD, MD



Catherine G Schairer



Ruth  Pfeiffer; PhD



Jay  Lubin; PhD



Show all 12","Hans-Olov  Adami
(Karolinska Institute)




Johanna  Adami
(Karolinska Institute)




Johan  Askling
(Karolinska Institute)




Alicja  Bardin-Mikolajczak
(Dept. of Cancer Epi & Preven. Warsaw)




Paolo  Boffetta
(International Agency for Research on Cancer)




Paige  Bracci
(UCSF)


Show all 74","Mustafa  Dosemeci; PhD (Occupational and Environmental Epidemiology Branch)



Joseph  Fraumeni; MD (Office of the Director)



Ann  Hsing; PhD (Hormonal and Reproductive Epidemiology Branch)



Martha S Linet; PhD (Radiation Epidemiology Branch)



Debra  Silverman; ScD, ScM (Occupational and Environmental Epidemiology Branch)



Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)",NULL,"Ordered by publication type and then author name.



1.
Anderson WF, Devesa SS (2005). In situ male breast carcinoma in the Surveillance, Epidemiology, and End Results database of the National Cancer Institute. Cancer  104, 1733-41.   https://doi.org/10.1002/cncr.21353




PubMed


 


PubMed ID 16138363
    
     


 



2.
Edgren G, Hjalgrim H, Tran TN, Rostgaard K, Shanwell A, Titlestad K, Jakobsson L, Gridley G, Wideroff L, Jersild C, Adami J, Melbye M, Reilly M, Nyrén O (2006). A population-based binational register for monitoring long-term outcome and possible disease concordance among blood donors and recipients. Vox Sang  91, 316-23.   https://doi.org/10.1111/j.1423-0410.2006.00827.x




PubMed


 


PubMed ID 17105607
    
     


 



3.
Lubin JH, Caporaso NE (2006). Cigarette smoking and lung cancer: modeling total exposure and intensity. Cancer Epidemiol Biomarkers Prev  15, 517-23.   https://doi.org/10.1158/1055-9965.EPI-05-0863




PubMed


 


PubMed ID 16537710
    
     


 



4.
Moslehi R, Devesa SS, Schairer C, Fraumeni JF (2006). Rapidly increasing incidence of ocular non-hodgkin lymphoma. J Natl Cancer Inst  98, 936-9.   https://doi.org/10.1093/jnci/djj248




PubMed


 


PubMed ID 16818858",https://intramural.nih.gov/search/searchview.taf?ipid=43973
497,CP010184-04,"October 01, 2005 -  September 30, 2006",Consultation and Collaboration,Jay  Lubin; PhD,NULL,"Biostatistics Branch, NCI","Linda M Brown; MPH, DPhil



Nilanjan  Chatterjee



Mitchell Henry Gail; PhD, MD



Barry Ira Graubard; PhD



Gloria L Gridley



Junmo  Nam



Show all 8","Paul M.  Bakaki
(Makerere University Medical School and Mulago Hospital, Kampala, Uganda)




A.  Barrett
(National Heart, Lung, and Blood Institute)




Eleuterio  Bravo-Otero
(University of Puerto Rico)




David  Brenner
(Columbia University)




Robert  Burk
(Albert Einstein College of Medicine)




Julianne  Byrne
(Washington Children's hospital)


Show all 82","Michael  Alavanja; PhD (Occupational and Environmental Epidemiology Branch)



Aaron E Blair; PhD, MPH (Occupational and Environmental Epidemiology Branch)



Robert  Biggar; MD (Infection & Immunoepidemiology Branch)



Philip E Castle; PhD, MPH (Hormonal and Reproductive Epidemiology Branch)



Wong H Chow (Occupational and Environmental Epidemiology Branch)



Joseph B Coble (Occupational and Environmental Epidemiology Branch)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44026
498,CP010185-04,"October 01, 2005 -  September 30, 2006",Bioterrorism Studies,"Martha S Linet; PhD



IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI","Maureen Cusack Hatch; MD



Nickolas  Luckyanov



Elaine  Ron; PhD



Charles E. Land; PhD



Steven L Simon



Andre  Bouville



Show all 7","Harold  Beck
(DOE Environmental Measurements Laboratory (retired))




Victor  Kryuchkov
(Institute of Biophysics)




Dunstana Rabelo Melo





Brian  Moroz





Sergey  Shinkarev
(Moscow Institute of Biophysics)




Sergey  Sholom
(URPI)


Show all 8",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44025
499,CP010186-02,"October 01, 2005 -  September 30, 2006",Radiation-Induced Stomach Cancer,Lois B Travis; PhD,NULL,"Radiation Epidemiology Branch, NCI","Rochelle E Curtis



Ethel S Gilbert



Kiyohiko  Mabuchi; MD, DPhil



Regan A Howard","James  Allan
(University of Leeds)




Aage  Andersen
(Norwegian Cancer Registry)




Sophie  Fossa





Eric  Hall
(Columbia University, New York, NY)




Eric  Holowaty
(Cancer Care Ontario)




Charles  Lynch
(University of Iowa)


Show all 10","Linda M Brown; MPH, DPhil (Biostatistics Branch)



Mary Louise McMaster; MD (Genetic Epidemiology Branch)



Catherine G Schairer (Biostatistics Branch)



Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)



Ruth  Pfeiffer; PhD (Biostatistics Branch)



Anil Kumar Chaturvedi (Infection & Immunoepidemiology Branch)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=44035
500,CP010187-02,"October 01, 2005 -  September 30, 2006",CGEMS,"Robert  Hoover; MD, ScD



IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44037
501,CP010188-02,"October 01, 2005 -  September 30, 2006",Risk prediction methods,"Mitchell Henry Gail; PhD, MD



IRP Faculty Profile",NULL,"Biostatistics Branch, NCI",Catherine G Schairer,NULL,"Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)



Lois B Travis; PhD (Radiation Epidemiology Branch)



Demetrius  Albanes; MD (Office of the Director)



Andrew  Freedman (Risk Factor Monitoring and Methods Branch)



Kathleen A Cronin (Statistical Research and Applications Branch)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44029
502,CP010190-01,"October 01, 2005 -  September 30, 2006",Genetic Epidemiology of Telomere Maintenance,"Sharon Ann Savage



IRP Faculty Profile",NULL,"Clinical Genetics Branch, NCI",NULL,"Richard  Cawthon
(University of Utah)




Immaculata  DeVivo
(Harvard Medical School)




David  Hunter
(Harvard)",NULL,NULL,"Ordered by publication type and then author name.



1.
Savage SA, Stewart BJ, Weksler BB, Baerlocher GM, Lansdorp PM, Chanock SJ, Alter BP (2006). Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure. Blood Cells Mol Dis  37, 134-6.   https://doi.org/10.1016/j.bcmd.2006.07.001




PubMed


 


PubMed ID 16934504",https://intramural.nih.gov/search/searchview.taf?ipid=44593
503,SC000164-15,"October 01, 2005 -  September 30, 2006",The Molecular Mechanisms of Oncogene Action,Michael  Birrer,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Aaron B Bell



Howard  Donninger



Virna D Leaner",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Leaner VD, Donninger H, Ellis CA, Clark GJ, Birrer MJ (2005). p75-Ras-GRF1 is a c-Jun/AP-1 target protein: its up regulation results in increased Ras activity and is necessary for c-Jun-induced nonadherent growth of Rat1a cells. Mol Cell Biol  25, 3324-37.   https://doi.org/10.1128/MCB.25.8.3324-3337.2005




PubMed



        
     
Free Article


 


PubMed ID 15798216
         Pubmed Central ID 1069594",https://intramural.nih.gov/search/searchview.taf?ipid=44055
504,SC000165-15,"October 01, 2005 -  September 30, 2006",The Use of Transcriptional Factors as Targets and Agents in Carcinogenesis,Michael  Birrer,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Leaner VD, Donninger H, Ellis CA, Clark GJ, Birrer MJ (2005). p75-Ras-GRF1 is a c-Jun/AP-1 target protein: its up regulation results in increased Ras activity and is necessary for c-Jun-induced nonadherent growth of Rat1a cells. Mol Cell Biol  25, 3324-37.   https://doi.org/10.1128/MCB.25.8.3324-3337.2005




PubMed



        
     
Free Article


 


PubMed ID 15798216
         Pubmed Central ID 1069594",https://intramural.nih.gov/search/searchview.taf?ipid=44056
505,SC000167-15,"October 01, 2005 -  September 30, 2006",Molecular Pathology of Pulmonary Carcinogenesis,Ilona  Linnoila; MD,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Xiaoyang  Wang



Sandra  Jensen-Taubman



Heungnam  Kim



Kemi  Tomobi



Shobana  Gopalswamy",NULL,"Phillip A Dennis; MD, PhD (National Cancer Institute)



Jin  Jen (National Cancer Institute)



Jeffrey E Green; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Hollander MC, Philburn RT, Patterson AD, Velasco-Miguel S, Friedberg EC, Linnoila RI, Fornace AJ (2005). Deletion of XPC leads to lung tumors in mice and is associated with early events in human lung carcinogenesis. Proc Natl Acad Sci U S A  102, 13200-5.   https://doi.org/10.1073/pnas.0503133102




PubMed



        
     
Free Article


 


PubMed ID 16141330
         Pubmed Central ID 1201581 


 



2.
Linnoila I, DeMartini J, Malkinson A, Onn A, Politi K, Sharp M, Wong K, Pao W   (2006) Consensus on the epidemiology, preclinical models and pathogenesis of bronchioloalveolar carcinoma.  J. Thoracic Oncology, in press.




 



3.
Linnoila RI   (2006) Functional facets of the pulmonary neuroendocrine system.  Lab Invest 86:425-44.




PubMed


 


PubMed ID 16568108",https://intramural.nih.gov/search/searchview.taf?ipid=44058
506,SC000181-14,"October 01, 2005 -  September 30, 2006",The Molecular Genetics of Gynecologic Cancers,Michael  Birrer,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",NULL,"Denise  Connelly
(Ovarian SPORE, FOX Chase Cancer Center)




Samuel  Mok
(Gynecologic Oncology, Harvard University)




Anil  Sood
(Gynecologic Oncology, MDACC)",NULL,NULL,"Ordered by publication type and then author name.



1.
Birrer MJ (2006). Ovarian cancer: not a borderline issue! Cancer Biol Ther  5, 786-7.   https://doi.org/10.4161/cbt.5.7.3022




PubMed


 


PubMed ID 16921259
    
     


 



2.
Bonome T, Lee JY, Park DC, Radonovich M, Pise-Masison C, Brady J, Gardner GJ, Hao K, Wong WH, Barrett JC, Lu KH, Sood AK, Gershenson DM, Mok SC, Birrer MJ (2005). Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary. Cancer Res  65, 10602-12.   https://doi.org/10.1158/0008-5472.CAN-05-2240




PubMed


 


PubMed ID 16288054
    
     


 



3.
DiFeo A, Narla G, Hirshfeld J, Camacho-Vanegas O, Narla J, Rose SL, Kalir T, Yao S, Levine A, Birrer MJ, Bonome T, Friedman SL, Buller RE, Martignetti JA (2006). Roles of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination. Clin Cancer Res  12, 3730-9.   https://doi.org/10.1158/1078-0432.CCR-06-0054




PubMed


 


PubMed ID 16778100
    
     


 



4.
Jazaeri AA, Awtrey CS, Chandramouli GV, Chuang YE, Khan J, Sotiriou C, Aprelikova O, Yee CJ, Zorn KK, Birrer MJ, Barrett JC, Boyd J (2005). Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers. Clin Cancer Res  11, 6300-10.   https://doi.org/10.1158/1078-0432.CCR-04-2682




PubMed


 


PubMed ID 16144934
    
     


 



5.
Sunde JS, Donninger H, Wu K, Johnson ME, Pestell RG, Rose GS, Mok SC, Brady J, Bonome T, Birrer MJ (2006). Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer. Cancer Res  66, 8404-12.   https://doi.org/10.1158/0008-5472.CAN-06-0683




PubMed


 


PubMed ID 16951150
    
     


 



6.
Wamunyokoli FW, Bonome T, Lee JY, Feltmate CM, Welch WR, Radonovich M, Pise-Masison C, Brady J, Hao K, Berkowitz RS, Mok S, Birrer MJ (2006). Expression profiling of mucinous tumors of the ovary identifies genes of clinicopathologic importance. Clin Cancer Res  12, 690-700.   https://doi.org/10.1158/1078-0432.CCR-05-1110




PubMed


 


PubMed ID 16467078
    
     


 



7.
Zorn KK, Bonome T, Gangi L, Chandramouli GV, Awtrey CS, Gardner GJ, Barrett JC, Boyd J, Birrer MJ (2005). Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer. Clin Cancer Res  11, 6422-30.   https://doi.org/10.1158/1078-0432.CCR-05-0508




PubMed


 


PubMed ID 16166416",https://intramural.nih.gov/search/searchview.taf?ipid=44060
507,SC000550-26,"October 01, 2005 -  September 30, 2006",Lymphoma Disease Discovery and Defintion,"Elaine S Jaffe; MD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Mark  Raffeld; MD



Stefania  Pittaluga



Andrew L Feldman; MD



Wayne W Chen","Wing  Chan
(Pathology, University of Nebraska)




Andreas  Chott
(Pathology, University of Vienna)




Larry  Kwak
(NCI)




Leticia  Quintanilla-Martinez
(Pathology, Technical University of Munich)




Rein  Willemze
(Dermatology, Leiden University)","Robert  Biggar; MD (National Cancer Institute)



Louis  Staudt; MD (Lymphoid Malignancies Branch)



Susan H Garfield (National Cancer Institute)



Wyndham H Wilson; MD, PhD (National Cancer Institute)","Stephen E Straus; MD (NIAID) 



Stephen  Wincovitch (NHGRI)","Ordered by publication type and then author name.



1.
Ahmad E, Kingma DW, Jaffe ES, Schrager JA, Janik J, Wilson W, Stetler-Stevenson M (2005). Flow cytometric immunophenotypic profiles of mature gamma delta T-cell malignancies involving peripheral blood and bone marrow. Cytometry B Clin Cytom  67, 6-12.   https://doi.org/10.1002/cyto.b.20063




PubMed


 


PubMed ID 15973700
    
     


 



2.
Bea S, Zettl A, Wright G, Salaverria I, Jehn P, Moreno V, Burek C, Ott G, Puig X, Yang L, Lopez-Guillermo A, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Gascoyne RD, Connors JM, Grogan TM, Braziel R, Fisher RI, Smeland EB, Kvaloy S, Holte H, Delabie J, Simon R, Lymphoma/Leukemia Molecular Profiling Project, et al. [8 more authors] (2005). Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. Blood  106, 3183-90.   https://doi.org/10.1182/blood-2005-04-1399




PubMed



        
     
Free Article


 


PubMed ID 16046532
         Pubmed Central ID 1895326 


 



3.
Biggar RJ, Jaffe ES, Goedert JJ, Chaturvedi A, Pfeiffer R, Engels EA (2006). Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood  108, 3786-91.   https://doi.org/10.1182/blood-2006-05-024109




PubMed



        
     
Free Article


 


PubMed ID 16917006
         Pubmed Central ID 1895473 


 



4.
Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma EJ, Greiner TC, Weisenburger DD, Rosenwald A, Ott G, Müller-Hermelink HK, Gascoyne RD, Delabie J, Rimsza LM, Braziel RM, Grogan TM, Campo E, Jaffe ES, Dave BJ, Sanger W, Bast M, Vose JM, Armitage JO, Connors JM, Smeland EB, Lymphoma/Leukemia Molecular Profiling Project, et al. [13 more authors] (2006). Molecular diagnosis of Burkitt's lymphoma. N Engl J Med  354, 2431-42.   https://doi.org/10.1056/NEJMoa055759




PubMed


 


PubMed ID 16760443
    
     


 



5.
Fountaine TJ, Wincovitch SM, Geho DH, Garfield SH, Pittaluga S   (2006) Multispectral imaging of clinically relevant cellular targets in tonsil and lymphoid tissue using semiconductor quantum dots.  Mod Pathol 19:1181-91.




PubMed


 


PubMed ID 16778828
    
     


 



6.
Greiner TC, Dasgupta C, Ho VV, Weisenburger DD, Smith LM, Lynch JC, Vose JM, Fu K, Armitage JO, Braziel RM, Campo E, Delabie J, Gascoyne RD, Jaffe ES, Muller-Hermelink HK, Ott G, Rosenwald A, Staudt LM, Im MY, Karaman MW, Pike BL, Chan WC, Hacia JG (2006). Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma. Proc Natl Acad Sci U S A  103, 2352-7.   https://doi.org/10.1073/pnas.0510441103




PubMed



        
     
Free Article


 


PubMed ID 16461462
         Pubmed Central ID 1413716 


 



7.
Iqbal J, Neppalli VT, Wright G, Dave BJ, Horsman DE, Rosenwald A, Lynch J, Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Campo E, Ott G, Müller-Hermelink HK, Delabie J, Jaffe ES, Grogan TM, Connors JM, Vose JM, Armitage JO, Staudt LM, Chan WC (2006). BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma. J Clin Oncol  24, 961-8.   https://doi.org/10.1200/JCO.2005.03.4264




PubMed


 


PubMed ID 16418494
    
     


 



8.
Kobrin C, Cha SC, Qin H, Raffeld M, Fend F, Quintanilla-Martinez L, Grove S, Jaffe ES, Kwak LW (2006). Molecular analysis of light-chain switch and acute lymphoblastic leukemia transformation in two follicular lymphomas: implications for lymphomagenesis. Leuk Lymphoma  47, 1523-34.   https://doi.org/10.1080/10428190600612909




PubMed


 


PubMed ID 16966263
    
     


 



9.
Neelapu SS, Gause BL, Nikcevich DA, Schuster SJ, Winter J, Gockerman JP, Loughran T, Takeshita K, Inghirami G, McGaughey D, Watson TM, Snow S, Kubovic P, Ferraro M, Jones E, Jaffe ES, Schwartzentruber DJ, Danforth D, Sherry R, Kass E, Van Waes C, Reynolds CW, Kwak LJ (2005). Phase III randomized trial of patient-specific vaccination for previously untreated patients with follicular lymphoma in first complete remission: protocol summary and interim report. Clin Lymphoma  6, 61-4.   https://doi.org/10.3816/clm.2005.n.031




PubMed


 


PubMed ID 15989711
    
     


 



10.
Neelapu SS, Kwak LW, Kobrin CB, Reynolds CW, Janik JE, Dunleavy K, White T, Harvey L, Pennington R, Stetler-Stevenson M, Jaffe ES, Steinberg SM, Gress R, Hakim F, Wilson WH (2005). Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma. Nat Med  11, 986-91.   https://doi.org/10.1038/nm1290




PubMed


 


PubMed ID 16116429
    
     


 



11.
Prakash S, Fountaine T, Raffeld M, Jaffe ES, Pittaluga S (2006). IgD positive L&H cells identify a unique subset of nodular lymphocyte predominant Hodgkin lymphoma. Am J Surg Pathol  30, 585-92.   https://doi.org/10.1097/01.pas.0000194741.87798.45




PubMed


 


PubMed ID 16699312
    
     


 



12.
Quintanilla-Martinez L, Pittaluga S, Miething C, Klier M, Rudelius M, Davies-Hill T, Anastasov N, Martinez A, Vivero A, Duyster J, Jaffe ES, Fend F, Raffeld M (2006). NPM-ALK-dependent expression of the transcription factor CCAAT/enhancer binding protein beta in ALK-positive anaplastic large cell lymphoma. Blood  108, 2029-36.   https://doi.org/10.1182/blood-2005-10-014258




PubMed


 


PubMed ID 16709933
    
     


 



13.
Rao VK, Carrasquillo JA, Dale JK, Bacharach SL, Whatley M, Dugan F, Tretler J, Fleisher T, Puck JM, Wilson W, Jaffe ES, Avila N, Chen CC, Straus SE (2006). Fluorodeoxyglucose positron emission tomography (FDG-PET) for monitoring lymphadenopathy in the autoimmune lymphoproliferative syndrome (ALPS). Am J Hematol  81, 81-5.   https://doi.org/10.1002/ajh.20523




PubMed


 


PubMed ID 16432855
    
     


 



14.
Rimsza LM, Roberts RA, Campo E, Grogan TM, Bea S, Salaverria I, Zettl A, Rosenwald A, Ott G, Muller-Hermelink HK, Delabie J, Fisher RI, Unger JM, Leblanc M, Staudt LM, Jaffe ES, Gascoyne RD, Chan WC, Weisenburger DD, Greiner T, Braziel RM, Miller TP (2006). Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions. Blood  107, 1101-7.   https://doi.org/10.1182/blood-2005-04-1510




PubMed



        
     
Free Article


 


PubMed ID 16239429
         Pubmed Central ID 1895908 


 



15.
Rudelius M, Pittaluga S, Nishizuka S, Pham TH, Fend F, Jaffe ES, Quintanilla-Martinez L, Raffeld M (2006). Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma. Blood  108, 1668-76.   https://doi.org/10.1182/blood-2006-04-015586




PubMed



        
     
Free Article


 


PubMed ID 16645163
         Pubmed Central ID 1895501 


 



16.
Valiathan M, Rao RV, Rao L, Jaffe ES, Pillai S (2005). Nasal NK/T cell lymphoma mimicking a squamous cell carcinoma: a case report. Indian J Pathol Microbiol  48, 257-9.




PubMed


 


PubMed ID 16758689
    
     


 



17.
Vega F, Chang CC, Schwartz MR, Preti HA, Younes M, Ewton A, Verm R, Jaffe ES (2006). Atypical NK-cell proliferation of the gastrointestinal tract in a patient with antigliadin antibodies but not celiac disease. Am J Surg Pathol  30, 539-44.   https://doi.org/10.1097/00000478-200604000-00017




PubMed


 


PubMed ID 16625103",https://intramural.nih.gov/search/searchview.taf?ipid=44062
508,SC000853-53,"October 01, 2005 -  September 30, 2006",Surgical Pathology,"Maria  Merino; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Bakalov VK, Anasti JN, Calis KA, Vanderhoof VH, Premkumar A, Chen S, Furmaniak J, Smith BR, Merino MJ, Nelson LM (2005). Autoimmune oophoritis as a mechanism of follicular dysfunction in women with 46,XX spontaneous premature ovarian failure. Fertil Steril  84, 958-65.   https://doi.org/10.1016/j.fertnstert.2005.04.060




PubMed


 


PubMed ID 16213850
    
     


 



2.
Castillo M, Sanjuán A, Pérez N, Zanón G, Bons N, Vilanova M, Vanrell JA, Merino MJ, Fernández PL (2006). Fibrous Histiocytoma-like Spindle-Cell Proliferation in the Nipple After Body-Piercing. Int J Surg Pathol  14, 89-93.




PubMed


 


PubMed ID 16501844
    
     


 



3.
Paláu MA, Merino MJ, Quezado M (2006). Corticotropin-producing pulmonary gangliocytic paraganglioma associated with Cushings syndrome. Hum Pathol  37, 623-6.   https://doi.org/10.1016/j.humpath.2005.12.006




PubMed


 


PubMed ID 16647961",https://intramural.nih.gov/search/searchview.taf?ipid=44063
509,SC000892-23,"October 01, 2005 -  September 30, 2006",Molecular Biology of the Metastatic Phenotype,"Patricia  Steeg; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI","Douglas O Halverson



Christine E Horak



Diane  Palmieri



Jong Heun Lee","Jean-Yves  Daniel
(Biologie de Differentiation et Development, Universite Victor Segalen)




Marie-Lise  Lacombe
(Faculte de Medicine Saint Antoine, Iniversite Pierre et Marie Curie)




Kathy  Miller
(Oncology, Indiana University)","Donald P Bottaro; PhD (National Cancer Institute)



Maria  Merino; PhD (National Cancer Institute)



David A Berrigan (National Cancer Institute)



William D Figg; PharmD (National Cancer Institute)



Melinda  Hollingshead (National Cancer Institute)



Seth M Steinberg; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Athauda G, Giubellino A, Coleman JA, Horak C, Steeg PS, Lee MJ, Trepel J, Wimberly J, Sun J, Coxon A, Burgess TL, Bottaro DP (2006). c-Met ectodomain shedding rate correlates with malignant potential. Clin Cancer Res  12, 4154-62.   https://doi.org/10.1158/1078-0432.CCR-06-0250




PubMed


 


PubMed ID 16857786
    
     


 



2.
Palmieri D, Horak CE, Lee JH, Halverson DO, Steeg PS (2006). Translational approaches using metastasis suppressor genes. J Bioenerg Biomembr  38, 151-61.   https://doi.org/10.1007/s10863-006-9039-9




PubMed


 


PubMed ID 16944301
    
     


 



3.
Steeg PS (2005). Cancer biology: emissaries set up new sites. Nature  438, 750-1.   https://doi.org/10.1038/438750b




PubMed


 


PubMed ID 16341000
    
     


 



4.
Steeg PS (2006). Tumor metastasis: mechanistic insights and clinical challenges. Nat Med  12, 895-904.   https://doi.org/10.1038/nm1469




PubMed


 


PubMed ID 16892035",https://intramural.nih.gov/search/searchview.taf?ipid=44065
510,SC003657-32,"October 01, 2005 -  September 30, 2006",Immunopathologic Mechanisms Involved in Inflammatory Skin Diseases,"Stephen I Katz; PhD, MD",NULL,"Dermatology Branch, NCI","Jay T Linton



Fumi  Miyagawa



Kristine  Nograles



Young-Hun  Cho



Emily Anne Nelson",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44066
511,SC003669-17,"October 01, 2005 -  September 30, 2006",Regulation of Cutaneous Accessory Cell Activity in Health and Disease,Mark  Udey; MD,NULL,"Dermatology Branch, NCI","Xu  Feng; PhD



Melanie  Neutzner



Wolfgang W Leitner; MS, PhD



Miklos  Sardy



Keisuke  Nagao



Michael C Lu","Erika  Crouch
(Pathology, Washington University School of Medicine)




Esther  von Stebut
(Dermatology, University of Mainz)","Jonathan  Vogel; MD (National Cancer Institute)



Sam  Hwang; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Kostka SL, Knop J, Konur A, Udey MC, von Stebut E (2006). Distinct roles for IL-1 receptor type I signaling in early versus established Leishmania major infections. J Invest Dermatol  126, 1582-9.   https://doi.org/10.1038/sj.jid.5700309




PubMed


 


PubMed ID 16645594
    
     


 



2.
Ohyama M, Terunuma A, Tock CL, Radonovich MF, Pise-Masison CA, Hopping SB, Brady JN, Udey MC, Vogel JC (2006). Characterization and isolation of stem cell-enriched human hair follicle bulge cells. J Clin Invest  116, 249-60.   https://doi.org/10.1172/JCI26043




PubMed



        
     
Free Article


 


PubMed ID 16395407
         Pubmed Central ID 1323261 


 



3.
Tada Y, Riedl E, Lowenthal MS, Liotta LA, Briner DM, Crouch EC, Udey MC (2006). Identification and characterization of endogenous Langerin ligands in murine extracellular matrix. J Invest Dermatol  126, 1549-58.   https://doi.org/10.1038/sj.jid.5700283




PubMed


 


PubMed ID 16557233
    
     


 



4.
Udey MC (2006). Langerhans cells on guard in the epidermis: poised to dSEARCH and ..? J Invest Dermatol  126, 705-7.   https://doi.org/10.1038/sj.jid.5700222




PubMed


 


PubMed ID 16541095
    
     


 



5.
Woelbing F, Kostka SL, Moelle K, Belkaid Y, Sunderkoetter C, Verbeek S, Waisman A, Nigg AP, Knop J, Udey MC, von Stebut E (2006). Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity. J Exp Med  203, 177-88.   https://doi.org/10.1084/jem.20052288




PubMed



        
     
Free Article


 


PubMed ID 16418399
         Pubmed Central ID 2118064",https://intramural.nih.gov/search/searchview.taf?ipid=44067
512,SC003670-14,"October 01, 2005 -  September 30, 2006",Keratinocyte Gene Therapy,Jonathan  Vogel; MD,NULL,"Dermatology Branch, NCI","Carole L Yee



Atsushi  Terunuma



Jean-Philippe  Therrien",NULL,NULL,Jurgen B Schnermann; MD (NIDDK),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44068
513,SC003800-36,"October 01, 2005 -  September 30, 2006",Surgical Consultants & Collaborative Research Involving Surgical Services at NIH,"Steven Aaron Rosenberg; MD, PhD



IRP Faculty Profile",NULL,"Surgery Branch, NCI","Steven  Libutti; MD



David  Danforth



David  Schrump; MD



James Chung-Yin Yang; MD, PhD



Mary Elizabeth Hughes; PhD



Richard  Sherry; MD



Show all 9",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Ahmadzadeh M, Rosenberg SA (2006). IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients. Blood  107, 2409-14.   https://doi.org/10.1182/blood-2005-06-2399




PubMed



        
     
Free Article


 


PubMed ID 16304057
         Pubmed Central ID 1473973 


 



2.
Aisner DL, Maker A, Rosenberg SA, Berman DM (2005). Loss of S100 antigenicity in metastatic melanoma. Hum Pathol  36, 1016-9.   https://doi.org/10.1016/j.humpath.2005.07.010




PubMed



        
     
Free Article


 


PubMed ID 16153466
         Pubmed Central ID 2656365 


 



3.
Beck KE, Blansfield JA, Tran KQ, Feldman AL, Hughes MS, Royal RE, Kammula US, Topalian SL, Sherry RM, Kleiner D, Quezado M, Lowy I, Yellin M, Rosenberg SA, Yang JC (2006). Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4. J Clin Oncol  24, 2283-9.   https://doi.org/10.1200/JCO.2005.04.5716




PubMed



        
     
Free Article


 


PubMed ID 16710025
         Pubmed Central ID 2140223 


 



4.
Cohen CJ, Zhao Y, Zheng Z, Rosenberg SA, Morgan RA (2006). Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability. Cancer Res  66, 8878-86.   https://doi.org/10.1158/0008-5472.CAN-06-1450




PubMed



        
     
Free Article


 


PubMed ID 16951205
         Pubmed Central ID 2147082 


 



5.
Cohen CJ, Zheng Z, Bray R, Zhao Y, Sherman LA, Rosenberg SA, Morgan RA (2005). Recognition of fresh human tumor by human peripheral blood lymphocytes transduced with a bicistronic retroviral vector encoding a murine anti-p53 TCR. J Immunol  175, 5799-808.   https://doi.org/10.4049/jimmunol.175.9.5799




PubMed



        
     
Free Article


 


PubMed ID 16237072
         Pubmed Central ID 1473968 


 



6.
Gattinoni L, Finkelstein SE, Klebanoff CA, Antony PA, Palmer DC, Spiess PJ, Hwang LN, Yu Z, Wrzesinski C, Heimann DM, Surh CD, Rosenberg SA, Restifo NP (2005). Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells. J Exp Med  202, 907-12.   https://doi.org/10.1084/jem.20050732




PubMed



        
     
Free Article


 


PubMed ID 16203864
         Pubmed Central ID 1397916 


 



7.
Gattinoni L, Powell DJ, Rosenberg SA, Restifo NP (2006). Adoptive immunotherapy for cancer: building on success. Nat Rev Immunol  6, 383-93.   https://doi.org/10.1038/nri1842




PubMed



        
     
Free Article


 


PubMed ID 16622476
         Pubmed Central ID 1473162 


 



8.
Gattinoni L, Ranganathan A, Surman DR, Palmer DC, Antony PA, Theoret MR, Heimann DM, Rosenberg SA, Restifo NP (2006). CTLA-4 dysregulation of self/tumor-reactive CD8+ T-cell function is CD4+ T-cell dependent. Blood  108, 3818-23.   https://doi.org/10.1182/blood-2006-07-034066




PubMed



        
     
Free Article


 


PubMed ID 16882704
         Pubmed Central ID 1679662 


 



9.
Huang J, Kerstann KW, Ahmadzadeh M, Li YF, El-Gamil M, Rosenberg SA, Robbins PF (2006). Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: importance for the therapeutic effectiveness of cell transfer immunotherapy. J Immunol  176, 7726-35.   https://doi.org/10.4049/jimmunol.176.12.7726




PubMed



        
     
Free Article


 


PubMed ID 16751420
         Pubmed Central ID 1532931 


 



10.
Jaber SH, Cowen EW, Haworth LR, Booher SL, Berman DM, Rosenberg SA, Hwang ST (2006). Skin reactions in a subset of patients with stage IV melanoma treated with anti-cytotoxic T-lymphocyte antigen 4 monoclonal antibody as a single agent. Arch Dermatol  142, 166-72.   https://doi.org/10.1001/archderm.142.2.166




PubMed


 


PubMed ID 16490844
    
     


 



11.
Klebanoff CA, Gattinoni L, Torabi-Parizi P, Kerstann K, Cardones AR, Finkelstein SE, Palmer DC, Antony PA, Hwang ST, Rosenberg SA, Waldmann TA, Restifo NP (2005). Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. Proc Natl Acad Sci U S A  102, 9571-6.   https://doi.org/10.1073/pnas.0503726102




PubMed



        
     
Free Article


 


PubMed ID 15980149
         Pubmed Central ID 1172264 


 



12.
Lindsey KR, Gritz L, Sherry R, Abati A, Fetsch PA, Goldfeder LC, Gonzales MI, Zinnack KA, Rogers-Freezer L, Haworth L, Mavroukakis SA, White DE, Steinberg SM, Restifo NP, Panicali DL, Rosenberg SA, Topalian SL (2006). Evaluation of prime/boost regimens using recombinant poxvirus/tyrosinase vaccines for the treatment of patients with metastatic melanoma. Clin Cancer Res  12, 2526-37.   https://doi.org/10.1158/1078-0432.CCR-05-2061




PubMed



        
     
Free Article


 


PubMed ID 16638862
         Pubmed Central ID 2151202 


 



13.
Maker AV, Attia P, Rosenberg SA (2005). Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade. J Immunol  175, 7746-54.   https://doi.org/10.4049/jimmunol.175.11.7746




PubMed



        
     
Free Article


 


PubMed ID 16301685
         Pubmed Central ID 1473972 


 



14.
Maker AV, Phan GQ, Attia P, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Haworth LR, Levy C, Kleiner D, Mavroukakis SA, Yellin M, Rosenberg SA (2005). Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study. Ann Surg Oncol  12, 1005-16.   https://doi.org/10.1245/ASO.2005.03.536




PubMed



        
     
Free Article


 


PubMed ID 16283570
         Pubmed Central ID 1473970 


 



15.
Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, Sherry RM, Royal RE, Topalian SL, Kammula US, Restifo NP, Zheng Z, Nahvi A, de Vries CR, Rogers-Freezer LJ, Mavroukakis SA, Rosenberg SA (2006). Cancer regression in patients after transfer of genetically engineered lymphocytes. Science  314, 126-9.   https://doi.org/10.1126/science.1129003




PubMed



        
     
Free Article


 


PubMed ID 16946036
         Pubmed Central ID 2267026 


 



16.
Powell DJ, Dudley ME, Robbins PF, Rosenberg SA (2005). Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy. Blood  105, 241-50.   https://doi.org/10.1182/blood-2004-06-2482




PubMed



        
     
Free Article


 


PubMed ID 15345595
         Pubmed Central ID 2553211 


 



17.
Restifo NP, Rosenberg SA (2005). Use of standard criteria for assessment of cancer vaccines. Lancet Oncol  6, 3-4.   https://doi.org/10.1016/S1470-2045(04)01693-6




PubMed



        
     
Free Article


 


PubMed ID 15629270
         Pubmed Central ID 1484507 


 



18.
Romeo MJ, Wunderlich J, Ngo L, Rosenberg SA, Steinberg SM, Berman DM (2006). Measuring tissue-based biomarkers by immunochromatography coupled with reverse-phase lysate microarray. Clin Cancer Res  12, 2463-7.   https://doi.org/10.1158/1078-0432.CCR-05-1479




PubMed



        
     
Free Article


 


PubMed ID 16638853
         Pubmed Central ID 2147079 


 



19.
Rosenberg SA (2005). Cancer immunotherapy comes of age. Nat Clin Pract Oncol  2, 115.   https://doi.org/10.1038/ncponc0101




PubMed



        
     
Free Article


 


PubMed ID 16264884
         Pubmed Central ID 2656369 


 



20.
Rosenberg SA (2005). Cell transfer and other immunotherapeutic strategies. Clin Adv Hematol Oncol  3, 28-9.




PubMed


 


PubMed ID 16166964
    
     


 



21.
Rosenberg SA, Sherry RM, Morton KE, Scharfman WJ, Yang JC, Topalian SL, Royal RE, Kammula U, Restifo NP, Hughes MS, Schwartzentruber D, Berman DM, Schwarz SL, Ngo LT, Mavroukakis SA, White DE, Steinberg SM (2005). Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma. J Immunol  175, 6169-76.   https://doi.org/10.4049/jimmunol.175.9.6169




PubMed


 


PubMed ID 16237114
    
     


 



22.
Zhao Y, Zheng Z, Robbins PF, Khong HT, Rosenberg SA, Morgan RA (2005). Primary human lymphocytes transduced with NY-ESO-1 antigen-specific TCR genes recognize and kill diverse human tumor cell lines. J Immunol  174, 4415-23.   https://doi.org/10.4049/jimmunol.174.7.4415




PubMed



        
     
Free Article


 


PubMed ID 15778407
         Pubmed Central ID 2174604 


 



23.
Zhou J, Shen X, Huang J, Hodes RJ, Rosenberg SA, Robbins PF (2005). Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy. J Immunol  175, 7046-52.   https://doi.org/10.4049/jimmunol.175.10.7046




PubMed



        
     
Free Article


 


PubMed ID 16272366
         Pubmed Central ID 1351312",https://intramural.nih.gov/search/searchview.taf?ipid=44069
514,SC003811-32,"October 01, 2005 -  September 30, 2006",The Immunotherapy of Animal and Human Cancer,"Steven Aaron Rosenberg; MD, PhD



IRP Faculty Profile",NULL,"Surgery Branch, NCI","Daniel J Powell



Mojgan  Ahmadzadeh



Keith William Kerstann



Bianca  Heemskerk



Marc R Theoret",NULL,"Richard  Sherry; MD (National Cancer Institute)



Marybeth S Hughes (National Cancer Institute)



Udai S Kammula (National Cancer Institute)



James Chung-Yin Yang; MD, PhD (National Cancer Institute)



Nicholas Phillip Restifo; MD (National Cancer Institute)



Richard Eldon Royal (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Ahmadzadeh M, Rosenberg SA (2006). IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients. Blood  107, 2409-14.   https://doi.org/10.1182/blood-2005-06-2399




PubMed



        
     
Free Article


 


PubMed ID 16304057
         Pubmed Central ID 1473973 


 



2.
Aisner DL, Maker A, Rosenberg SA, Berman DM (2005). Loss of S100 antigenicity in metastatic melanoma. Hum Pathol  36, 1016-9.   https://doi.org/10.1016/j.humpath.2005.07.010




PubMed



        
     
Free Article


 


PubMed ID 16153466
         Pubmed Central ID 2656365 


 



3.
Antony PA, Piccirillo CA, Akpinarli A, Finkelstein SE, Speiss PJ, Surman DR, Palmer DC, Chan CC, Klebanoff CA, Overwijk WW, Rosenberg SA, Restifo NP (2005). CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells. J Immunol  174, 2591-601.   https://doi.org/10.4049/jimmunol.174.5.2591




PubMed



        
     
Free Article


 


PubMed ID 15728465
         Pubmed Central ID 1403291 


 



4.
Beck KE, Blansfield JA, Tran KQ, Feldman AL, Hughes MS, Royal RE, Kammula US, Topalian SL, Sherry RM, Kleiner D, Quezado M, Lowy I, Yellin M, Rosenberg SA, Yang JC (2006). Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4. J Clin Oncol  24, 2283-9.   https://doi.org/10.1200/JCO.2005.04.5716




PubMed



        
     
Free Article


 


PubMed ID 16710025
         Pubmed Central ID 2140223 


 



5.
Blansfield JA, Beck KE, Tran K, Yang JC, Hughes MS, Kammula US, Royal RE, Topalian SL, Haworth LR, Levy C, Rosenberg SA, Sherry RM (2005). Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer. J Immunother  28, 593-8.   https://doi.org/10.1097/01.cji.0000178913.41256.06




PubMed



        
     
Free Article


 


PubMed ID 16224277
         Pubmed Central ID 2154350 


 



6.
Cohen CJ, Zhao Y, Zheng Z, Rosenberg SA, Morgan RA (2006). Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability. Cancer Res  66, 8878-86.   https://doi.org/10.1158/0008-5472.CAN-06-1450




PubMed



        
     
Free Article


 


PubMed ID 16951205
         Pubmed Central ID 2147082 


 



7.
Cohen CJ, Zheng Z, Bray R, Zhao Y, Sherman LA, Rosenberg SA, Morgan RA (2005). Recognition of fresh human tumor by human peripheral blood lymphocytes transduced with a bicistronic retroviral vector encoding a murine anti-p53 TCR. J Immunol  175, 5799-808.   https://doi.org/10.4049/jimmunol.175.9.5799




PubMed



        
     
Free Article


 


PubMed ID 16237072
         Pubmed Central ID 1473968 


 



8.
Downey SG, Klapper JA, Smith FO, Yang JC, Sherry RM, Royal RE, Kammula US, Hughes MS, Allen TE, Levy CL, Yellin M, Nichol G, White DE, Steinberg SM, Rosenberg SA (2007). Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade. Clin Cancer Res  13, 6681-8.   https://doi.org/10.1158/1078-0432.CCR-07-0187




PubMed



        
     
Free Article


 


PubMed ID 17982122
         Pubmed Central ID 2147083 


 



9.
Gattinoni L, Finkelstein SE, Klebanoff CA, Antony PA, Palmer DC, Spiess PJ, Hwang LN, Yu Z, Wrzesinski C, Heimann DM, Surh CD, Rosenberg SA, Restifo NP (2005). Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells. J Exp Med  202, 907-12.   https://doi.org/10.1084/jem.20050732




PubMed



        
     
Free Article


 


PubMed ID 16203864
         Pubmed Central ID 1397916 


 



10.
Gattinoni L, Powell DJ, Rosenberg SA, Restifo NP (2006). Adoptive immunotherapy for cancer: building on success. Nat Rev Immunol  6, 383-93.   https://doi.org/10.1038/nri1842




PubMed



        
     
Free Article


 


PubMed ID 16622476
         Pubmed Central ID 1473162 


 



11.
Gattinoni L, Ranganathan A, Surman DR, Palmer DC, Antony PA, Theoret MR, Heimann DM, Rosenberg SA, Restifo NP (2006). CTLA-4 dysregulation of self/tumor-reactive CD8+ T-cell function is CD4+ T-cell dependent. Blood  108, 3818-23.   https://doi.org/10.1182/blood-2006-07-034066




PubMed



        
     
Free Article


 


PubMed ID 16882704
         Pubmed Central ID 1679662 


 



12.
Grover A, Kim GJ, Lizée G, Tschoi M, Wang G, Wunderlich JR, Rosenberg SA, Hwang ST, Hwu P (2006). Intralymphatic dendritic cell vaccination induces tumor antigen-specific, skin-homing T lymphocytes. Clin Cancer Res  12, 5801-8.   https://doi.org/10.1158/1078-0432.CCR-05-2421




PubMed



        
     
Free Article


 


PubMed ID 17020987
         Pubmed Central ID 2174601 


 



13.
Huang J, Kerstann KW, Ahmadzadeh M, Li YF, El-Gamil M, Rosenberg SA, Robbins PF (2006). Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: importance for the therapeutic effectiveness of cell transfer immunotherapy. J Immunol  176, 7726-35.   https://doi.org/10.4049/jimmunol.176.12.7726




PubMed



        
     
Free Article


 


PubMed ID 16751420
         Pubmed Central ID 1532931 


 



14.
Jaber SH, Cowen EW, Haworth LR, Booher SL, Berman DM, Rosenberg SA, Hwang ST (2006). Skin reactions in a subset of patients with stage IV melanoma treated with anti-cytotoxic T-lymphocyte antigen 4 monoclonal antibody as a single agent. Arch Dermatol  142, 166-72.   https://doi.org/10.1001/archderm.142.2.166




PubMed


 


PubMed ID 16490844
    
     


 



15.
Johnson LA, Heemskerk B, Powell DJ, Cohen CJ, Morgan RA, Dudley ME, Robbins PF, Rosenberg SA (2006). Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes. J Immunol  177, 6548-59.   https://doi.org/10.4049/jimmunol.177.9.6548




PubMed



        
     
Free Article


 


PubMed ID 17056587
         Pubmed Central ID 2174608 


 



16.
Kershaw MH, Westwood JA, Parker LL, Wang G, Eshhar Z, Mavroukakis SA, White DE, Wunderlich JR, Canevari S, Rogers-Freezer L, Chen CC, Yang JC, Rosenberg SA, Hwu P (2006). A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer. Clin Cancer Res  12, 6106-15.   https://doi.org/10.1158/1078-0432.CCR-06-1183




PubMed



        
     
Free Article


 


PubMed ID 17062687
         Pubmed Central ID 2154351 


 



17.
Klebanoff CA, Gattinoni L, Torabi-Parizi P, Kerstann K, Cardones AR, Finkelstein SE, Palmer DC, Antony PA, Hwang ST, Rosenberg SA, Waldmann TA, Restifo NP (2005). Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. Proc Natl Acad Sci U S A  102, 9571-6.   https://doi.org/10.1073/pnas.0503726102




PubMed



        
     
Free Article


 


PubMed ID 15980149
         Pubmed Central ID 1172264 


 



18.
Lindsey KR, Gritz L, Sherry R, Abati A, Fetsch PA, Goldfeder LC, Gonzales MI, Zinnack KA, Rogers-Freezer L, Haworth L, Mavroukakis SA, White DE, Steinberg SM, Restifo NP, Panicali DL, Rosenberg SA, Topalian SL (2006). Evaluation of prime/boost regimens using recombinant poxvirus/tyrosinase vaccines for the treatment of patients with metastatic melanoma. Clin Cancer Res  12, 2526-37.   https://doi.org/10.1158/1078-0432.CCR-05-2061




PubMed



        
     
Free Article


 


PubMed ID 16638862
         Pubmed Central ID 2151202 


 



19.
Lotem M, Zhao Y, Riley J, Hwu P, Morgan RA, Rosenberg SA, Parkhurst MR (2006). Presentation of tumor antigens by dendritic cells genetically modified with viral and nonviral vectors. J Immunother  29, 616-27.   https://doi.org/10.1097/01.cji.0000211312.36363.56




PubMed



        
     
Free Article


 


PubMed ID 17063124
         Pubmed Central ID 2174598 


 



20.
Maker AV, Attia P, Rosenberg SA (2005). Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade. J Immunol  175, 7746-54.   https://doi.org/10.4049/jimmunol.175.11.7746




PubMed



        
     
Free Article


 


PubMed ID 16301685
         Pubmed Central ID 1473972 


 



21.
Maker AV, Phan GQ, Attia P, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Haworth LR, Levy C, Kleiner D, Mavroukakis SA, Yellin M, Rosenberg SA (2005). Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study. Ann Surg Oncol  12, 1005-16.   https://doi.org/10.1245/ASO.2005.03.536




PubMed



        
     
Free Article


 


PubMed ID 16283570
         Pubmed Central ID 1473970 


 



22.
Maker AV, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Hughes M, Yellin MJ, Haworth LR, Levy C, Allen T, Mavroukakis SA, Attia P, Rosenberg SA (2006). Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanoma. J Immunother  29, 455-63.   https://doi.org/10.1097/01.cji.0000208259.73167.58




PubMed



        
     
Free Article


 


PubMed ID 16799341
         Pubmed Central ID 2134804 


 



23.
Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, Sherry RM, Royal RE, Topalian SL, Kammula US, Restifo NP, Zheng Z, Nahvi A, de Vries CR, Rogers-Freezer LJ, Mavroukakis SA, Rosenberg SA (2006). Cancer regression in patients after transfer of genetically engineered lymphocytes. Science  314, 126-9.   https://doi.org/10.1126/science.1129003




PubMed



        
     
Free Article


 


PubMed ID 16946036
         Pubmed Central ID 2267026 


 



24.
Paulos CM, Kaiser A, Wrzesinski C, Hinrichs CS, Cassard L, Boni A, Muranski P, Sanchez-Perez L, Palmer DC, Yu Z, Antony PA, Gattinoni L, Rosenberg SA, Restifo NP (2007). Toll-like receptors in tumor immunotherapy. Clin Cancer Res  13, 5280-9.   https://doi.org/10.1158/1078-0432.CCR-07-1378




PubMed



        
     
Free Article


 


PubMed ID 17875756
         Pubmed Central ID 2131730 


 



25.
Powell DJ, de Vries CR, Allen T, Ahmadzadeh M, Rosenberg SA (2007). Inability to mediate prolonged reduction of regulatory T Cells after transfer of autologous CD25-depleted PBMC and interleukin-2 after lymphodepleting chemotherapy. J Immunother  30, 438-47.   https://doi.org/10.1097/CJI.0b013e3180600ff9




PubMed



        
     
Free Article


 


PubMed ID 17457218
         Pubmed Central ID 2140222 


 



26.
Powell DJ, Dudley ME, Hogan KA, Wunderlich JR, Rosenberg SA (2006). Adoptive transfer of vaccine-induced peripheral blood mononuclear cells to patients with metastatic melanoma following lymphodepletion. J Immunol  177, 6527-39.   https://doi.org/10.4049/jimmunol.177.9.6527




PubMed



        
     
Free Article


 


PubMed ID 17056585
         Pubmed Central ID 2174602 


 



27.
Powell DJ, Dudley ME, Robbins PF, Rosenberg SA (2005). Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy. Blood  105, 241-50.   https://doi.org/10.1182/blood-2004-06-2482




PubMed



        
     
Free Article


 


PubMed ID 15345595
         Pubmed Central ID 2553211 


 



28.
Powell DJ, Felipe-Silva A, Merino MJ, Ahmadzadeh M, Allen T, Levy C, White DE, Mavroukakis S, Kreitman RJ, Rosenberg SA, Pastan I (2007). Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo. J Immunol  179, 4919-28.   https://doi.org/10.4049/jimmunol.179.7.4919




PubMed



        
     
Free Article


 


PubMed ID 17878392
         Pubmed Central ID 2134981 


 



29.
Restifo NP, Rosenberg SA (2005). Use of standard criteria for assessment of cancer vaccines. Lancet Oncol  6, 3-4.   https://doi.org/10.1016/S1470-2045(04)01693-6




PubMed



        
     
Free Article


 


PubMed ID 15629270
         Pubmed Central ID 1484507 


 



30.
Romeo MJ, Wunderlich J, Ngo L, Rosenberg SA, Steinberg SM, Berman DM (2006). Measuring tissue-based biomarkers by immunochromatography coupled with reverse-phase lysate microarray. Clin Cancer Res  12, 2463-7.   https://doi.org/10.1158/1078-0432.CCR-05-1479




PubMed



        
     
Free Article


 


PubMed ID 16638853
         Pubmed Central ID 2147079 


 



31.
Rosenberg SA (2005). Cancer immunotherapy comes of age. Nat Clin Pract Oncol  2, 115.   https://doi.org/10.1038/ncponc0101




PubMed



        
     
Free Article


 


PubMed ID 16264884
         Pubmed Central ID 2656369 


 



32.
Rosenberg SA (2005). Cell transfer and other immunotherapeutic strategies. Clin Adv Hematol Oncol  3, 28-9.




PubMed


 


PubMed ID 16166964
    
     


 



33.
Rosenberg SA (2007). Interleukin 2 for patients with renal cancer. Nat Clin Pract Oncol  4, 497.   https://doi.org/10.1038/ncponc0926




PubMed



        
     
Free Article


 


PubMed ID 17728709
         Pubmed Central ID 2147080 


 



34.
Rosenberg SA, Sherry RM, Morton KE, Scharfman WJ, Yang JC, Topalian SL, Royal RE, Kammula U, Restifo NP, Hughes MS, Schwartzentruber D, Berman DM, Schwarz SL, Ngo LT, Mavroukakis SA, White DE, Steinberg SM (2005). Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma. J Immunol  175, 6169-76.   https://doi.org/10.4049/jimmunol.175.9.6169




PubMed


 


PubMed ID 16237114
    
     


 



35.
Yang JC, Hughes M, Kammula U, Royal R, Sherry RM, Topalian SL, Suri KB, Levy C, Allen T, Mavroukakis S, Lowy I, White DE, Rosenberg SA (2007). Ipilimumab (anti-CTLA4 antibody) causes regression of metastatic renal cell cancer associated with enteritis and hypophysitis. J Immunother  30, 825-30.   https://doi.org/10.1097/CJI.0b013e318156e47e




PubMed



        
     
Free Article


 


PubMed ID 18049334
         Pubmed Central ID 2134980 


 



36.
Zhao Y, Bennett AD, Zheng Z, Wang QJ, Robbins PF, Yu LY, Li Y, Molloy PE, Dunn SM, Jakobsen BK, Rosenberg SA, Morgan RA (2007). High-affinity TCRs generated by phage display provide CD4+ T cells with the ability to recognize and kill tumor cell lines. J Immunol  179, 5845-54.   https://doi.org/10.4049/jimmunol.179.9.5845




PubMed



        
     
Free Article


 


PubMed ID 17947658
         Pubmed Central ID 2140228 


 



37.
Zhao Y, Zheng Z, Robbins PF, Khong HT, Rosenberg SA, Morgan RA (2005). Primary human lymphocytes transduced with NY-ESO-1 antigen-specific TCR genes recognize and kill diverse human tumor cell lines. J Immunol  174, 4415-23.   https://doi.org/10.4049/jimmunol.174.7.4415




PubMed



        
     
Free Article


 


PubMed ID 15778407
         Pubmed Central ID 2174604 


 



38.
Zhou J, Shen X, Huang J, Hodes RJ, Rosenberg SA, Robbins PF (2005). Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy. J Immunol  175, 7046-52.   https://doi.org/10.4049/jimmunol.175.10.7046




PubMed



        
     
Free Article


 


PubMed ID 16272366
         Pubmed Central ID 1351312 


 



39.
Morgan RA, Cohen CA, Rosenberg SA (submitted in 2006) Chimeric T Cells Receptors And Related Materials And Methods Of Use. Patents issued: 2016102 (BE in 2012); 2016102 (CH in 2012); 2016102 (AT in 2012); 602007021492 (DE in 2012); 2016102 (DK in 2012); 2016102 (EP in 2012); 2016102 (FR in 2012); 2016102 (GB in 2012); 2016102 (IE in 2012); 2016102 (IT in 2012); 2016102 (NL in 2012); 2016102 (PT in 2012); 2016102 (SE in 2012); 2007248019 (AU in 2013). Patents pending: 2,651,174 (CA application); PCT/US2007/068113 (PC application); 12/298,927 (US application); 13/667,036 (US application).




 



40.
Robbins P, Bennett A, Morgan R, Rosenberg S (submitted in 2006) Modified T Cell Receptors And Related Materials And Methods. Patents issued: 8,088,379 (US in 2012); 9,128,080 (US in 2015). Patent pending: PCT/US2007/079487 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=44070
515,SC004002-37,"October 01, 2005 -  September 30, 2006",Defects in Immunoregulatory Cell Receptors in Patients with LeukemiaLymphoma,"Thomas Alexander Waldmann; MD, PhD



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI","Liyanage P Perera; PhD



Yutaka  Tagaya; MD, PhD



Jean  Decker



Sigrid Priscilla Dubois



Carolyn  Goldman



Michael N Petrus



Show all 13","Roland  Martin
(Hospital Universitari Vall d'Hebron)
















Clark  Anderson, M.D.
(Division of Immunology and Rheumatology, The Ohio State University)




Sandor  Damjanovich, M.D.
(Dept of Biophysics and Cell Biology, University of Debrecen)




Christophe  Nicot, Ph.D.
(Dept of Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center)




Nicole  Urquhart
(Dept of, University of the West Indies)




David  Weiner, Ph.D.
(Dept of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine)


Show all 7","Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)","Jorge A Carrasquillo; MD (CC) 



Henry F McFarland; MD (NINDS) 



Robert B. Nussenblatt; MD (NEI)","Ordered by publication type and then author name.



1.
Bene L, Szöllosi J, Szentesi G, Damjanovich L, Gáspár R, Waldmann TA, Damjanovich S (2005). Detection of receptor trimers on the cell surface by flow cytometric fluorescence energy homotransfer measurements. Biochim Biophys Acta  1744, 176-98.   https://doi.org/10.1016/j.bbamcr.2005.02.002




PubMed


 


PubMed ID 15950751
    
     


 



2.
Bielekova B, Catalfamo M, Reichert-Scrivner S, Packer A, Cerna M, Waldmann TA, McFarland H, Henkart PA, Martin R (2006). Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis. Proc Natl Acad Sci U S A  103, 5941-6.   https://doi.org/10.1073/pnas.0601335103




PubMed



        
     
Free Article


 


PubMed ID 16585503
         Pubmed Central ID 1458677 


 



3.
Datta A, Bellon M, Sinha-Datta U, Bazarbachi A, Lepelletier Y, Canioni D, Waldmann TA, Hermine O, Nicot C (2006). Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence. Blood  108, 1021-9.   https://doi.org/10.1182/blood-2006-01-0067




PubMed



        
     
Free Article


 


PubMed ID 16569765
         Pubmed Central ID 1895862 


 



4.
Dubois S, Waldmann TA, Müller JR (2006). ITK and IL-15 support two distinct subsets of CD8+ T cells. Proc Natl Acad Sci U S A  103, 12075-80.   https://doi.org/10.1073/pnas.0605212103




PubMed



        
     
Free Article


 


PubMed ID 16880398
         Pubmed Central ID 1567699 


 



5.
Dubois SP, Waldmann TA, Müller JR (2005). Survival adjustment of mature dendritic cells by IL-15. Proc Natl Acad Sci U S A  102, 8662-7.   https://doi.org/10.1073/pnas.0503360102




PubMed



        
     
Free Article


 


PubMed ID 15932944
         Pubmed Central ID 1150852 


 



6.
Klebanoff CA, Gattinoni L, Torabi-Parizi P, Kerstann K, Cardones AR, Finkelstein SE, Palmer DC, Antony PA, Hwang ST, Rosenberg SA, Waldmann TA, Restifo NP (2005). Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. Proc Natl Acad Sci U S A  102, 9571-6.   https://doi.org/10.1073/pnas.0503726102




PubMed



        
     
Free Article


 


PubMed ID 15980149
         Pubmed Central ID 1172264 


 



7.
Kobayashi H, Kawamoto S, Brechbiel MW, Bernardo M, Sato N, Waldmann TA, Tagaya Y, Choyke PL (2005). Detection of lymph node involvement in hematologic malignancies using micromagnetic resonance lymphangiography with a gadolinum-labeled dendrimer nanoparticle. Neoplasia  7, 984-91.   https://doi.org/10.1593/neo.05454




PubMed



        
     
Free Article


 


PubMed ID 16331884
         Pubmed Central ID 1502021 


 



8.
Koon HB, Severy P, Hagg DS, Butler K, Hill T, Jones AG, Waldmann TA, Junghans RP (2006). Antileukemic effect of daclizumab in CD25 high-expressing leukemias and impact of tumor burden on antibody dosing. Leuk Res  30, 190-203.   https://doi.org/10.1016/j.leukres.2005.06.007




PubMed


 


PubMed ID 16165209
    
     


 



9.
Kutzler MA, Robinson TM, Chattergoon MA, Choo DK, Choo AY, Choe PY, Ramanathan MP, Parkinson R, Kudchodkar S, Tamura Y, Sidhu M, Roopchand V, Kim JJ, Pavlakis GN, Felber BK, Waldmann TA, Boyer JD, Weiner DB (2005). Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help. J Immunol  175, 112-23.   https://doi.org/10.4049/jimmunol.175.1.112




PubMed


 


PubMed ID 15972637
    
     


 



10.
Morris JC, Janik JE, White JD, Fleisher TA, Brown M, Tsudo M, Goldman CK, Bryant B, Petrus M, Top L, Lee CC, Gao W, Waldmann TA (2006). Preclinical and phase I clinical trial of blockade of IL-15 using Mikbeta1 monoclonal antibody in T cell large granular lymphocyte leukemia. Proc Natl Acad Sci U S A  103, 401-6.   https://doi.org/10.1073/pnas.0509575103




PubMed



        
     
Free Article


 


PubMed ID 16387851
         Pubmed Central ID 1326174 


 



11.
Rubovszky B, Hajdú P, Krasznai Z, Gáspár R, Waldmann TA, Damjanovich S, Bene L (2005). Detection of channel proximity by nanoparticle-assisted delaying of toxin binding; a combined patch-clamp and flow cytometric energy transfer study. Eur Biophys J  34, 127-43.   https://doi.org/10.1007/s00249-004-0436-x




PubMed


 


PubMed ID 15375639
    
     


 



12.
Talanov VS, Garmestani K, Regino CA, Milenic DE, Plascjak PS, Waldmann TA, Brechbiel MW (2006). Preparation and in vivo evaluation of a novel stabilized linker for 211At labeling of protein. Nucl Med Biol  33, 469-80.   https://doi.org/10.1016/j.nucmedbio.2006.03.001




PubMed


 


PubMed ID 16720238
    
     


 



13.
Waldmann TA (2006). Effective cancer therapy through immunomodulation . Annu Rev Med  57, 65-81.




PubMed


 


PubMed ID 16176164
    
     


 



14.
Waldmann TA (2006). Effective cancer therapy through immunomodulation. Annu Rev Med  57, 65-81.   https://doi.org/10.1146/annurev.med.56.082103.104549




PubMed


 


PubMed ID 16409137
    
     


 



15.
Waldmann TA (2006). The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev Immunol  6, 595-601.   https://doi.org/10.1038/nri1901




PubMed


 


PubMed ID 16868550
    
     


 



16.
Waldmann TA, Morris JC (2006). Development of antibodies and chimeric molecules for cancer immunotherapy. Adv Immunol  90, 83-131.   https://doi.org/10.1016/S0065-2776(06)90003-0




PubMed


 


PubMed ID 16730262
    
     


 



17.
Wani MA, Haynes LD, Kim J, Bronson CL, Chaudhury C, Mohanty S, Waldmann TA, Robinson JM, Anderson CL (2006). Familial hypercatabolic hypoproteinemia caused by deficiency of the neonatal Fc receptor, FcRn, due to a mutant beta2-microglobulin gene. Proc Natl Acad Sci U S A  103, 5084-9.   https://doi.org/10.1073/pnas.0600548103




PubMed



        
     
Free Article


 


PubMed ID 16549777
         Pubmed Central ID 1458798 


 



18.
Zhang M, Yao Z, Zhang Z, Garmestani K, Goldman CK, Ravetch JV, Janik J, Brechbiel MW, Waldmann TA (2006). Effective therapy for a murine model of human anaplastic large-cell lymphoma with the anti-CD30 monoclonal antibody, HeFi-1, does not require activating Fc receptors. Blood  108, 705-10.   https://doi.org/10.1182/blood-2005-11-4607




PubMed



        
     
Free Article


 


PubMed ID 16551968
         Pubmed Central ID 1895489 


 



19.
Zhang M, Yao Z, Zhang Z, Garmestani K, Talanov VS, Plascjak PS, Yu S, Kim HS, Goldman CK, Paik CH, Brechbiel MW, Carrasquillo JA, Waldmann TA (2006). The anti-CD25 monoclonal antibody 7G7/B6, armed with the alpha-emitter 211At, provides effective radioimmunotherapy for a murine model of leukemia. Cancer Res  66, 8227-32.   https://doi.org/10.1158/0008-5472.CAN-06-1189




PubMed


 


PubMed ID 16912202
    
     


 



20.
Zhang M, Zhang Z, Goldman CK, Janik J, Waldmann TA (2005). Combination therapy for adult T-cell leukemia-xenografted mice: flavopiridol and anti-CD25 monoclonal antibody. Blood  105, 1231-6.   https://doi.org/10.1182/blood-2004-05-1709




PubMed


 


PubMed ID 15383455
    
     


 



21.
Zhang Z, Zhang M, Garmestani K, Talanov VS, Plascjak PS, Beck B, Goldman C, Brechbiel MW, Waldmann TA (2006). Effective treatment of a murine model of adult T-cell leukemia using 211At-7G7/B6 and its combination with unmodified anti-Tac (daclizumab) directed toward CD25. Blood  108, 1007-12.   https://doi.org/10.1182/blood-2005-11-4757




PubMed



        
     
Free Article


 


PubMed ID 16569769
         Pubmed Central ID 1895861",https://intramural.nih.gov/search/searchview.taf?ipid=44071
516,SC004017-28,"October 01, 2005 -  September 30, 2006",Biology of the Immune Response,"David  Nelson; MD, PhD",NULL,"Lymphoid Malignancies Branch, NCI","Donn M Stewart; MD



Haiying  Qin



Musafumi  Yamada",NULL,Elaine S Jaffe; MD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44072
517,SC004020-29,"October 01, 2005 -  September 30, 2006","Antigen-specific T-cell activation, application to vaccines for Cancer and AIDS","Jay Arthur Berzofsky; MD, PhD



IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Igor M. Belyakov; MD, PhD



Michael G Lemon



Jong Kuk Park



Sangkon  Oh



Charles D Pendleton



Amiran  Dzutsev; PhD



Show all 14","Vincenzo  Bronte





Donald  Burke
(Ctr Immunization Research, Johns Hopkins Sch Publ Health)




David  Carbone
(Dept. of Medicine, Vanderbilt University)




Charles  Delisi





Debra  Donaldson; PhD
(Immunology, Wyeth-Genetics Institute)




Guido  Forni
(Clinical and Biological Sciences, University of Turin)


Show all 19","Lee Jay Helman; MD (National Cancer Institute)



Thomas Alexander Waldmann; MD, PhD (National Cancer Institute)



Lalage  Wakefield; PhD (National Cancer Institute)



Genoveffa  Franchini; MD (National Cancer Institute)



John  Janik; MD (National Cancer Institute)



John Charles Morris; MD (National Cancer Institute)","Dennis M Klinman; MD, PhD (OD) 



David Harvey Margulies; MD, PhD (NIAID) 



William E Paul; MD (NIAID) 



Warren  Strober; MD (NIAID) 



Patricia  Earl; PhD (NIAID) 



Brian R. Murphy; MD (NIAID)","Ordered by publication type and then author name.



1.
Belyakov IM, Kuznetsov VA, Kelsall B, Klinman D, Moniuszko M, Lemon M, Markham PD, Pal R, Clements JD, Lewis MG, Strober W, Franchini G, Berzofsky JA (2006). Impact of vaccine-induced mucosal high-avidity CD8+ CTLs in delay of AIDS viral dissemination from mucosa. Blood  107, 3258-64.   https://doi.org/10.1182/blood-2005-11-4374




PubMed



        
     
Free Article


 


PubMed ID 16373659
         Pubmed Central ID 1895757 


 



2.
Berzofsky J, Dzutsev A, Zhu Q, Isakov D, Klinman D   (2006) Enhancement of CD8+ T cell immunity in the lung by CpG ODN increases protective efficacy of a Modified Vaccinia Ankara vaccine against lethal poxvirus infection even in CD4-deficient host.  Journal of Immunology, in press.




 



3.
Berzofsky JA, Oh S, Terabe M (2005). Peptide vaccines against cancer. Cancer Treat Res  123, 115-36.   https://doi.org/10.1007/0-387-27545-2_5




PubMed


 


PubMed ID 16211868
    
     


 



4.
Dong Y, Qian J, Ibrahim R, Berzofsky JA, Khleif SN (2006). Identification of H-2Db-specific CD8+ T-cell epitopes from mouse VEGFR2 that can inhibit angiogenesis and tumor growth. J Immunother  29, 32-40.   https://doi.org/10.1097/01.cji.0000175494.13476.56




PubMed


 


PubMed ID 16365598
    
     


 



5.
Kawakami K, Terabe M, Kawakami M, Berzofsky JA, Puri RK (2006). Characterization of a novel human tumor antigen interleukin-13 receptor alpha2 chain. Cancer Res  66, 4434-42.   https://doi.org/10.1158/0008-5472.CAN-05-1265




PubMed


 


PubMed ID 16618770
    
     


 



6.
Kawakami K, Terabe M, Kioi M, Berzofsky JA, Puri RK (2006). Intratumoral therapy with IL13-PE38 results in effective CTL-mediated suppression of IL-13Ralpha2-expressing contralateral tumors. Clin Cancer Res  12, 4678-86.   https://doi.org/10.1158/1078-0432.CCR-06-0192




PubMed


 


PubMed ID 16899618
    
     


 



7.
Kotelkin A, Belyakov IM, Yang L, Berzofsky JA, Collins PL, Bukreyev A (2006). The NS2 protein of human respiratory syncytial virus suppresses the cytotoxic T-cell response as a consequence of suppressing the type I interferon response. J Virol  80, 5958-67.   https://doi.org/10.1128/JVI.00181-06




PubMed



        
     
Free Article


 


PubMed ID 16731934
         Pubmed Central ID 1472589 


 



8.
Oh S, Stegman B, Pendleton CD, Ota MO, Pan CH, Griffin DE, Burke DS, Berzofsky JA (2006). Protective immunity provided by HLA-A2 epitopes for fusion and hemagglutinin proteins of measles virus. Virology  352, 390-9.   https://doi.org/10.1016/j.virol.2006.04.040




PubMed


 


PubMed ID 16781760
    
     


 



9.
Okazaki T, Pendleton CD, Sarobe P, Thomas EK, Iyengar S, Harro C, Schwartz D, Berzofsky JA (2006). Epitope enhancement of a CD4 HIV epitope toward the development of the next generation HIV vaccine. J Immunol  176, 3753-9.   https://doi.org/10.4049/jimmunol.176.6.3753




PubMed


 


PubMed ID 16517744
    
     


 



10.
Okazaki T, Terabe M, Catanzaro AT, Pendleton CD, Yarchoan R, Berzofsky JA (2006). Possible therapeutic vaccine strategy against human immunodeficiency virus escape from reverse transcriptase inhibitors studied in HLA-A2 transgenic mice. J Virol  80, 10645-51.   https://doi.org/10.1128/JVI.01351-05




PubMed



        
     
Free Article


 


PubMed ID 16920824
         Pubmed Central ID 1641790 


 



11.
Pal R, Venzon D, Santra S, Kalyanaraman VS, Montefiori DC, Hocker L, Hudacik L, Rose N, Nacsa J, Edghill-Smith Y, Moniuszko M, Hel Z, Belyakov IM, Berzofsky JA, Parks RW, Markham PD, Letvin NL, Tartaglia J, Franchini G (2006). Systemic immunization with an ALVAC-HIV-1/protein boost vaccine strategy protects rhesus macaques from CD4+ T-cell loss and reduces both systemic and mucosal simian-human immunodeficiency virus SHIVKU2 RNA levels. J Virol  80, 3732-42.   https://doi.org/10.1128/JVI.80.8.3732-3742.2006




PubMed



        
     
Free Article


 


PubMed ID 16571790
         Pubmed Central ID 1440474 


 



12.
Pinto LA, Viscidi R, Harro CD, Kemp TJ, García-Piñeres AJ, Trivett M, Demuth F, Lowy DR, Schiller JT, Berzofsky JA, Hildesheim A (2006). Cellular immune responses to HPV-18, -31, and -53 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles. Virology  353, 451-62.   https://doi.org/10.1016/j.virol.2006.06.021




PubMed


 


PubMed ID 16863657
    
     


 



13.
Qian J, Dong Y, Pang YY, Ibrahim R, Berzofsky JA, Schiller JT, Khleif SN (2006). Combined prophylactic and therapeutic cancer vaccine: enhancing CTL responses to HPV16 E2 using a chimeric VLP in HLA-A2 mice. Int J Cancer  118, 3022-9.   https://doi.org/10.1002/ijc.21781




PubMed


 


PubMed ID 16425257
    
     


 



14.
Terabe M, Khanna C, Bose S, Melchionda F, Mendoza A, Mackall CL, Helman LJ, Berzofsky JA (2006). CD1d-restricted natural killer T cells can down-regulate tumor immunosurveillance independent of interleukin-4 receptor-signal transducer and activator of transcription 6 or transforming growth factor-beta. Cancer Res  66, 3869-75.   https://doi.org/10.1158/0008-5472.CAN-05-3421




PubMed


 


PubMed ID 16585215
    
     


 



15.
Terabe M, Swann J, Ambrosino E, Sinha P, Takaku S, Hayakawa Y, Godfrey DI, Ostrand-Rosenberg S, Smyth MJ, Berzofsky JA (2005). A nonclassical non-Valpha14Jalpha18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance. J Exp Med  202, 1627-33.   https://doi.org/10.1084/jem.20051381




PubMed



        
     
Free Article


 


PubMed ID 16365146
         Pubmed Central ID 2212961 


 



16.
van den Broeke LT, Pendleton CD, Mackall C, Helman LJ, Berzofsky JA (2006). Identification and epitope enhancement of a PAX-FKHR fusion protein breakpoint epitope in alveolar rhabdomyosarcoma cells created by a tumorigenic chromosomal translocation inducing CTL capable of lysing human tumors. Cancer Res  66, 1818-23.   https://doi.org/10.1158/0008-5472.CAN-05-2549




PubMed


 


PubMed ID 16452243
    
     


 



17.
Wang YE, Zhang C, Berzofsky J, DeLisi C (2005). Selecting stable molecular targets for treatment and prevention of AIDS. Genome Inform  16, 254-61.




PubMed


 


PubMed ID 16362928
    
     


 



18.
Zeng R, Spolski R, Finkelstein SE, Oh S, Kovanen PE, Hinrichs CS, Pise-Masison CA, Radonovich MF, Brady JN, Restifo NP, Berzofsky JA, Leonard WJ (2005). Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. J Exp Med  201, 139-48.   https://doi.org/10.1084/jem.20041057




PubMed



        
     
Free Article


 


PubMed ID 15630141
         Pubmed Central ID 2212766 


 



19.
Zhang H, Chua KS, Guimond M, Kapoor V, Brown MV, Fleisher TA, Long LM, Bernstein D, Hill BJ, Douek DC, Berzofsky JA, Carter CS, Read EJ, Helman LJ, Mackall CL (2005). Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells. Nat Med  11, 1238-43.   https://doi.org/10.1038/nm1312




PubMed


 


PubMed ID 16227988",https://intramural.nih.gov/search/searchview.taf?ipid=44073
518,SC004024-19,"October 01, 2005 -  September 30, 2006",Molecular Biology of Human Lymphoid Malignancies,"Louis  Staudt; MD



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI","Arthur L Shaffer



Richard E Davis



Hong  Zhao



Lam  Lloyd



Vu  Ngo



Laurence  Lamy



Show all 10","Elias  Campo
(Pathology, University of Barcelona)




John  Chan
(Univ. of Nebraska Medical Center)




Richard  Fisher
(Southwest Oncology Group)




Randy  Gascoyne
(British Columbia Cancer Center)




Konrad  Muller-Hermelink
(Univ. of Wuerzburg)




Harinder  Singh



Show all 7","Elaine S Jaffe; MD (National Cancer Institute)



Walter M Kuehl; MD, PhD (National Cancer Institute)



Wyndham H Wilson; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma EJ, Greiner TC, Weisenburger DD, Rosenwald A, Ott G, Müller-Hermelink HK, Gascoyne RD, Delabie J, Rimsza LM, Braziel RM, Grogan TM, Campo E, Jaffe ES, Dave BJ, Sanger W, Bast M, Vose JM, Armitage JO, Connors JM, Smeland EB, Lymphoma/Leukemia Molecular Profiling Project, et al. [13 more authors] (2006). Molecular diagnosis of Burkitt's lymphoma. N Engl J Med  354, 2431-42.   https://doi.org/10.1056/NEJMoa055759




PubMed


 


PubMed ID 16760443
    
     


 



2.
Fu K, Weisenburger DD, Greiner TC, Dave S, Wright G, Rosenwald A, Chiorazzi M, Iqbal J, Gesk S, Siebert R, De Jong D, Jaffe ES, Wilson WH, Delabie J, Ott G, Dave BJ, Sanger WG, Smith LM, Rimsza L, Braziel RM, Müller-Hermelink HK, Campo E, Gascoyne RD, Staudt LM, Chan WC, Lymphoma/Leukemia Molecular Profiling Project (2005). Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. Blood  106, 4315-21.   https://doi.org/10.1182/blood-2005-04-1753




PubMed



        
     
Free Article


 


PubMed ID 16123218
         Pubmed Central ID 1895253 


 



3.
Iqbal J, Neppalli VT, Wright G, Dave BJ, Horsman DE, Rosenwald A, Lynch J, Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Campo E, Ott G, Müller-Hermelink HK, Delabie J, Jaffe ES, Grogan TM, Connors JM, Vose JM, Armitage JO, Staudt LM, Chan WC (2006). BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma. J Clin Oncol  24, 961-8.   https://doi.org/10.1200/JCO.2005.03.4264




PubMed


 


PubMed ID 16418494
    
     


 



4.
Ngo VN, Davis RE, Lamy L, Yu X, Zhao H, Lenz G, Lam LT, Dave S, Yang L, Powell J, Staudt LM (2006). A loss-of-function RNA interference screen for molecular targets in cancer. Nature  441, 106-10.   https://doi.org/10.1038/nature04687




PubMed


 


PubMed ID 16572121
    
     


 



5.
Sciammas R, Shaffer AL, Schatz JH, Zhao H, Staudt LM, Singh H (2006). Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity  25, 225-36.   https://doi.org/10.1016/j.immuni.2006.07.009




PubMed


 


PubMed ID 16919487
    
     


 



6.
Shaffer AL, Wright G, Yang L, Powell J, Ngo V, Lamy L, Lam LT, Davis RE, Staudt LM (2006). A library of gene expression signatures to illuminate normal and pathological lymphoid biology. Immunol Rev  210, 67-85.   https://doi.org/10.1111/j.0105-2896.2006.00373.x




PubMed


 


PubMed ID 16623765",https://intramural.nih.gov/search/searchview.taf?ipid=44074
519,SC006321-27,"October 01, 2005 -  September 30, 2006",Modulation of Therapeutic Response,"James B Mitchell; PhD



IRP Faculty Profile",NULL,"Radiation Biology Branch, NCI","John Andrew Cook; PhD



William  Degraff



Anastasia L Sowers



Janet W Gamson



Deborah O Coffin



Rajani  Choudhuri



Show all 7","Dr. Paul  Amazeen
(Research, Imalux Corporation)




Dr. Kameron  Maxwell
(Research, Mitos)",NULL,NULL,"Ordered by publication type and then author name.



1.
Chan LW, Hapdey S, English S, Seidel J, Carson J, Sowers AL, Krishna MC, Green MV, Mitchell JB, Bacharach SL (2006). The influence of tumor oxygenation on (18)F-FDG (fluorine-18 deoxyglucose) uptake: a mouse study using positron emission tomography (PET). Radiat Oncol  1, 3.   https://doi.org/10.1186/1748-717X-1-3




PubMed



        
     
Free Article


 


PubMed ID 16722588
         Pubmed Central ID 1436004 


 



2.
Matsumoto K, Bernardo M, Subramanian S, Choyke P, Mitchell JB, Krishna MC, Lizak MJ (2006). MR assessment of changes of tumor in response to hyperbaric oxygen treatment. Magn Reson Med  56, 240-6.   https://doi.org/10.1002/mrm.20961




PubMed


 


PubMed ID 16795082
    
     


 



3.
Matsumoto K, Hyodo F, Matsumoto A, Koretsky AP, Sowers AL, Mitchell JB, Krishna MC (2006). High-resolution mapping of tumor redox status by magnetic resonance imaging using nitroxides as redox-sensitive contrast agents. Clin Cancer Res  12, 2455-62.   https://doi.org/10.1158/1078-0432.CCR-05-2747




PubMed


 


PubMed ID 16638852
    
     


 



4.
Matsumoto K, Subramanian S, Devasahayam N, Aravalluvan T, Murugesan R, Cook JA, Mitchell JB, Krishna MC (2006). Electron paramagnetic resonance imaging of tumor hypoxia: enhanced spatial and temporal resolution for in vivo pO2 determination. Magn Reson Med  55, 1157-63.   https://doi.org/10.1002/mrm.20872




PubMed


 


PubMed ID 16596636",https://intramural.nih.gov/search/searchview.taf?ipid=44075
520,SC006329-25,"October 01, 2005 -  September 30, 2006",Clinical Radiation Physics Service,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI","George  Li



Hu-Chen  Xie



Holly  Ning



Frank S Harrington



Barbara Chin Arora",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44046
521,SC006330-25,"October 01, 2005 -  September 30, 2006",Radiation Field Modeling and Computerized Treatment Planning,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI","George  Li



Hu-Chen  Xie



Holly  Ning



Frank S Harrington



Barbara Chin Arora","Thomas  Fearon
(Radiology, Children's National Medical Center)




Chang-Ming  Ma
(Radiation Oncology Department, Fox Chase Cancer Center)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44047
522,SC006353-24,"October 01, 2005 -  September 30, 2006",Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy,"Martin W Brechbiel; PhD



IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI","Celeste A Regino



Diane E Milenic



Charles A Boswell



Heng  Xu



Voltaire  Organo","Greg  Adams
(Fox Chase Cancer Center)




Barry  Allen
(Experiemental Radiation Oncology, St. George Cancer Care Center)




Andrew  Scott
(Ludwig Institute)




Scott  Wilbur
(Radiation Oncology, U. of Washington)","Peter L Choyke; MD (National Cancer Institute)



Thomas Alexander Waldmann; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Boswell CA, Brechbiel MW (2005). Auger electrons: lethal, low energy, and coming soon to a tumor cell nucleus near you. J Nucl Med  46, 1946-7.




PubMed


 


PubMed ID 16330556
    
     


 



2.
Boswell CA, Brechbiel MW (2007). Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view. Nucl Med Biol  34, 757-78.   https://doi.org/10.1016/j.nucmedbio.2007.04.001




PubMed



        
     
Free Article


 


PubMed ID 17921028
         Pubmed Central ID 2212602 


 



3.
Brechbiel MW (2007). Targeted alpha-therapy: past, present, future? Dalton Trans   4918-28  https://doi.org/10.1039/b704726f




PubMed



        
     
Free Article


 


PubMed ID 17992276
         Pubmed Central ID 2408446 


 



4.
Chong HS, Mhaske S, Lin M, Bhuniya S, Song HA, Brechbiel MW, Sun X (2007). Novel synthetic ligands for targeted PET imaging and radiotherapy of copper. Bioorg Med Chem Lett  17, 6107-10.   https://doi.org/10.1016/j.bmcl.2007.09.052




PubMed



        
     
Free Article


 


PubMed ID 17911020
         Pubmed Central ID 2410210 


 



5.
Chong HS, Milenic DE, Garmestani K, Brady ED, Arora H, Pfiester C, Brechbiel MW (2006). In vitro and in vivo evaluation of novel ligands for radioimmunotherapy. Nucl Med Biol  33, 459-67.   https://doi.org/10.1016/j.nucmedbio.2006.03.004




PubMed


 


PubMed ID 16720237
    
     


 



6.
Clifford T, Boswell CA, Biddlecombe GB, Lewis JS, Brechbiel MW (2006). Validation of a novel CHX-A'' derivative suitable for peptide conjugation: small animal PET/CT imaging using yttrium-86-CHX-A''-octreotide. J Med Chem  49, 4297-304.   https://doi.org/10.1021/jm060317v




PubMed


 


PubMed ID 16821789
    
     


 



7.
Garmestani K, Milenic DE, Brady ED, Plascjak PS, Brechbiel MW (2005). Purification of cyclotron-produced 203Pb for labeling Herceptin. Nucl Med Biol  32, 301-5.   https://doi.org/10.1016/j.nucmedbio.2004.11.004




PubMed


 


PubMed ID 15820766
    
     


 



8.
Kelly MP, Lee FT, Smyth FE, Brechbiel MW, Scott AM (2006). Enhanced efficacy of 90Y-radiolabeled anti-Lewis Y humanized monoclonal antibody hu3S193 and paclitaxel combined-modality radioimmunotherapy in a breast cancer model. J Nucl Med  47, 716-25.




PubMed


 


PubMed ID 16595507
    
     


 



9.
Lee FT, Mountain AJ, Kelly MP, Hall C, Rigopoulos A, Johns TG, Smyth FE, Brechbiel MW, Nice EC, Burgess AW, Scott AM (2005). Enhanced efficacy of radioimmunotherapy with 90Y-CHX-A''-DTPA-hu3S193 by inhibition of epidermal growth factor receptor (EGFR) signaling with EGFR tyrosine kinase inhibitor AG1478. Clin Cancer Res  11, 7080s-7086s.   https://doi.org/10.1158/1078-0432.CCR-1004-0019




PubMed


 


PubMed ID 16203806
    
     


 



10.
Norenberg JP, Krenning BJ, Konings IR, Kusewitt DF, Nayak TK, Anderson TL, de Jong M, Garmestani K, Brechbiel MW, Kvols LK (2006). 213Bi-[DOTA0, Tyr3]octreotide peptide receptor radionuclide therapy of pancreatic tumors in a preclinical animal model. Clin Cancer Res  12, 897-903.   https://doi.org/10.1158/1078-0432.CCR-05-1264




PubMed


 


PubMed ID 16467104
    
     


 



11.
Panousis C, Rayzman VM, Johns TG, Renner C, Liu Z, Cartwright G, Lee FT, Wang D, Gan H, Cao D, Kypridis A, Smyth FE, Brechbiel MW, Burgess AW, Old LJ, Scott AM (2005). Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR. Br J Cancer  92, 1069-77.   https://doi.org/10.1038/sj.bjc.6602470




PubMed



        
     
Free Article


 


PubMed ID 15770208
         Pubmed Central ID 2361945 


 



12.
Qu CF, Songl YJ, Rizvi SM, Li Y, Smith R, Perkins AC, Morgenstern A, Brechbiel M, Allen BJ (2005). In vivo and in vitro inhibition of pancreatic cancer growth by targeted alpha therapy using 213Bi-CHX.A""-C595. Cancer Biol Ther  4, 848-53.   https://doi.org/10.4161/cbt.4.8.1892




PubMed


 


PubMed ID 16082185
    
     


 



13.
Rogers BE, Roberson PL, Shen S, Khazaeli MB, Carpenter M, Yokoyama S, Brechbiel MW, LoBuglio AF, Buchsbaum DJ (2005). Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 region. Cancer Biother Radiopharm  20, 502-13.   https://doi.org/10.1089/cbr.2005.20.502




PubMed


 


PubMed ID 16248766
    
     


 



14.
Sato N, Hassan R, Axworthy DB, Wong KJ, Yu S, Theodore LJ, Lin Y, Park L, Brechbiel MW, Pastan I, Paik CH, Carrasquillo JA (2005). Pretargeted radioimmunotherapy of mesothelin-expressing cancer using a tetravalent single-chain Fv-streptavidin fusion protein. J Nucl Med  46, 1201-9.




PubMed


 


PubMed ID 16000290
    
     


 



15.
Talanov VS, Garmestani K, Regino CA, Milenic DE, Plascjak PS, Waldmann TA, Brechbiel MW (2006). Preparation and in vivo evaluation of a novel stabilized linker for 211At labeling of protein. Nucl Med Biol  33, 469-80.   https://doi.org/10.1016/j.nucmedbio.2006.03.001




PubMed


 


PubMed ID 16720238
    
     


 



16.
Vearing C, Lee FT, Wimmer-Kleikamp S, Spirkoska V, To C, Stylianou C, Spanevello M, Brechbiel M, Boyd AW, Scott AM, Lackmann M (2005). Concurrent binding of anti-EphA3 antibody and ephrin-A5 amplifies EphA3 signaling and downstream responses: potential as EphA3-specific tumor-targeting reagents. Cancer Res  65, 6745-54.   https://doi.org/10.1158/0008-5472.CAN-05-0758




PubMed


 


PubMed ID 16061656
    
     


 



17.
Xu H, Baidoo K, Gunn AJ, Boswell CA, Milenic DE, Choyke PL, Brechbiel MW (2007). Design, synthesis, and characterization of a dual modality positron emission tomography and fluorescence imaging agent for monoclonal antibody tumor-targeted imaging. J Med Chem  50, 4759-65.   https://doi.org/10.1021/jm070657w




PubMed



        
     
Free Article


 


PubMed ID 17725340
         Pubmed Central ID 2366096 


 



18.
Zhang M, Yao Z, Zhang Z, Garmestani K, Goldman CK, Ravetch JV, Janik J, Brechbiel MW, Waldmann TA (2006). Effective therapy for a murine model of human anaplastic large-cell lymphoma with the anti-CD30 monoclonal antibody, HeFi-1, does not require activating Fc receptors. Blood  108, 705-10.   https://doi.org/10.1182/blood-2005-11-4607




PubMed



        
     
Free Article


 


PubMed ID 16551968
         Pubmed Central ID 1895489 


 



19.
Zhang M, Yao Z, Zhang Z, Garmestani K, Talanov VS, Plascjak PS, Yu S, Kim HS, Goldman CK, Paik CH, Brechbiel MW, Carrasquillo JA, Waldmann TA (2006). The anti-CD25 monoclonal antibody 7G7/B6, armed with the alpha-emitter 211At, provides effective radioimmunotherapy for a murine model of leukemia. Cancer Res  66, 8227-32.   https://doi.org/10.1158/0008-5472.CAN-06-1189




PubMed


 


PubMed ID 16912202
    
     


 



20.
Zhang Z, Zhang M, Garmestani K, Talanov VS, Plascjak PS, Beck B, Goldman C, Brechbiel MW, Waldmann TA (2006). Effective treatment of a murine model of adult T-cell leukemia using 211At-7G7/B6 and its combination with unmodified anti-Tac (daclizumab) directed toward CD25. Blood  108, 1007-12.   https://doi.org/10.1182/blood-2005-11-4757




PubMed



        
     
Free Article


 


PubMed ID 16569769
         Pubmed Central ID 1895861",https://intramural.nih.gov/search/searchview.taf?ipid=44076
523,SC006358-23,"October 01, 2005 -  September 30, 2006","Radiolysis, Photolysis, Sonolysis and Sonoprotection of Cells and their Constitu",Peter  Riesz; PhD,NULL,"Radiation Biology Branch, NCI",NULL,NULL,William  Degraff (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Cheng JY, Riesz P (2007). Mechanism of the protective effects of long chain n-alkyl glucopyranosides against ultrasound-induced cytolysis of HL-60 cells. Ultrason Sonochem  14, 667-71.   https://doi.org/10.1016/j.ultsonch.2006.10.011




PubMed



        
     
Free Article


 


PubMed ID 17224298
         Pubmed Central ID 2034332",https://intramural.nih.gov/search/searchview.taf?ipid=44077
524,SC006387-19,"October 01, 2005 -  September 30, 2006",Nitroxides as Protectors Against Oxidative Stress,"James B Mitchell; PhD



IRP Faculty Profile",NULL,"Radiation Biology Branch, NCI","John Andrew Cook; PhD



William  Degraff



Anastasia L Sowers



Janet W Gamson



Deborah O Coffin



Rajani  Choudhuri","Dr. Paul  Amazeen
(Research, Imalux Corporation)




Dr. Kameron  Maxwell
(Research, Mitos)",NULL,NULL,"Ordered by publication type and then author name.



1.
Matsumoto K, Hyodo F, Matsumoto A, Koretsky AP, Sowers AL, Mitchell JB, Krishna MC (2006). High-resolution mapping of tumor redox status by magnetic resonance imaging using nitroxides as redox-sensitive contrast agents. Clin Cancer Res  12, 2455-62.   https://doi.org/10.1158/1078-0432.CCR-05-2747




PubMed


 


PubMed ID 16638852
    
     


 



2.
Okajo A, Matsumoto K, Mitchell JB, Krishna MC, Endo K (2006). Competition of nitroxyl contrast agents as an in vivo tissue redox probe: comparison of pharmacokinetics by the bile flow monitoring (BFM) and blood circulating monitoring (BCM) methods using X-band EPR and simulation of decay profiles. Magn Reson Med  56, 422-31.   https://doi.org/10.1002/mrm.20958




PubMed


 


PubMed ID 16810697
    
     


 



3.
Patel K, Chen Y, Dennehy K, Blau J, Connors S, Mendonca M, Tarpey M, Krishna M, Mitchell JB, Welch WJ, Wilcox CS (2006). Acute antihypertensive action of nitroxides in the spontaneously hypertensive rat. Am J Physiol Regul Integr Comp Physiol  290, R37-43.   https://doi.org/10.1152/ajpregu.00469.2005




PubMed


 


PubMed ID 16179488
    
     


 



4.
Thomas DD, Ridnour LA, Espey MG, Donzelli S, Ambs S, Hussain SP, Harris CC, DeGraff W, Roberts DD, Mitchell JB, Wink DA (2006). Superoxide fluxes limit nitric oxide-induced signaling. J Biol Chem  281, 25984-93.   https://doi.org/10.1074/jbc.M602242200




PubMed


 


PubMed ID 16829532
    
     


 



5.
Van Waes C, Chang AA, Lebowitz PF, Druzgal CH, Chen Z, Elsayed YA, Sunwoo JB, Rudy SF, Morris JC, Mitchell JB, Camphausen K, Gius D, Adams J, Sausville EA, Conley BA (2005). Inhibition of nuclear factor-kappaB and target genes during combined therapy with proteasome inhibitor bortezomib and reirradiation in patients with recurrent head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys  63, 1400-12.   https://doi.org/10.1016/j.ijrobp.2005.05.007




PubMed


 


PubMed ID 16005577",https://intramural.nih.gov/search/searchview.taf?ipid=44078
525,SC006538-13,"October 01, 2005 -  September 30, 2006",Development of Angiogenesis Inhibitors,"William D Figg; PharmD



IRP Faculty Profile",NULL,"Medical Oncology Branch, NCI","Cindy Huong-Bich Chau



Haiqing  Li



Kristina  Cook



Douglas K Price","Ken  Anderson
(Medical Oncology/Hematologic Neoplasia, Dana-Farber Cancer Institute)




Shaji  Kumar
(Hematology, Mayo Clinic)","Phillip A Dennis; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Dahut WL, Lakhani NJ, Gulley JL, Arlen PM, Kohn EC, Kotz H, McNally D, Parr A, Nguyen D, Yang SX, Steinberg SM, Venitz J, Sparreboom A, Figg WD (2006). Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors. Cancer Biol Ther  5, 22-7.   https://doi.org/10.4161/cbt.5.1.2349




PubMed


 


PubMed ID 16357512
    
     


 



2.
Ge Y, Montano I, Rustici G, Freebern WJ, Haggerty CM, Cui W, Ponciano-Jackson D, Chandramouli GV, Gardner ER, Figg WD, Abu-Asab M, Tsokos M, Jackson SH, Gardner K (2006). Selective leukemic-cell killing by a novel functional class of thalidomide analogs. Blood  108, 4126-35.   https://doi.org/10.1182/blood-2006-04-017046




PubMed



        
     
Free Article


 


PubMed ID 16940421
         Pubmed Central ID 1895447 


 



3.
Jain L, Venitz J, Figg WD (2006). Randomized discontinuation trial of sorafenib (BAY 43-9006). Cancer Biol Ther  5, 1270-2.   https://doi.org/10.4161/cbt.5.10.3290




PubMed


 


PubMed ID 16969070
    
     


 



4.
Lepper ER, Smith NF, Cox MC, Scripture CD, Figg WD (2006). Thalidomide metabolism and hydrolysis: mechanisms and implications. Curr Drug Metab  7, 677-85.   https://doi.org/10.2174/138920006778017777




PubMed


 


PubMed ID 16918319
    
     


 



5.
Longoria RL, Cox MC, Figg WD (2005). Antiangiogenesis: a possible treatment option for prostate cancer? Clin Genitourin Cancer  4, 197-202.   https://doi.org/10.3816/CGC.2005.n.033




PubMed


 


PubMed ID 16425989
    
     


 



6.
Luzzio FA, Duveau DY, Lepper ER, Figg WD (2005). Synthesis of racemic cis-5-hydroxy-3-phthalimidoglutarimide. A metabolite of thalidomide isolated from human plasma. J Org Chem  70, 10117-20.   https://doi.org/10.1021/jo0514772




PubMed


 


PubMed ID 16292851
    
     


 



7.
Sion AM, Figg WD (2006). Lysyl oxidase (LOX) and hypoxia-induced metastases. Cancer Biol Ther  5, 909-11.   https://doi.org/10.4161/cbt.5.8.3230




PubMed


 


PubMed ID 16969095
    
     


 



8.
Tkacz VL, Tohnya TM, Figg WD (2005). Cyclooxygenase-2 and angiogenesis in prostate cancer. Cancer Biol Ther  4, 813-4.   https://doi.org/10.4161/cbt.4.8.2089




PubMed


 


PubMed ID 16123581
    
     


 



9.
Warfel NA, Lepper ER, Zhang C, Figg WD, Dennis PA (2006). Importance of the stress kinase p38alpha in mediating the direct cytotoxic effects of the thalidomide analogue, CPS49, in cancer cells and endothelial cells. Clin Cancer Res  12, 3502-9.   https://doi.org/10.1158/1078-0432.CCR-05-1837




PubMed


 


PubMed ID 16740776
    
     


 



10.
Figg WD, Ambrozak AD, Gutschow MD, Lepper ED (submitted in 2006) Tetrahalogenated Compounds Useful As Inhibitors Of Angiogenesis. Patents issued: 8,143,252 (US in 2012); 2007238785 (AU in 2013); 2648216 (CA in 2016); 2004614 (DE in 2017); 2004614 (EP in 2017); 2004614 (FR in 2017); 2004614 (GB in 2017). Patent pending: PCT/US2007/008849 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=44079
526,SC006581-23,"October 01, 2005 -  September 30, 2006",Molecular Pathogenesis of Multiple Myeloma,"Walter M Kuehl; MD, PhD",NULL,"Cancer Genetics Branch, NCI","Constance M Cultraro



Leslie Ann Brents



Adriana  Zingone; MD



Sheila  Teves



Yulia  Demchenko","P.  Bergsagel
(Divison of Hematology, Mayo Clinic)




Rafael  Fonseca
(Division of Hematology, Mayo Clinic)




Thomas  Rasmussen
(Department of Hematology, University of Copenhagen)




John  Shaughnessy
(Lambert Laboratory of Myeloma Genetics, Universiy of Arkansas for Medical Sciences)",Louis  Staudt; MD (Lymphoid Malignancies Branch),NULL,"Ordered by publication type and then author name.



1.
Bergsagel PL, Kuehl WM (2005). Molecular pathogenesis and a consequent classification of multiple myeloma. J Clin Oncol  23, 6333-8.   https://doi.org/10.1200/JCO.2005.05.021




PubMed


 


PubMed ID 16155016",https://intramural.nih.gov/search/searchview.taf?ipid=44080
527,SC006659-24,"October 01, 2005 -  September 30, 2006",Molecular Genetics of Kidney Cancer,"William Marston Linehan; MD



IRP Faculty Profile",NULL,"Urologic Oncology Branch, NCI","Lindsay A. Middelton



Cathy  Vocke; PhD



Youfeng  Yang



Jonathan A Coleman



Donald P Bottaro; PhD



Peter A Pinto; MD



Show all 13","William  Kaelin, M.D.
(HHMI, Dana Farber Cancer Institute)




Alfred  Knudson, M.D.
(Genetics, Fox Chase Cancer Center)




Masahiro  Yao, M.D.
(Urologic Surgery, Yokohama City University Medical School)","Leonard  Neckers; PhD (National Cancer Institute)



Maria  Merino; PhD (National Cancer Institute)



Peter L Choyke; MD (National Cancer Institute)



James  McMahon; PhD (DISCOVERY SECT)



Maria L Turner; MD (National Cancer Institute)



Steven  Libutti; MD (National Cancer Institute)","Edward H. Oldfield; MD (NINDS) 



Karel  Pacak; MD, PhD (NICHD) 



Richard  Childs; MD (NHLBI) 



Emily Y Chew; MD (NEI) 



Pamela  Stratton; MD (NICHD) 



Bradford J Wood; MD (CC)","Ordered by publication type and then author name.



1.
Choyke P   (2006) Genetic Basis of Kidney Cancer, in Comprehensive Textbook of Genitourinary Oncology. Vogelzang x, Scardino x, Shipley x, D x, eds., Lippincott Williams and Wilkins (Philadelphia), pp. 709-723.




 



2.
Dhanani N, Vocke C, Bratslavsky G, Line W   (2006) Molecular Genetics in Inherited Renal Cell Carcinoma: Identification of Targets in the Hereditary Syndromes, in Renal Cell Carcinoma: Molecular Targets and Clinical Applications.  Humana Press, in press.




 



3.
Linehan W, Walther M, Zbar B   (2006) Genetic Basis of Kidney Cancer, in Comprehensive Textbook of Genitourinary Oncology. Vogelzang x, Scardino x, Shipley x, Debruyne x, eds., Lippincott Williams and Wilkins (Philadelphia), pp. 701-708.




 



4.
Athauda G, Giubellino A, Coleman JA, Horak C, Steeg PS, Lee MJ, Trepel J, Wimberly J, Sun J, Coxon A, Burgess TL, Bottaro DP (2006). c-Met ectodomain shedding rate correlates with malignant potential. Clin Cancer Res  12, 4154-62.   https://doi.org/10.1158/1078-0432.CCR-06-0250




PubMed


 


PubMed ID 16857786
    
     


 



5.
Beppu K, Nakamura K, Linehan WM, Rapisarda A, Thiele CJ (2005). Topotecan blocks hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cells. Cancer Res  65, 4775-81.   https://doi.org/10.1158/0008-5472.CAN-04-3332




PubMed


 


PubMed ID 15930297
    
     


 



6.
Bottaro DP, Linehan WM (2005). Multifocal renal cancer: genetic basis and its medical relevance. Clin Cancer Res  11, 7206-8.   https://doi.org/10.1158/1078-0432.CCR-05-1343




PubMed


 


PubMed ID 16243789
    
     


 



7.
Davis IJ, Kim JJ, Ozsolak F, Widlund HR, Rozenblatt-Rosen O, Granter SR, Du J, Fletcher JA, Denny CT, Lessnick SL, Linehan WM, Kung AL, Fisher DE (2006). Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancers. Cancer Cell  9, 473-84.   https://doi.org/10.1016/j.ccr.2006.04.021




PubMed


 


PubMed ID 16766266
    
     


 



8.
Dharmawardana PG, Peruzzi B, Giubellino A, Burke TR, Bottaro DP (2006). Molecular targeting of growth factor receptor-bound 2 (Grb2) as an anti-cancer strategy. Anticancer Drugs  17, 13-20.   https://doi.org/10.1097/01.cad.0000185180.72604.ac




PubMed


 


PubMed ID 16317285
    
     


 



9.
Diner EK, Franks ME, Behari A, Linehan WM, Walther MM (2005). Partial adrenalectomy: the National Cancer Institute experience. Urology  66, 19-23.   https://doi.org/10.1016/j.urology.2005.01.009




PubMed


 


PubMed ID 15961144
    
     


 



10.
Diner EK, Linehan M, Walther M (2005). Response of papillary renal cell carcinoma in a solitary kidney to high dose interleukin therapy. Int J Urol  12, 996-7.   https://doi.org/10.1111/j.1442-2042.2005.01193.x




PubMed


 


PubMed ID 16351658
    
     


 



11.
Diner EK, Williams CR, Behari A, Pinto PA, Linehan WM, Walther MM (2005). Metastatic renal cell carcinoma to contralateral ureter presenting as acute obstructive renal failure after radical nephrectomy. Urology  65, 1001.   https://doi.org/10.1016/j.urology.2004.11.036




PubMed


 


PubMed ID 15882744
    
     


 



12.
Grubb RL, Choyke PL, Pinto PA, Linehan WM, Walther MM (2005). Management of von Hippel-Lindau-associated kidney cancer. Nat Clin Pract Urol  2, 248-55.   https://doi.org/10.1038/ncpuro0179




PubMed


 


PubMed ID 16474836
    
     


 



13.
Hong SB, Furihata M, Baba M, Zbar B, Schmidt LS   (2006) Vascular defects and liver damage by the acute inactivation of the VHL gene during mouse embryogenesis.  Lab Invest 86:664-75.




PubMed


 


PubMed ID 16652107
    
     


 



14.
Isaacs JS, Jung YJ, Mole DR, Lee S, Torres-Cabala C, Chung YL, Merino M, Trepel J, Zbar B, Toro J, Ratcliffe PJ, Linehan WM, Neckers L (2005). HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell  8, 143-53.   https://doi.org/10.1016/j.ccr.2005.06.017




PubMed


 


PubMed ID 16098467
    
     


 



15.
Kang SU, Shi ZD, Worthy KM, Bindu LK, Dharmawardana PG, Choyke SJ, Bottaro DP, Fisher RJ, Burke TR (2005). Examination of phosphoryl-mimicking functionalities within a macrocyclic Grb2 SH2 domain-binding platform. J Med Chem  48, 3945-8.   https://doi.org/10.1021/jm050059m




PubMed


 


PubMed ID 15943469
    
     


 



16.
Kim CM, Vocke C, Torres-Cabala C, Yang Y, Schmidt L, Walther M, Linehan WM (2006). Expression of hypoxia inducible factor-1alpha and 2alpha in genetically distinct early renal cortical tumors. J Urol  175, 1908-14.   https://doi.org/10.1016/S0022-5347(05)00890-6




PubMed


 


PubMed ID 16600797
    
     


 



17.
Lattouf JB, Srinivasan R, Pinto PA, Linehan WM, Neckers L (2006). Mechanisms of disease: the role of heat-shock protein 90 in genitourinary malignancy. Nat Clin Pract Urol  3, 590-601.   https://doi.org/10.1038/ncpuro0604




PubMed


 


PubMed ID 17088927
    
     


 



18.
Lee YS, Vortmeyer AO, Lubensky IA, Vogel TW, Ikejiri B, Ferlicot S, Benoît G, Giraud S, Oldfield EH, Linehan WM, Teh BT, Richard S, Zhuang Z (2005). Coexpression of erythropoietin and erythropoietin receptor in von Hippel-Lindau disease-associated renal cysts and renal cell carcinoma. Clin Cancer Res  11, 1059-64.




PubMed


 


PubMed ID 15709172
    
     


 



19.
Linehan W, Novakovic K, Pinto P   (2006) Genetic Basis of Kidney Cancer: A Model for Development of Molecular Targeted Therapies.  British Journal of Urology, in press.




 



20.
Linehan WM (2006). Identification of the genes for kidney cancer. Cancer Biol Ther  5, 696-9.   https://doi.org/10.4161/cbt.5.6.2948




PubMed


 


PubMed ID 16775424
    
     


 



21.
Linehan WM, Grubb RL, Coleman JA, Zbar B, Walther MM (2005). The genetic basis of cancer of kidney cancer: implications for gene-specific clinical management. BJU Int  95 Suppl 2, 2-7.   https://doi.org/10.1111/j.1464-410X.2005.05189.x




PubMed


 


PubMed ID 15720328
    
     


 



22.
Linehan WM, Pinto PA, Srinivasan R, Merino M, Choyke P, Choyke L, Coleman J, Toro J, Glenn G, Vocke C, Zbar B, Schmidt LS, Bottaro D, Neckers L (2007). Identification of the genes for kidney cancer: opportunity for disease-specific targeted therapeutics. Clin Cancer Res  13, 671s-679s.   https://doi.org/10.1158/1078-0432.CCR-06-1870




PubMed


 


PubMed ID 17255292
    
     


 



23.
Matyakhina L, Freedman RJ, Bourdeau I, Wei MH, Stergiopoulos SG, Chidakel A, Walther M, Abu-Asab M, Tsokos M, Keil M, Toro J, Linehan WM, Stratakis CA (2005). Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical cushing syndrome: a clinical and molecular genetic investigation. J Clin Endocrinol Metab  90, 3773-9.   https://doi.org/10.1210/jc.2004-2377




PubMed


 


PubMed ID 15741255
    
     


 



24.
Pavlovich CP, Grubb RL, Hurley K, Glenn GM, Toro J, Schmidt LS, Torres-Cabala C, Merino MJ, Zbar B, Choyke P, Walther MM, Linehan WM (2005). Evaluation and management of renal tumors in the Birt-Hogg-Dubé syndrome. J Urol  173, 1482-6.   https://doi.org/10.1097/01.ju.0000154629.45832.30




PubMed


 


PubMed ID 15821464
    
     


 



25.
Peruzzi B, Athauda G, Bottaro DP   (2006) The von Hippel-Lindau tumor suppressor gene product represses oncogenic beta-catenin signaling in renal carcinoma cells.  Proc Natl Acad Sci U S A 103:14531-6.




PubMed



        
     
Free Article


 


PubMed ID 16983094
         Pubmed Central ID 1599994 


 



26.
Peruzzi B, Bottaro DP   (2006) Targeting the c-Met signaling pathway in cancer.  Clin Cancer Res 12:3657-60.




PubMed


 


PubMed ID 16778093
    
     


 



27.
Pithukpakorn M, Wei MH, Toure O, Steinbach PJ, Glenn GM, Zbar B, Linehan WM, Toro JR (2006). Fumarate hydratase enzyme activity in lymphoblastoid cells and fibroblasts of individuals in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet  43, 755-62.   https://doi.org/10.1136/jmg.2006.041087




PubMed



        
     
Free Article


 


PubMed ID 16597677
         Pubmed Central ID 2564577 


 



28.
Riss J, Khanna C, Koo S, Chandramouli GV, Yang HH, Hu Y, Kleiner DE, Rosenwald A, Schaefer CF, Ben-Sasson SA, Yang L, Powell J, Kane DW, Star RA, Aprelikova O, Bauer K, Vasselli JR, Maranchie JK, Kohn KW, Buetow KH, Linehan WM, Weinstein JN, Lee MP, Klausner RD, Barrett JC (2006). Cancers as wounds that do not heal: differences and similarities between renal regeneration/repair and renal cell carcinoma. Cancer Res  66, 7216-24.   https://doi.org/10.1158/0008-5472.CAN-06-0040




PubMed


 


PubMed ID 16849569
    
     


 



29.
Rothman A, Glenn G, Choyke L, Srinivasan R, Linehan WM, Cowen EW (2006). Multiple painful cutaneous nodules and renal mass. J Am Acad Dermatol  55, 683-6.   https://doi.org/10.1016/j.jaad.2006.06.026




PubMed


 


PubMed ID 17010749
    
     


 



30.
Schmidt LS, Nickerson ML, Warren MB, Glenn GM, Toro JR, Merino MJ, Turner ML, Choyke PL, Sharma N, Peterson J, Morrison P, Maher ER, Walther MM, Zbar B, Linehan WM (2005). Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dubé syndrome. Am J Hum Genet  76, 1023-33.   https://doi.org/10.1086/430842




PubMed



        
     
Free Article


 


PubMed ID 15852235
         Pubmed Central ID 1196440 


 



31.
Shi ZD, Karki RG, Oishi S, Worthy KM, Bindu LK, Dharmawardana PG, Nicklaus MC, Bottaro DP, Fisher RJ, Burke TR (2005). Utilization of a nitrobenzoxadiazole (NBD) fluorophore in the design of a Grb2 SH2 domain-binding peptide mimetic. Bioorg Med Chem Lett  15, 1385-8.   https://doi.org/10.1016/j.bmcl.2005.01.017




PubMed


 


PubMed ID 15713392
    
     


 



32.
Singh SR, Zhen W, Zheng Z, Wang H, Oh SW, Liu W, Zbar B, Schmidt LS, Hou SX   (2006) The Drosophila homolog of the human tumor suppressor gene BHD interacts with the JAK-STAT and Dpp signaling pathways in regulating male germline stem cell maintenance.  Oncogene 25:5933-41.




PubMed


 


PubMed ID 16636660
    
     


 



33.
Srinivasan R, Linehan WM (2005). Targeted for destruction: the molecular basis for development of novel therapeutic strategies in renal cell cancer. J Clin Oncol  23, 410-2.   https://doi.org/10.1200/JCO.2005.09.907




PubMed


 


PubMed ID 15572728
    
     


 



34.
Sudarshan S, Linehan WM (2006). Genetic basis of cancer of the kidney. Semin Oncol  33, 544-51.   https://doi.org/10.1053/j.seminoncol.2006.06.008




PubMed


 


PubMed ID 17045083
    
     


 



35.
Vocke CD, Yang Y, Pavlovich CP, Schmidt LS, Nickerson ML, Torres-Cabala CA, Merino MJ, Walther MM, Zbar B, Linehan WM (2005). High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dubé-associated renal tumors. J Natl Cancer Inst  97, 931-5.   https://doi.org/10.1093/jnci/dji154




PubMed


 


PubMed ID 15956655
    
     


 



36.
Vogel TW, Brouwers FM, Lubensky IA, Vortmeyer AO, Weil RJ, Walther MM, Oldfield EH, Linehan WM, Pacak K, Zhuang Z (2005). Differential expression of erythropoietin and its receptor in von hippel-lindau-associated and multiple endocrine neoplasia type 2-associated pheochromocytomas. J Clin Endocrinol Metab  90, 3747-51.   https://doi.org/10.1210/jc.2004-1899




PubMed


 


PubMed ID 15769989
    
     


 



37.
Warburton HE, Brady M, Vlatković N, Linehan WM, Parsons K, Boyd MT (2005). p53 regulation and function in renal cell carcinoma. Cancer Res  65, 6498-503.   https://doi.org/10.1158/0008-5472.CAN-05-0017




PubMed


 


PubMed ID 16061625
    
     


 



38.
Wei MH, Toure O, Glenn GM, Pithukpakorn M, Neckers L, Stolle C, Choyke P, Grubb R, Middelton L, Turner ML, Walther MM, Merino MJ, Zbar B, Linehan WM, Toro JR (2006). Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet  43, 18-27.   https://doi.org/10.1136/jmg.2005.033506




PubMed



        
     
Free Article


 


PubMed ID 15937070
         Pubmed Central ID 2564499 


 



39.
Woldemichael GM, Vasselli JR, Gardella RS, McKee TC, Linehan WM, McMahon JB (2006). Development of a cell-based reporter assay for screening of inhibitors of hypoxia-inducible factor 2-induced gene expression. J Biomol Screen  11, 678-87.   https://doi.org/10.1177/1087057106289234




PubMed


 


PubMed ID 16858007
    
     


 



40.
Zbar B, Glenn G, Merino M, Middelton L, Peterson J, Toro J, Coleman J, Pinto P, Schmidt LS, Choyke P, Linehan WM (2007). Familial renal carcinoma: clinical evaluation, clinical subtypes and risk of renal carcinoma development. J Urol  177, 461-5; discussion 465.   https://doi.org/10.1016/j.juro.2006.09.037




PubMed


 


PubMed ID 17222609",https://intramural.nih.gov/search/searchview.taf?ipid=44081
528,SC006660-22,"October 01, 2005 -  September 30, 2006",Defining the T-cell Response to Human Renal Cancer,"James Chung-Yin Yang; MD, PhD



IRP Faculty Profile",NULL,"Surgery Branch, NCI","Qiong J Wang



Cynthia  Liu



Takashi  Inozume",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Beck KE, Blansfield JA, Tran KQ, Feldman AL, Hughes MS, Royal RE, Kammula US, Topalian SL, Sherry RM, Kleiner D, Quezado M, Lowy I, Yellin M, Rosenberg SA, Yang JC (2006). Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4. J Clin Oncol  24, 2283-9.   https://doi.org/10.1200/JCO.2005.04.5716




PubMed



        
     
Free Article


 


PubMed ID 16710025
         Pubmed Central ID 2140223",https://intramural.nih.gov/search/searchview.taf?ipid=44048
529,SC006663-17,"October 01, 2005 -  September 30, 2006",Characterization and Regulation of High Risk and Malignant Breast Epithelium,David  Danforth,NULL,"Surgery Branch, NCI",NULL,NULL,"Andrea  Abati; BS, MD (National Cancer Institute)



Richard  Simon (National Cancer Institute)



Karl Thomas Ried; MD (National Cancer Institute)



Jennifer  Eng Wong (National Cancer Institute)



Patricia  Steeg; PhD (National Cancer Institute)



Barbara V Vonderhaar; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Danforth D, Prindiville S, Palmieri D, Simon R, Ried T, Steeg P   (2006) Combined breast ductal lavage and ductal endoscopy for the evaluation of the high risk breast: A feasability study.  Journal of Surgical Oncology, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=44082
530,SC006732-18,"October 01, 2005 -  September 30, 2006",Multidrug resistance Mediated by P-glycoprotein,"Antonio  Fojo; MD, PhD",NULL,"Medical Oncology Branch, NCI",Lyn  Mickley Huff,"Branimir  Sikic
(Division of Oncology, Stanford University)




Wilfred  Stein
(Biological Chemistry, Silberman Institute of Life Sciences, Hebrew University of Jerusalem)","Susan  Bates; MD (National Cancer Institute)



William D Figg; PharmD (National Cancer Institute)



Frank M Balis; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bates SE, Rosing DR, Fojo T, Piekarz RL (2006). Challenges of evaluating the cardiac effects of anticancer agents. Clin Cancer Res  12, 3871-4.   https://doi.org/10.1158/1078-0432.CCR-06-1017




PubMed


 


PubMed ID 16818679
    
     


 



2.
Fojo AT (2005). Introduction: chemotherapies in the treatment of breast cancer. Semin Oncol  32, S1-2.   https://doi.org/10.1053/j.seminoncol.2005.09.012




PubMed


 


PubMed ID 16360715
    
     


 



3.
Huff LM, Lee JS, Robey RW, Fojo T (2006) Characterization of gene rearrangements leading to activation of MDR-1. J Biol Chem 281:36501-9




PubMed


 


PubMed ID 16956878
    
     


 



4.
Huff LM, Wang Z, Iglesias A, Fojo T, Lee JS (2005). Aberrant transcription from an unrelated promoter can result in MDR-1 expression following drug selection in vitro and in relapsed lymphoma samples. Cancer Res  65, 11694-703.   https://doi.org/10.1158/0008-5472.CAN-04-1349




PubMed


 


PubMed ID 16357181
    
     


 



5.
Piekarz RL, Frye AR, Wright JJ, Steinberg SM, Liewehr DJ, Rosing DR, Sachdev V, Fojo T, Bates SE (2006). Cardiac studies in patients treated with depsipeptide, FK228, in a phase II trial for T-cell lymphoma. Clin Cancer Res  12, 3762-73.   https://doi.org/10.1158/1078-0432.CCR-05-2095




PubMed


 


PubMed ID 16778104
    
     


 



6.
Robey RW, Zhan Z, Piekarz RL, Kayastha GL, Fojo T, Bates SE (2006). Increased MDR1 expression in normal and malignant peripheral blood mononuclear cells obtained from patients receiving depsipeptide (FR901228, FK228, NSC630176). Clin Cancer Res  12, 1547-55.   https://doi.org/10.1158/1078-0432.CCR-05-1423




PubMed


 


PubMed ID 16533780
    
     


 



7.
Stein WD, Litman T, Fojo T, Bates SE (2005). Differential expression of cell adhesion genes: implications for drug resistance. Int J Cancer  113, 861-5.   https://doi.org/10.1002/ijc.20671




PubMed


 


PubMed ID 15514970",https://intramural.nih.gov/search/searchview.taf?ipid=44085
531,SC006737-15,"October 01, 2005 -  September 30, 2006",Development of Novel Therapies for HIV Infection and AIDS-Related Malignancies,"Robert  Yarchoan; MD



IRP Faculty Profile",NULL,"HIV and AIDS Malignancy Branch, NCI","Richard  Little; MD, PhD



Muzammel  Haque



David A Davis; MD



Victoria Y Wang



Kathleen M Wyvill



Karen O Aleman



Show all 9","Shinji  Harada
(Department of Medical Virology, Kumomoto University)




Takahiro  Okazaki
(Internal Medicine, St. Marianna School of Medicine)","Giovanna  Tosato; PhD (National Cancer Institute)



Wyndham H Wilson; MD, PhD (National Cancer Institute)



Hiroaki  Mitsuya (National Cancer Institute)



Denise  Whitby (National Cancer Institute)



Yves  Pommier; PhD (National Cancer Institute)



Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)","Henry M. Fales; PhD (NHLBI) 



Paul T Wingfield; PhD (NIAMS) 



Joseph A Kovacs; MD (CC) 



Amir Hossein Gandjbakhche; PhD (NICHD) 



Jeffrey  Cohen; MD (NIAID)","Ordered by publication type and then author name.



1.
Yarchoan R, Chernomordik V, Vogel A, Hattery D, Gannot I, Gandjibakhche A   (2006) Infrared imaging for tissue characterization and function, in The Biomedical Engineering Handbook, Third Edition, Bronzino JD, Ed. CRC Press (Boca Raton, FL), pp. 30-1 - 30-25.




 



2.
Bernstein WB, Little RF, Wilson WH, Yarchoan R (2006). Acquired immunodeficiency syndrome-related malignancies in the era of highly active antiretroviral therapy. Int J Hematol  84, 3-11.   https://doi.org/10.1532/IJH97.06088




PubMed


 


PubMed ID 16867895
    
     


 



3.
Haque M, Wang V, Davis DA, Zheng ZM, Yarchoan R (2006). Genetic organization and hypoxic activation of the Kaposi's sarcoma-associated herpesvirus ORF34-37 gene cluster. J Virol  80, 7037-51.   https://doi.org/10.1128/JVI.00553-06




PubMed



        
     
Free Article


 


PubMed ID 16809309
         Pubmed Central ID 1489055 


 



4.
Little RF, Pluda JM, Wyvill KM, Rodriguez-Chavez IR, Tosato G, Catanzaro AT, Steinberg SM, Yarchoan R (2006). Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcoma. Blood  107, 4650-7.   https://doi.org/10.1182/blood-2005-11-4455




PubMed



        
     
Free Article


 


PubMed ID 16507779
         Pubmed Central ID 1475826 


 



5.
Semenova EA, Johnson AA, Marchand C, Davis DA, Yarchoan R, Pommier Y (2006). Preferential inhibition of the magnesium-dependent strand transfer reaction of HIV-1 integrase by alpha-hydroxytropolones. Mol Pharmacol  69, 1454-60.   https://doi.org/10.1124/mol.105.020321




PubMed


 


PubMed ID 16418335
    
     


 



6.
Yarchoan R   (2006) KSHV wages a two-front war on PECAM/CD31 [Editorial].  Blood  1790-1791 pp.




 



7.
Yarchoan R, Parks T, Bagni R, Wang C, Samols M, Hu J, Wyvill K, Aleman K, Little R, Renne R, Whitby D   (2006) Conservation of virally-encoded microRNA's in the the Kaposis sarcoma associated herpesvirus (KSHV) in primary effusion lymphoma cell lines and in patients with Kaposis sarcoma or multicentric Castlemans disease.  The Journal of Infectious Diseases, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=44086
532,SC006738-14,"October 01, 2005 -  September 30, 2006",Development of Antiviral Therapy of HIV-1 Infection,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI","Shigeyoshi  Harada



Kenji  Maeda



Kiyoto  Tsuchiya","Nobutaka 	  Fujii	
(Department of Pharmacy, Kyoto University)




Arun  Ghosh





Yoshio 		  Koyanagi
(Institute for Virus Research, Kyoto University)




Masao 		  Matsuoka
(Institute for Virus Research, Kyoto University)




Shinichi 	  Oka	
(AIDS clinical center, International Medical Center of Japan)




Jiri 	  Zemlicka	
(Karmanos Cancer Institute, Wayne State University School of Medicine)",Robert  Yarchoan; MD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Davis DA, Brown CA, Singer KE, Wang V, Kaufman J, Stahl SJ, Wingfield P, Maeda K, Harada S, Yoshimura K, Kosalaraksa P, Mitsuya H, Yarchoan R (2006). Inhibition of HIV-1 replication by a peptide dimerization inhibitor of HIV-1 protease. Antiviral Res  72, 89-99.   https://doi.org/10.1016/j.antiviral.2006.03.015




PubMed


 


PubMed ID 16687179
    
     


 



2.
Depboylu C, Schäfer MK, Schwaeble WJ, Reinhart TA, Maeda H, Mitsuya H, Damadzic R, Rausch DM, Eiden LE, Weihe E (2005). Increase of C1q biosynthesis in brain microglia and macrophages during lentivirus infection in the rhesus macaque is sensitive to antiretroviral treatment with 6-chloro-2',3'-dideoxyguanosine. Neurobiol Dis  20, 12-26.   https://doi.org/10.1016/j.nbd.2005.01.030




PubMed


 


PubMed ID 16137563
    
     


 



3.
Gatanaga H, Das D, Suzuki Y, Yeh DD, Hussain KA, Ghosh AK, Mitsuya H (2006). Altered HIV-1 Gag protein interactions with cyclophilin A (CypA) on the acquisition of H219Q and H219P substitutions in the CypA binding loop. J Biol Chem  281, 1241-50.   https://doi.org/10.1074/jbc.M505920200




PubMed


 


PubMed ID 16275650
    
     


 



4.
Ghosh AK, Ramu Sridhar P, Kumaragurubaran N, Koh Y, Weber IT, Mitsuya H (2006). Bis-tetrahydrofuran: a privileged ligand for darunavir and a new generation of hiv protease inhibitors that combat drug resistance. ChemMedChem  1, 939-50.   https://doi.org/10.1002/cmdc.200600103




PubMed


 


PubMed ID 16927344
    
     


 



5.
Ghosh AK, Schiltz G, Perali RS, Leshchenko S, Kay S, Walters DE, Koh Y, Maeda K, Mitsuya H (2006). Design and synthesis of novel HIV-1 protease inhibitors incorporating oxyindoles as the P2'-ligands. Bioorg Med Chem Lett  16, 1869-73.   https://doi.org/10.1016/j.bmcl.2006.01.011




PubMed


 


PubMed ID 16480871
    
     


 



6.
Ghosh AK, Sridhar PR, Leshchenko S, Hussain AK, Li J, Kovalevsky AY, Walters DE, Wedekind JE, Grum-Tokars V, Das D, Koh Y, Maeda K, Gatanaga H, Weber IT, Mitsuya H (2006). Structure-based design of novel HIV-1 protease inhibitors to combat drug resistance. J Med Chem  49, 5252-61.   https://doi.org/10.1021/jm060561m




PubMed


 


PubMed ID 16913714
    
     


 



7.
Habashita H, Kokubo M, Hamano S, Hamanaka N, Toda M, Shibayama S, Tada H, Sagawa K, Fukushima D, Maeda K, Mitsuya H (2006). Design, synthesis, and biological evaluation of the combinatorial library with a new spirodiketopiperazine scaffold. Discovery of novel potent and selective low-molecular-weight CCR5 antagonists. J Med Chem  49, 4140-52.   https://doi.org/10.1021/jm060051s




PubMed


 


PubMed ID 16821774
    
     


 



8.
Hanaoka N, Kawaguchi T, Horikawa K, Nagakura S, Mitsuya H, Nakakuma H (2006). Immunoselection by natural killer cells of PIGA mutant cells missing stress-inducible ULBP. Blood  107, 1184-91.   https://doi.org/10.1182/blood-2005-03-1337




PubMed


 


PubMed ID 16195329
    
     


 



9.
Hata H, Mitsuya H (2006). [Management of bone lesions in multiple myeloma]. Gan To Kagaku Ryoho  33, 1072-6.




PubMed


 


PubMed ID 16912524
    
     


 



10.
Kuwata K, Yamada S, Kinuwaki E, Naito M, Mitsuya H (2006). Peripheral hemophagocytosis: An early indicator of advanced systemic inflammatory response syndrome/hemophagocytic syndrome. Shock  25, 344-50.   https://doi.org/10.1097/01.shk.0000209520.82377.41




PubMed


 


PubMed ID 16670635
    
     


 



11.
Maeda K, Das D, Ogata-Aoki H, Nakata H, Miyakawa T, Tojo Y, Norman R, Takaoka Y, Ding J, Arnold GF, Arnold E, Mitsuya H (2006). Structural and molecular interactions of CCR5 inhibitors with CCR5. J Biol Chem  281, 12688-98.   https://doi.org/10.1074/jbc.M512688200




PubMed


 


PubMed ID 16476734
    
     


 



12.
Miyazato P, Yasunaga J, Taniguchi Y, Koyanagi Y, Mitsuya H, Matsuoka M (2006). De novo human T-cell leukemia virus type 1 infection of human lymphocytes in NOD-SCID, common gamma-chain knockout mice. J Virol  80, 10683-91.   https://doi.org/10.1128/JVI.01009-06




PubMed



        
     
Free Article


 


PubMed ID 16943297
         Pubmed Central ID 1641804 


 



13.
Morito N, Yoh K, Fujioka Y, Nakano T, Shimohata H, Hashimoto Y, Yamada A, Maeda A, Matsuno F, Hata H, Suzuki A, Imagawa S, Mitsuya H, Esumi H, Koyama A, Yamamoto M, Mori N, Takahashi S (2006). Overexpression of c-Maf contributes to T-cell lymphoma in both mice and human. Cancer Res  66, 812-9.   https://doi.org/10.1158/0008-5472.CAN-05-2154




PubMed


 


PubMed ID 16424013
    
     


 



14.
Nakamura M, Gotoh T, Okuno Y, Tatetsu H, Sonoki T, Uneda S, Mori M, Mitsuya H, Hata H (2006). Activation of the endoplasmic reticulum stress pathway is associated with survival of myeloma cells. Leuk Lymphoma  47, 531-9.   https://doi.org/10.1080/10428190500312196




PubMed


 


PubMed ID 16396777
    
     


 



15.
Nanri T, Matsuno N, Kawakita T, Mitsuya H, Asou N (2005). Imatinib mesylate for refractory acute myeloblastic leukemia harboring inv(16) and a C-KIT exon 8 mutation. Leukemia  19, 1673-5.   https://doi.org/10.1038/sj.leu.2403889




PubMed


 


PubMed ID 16049512
    
     


 



16.
Sonoki T, Iwanaga E, Mitsuya H, Asou N (2005). Ovarian relapse seven years after bone marrow transplantation for B-cell acute lymphoblastic leukemia: an unusual Krukenberg tumor. Am J Hematol  80, 75-6.   https://doi.org/10.1002/ajh.20420




PubMed


 


PubMed ID 16138346
    
     


 



17.
Tatetsu H, Asou N, Nakamura M, Hanaoka N, Matsuno F, Horikawa K, Mitsuya H (2006). Torsades de pointes upon fluconazole administration in a patient with acute myeloblastic leukemia. Am J Hematol  81, 366-9.   https://doi.org/10.1002/ajh.20557




PubMed


 


PubMed ID 16628725
    
     


 



18.
Tatetsu H, Okuno Y, Nakamura M, Matsuno F, Sonoki T, Taniguchi I, Uneda S, Umezawa K, Mitsuya H, Hata H (2005). Dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, induces apoptosis in multiple myeloma cells in an IkappaBalpha-independent manner. Mol Cancer Ther  4, 1114-20.   https://doi.org/10.1158/1535-7163.MCT-04-0198




PubMed


 


PubMed ID 16020669
    
     


 



19.
Yamada Y, Nishimoto E, Mitsuya H, Yonemura Y (2006). In vitro transdifferentiation of adult bone marrow Sca-1+ cKit- cells cocultured with fetal liver cells into hepatic-like cells without fusion. Exp Hematol  34, 97-106.   https://doi.org/10.1016/j.exphem.2005.09.018




PubMed


 


PubMed ID 16413396
    
     


 



20.
Yin PD, Das D, Mitsuya H (2006). Overcoming HIV drug resistance through rational drug design based on molecular, biochemical, and structural profiles of HIV resistance. Cell Mol Life Sci  63, 1706-24.   https://doi.org/10.1007/s00018-006-6009-7




PubMed


 


PubMed ID 16715409
    
     


 



21.
Yonemura Y, Miyake H, Asou N, Mitsuya H (2005). Long-term efficacy of pegylated recombinant human megakaryocyte growth and development factor in therapy of aplastic anemia. Int J Hematol  82, 307-9.   https://doi.org/10.1532/IJH97.05032




PubMed


 


PubMed ID 16298819
    
     


 



22.
Yoshimura K, Shibata J, Kimura T, Honda A, Maeda Y, Koito A, Murakami T, Mitsuya H, Matsushita S (2006). Resistance profile of a neutralizing anti-HIV monoclonal antibody, KD-247, that shows favourable synergism with anti-CCR5 inhibitors. AIDS  20, 2065-73.   https://doi.org/10.1097/01.aids.0000247587.31320.fe




PubMed


 


PubMed ID 17053352
    
     


 



23.
Zhou S, Kern ER, Gullen E, Cheng YC, Drach JC, Tamiya S, Mitsuya H, Zemlicka J (2006). 9-{[3-fluoro-2-(hydroxymethyl)cyclopropylidene]methyl}adenines and -guanines. Synthesis and antiviral activity of all stereoisomers1. J Med Chem  49, 6120-8.   https://doi.org/10.1021/jm0607404




PubMed



        
     
Free Article


 


PubMed ID 17004726
         Pubmed Central ID 2562564",https://intramural.nih.gov/search/searchview.taf?ipid=44049
533,SC006741-13,"October 01, 2005 -  September 30, 2006",Lymphoma Studies,"Wyndham H Wilson; MD, PhD



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Kieron Michael Dunleavy,NULL,"Louis  Staudt; MD (Lymphoid Malignancies Branch)



Elaine S Jaffe; MD (National Cancer Institute)



John  Janik; MD (National Cancer Institute)



Maryalice  Stetler-Stevenson; MD, PhD (National Cancer Institute)



Stefania  Pittaluga (National Cancer Institute)



Andrea  Abati; BS, MD (National Cancer Institute)","Adrian U Wiestner; MD, PhD (NHLBI)","Ordered by publication type and then author name.



1.
Dunleavy K, Hakim F, Kim HK, Janik JE, Grant N, Nakayama T, White T, Wright G, Kwak L, Gress R, Tosato G, Wilson WH (2005). B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasis. Blood  106, 795-802.   https://doi.org/10.1182/blood-2004-08-3198




PubMed



        
     
Free Article


 


PubMed ID 15718416
         Pubmed Central ID 1895166",https://intramural.nih.gov/search/searchview.taf?ipid=44050
534,SC006743-13,"October 01, 2005 -  September 30, 2006",Signal Transduction Events and the Regulation of Cell Growth,Jane Beth Trepel,Lee Jay Helman; MD,"Medical Oncology Branch, NCI",Sunmin T Lee,NULL,"J. Frederic Mushinski; MD (National Cancer Institute)



Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)



Leonard  Neckers; PhD (National Cancer Institute)



John  Janik; MD (National Cancer Institute)



William Marston Linehan; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Athauda G, Giubellino A, Coleman JA, Horak C, Steeg PS, Lee MJ, Trepel J, Wimberly J, Sun J, Coxon A, Burgess TL, Bottaro DP (2006). c-Met ectodomain shedding rate correlates with malignant potential. Clin Cancer Res  12, 4154-62.   https://doi.org/10.1158/1078-0432.CCR-06-0250




PubMed


 


PubMed ID 16857786
    
     


 



2.
Chung EJ, Lee MJ, Lee S, Trepel JB (2006). Assays for pharmacodynamic analysis of histone deacetylase inhibitors. Expert Opin Drug Metab Toxicol  2, 213-30.   https://doi.org/10.1517/17425255.2.2.213




PubMed


 


PubMed ID 16866608
    
     


 



3.
Isaacs JS, Jung YJ, Mole DR, Lee S, Torres-Cabala C, Chung YL, Merino M, Trepel J, Zbar B, Toro J, Ratcliffe PJ, Linehan WM, Neckers L (2005). HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell  8, 143-53.   https://doi.org/10.1016/j.ccr.2005.06.017




PubMed


 


PubMed ID 16098467
    
     


 



4.
Marcu MG, Jung YJ, Lee S, Chung EJ, Lee MJ, Trepel J, Neckers L (2006). Curcumin is an inhibitor of p300 histone acetylatransferase. Med Chem  2, 169-74.   https://doi.org/10.2174/157340606776056133




PubMed


 


PubMed ID 16787365
    
     


 



5.
Niedermeier A, Talanin N, Chung EJ, Sells RE, Borris DL, Orenstein JM, Trepel JB, Blauvelt A (2006). Histone deacetylase inhibitors induce apoptosis with minimal viral reactivation in cells infected with Kaposi's sarcoma-associated herpesvirus. J Invest Dermatol  126, 2516-24.   https://doi.org/10.1038/sj.jid.5700438




PubMed


 


PubMed ID 16810301
    
     


 



6.
Posadas EM, Gulley J, Arlen PM, Trout A, Parnes HL, Wright J, Lee MJ, Chung EJ, Trepel JB, Sparreboom A, Chen C, Jones E, Steinberg SM, Daniels A, Figg WD, Dahut WL (2005). A phase II study of perifosine in androgen independent prostate cancer. Cancer Biol Ther  4, 1133-7.   https://doi.org/10.4161/cbt.4.10.2064




PubMed


 


PubMed ID 16138006
    
     


 



7.
Rubinstein YR, Furusawa T, Lim JH, Postnikov YV, West KL, Birger Y, Lee S, Nguyen P, Trepel JB, Bustin M (2005). Chromosomal protein HMGN1 modulates the expression of N-cadherin. FEBS J  272, 5853-63.   https://doi.org/10.1111/j.1742-4658.2005.04980.x




PubMed



        
     
Free Article


 


PubMed ID 16279949
         Pubmed Central ID 3730465 


 



8.
Ryan QC, Headlee D, Acharya M, Sparreboom A, Trepel JB, Ye J, Figg WD, Hwang K, Chung EJ, Murgo A, Melillo G, Elsayed Y, Monga M, Kalnitskiy M, Zwiebel J, Sausville EA (2005). Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma. J Clin Oncol  23, 3912-22.   https://doi.org/10.1200/JCO.2005.02.188




PubMed


 


PubMed ID 15851766
    
     


 



9.
Steiner FA, Hong JA, Fischette MR, Beer DG, Guo ZS, Chen GA, Weiser TS, Kassis ES, Nguyen DM, Lee S, Trepel JB, Schrump DS (2005). Sequential 5-Aza 2'-deoxycytidine/depsipeptide FK228 treatment induces tissue factor pathway inhibitor 2 (TFPI-2) expression in cancer cells. Oncogene  24, 2386-97.   https://doi.org/10.1038/sj.onc.1208376




PubMed


 


PubMed ID 15735751
    
     


 



10.
Trepel J, Chung E, Lee S   (2006) Beta-catenin signalling: A new therapeutic target in haematological malignancies.  Expert Opinion on Therapeutic Targets, in press.




 



11.
Trepel J, Vuppalanchi D, van Niekerk E, Schanen N, Twiss J   (2006) PC12 cells regulate ICER expression to differentially control CRE-dependent transcription in response to NGF and cAMP.  J. Neurochem, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=44157
535,SC006813-24,"October 01, 2005 -  September 30, 2006",Cell and Molecular Genetic Analysis of Pediatric Tumors,"Carol J Thiele



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Zhi-Jie  Li



Amy E Mckee



Jennifer  Jackson



Fei  Tan



Hideya  Onishi",NULL,"Giovanni  Melillo (National Cancer Institute)



Susan  Bates; MD (National Cancer Institute)



Javed  Khan; MD (National Cancer Institute)



Chand  Khanna; MD (National Cancer Institute)



Phillip A Dennis; MD, PhD (National Cancer Institute)



Stephen M Hewitt; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Li Z, Zhang J, Liu Z, Woo CW, Thiele CJ (2007). Downregulation of Bim by brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from paclitaxel but not etoposide or cisplatin-induced cell death. Cell Death Differ  14, 318-26.   https://doi.org/10.1038/sj.cdd.4401983




PubMed


 


PubMed ID 16778834
    
     


 



2.
Liu Z, Yang X, Tan F, Cullion K, Thiele CJ   (2006) Molecular cloning and characterization of human Castor, a novel human gene upregulated during cell differentiation.  Biochem Biophys Res Commun 344:834-44.




PubMed


 


PubMed ID 16631614
    
     


 



3.
McKee AE, Thiele CJ   (2006) Targeting caspase 8 to reduce the formation of metastases in neuroblastoma.  Expert Opin Ther Targets 10:703-8.




PubMed


 


PubMed ID 16981827
    
     


 



4.
Nakamura K, Martin KC, Jackson JK, Beppu K, Woo CW, Thiele CJ   (2006) Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1alpha in neuroblastoma cells.  Cancer Res 66:4249-55.




PubMed


 


PubMed ID 16618748
    
     


 



5.
Yang X, Zhang J, Jaboin J, Merchant M, Rajpal G, Mackall C, Thiele C   (2006) The sensitivity of TNF-related apoptosis-inducing ligand in Neuroblastoma is increased by elevated levels of N-myc but not blocked by BDNF/TrkB activation.  World J. Pediatrics  187-194 pp.",https://intramural.nih.gov/search/searchview.taf?ipid=44087
536,SC006830-36,"October 01, 2005 -  September 30, 2006","Treatment of Infections in Immunocompromised Children with Cancer, Hematopoietic",Thomas J. Walsh; MD,NULL,"Pediatric Oncology Branch, NCI","Karoll  Cortez



Miki B Kasai



Joanne S Peter



Robert L Schaufele



Theodouli  Stergiopoulou



Tatyana  Sarkisova



Show all 17","Antonio  Arrieta
(Infectious Diseases, Children's Hospital)




Donald  Buell
(Biomedical Research, Astellas)




Anthony  DeLucca
(Southern Regional Research Laboratory, USDA)




David  Denning; MD
(Department pf Medicine, Manchester University)




William  Dismukes
(Medicine, University of Alabama at Birmingham)




Gerald  Donowitz
(Medicine, Univ Virginia)


Show all 27","Elizabeth  Fox; MD (National Cancer Institute)



Alan S Wayne; MD (National Cancer Institute)



Juan Carlos Gea-Banacloche; MD (National Cancer Institute)



Terry J Fry (National Cancer Institute)



Javed  Khan; MD (National Cancer Institute)



Stephen J Chanock; MD, PhD (National Cancer Institute)","Anthony F Suffredini; MD (CC) 



Steven M Holland; MD (NIAID) 



Yvonne D Shea (CC) 



Susan M Harrington; PhD (CC) 



Richard  Childs; MD (NHLBI) 



Karim Anton Calis; PharmD, MPH (CC)","Ordered by publication type and then author name.



1.
Antachopoulos C, Meletiadis J, Roilides E, Sein T, Sutton DA, Wickes BL, Rinaldi MG, Merz WG, Shea YR, Walsh TJ (2006). Relationship between metabolism and biomass of medically important zygomycetes. Med Mycol  44, 429-38.   https://doi.org/10.1080/13693780600644878




PubMed


 


PubMed ID 16882609
    
     


 



2.
Antachopoulos C, Meletiadis J, Roilides E, Sein T, Walsh TJ (2006). Rapid susceptibility testing of medically important zygomycetes by XTT assay. J Clin Microbiol  44, 553-60.   https://doi.org/10.1128/JCM.44.2.553-560.2006




PubMed



        
     
Free Article


 


PubMed ID 16455912
         Pubmed Central ID 1392685 


 



3.
Benjamin DK, Driscoll T, Seibel NL, Gonzalez CE, Roden MM, Kilaru R, Clark K, Dowell JA, Schranz J, Walsh TJ   (2006) Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections.  Antimicrob Agents Chemother 50:632-8.




PubMed


 


PubMed ID 16436720
    
     


 



4.
Chu JH, Feudtner C, Heydon K, Walsh TJ, Zaoutis TE (2006). Hospitalizations for endemic mycoses: a population-based national study. Clin Infect Dis  42, 822-5.   https://doi.org/10.1086/500405




PubMed


 


PubMed ID 16477560
    
     


 



5.
Cortez KJ, Lyman CA, Kottilil S, Kim HS, Roilides E, Yang J, Fullmer B, Lempicki R, Walsh TJ (2006). Functional genomics of innate host defense molecules in normal human monocytes in response to Aspergillus fumigatus. Infect Immun  74, 2353-65.   https://doi.org/10.1128/IAI.74.4.2353-2365.2006




PubMed



        
     
Free Article


 


PubMed ID 16552065
         Pubmed Central ID 1418921 


 



6.
De Lucca AJ, Bland JM, Boue S, Vigo CB, Cleveland TE, Walsh TJ (2006). Synergism of CAY-1 with amphotericin B and itraconazole. Chemotherapy  52, 285-7.   https://doi.org/10.1159/000095959




PubMed


 


PubMed ID 17008779
    
     


 



7.
de Pauw BE, Sable CA, Walsh TJ, Lupinacci RJ, Bourque MR, Wise BA, Nguyen BY, DiNubile MJ, Teppler H (2006). Impact of alternate definitions of fever resolution on the composite endpoint in clinical trials of empirical antifungal therapy for neutropenic patients with persistent fever: analysis of results from the Caspofungin Empirical Therapy Study. Transpl Infect Dis  8, 31-7.   https://doi.org/10.1111/j.1399-3062.2006.00127.x




PubMed


 


PubMed ID 16623818
    
     


 



8.
Dennis CG, Greco WR, Brun Y, Youn R, Slocum HK, Bernacki RJ, Lewis R, Wiederhold N, Holland SM, Petraitiene R, Walsh TJ, Segal BH (2006). Effect of amphotericin B and micafungin combination on survival, histopathology, and fungal burden in experimental aspergillosis in the p47phox-/- mouse model of chronic granulomatous disease. Antimicrob Agents Chemother  50, 422-7.   https://doi.org/10.1128/AAC.50.2.422-427.2006




PubMed



        
     
Free Article


 


PubMed ID 16436692
         Pubmed Central ID 1366912 


 



9.
Dotis J, Simitsopoulou M, Dalakiouridou M, Konstantinou T, Taparkou A, Kanakoudi-Tsakalidou F, Walsh TJ, Roilides E (2006). Effects of lipid formulations of amphotericin B on activity of human monocytes against Aspergillus fumigatus. Antimicrob Agents Chemother  50, 868-73.   https://doi.org/10.1128/AAC.50.3.868-873.2006




PubMed



        
     
Free Article


 


PubMed ID 16495244
         Pubmed Central ID 1426430 


 



10.
Espinel-Ingroff A, Fothergill A, Ghannoum M, Manavathu E, Ostrosky-Zeichner L, Pfaller M, Rinaldi M, Schell W, Walsh T (2005). Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M 38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole. J Clin Microbiol  43, 5243-6.   https://doi.org/10.1128/JCM.43.10.5243-5246.2005




PubMed



        
     
Free Article


 


PubMed ID 16207990
         Pubmed Central ID 1248457 


 



11.
Francesconi A, Kasai M, Petraitiene R, Petraitis V, Kelaher AM, Schaufele R, Hope WW, Shea YR, Bacher J, Walsh TJ (2006). Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis. J Clin Microbiol  44, 2475-80.   https://doi.org/10.1128/JCM.02693-05




PubMed



        
     
Free Article


 


PubMed ID 16825367
         Pubmed Central ID 1489482 


 



12.
Groll AH, Lyman CA, Petraitis V, Petraitiene R, Armstrong D, Mickiene D, Alfaro RM, Schaufele RL, Sein T, Bacher J, Walsh TJ (2006). Compartmentalized intrapulmonary pharmacokinetics of amphotericin B and its lipid formulations. Antimicrob Agents Chemother  50, 3418-23.   https://doi.org/10.1128/AAC.00241-06




PubMed



        
     
Free Article


 


PubMed ID 17005824
         Pubmed Central ID 1610093 


 



13.
Groll AH, Mickiene D, Petraitis V, Petraitiene R, Kelaher A, Sarafandi A, Wuerthwein G, Bacher J, Walsh TJ (2005). Compartmental pharmacokinetics and tissue distribution of the antifungal triazole ravuconazole following intravenous administration of its di-lysine phosphoester prodrug (BMS-379224) in rabbits. J Antimicrob Chemother  56, 899-907.   https://doi.org/10.1093/jac/dki287




PubMed


 


PubMed ID 16172108
    
     


 



14.
Groll AH, Walsh TJ (2006). Antifungal efficacy and pharmacodynamics of posaconazole in experimental models of invasive fungal infections. Mycoses  49 Suppl 1, 7-16.   https://doi.org/10.1111/j.1439-0507.2006.01296.x




PubMed


 


PubMed ID 16961576
    
     


 



15.
Hope WW, Walsh TJ, Denning DW (2005). Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis  5, 609-22.   https://doi.org/10.1016/S1473-3099(05)70238-3




PubMed


 


PubMed ID 16183515
    
     


 



16.
Hope WW, Warn PA, Sharp A, Howard S, Kasai M, Louie A, Walsh TJ, Drusano GL, Denning DW (2006). Derivation of an in vivo drug exposure breakpoint for flucytosine against Candida albicans and Impact of the MIC, growth rate, and resistance genotype on the antifungal effect. Antimicrob Agents Chemother  50, 3680-8.   https://doi.org/10.1128/AAC.00369-06




PubMed



        
     
Free Article


 


PubMed ID 16954320
         Pubmed Central ID 1635226 


 



17.
Kasai M, Francesconi A, Petraitiene R, Petraitis V, Kelaher AM, Kim HS, Meletiadis J, Sein T, Bacher J, Walsh TJ (2006). Use of quantitative real-time PCR to study the kinetics of extracellular DNA released from Candida albicans, with implications for diagnosis of invasive Candidiasis. J Clin Microbiol  44, 143-50.   https://doi.org/10.1128/JCM.44.1.143-150.2006




PubMed



        
     
Free Article


 


PubMed ID 16390962
         Pubmed Central ID 1351963 


 



18.
Kontny U, Walsh TJ, Rossler J, Uhl M, Niemeyer CM (2007). Successful treatment of refractory chronic disseminated candidiasis after prolonged administration of caspofungin in a child with acute myeloid leukemia. Pediatr Blood Cancer  49, 360-2.   https://doi.org/10.1002/pbc.20751




PubMed


 


PubMed ID 16444677
    
     


 



19.
La Via WV, Lambert JL, Pelletier MJ, Morookian JM, Sirk SJ, Mickiene D, Walsh TJ, Borchert MS (2006). Measurement of amphotericin B concentration by resonant Raman spectroscopy--a novel technique that may be useful for non-invasive monitoring. Med Mycol  44, 169-74.   https://doi.org/10.1080/13693780500338761




PubMed


 


PubMed ID 16519020
    
     


 



20.
Meletiadis J, Petraitis V, Petraitiene R, Lin P, Stergiopoulou T, Kelaher AM, Sein T, Schaufele RL, Bacher J, Walsh TJ (2006). Triazole-polyene antagonism in experimental invasive pulmonary aspergillosis: in vitro and in vivo correlation. J Infect Dis  194, 1008-18.   https://doi.org/10.1086/506617




PubMed


 


PubMed ID 16960790
    
     


 



21.
Panicker J, Walsh T, Kamani N (2006). Recurrent central nervous system blastomycosis in an immunocompetent child treated successfully with sequential liposomal amphotericin B and voriconazole. Pediatr Infect Dis J  25, 377-9.   https://doi.org/10.1097/01.inf.0000207475.89745.51




PubMed


 


PubMed ID 16567998
    
     


 



22.
Pannaraj PS, Walsh TJ, Baker CJ (2005). Advances in antifungal therapy. Pediatr Infect Dis J  24, 921-2.   https://doi.org/10.1097/01.inf.0000181742.93963.bb




PubMed


 


PubMed ID 16220093
    
     


 



23.
Pelletier R, Alarie I, Lagacé R, Walsh TJ (2005). Emergence of disseminated candidiasis caused by Candida krusei during treatment with caspofungin: case report and review of literature. Med Mycol  43, 559-64.   https://doi.org/10.1080/13693780500220415




PubMed


 


PubMed ID 16320498
    
     


 



24.
Petraitis V, Petraitiene R, Solomon J, Kelaher AM, Murray HA, Mya-San C, Bhandary AK, Sein T, Avila NA, Basevicius A, Bacher J, Walsh TJ (2006). Multidimensional volumetric imaging of pulmonary infiltrates for measuring therapeutic response to antifungal therapy in experimental invasive pulmonary aspergillosis. Antimicrob Agents Chemother  50, 1510-7.   https://doi.org/10.1128/AAC.50.4.1510-1517.2006




PubMed



        
     
Free Article


 


PubMed ID 16569871
         Pubmed Central ID 1426931 


 



25.
Pfaller MA, Diekema DJ, Rex JH, Espinel-Ingroff A, Johnson EM, Andes D, Chaturvedi V, Ghannoum MA, Odds FC, Rinaldi MG, Sheehan DJ, Troke P, Walsh TJ, Warnock DW (2006). Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints. J Clin Microbiol  44, 819-26.   https://doi.org/10.1128/JCM.44.3.819-826.2006




PubMed



        
     
Free Article


 


PubMed ID 16517860
         Pubmed Central ID 1393146 


 



26.
Roilides E, Lyman CA, Armstrong D, Stergiopoulou T, Petraitiene R, Walsh TJ (2006). Deoxycholate amphotericin B and amphotericin B lipid complex exert additive antifungal activity in combination with pulmonary alveolar macrophages against Fusarium solani. Mycoses  49, 109-13.   https://doi.org/10.1111/j.1439-0507.2006.01202.x




PubMed


 


PubMed ID 16466443
    
     


 



27.
Segal BH, Kwon-Chung J, Walsh TJ, Klein BS, Battiwalla M, Almyroudis NG, Holland SM, Romani L (2006). Immunotherapy for fungal infections. Clin Infect Dis  42, 507-15.   https://doi.org/10.1086/499811




PubMed


 


PubMed ID 16421795
    
     


 



28.
Segal BH, Walsh TJ (2006). Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med  173, 707-17.   https://doi.org/10.1164/rccm.200505-727SO




PubMed


 


PubMed ID 16387806
    
     


 



29.
Steinbach WJ, Walsh TJ (2006). Mycoses in pediatric patients. Infect Dis Clin North Am  20, 663-78.   https://doi.org/10.1016/j.idc.2006.06.006




PubMed


 


PubMed ID 16984874
    
     


 



30.
Würthwein G, Groll AH, Hempel G, Adler-Shohet FC, Lieberman JM, Walsh TJ (2005). Population pharmacokinetics of amphotericin B lipid complex in neonates. Antimicrob Agents Chemother  49, 5092-8.   https://doi.org/10.1128/AAC.49.12.5092-5098.2005




PubMed



        
     
Free Article


 


PubMed ID 16304177
         Pubmed Central ID 1315949 


 



31.
Walsh TJ, Adamson PC, Seibel NL, Flynn PM, Neely MN, Schwartz C, Shad A, Kaplan SL, Roden MM, Stone JA, Miller A, Bradshaw SK, Li SX, Sable CA, Kartsonis NA (2005). Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents. Antimicrob Agents Chemother  49, 4536-45.   https://doi.org/10.1128/AAC.49.11.4536-4545.2005




PubMed



        
     
Free Article


 


PubMed ID 16251293
         Pubmed Central ID 1280172 


 



32.
Walsh TJ, Orsega S, Banks D (2006). Lessons from Hurricane Rita: organizing to provide medical care during a natural disaster. Ann Intern Med  145, 468-70.   https://doi.org/10.7326/0003-4819-145-6-200609190-00137




PubMed


 


PubMed ID 16908910
    
     


 



33.
Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C (2005). The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis  41, 1232-9.   https://doi.org/10.1086/496922




PubMed


 


PubMed ID 16206095
    
     


 



34.
Zaoutis TE, Heydon K, Chu JH, Walsh TJ, Steinbach WJ (2006). Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000. Pediatrics  117, e711-6.   https://doi.org/10.1542/peds.2005-1161




PubMed


 


PubMed ID 16533892",https://intramural.nih.gov/search/searchview.taf?ipid=44088
537,SC006880-29,"October 01, 2005 -  September 30, 2006",Drug Development and Clinical Pharmacology of Anticancer Drugs for Childhood Can,"Frank M Balis; MD, PhD",NULL,"Pediatric Oncology Branch, NCI","Patricia O Whitcomb



Elizabeth  Fox; MD



Diane  Cole



Mary  Hawkins



Nalini M Jayaprakash



Robert F Murphy



Show all 9","Peter Charles Adamson; MD





Adekunle  Adesina





Eliel  Bayever
(Oncology, Johnson & Johnson)




Stacey  Berg
(Pediatric Oncology, Baylor Univ.)




Susan  Blaney
(Pediatric Oncology, Baylor)




Susan  Cohn
(Pediatric Oncology, Children's Memorial Med Ctr)


Show all 24","Antonio  Fojo; MD, PhD (National Cancer Institute)



Susan  Bates; MD (National Cancer Institute)



Wyndham H Wilson; MD, PhD (National Cancer Institute)



Katherine Elizabeth Warren; MD (National Cancer Institute)



Mark  Raffeld; MD (National Cancer Institute)



Maria  Tsokos; MD (National Cancer Institute)","Peter Montague Bungay; PhD (OD) 



Jay Robert Knutson; PhD (NHLBI) 



Clara Chi Chen; MD (CC) 



Danny L Sackett; PhD (NICHD) 



John D. Bacher; BS, DVM, MS (OD)","Ordered by publication type and then author name.



1.
Adamson PC, Matthay KK, O'Brien M, Reaman GH, Sato JK, Balis FM (2007). A phase 2 trial of all-trans-retinoic acid in combination with interferon-alpha2a in children with recurrent neuroblastoma or Wilms tumor: A Pediatric Oncology Branch, NCI and Children's Oncology Group Study. Pediatr Blood Cancer  49, 661-5.   https://doi.org/10.1002/pbc.21011




PubMed


 


PubMed ID 16900483
    
     


 



2.
Blaney SM, Balis FM, Berg S, Arndt CA, Heideman R, Geyer JR, Packer R, Adamson PC, Jaeckle K, Klenke R, Aikin A, Murphy R, McCully C, Poplack DG (2005). Intrathecal mafosfamide: a preclinical pharmacology and phase I trial. J Clin Oncol  23, 1555-63.   https://doi.org/10.1200/JCO.2005.06.053




PubMed


 


PubMed ID 15735131
    
     


 



3.
Fox E, Maris JM, Widemann BC, Meek K, Goodwin A, Goodspeed W, Kromplewski M, Fouts ME, Medina D, Cho SY, Cohn SL, Krivoshik A, Hagey AE, Adamson PC, Balis FM (2006). A phase 1 study of ABT-751, an orally bioavailable tubulin inhibitor, administered daily for 7 days every 21 days in pediatric patients with solid tumors. Clin Cancer Res  12, 4882-7.   https://doi.org/10.1158/1078-0432.CCR-06-0534




PubMed


 


PubMed ID 16914576
    
     


 



4.
Jacobs SS, Stork LC, Bostrom BC, Hutchinson R, Holcenberg J, Reaman GH, Erdmann G, Franklin J, Neglia JP, Steinberg SM, Balis FM, Adamson PC, Children''s Oncology Group, National Cancer Institute (2007). Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: a collaborative Children's Oncology Group/National Cancer Institute pilot trial (CCG-1942). Pediatr Blood Cancer  49, 250-5.   https://doi.org/10.1002/pbc.20964




PubMed


 


PubMed ID 16856155
    
     


 



5.
Lebowitz PF, Eng-Wong J, Widemann BC, Balis FM, Jayaprakash N, Chow C, Clark G, Gantz SB, Venzon D, Zujewski J (2005). A phase I trial and pharmacokinetic study of tipifarnib, a farnesyltransferase inhibitor, and tamoxifen in metastatic breast cancer. Clin Cancer Res  11, 1247-52.




PubMed


 


PubMed ID 15709195
    
     


 



6.
Rao VK, Knutsen T, Ried T, Wangsa D, Flynn BM, Langham G, Egorin MJ, Cole D, Balis F, Steinberg SM, Bates S, Fojo T (2005). The extent of chromosomal aberrations induced by chemotherapy in non-human primates depends on the schedule of administration. Mutat Res  583, 105-19.   https://doi.org/10.1016/j.mrgentox.2005.01.013




PubMed


 


PubMed ID 15927870
    
     


 



7.
Warren K, Jakacki R, Widemann B, Aikin A, Libucha M, Packer R, Vezina G, Reaman G, Shaw D, Krailo M, Osborne C, Cehelsky J, Caldwell D, Stanwood J, Steinberg SM, Balis FM (2006). Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors: a report from the Children's Oncology Group. Cancer Chemother Pharmacol  58, 343-7.   https://doi.org/10.1007/s00280-005-0172-7




PubMed


 


PubMed ID 16408203
    
     


 



8.
Warren KE, Aikin AA, Libucha M, Widemann BC, Fox E, Packer RJ, Balis FM (2005). Phase I study of O6-benzylguanine and temozolomide administered daily for 5 days to pediatric patients with solid tumors. J Clin Oncol  23, 7646-53.   https://doi.org/10.1200/JCO.2005.02.0024




PubMed


 


PubMed ID 16234526
    
     


 



9.
Widemann BC, Salzer WL, Arceci RJ, Blaney SM, Fox E, End D, Gillespie A, Whitcomb P, Palumbo JS, Pitney A, Jayaprakash N, Zannikos P, Balis FM (2006). Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas. J Clin Oncol  24, 507-16.   https://doi.org/10.1200/JCO.2005.03.8638




PubMed


 


PubMed ID 16421428",https://intramural.nih.gov/search/searchview.taf?ipid=44089
538,SC006891-18,"October 01, 2005 -  September 30, 2006",Solid Tumors,"Lee Jay Helman; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI",Lauren M Long,NULL,"Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)



Crystal L. Mackall; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Nathan PC, Tsokos M, Long L, Bernstein D, Wexler LH, Mackall CL, Helman LJ (2005). Adjuvant chemotherapy for the treatment of advanced pediatric nonrhabdomyosarcoma soft tissue sarcoma: the National Cancer Institute experience. Pediatr Blood Cancer  44, 449-54.   https://doi.org/10.1002/pbc.20262




PubMed


 


PubMed ID 15547929
    
     


 



2.
Zhang H, Chua KS, Guimond M, Kapoor V, Brown MV, Fleisher TA, Long LM, Bernstein D, Hill BJ, Douek DC, Berzofsky JA, Carter CS, Read EJ, Helman LJ, Mackall CL (2005). Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells. Nat Med  11, 1238-43.   https://doi.org/10.1038/nm1312




PubMed


 


PubMed ID 16227988",https://intramural.nih.gov/search/searchview.taf?ipid=44090
539,SC006892-18,"October 01, 2005 -  September 30, 2006",Molecular Biology of Pediatric Tumors,"Lee Jay Helman; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Xiaolin  Wan



Choh L Yeung



Martin  Mendoza; BS",NULL,"Nealapheur L Khan (National Cancer Institute)



Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)



Glenn  Merlino; PhD (National Cancer Institute)



Crystal L. Mackall; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Helman L, Bruce B, Hewitt S, Dafydd T, Khanna C   (2006) Ezrin mediates growth and survival in Ewings sarcoma through the AKT/mTOR, but not the MAPK signaling pathway.  Ezrin mediates growth and survival in Ewings sarcoma through the AKT/mTOR, but not the MAPK signaling pathway, in press.




 



2.
Helman L, Harkavy B, Shen N, Grohar P   (2006) Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism.  Oncogene, in press.




 



3.
Khanna C, Helman LJ (2006). Molecular approaches in pediatric oncology. Annu Rev Med  57, 83-97.   https://doi.org/10.1146/annurev.med.57.121304.131247




PubMed


 


PubMed ID 16409138
    
     


 



4.
Krishnan K, Khanna C, Helman LJ (2006). The molecular biology of pulmonary metastasis. Thorac Surg Clin  16, 115-24.   https://doi.org/10.1016/j.thorsurg.2005.12.003




PubMed


 


PubMed ID 16805200
    
     


 



5.
Man TK, Chintagumpala M, Visvanathan J, Shen J, Perlaky L, Hicks J, Johnson M, Davino N, Murray J, Helman L, Meyer W, Triche T, Wong KK, Lau CC (2005). Expression profiles of osteosarcoma that can predict response to chemotherapy. Cancer Res  65, 8142-50.   https://doi.org/10.1158/0008-5472.CAN-05-0985




PubMed


 


PubMed ID 16166288
    
     


 



6.
Terabe M, Khanna C, Bose S, Melchionda F, Mendoza A, Mackall CL, Helman LJ, Berzofsky JA (2006). CD1d-restricted natural killer T cells can down-regulate tumor immunosurveillance independent of interleukin-4 receptor-signal transducer and activator of transcription 6 or transforming growth factor-beta. Cancer Res  66, 3869-75.   https://doi.org/10.1158/0008-5472.CAN-05-3421




PubMed


 


PubMed ID 16585215
    
     


 



7.
van den Broeke LT, Pendleton CD, Mackall C, Helman LJ, Berzofsky JA (2006). Identification and epitope enhancement of a PAX-FKHR fusion protein breakpoint epitope in alveolar rhabdomyosarcoma cells created by a tumorigenic chromosomal translocation inducing CTL capable of lysing human tumors. Cancer Res  66, 1818-23.   https://doi.org/10.1158/0008-5472.CAN-05-2549




PubMed


 


PubMed ID 16452243
    
     


 



8.
Wan X, Shen N, Mendoza A, Khanna C, Helman LJ (2006). CCI-779 inhibits rhabdomyosarcoma xenograft growth by an antiangiogenic mechanism linked to the targeting of mTOR/Hif-1alpha/VEGF signaling. Neoplasia  8, 394-401.   https://doi.org/10.1593/neo.05820




PubMed



        
     
Free Article


 


PubMed ID 16790088
         Pubmed Central ID 1592447",https://intramural.nih.gov/search/searchview.taf?ipid=44091
540,SC007202-22,"October 01, 2005 -  September 30, 2006",Biostatistics and Data Management Section,"Seth M Steinberg; PhD



IRP Faculty Profile",NULL,"Office of the Director, NCI","David J Venzon; PhD



David J Liewehr",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Arlen PM, Gulley JL, Parker C, Skarupa L, Pazdur M, Panicali D, Beetham P, Tsang KY, Grosenbach DW, Feldman J, Steinberg SM, Jones E, Chen C, Marte J, Schlom J, Dahut W (2006). A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer. Clin Cancer Res  12, 1260-9.   https://doi.org/10.1158/1078-0432.CCR-05-2059




PubMed



        
     
Free Article


 


PubMed ID 16489082
         Pubmed Central ID 1526707 


 



2.
Arons E, Sorbara L, Raffeld M, Stetler-Stevenson M, Steinberg SM, Liewehr DJ, Pastan I, Kreitman RJ (2006). Characterization of T-cell repertoire in hairy cell leukemia patients before and after recombinant immunotoxin BL22 therapy. Cancer Immunol Immunother  55, 1100-10.   https://doi.org/10.1007/s00262-005-0099-1




PubMed


 


PubMed ID 16311729
    
     


 



3.
Chen QR, Bilke S, Wei JS, Greer BT, Steinberg SM, Westermann F, Schwab M, Khan J (2006). Increased WSB1 copy number correlates with its over-expression which associates with increased survival in neuroblastoma. Genes Chromosomes Cancer  45, 856-62.   https://doi.org/10.1002/gcc.20349




PubMed


 


PubMed ID 16804916
    
     


 



4.
Chute JP, Taylor E, Williams J, Kaye F, Venzon D, Johnson BE (2006). A metabolic study of patients with lung cancer and hyponatremia of malignancy. Clin Cancer Res  12, 888-96.   https://doi.org/10.1158/1078-0432.CCR-05-1536




PubMed


 


PubMed ID 16467103
    
     


 



5.
Dahut WL, Lakhani NJ, Gulley JL, Arlen PM, Kohn EC, Kotz H, McNally D, Parr A, Nguyen D, Yang SX, Steinberg SM, Venitz J, Sparreboom A, Figg WD (2006). Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors. Cancer Biol Ther  5, 22-7.   https://doi.org/10.4161/cbt.5.1.2349




PubMed


 


PubMed ID 16357512
    
     


 



6.
Davidson B, Espina V, Steinberg SM, Flørenes VA, Liotta LA, Kristensen GB, Tropé CG, Berner A, Kohn EC (2006). Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling. Clin Cancer Res  12, 791-9.   https://doi.org/10.1158/1078-0432.CCR-05-2516




PubMed


 


PubMed ID 16467090
    
     


 



7.
Ehrlich A, Koch T, Amin B, Liewehr DJ, Steinberg SM, Turner ML, Blauvelt A (2006). Development and reliability testing of a standardized questionnaire to assess psoriasis phenotype. J Am Acad Dermatol  54, 987.e1-14.   https://doi.org/10.1016/j.jaad.2006.02.003




PubMed


 


PubMed ID 16713452
    
     


 



8.
Eng-Wong J, Reynolds JC, Venzon D, Liewehr D, Gantz S, Danforth D, Liu ET, Chow C, Zujewski J   (2006) Effect of raloxifene on bone mineral density in premenopausal women at increased risk of breast cancer.  J Clin Endocrinol Metab 91:3941-6.




PubMed


 


PubMed ID 16868059
    
     


 



9.
Faupel-Badger JM, Prindiville SA, Venzon D, Vonderhaar BK, Zujewski JA, Eng-Wong J (2006). Effects of raloxifene on circulating prolactin and estradiol levels in premenopausal women at high risk for developing breast cancer. Cancer Epidemiol Biomarkers Prev  15, 1153-8.   https://doi.org/10.1158/1055-9965.EPI-05-0898




PubMed


 


PubMed ID 16775175
    
     


 



10.
Figg WD, Dunn L, Liewehr DJ, Steinberg SM, Thurman PW, Barrett JC, Birkinshaw J (2006). Scientific collaboration results in higher citation rates of published articles. Pharmacotherapy  26, 759-67.   https://doi.org/10.1592/phco.26.6.759




PubMed


 


PubMed ID 16716129
    
     


 



11.
Florese RH, Van Rompay KK, Aldrich K, Forthal DN, Landucci G, Mahalanabis M, Haigwood N, Venzon D, Kalyanaraman VS, Marthas ML, Robert-Guroff M (2006). Evaluation of passively transferred, nonneutralizing antibody-dependent cellular cytotoxicity-mediating IgG in protection of neonatal rhesus macaques against oral SIVmac251 challenge. J Immunol  177, 4028-36.   https://doi.org/10.4049/jimmunol.177.6.4028




PubMed


 


PubMed ID 16951366
    
     


 



12.
Gómez-Román VR, Florese RH, Patterson LJ, Peng B, Venzon D, Aldrich K, Robert-Guroff M (2006). A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity. J Immunol Methods  308, 53-67.   https://doi.org/10.1016/j.jim.2005.09.018




PubMed


 


PubMed ID 16343526
    
     


 



13.
Gómez-Román VR, Florese RH, Peng B, Montefiori DC, Kalyanaraman VS, Venzon D, Srivastava I, Barnett SW, Robert-Guroff M (2006). An adenovirus-based HIV subtype B prime/boost vaccine regimen elicits antibodies mediating broad antibody-dependent cellular cytotoxicity against non-subtype B HIV strains. J Acquir Immune Defic Syndr  43, 270-7.   https://doi.org/10.1097/01.qai.0000230318.40170.60




PubMed


 


PubMed ID 16940858
    
     


 



14.
Hassan R, Williams-Gould J, Steinberg SM, Liewehr DJ, Yokokawa J, Tsang KY, Surawski RJ, Scott T, Camphausen K (2006). Tumor-directed radiation and the immunotoxin SS1P in the treatment of mesothelin-expressing tumor xenografts. Clin Cancer Res  12, 4983-8.   https://doi.org/10.1158/1078-0432.CCR-06-0441




PubMed


 


PubMed ID 16914588
    
     


 



15.
Heraud JM, Edghill-Smith Y, Ayala V, Kalisz I, Parrino J, Kalyanaraman VS, Manischewitz J, King LR, Hryniewicz A, Trindade CJ, Hassett M, Tsai WP, Venzon D, Nalca A, Vaccari M, Silvera P, Bray M, Graham BS, Golding H, Hooper JW, Franchini G (2006). Subunit recombinant vaccine protects against monkeypox. J Immunol  177, 2552-64.   https://doi.org/10.4049/jimmunol.177.4.2552




PubMed


 


PubMed ID 16888017
    
     


 



16.
Jacobs SS, Stork LC, Bostrom BC, Hutchinson R, Holcenberg J, Reaman GH, Erdmann G, Franklin J, Neglia JP, Steinberg SM, Balis FM, Adamson PC, Children''s Oncology Group, National Cancer Institute (2007). Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: a collaborative Children's Oncology Group/National Cancer Institute pilot trial (CCG-1942). Pediatr Blood Cancer  49, 250-5.   https://doi.org/10.1002/pbc.20964




PubMed


 


PubMed ID 16856155
    
     


 



17.
Lee JJ, Low JA, Croarkin E, Parks R, Berman AW, Mannan N, Steinberg SM, Swain SM (2006). Changes in neurologic function tests may predict neurotoxicity caused by ixabepilone. J Clin Oncol  24, 2084-91.   https://doi.org/10.1200/JCO.2005.04.2820




PubMed


 


PubMed ID 16648510
    
     


 



18.
Lindsey KR, Gritz L, Sherry R, Abati A, Fetsch PA, Goldfeder LC, Gonzales MI, Zinnack KA, Rogers-Freezer L, Haworth L, Mavroukakis SA, White DE, Steinberg SM, Restifo NP, Panicali DL, Rosenberg SA, Topalian SL (2006). Evaluation of prime/boost regimens using recombinant poxvirus/tyrosinase vaccines for the treatment of patients with metastatic melanoma. Clin Cancer Res  12, 2526-37.   https://doi.org/10.1158/1078-0432.CCR-05-2061




PubMed



        
     
Free Article


 


PubMed ID 16638862
         Pubmed Central ID 2151202 


 



19.
Little RF, Pluda JM, Wyvill KM, Rodriguez-Chavez IR, Tosato G, Catanzaro AT, Steinberg SM, Yarchoan R (2006). Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcoma. Blood  107, 4650-7.   https://doi.org/10.1182/blood-2005-11-4455




PubMed



        
     
Free Article


 


PubMed ID 16507779
         Pubmed Central ID 1475826 


 



20.
Moniuszko M, Edghill-Smith Y, Venzon D, Stevceva L, Nacsa J, Tryniszewska E, Tsai WP, Franchini G (2006) Decreased number of CD4+ and CD8+ T cells that express the interleukin-7 receptor in blood and tissues of SIV-infected macaques. Virology 356:188-97




PubMed


 


PubMed ID 16934309
    
     


 



21.
Norton JA, Fraker DL, Alexander HR, Gibril F, Liewehr DJ, Venzon DJ, Jensen RT (2006). Surgery increases survival in patients with gastrinoma. Ann Surg  244, 410-9.   https://doi.org/10.1097/01.sla.0000234802.44320.a5




PubMed



        
     
Free Article


 


PubMed ID 16926567
         Pubmed Central ID 1856542 


 



22.
Piekarz RL, Frye AR, Wright JJ, Steinberg SM, Liewehr DJ, Rosing DR, Sachdev V, Fojo T, Bates SE (2006). Cardiac studies in patients treated with depsipeptide, FK228, in a phase II trial for T-cell lymphoma. Clin Cancer Res  12, 3762-73.   https://doi.org/10.1158/1078-0432.CCR-05-2095




PubMed


 


PubMed ID 16778104
    
     


 



23.
Romeo MJ, Wunderlich J, Ngo L, Rosenberg SA, Steinberg SM, Berman DM (2006). Measuring tissue-based biomarkers by immunochromatography coupled with reverse-phase lysate microarray. Clin Cancer Res  12, 2463-7.   https://doi.org/10.1158/1078-0432.CCR-05-1479




PubMed



        
     
Free Article


 


PubMed ID 16638853
         Pubmed Central ID 2147079 


 



24.
Warren K, Jakacki R, Widemann B, Aikin A, Libucha M, Packer R, Vezina G, Reaman G, Shaw D, Krailo M, Osborne C, Cehelsky J, Caldwell D, Stanwood J, Steinberg SM, Balis FM (2006). Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors: a report from the Children's Oncology Group. Cancer Chemother Pharmacol  58, 343-7.   https://doi.org/10.1007/s00280-005-0172-7




PubMed


 


PubMed ID 16408203
    
     


 



25.
Wedam SB, Low JA, Yang SX, Chow CK, Choyke P, Danforth D, Hewitt SM, Berman A, Steinberg SM, Liewehr DJ, Plehn J, Doshi A, Thomasson D, McCarthy N, Koeppen H, Sherman M, Zujewski J, Camphausen K, Chen H, Swain SM (2006). Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer. J Clin Oncol  24, 769-77.   https://doi.org/10.1200/JCO.2005.03.4645




PubMed


 


PubMed ID 16391297",https://intramural.nih.gov/search/searchview.taf?ipid=44042
541,SC007256-18,"October 01, 2005 -  September 30, 2006",Mechanisms of Oncogene Action in Tumorigenesis,Frederic  Kaye; MD,NULL,"Cancer Genetics Branch, NCI","Amy B Coxon



Yoon Soo  Park



Takefumi  Komiya","Adel  El-Naggar
(MD Anderson Cancer Center)




Isabel  Fonseca
(Pathology, Portugal Cancer Institute)




Pasi  Janne
(Oncology, Dana-Farber Cancer Center)




Anthony  Pawson
(Biochemistry, Mount Sinai Hospital)




Roman  Thomas
(Oncology, Broad Institute)




Sellers  William
(Oncology, Dana-Farber Cancer Center)",NULL,Aravind L Iyer; PhD (NLM),"Ordered by publication type and then author name.



1.
Chute JP, Taylor E, Williams J, Kaye F, Venzon D, Johnson BE (2006). A metabolic study of patients with lung cancer and hyponatremia of malignancy. Clin Cancer Res  12, 888-96.   https://doi.org/10.1158/1078-0432.CCR-05-1536




PubMed


 


PubMed ID 16467103
    
     


 



2.
Kaye F, Enlund F, Mark J, Stenman G, Fonseca I, Martins C   (2006) The MECT1-MAML2 Gene Fusion and Benign Warthins Tumor: Is the MECT1-MAML2 Gene Fusion Specific to Mucoepidermoid Carcinoma?  Journal of Molecular Diagnostics  394-396 pp.




 



3.
Kaye FJ (2006). Emerging biology of malignant salivary gland tumors offers new insights into the classification and treatment of mucoepidermoid cancer. Clin Cancer Res  12, 3878-81.   https://doi.org/10.1158/1078-0432.CCR-06-0791




PubMed


 


PubMed ID 16818681
    
     


 



4.
Komiya T, Park Y, Modi S, Coxon AB, Oh H, Kaye FJ (2006). Sustained expression of Mect1-Maml2 is essential for tumor cell growth in salivary gland cancers carrying the t(11;19) translocation. Oncogene  25, 6128-32.   https://doi.org/10.1038/sj.onc.1209627




PubMed


 


PubMed ID 16652146",https://intramural.nih.gov/search/searchview.taf?ipid=44092
542,SC007263-14,"October 01, 2005 -  September 30, 2006",Signal Transduction in Epithelial Cancer Cells,"Stanley  Lipkowitz; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI","Janet  Pumphrey



Marion M Nau



Monzur  Rahman



Jeremy  Karlin



Philip  Ryan","Morag  Park
(Dept. Biochemistry and Oncology, McGill University)




Yosef  Yarden
(Biological Regulation, Weizmann Institute of Science)","Dao M Nguyen; MD, MS (National Cancer Institute)



Sandra M Swain; MD (National Cancer Institute)



Allan M Weissman; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Lipkowitz S   (2006) Ubiquitin mediated degradation of receptor tyrosine kinases and cancer, in AACR Education Book. AACR (Philadelphia), pp. 157-161.




 



2.
Choong NW, Dietrich S, Seiwert TY, Tretiakova MS, Nallasura V, Davies GC, Lipkowitz S, Husain AN, Salgia R, Ma PC (2006). Gefitinib response of erlotinib-refractory lung cancer involving meninges--role of EGFR mutation. Nat Clin Pract Oncol  3, 50-7; quiz 1 p following 57.   https://doi.org/10.1038/ncponc0400




PubMed


 


PubMed ID 16407879
    
     


 



3.
Davies GC, Ryan PE, Rahman L, Zajac-Kaye M, Lipkowitz S (2006). EGFRvIII undergoes activation-dependent downregulation mediated by the Cbl proteins. Oncogene  25, 6497-509.   https://doi.org/10.1038/sj.onc.1209662




PubMed



        
     
Free Article


 


PubMed ID 16702950
         Pubmed Central ID 2274962 


 



4.
Lipkowitz S, Kato S, Espinoza N, Lange S, Llados C, Espinoza M, Villalon M, Cuello M, Owen G   (2006) TRAIL mediates apoptosis in cancerous but not normal primary cultured cells of the human reproductive tract.  Apoptosis, in press.




 



5.
Lipkowitz S, Kato S, Sadarangani A, Saez C, Gejman R, Owen G   (2006) Receptor mediated cell death: role of ovarian steroid hormones in TRAIL induced apoptosis in gynecologic cancers.  Bulletin of the School of Medicine of Chile  5-16 pp.




 



6.
Ryan PE, Davies GC, Nau MM, Lipkowitz S (2006). Regulating the regulator: negative regulation of Cbl ubiquitin ligases. Trends Biochem Sci  31, 79-88.   https://doi.org/10.1016/j.tibs.2005.12.004




PubMed


 


PubMed ID 16406635",https://intramural.nih.gov/search/searchview.taf?ipid=44093
543,SC007264-11,"October 01, 2005 -  September 30, 2006",Medical Oncology Fellowship Office,Barry  Gause; PhD,Lee Jay Helman; MD,"Medical Oncology Branch, NCI","Richard J Moon



Sandra J Snow



Thelma M Watson



Miriam  Ferraro",NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=44041
544,SC007281-13,"October 01, 2005 -  September 30, 2006",Nitric Oxide as a Modifier of Oxidative Stress,"David Anderson Wink



IRP Faculty Profile",NULL,"Radiation Biology Branch, NCI","Michael G Espey; MT, PhD



Douglas D Thomas



Lisa Ann Ridnour



Sonia  Donzelli



Alisha  Windhausen



Christopher H Switzer",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Wink D, Ridnour L, Donzelli S, Espey M, Mancardi D, Isenberg J, Feelisch M, Roberts D   (2006) Nitric Oxide and Related Nitrogen Oxides: Chemistry of Protein Adducts, in Redox Proteomics: From Protein Modifications to Cellular Dysfunction and Diseases. Dalle-Done I, Scaloni A, Butterfield A, eds., Wiley Interscience (New York), pp. 25-58.




 



2.
Donzelli S, Espey MG, Thomas DD, Mancardi D, Tocchetti CG, Ridnour LA, Paolocci N, King SB, Miranda KM, Lazzarino G, Fukuto JM, Wink DA (2006). Discriminating formation of HNO from other reactive nitrogen oxide species. Free Radic Biol Med  40, 1056-66.   https://doi.org/10.1016/j.freeradbiomed.2005.10.058




PubMed


 


PubMed ID 16540401
    
     


 



3.
Dutton AS, Suhrada CP, Miranda KM, Wink DA, Fukuto JM, Houk KN (2006). Mechanism of pH-dependent decomposition of monoalkylamine diazeniumdiolates to form HNO and NO, deduced from the model compound methylamine diazeniumdiolate, density functional theory, and CBS-QB3 calculations. Inorg Chem  45, 2448-56.   https://doi.org/10.1021/ic051505z




PubMed



        
     
Free Article


 


PubMed ID 16529464
         Pubmed Central ID 3164114 


 



4.
Fukuto JM, Bartberger MD, Dutton AS, Paolocci N, Wink DA, Houk KN (2005). The physiological chemistry and biological activity of nitroxyl (HNO): the neglected, misunderstood, and enigmatic nitrogen oxide. Chem Res Toxicol  18, 790-801.   https://doi.org/10.1021/tx0496800




PubMed


 


PubMed ID 15892572
    
     


 



5.
Gladwin MT, Schechter AN, Kim-Shapiro DB, Patel RP, Hogg N, Shiva S, Cannon RO, Kelm M, Wink DA, Espey MG, Oldfield EH, Pluta RM, Freeman BA, Lancaster JR, Feelisch M, Lundberg JO (2005). The emerging biology of the nitrite anion. Nat Chem Biol  1, 308-14.   https://doi.org/10.1038/nchembio1105-308




PubMed


 


PubMed ID 16408064
    
     


 



6.
Hewett SJ, Espey MG, Uliasz TF, Wink DA (2005). Neurotoxicity of nitroxyl: insights into HNO and NO biochemical imbalance. Free Radic Biol Med  39, 1478-88.   https://doi.org/10.1016/j.freeradbiomed.2005.07.007




PubMed


 


PubMed ID 16274883
    
     


 



7.
Isenberg JS, Ridnour LA, Espey MG, Wink DA, Roberts DD (2005). Nitric oxide in wound-healing. Microsurgery  25, 442-51.   https://doi.org/10.1002/micr.20168




PubMed


 


PubMed ID 16044466
    
     


 



8.
Isenberg JS, Ridnour LA, Perruccio EM, Espey MG, Wink DA, Roberts DD (2005). Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner. Proc Natl Acad Sci U S A  102, 13141-6.   https://doi.org/10.1073/pnas.0502977102




PubMed



        
     
Free Article


 


PubMed ID 16150726
         Pubmed Central ID 1201579 


 



9.
Isenberg JS, Ridnour LA, Thomas DD, Wink DA, Roberts DD, Espey MG (2006). Guanylyl cyclase-dependent chemotaxis of endothelial cells in response to nitric oxide gradients. Free Radic Biol Med  40, 1028-33.   https://doi.org/10.1016/j.freeradbiomed.2005.10.053




PubMed


 


PubMed ID 16540398
    
     


 



10.
Ridnour LA, Isenberg JS, Espey MG, Thomas DD, Roberts DD, Wink DA (2005). Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1. Proc Natl Acad Sci U S A  102, 13147-52.   https://doi.org/10.1073/pnas.0502979102




PubMed



        
     
Free Article


 


PubMed ID 16141331
         Pubmed Central ID 1201580 


 



11.
Wink D, Switzer C, Thomas D, Ridnour L, Espey M, Isenberg J, Tocchetti C, King S, Lazzarino G, Miranda K, Roberts D, Feelisch M   (2006) The Activation of Metabolites of Nitric Oxide Synthase by Metals is Both Redox-and Oxygen-Dependent: A New Feature of Nitrogen Oxide Signaling.  Antioxid. Redox Sig,, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=44095
545,SC009144-22,"October 01, 2005 -  September 30, 2006",Mechanisms of transcription factor integration at the c-myc promoter,"David  Levens; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Larry  Benjamin



Hye-Jung  Chung



Fedor Edmundovich Kouzine



Juhong  Liu



Suzanne Laurie Sanford



Matthew  Vogt



Show all 8",NULL,Gordon Lee Hager; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Chung HJ, Liu J, Dundr M, Nie Z, Sanford S, Levens D (2006). FBPs are calibrated molecular tools to adjust gene expression. Mol Cell Biol  26, 6584-97.   https://doi.org/10.1128/MCB.00754-06




PubMed



        
     
Free Article


 


PubMed ID 16914741
         Pubmed Central ID 1592819 


 



2.
Liu J, Kouzine F, Nie Z, Chung HJ, Elisha-Feil Z, Weber A, Zhao K, Levens D (2006). The FUSE/FBP/FIR/TFIIH system is a molecular machine programming a pulse of c-myc expression. EMBO J  25, 2119-30.   https://doi.org/10.1038/sj.emboj.7601101




PubMed



        
     
Free Article


 


PubMed ID 16628215
         Pubmed Central ID 1462968 


 



3.
Liu J, Levens D (2006). Making myc. Curr Top Microbiol Immunol  302, 1-32.   https://doi.org/10.1007/3-540-32952-8_1




PubMed


 


PubMed ID 16620023
    
     


 



4.
Matsushita K, Tomonaga T, Shimada H, Shioya A, Higashi M, Matsubara H, Harigaya K, Nomura F, Libutti D, Levens D, Ochiai T (2006). An essential role of alternative splicing of c-myc suppressor FUSE-binding protein-interacting repressor in carcinogenesis. Cancer Res  66, 1409-17.   https://doi.org/10.1158/0008-5472.CAN-04-4459




PubMed


 


PubMed ID 16452196
    
     


 



5.
Weber A, Gutierrez MI, Levens D (2006). The CT-element of the c-myc gene does not predispose to chromosomal breakpoints in Burkitt's lymphoma. Cell Oncol  28, 31-5.   https://doi.org/10.1155/2006/695262




PubMed



        
     
Free Article


 


PubMed ID 16675879
         Pubmed Central ID 4615165",https://intramural.nih.gov/search/searchview.taf?ipid=44096
546,SC009163-19,"October 01, 2005 -  September 30, 2006",Signal Transduction Therapy--Basic Science,Elise C Kohn; MD,NULL,"Laboratory of Pathology, NCI","Jeremiah Benjamin Frueauf



Jareer Nabeel Kassis



Victoria M Virador



Nana E Tchabo



Nabila  Rasool



Shu-Fen  Mai



Show all 7",NULL,"Florence M Davidson; MS, PhD, BA (National Cancer Institute)



David R Gius; MD, PhD (National Cancer Institute)



David Jay Goldstein (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Davidson B, Espina V, Steinberg SM, Flørenes VA, Liotta LA, Kristensen GB, Tropé CG, Berner A, Kohn EC (2006). Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling. Clin Cancer Res  12, 791-9.   https://doi.org/10.1158/1078-0432.CCR-05-2516




PubMed


 


PubMed ID 16467090
    
     


 



2.
Kassis J, Klominek J, Kohn EC (2005). Tumor microenvironment: what can effusions teach us? Diagn Cytopathol  33, 316-9.   https://doi.org/10.1002/dc.20280




PubMed


 


PubMed ID 16240401
    
     


 



3.
Kassis JN, Guancial EA, Doong H, Virador V, Kohn EC (2006). CAIR-1/BAG-3 modulates cell adhesion and migration by downregulating activity of focal adhesion proteins. Exp Cell Res  312, 2962-71.   https://doi.org/10.1016/j.yexcr.2006.05.023




PubMed


 


PubMed ID 16859681",https://intramural.nih.gov/search/searchview.taf?ipid=44097
547,SC009170-19,"October 01, 2005 -  September 30, 2006",Genes regulating pattern formation during embryonic development,"Susan  Mackem; MD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Hai  Huang



Minh-Thanh T. Nguyen; PhD



Jianjian  Zhu



Aki  Furusawa



Junming  Yang","Richard R. Behringer
(Department of Molecular Genetics, University of Texas M.D. Anderson Cancer Center)




Denis  Duboule
(Zoology and Animal Biology, Univ. of Geneva)




Gerard  Evan
(UCSF)




Beate  Lanske
(Department of Oral & Developmental Biology, Harvard Univ.)




Lance  Liotta
(Center for Applied Proteomics and Molecular Medicine, George Mason Univ.)",Michael  Bustin; PhD (National Cancer Institute),"Yingzi  Yang; PhD (NHGRI) 












Alexandra L Joyner (NHGRI)","Ordered by publication type and then author name.



1.
Furusawa T, Lim JH, Catez F, Birger Y, Mackem S, Bustin M (2006). Down-regulation of nucleosomal binding protein HMGN1 expression during embryogenesis modulates Sox9 expression in chondrocytes. Mol Cell Biol  26, 592-604.   https://doi.org/10.1128/MCB.26.2.592-604.2006




PubMed



        
     
Free Article


 


PubMed ID 16382150
         Pubmed Central ID 1346905 


 



2.
Nakamura E, Nguyen MT, Mackem S (2006). Kinetics of tamoxifen-regulated Cre activity in mice using a cartilage-specific CreER(T) to assay temporal activity windows along the proximodistal limb skeleton. Dev Dyn  235, 2603-12.   https://doi.org/10.1002/dvdy.20892




PubMed


 


PubMed ID 16894608",https://intramural.nih.gov/search/searchview.taf?ipid=44098
548,SC009172-18,"October 01, 2005 -  September 30, 2006",Cellular Interactions with Thrombospondin,"David D Roberts; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Jo A Cashel



Jeffrey S Isenberg



Svetlana A Kuznetsova



John M Sipes



Elizabeth M Perruccio



Yifeng  Jia



Show all 7","Willaim  Frazier
(Biochemistry and Molecular Biophysics, Washington University)




Julien  Furrer
(Institute for Organic Chemistry and Biochemistry, Technische Universitat Muenchen)




Deane  Mosher
(Medicine, University of Wisconsin)","Venkatesha  Basrur; PhD (National Cancer Institute)



David Anderson Wink (National Cancer Institute)



Joseph John Barchi (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Isenberg JS, Ridnour LA, Dimitry J, Frazier WA, Wink DA, Roberts DD (2006). CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1. J Biol Chem  281, 26069-80.   https://doi.org/10.1074/jbc.M605040200




PubMed


 


PubMed ID 16835222
    
     


 



2.
Isenberg JS, Ridnour LA, Perruccio EM, Espey MG, Wink DA, Roberts DD (2005). Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner. Proc Natl Acad Sci U S A  102, 13141-6.   https://doi.org/10.1073/pnas.0502977102




PubMed



        
     
Free Article


 


PubMed ID 16150726
         Pubmed Central ID 1201579 


 



3.
Isenberg JS, Ridnour LA, Thomas DD, Wink DA, Roberts DD, Espey MG (2006). Guanylyl cyclase-dependent chemotaxis of endothelial cells in response to nitric oxide gradients. Free Radic Biol Med  40, 1028-33.   https://doi.org/10.1016/j.freeradbiomed.2005.10.053




PubMed


 


PubMed ID 16540398
    
     


 



4.
Isenberg JS, Wink DA, Roberts DD (2006). Thrombospondin-1 antagonizes nitric oxide-stimulated vascular smooth muscle cell responses. Cardiovasc Res  71, 785-93.   https://doi.org/10.1016/j.cardiores.2006.05.024




PubMed


 


PubMed ID 16820142
    
     


 



5.
Thomas DD, Ridnour LA, Espey MG, Donzelli S, Ambs S, Hussain SP, Harris CC, DeGraff W, Roberts DD, Mitchell JB, Wink DA (2006). Superoxide fluxes limit nitric oxide-induced signaling. J Biol Chem  281, 25984-93.   https://doi.org/10.1074/jbc.M602242200




PubMed


 


PubMed ID 16829532
    
     


 



6.
Zhou L, Isenberg JS, Cao Z, Roberts DD (2006). Type I collagen is a molecular target for inhibition of angiogenesis by endogenous thrombospondin-1. Oncogene  25, 536-45.   https://doi.org/10.1038/sj.onc.1209069




PubMed


 


PubMed ID 16247480
    
     


 



7.
Roberts DD, Frazier WD, Isenberg JD (submitted in 2006) Prevention Of Tissue Ischemia, Related Methods And Compositions. Patents issued: 8,236,313 (US in 2012); 2007319576 (AU in 2014); 8,557,788 (US in 2014); 8,865,672 (US in 2015); 2014201936 (AU in 2017); 2016238894 (AU in 2018). Patents pending: 2018200921 (AU application); 2,665,287 (CA application); 07868382.8 (EP application); 13180563.2 (EP application); PCT/US2007/080647 (PC application); 14/500,861 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=44044
549,SC009173-18,"October 01, 2005 -  September 30, 2006",Host Colonization and Vascular Dissemination of Candida albicans,"David D Roberts; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Mike  Pendrak



Alexander W Peterson



John M Sipes",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Pendrak M, Yan S   (2006) Non-Polymerase Chain Reaction Mediated Target Amplification Techniques, in Advanced Techniques in Diagnostic Microbiology. Tang x, Stratton x, eds., Springer (New York), pp. 184-209.




 



2.
Roberts D   (2006) Hemoglobin is an effective inducer of hyphal differentiation in Candida albicans.  Med. Mycol, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=44045
550,SC009174-18,"October 01, 2005 -  September 30, 2006",Role of Glycoconjugates in Tumor Biology,"David D Roberts; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI","Svetlana A Kuznetsova



John M Sipes","Anthony  Day
(Biochemistry, University of Oxford)




Thomas  Wight
(The Hope Heart Program, University of Washington)",NULL,NULL,"Ordered by publication type and then author name.



1.
Roberts D, Issa P, Perruccio E, Zeng B, Sipes J, Ward Y, Seyfried N, Fielder H, Day A, Wight T   (2006) Versican- thrombospondin-1 binding in vitro and colocalization in microfibrils induced by inflammation on vascular smooth muscle cells.  J Cell Sci, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=44043
551,SC009179-18,"October 01, 2005 -  September 30, 2006",The Role of TIMPs in the Regulation of Cell Growth and Differentiation,"William G Stetler-Stevenson; MD, PhD



IRP Faculty Profile",NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Liliana  Guedez; PhD



Beiyang  Wei



Seo-Jin  Lee



Renuka  Sivendran",NULL,"Frank  Cuttitta; PhD (National Cancer Institute)



Steven  Libutti; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Chang H, Lee J, Poo H, Noda M, Diaz T, Wei B, Stetler-Stevenson WG, Oh J (2006). TIMP-2 promotes cell spreading and adhesion via upregulation of Rap1 signaling. Biochem Biophys Res Commun  345, 1201-6.   https://doi.org/10.1016/j.bbrc.2006.05.044




PubMed


 


PubMed ID 16716258
    
     


 



2.
Oh J, Diaz T, Wei B, Chang H, Noda M, Stetler-Stevenson WG (2006). TIMP-2 upregulates RECK expression via dephosphorylation of paxillin tyrosine residues 31 and 118. Oncogene  25, 4230-4.   https://doi.org/10.1038/sj.onc.1209444




PubMed



        
     
Free Article


 


PubMed ID 16491114
         Pubmed Central ID 1502148 


 



3.
Seo DW, Li H, Qu CK, Oh J, Kim YS, Diaz T, Wei B, Han JW, Stetler-Stevenson WG (2006). Shp-1 mediates the antiproliferative activity of tissue inhibitor of metalloproteinase-2 in human microvascular endothelial cells. J Biol Chem  281, 3711-21.   https://doi.org/10.1074/jbc.M509932200




PubMed



        
     
Free Article


 


PubMed ID 16326706
         Pubmed Central ID 1361361",https://intramural.nih.gov/search/searchview.taf?ipid=44099
552,SC009372-14,"October 01, 2005 -  September 30, 2006",Flow Cytometric Analysis of Benign and Malignant Tumors,"Maryalice  Stetler-Stevenson; MD, PhD",Elaine S Jaffe; MD,"Laboratory of Pathology, NCI",Linda Shonk Weaver,NULL,"Robert J Kreitman; MD, PhD (National Cancer Institute)



Steven  Libutti; MD (National Cancer Institute)



Susan  Bates; MD (National Cancer Institute)



Ira H Pastan; MD (National Cancer Institute)



John  Janik; MD (National Cancer Institute)



John Charles Morris; MD (National Cancer Institute)","Adrian U Wiestner; MD, PhD (NHLBI)","Ordered by publication type and then author name.



1.
Arons E, Margulies I, Sorbara L, Raffeld M, Stetler-Stevenson M, Pastan I, Kreitman RJ (2006). Minimal residual disease in hairy cell leukemia patients assessed by clone-specific polymerase chain reaction. Clin Cancer Res  12, 2804-11.   https://doi.org/10.1158/1078-0432.CCR-05-2315




PubMed


 


PubMed ID 16675574
    
     


 



2.
Arons E, Sorbara L, Raffeld M, Stetler-Stevenson M, Steinberg SM, Liewehr DJ, Pastan I, Kreitman RJ (2006). Characterization of T-cell repertoire in hairy cell leukemia patients before and after recombinant immunotoxin BL22 therapy. Cancer Immunol Immunother  55, 1100-10.   https://doi.org/10.1007/s00262-005-0099-1




PubMed


 


PubMed ID 16311729
    
     


 



3.
Schinstine M, Filie AC, Wilson W, Stetler-Stevenson M, Abati A (2006). Detection of malignant hematopoietic cells in cerebral spinal fluid previously diagnosed as atypical or suspicious. Cancer  108, 157-62.   https://doi.org/10.1002/cncr.21915




PubMed


 


PubMed ID 16649227",https://intramural.nih.gov/search/searchview.taf?ipid=44051
553,SC009373-14,"October 01, 2005 -  September 30, 2006",Thr Role of TIMP1 in B Cell Differentiation and Survival,"Maryalice  Stetler-Stevenson; MD, PhD",Elaine S Jaffe; MD,"Laboratory of Pathology, NCI",NULL,NULL,"William G Stetler-Stevenson; MD, PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44052
554,SC009374-15,"October 01, 2005 -  September 30, 2006",Signaling Pathways as Molecular Targets in Angiogenesis and Microenvironment,Elise C Kohn; MD,NULL,"Laboratory of Pathology, NCI","Victoria M Virador



Nana E Tchabo



Dana  Roque



Amit  Dhamoon","Riccardo  Alessandro
(Univ. Palermo)




Ben  Davidson
(Pathology, Norwegian Radium Hospital)




Gordon  Mills
(Molecular Therapeutics, MD Anderson Cancer Center)




Nicole  Urban
(SPORE, Fred Hutchinson Cancer Center)","Gordon  Whiteley (National Cancer Institute)



William D Figg; PharmD (National Cancer Institute)



Barbara V Vonderhaar; PhD (National Cancer Institute)



Seth M Steinberg; PhD (Biostatistics and Data Management Section)",NULL,"Ordered by publication type and then author name.



1.
Alessandro R, Di Bella MA, Flugy AM, Fontana S, Damiani F, Corrado C, Colomba P, Todaro M, Russo D, Santoro A, Kohn EC, De Leo G (2006). Comparative study of T84 and T84SF human colon carcinoma cells: in vitro and in vivo ultrastructural and functional characterization of cell culture and metastasis. Virchows Arch  449, 48-61.   https://doi.org/10.1007/s00428-006-0179-4




PubMed


 


PubMed ID 16612624
    
     


 



2.
Azad NS, Rasool N, Annunziata CM, Minasian L, Whiteley G, Kohn EC (2006). Proteomics in clinical trials and practice: present uses and future promise. Mol Cell Proteomics  5, 1819-29.   https://doi.org/10.1074/mcp.R600008-MCP200




PubMed


 


PubMed ID 16737951
    
     


 



3.
Balkwill FR, Ashworth A, Bast RC, Berek JS, Boyd J, Disis ML, Gabra H, Gore ME, Hamilton TC, Jacobs IJ, Kaye SB, Kohn EC, Mills GB, Urban ND (2006). 10th Biennial Helene Harris Memorial Trust meeting. Cancer Res  66, 2904-6.   https://doi.org/10.1158/0008-5472.CAN-05-2093




PubMed


 


PubMed ID 16540635
    
     


 



4.
Davidson B, Espina V, Steinberg SM, Flørenes VA, Liotta LA, Kristensen GB, Tropé CG, Berner A, Kohn EC (2006). Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling. Clin Cancer Res  12, 791-9.   https://doi.org/10.1158/1078-0432.CCR-05-2516




PubMed


 


PubMed ID 16467090
    
     


 



5.
Kassis J, Klominek J, Kohn EC (2005). Tumor microenvironment: what can effusions teach us? Diagn Cytopathol  33, 316-9.   https://doi.org/10.1002/dc.20280




PubMed


 


PubMed ID 16240401
    
     


 



6.
Kassis JN, Guancial EA, Doong H, Virador V, Kohn EC (2006). CAIR-1/BAG-3 modulates cell adhesion and migration by downregulating activity of focal adhesion proteins. Exp Cell Res  312, 2962-71.   https://doi.org/10.1016/j.yexcr.2006.05.023




PubMed


 


PubMed ID 16859681
    
     


 



7.
Kohn EC, Travers LA, Kassis J, Broome U, Klominek J (2005). Malignant effusions are sources of fibronectin and other promigratory and proinvasive components. Diagn Cytopathol  33, 300-8.   https://doi.org/10.1002/dc.20279




PubMed


 


PubMed ID 16240400
    
     


 



8.
Stevens EV, Raffeld M, Espina V, Kristensen GB, Trope' CG, Kohn EC, Davidson B (2005). Expression of xeroderma pigmentosum A protein predicts improved outcome in metastatic ovarian carcinoma. Cancer  103, 2313-9.   https://doi.org/10.1002/cncr.21031




PubMed


 


PubMed ID 15844177",https://intramural.nih.gov/search/searchview.taf?ipid=44100
555,SC009375-14,"October 01, 2005 -  September 30, 2006",Signal Transduction Therapy--Clinical,Elise C Kohn; MD,NULL,"Laboratory of Pathology, NCI","Jeremiah Benjamin Frueauf



Jareer Nabeel Kassis



Nana E Tchabo



Dana  Roque



Nilofer S Azad","Mac  Barnes
(Gynecologic Oncology, U-AB)




Robert  Bast
(Medicine, MD Anderson Cancer Center)




Andrew  Berchuck
(Gyn Oncology, Duke Univ)




Mary B Daly





Beth  Karlan
(Gynecologic Oncology, Cedars Sinai Cancer Center)




Gustavo  Rodriguez
(Gynecologic Oncology, Evanston Northwestern Hospital)


Show all 8","Gordon  Whiteley (National Cancer Institute)



William Laurence Dahut; MD (National Cancer Institute)



Michael  Birrer (National Cancer Institute)



William D Figg; PharmD (National Cancer Institute)



Seth M Steinberg; PhD (Biostatistics and Data Management Section)",NULL,"Ordered by publication type and then author name.



1.
Kohn E   (2006) Invasion and Metastasis, in Cancer Medicine 7. Kufe x, Pollock x, Weicheselbaum x, Bast x, Gansler x, Holland x, Frei x, eds., B. C. Decker (Hamilton and London), pp. 148-156.




 



2.
Kohn E, Roque D, Azad N   (2006) Application of werum and tissue proteomics to understand and detect solid tumors, in Proteomics in Cancer Therapy. Daoud x, ed., Humana Press (Totowa, NJ), pp. in press.




 



3.
Azad NS, Rasool N, Annunziata CM, Minasian L, Whiteley G, Kohn EC (2006). Proteomics in clinical trials and practice: present uses and future promise. Mol Cell Proteomics  5, 1819-29.   https://doi.org/10.1074/mcp.R600008-MCP200




PubMed


 


PubMed ID 16737951
    
     


 



4.
Balkwill FR, Ashworth A, Bast RC, Berek JS, Boyd J, Disis ML, Gabra H, Gore ME, Hamilton TC, Jacobs IJ, Kaye SB, Kohn EC, Mills GB, Urban ND (2006). 10th Biennial Helene Harris Memorial Trust meeting. Cancer Res  66, 2904-6.   https://doi.org/10.1158/0008-5472.CAN-05-2093




PubMed


 


PubMed ID 16540635
    
     


 



5.
Boyce EA, Kohn EC (2005). Ovarian cancer in the proteomics era: diagnosis, prognosis, and therapeutics targets. Int J Gynecol Cancer  15 Suppl 3, 266-73.   https://doi.org/10.1111/j.1525-1438.2005.00434.x




PubMed


 


PubMed ID 16343243
    
     


 



6.
Dahut WL, Lakhani NJ, Gulley JL, Arlen PM, Kohn EC, Kotz H, McNally D, Parr A, Nguyen D, Yang SX, Steinberg SM, Venitz J, Sparreboom A, Figg WD (2006). Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors. Cancer Biol Ther  5, 22-7.   https://doi.org/10.4161/cbt.5.1.2349




PubMed


 


PubMed ID 16357512
    
     


 



7.
Davidson B, Espina V, Steinberg SM, Flørenes VA, Liotta LA, Kristensen GB, Tropé CG, Berner A, Kohn EC (2006). Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling. Clin Cancer Res  12, 791-9.   https://doi.org/10.1158/1078-0432.CCR-05-2516




PubMed


 


PubMed ID 16467090",https://intramural.nih.gov/search/searchview.taf?ipid=44101
556,SC009389-13,"October 01, 2005 -  September 30, 2006",A Mitogen-induced G Protein-coupled Receptor,"Kathleen  Kelly; PhD



IRP Faculty Profile",NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Yvona  Ward; PhD



Ross G Lake",NULL,Sheueyann  Cheng; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44103
557,SC009392-13,"October 01, 2005 -  September 30, 2006",Proteomic Analysis of Renal Tumors,"Maria  Merino; PhD



IRP Faculty Profile",NULL,"Laboratory of Pathology, NCI",Linda S Wrathall,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Schmidt LS, Nickerson ML, Warren MB, Glenn GM, Toro JR, Merino MJ, Turner ML, Choyke PL, Sharma N, Peterson J, Morrison P, Maher ER, Walther MM, Zbar B, Linehan WM (2005). Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dubé syndrome. Am J Hum Genet  76, 1023-33.   https://doi.org/10.1086/430842




PubMed



        
     
Free Article


 


PubMed ID 15852235
         Pubmed Central ID 1196440 


 



2.
Torres-Cabala C, Bibbo M, Panizo-Santos A, Barazi H, Krutzsch H, Roberts DD, Merino MJ   (2006) Proteomic identification of new biomarkers and application in thyroid cytology.  Acta Cytol 50:518-28.




PubMed


 


PubMed ID 17017437
    
     


 



3.
Wei MH, Toure O, Glenn GM, Pithukpakorn M, Neckers L, Stolle C, Choyke P, Grubb R, Middelton L, Turner ML, Walther MM, Merino MJ, Zbar B, Linehan WM, Toro JR (2006). Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet  43, 18-27.   https://doi.org/10.1136/jmg.2005.033506




PubMed



        
     
Free Article


 


PubMed ID 15937070
         Pubmed Central ID 2564499",https://intramural.nih.gov/search/searchview.taf?ipid=44104
558,SC009394-13,"October 01, 2005 -  September 30, 2006",Diagnostic Electron Microscopy  (EM),Maria  Tsokos; MD,NULL,"Laboratory of Pathology, NCI","Mones  Abu-Asab



Celeste Rita Riley",NULL,NULL,"Alexander Oliver Vortmeyer; MD (NINDS) 



Edward H. Oldfield; MD (NINDS)","Ordered by publication type and then author name.



1.
Ge Y, Montano I, Rustici G, Freebern WJ, Haggerty CM, Cui W, Ponciano-Jackson D, Chandramouli GV, Gardner ER, Figg WD, Abu-Asab M, Tsokos M, Jackson SH, Gardner K (2006). Selective leukemic-cell killing by a novel functional class of thalidomide analogs. Blood  108, 4126-35.   https://doi.org/10.1182/blood-2006-04-017046




PubMed



        
     
Free Article


 


PubMed ID 16940421
         Pubmed Central ID 1895447 


 



2.
Schiffmann R, Rapkiewicz A, Abu-Asab M, Ries M, Askari H, Tsokos M, Quezado M (2006). Pathological findings in a patient with Fabry disease who died after 2.5 years of enzyme replacement. Virchows Arch  448, 337-43.   https://doi.org/10.1007/s00428-005-0089-x




PubMed



        
     
Free Article


 


PubMed ID 16315019
         Pubmed Central ID 2288734 


 



3.
Vortmeyer AO, Tran MG, Zeng W, Gläsker S, Riley C, Tsokos M, Ikejiri B, Merrill MJ, Raffeld M, Zhuang Z, Lonser RR, Maxwell PH, Oldfield EH (2006). Evolution of VHL tumourigenesis in nerve root tissue. J Pathol  210, 374-82.   https://doi.org/10.1002/path.2062




PubMed


 


PubMed ID 16981244",https://intramural.nih.gov/search/searchview.taf?ipid=44105
559,SC009431-12,"October 01, 2005 -  September 30, 2006",Histologic and Molecular Characterization of Solid Pediatric Tumors,Maria  Tsokos; MD,NULL,"Laboratory of Pathology, NCI","Susana Beatriz Galli



Celeste Rita Riley",NULL,"Lee Jay Helman; MD (National Cancer Institute)



Crystal L. Mackall; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Schinstine M, Abati A, Tsokos M, Fox E, Filie AC (2006). Cytological identification of metastatic epithelial nephroblastoma in pleural fluid: report of a case and review of literature. Diagn Cytopathol  34, 621-5.   https://doi.org/10.1002/dc.20535




PubMed


 


PubMed ID 16900470",https://intramural.nih.gov/search/searchview.taf?ipid=44106
560,SC010051-11,"October 01, 2005 -  September 30, 2006",Metal Chelate Conjugated Dendrimer Constructs for Diagnosis and Therapy,"Martin W Brechbiel; PhD



IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI","Celeste A Regino



Diane E Milenic



Charles A Boswell



Heng  Xu",NULL,Peter L Choyke; MD (National Cancer Institute),Robert  Star; MD (NIDDK),"Ordered by publication type and then author name.



1.
Dear JW, Kobayashi H, Brechbiel MW, Star RA (2006). Imaging acute renal failure with polyamine dendrimer-based MRI contrast agents. Nephron Clin Pract  103, c45-9.   https://doi.org/10.1159/000090608




PubMed


 


PubMed ID 16543755
    
     


 



2.
Dear JW, Kobayashi H, Jo SK, Holly MK, Hu X, Yuen PS, Brechbiel MW, Star RA (2005). Dendrimer-enhanced MRI as a diagnostic and prognostic biomarker of sepsis-induced acute renal failure in aged mice. Kidney Int  67, 2159-67.   https://doi.org/10.1111/j.1523-1755.2005.00321.x




PubMed


 


PubMed ID 15882259
    
     


 



3.
Kobayashi H, Brechbiel MW (2005). Nano-sized MRI contrast agents with dendrimer cores. Adv Drug Deliv Rev  57, 2271-86.   https://doi.org/10.1016/j.addr.2005.09.016




PubMed


 


PubMed ID 16290152
    
     


 



4.
Kobayashi H, Kawamoto S, Bernardo M, Brechbiel MW, Knopp MV, Choyke PL (2006). Delivery of gadolinium-labeled nanoparticles to the sentinel lymph node: comparison of the sentinel node visualization and estimations of intra-nodal gadolinium concentration by the magnetic resonance imaging. J Control Release  111, 343-51.   https://doi.org/10.1016/j.jconrel.2005.12.019




PubMed


 


PubMed ID 16490277
    
     


 



5.
Murad GJ, Walbridge S, Morrison PF, Garmestani K, Degen JW, Brechbiel MW, Oldfield EH, Lonser RR (2006). Real-time, image-guided, convection-enhanced delivery of interleukin 13 bound to pseudomonas exotoxin. Clin Cancer Res  12, 3145-51.   https://doi.org/10.1158/1078-0432.CCR-05-2583




PubMed


 


PubMed ID 16707614
    
     


 



6.
Talanov VS, Regino CA, Kobayashi H, Bernardo M, Choyke PL, Brechbiel MW (2006). Dendrimer-based nanoprobe for dual modality magnetic resonance and fluorescence imaging. Nano Lett  6, 1459-63.   https://doi.org/10.1021/nl060765q




PubMed


 


PubMed ID 16834429
    
     


 



7.
Venditto VJ, Regino CA, Brechbiel MW (2005). PAMAM dendrimer based macromolecules as improved contrast agents. Mol Pharm  2, 302-11.   https://doi.org/10.1021/mp050019e




PubMed


 


PubMed ID 16053333
    
     


 



8.
Xu H, Baidoo K, Gunn AJ, Boswell CA, Milenic DE, Choyke PL, Brechbiel MW (2007). Design, synthesis, and characterization of a dual modality positron emission tomography and fluorescence imaging agent for monoclonal antibody tumor-targeted imaging. J Med Chem  50, 4759-65.   https://doi.org/10.1021/jm070657w




PubMed



        
     
Free Article


 


PubMed ID 17725340
         Pubmed Central ID 2366096 


 



9.
Brechbiel MW, Xu HW (submitted in 2006) Method Of Preparing Macromolecular Contrast Agents And Uses Thereof. Patent issued: 8,288,530 (US in 2013). Patent pending: PCT/US2007/083734 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=44107
561,SC010056-11,"October 01, 2005 -  September 30, 2006",Mechanisms of Transcriptional Regulation in Activated T-cells,"Kevin  Gardner; MD, PhD",NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Gardner K, Feng Y, Xie D, Li X, Xiao W, Qin J, Hu J, Judge S, Li Q, Gong J   (2006) Unsheduled CDK1 activity in G1 phase of the cell cycle triggers apoptosis in X-irradiated lymphocytic leukemia cells.  Cell Mol.Life Sci, in press.




 



2.
Gardner K, Taub D   (2006) qPrimerDepot: A primer database for quantitative real time PCR.  Nucleic Acids Research  in Press pp.




 



3.
Gardner K, Wang J, Zhang H, Shi W, Yu M, Li Q, Jiang X, Gong F, Li Q, Li Z   (2006) Dual regulation of soluble tumor necrosis factor-alpha induced activation of human monocytic cells via modulating transmembrane TNF-alpha-mediated 'reverse signaling'.  Int.J.Mol.Med, in press.




 



4.
Ge Y, Montano I, Rustici G, Freebern WJ, Haggerty CM, Cui W, Ponciano-Jackson D, Chandramouli GV, Gardner ER, Figg WD, Abu-Asab M, Tsokos M, Jackson SH, Gardner K (2006). Selective leukemic-cell killing by a novel functional class of thalidomide analogs. Blood  108, 4126-35.   https://doi.org/10.1182/blood-2006-04-017046




PubMed



        
     
Free Article


 


PubMed ID 16940421
         Pubmed Central ID 1895447",https://intramural.nih.gov/search/searchview.taf?ipid=44108
562,SC010058-11,"October 01, 2005 -  September 30, 2006",Regulation of apoptosis in Ewings sarcoma and neuroblastoma,Maria  Tsokos; MD,NULL,"Laboratory of Pathology, NCI",Yan  Ren,NULL,"Lee Jay Helman; MD (National Cancer Institute)



Crystal L. Mackall; MD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44109
563,SC010074-11,"October 01, 2005 -  September 30, 2006",Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction,"Leonard  Neckers; PhD



IRP Faculty Profile",NULL,"Urologic Oncology Branch, NCI","Wanping  Xu



Tomohiro  Kajiguchi



Hye-Sik  Kong",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Koga F, Xu W, Karpova TS, McNally JG, Baron R, Neckers L (2006). Hsp90 inhibition transiently activates Src kinase and promotes Src-dependent Akt and Erk activation. Proc Natl Acad Sci U S A  103, 11318-22.   https://doi.org/10.1073/pnas.0604705103




PubMed



        
     
Free Article


 


PubMed ID 16844778
         Pubmed Central ID 1544084 


 



2.
Mimnaugh EG, Neckers LM (2005). Measuring ubiquitin conjugation in cells. Methods Mol Biol  301, 223-41.   https://doi.org/10.1385/1-59259-895-1:223




PubMed


 


PubMed ID 15917635
    
     


 



3.
Neckers L (2006). Chaperoning oncogenes: Hsp90 as a target of geldanamycin. Handb Exp Pharmacol   259-77  https://doi.org/10.1007/3-540-29717-0_11




PubMed


 


PubMed ID 16610363
    
     


 



4.
Neckers L (2006). Using natural product inhibitors to validate Hsp90 as a molecular target in cancer. Curr Top Med Chem  6, 1163-71.   https://doi.org/10.2174/156802606777811979




PubMed


 


PubMed ID 16842153
    
     


 



5.
Yu XM, Shen G, Neckers L, Blake H, Holzbeierlein J, Cronk B, Blagg BS (2005). Hsp90 inhibitors identified from a library of novobiocin analogues. J Am Chem Soc  127, 12778-9.   https://doi.org/10.1021/ja0535864




PubMed


 


PubMed ID 16159253",https://intramural.nih.gov/search/searchview.taf?ipid=44110
564,SC010083-10,"October 01, 2005 -  September 30, 2006",Investigation of Germ-line Genetic Variation and Susceptibility to Cancer and it,"Stephen J Chanock; MD, PhD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Renee A Chen



Vincent  Bekker



Nicholas Jon Orr","Anne-Lise  Borresen-Dale
(Radium Hospital, Oslo)




Paul  Brennan
(International Agency for Research on Cancer, Lyon, France)




Howard  Cann
(Centre d'Etudes du Polymorphisme Humain)




Brian  Henderson; MD
(Preventive Medicine, University of Southern California School of Medicine)




Austin L. Hughes; PhD
(University of South Carolina)




David  Hunter
(Harvard)


Show all 16","Joseph  Fraumeni; MD (National Cancer Institute)



Wong H Chow (National Cancer Institute)



Lee Elizabeth Moore; PhD, MD (National Cancer Institute)



Debra  Silverman; ScD, ScM (Occupational and Environmental Epidemiology Branch)



Qing  Lan (National Cancer Institute)



Nilanjan  Chatterjee (National Cancer Institute)","James G Taylor; MD (NHLBI) 



Neal S Young; MD (NHLBI) 



Mark T Gladwin; MD (NHLBI) 



Harry Lewis Malech; MD (NIAID) 



Steven M Holland; MD (NIAID)","Ordered by publication type and then author name.



1.
Baccarelli A, Hou L, Chen J, Lissowska J, El-Omar EM, Grillo P, Giacomini SM, Yaeger M, Bernig T, Zatonski W, Fraumeni JF, Chanock SJ, Chow WH (2006). Mannose-binding lectin-2 genetic variation and stomach cancer risk. Int J Cancer  119, 1970-5.   https://doi.org/10.1002/ijc.22075




PubMed


 


PubMed ID 16721783
    
     


 



2.
Bergen AW, Qi Y, Haque KA, Welch RA, Chanock SJ (2005). Effects of DNA mass on multiple displacement whole genome amplification and genotyping performance. BMC Biotechnol  5, 24.   https://doi.org/10.1186/1472-6750-5-24




PubMed



        
     
Free Article


 


PubMed ID 16168060
         Pubmed Central ID 1249558 


 



3.
Bernig T, Chanock SJ (2006). Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer. Expert Rev Mol Diagn  6, 319-31.   https://doi.org/10.1586/14737159.6.3.319




PubMed


 


PubMed ID 16706736
    
     


 



4.
Boersma BJ, Howe TM, Goodman JE, Yfantis HG, Lee DH, Chanock SJ, Ambs S (2006). Association of breast cancer outcome with status of p53 and MDM2 SNP309. J Natl Cancer Inst  98, 911-9.   https://doi.org/10.1093/jnci/djj245




PubMed


 


PubMed ID 16818855
    
     


 



5.
Breunis WB, Biezeveld MH, Geissler J, Ottenkamp J, Kuipers IM, Lam J, Hutchinson A, Welch R, Chanock SJ, Kuijpers TW (2006). Vascular endothelial growth factor gene haplotypes in Kawasaki disease. Arthritis Rheum  54, 1588-94.   https://doi.org/10.1002/art.21811




PubMed


 


PubMed ID 16645995
    
     


 



6.
Brown EE, Fallin D, Ruczinski I, Hutchinson A, Staats B, Vitale F, Lauria C, Serraino D, Rezza G, Mbisa G, Whitby D, Messina A, Goedert JJ, Chanock SJ (2006). Associations of classic Kaposi sarcoma with common variants in genes that modulate host immunity. Cancer Epidemiol Biomarkers Prev  15, 926-34.   https://doi.org/10.1158/1055-9965.EPI-05-0791




PubMed


 


PubMed ID 16702372
    
     


 



7.
Brown EE, Fallin MD, Goedert JJ, Hutchinson A, Vitale F, Lauria C, Giuliani M, Marshall V, Mbisa G, Serraino D, Messina A, Durum S, Whitby D, Chanock SJ, Kaposi Sarcoma Genetics Working Group (2006). Host immunogenetics and control of human herpesvirus-8 infection. J Infect Dis  193, 1054-62.   https://doi.org/10.1086/501470




PubMed


 


PubMed ID 16544245
    
     


 



8.
Choi EH, Ehrmantraut M, Foster CB, Moss J, Chanock SJ (2006). Association of common haplotypes of surfactant protein A1 and A2 (SFTPA1 and SFTPA2) genes with severity of lung disease in cystic fibrosis. Pediatr Pulmonol  41, 255-62.   https://doi.org/10.1002/ppul.20361




PubMed


 


PubMed ID 16429424
    
     


 



9.
Erichsen HC, Engel SA, Eck PK, Welch R, Yeager M, Levine M, Siega-Riz AM, Olshan AF, Chanock SJ (2006). Genetic variation in the sodium-dependent vitamin C transporters, SLC23A1, and SLC23A2 and risk for preterm delivery. Am J Epidemiol  163, 245-54.   https://doi.org/10.1093/aje/kwj035




PubMed


 


PubMed ID 16357110
    
     


 



10.
Feigelson HS, Cox DG, Cann HM, Wacholder S, Kaaks R, Henderson BE, Albanes D, Altshuler D, Berglund G, Berrino F, Bingham S, Buring JE, Burtt NP, Calle EE, Chanock SJ, Clavel-Chapelon F, Colditz G, Diver WR, Freedman ML, Haiman CA, Hankinson SE, Hayes RB, Hirschhorn JN, Hunter D, Kolonel LN, et al. [14 more authors] (2006). Haplotype analysis of the HSD17B1 gene and risk of breast cancer: a comprehensive approach to multicenter analyses of prospective cohort studies. Cancer Res  66, 2468-75.   https://doi.org/10.1158/0008-5472.CAN-05-3574




PubMed


 


PubMed ID 16489054
    
     


 



11.
Fredman D, Sawyer SL, Strömqvist L, Mottagui-Tabar S, Kidd KK, Wahlestedt C, Chanock SJ, Brookes AJ (2006). Nonsynonymous SNPs: validation characteristics, derived allele frequency patterns, and suggestive evidence for natural selection. Hum Mutat  27, 173-86.   https://doi.org/10.1002/humu.20289




PubMed


 


PubMed ID 16429399
    
     


 



12.
Gunter MJ, Canzian F, Landi S, Chanock SJ, Sinha R, Rothman N (2006). Inflammation-related gene polymorphisms and colorectal adenoma. Cancer Epidemiol Biomarkers Prev  15, 1126-31.   https://doi.org/10.1158/1055-9965.EPI-06-0042




PubMed


 


PubMed ID 16775170
    
     


 



13.
Huang WY, Berndt SI, Kang D, Chatterjee N, Chanock SJ, Yeager M, Welch R, Bresalier RS, Weissfeld JL, Hayes RB (2006). Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: XPC polymorphisms modify smoking-related risk. Cancer Epidemiol Biomarkers Prev  15, 306-11.   https://doi.org/10.1158/1055-9965.EPI-05-0751




PubMed


 


PubMed ID 16492920
    
     


 



14.
Hughes AL, Packer B, Welch R, Chanock SJ, Yeager M (2005). High level of functional polymorphism indicates a unique role of natural selection at human immune system loci. Immunogenetics  57, 821-7.   https://doi.org/10.1007/s00251-005-0052-7




PubMed


 


PubMed ID 16261383
    
     


 



15.
Hunter DJ, Riboli E, Haiman CA, Albanes D, Altshuler D, Chanock SJ, Haynes RB, Henderson BE, Kaaks R, Stram DO, Thomas G, Thun MJ, Blanché H, Buring JE, Burtt NP, Calle EE, Cann H, Canzian F, Chen YC, Colditz GA, Cox DG, Dunning AM, Feigelson HS, Freedman ML, Gaziano JM, National Cancer Institute Breast and Prostate Cancer Cohort Consortium, et al. [21 more authors] (2005). A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer  5, 977-85.   https://doi.org/10.1038/nrc1754




PubMed


 


PubMed ID 16341085
    
     


 



16.
Kogevinas M, Fernandez F, Garcia-Closas M, Tardon A, Garcia-Closas R, Serra C, Carrato A, Castano-Vinyals G, Yeager M, Chanock SJ, Lloreta J, Rothman N, Real FX, Dosemeci M, Malats N, Silverman D (2006). Hair dye use is not associated with risk for bladder cancer: evidence from a case-control study in Spain. Eur J Cancer  42, 1448-54.   https://doi.org/10.1016/j.ejca.2006.02.009




PubMed


 


PubMed ID 16740387
    
     


 



17.
O'Hanlon TP, Carrick DM, Arnett FC, Reveille JD, Carrington M, Gao X, Oddis CV, Morel PA, Malley JD, Malley K, Dreyfuss J, Shamim EA, Rider LG, Chanock SJ, Foster CB, Bunch T, Plotz PH, Love LA, Miller FW (2005). Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 allelic profiles and motifs define clinicopathologic groups in caucasians. Medicine (Baltimore)  84, 338-49.   https://doi.org/10.1097/01.md.0000189818.63141.8c




PubMed


 


PubMed ID 16267409
    
     


 



18.
O'Hanlon TP, Carrick DM, Targoff IN, Arnett FC, Reveille JD, Carrington M, Gao X, Oddis CV, Morel PA, Malley JD, Malley K, Shamim EA, Rider LG, Chanock SJ, Foster CB, Bunch T, Blackshear PJ, Plotz PH, Love LA, Miller FW (2006). Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies. Medicine (Baltimore)  85, 111-27.   https://doi.org/10.1097/01.md.0000217525.82287.eb




PubMed


 


PubMed ID 16609350
    
     


 



19.
Packer BR, Yeager M, Burdett L, Welch R, Beerman M, Qi L, Sicotte H, Staats B, Acharya M, Crenshaw A, Eckert A, Puri V, Gerhard DS, Chanock SJ (2006). SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res  34, D617-21.   https://doi.org/10.1093/nar/gkj151




PubMed



        
     
Free Article


 


PubMed ID 16381944
         Pubmed Central ID 1347513 


 



20.
Rocha D, Gut I, Jeffreys AJ, Kwok PY, Brookes AJ, Chanock SJ (2006). Seventh international meeting on single nucleotide polymorphism and complex genome analysis: 'ever bigger scans and an increasingly variable genome'. Hum Genet  119, 451-6.   https://doi.org/10.1007/s00439-006-0151-z




PubMed


 


PubMed ID 16501918
    
     


 



21.
Savage SA, Calado RT, Xin ZT, Ly H, Young NS, Chanock SJ (2006). Genetic variation in telomeric repeat binding factors 1 and 2 in aplastic anemia. Exp Hematol  34, 664-71.   https://doi.org/10.1016/j.exphem.2006.02.008




PubMed


 


PubMed ID 16647572
    
     


 



22.
Savage SA, Hou L, Lissowska J, Chow WH, Zatonski W, Chanock SJ, Yeager M (2006). Interleukin-8 polymorphisms are not associated with gastric cancer risk in a Polish population. Cancer Epidemiol Biomarkers Prev  15, 589-91.   https://doi.org/10.1158/1055-9965.EPI-05-0887




PubMed


 


PubMed ID 16537722
    
     


 



23.
Stredrick DL, Garcia-Closas M, Pineda MA, Bhatti P, Alexander BH, Doody MM, Lissowska J, Peplonska B, Brinton LA, Chanock SJ, Struewing JP, Sigurdson AJ (2006). The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer. Hum Mutat  27, 538-44.   https://doi.org/10.1002/humu.20323




PubMed



        
     
Free Article


 


PubMed ID 16652348
         Pubmed Central ID 1850333 


 



24.
Wang SS, Cozen W, Severson RK, Hartge P, Cerhan JR, Davis S, Welch R, Rothman N, Chanock SJ (2006). Cyclin D1 splice variant and risk for non-Hodgkin lymphoma. Hum Genet  120, 297-300.   https://doi.org/10.1007/s00439-006-0212-3




PubMed


 


PubMed ID 16783567
    
     


 



25.
Wang SS, Davis S, Cerhan JR, Hartge P, Severson RK, Cozen W, Lan Q, Welch R, Chanock SJ, Rothman N (2006). Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma. Carcinogenesis  27, 1828-34.   https://doi.org/10.1093/carcin/bgl013




PubMed


 


PubMed ID 16543247",https://intramural.nih.gov/search/searchview.taf?ipid=44111
565,SC010084-35,"October 01, 2005 -  September 30, 2006",Pediatric HIVAIDS Clinical Research,"Robert  Yarchoan; MD



IRP Faculty Profile",NULL,"HIV and AIDS Malignancy Branch, NCI",NULL,NULL,"Lori  Wiener; PhD, LCSW-C (National Cancer Institute)



Lauren V Wood; MD (National Cancer Institute)



Rohan  Hazra (National Cancer Institute)



Steven Leonard Zeichner; MD, PhD (Center for Cancer Research)",Eugene O Major; PhD (NINDS),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44112
566,SC010090-10,"October 01, 2005 -  September 30, 2006",Fluorescent Pteridine Nucleoside Analogs,"Frank M Balis; MD, PhD",NULL,"Pediatric Oncology Branch, NCI",Mary  Hawkins,"Jean  Brochon
(Biology, Centre National de la Recherche Scientifique)




Lesley  Davenport
(Biochemistry, Brooklyn College)




Basil  Hanss
(Biochemistry, Mt. Sinai Univer)




Craig  Martin
(University of Massachusetts)




Ishita  Mukerji
(Biochemistry, Wesleyan Univer)




Tom  Nordlund
(Biochemistry, University of Alabama)


Show all 10",Victor  Zhurkin; PhD (National Cancer Institute),Jay Robert Knutson; PhD (NHLBI),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44114
567,SC010093-09,"October 01, 2005 -  September 30, 2006",Targeting the Epigenome for Lung Cancer Therapy,"David  Schrump; MD



IRP Faculty Profile",NULL,"Surgery Branch, NCI","Aaron  Chen



Ana R Hancox



Julie A Hong



Tricia  Kunst



Ming  Zhao



Yang  Kang



Show all 8",NULL,"Dao M Nguyen; MD, MS (National Cancer Institute)



Jane Beth Trepel (National Cancer Institute)",Richard  Childs; MD (NHLBI),"Ordered by publication type and then author name.



1.
Guo ZS, Hong JA, Irvine KR, Chen GA, Spiess PJ, Liu Y, Zeng G, Wunderlich JR, Nguyen DM, Restifo NP, Schrump DS (2006). De novo induction of a cancer/testis antigen by 5-aza-2'-deoxycytidine augments adoptive immunotherapy in a murine tumor model. Cancer Res  66, 1105-13.   https://doi.org/10.1158/0008-5472.CAN-05-3020




PubMed



        
     
Free Article


 


PubMed ID 16424047
         Pubmed Central ID 2242843 


 



2.
Hong JA, Kang Y, Abdullaev Z, Flanagan PT, Pack SD, Fischette MR, Adnani MT, Loukinov DI, Vatolin S, Risinger JI, Custer M, Chen GA, Zhao M, Nguyen DM, Barrett JC, Lobanenkov VV, Schrump DS (2005). Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells. Cancer Res  65, 7763-74.   https://doi.org/10.1158/0008-5472.CAN-05-0823




PubMed


 


PubMed ID 16140944
    
     


 



3.
Kang Y, Hong J, Chen G, Nguyen D   (2006) Dynamic transcriptional regulatory complexes including BORIS, CTCF, and Sp1 modulate NY-ESO-1 expression in lung cancer cells.  Oncogene, in press.




 



4.
Kassis ES, Zhao M, Hong JA, Chen GA, Nguyen DM, Schrump DS (2006). Depletion of DNA methyltransferase 1 and/or DNA methyltransferase 3b mediates growth arrest and apoptosis in lung and esophageal cancer and malignant pleural mesothelioma cells. J Thorac Cardiovasc Surg  131, 298-306.   https://doi.org/10.1016/j.jtcvs.2005.05.022




PubMed


 


PubMed ID 16434257
    
     


 



5.
Lundqvist A, Abrams SI, Schrump DS, Alvarez G, Suffredini D, Berg M, Childs R (2006). Bortezomib and depsipeptide sensitize tumors to tumor necrosis factor-related apoptosis-inducing ligand: a novel method to potentiate natural killer cell tumor cytotoxicity. Cancer Res  66, 7317-25.   https://doi.org/10.1158/0008-5472.CAN-06-0680




PubMed


 


PubMed ID 16849582
    
     


 



6.
Schrump D   (2006) Staging lung cancer in the genomic era.  Thoracic Surg Clinics, in press.




 



7.
Schrump D   (2006) Utilization of chromatin remodeling agents for lung cancer therapy.  Thoracic Surg Clinics, in press.




 



8.
Schrump D, Chandramouli G, Maxwell L, Custer M, Pack S, Loukinov D, Aprelikova O, Litzi T, Berchuck A, Lobanenkov V, Barrett J   (2006) Global expression analysis of cancer-testis genes in uterine cancers reveals a high incidence of BORIS expression.  Mol Cancer Res, in press.




 



9.
Schrump D, Reddy R, Nguyen D   (2006) Enhancement of Apo2L/TRAIL mediated cytotoxicity in esophageal cancer cells by cisplatin: recruitment of the mitochondria dependent death signaling pathway.  Mol Cancer Therapeutics, in press.




 



10.
Schrump D, Ziauddin M, Yeow W, Baras A, Choa A, Shamimi-Noori S, Zou J, Nguyen D   (2006) Rapid and profound potentiation of Apo2L/TRAIL-mediated cytotoxicity and apoptosis in thoracic cancer cells by the histone deacetylase inhibitor Trichostatin.  Apoptosis, in press.




 



11.
Schrump DS, Fischette MR, Nguyen DM, Zhao M, Li X, Kunst TF, Hancox A, Hong JA, Chen GA, Pishchik V, Figg WD, Murgo AJ, Steinberg SM (2006). Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura. Clin Cancer Res  12, 5777-85.   https://doi.org/10.1158/1078-0432.CCR-06-0669




PubMed


 


PubMed ID 17020984
    
     


 



12.
Schrump DS, Nguyen DM (2005). Targeting the epigenome for the treatment and prevention of lung cancer. Semin Oncol  32, 488-502.   https://doi.org/10.1053/j.seminoncol.2005.07.007




PubMed


 


PubMed ID 16210090
    
     


 



13.
Vatolin S, Abdullaev Z, Pack SD, Flanagan PT, Custer M, Loukinov DI, Pugacheva E, Hong JA, Morse H, Schrump DS, Risinger JI, Barrett JC, Lobanenkov VV (2005). Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes. Cancer Res  65, 7751-62.   https://doi.org/10.1158/0008-5472.CAN-05-0858




PubMed


 


PubMed ID 16140943
    
     


 



14.
Yeow WS, Ziauddin MF, Maxhimer JB, Shamimi-Noori S, Baras A, Chua A, Schrump DS, Nguyen DM (2006). Potentiation of the anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the kinase inhibitor Staurosporine or its clinically relevant analogue UCN-01. Br J Cancer  94, 1436-45.   https://doi.org/10.1038/sj.bjc.6603132




PubMed



        
     
Free Article


 


PubMed ID 16705314
         Pubmed Central ID 2361280 


 



15.
Ziauddin MF, Yeow WS, Maxhimer JB, Baras A, Chua A, Reddy RM, Tsai W, Cole GW, Schrump DS, Nguyen DM (2006). Valproic acid, an antiepileptic drug with histone deacetylase inhibitory activity, potentiates the cytotoxic effect of Apo2L/TRAIL on cultured thoracic cancer cells through mitochondria-dependent caspase activation. Neoplasia  8, 446-57.   https://doi.org/10.1593/neo.05823




PubMed



        
     
Free Article


 


PubMed ID 16820090
         Pubmed Central ID 1601472",https://intramural.nih.gov/search/searchview.taf?ipid=44053
568,SC010097-07,"October 01, 2005 -  September 30, 2006",Inflammatory Breast Cancer,Sandra M Swain; MD,NULL,"Medical Oncology Branch, NCI","Diana A Nguyen



Arlene Wendy Berman



Neelima  Denduluri



Margarita R Velarde; CRNP",NULL,"Stephen M Hewitt; MD, PhD (National Cancer Institute)



Seth M Steinberg; PhD (Biostatistics and Data Management Section)



Kevin A Camphausen; MD (National Cancer Institute)



Peter L Choyke; MD (National Cancer Institute)","Sherry M Yang (NINDS) 



Catherine K Chow; MD (CC) 



David M Thomasson; PhD (CC)","Ordered by publication type and then author name.



1.
Wedam SB, Low JA, Yang SX, Chow CK, Choyke P, Danforth D, Hewitt SM, Berman A, Steinberg SM, Liewehr DJ, Plehn J, Doshi A, Thomasson D, McCarthy N, Koeppen H, Sherman M, Zujewski J, Camphausen K, Chen H, Swain SM (2006). Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer. J Clin Oncol  24, 769-77.   https://doi.org/10.1200/JCO.2005.03.4645




PubMed


 


PubMed ID 16391297",https://intramural.nih.gov/search/searchview.taf?ipid=44115
569,SC010100-07,"October 01, 2005 -  September 30, 2006",Developmental Therapeutics for Improved Treatment of Tumors of the Central Nervo,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI","Katherine Elizabeth Warren; MD



Cheryl L Royce



Benjamin W Purow



Wei  Zhang



Lyndon J Kim



Karna L Robinson



Show all 32","Lauren  Abrey
(NABTC, NABTC)




Ken  Aldape
(NABTC, NABTC)




Gene  Barnett
(NABTT, NABTT)




Tracy  Batchelor
(NABTT, NABTT)




Mitchel  Berger
(Neurosurgery, University of California)




Darell  Bigner
(NABTC, NABTC)


Show all 41",NULL,NULL,"Ordered by publication type and then author name.



1.
Brem SS, Bierman PJ, Black P, Blumenthal DT, Brem H, Chamberlain MC, Chiocca EA, DeAngelis LM, Fenstermaker RA, Fine HA, Friedman A, Glass J, Grossman SA, Heimberger AB, Junck L, Levin V, Loeffler JJ, Maor MH, Narayana A, Newton HB, Olivi A, Portnow J, Prados M, Raizer JJ, Rosenfeld SS, National Comprehensive Cancer Network, et al. [4 more authors] (2005). Central nervous system cancers: Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw  3, 644-90.   https://doi.org/10.6004/jnccn.2005.0038




PubMed


 


PubMed ID 16194456
    
     


 



2.
Camphausen K, Cerna D, Scott T, Sproull M, Burgan WE, Cerra MA, Fine H, Tofilon PJ (2005). Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid. Int J Cancer  114, 380-6.   https://doi.org/10.1002/ijc.20774




PubMed


 


PubMed ID 15578701
    
     


 



3.
Cho SY, Ravasi L, Szajek LP, Seidel J, Green MV, Fine HA, Eckelman WC (2005). Evaluation of (76)Br-FBAU as a PET reporter probe for HSV1-tk gene expression imaging using mouse models of human glioma. J Nucl Med  46, 1923-30.




PubMed


 


PubMed ID 16269608
    
     


 



4.
De Roos AJ, Rothman N, Brown M, Bell DA, Pittman GS, Shapiro WR, Selker RG, Fine HA, Black PM, Inskip PD (2006). Variation in genes relevant to aromatic hydrocarbon metabolism and the risk of adult brain tumors. Neuro Oncol  8, 145-55.   https://doi.org/10.1215/15228517-2005-003




PubMed



        
     
Free Article


 


PubMed ID 16598069
         Pubmed Central ID 1871937 


 



5.
Fine HA (2005). Radiotherapy plus adjuvant temozolomide for the treatment of glioblastoma--a paradigm shift. Nat Clin Pract Oncol  2, 334-5.   https://doi.org/10.1038/ncponc0204




PubMed


 


PubMed ID 16075787
    
     


 



6.
Hatch EE, Linet MS, Zhang J, Fine HA, Shapiro WR, Selker RG, Black PM, Inskip PD (2005). Reproductive and hormonal factors and risk of brain tumors in adult females. Int J Cancer  114, 797-805.   https://doi.org/10.1002/ijc.20776




PubMed


 


PubMed ID 15609304
    
     


 



7.
Kleinerman RA, Linet MS, Hatch EE, Tarone RE, Black PM, Selker RG, Shapiro WR, Fine HA, Inskip PD (2005). Self-reported electrical appliance use and risk of adult brain tumors. Am J Epidemiol  161, 136-46.   https://doi.org/10.1093/aje/kwi013




PubMed


 


PubMed ID 15632263
    
     


 



8.
Kotliarov Y, Steed ME, Christopher N, Walling J, Su Q, Center A, Heiss J, Rosenblum M, Mikkelsen T, Zenklusen JC, Fine HA (2006). High-resolution global genomic survey of 178 gliomas reveals novel regions of copy number alteration and allelic imbalances. Cancer Res  66, 9428-36.   https://doi.org/10.1158/0008-5472.CAN-06-1691




PubMed



        
     
Free Article


 


PubMed ID 17018597
         Pubmed Central ID 4316202 


 



9.
Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, Park JK, Fine HA (2006). Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell  9, 391-403.   https://doi.org/10.1016/j.ccr.2006.03.030




PubMed


 


PubMed ID 16697959
    
     


 



10.
Prados MD, Lamborn K, Yung WK, Jaeckle K, Robins HI, Mehta M, Fine HA, Wen PY, Cloughesy T, Chang S, Nicholas MK, Schiff D, Greenberg H, Junck L, Fink K, Hess K, Kuhn J, North American Brain Tumor Consortium (2006) A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study. Neuro Oncol 8:189-93.




PubMed



        
     
Free Article


 


PubMed ID 16533878
         Pubmed Central ID 1871932 


 



11.
Purow BW, Haque RM, Noel MW, Su Q, Burdick MJ, Lee J, Sundaresan T, Pastorino S, Park JK, Mikolaenko I, Maric D, Eberhart CG, Fine HA (2005). Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Res  65, 2353-63.   https://doi.org/10.1158/0008-5472.CAN-04-1890




PubMed


 


PubMed ID 15781650
    
     


 



12.
Rajaraman P, Schwartz BS, Rothman N, Yeager M, Fine HA, Shapiro WR, Selker RG, Black PM, Inskip PD (2005). Delta-aminolevulinic acid dehydratase polymorphism and risk of brain tumors in adults. Environ Health Perspect  113, 1209-11.   https://doi.org/10.1289/ehp.7986




PubMed



        
     
Free Article


 


PubMed ID 16140629
         Pubmed Central ID 1280403 


 



13.
Sun L, Hui AM, Su Q, Vortmeyer A, Kotliarov Y, Pastorino S, Passaniti A, Menon J, Walling J, Bailey R, Rosenblum M, Mikkelsen T, Fine HA (2006). Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell  9, 287-300.   https://doi.org/10.1016/j.ccr.2006.03.003




PubMed


 


PubMed ID 16616334
    
     


 



14.
Wen PY, Yung WK, Lamborn KR, Dahia PL, Wang Y, Peng B, Abrey LE, Raizer J, Cloughesy TF, Fink K, Gilbert M, Chang S, Junck L, Schiff D, Lieberman F, Fine HA, Mehta M, Robins HI, DeAngelis LM, Groves MD, Puduvalli VK, Levin V, Conrad C, Maher EA, Aldape K, et al. [8 more authors] (2006). Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08. Clin Cancer Res  12, 4899-907.   https://doi.org/10.1158/1078-0432.CCR-06-0773




PubMed


 


PubMed ID 16914578",https://intramural.nih.gov/search/searchview.taf?ipid=44116
570,SC010277-09,"October 01, 2005 -  September 30, 2006",Chemokines in Skin Immune Cell Trafficking & Cancer Progression,"Sam  Hwang; MD, PhD",NULL,"Dermatology Branch, NCI","Lei  Fang



Anke Susanne Lonsdorf



Emily  Cha



Victor  Huang



Hiroshi  Mitsui",NULL,Nicholas Phillip Restifo; MD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Cardones AR, Leitner WW, Fang L, Murakami T, Kapoor V, Udey MC, Hwang ST (2006). Genetic immunization with LYVE-1 cDNA yields function-blocking antibodies against native protein. Microvasc Res  71, 32-9.   https://doi.org/10.1016/j.mvr.2005.09.002




PubMed


 


PubMed ID 16257423
    
     


 



2.
Kakinuma T, Hwang ST (2006). Chemokines, chemokine receptors, and cancer metastasis. J Leukoc Biol  79, 639-51.   https://doi.org/10.1189/jlb.1105633




PubMed


 


PubMed ID 16478915",https://intramural.nih.gov/search/searchview.taf?ipid=44117
571,SC010278-09,"October 01, 2005 -  September 30, 2006",Waldenstroms Macroglobulinemia,"Walter M Kuehl; MD, PhD",NULL,"Cancer Genetics Branch, NCI","Leslie Ann Brents



Adriana  Zingone; MD",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44118
572,SC010281-09,"October 01, 2005 -  September 30, 2006",Biology and Therapy of T Cell Depletion,Crystal L. Mackall; MD,NULL,"Pediatric Oncology Branch, NCI","Kevin  Chua



Hua  Zhang



Terry J Fry



Martin  Guimond



Sarah G Herby



Aviva  Krauss","Bruce  Blazar
(Department of Pediatrics, University of Minnesota)




Francesca  Chiodi; PhD
(Microbiology-Tumor Biology, Karolinska)","Ronald E Gress; MD (National Cancer Institute)



Claude  Sportes (National Cancer Institute)



Michael R Bishop; MD (National Cancer Institute)



Steven Aaron Rosenberg; MD, PhD (National Cancer Institute)



Alan S Wayne; MD (National Cancer Institute)",Daniel C Douek; MD (NIAID),"Ordered by publication type and then author name.



1.
Crooks GM, Weinberg K, Mackall C (2006). Immune reconstitution: from stem cells to lymphocytes. Biol Blood Marrow Transplant  12, 42-6.   https://doi.org/10.1016/j.bbmt.2005.10.015




PubMed


 


PubMed ID 16399583
    
     


 



2.
Fry TJ, Mackall CL (2005). The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J Immunol  174, 6571-6.   https://doi.org/10.4049/jimmunol.174.11.6571




PubMed


 


PubMed ID 15905493
    
     


 



3.
Hazra R, Mackall C (2005). Thymic function in HIV infection. Curr HIV/AIDS Rep  2, 24-8.   https://doi.org/10.1007/s11904-996-0005-2




PubMed


 


PubMed ID 16091245
    
     


 



4.
Krupica T, Fry TJ, Mackall CL (2006). Autoimmunity during lymphopenia: a two-hit model. Clin Immunol  120, 121-8.   https://doi.org/10.1016/j.clim.2006.04.569




PubMed


 


PubMed ID 16766227
    
     


 



5.
Lucas PJ, Kim SJ, Mackall CL, Telford WG, Chu YW, Hakim FT, Gress RE (2006). Dysregulation of IL-15-mediated T-cell homeostasis in TGF-beta dominant-negative receptor transgenic mice. Blood  108, 2789-95.   https://doi.org/10.1182/blood-2006-05-025676




PubMed



        
     
Free Article


 


PubMed ID 16788095
         Pubmed Central ID 1895588 


 



6.
Snyder KM, Mackall CL, Fry TJ (2006). IL-7 in allogeneic transplant: clinical promise and potential pitfalls. Leuk Lymphoma  47, 1222-8.   https://doi.org/10.1080/10428190600555876




PubMed


 


PubMed ID 16923550
    
     


 



7.
Zhang H, Chua KS, Guimond M, Kapoor V, Brown MV, Fleisher TA, Long LM, Bernstein D, Hill BJ, Douek DC, Berzofsky JA, Carter CS, Read EJ, Helman LJ, Mackall CL (2005). Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells. Nat Med  11, 1238-43.   https://doi.org/10.1038/nm1312




PubMed


 


PubMed ID 16227988",https://intramural.nih.gov/search/searchview.taf?ipid=44121
573,SC010282-09,"October 01, 2005 -  September 30, 2006",Cytogenetic Studies of B-cell Chronic Lymphocytic Leukemia (B-CLL),Diane Carol Arthur; MD,NULL,"Laboratory of Pathology, NCI","Shannon I Skarshaug



Alexander Cm Smith",NULL,"Michael R Bishop; MD (National Cancer Institute)



Daniel H Fowler (National Cancer Institute)



Maryalice  Stetler-Stevenson; MD, PhD (National Cancer Institute)



Neil Edward Caporaso; MS, MD (National Cancer Institute)



Jorge R Toro (National Cancer Institute)



Wyndham H Wilson; MD, PhD (National Cancer Institute)","Adrian U Wiestner; MD, PhD (NHLBI) 



Gerald Ernest Marti (OD)","Ordered by publication type and then author name.



1.
Arthur D, Toure O, Wei M, Abbasi F, Fontaine L, Marti G, Fraumeni, Jr. J, Goldin L, Caporaso N, Toro J   (2006) Identification of a novel chromosome region 13q2133-q222 for susceptibility genes in familial chronic lymphocytic leukemia.  Blood, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=44122
574,SC010288-09,"October 01, 2005 -  September 30, 2006",Th1Th2 and Tc1Tc2 T Cell Subsets in Transplantation Therapy,Daniel H Fowler,NULL,"Experimental Transplantation and Immunology Branch, NCI","J  Foley



Jacopo  Mariotti



Elaine  Wong","Carl  June
(Abramson Family Cancer Research Institute, University of Penn)




Bruce  Levine
(Abramson Family Cancer Research Center, University of Pennsylvania)","Frances  Hakim; PhD (National Cancer Institute)



Ronald E Gress; MD (National Cancer Institute)



Michael R Bishop; MD (National Cancer Institute)



Steven  Pavletic; MD, MS (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Foley JE, Jung U, Miera A, Borenstein T, Mariotti J, Eckhaus M, Bierer BE, Fowler DH (2005). Ex vivo rapamycin generates donor Th2 cells that potently inhibit graft-versus-host disease and graft-versus-tumor effects via an IL-4-dependent mechanism. J Immunol  175, 5732-43.   https://doi.org/10.4049/jimmunol.175.9.5732




PubMed


 


PubMed ID 16237064
    
     


 



2.
Fowler D, Foley J, Erdmann A, Toda Y, Borenstein T, Mariotti J   (2006) Ex vivo rapamycin generates TH1/Tc1 or Th2/Tc2 effector T cells with enhanced in vivo funcion and differential sensitivity to post-transplant rapmycin therapy.  Biology of Blood and Marrow Transplantation  905-918 pp.




 



3.
Fowler D, Steinberg S, Chow C, Foley J, Kogan Y, Hou J, Gea-Banacloche J, Sportes C, Pavletic S, Leitman S, Read E, Carter C, Kolstad A, Fox R, Beatty G, Vonderheide R, Levine B, June C, Gress R, Bishop M   (2006) Phase I Clinical Trial of Co-stimulated, IL-4 Polarized Donor CD4+ T Cells as Augmentation of Allogeneic Hematopoietic Cell Transplantation.  Biology of Blood and Marrow Transplantation, in press.




 



4.
Fowler DH (2006). Shared biology of GVHD and GVT effects: potential methods of separation. Crit Rev Oncol Hematol  57, 225-44.   https://doi.org/10.1016/j.critrevonc.2005.07.001




PubMed


 


PubMed ID 16207532",https://intramural.nih.gov/search/searchview.taf?ipid=44123
575,SC010289-08,"October 01, 2005 -  September 30, 2006",Immunobiology and Immunotherapy of Pediatric Tumors,Crystal L. Mackall; MD,NULL,"Pediatric Oncology Branch, NCI","Kevin  Chua



Hua  Zhang



Terry J Fry



Kristen M Snyder



David  Grindler



Sarah G Herby



Show all 7","Nai-Kong  Cheung
(Memorial Sloan Kettering Cancer Center)




Carl  June
(Abramson Cancer Center, University of Pennsylvania)




Melinda S Merchant





Robert  Vonderheide
(UNIVERSITY OF PENNSYLVANIA)","Lee Jay Helman; MD (National Cancer Institute)



Javed  Khan; MD (National Cancer Institute)



Carol J Thiele (National Cancer Institute)



Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)",Elizabeth J Read; MD (CC),"Ordered by publication type and then author name.



1.
Mackall CL, Rhee EH, Read EJ, Khuu HM, Leitman SF, Bernstein D, Tesso M, Long LM, Grindler D, Merino M, Kopp W, Tsokos M, Berzofsky JA, Helman LJ (2008). A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas. Clin Cancer Res  14, 4850-8.   https://doi.org/10.1158/1078-0432.CCR-07-4065




PubMed



        
     
Free Article


 


PubMed ID 18676758
         Pubmed Central ID 2497450 


 



2.
Terabe M, Khanna C, Bose S, Melchionda F, Mendoza A, Mackall CL, Helman LJ, Berzofsky JA (2006). CD1d-restricted natural killer T cells can down-regulate tumor immunosurveillance independent of interleukin-4 receptor-signal transducer and activator of transcription 6 or transforming growth factor-beta. Cancer Res  66, 3869-75.   https://doi.org/10.1158/0008-5472.CAN-05-3421




PubMed


 


PubMed ID 16585215
    
     


 



3.
van den Broeke LT, Pendleton CD, Mackall C, Helman LJ, Berzofsky JA (2006). Identification and epitope enhancement of a PAX-FKHR fusion protein breakpoint epitope in alveolar rhabdomyosarcoma cells created by a tumorigenic chromosomal translocation inducing CTL capable of lysing human tumors. Cancer Res  66, 1818-23.   https://doi.org/10.1158/0008-5472.CAN-05-2549




PubMed


 


PubMed ID 16452243
    
     


 



4.
Wiener L, Battles H, Bernstein D, Long L, Derdak J, Mackall CL, Mansky PJ (2006). Persistent psychological distress in long-term survivors of pediatric sarcoma: the experience at a single institution. Psychooncology  15, 898-910.   https://doi.org/10.1002/pon.1024




PubMed



        
     
Free Article


 


PubMed ID 16402373
         Pubmed Central ID 2289870",https://intramural.nih.gov/search/searchview.taf?ipid=44124
576,SC010292-08,"October 01, 2005 -  September 30, 2006",Identification and regulation of signal transduction pathways that promote survi,"Phillip A Dennis; MD, PhD",NULL,"Medical Oncology Branch, NCI","Chunyu  Zhang



Joell J Gills



Courtney A Granville



Wei  Han



Noel Andrew Warfel



Jaminelli J Liwanag","Vali  Egilsson
(Pathology, University of Iceland)




William  Travis
(Pathology, Memorial Sloan Kettering Cancer Center)","Ilona  Linnoila; MD (National Cancer Institute)



Stephen M Hewitt; MD, PhD (National Cancer Institute)



Curtis  Harris; MD (National Cancer Institute)



William D Figg; PharmD (National Cancer Institute)



Joanna H Shih (National Cancer Institute)



Frederic  Kaye; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Dennis PA, Van Waes C, Gutkind JS, Kellar KJ, Vinson C, Mukhin AG, Spitz MR, Bailey-Wilson JE, Yeh GC, Anderson LM, Wiest JS (2005). The biology of tobacco and nicotine: bench to bedside. Cancer Epidemiol Biomarkers Prev  14, 764-7.   https://doi.org/10.1158/1055-9965.EPI-04-0652




PubMed



        
     
Free Article


 


PubMed ID 15824140
         Pubmed Central ID 3459058 


 



2.
Granville CA, Dennis PA (2005). An overview of lung cancer genomics and proteomics. Am J Respir Cell Mol Biol  32, 169-76.   https://doi.org/10.1165/rcmb.F290




PubMed


 


PubMed ID 15713815
    
     


 



3.
Li Z, Jaboin J, Dennis PA, Thiele CJ (2005). Genetic and pharmacologic identification of Akt as a mediator of brain-derived neurotrophic factor/TrkB rescue of neuroblastoma cells from chemotherapy-induced cell death. Cancer Res  65, 2070-5.   https://doi.org/10.1158/0008-5472.CAN-04-3606




PubMed


 


PubMed ID 15781614
    
     


 



4.
Tsurutani J, Fukuoka J, Tsurutani H, Shih JH, Hewitt SM, Travis WD, Jen J, Dennis PA (2006). Evaluation of two phosphorylation sites improves the prognostic significance of Akt activation in non-small-cell lung cancer tumors. J Clin Oncol  24, 306-14.   https://doi.org/10.1200/JCO.2005.02.4133




PubMed


 


PubMed ID 16330671
    
     


 



5.
Tsurutani J, West KA, Sayyah J, Gills JJ, Dennis PA (2005). Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy. Cancer Res  65, 8423-32.   https://doi.org/10.1158/0008-5472.CAN-05-0058




PubMed


 


PubMed ID 16166321",https://intramural.nih.gov/search/searchview.taf?ipid=44125
577,SC010298-08,"October 01, 2005 -  September 30, 2006",Identification of Chromosomal Aberrations in HematologicalEpithelial Cancers,"Karl Thomas Ried; MD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Michael John Difilippantonio; PhD



Buddy  Chen



Nicole E Mcneil



Hesed M Padilla Nash



Linda I Stapleton



Damrong M Wangsa



Show all 8",NULL,"Siegfried  Janz; MD, DSc (National Cancer Institute)



Andre A Nussenzweig; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bowen TJ, Yakushiji H, Montagna C, Jain S, Ried T, Wynshaw-Boris A (2005). Atm heterozygosity cooperates with loss of Brca1 to increase the severity of mammary gland cancer and reduce ductal branching. Cancer Res  65, 8736-46.   https://doi.org/10.1158/0008-5472.CAN-05-1598




PubMed


 


PubMed ID 16204043
    
     


 



2.
Han SS, Shaffer AL, Peng L, Chung ST, Lim JH, Maeng S, Kim JS, McNeil N, Ried T, Staudt LM, Janz S (2005). Molecular and cytological features of the mouse B-cell lymphoma line iMycEmu-1. Mol Cancer  4, 40.   https://doi.org/10.1186/1476-4598-4-40




PubMed



        
     
Free Article


 


PubMed ID 16277667
         Pubmed Central ID 1298327 


 



3.
Knutsen T, Gobu V, Knaus R, Padilla-Nash H, Augustus M, Strausberg RL, Kirsch IR, Sirotkin K, Ried T (2005). The interactive online SKY/M-FISH & CGH database and the Entrez cancer chromosomes search database: linkage of chromosomal aberrations with the genome sequence. Genes Chromosomes Cancer  44, 52-64.   https://doi.org/10.1002/gcc.20224




PubMed



        
     
Free Article


 


PubMed ID 15934046
         Pubmed Central ID 1224735",https://intramural.nih.gov/search/searchview.taf?ipid=44127
578,SC010299-08,"October 01, 2005 -  September 30, 2006",Consequences of Chromosomal Aneuploidy on the Cancer Transcriptome,"Karl Thomas Ried; MD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Michael John Difilippantonio; PhD



Buddy  Chen



Nicole E Mcneil



Hesed M Padilla Nash



Linda I Stapleton



Damrong M Wangsa



Show all 9","Gert  Auer





Michael  Ghadimi
(Surgery, U. of Goettingen)","Siegfried  Janz; MD, DSc (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Desper R, Difilippantonio MJ, Ried T, Schäffer AA (2005). A comprehensive continuous-time model for the appearance of CGH signal due to chromosomal missegregations during mitosis. Math Biosci  197, 67-87.   https://doi.org/10.1016/j.mbs.2005.05.005




PubMed



        
     
Free Article


 


PubMed ID 16043196
         Pubmed Central ID 1356526 


 



2.
Focarelli ML, Montagna C, Colombo R, Ried T, Vezzoni P, Musio A (2006). SMC1 inhibition results in FRA3B expression but has no effect on its delayed replication. Mutat Res  595, 23-8.   https://doi.org/10.1016/j.mrfmmm.2005.09.002




PubMed


 


PubMed ID 16242161
    
     


 



3.
Grade M, Ghadimi BM, Varma S, Simon R, Wangsa D, Barenboim-Stapleton L, Liersch T, Becker H, Ried T, Difilippantonio MJ (2006). Aneuploidy-dependent massive deregulation of the cellular transcriptome and apparent divergence of the Wnt/beta-catenin signaling pathway in human rectal carcinomas. Cancer Res  66, 267-82.   https://doi.org/10.1158/0008-5472.CAN-05-2533




PubMed



               Available in future as a Free Article 


 


PubMed ID 16397240
         Pubmed Central ID 4737482 


 



4.
Jang W, Yonescu R, Knutsen T, Brown T, Reppert T, Sirotkin K, Schuler GD, Ried T, Kirsch IR (2006). Linking the human cytogenetic map with nucleotide sequence: the CCAP clone set. Cancer Genet Cytogenet  168, 89-97.   https://doi.org/10.1016/j.cancergencyto.2006.01.001




PubMed


 


PubMed ID 16843097
    
     


 



5.
Knutsen T, Gobu V, Knaus R, Padilla-Nash H, Augustus M, Strausberg RL, Kirsch IR, Sirotkin K, Ried T (2005). The interactive online SKY/M-FISH & CGH database and the Entrez cancer chromosomes search database: linkage of chromosomal aberrations with the genome sequence. Genes Chromosomes Cancer  44, 52-64.   https://doi.org/10.1002/gcc.20224




PubMed



        
     
Free Article


 


PubMed ID 15934046
         Pubmed Central ID 1224735 


 



6.
Mazumdar M, Lee JH, Sengupta K, Ried T, Rane S, Misteli T (2006). Tumor formation via loss of a molecular motor protein. Curr Biol  16, 1559-64.   https://doi.org/10.1016/j.cub.2006.06.029




PubMed



        
     
Free Article


 


PubMed ID 16890532
         Pubmed Central ID 1853379 


 



7.
Miura M, Miura Y, Padilla-Nash HM, Molinolo AA, Fu B, Patel V, Seo BM, Sonoyama W, Zheng JJ, Baker CC, Chen W, Ried T, Shi S (2006). Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells  24, 1095-103.   https://doi.org/10.1634/stemcells.2005-0403




PubMed


 


PubMed ID 16282438
    
     


 



8.
Musio A, Montagna C, Mariani T, Tilenni M, Focarelli ML, Brait L, Indino E, Benedetti PA, Chessa L, Albertini A, Ried T, Vezzoni P (2005). SMC1 involvement in fragile site expression. Hum Mol Genet  14, 525-33.   https://doi.org/10.1093/hmg/ddi049




PubMed


 


PubMed ID 15640246",https://intramural.nih.gov/search/searchview.taf?ipid=44128
579,SC010300-08,"October 01, 2005 -  September 30, 2006",Translational Genomics,"Karl Thomas Ried; MD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Buddy  Chen



Linda I Stapleton



Tom  Ellerman



Amanda  Hummon



Starsha N Valentine","Gert  Auer





Michael  Ghadimi
(Surgery, U. of Goettingen)",Kerstin  Heselmeyer (Cancer Genetics Branch),NULL,"Ordered by publication type and then author name.



1.
Andersson S, Wallin KL, Hellström AC, Morrison LE, Hjerpe A, Auer G, Ried T, Larsson C, Heselmeyer-Haddad K (2006). Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas. Br J Cancer  95, 331-8.   https://doi.org/10.1038/sj.bjc.6603253




PubMed



        
     
Free Article


 


PubMed ID 16847471
         Pubmed Central ID 2360637 


 



2.
Grade M, Becker H, Liersch T, Ried T, Ghadimi BM (2006). Molecular cytogenetics: genomic imbalances in colorectal cancer and their clinical impact. Cell Oncol  28, 71-84.   https://doi.org/10.1155/2006/173815




PubMed



        
     
Free Article


 


PubMed ID 16823176
         Pubmed Central ID 4615150 


 



3.
Grade M, Ghadimi BM, Varma S, Simon R, Wangsa D, Barenboim-Stapleton L, Liersch T, Becker H, Ried T, Difilippantonio MJ (2006). Aneuploidy-dependent massive deregulation of the cellular transcriptome and apparent divergence of the Wnt/beta-catenin signaling pathway in human rectal carcinomas. Cancer Res  66, 267-82.   https://doi.org/10.1158/0008-5472.CAN-05-2533




PubMed



               Available in future as a Free Article 


 


PubMed ID 16397240
         Pubmed Central ID 4737482 


 



4.
Helou K, Padilla-Nash H, Wangsa D, Karlsson E, Osterberg L, Karlsson P, Ried T, Knutsen T (2006). Comparative genome hybridization reveals specific genomic imbalances during the genesis from benign through borderline to malignant ovarian tumors. Cancer Genet Cytogenet  170, 1-8.   https://doi.org/10.1016/j.cancergencyto.2006.04.010




PubMed


 


PubMed ID 16965948
    
     


 



5.
Knutsen T, Gobu V, Knaus R, Padilla-Nash H, Augustus M, Strausberg RL, Kirsch IR, Sirotkin K, Ried T (2005). The interactive online SKY/M-FISH & CGH database and the Entrez cancer chromosomes search database: linkage of chromosomal aberrations with the genome sequence. Genes Chromosomes Cancer  44, 52-64.   https://doi.org/10.1002/gcc.20224




PubMed



        
     
Free Article


 


PubMed ID 15934046
         Pubmed Central ID 1224735 


 



6.
Kronenwett U, Huwendiek S, Castro J, Ried T, Auer G (2005). Characterisation of breast fine-needle aspiration biopsies by centrosome aberrations and genomic instability. Br J Cancer  92, 389-95.   https://doi.org/10.1038/sj.bjc.6602246




PubMed



        
     
Free Article


 


PubMed ID 15558069
         Pubmed Central ID 2361862 


 



7.
Rao VK, Wangsa D, Robey RW, Huff L, Honjo Y, Hung J, Knutsen T, Ried T, Bates SE (2005). Characterization of ABCG2 gene amplification manifesting as extrachromosomal DNA in mitoxantrone-selected SF295 human glioblastoma cells. Cancer Genet Cytogenet  160, 126-33.   https://doi.org/10.1016/j.cancergencyto.2004.12.013




PubMed


 


PubMed ID 15993268",https://intramural.nih.gov/search/searchview.taf?ipid=44129
580,SC010353-07,"October 01, 2005 -  September 30, 2006",Experimental Therapeutics of Pediatric Hematopoietic Malignancies,Alan S Wayne; MD,NULL,"Pediatric Oncology Branch, NCI","Cynthia P Love



Paula K Layton



Kristin  Baird","Robert  Arceci
(Pediatric Hematology-Oncology, Johns Hopkins University)




Civin  Curt
(Pediatric Oncology, Johns Hopkins University)




Harry  Findley
(Pediatric Hematology-Oncology, Emory University/AFLAC Cancer Center)




Sima  Jeha
(Pediatric Oncology, St Jude Children's Cancer Research Hospital)




Glen  Lew
(Pediatric Hematology-Oncology, Emory University/AFLAC Cancer Center)




David  Loeb
(Pediatric Hematology-Oncology, Johns Hopkins University)


Show all 8","Michael R Bishop; MD (National Cancer Institute)



Nealapheur L Khan (National Cancer Institute)



Maryalice  Stetler-Stevenson; MD, PhD (National Cancer Institute)



Diane Carol Arthur; MD (National Cancer Institute)



Ira H Pastan; MD (National Cancer Institute)



Robert J Kreitman; MD, PhD (National Cancer Institute)","Austin John Barrett; MD (NHLBI) 



Charles  Bolan; BS, MS, MD (CC) 



Roger  Kurlander; MD (CC) 



Elizabeth J Read; MD (CC)","Ordered by publication type and then author name.



1.
Couriel D, Carpenter PA, Cutler C, Bolaños-Meade J, Treister NS, Gea-Banacloche J, Shaughnessy P, Hymes S, Kim S, Wayne AS, Chien JW, Neumann J, Mitchell S, Syrjala K, Moravec CK, Abramovitz L, Liebermann J, Berger A, Gerber L, Schubert M, Filipovich AH, Weisdorf D, Schubert MM, Shulman H, Schultz K, et al. [6 more authors] (2006). Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant  12, 375-96.   https://doi.org/10.1016/j.bbmt.2006.02.003




PubMed


 


PubMed ID 16545722
    
     


 



2.
Yamashita K, Horwitz ME, Kwatemaa A, Nomicos E, Castro K, Sokolic R, Foster SF, Garofalo M, Choi U, Ryherd M, Brown MR, Leitman SF, Wayne AS, Fowler DH, Bishop MR, Childs RW, Barrett AJ, Pavletic SZ, Malech HL (2006). Unique abnormalities of CD4(+) and CD8(+) central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis. Biol Blood Marrow Transplant  12, 22-30.   https://doi.org/10.1016/j.bbmt.2005.11.004




PubMed


 


PubMed ID 16399598",https://intramural.nih.gov/search/searchview.taf?ipid=44130
581,SC010354-07,"October 01, 2005 -  September 30, 2006",Clinical Development of Novel Drugs for Children with Cancer and Neurofibromatos,"Brigitte  Widemann; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI",NULL,"Peter Charles Adamson; MD





Robert  Arceci
(Pediatric Oncology, Johns Hopkins)




Dusica  Babovic-Vuksanovich
(Genetics, Mayo-Clinic)




Larry  Baker
(Oncology, SARC)




Jean  Belasco
(Neurooncology, Children's Hospital of Philadelphia)




Susan  Blaney
(Pediatric Oncology, Texas Children's Cancer Center)


Show all 22","Katherine Elizabeth Warren; MD (National Cancer Institute)



Pamela  Wolters (National Cancer Institute)



Thomas J Hornyak (National Cancer Institute)



Antonio  Fojo; MD, PhD (National Cancer Institute)","Ann M Cohen-Berger; MD (CC) 



Nicholas  Patronas; MD (CC) 



Douglas Russell Stewart; BA, MD (NHGRI) 



Scott Mitchell Paul; MD (CC) 



Constantine Argyrios Stratakis; MD, DSc (NICHD) 



Jeffrey M Solomon; BS, MS, PhD (CC)","Ordered by publication type and then author name.



1.
Fox E, Maris JM, Widemann BC, Meek K, Goodwin A, Goodspeed W, Kromplewski M, Fouts ME, Medina D, Cho SY, Cohn SL, Krivoshik A, Hagey AE, Adamson PC, Balis FM (2006). A phase 1 study of ABT-751, an orally bioavailable tubulin inhibitor, administered daily for 7 days every 21 days in pediatric patients with solid tumors. Clin Cancer Res  12, 4882-7.   https://doi.org/10.1158/1078-0432.CCR-06-0534




PubMed


 


PubMed ID 16914576
    
     


 



2.
Widemann B, Dombi E, Gillespie A, Wolters P, Toledo-Tamula M, O'Neil B, Fox E, MacDonald T, Beck H, Packer R   (2006) Phase I trial of pirfenidone in children with neurofibromatosis type 1 (NF1) and plexiform neurofibromas PN).  J Pediatr Neurology, in press.




 



3.
Widemann B, Solomon J, Gillespie A, Fox E, Balis F, Patronas N, Korf B, Babovic D, Packer R, Belasco J, Goldman S, Jakacki R, Kieran M, Steinberg S   (2006) Plexiform neurofibroma growth rate by volumetric MRI: Relationship to age and body weight.  Neuorlogy, in press.




 



4.
Widemann BC, Adamson PC (2006). Understanding and managing methotrexate nephrotoxicity. Oncologist  11, 694-703.   https://doi.org/10.1634/theoncologist.11-6-694




PubMed


 


PubMed ID 16794248
    
     


 



5.
Widemann BC, Salzer WL, Arceci RJ, Blaney SM, Fox E, End D, Gillespie A, Whitcomb P, Palumbo JS, Pitney A, Jayaprakash N, Zannikos P, Balis FM (2006). Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas. J Clin Oncol  24, 507-16.   https://doi.org/10.1200/JCO.2005.03.8638




PubMed


 


PubMed ID 16421428",https://intramural.nih.gov/search/searchview.taf?ipid=44131
582,SC010355-07,"October 01, 2005 -  September 30, 2006",Angiogenesis and Tumor Growth,"Giovanna  Tosato; PhD



IRP Faculty Profile",NULL,"Basic Research Laboratory, NCI","Takayuki  Nakayama



Masashi  Narazaki



Cassin Elizabeth Kimmel; BS



Bernhard  Lange-Asschenfeldt



Taeko  Ishii



Peter J Mccormick",NULL,"Robert  Yarchoan; MD (National Cancer Institute)



David A Davis; MD (National Cancer Institute)","Joshua  Farber; MD (NIAID) 



Henry M. Fales; PhD (NHLBI)","Ordered by publication type and then author name.



1.
Nakayama T, Mutsuga N, Yao L, Tosato G (2006). Prostaglandin E2 promotes degranulation-independent release of MCP-1 from mast cells. J Leukoc Biol  79, 95-104.   https://doi.org/10.1189/jlb.0405226




PubMed


 


PubMed ID 16275896
    
     


 



2.
Narazaki M, Tosato G (2006). Canstatin: an inhibitor of angiogenesis and tumor growth revisited. Cancer J  12, 110-2.




PubMed


 


PubMed ID 16630401
    
     


 



3.
Narazaki M, Tosato G (2006). Conflicting results from clinical observations and murine models: what is the role of plasminogen activators in tumor growth? J Natl Cancer Inst  98, 726-7.   https://doi.org/10.1093/jnci/djj227




PubMed


 


PubMed ID 16757692
    
     


 



4.
Narazaki M, Tosato G (2006). Ligand-induced internalization selects use of common receptor neuropilin-1 by VEGF165 and semaphorin3A. Blood  107, 3892-901.   https://doi.org/10.1182/blood-2005-10-4113




PubMed



        
     
Free Article


 


PubMed ID 16424390
         Pubmed Central ID 1895286 


 



5.
Narazaki M, Tosato G (2006). Tumor cell populations differ in angiogenic activity: a model system for spontaneous angiogenic switch can tell us why. J Natl Cancer Inst  98, 294-5.   https://doi.org/10.1093/jnci/djj099




PubMed


 


PubMed ID 16507821
    
     


 



6.
Salvucci O, de la Luz Sierra M, Martina JA, McCormick PJ, Tosato G (2006). EphB2 and EphB4 receptors forward signaling promotes SDF-1-induced endothelial cell chemotaxis and branching remodeling. Blood  108, 2914-22.   https://doi.org/10.1182/blood-2006-05-023341




PubMed



        
     
Free Article


 


PubMed ID 16840724
         Pubmed Central ID 1895526",https://intramural.nih.gov/search/searchview.taf?ipid=44132
583,SC010356-07,"October 01, 2005 -  September 30, 2006",A Role for KSHV in the Pathogenesis of Malignancies,"Giovanna  Tosato; PhD



IRP Faculty Profile",NULL,"Basic Research Laboratory, NCI","Maria N Labo



Paola  Gasperini



Peter J Mccormick",NULL,"Robert  Yarchoan; MD (National Cancer Institute)



Seth M Steinberg; PhD (National Cancer Institute)



Richard  Little; MD, PhD (National Cancer Institute)



David A Davis; MD (National Cancer Institute)



Wyndham H Wilson; MD, PhD (National Cancer Institute)","Joshua  Farber; MD (NIAID) 



Henry M. Fales; PhD (NHLBI)","Ordered by publication type and then author name.



1.
Kim HK, De La Luz Sierra M, Williams CK, Gulino AV, Tosato G (2006). G-CSF down-regulation of CXCR4 expression identified as a mechanism for mobilization of myeloid cells. Blood  108, 812-20.   https://doi.org/10.1182/blood-2005-10-4162




PubMed



        
     
Free Article


 


PubMed ID 16537807
         Pubmed Central ID 1895847 


 



2.
Little RF, Pluda JM, Wyvill KM, Rodriguez-Chavez IR, Tosato G, Catanzaro AT, Steinberg SM, Yarchoan R (2006). Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcoma. Blood  107, 4650-7.   https://doi.org/10.1182/blood-2005-11-4455




PubMed



        
     
Free Article


 


PubMed ID 16507779
         Pubmed Central ID 1475826",https://intramural.nih.gov/search/searchview.taf?ipid=44133
584,SC010357-07,"October 01, 2005 -  September 30, 2006",Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses,"Zhi Ming  Zheng; MD, PhD



IRP Faculty Profile",NULL,"HIV and AIDS Malignancy Branch, NCI","Shuang  Tang



Vladimir  Majerciak



Rong  Jia



Natalia Sergeevna Pripuzova



Xiaohong  Wang","Elliot  Androphy
(Medicine, University of Massachusetts Medical School)




Shou-Jiang  Gao
(University of Texas)




Craig  Meyers
(Microbiology and Immunology, Penn State University College of Medicine)




Janet  Rader
(Gynercology, Washington University)",Robert  Yarchoan; MD (National Cancer Institute),John Philip McCoy (NHLBI),"Ordered by publication type and then author name.



1.
Bodaghi S, Wood LV, Roby G, Ryder C, Steinberg SM, Zheng ZM (2005). Could human papillomaviruses be spread through blood? J Clin Microbiol  43, 5428-34.   https://doi.org/10.1128/JCM.43.11.5428-5434.2005




PubMed



        
     
Free Article


 


PubMed ID 16272465
         Pubmed Central ID 1287818 


 



2.
Bodaghi S, Yamanegi K, Xiao SY, Da Costa M, Palefsky JM, Zheng ZM (2005). Colorectal papillomavirus infection in patients with colorectal cancer. Clin Cancer Res  11, 2862-7.   https://doi.org/10.1158/1078-0432.CCR-04-1680




PubMed



        
     
Free Article


 


PubMed ID 15837733
         Pubmed Central ID 1479314 


 



3.
Haque M, Wang V, Davis DA, Zheng ZM, Yarchoan R (2006). Genetic organization and hypoxic activation of the Kaposi's sarcoma-associated herpesvirus ORF34-37 gene cluster. J Virol  80, 7037-51.   https://doi.org/10.1128/JVI.00553-06




PubMed



        
     
Free Article


 


PubMed ID 16809309
         Pubmed Central ID 1489055 


 



4.
Majerciak V, Yamanegi K, Nie SH, Zheng ZM (2006). Structural and functional analyses of Kaposi sarcoma-associated herpesvirus ORF57 nuclear localization signals in living cells. J Biol Chem  281, 28365-78.   https://doi.org/10.1074/jbc.M603095200




PubMed


 


PubMed ID 16829516
    
     


 



5.
Tang S, Tao M, McCoy JP, Zheng ZM (2006). Short-term induction and long-term suppression of HPV16 oncogene silencing by RNA interference in cervical cancer cells. Oncogene  25, 2094-104.   https://doi.org/10.1038/sj.onc.1209244




PubMed



        
     
Free Article


 


PubMed ID 16369495
         Pubmed Central ID 1800826 


 



6.
Tang S, Tao M, McCoy JP, Zheng ZM (2006). The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation. J Virol  80, 4249-63.   https://doi.org/10.1128/JVI.80.9.4249-4263.2006




PubMed



        
     
Free Article


 


PubMed ID 16611884
         Pubmed Central ID 1472016 


 



7.
Yamanegi K, Tang S, Zheng ZM (2005). Kaposi's sarcoma-associated herpesvirus K8beta is derived from a spliced intermediate of K8 pre-mRNA and antagonizes K8alpha (K-bZIP) to induce p21 and p53 and blocks K8alpha-CDK2 interaction. J Virol  79, 14207-21.   https://doi.org/10.1128/JVI.79.22.14207-14221.2005




PubMed



        
     
Free Article


 


PubMed ID 16254356
         Pubmed Central ID 1280184 


 



8.
Zheng ZM, Baker CC (2006). Papillomavirus genome structure, expression, and post-transcriptional regulation. Front Biosci  11, 2286-302.   https://doi.org/10.2741/1971




PubMed



        
     
Free Article


 


PubMed ID 16720315
         Pubmed Central ID 1472295",https://intramural.nih.gov/search/searchview.taf?ipid=44134
585,SC010360-08,"October 01, 2005 -  September 30, 2006",Determinants of Chromosome Transmission and Cell Cycle Regulation in Yeast,"Munira A Basrai; PhD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Wei-Chun  Au



Ayca  Akal-strader



Suveena  Sharma; PhD



Matthew  Crisp","Jef  Boeke
(Molecular Biology and Genetics, The Johns Hopkins School of Medicine)




Ron  Davis
(Biochemistry and Genome Technology Center, Stanford University)




Michael  Snyder
(Molecular, Cellular and Developmental Biology, Yale University)




Forrest  Spencer
(Mol Biol and Genetics, The Johns Hopkins School of Medicine)




Mark  Winey
(Mol. Cell and Dev. Biology, Univ. of Colorado)




Richard  Wozniak
(Cell Biology, Univ. of Alberta)",Michael Joseph Lichten; PhD (National Cancer Institute),"Alexander V Strunnikov; PhD (NICHD) 



Alison Anne McBride; PhD (NIAID)","Ordered by publication type and then author name.



1.
Carter CD, Kitchen LE, Au WC, Babic CM, Basrai MA (2005). Loss of SOD1 and LYS7 sensitizes Saccharomyces cerevisiae to hydroxyurea and DNA damage agents and downregulates MEC1 pathway effectors. Mol Cell Biol  25, 10273-85.   https://doi.org/10.1128/MCB.25.23.10273-10285.2005




PubMed



        
     
Free Article


 


PubMed ID 16287844
         Pubmed Central ID 1291217 


 



2.
Kastenmayer JP, Ni L, Chu A, Kitchen LE, Au WC, Yang H, Carter CD, Wheeler D, Davis RW, Boeke JD, Snyder MA, Basrai MA (2006). Functional genomics of genes with small open reading frames (sORFs) in S. cerevisiae. Genome Res  16, 365-73.   https://doi.org/10.1101/gr.4355406




PubMed



        
     
Free Article


 


PubMed ID 16510898
         Pubmed Central ID 1415214",https://intramural.nih.gov/search/searchview.taf?ipid=44136
586,SC010364-06,"October 01, 2005 -  September 30, 2006",Tissue Microarray Design and Development for Novel Gene and Gene Product Screeni,"David Erwin Kleiner; MD, PhD",Elaine S Jaffe; MD,"Laboratory of Pathology, NCI","Stephen M Hewitt; MD, PhD



Kimberly  Tuttle



Langston  Lim",NULL,"Phillip A Dennis; MD, PhD (National Cancer Institute)



Philip  Taylor; MD, ScD (National Cancer Institute)



Michael R Emmert-Buck; MD, PhD (National Cancer Institute)



Nealapheur L Khan (National Cancer Institute)



Mark E Sherman; MD (National Cancer Institute)



Montserrat  Garcia-Closas; MD, PhD (National Cancer Institute)","Ira W Levin; PhD (NIDDK) 



Robert  Star; MD (NIDDK)","Ordered by publication type and then author name.



1.
Bhargava R, Fernandez DC, Hewitt SM, Levin IW (2006). High throughput assessment of cells and tissues: Bayesian classification of spectral metrics from infrared vibrational spectroscopic imaging data. Biochim Biophys Acta  1758, 830-45.   https://doi.org/10.1016/j.bbamem.2006.05.007




PubMed


 


PubMed ID 16822477
    
     


 



2.
Braunschweig T, Chung JY, Hewitt SM (2005). Tissue microarrays: bridging the gap between research and the clinic. Expert Rev Proteomics  2, 325-36.   https://doi.org/10.1586/14789450.2.3.325




PubMed


 


PubMed ID 16000080
    
     


 



3.
Chung JY, Braunschweig T, Baibakov G, Galperin M, Ramesh A, Skacel M, Gannot G, Knezevic V, Hewitt SM (2006). Transfer and multiplex immunoblotting of a paraffin embedded tissue. Proteomics  6, 767-74.   https://doi.org/10.1002/pmic.200401343




PubMed


 


PubMed ID 16400680
    
     


 



4.
Chung JY, Braunschweig T, Hu N, Roth M, Traicoff JL, Wang QH, Knezevic V, Taylor PR, Hewitt SM   (2006) A multiplex tissue immunoblotting assay for proteomic profiling: a pilot study of the normal to tumor transition of esophageal squamous cell carcinoma.  Cancer Epidemiol Biomarkers Prev 15:1403-8.




PubMed


 


PubMed ID 16835344
    
     


 



5.
Dear JW, Yasuda H, Hu X, Hieny S, Yuen PS, Hewitt SM, Sher A, Star RA (2006). Sepsis-induced organ failure is mediated by different pathways in the kidney and liver: acute renal failure is dependent on MyD88 but not renal cell apoptosis. Kidney Int  69, 832-6.   https://doi.org/10.1038/sj.ki.5000165




PubMed



        
     
Free Article


 


PubMed ID 16518342
         Pubmed Central ID 2271059 


 



6.
Elaraj DM, Weinreich DM, Varghese S, Puhlmann M, Hewitt SM, Carroll NM, Feldman ED, Turner EM, Alexander HR   (2006) The role of interleukin 1 in growth and metastasis of human cancer xenografts.  Clin Cancer Res 12:1088-96.




PubMed


 


PubMed ID 16489061
    
     


 



7.
Gannot G, Tangrea MA, Richardson AM, Flaig MJ, Hewitt SM, Marcus EM, Emmert-Buck MR, Chuaqui RF (2007). Layered expression scanning: multiplex molecular analysis of diverse life science platforms. Clin Chim Acta  376, 9-16.   https://doi.org/10.1016/j.cca.2006.08.007




PubMed


 


PubMed ID 16996046
    
     


 



8.
Hewitt SM   (2006) The application of tissue microarrays in the validation of microarray results.  Methods Enzymol 410:400-15.




PubMed


 


PubMed ID 16938563
    
     


 



9.
Holly MK, Dear JW, Hu X, Schechter AN, Gladwin MT, Hewitt SM, Yuen PS, Star RA (2006). Biomarker and drug-target discovery using proteomics in a new rat model of sepsis-induced acute renal failure. Kidney Int  70, 496-506.   https://doi.org/10.1038/sj.ki.5001575




PubMed



        
     
Free Article


 


PubMed ID 16760904
         Pubmed Central ID 2276658 


 



10.
Rabinovich A, Krajewski S, Krajewska M, Shabaik A, Hewitt SM, Belongie S, Reed JC, Price JH   (2006) Framework for parsing, visualizing and scoring tissue microarray images.  IEEE Trans Inf Technol Biomed 10:209-19.




PubMed


 


PubMed ID 16617609
    
     


 



11.
Tsurutani J, Fukuoka J, Tsurutani H, Shih JH, Hewitt SM, Travis WD, Jen J, Dennis PA (2006). Evaluation of two phosphorylation sites improves the prognostic significance of Akt activation in non-small-cell lung cancer tumors. J Clin Oncol  24, 306-14.   https://doi.org/10.1200/JCO.2005.02.4133




PubMed


 


PubMed ID 16330671
    
     


 



12.
Wang Y, Hewitt SM, Liu S, Zhou X, Zhu H, Zhou C, Zhang G, Quan L, Bai J, Xu N   (2006) Tissue microarray analysis of human FRAT1 expression and its correlation with the subcellular localisation of beta-catenin in ovarian tumours.  Br J Cancer 94:686-91.




PubMed



        
     
Free Article


 


PubMed ID 16479254
         Pubmed Central ID 2361213 


 



13.
Wedam SB, Low JA, Yang SX, Chow CK, Choyke P, Danforth D, Hewitt SM, Berman A, Steinberg SM, Liewehr DJ, Plehn J, Doshi A, Thomasson D, McCarthy N, Koeppen H, Sherman M, Zujewski J, Camphausen K, Chen H, Swain SM (2006). Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer. J Clin Oncol  24, 769-77.   https://doi.org/10.1200/JCO.2005.03.4645




PubMed


 


PubMed ID 16391297
    
     


 



14.
Yang XR, Charette LA, Garcia-Closas M, Lissowska J, Paal E, Sidawy M, Hewitt SM, Rimm DL, Sherman ME (2006). Construction and validation of tissue microarrays of ductal carcinoma in situ and terminal duct lobular units associated with invasive breast carcinoma. Diagn Mol Pathol  15, 157-61.   https://doi.org/10.1097/01.pdm.0000213453.45398.e0




PubMed


 


PubMed ID 16932071
    
     


 



15.
Zhu Y, Singh B, Hewitt S, Liu A, Gomez B, Wang A, Clarke R (2006). Expression patterns among interferon regulatory factor-1, human X-box binding protein-1, nuclear factor kappa B, nucleophosmin, estrogen receptor-alpha and progesterone receptor proteins in breast cancer tissue microarrays. Int J Oncol  28, 67-76.




PubMed


 


PubMed ID 16327981",https://intramural.nih.gov/search/searchview.taf?ipid=44054
587,SC010365-07,"October 01, 2005 -  September 30, 2006",Optimizing the Graft-Versus-Tumor Effect in Allogeneic HSTC,Michael R Bishop; MD,NULL,"Experimental Transplantation and Immunology Branch, NCI","Nancy M Hardy



Jennifer Sproul Wilder","Sergio  Giralt
(M.D. ANDERSON CANCER CENTER)




Carl  June
(University of Pennsylvania)




Larry  Kwak
(NCI)




Sattva  Neelapu
(M.D. ANDERSON CANCER CENTER)","Daniel H Fowler (National Cancer Institute)



Ronald E Gress; MD (National Cancer Institute)



Crystal L. Mackall; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bevans MF, Marden S, Leidy NK, Soeken K, Cusack G, Rivera P, Mayberry H, Bishop MR, Childs R, Barrett AJ (2006). Health-related quality of life in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant  38, 101-9.   https://doi.org/10.1038/sj.bmt.1705406




PubMed


 


PubMed ID 16751786
    
     


 



2.
Hardy NM, Fowler DH, Bishop MR (2006). Immunotherapy of metastatic breast cancer: phase I trail of reduced-intensity allogeneic hematopoietic stem cell transplantation with Th2/Tc2 T-cell exchange. Clin Breast Cancer  7, 87-9.   https://doi.org/10.3816/cbc.2006.n.019




PubMed


 


PubMed ID 16764750
    
     


 



3.
O'Mahony D, Bishop MR (2006). Monoclonal antibody therapy. Front Biosci  11, 1620-35.   https://doi.org/10.2741/1909




PubMed


 


PubMed ID 16368542
    
     


 



4.
Pavletic SZ, Smith LM, Bishop MR, Lynch JC, Tarantolo SR, Vose JM, Bierman PJ, Hadi A, Armitage JO, Kessinger A (2005). Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation. Am J Hematol  78, 265-74.   https://doi.org/10.1002/ajh.20275




PubMed


 


PubMed ID 15795914
    
     


 



5.
Tallman MS, Pérez WS, Lazarus HM, Gale RP, Maziarz RT, Rowe JM, Marks DI, Cahn JY, Bashey A, Bishop MR, Christiansen N, Frankel SR, García JJ, Ilhan O, Laughlin MJ, Liesveld J, Linker C, Litzow MR, Luger S, McCarthy PL, Milone GA, Pavlovsky S, Phillips GL, Russell JA, Saez RA, et al. [8 more authors] (2006). Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission. Biol Blood Marrow Transplant  12, 204-16.   https://doi.org/10.1016/j.bbmt.2005.10.013




PubMed


 


PubMed ID 16443518
    
     


 



6.
Yamashita K, Horwitz ME, Kwatemaa A, Nomicos E, Castro K, Sokolic R, Foster SF, Garofalo M, Choi U, Ryherd M, Brown MR, Leitman SF, Wayne AS, Fowler DH, Bishop MR, Childs RW, Barrett AJ, Pavletic SZ, Malech HL (2006). Unique abnormalities of CD4(+) and CD8(+) central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis. Biol Blood Marrow Transplant  12, 22-30.   https://doi.org/10.1016/j.bbmt.2005.11.004




PubMed


 


PubMed ID 16399598",https://intramural.nih.gov/search/searchview.taf?ipid=44138
588,SC010366-06,"October 01, 2005 -  September 30, 2006",Identification of Genes for Predicting Prognosis in Pediatric Cancers,"Javed  Khan; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Branch, NCI","Jun S Wei



Sven  Bilke



Qingrong  Chen



Young K Song



Quangeng  Zhang



Xinyu  Wen



Show all 7","John  Maris
(Pharmacology, Children's Hospital of Philadelphia)




Andrew  Pearson
(Paediatric Section, Institute of Cancer Research)




Manfred  Schwab
(Division Tumour Genetics, German Cancer Research Center)",NULL,NULL,"Ordered by publication type and then author name.



1.
Chen QR, Bilke S, Wei JS, Greer BT, Steinberg SM, Westermann F, Schwab M, Khan J (2006). Increased WSB1 copy number correlates with its over-expression which associates with increased survival in neuroblastoma. Genes Chromosomes Cancer  45, 856-62.   https://doi.org/10.1002/gcc.20349




PubMed


 


PubMed ID 16804916
    
     


 



2.
Henrich KO, Fischer M, Mertens D, Benner A, Wiedemeyer R, Brors B, Oberthuer A, Berthold F, Wei JS, Khan J, Schwab M, Westermann F (2006). Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients. Clin Cancer Res  12, 131-8.   https://doi.org/10.1158/1078-0432.CCR-05-1431




PubMed


 


PubMed ID 16397034",https://intramural.nih.gov/search/searchview.taf?ipid=44139
589,SC010367-06,"October 01, 2005 -  September 30, 2006",Regulation of the cell cycle by cyclin-dependent kinases,Philipp  Kaldis; PhD,NULL,"Mouse Cancer Genetics Program, NCI","Cyril  Berthet



Kristy L Mcdowell



Weimin  Li



Shuhei  Kotoshiba","Hiroaki  Kiyokawa
(Molecular Pharmacology and Biological Chemistry, Northwestern University The Feinberg School of Medicine)




Keiichi  Nakayama
(Molecular and Cellular Biology, Division of Cell Biology, Kyushu University)




Neil  Segil
(Cell and Molecular Biology, House Ear Institute)",Jonathan  Keller; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Aleem E, Kaldis P (2006). Mouse models of cell cycle regulators: new paradigms. Results Probl Cell Differ  42, 271-328.   https://doi.org/10.1007/400_023




PubMed


 


PubMed ID 16903215
    
     


 



2.
Berthet C, Kaldis P (2006). Cdk2 and Cdk4 cooperatively control the expression of Cdc2. Cell Div  1, 10.   https://doi.org/10.1186/1747-1028-1-10




PubMed



        
     
Free Article


 


PubMed ID 16759374
         Pubmed Central ID 1524953 


 



3.
Berthet C, Klarmann KD, Hilton MB, Suh HC, Keller JR, Kiyokawa H, Kaldis P (2006). Combined loss of Cdk2 and Cdk4 results in embryonic lethality and Rb hypophosphorylation. Dev Cell  10, 563-73.   https://doi.org/10.1016/j.devcel.2006.03.004




PubMed


 


PubMed ID 16678773
    
     


 



4.
Kaldis P, Aleem E (2005). Cell cycle sibling rivalry: Cdc2 vs. Cdk2. Cell Cycle  4, 1491-4.   https://doi.org/10.4161/cc.4.11.2124




PubMed


 


PubMed ID 16258277",https://intramural.nih.gov/search/searchview.taf?ipid=44140
590,SC010368-06,"October 01, 2005 -  September 30, 2006",Targeting the Tumor Vasculature to Treat Cancer,Steven  Libutti; MD,NULL,"Surgery Branch, NCI","Dominique  Lorang; PhD



Anita T Tandle



Geoffrey D Seidel



Mei  He



David P Mangiameli



Yvonne  Shutack



Show all 15","Wadih  Arap





Renata  Pasqualini
(Urology, MD Anderson)




David  Stirling
(R&D, Celgene Corporation)




Lawrence  Tamarkin
(President, Cytimmune Sciences)","Maryalice  Stetler-Stevenson; MD, PhD (National Cancer Institute)



William G Stetler-Stevenson; MD, PhD (National Cancer Institute)



Michael R Emmert-Buck; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Farma JM, Pingpank JF, Libutti SK, Bartlett DL, Ohl S, Beresneva T, Alexander HR (2005). Limited survival in patients with carcinomatosis from foregut malignancies after cytoreduction and continuous hyperthermic peritoneal perfusion. J Gastrointest Surg  9, 1346-53.   https://doi.org/10.1016/j.gassur.2005.06.016




PubMed


 


PubMed ID 16332493
    
     


 



2.
Grover AC, Skarulis M, Alexander HR, Pingpank JF, Javor ED, Chang R, Shawker T, Gorden P, Cochran C, Libutti SK (2005). A prospective evaluation of laparoscopic exploration with intraoperative ultrasound as a technique for localizing sporadic insulinomas. Surgery  138, 1003-8; discussion 1008.   https://doi.org/10.1016/j.surg.2005.09.017




PubMed


 


PubMed ID 16360384
    
     


 



3.
Grover AC, Tangrea MA, Woodson KG, Wallis BS, Hanson JC, Chuaqui RF, Gillespie JW, Erickson HS, Bonner RF, Pohida TJ, Emmert-Buck MR, Libutti SK (2006). Tumor-associated endothelial cells display GSTP1 and RARbeta2 promoter methylation in human prostate cancer. J Transl Med  4, 13.   https://doi.org/10.1186/1479-5876-4-13




PubMed



        
     
Free Article


 


PubMed ID 16512911
         Pubmed Central ID 1420331 


 



4.
Hanson JA, Gillespie JW, Grover A, Tangrea MA, Chuaqui RF, Emmert-Buck MR, Tangrea JA, Libutti SK, Linehan WM, Woodson KG (2006). Gene promoter methylation in prostate tumor-associated stromal cells. J Natl Cancer Inst  98, 255-61.   https://doi.org/10.1093/jnci/djj051




PubMed


 


PubMed ID 16478744
    
     


 



5.
Koch CA, Brouwers FM, Vortmeyer AO, Tannapfel A, Libutti SK, Zhuang Z, Pacak K, Neumann HP, Paschke R (2006). Somatic VHL gene alterations in MEN2-associated medullary thyroid carcinoma. BMC Cancer  6, 131.   https://doi.org/10.1186/1471-2407-6-131




PubMed



        
     
Free Article


 


PubMed ID 16707008
         Pubmed Central ID 1483898 


 



6.
Kwon M, Libutti SK (2006). Advances in understanding angiogenesis through molecular studies. Int J Radiat Oncol Biol Phys  64, 26-32.   https://doi.org/10.1016/j.ijrobp.2005.03.024




PubMed


 


PubMed ID 16377412
    
     


 



7.
Libutti SK, Alexander HR (2006). Gastrinoma: sporadic and familial disease. Surg Oncol Clin N Am  15, 479-96.   https://doi.org/10.1016/j.soc.2006.05.001




PubMed


 


PubMed ID 16882493
    
     


 



8.
Sudheendra D, Neeman Z, Kam A, Locklin J, Libutti SK, Wood BJ (2006). Intermittent hepatic vein balloon occlusion during radiofrequency ablation in the liver. Cardiovasc Intervent Radiol  29, 1088-92.   https://doi.org/10.1007/s00270-006-0040-9




PubMed



        
     
Free Article


 


PubMed ID 16967215
         Pubmed Central ID 2374752 


 



9.
Tang JS, Choy G, Bernardo M, Thomasson D, Libutti SK, Choyke PL (2006). Dynamic contrast-enhanced magnetic resonance imaging in the assessment of early response to tumor necrosis factor alpha in a colon carcinoma model. Invest Radiol  41, 691-6.   https://doi.org/10.1097/01.rli.0000233882.83800.fb




PubMed


 


PubMed ID 16896304",https://intramural.nih.gov/search/searchview.taf?ipid=44141
591,SC010370-06,"October 01, 2005 -  September 30, 2006",Comparative Genomics of Genes Located on Chromosomes X and Y,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI","Warren  Johnson



Alfred L Roca



Jill  Slattery



Joan  Pontius



Carrie  Mccracken



Lucy  Bill",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
O'Brien S, Roelke M, Marker L, Pecon-Slattery J   (2006) Plagues and adaptation: Lessions from the Felidae models for SARS and AIDS.  Biological Conservation, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=44142
592,SC010371-06,"October 01, 2005 -  September 30, 2006",Mechanisms of Tumor Escape and Metastatic Development in Mouse Models of Experim,Scott  Abrams; PhD,NULL,"Laboratory of Tumor Immunology and Biology, NCI","Trina J Stewart



Kristy M Greeneltch



Monika  Schneider","Kebin  Liu
(Biochemistry & Molecular Biology, Medical College of Georgia)




Michail  Sitkovsky
(Biology & Pharmaceutical Sciences, Northeastern Univ)","James W Hodge; PhD (National Cancer Institute)



Philip M Arlen; MD (National Cancer Institute)



Kevin A Camphausen; MD (National Cancer Institute)",Richard  Childs; MD (NHLBI),"Ordered by publication type and then author name.



1.
Liu K, Caldwell SA, Greeneltch KM, Yang D, Abrams SI (2006). CTL adoptive immunotherapy concurrently mediates tumor regression and tumor escape. J Immunol  176, 3374-82.   https://doi.org/10.4049/jimmunol.176.6.3374




PubMed


 


PubMed ID 16517705",https://intramural.nih.gov/search/searchview.taf?ipid=44143
593,SC010372-06,"October 01, 2005 -  September 30, 2006",Molecular profiling of patients undergoing radiotherapy,"Kevin A Camphausen; MD



IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI","Mary T Sproull



Robert J Surawski



Michael  Klodnicki",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44144
594,SC010373-06,"October 01, 2005 -  September 30, 2006",The synergy between radiotherapy and molecularly targeted agents,"Kevin A Camphausen; MD



IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI","Mary T Sproull



Tamalee  Scott



Merriline M Satyamitra",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Ahlers CM, Camphausen K, Citrin D, Arlen PM, Gulley JL (2006). A pilot trial of a carcinoembryonic antigen/ TRICOM-based vaccine and radiation to liver metastases in patients with carcinoembryonic antigen-positive solid tumors. Clin Colorectal Cancer  6, 72-5.   https://doi.org/10.3816/CCC.2006.n.025




PubMed


 


PubMed ID 16796796
    
     


 



2.
Barker CA, Burgan WE, Carter DJ, Cerna D, Gius D, Hollingshead MG, Camphausen K, Tofilon PJ (2006). In vitro and in vivo radiosensitization induced by the ribonucleotide reductase inhibitor Triapine (3-aminopyridine-2-carboxaldehyde-thiosemicarbazone). Clin Cancer Res  12, 2912-8.   https://doi.org/10.1158/1078-0432.CCR-05-2860




PubMed


 


PubMed ID 16675588
    
     


 



3.
Camphausen K, Cerna D, Scott T, Sproull M, Burgan WE, Cerra MA, Fine H, Tofilon PJ (2005). Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid. Int J Cancer  114, 380-6.   https://doi.org/10.1002/ijc.20774




PubMed


 


PubMed ID 15578701
    
     


 



4.
Camphausen K, Purow B, Sproull M, Scott T, Ozawa T, Deen DF, Tofilon PJ (2005). Influence of in vivo growth on human glioma cell line gene expression: convergent profiles under orthotopic conditions. Proc Natl Acad Sci U S A  102, 8287-92.   https://doi.org/10.1073/pnas.0502887102




PubMed



        
     
Free Article


 


PubMed ID 15928080
         Pubmed Central ID 1142119 


 



5.
Cerna D, Camphausen K, Tofilon PJ (2006). Histone deacetylation as a target for radiosensitization. Curr Top Dev Biol  73, 173-204.   https://doi.org/10.1016/S0070-2153(05)73006-4




PubMed


 


PubMed ID 16782459
    
     


 



6.
Citrin D, Ménard C, Camphausen K (2006). Combining radiotherapy and angiogenesis inhibitors: clinical trial design. Int J Radiat Oncol Biol Phys  64, 15-25.   https://doi.org/10.1016/j.ijrobp.2005.03.065




PubMed


 


PubMed ID 16377411
    
     


 



7.
de la Peña L, Burgan WE, Carter DJ, Hollingshead MG, Satyamitra M, Camphausen K, Tofilon PJ (2006). Inhibition of Akt by the alkylphospholipid perifosine does not enhance the radiosensitivity of human glioma cells. Mol Cancer Ther  5, 1504-10.   https://doi.org/10.1158/1535-7163.MCT-06-0091




PubMed


 


PubMed ID 16818509
    
     


 



8.
Dote H, Cerna D, Burgan WE, Camphausen K, Tofilon PJ (2005). ErbB3 expression predicts tumor cell radiosensitization induced by Hsp90 inhibition. Cancer Res  65, 6967-75.   https://doi.org/10.1158/0008-5472.CAN-05-1304




PubMed


 


PubMed ID 16061682
    
     


 



9.
Dote H, Cerna D, Burgan WE, Carter DJ, Cerra MA, Hollingshead MG, Camphausen K, Tofilon PJ (2005). Enhancement of in vitro and in vivo tumor cell radiosensitivity by the DNA methylation inhibitor zebularine. Clin Cancer Res  11, 4571-9.   https://doi.org/10.1158/1078-0432.CCR-05-0050




PubMed


 


PubMed ID 15958643
    
     


 



10.
Gulley JL, Arlen PM, Bastian A, Morin S, Marte J, Beetham P, Tsang KY, Yokokawa J, Hodge JW, Ménard C, Camphausen K, Coleman CN, Sullivan F, Steinberg SM, Schlom J, Dahut W (2005). Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer. Clin Cancer Res  11, 3353-62.   https://doi.org/10.1158/1078-0432.CCR-04-2062




PubMed


 


PubMed ID 15867235
    
     


 



11.
Hassan R, Williams-Gould J, Steinberg SM, Liewehr DJ, Yokokawa J, Tsang KY, Surawski RJ, Scott T, Camphausen K (2006). Tumor-directed radiation and the immunotoxin SS1P in the treatment of mesothelin-expressing tumor xenografts. Clin Cancer Res  12, 4983-8.   https://doi.org/10.1158/1078-0432.CCR-06-0441




PubMed


 


PubMed ID 16914588
    
     


 



12.
Kudo-Saito C, Schlom J, Camphausen K, Coleman CN, Hodge JW (2005). The requirement of multimodal therapy (vaccine, local tumor radiation, and reduction of suppressor cells) to eliminate established tumors. Clin Cancer Res  11, 4533-44.   https://doi.org/10.1158/1078-0432.CCR-04-2237




PubMed


 


PubMed ID 15958639
    
     


 



13.
Lü X, de la Peña L, Barker C, Camphausen K, Tofilon PJ (2006). Radiation-induced changes in gene expression involve recruitment of existing messenger RNAs to and away from polysomes. Cancer Res  66, 1052-61.   https://doi.org/10.1158/0008-5472.CAN-05-3459




PubMed


 


PubMed ID 16424041
    
     


 



14.
Reits EA, Hodge JW, Herberts CA, Groothuis TA, Chakraborty M, Wansley EK, Camphausen K, Luiten RM, de Ru AH, Neijssen J, Griekspoor A, Mesman E, Verreck FA, Spits H, Schlom J, van Veelen P, Neefjes JJ (2006). Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J Exp Med  203, 1259-71.   https://doi.org/10.1084/jem.20052494




PubMed



        
     
Free Article


 


PubMed ID 16636135
         Pubmed Central ID 3212727",https://intramural.nih.gov/search/searchview.taf?ipid=44145
595,SC010375-06,"October 01, 2005 -  September 30, 2006",Regulation of TAFI Activity by TAF7,"Dinah  Singer; PhD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI",Jocelyn D Weissman,NULL,John N Brady; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=44146
596,SC010376-06,"October 01, 2005 -  September 30, 2006",Molecular mechanism of TNF signaling and apoptosis,"Zhenggang  Liu; PhD



IRP Faculty Profile",NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI","Swati Suresh Choksi



You Sun  Kim



Michael J Morgan



Peter S Levitt



Elena  Pobezinskaya",NULL,Leonard  Neckers; PhD (National Cancer Institute),Chung  Park (NIAID),"Ordered by publication type and then author name.



1.
Shen H, Z-G L   (2006) Oxidative stress, JNK activation and Cell death, in The JNK signaling pathway. Landes Bioscience (Georgetown, Texas), pp. 73-82.




 



2.
Grivennikov SI, Kuprash DV, Liu ZG, Nedospasov SA (2006). Intracellular signals and events activated by cytokines of the tumor necrosis factor superfamily: From simple paradigms to complex mechanisms. Int Rev Cytol  252, 129-61.   https://doi.org/10.1016/S0074-7696(06)52002-9




PubMed


 


PubMed ID 16984817
    
     


 



3.
Hur GM, Kim YS, Won M, Choksi S, Liu ZG (2006). The death domain kinase RIP has an important role in DNA damage-induced, p53-independent cell death. J Biol Chem  281, 25011-7.   https://doi.org/10.1074/jbc.M605577200




PubMed


 


PubMed ID 16825191
    
     


 



4.
Lin Y, Yang Q, Wang X, Liu ZG (2006). The essential role of the death domain kinase receptor-interacting protein in insulin growth factor-I-induced c-Jun N-terminal kinase activation. J Biol Chem  281, 23525-32.   https://doi.org/10.1074/jbc.M601487200




PubMed


 


PubMed ID 16793775
    
     


 



5.
Shen HM, Liu ZG (2006). JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species. Free Radic Biol Med  40, 928-39.   https://doi.org/10.1016/j.freeradbiomed.2005.10.056




PubMed


 


PubMed ID 16540388
    
     


 



6.
Yang Q, Kim YS, Lin Y, Lewis J, Neckers L, Liu ZG (2006). Tumour necrosis factor receptor 1 mediates endoplasmic reticulum stress-induced activation of the MAP kinase JNK. EMBO Rep  7, 622-7.   https://doi.org/10.1038/sj.embor.7400687




PubMed



        
     
Free Article


 


PubMed ID 16680093
         Pubmed Central ID 1479600",https://intramural.nih.gov/search/searchview.taf?ipid=44147
597,SC010378-06,"October 01, 2005 -  September 30, 2006",Activation of Proto-Oncogenes by Chromosomal Translocation,"Peter D Aplan; MD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Zhenhua  Zhang



Christopher  Slape



David L Caudell



Yang-Jo  Chung



Helge  Hartung","Adolfo  Ferrando
(Genetics, Columbia U.)




Theresa  Hahn
(Medicine, Roswell Park Cancer Institute)




Trang  Hoang
(Immunology, U. Montreal)




Christoph  Plass
(Genetics, Ohio State Univ.)




Armelle  Regnault
(Hematology, Hopital St. Louis)




Linda  Resar
(Johns Hopkins)","John J Letterio; MD (National Cancer Institute)



Lino  Tessarollo (National Cancer Institute)



Linda  Wolff; PhD (National Cancer Institute)","Paul P. Liu; MD, PhD (NHGRI)","Ordered by publication type and then author name.



1.
Fiorentino S, Chopin M, Dastot H, Boissel N, Reboul M, Legrès L, Janin A, Aplan P, Sigaux F, Regnault A (2005). Disruption of T cell regulatory pathways is necessary for immunotherapeutic cure of T cell acute lymphoblastic leukemia in mice. Eur Cytokine Netw  16, 300-8.




PubMed


 


PubMed ID 16464745
    
     


 



2.
Lin YW, Nichols RA, Letterio JJ, Aplan PD (2006). Notch1 mutations are important for leukemic transformation in murine models of precursor-T leukemia/lymphoma. Blood  107, 2540-3.   https://doi.org/10.1182/blood-2005-07-3013




PubMed



        
     
Free Article


 


PubMed ID 16282337
         Pubmed Central ID 1414627",https://intramural.nih.gov/search/searchview.taf?ipid=44148
598,SC010379-06,"October 01, 2005 -  September 30, 2006",Mechanisms of Chromosomal Translocation,"Peter D Aplan; MD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Zhenhua  Zhang



Yue  Cheng



Bridget P Keenan",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Aplan PD (2006). Causes of oncogenic chromosomal translocation. Trends Genet  22, 46-55.   https://doi.org/10.1016/j.tig.2005.10.002




PubMed



        
     
Free Article


 


PubMed ID 16257470
         Pubmed Central ID 1762911 


 



2.
Aplan PD (2006). Chromosomal translocations involving the MLL gene: molecular mechanisms. DNA Repair (Amst)  5, 1265-72.   https://doi.org/10.1016/j.dnarep.2006.05.034




PubMed



        
     
Free Article


 


PubMed ID 16797254
         Pubmed Central ID 1635494 


 



3.
Cheng Y, Zhang Z, Slape C, Aplan PD (2007). Cre-loxP-mediated recombination between the SIL and SCL genes leads to a block in T-cell development at the CD4- CD8- to CD4+ CD8+ transition. Neoplasia  9, 315-21.   https://doi.org/10.1593/neo.07148




PubMed



        
     
Free Article


 


PubMed ID 17460775
         Pubmed Central ID 1854848",https://intramural.nih.gov/search/searchview.taf?ipid=44149
599,SC010384-06,"October 01, 2005 -  September 30, 2006",Hematopoietic Stem Cell Gene Therapy for Leukocyte Adhesion Deficiency,"Dennis D Hickstein



IRP Faculty Profile",NULL,"Experimental Transplantation and Immunology Branch, NCI","Thomas R Bauer



Yuchen  Gu



Mehreen  Hai","Alan W Flake; MD
(Department of Surgery, Children's Hospital of Philadelphia)




David W Russell",NULL,NULL,"Ordered by publication type and then author name.



1.
Bauer TR, Hai M, Tuschong LM, Burkholder TH, Gu YC, Sokolic RA, Ferguson C, Dunbar CE, Hickstein DD (2006). Correction of the disease phenotype in canine leukocyte adhesion deficiency using ex vivo hematopoietic stem cell gene therapy. Blood  108, 3313-20.   https://doi.org/10.1182/blood-2006-03-006908




PubMed



        
     
Free Article


 


PubMed ID 16868255
         Pubmed Central ID 1895427 


 



2.
Burkholder TH, Colenda L, Tuschong LM, Starost MF, Bauer TR, Hickstein DD (2006). Reproductive capability in dogs with canine leukocyte adhesion deficiency treated with nonmyeloablative conditioning prior to allogeneic hematopoietic stem cell transplantation. Blood  108, 1767-9.   https://doi.org/10.1182/blood-2006-02-005645




PubMed



        
     
Free Article


 


PubMed ID 16645166
         Pubmed Central ID 1553182 


 



3.
Engel ME, Hickstein DD, Bauer TR, Calder C, Manes B, Frangoul H (2006). Matched unrelated bone marrow transplantation with reduced-intensity conditioning for leukocyte adhesion deficiency. Bone Marrow Transplant  37, 717-8.   https://doi.org/10.1038/sj.bmt.1705301




PubMed


 


PubMed ID 16489359
    
     


 



4.
Gu YC, Bauer TR, Sokolic RA, Hai M, Tuschong LM, Burkholder T, Bacher J, Starost MF, Hickstein DD (2006). Conversion of the severe to the moderate disease phenotype with donor leukocyte microchimerism in canine leukocyte adhesion deficiency. Bone Marrow Transplant  37, 607-14.   https://doi.org/10.1038/sj.bmt.1705291




PubMed


 


PubMed ID 16444276
    
     


 



5.
Sokolic RA, Bauer TR, Gu YC, Hai M, Tuschong LM, Burkholder T, Colenda L, Bacher J, Starost MF, Hickstein DD (2005). Nonmyeloablative conditioning with busulfan before matched littermate bone marrow transplantation results in reversal of the disease phenotype in canine leukocyte adhesion deficiency. Biol Blood Marrow Transplant  11, 755-63.   https://doi.org/10.1016/j.bbmt.2005.07.011




PubMed



        
     
Free Article


 


PubMed ID 16182176
         Pubmed Central ID 1351378",https://intramural.nih.gov/search/searchview.taf?ipid=44152
600,SC010385-07,"October 01, 2005 -  September 30, 2006",Molecular Classification of Human and Mouse Hepatocellular Carcinoma by Gene Exp,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI","Timothy V Benjamin



Elizabeth A Conner



Anita  Ton



Tanya N Hoang



Pal  Kaposi-Novak



Joe W Grisham



Show all 7","Ghassan  Abou-Alfa
(Gastrointestinal Medical Oncology, Memorial Sloan-Kettering Cancer Center)




Diego F Calvisi
(NCI)




Anthony  Demetris
(Transplantation Pathology, University of Pittsburgh Medical Center)




JeanFranois  Dufour
(Clinical Pharmacology, University of Bern)




Nelson  Fausto
(Pathology, University of Washington School of Medicine)




Scott  Friedman
(Division of Liver Diseases, Mount Sinai School of Medicine)


Show all 10","Valentina  Factor (Cellular and Molecular Biology Section)



Frank Jess Gonzalez; PhD (National Cancer Institute)



Udai S Kammula (National Cancer Institute)



Steven Aaron Rosenberg; MD, PhD (National Cancer Institute)



Curtis  Harris; MD (National Cancer Institute)



Douglas  Lowy; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Calvisi DF, Ladu S, Gorden A, Farina M, Conner EA, Lee JS, Factor VM, Thorgeirsson SS (2006). Ubiquitous activation of Ras and Jak/Stat pathways in human HCC. Gastroenterology  130, 1117-28.   https://doi.org/10.1053/j.gastro.2006.01.006




PubMed


 


PubMed ID 16618406
    
     


 



2.
Kaposi-Novak P, Lee JS, Gòmez-Quiroz L, Coulouarn C, Factor VM, Thorgeirsson SS (2006). Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype. J Clin Invest  116, 1582-95.   https://doi.org/10.1172/JCI27236




PubMed



        
     
Free Article


 


PubMed ID 16710476
         Pubmed Central ID 1462944 


 



3.
Lee JS, Heo J, Libbrecht L, Chu IS, Kaposi-Novak P, Calvisi DF, Mikaelyan A, Roberts LR, Demetris AJ, Sun Z, Nevens F, Roskams T, Thorgeirsson SS (2006). A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med  12, 410-6.   https://doi.org/10.1038/nm1377




PubMed


 


PubMed ID 16532004
    
     


 



4.
Lee JS, Thorgeirsson SS (2005). Genetic profiling of human hepatocellular carcinoma. Semin Liver Dis  25, 125-32.   https://doi.org/10.1055/s-2005-871192




PubMed


 


PubMed ID 15918141
    
     


 



5.
Lee JS, Thorgeirsson SS (2006). Comparative and integrative functional genomics of HCC. Oncogene  25, 3801-9.   https://doi.org/10.1038/sj.onc.1209561




PubMed


 


PubMed ID 16799621
    
     


 



6.
Martin J, Magnino F, Schmidt K, Piguet AC, Lee JS, Semela D, St-Pierre MV, Ziemiecki A, Cassio D, Brenner C, Thorgeirsson SS, Dufour JF (2006). Hint2, a mitochondrial apoptotic sensitizer down-regulated in hepatocellular carcinoma. Gastroenterology  130, 2179-88.   https://doi.org/10.1053/j.gastro.2006.03.024




PubMed



        
     
Free Article


 


PubMed ID 16762638
         Pubmed Central ID 2569837 


 



7.
Pascale RM, Simile MM, Calvisi DF, Frau M, Muroni MR, Seddaiu MA, Daino L, Muntoni MD, De Miglio MR, Thorgeirsson SS, Feo F   (2005) Role of HSP90, CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer.  Hepatology 42:1310-9.




PubMed


 


PubMed ID 16317707
    
     


 



8.
Takami T, Terai S, Yokoyama Y, Tanimoto H, Tajima K, Uchida K, Yamasaki T, Sakaida I, Nishina H, Thorgeirsson SS, Okita K (2005). Human homologue of maid is a useful marker protein in hepatocarcinogenesis. Gastroenterology  128, 1369-80.   https://doi.org/10.1053/j.gastro.2005.03.014




PubMed


 


PubMed ID 15887118
    
     


 



9.
Thorgeirsson SS, Lee JS, Grisham JW (2006). Functional genomics of hepatocellular carcinoma. Hepatology  43, S145-50.   https://doi.org/10.1002/hep.21063




PubMed


 


PubMed ID 16447291
    
     


 



10.
Thorgeirsson SS, Lee JS, Grisham JW (2006). Molecular prognostication of liver cancer: end of the beginning. J Hepatol  44, 798-805.   https://doi.org/10.1016/j.jhep.2006.01.008




PubMed


 


PubMed ID 16488507",https://intramural.nih.gov/search/searchview.taf?ipid=44153
601,SC010386-05,"October 01, 2005 -  September 30, 2006","Crystallographic Studies of Chemokines, Chemokine Receptors, and Related Protein",Jacek Tadeusz Lubkowski,NULL,"Macromolecular Crystallography Laboratory, NCI",Marzena E Pazgier,NULL,"Joost J Oppenheim; MD (National Cancer Institute)



Douglas  Lowy; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Buck CB, Day PM, Thompson CD, Lubkowski J, Lu W, Lowy DR, Schiller JT (2006). Human alpha-defensins block papillomavirus infection. Proc Natl Acad Sci U S A  103, 1516-21.   https://doi.org/10.1073/pnas.0508033103




PubMed



        
     
Free Article


 


PubMed ID 16432216
         Pubmed Central ID 1360544 


 



2.
Pazgier M, Hoover DM, Yang D, Lu W, Lubkowski J (2006). Human beta-defensins. Cell Mol Life Sci  63, 1294-313.   https://doi.org/10.1007/s00018-005-5540-2




PubMed


 


PubMed ID 16710608
    
     


 



3.
Pazgier M, Lubkowski J (2006). Expression and purification of recombinant human alpha-defensins in Escherichia coli. Protein Expr Purif  49, 1-8.   https://doi.org/10.1016/j.pep.2006.05.004




PubMed


 


PubMed ID 16839776",https://intramural.nih.gov/search/searchview.taf?ipid=44155
602,SC010437-06,"October 01, 2005 -  September 30, 2006",Molecular Pathology of Cancer,"Michael R Emmert-Buck; MD, PhD",NULL,"Laboratory of Pathology, NCI",NULL,NULL,"William Marston Linehan; MD (National Cancer Institute)



Philip  Taylor; MD, ScD (National Cancer Institute)



Karen  Woodson (National Cancer Institute)



Steven  Libutti; MD (National Cancer Institute)



Maria  Merino; PhD (National Cancer Institute)



William D Figg; PharmD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Grover AC, Tangrea MA, Woodson KG, Wallis BS, Hanson JC, Chuaqui RF, Gillespie JW, Erickson HS, Bonner RF, Pohida TJ, Emmert-Buck MR, Libutti SK (2006). Tumor-associated endothelial cells display GSTP1 and RARbeta2 promoter methylation in human prostate cancer. J Transl Med  4, 13.   https://doi.org/10.1186/1479-5876-4-13




PubMed



        
     
Free Article


 


PubMed ID 16512911
         Pubmed Central ID 1420331 


 



2.
Hanson JA, Gillespie JW, Grover A, Tangrea MA, Chuaqui RF, Emmert-Buck MR, Tangrea JA, Libutti SK, Linehan WM, Woodson KG (2006). Gene promoter methylation in prostate tumor-associated stromal cells. J Natl Cancer Inst  98, 255-61.   https://doi.org/10.1093/jnci/djj051




PubMed


 


PubMed ID 16478744
    
     


 



3.
Hu N, Su H, Li WJ, Giffen C, Goldstein AM, Hu Y, Wang C, Roth MJ, Li G, Dawsey SM, Xu Y, Taylor PR, Emmert-Buck MR (2005). Allelotyping of esophageal squamous-cell carcinoma on chromosome 13 defines deletions related to family history. Genes Chromosomes Cancer  44, 271-8.   https://doi.org/10.1002/gcc.20242




PubMed


 


PubMed ID 16015646",https://intramural.nih.gov/search/searchview.taf?ipid=44156
